Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.6936630832095514,2.3130496811359547,0.0,0.0,0.0,59/121,20.46%,EPHA7;FEZF2;PCDH8;ANK2;SOX5;FUT9;CADM2;SNAP91;ATP2B3;LSAMP;LHX6;ASCL1;CAMKV;ADGRB3;ADGRL3;AMER2;RBFOX1;STIM2;CACNA1B;UNC79;NOL4;SLC35F1;KIF5A;CTNNA2;ROBO1;HIVEP2;PPFIA2;NRXN1;NPAS3;LRRC4C;ADGRA1;KCNQ2;ASTN1;OLFM3;MAPK4;PAK3;NF1;CELF3;GPM6B;SLITRK1;KIF1B;ERC2;BCL2;ELAVL3;PURG;CSRNP3;PCLO;OPCML;CTNND2;DPYSL5;NOVA1;NTRK3;NOVA2;FAT3;GRIA2;UNC13A;POU3F2;CLVS2;VSTM2A
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.703503176472491,2.2375121665526483,0.0,0.0,0.0,42/101,21.02%,GABRG1;FUT9;SNAP91;ATP2B3;LSAMP;GLS;PSD2;AMER2;RBFOX1;GRIN1;CACNA1B;UNC79;NOL4;CACNG3;KCTD16;CTNNA2;CAMK2A;PPFIA2;NRXN1;ADGRA1;ASTN1;OLFM3;MEIS2;CELF3;SLITRK1;TMEM196;CA10;GRM1;MAGI2;TRPM3;ELAVL3;CSRNP3;KCNC2;OPCML;GRIN2B;NTRK3;GRIA2;UNC13A;CLVS2;VSTM2A;PHYHIPL;SLC6A1
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.5892883912750446,2.0851510670634044,0.0,0.012962322848254406,0.02,46/146,12.82%,TAFA1;MAPK10;TUB;CNTN1;NMNAT2;EFNA5;ANK2;CADM2;SNAP91;TAFA5;ATP2B3;LSAMP;RGS3;TSHZ1;ADGRB3;ADGRL3;RBFOX1;PARVA;CACNA1B;STXBP5;TOX;PCDH17;KCTD16;CACNA2D1;CYTH3;NTRK2;ARHGAP26;PPFIA2;NRXN1;PIK3CA;TTBK2;LRRC4C;ADGRA1;ASTN1;CDK5R2;GUCY1A2;OLFM3;SHC3;MAPK4;CELF3;TMEM196;CA10;RGS7BP;KIF1B;ASXL3;LY6H
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.6843432143169978,2.0303601240342313,0.0,0.014582613204286207,0.03,20/52,17.21%,VEGFD;NCK2;FLT1;NRP2;MAPK11;PIK3CA;PIK3R1;CYFIP2;VEGFC;MAPKAPK2;PRKD1;PTK2;NCK1;NCKAP1;ABI1;NRP1;ROCK2;PXN;CYFIP1;FYN
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.8219349304293598,-2.012571983138325,0.0,0.0,0.0,57/85,12.92%,RPL19;RPS13;RPL12;RPS14;RPL23;RPS21;RPL41;RPS27;RPS4X;RPS23;RPL27A;RPL10;RPL39;RPLP1;RPL8;RPL34;RPL29;RPL15;RPL7A;RPL35;RPS27A;RPL24;RPL11;RPL38;RPL35A;RPS8;RPS7;RPS25;RPL27;RPS15;RPL9;RPL18A;RPLP2;RPL3;RPL23A;RPL30;RPS6;RPS26;RPL18;RPS9;RPS12;RPL5;RPL13;RPL21;RPS28;RPL32;RPL7;RPS24;RPS16;RPS3A;RPS18;RPL13A;RPL14;RPS11;RPL6;RPL10A;RPS20
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.8087093683011297,-2.0059923606818684,0.0,0.0,0.0,58/97,12.92%,RPL19;RPS13;RPL12;RPS14;RPL23;RPS21;RPL41;RPS27;RPS4X;RPS23;RPL27A;RPL10;RPL39;SRPRA;RPLP1;RPL8;RPL34;RPL29;RPL15;RPL7A;RPL35;RPS27A;RPL24;RPL11;RPL38;RPL35A;RPS8;RPS7;RPS25;RPL27;RPS15;RPL9;RPL18A;RPLP2;RPL3;RPL23A;RPL30;RPS6;RPS26;RPL18;RPS9;RPS12;RPL5;RPL13;RPL21;RPS28;RPL32;RPL7;RPS24;RPS16;RPS3A;RPS18;RPL13A;RPL14;RPS11;RPL6;RPL10A;RPS20
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.5916227490554777,1.9974887198460947,0.0,0.023332181126857934,0.05,69/155,21.39%,EPHA7;GNL3L;PCDH19;PCDH8;DNM3;ANK2;DACH1;FUT9;CADM2;SNAP91;CNR1;CAMKV;ADGRB3;ADGRL3;CACNA1B;NOL4;SLC35F1;KIF5A;MEGF10;ZIC2;FAM171B;PPFIA2;LINGO2;KCNQ2;ABCC5;CDH4;ASTN1;OLFM3;TMEM170B;CLSTN2;KCNH7;ADAM12;MAPK4;ISOC1;CELF3;KIF5C;GPM6B;SLITRK1;KIF1B;ERC2;NBEA;ELAVL3;LZTFL1;PURG;NRG1;MAPK8;CSRNP3;TRIM44;B3GALT1;AATF;NDNF;RALGPS2;OPCML;DPYSL5;CCM2;TBCK;RAB11FIP2;BRINP1;LRCH2;ELAVL2;NOVA1;FAT3;GRIA2;CLVS2;ZDBF2;NLGN1;HOMER2;TMEM59L;CNTNAP2
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.8127661083023752,-1.9754609687675018,0.0,0.0,0.0,58/88,12.92%,RPL19;RPS13;RPL12;RPS14;RPL23;RPS21;RPL41;RPS27;RPS4X;RPS23;RPL27A;RPL10;RPL39;SRPRA;RPLP1;RPL8;RPL34;RPL29;RPL15;RPL7A;RPL35;RPS27A;RPL24;RPL11;RPL38;RPL35A;RPS8;RPS7;RPS25;RPL27;RPS15;RPL9;RPL18A;RPLP2;RPL3;RPL23A;RPL30;RPS6;RPS26;RPL18;RPS9;RPS12;RPL5;RPL13;RPL21;RPS28;RPL32;RPL7;RPS24;RPS16;RPS3A;RPS18;RPL13A;RPL14;RPS11;RPL6;RPL10A;RPS20
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.6747746403714355,1.9656023643818352,0.0,0.029165226408572414,0.07,38/111,12.88%,POU6F2;SPSB4;EPHA7;SEMA5B;PCDH8;CCKBR;CSPG5;ERBB4;EPHA4;SNAP91;EFNA2;EGFR;TSHZ1;ASCL1;CNR1;CAMKV;ADGRL3;CACNA1B;RHBDL3;PPM1E;NOL4;SLC35F1;SALL3;MPP2;KIF5A;PBX1;FBLL1;KCNQ2;ASTN1;CDK5R2;UNC5D;MAPK4;LRP8;CELF3;KIF5C;ERC2;SIRT1;IGDCC3
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.8123106032013799,-1.9624119101266249,0.0,0.0,0.0,58/87,12.92%,RPL19;RPS13;RPL12;RPS14;RPL23;RPS21;RPL41;RPS27;RPS4X;RPS23;RPL27A;RPL10;RPL39;RPLP1;RPL8;RPL34;RPL29;RPL15;RPL7A;RPL35;RPS27A;RPL24;RPL11;RPL38;RPL35A;RPS8;RPS7;RPS25;RPL27;RPS15;RPL9;RPL18A;RPL3;RPL23A;RPL30;RPS6;RPS26;RPL18;RPS9;RPS12;RPL5;TMA7;RPL13;RPL21;RPS28;RPL32;RPL7;RPS24;RPS16;RPS3A;RPS18;RPL13A;RPL26L1;RPL14;RPS11;RPL6;RPL10A;RPS20
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.6644553135321778,1.9567291994130966,0.0,0.0277764061034023,0.08,15/53,11.86%,VAPB;SGMS1;CERS3;ELOVL7;VAPA;ACER3;HACD2;PLPP1;ELOVL6;SPNS2;PLPP2;PPM1L;ELOVL5;PRKD1;PLPP3
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.7942121386754342,-1.9550407071697335,0.0,0.0,0.0,58/105,12.92%,RPL19;RPS13;RPL12;RPS14;RPL23;RPS21;RPL41;RPS27;RPS4X;RPS23;RPL27A;RPL10;RPL39;RPLP1;RPL8;RPL34;RPL29;RPL15;RPL7A;RPL35;RPS27A;RPL24;RPL11;RPL38;RPL35A;RPS8;RPS7;RPS25;RPL27;RPS15;RPL9;RPL18A;RPLP2;HELZ2;RPL3;RPL23A;RPL30;RPS6;RPS26;RPL18;RPS9;RPS12;RPL5;RPL13;RPL21;RPS28;RPL32;RPL7;RPS24;RPS16;RPS3A;RPS18;RPL13A;RPL14;RPS11;RPL6;RPL10A;RPS20
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.5889410495184105,1.9485931794544067,0.0,0.026734790874524714,0.09,61/146,22.05%,STK32C;PRKX;RPS6KA4;CAMKV;STK38L;RPS6KB2;RPS6KA3;CSNK1G3;CSNK2A1;AKT1;CAMK2A;DYRK1A;UHMK1;TTBK2;CSNK1E;RPS6KA2;NLK;MORC3;RPS6KB1;PRKCE;MAPKAPK2;MAST2;SMG1;PRKD1;CAMK2D;PLK1;TGFBR2;SGK3;PIKFYVE;HIPK2;TGFBR1;MAPKAPK5;VRK3;MAPK1;GSK3B;LATS1;MAP3K10;DYRK2;ROCK2;MAPK8;SBK1;MAST4;AKT2;CSNK2A2;SRPK2;CAB39;WNK1;CDK5R1;MAP2K2;MAPK9;ROCK1;PNCK;PRKCB;DYRK3;MARK1;AKT3;PRKCA;STK4;CAMK4;MARK3;TAF1
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.5994516176370841,1.9286724008731637,0.0,0.03240580712063602,0.12,43/95,21.79%,PCDH19;SEMA5B;PCDH8;ANK2;CSPG5;CADM2;SNAP91;CAMKV;ADGRL3;CACNA1B;SOX9;RHBDL3;NOL4;SLC35F1;SALL3;MEGF10;NR2E1;LRRC4C;KCNQ2;ASTN1;CDK5R2;UNC5D;MAPK4;CELF3;ZNF423;ERC2;PTPRZ1;ELAVL3;PURG;CSRNP3;PCLO;OPCML;CTNND2;DPYSL5;LRP4;IGDCC4;NOVA2;GRIA2;UNC13A;CLVS2;PHYHIPL;TMEM59L;CNTFR
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.6217401157441528,1.926884899039015,0.0,0.03305392326304874,0.14,57/109,23.85%,MAPK10;PCDH19;SEMA5B;ANK2;PDZRN3;SNAP91;ADGRB3;ADGRL3;OLIG2;PCDH17;SLC35F1;CACNA2D1;MEGF10;NTRK2;PPFIA2;NPAS3;LRRC4C;ADGRA1;CDH4;ASTN1;GUCY1A2;SHC3;GLI3;MAPK4;RUNX1T1;SLIT2;ZNF423;GPM6B;RGS7BP;ASXL3;LY6H;PTPRZ1;PLPPR4;PURG;CSRNP3;TMEM178A;OPCML;LRP4;BRINP1;LRCH2;NOVA1;FAM13C;FAT3;GRIA2;CLVS2;MARK1;ARNT2;PHYHIPL;SLC6A1;NLGN1;FAIM2;CNTFR;TMEM47;CNTN2;DOK5;FBXL7;TCEAL7
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.5327455811014942,1.9147864020322738,0.0,0.03181661062753355,0.14,116/337,21.17%,PDK4;EPHA7;DGKB;LIMD1;CDKL1;MAPK10;MAP3K11;CDK18;PASK;RPS6KA4;PRKACB;STK38L;CDKL5;CILK1;BMP2;MAP4K5;GRK3;CDK8;PRKG1;TEC;TNIK;PRKAR1B;CSNK2A1;CAMK2B;COPS2;AKT1;DAPK2;CAMK2A;DYRK1A;PIK3CA;CDK12;CSNK1E;DGKH;POMK;NLK;BMPR1B;PIK3R4;EIF2AK4;PANK2;MORC3;MAP3K20;DGKZ;LMTK3;PRKCE;BRAF;NEK4;MAP4K4;MAPKAPK2;PAK3;MAST2;PRKD1;CAMK2D;MAP3K5;ACVR1;OXSR1;MAP4K2;SIK2;PLK1;GK;GRK4;SIK3;PPP4R1;TGFBR2;SGK3;CDK19;MERTK;HIPK2;PRKAB1;TGFBR1;ACVR2A;FER;MAP4K3;DGKG;MAPK1;CDC42BPA;BMPR1A;TP53RK;TAOK2;GSK3B;LATS1;CDK13;PRKG2;DYRK2;ROCK2;STK11;PDK2;MAPK8;PPP3CB;TRIB2;CSK;FYN;MAML1;MAP3K1;SRPK2;CDK14;AGK;TBCK;WNK3;CDK9;WNK1;YWHAZ;FGGY;MAPK9;PANK3;ROCK1;DGKE;PAK4;PRKCB;FAM20B;DYRK3;MARK1;GK5;MAPK6;CTBP1;AKT3;PRKCA
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.6320018996199459,1.9069192908282169,0.0,0.03240580712063602,0.14,15/70,10.22%,STARD13;ABCC8;NPNT;ANK2;PDZRN3;SOWAHA;SPRED2;CEP170B;NOL4;CYS1;NTRK2;PCGF2;CDK5R2;GLIS3;FOXP4
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.5429502092442338,1.892576439851907,0.0,0.03888696854476322,0.19,88/309,16.02%,VEGFD;PDK4;EPHA7;ATP6V0D2;EPHA6;NCK2;CASS4;FOXO1;EFNA5;HNRNPH1;FLT1;AP3S1;ERBB4;CSF1R;EPHA4;EFNA2;EGFR;AP2B1;SORT1;GRIN1;GIT1;ATP6V1A;SPRED2;PDGFRA;RHOQ;ANKS1B;NRP2;FLRT2;NCSTN;MAPK11;EPHA2;CBL;EFNB1;FGF17;NTRK2;RAPGEF2;AKT1;PIK3CA;WASL;SPRED1;EPHA5;PIK3R1;PLCB1;IRS1;PDGFA;SHOC2;CYFIP2;ATP6V1C1;ROR1;RBFOX2;SHC3;ITSN1;VEGFC;IGF1;EFNB2;HGF;PTPRJ;MUC20;MTSS1;MAPKAPK2;PAK3;PRKD1;ANKS1A;SOS1;ADRB2;PTK2;NCK1;MERTK;NCKAP1;ABI1;SIRT2;FER;PDGFC;PTPRG;GAB1;MAPK1;TIAL1;ATP6V1B2;GSK3B;NRP1;ROCK2;PDK2;NRG1;PHIP;PTPN11;ARHGEF7;UBASH3B;PXN
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.7377829173049322,-1.880239673755998,0.0,0.0,0.0,62/142,13.52%,RPL19;RPS13;RPL12;RPS14;RPL23;RPS21;RPL41;RPS27;RPS4X;RPS23;RPL27A;RPL10;WARS1;RPL39;RPLP1;RPL8;RPL34;RPL29;RPL15;RPL7A;RPL35;RPS27A;RPL24;RPL11;RPL38;RPL35A;RPS8;RPS7;RPS25;RPL27;RPS15;RPL9;RPL18A;RPLP2;RPL3;RPL23A;RPL30;RPS6;RPS26;RPL18;RPS9;RPS12;RPL5;RPL13;RPL21;RPS28;RPL32;RPL7;RPS24;RPS16;RPS3A;RPS18;PCSK1;RPL13A;RPL14;MRPL51;RPS11;RPL6;RPL10A;RPS20;MRPL27;GGTA1
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.710269280132225,-1.8787843289006187,0.0,0.0,0.0,44/149,10.32%,RPL19;RPL12;RPS14;RPL23;RPL41;RPS27;RPL27A;RPL10;RPL39;RPLP1;RPL8;RPL34;RPL29;RPL15;RPL7A;RPL35;RPL24;RPL11;RPL38;RPL35A;RPS7;RPS25;RPL27;RPS15;RPL9;RPL18A;RPLP2;RPL3;RPL23A;RPL30;RPS6;RPL18;RPS9;RPL5;RPL13;RPL21;RPS28;RPL32;RPL7;RPS24;RPS16;EMG1;POP5;RPL13A
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.5253775431515515,1.8724449894717328,0.0,0.05971927312231495,0.34,148/408,22.05%,PDK4;CDKL1;MAPK10;MAP3K11;CDK18;FLT1;STK32C;PRKX;ERBB4;CSF1R;EPHA4;PASK;EGFR;RPS6KA4;CAMKV;PRKACB;STK38L;RPS6KB2;CDKL5;PDGFRA;CILK1;BMP2;MAP4K5;RPS6KA3;GRK3;CSNK1G3;CDK8;SMAD2;PRKG1;TEC;TNIK;NTRK2;PRKAR1B;CSNK2A1;CAMK2B;COPS2;AKT1;DAPK2;CAMK2A;DYRK1A;ABL2;UHMK1;CCNA2;TTBK2;CDK12;CSNK1E;RPS6KA2;NLK;BMPR1B;SMAD7;MAP3K7;PIK3R4;EIF2AK4;MORC3;RPS6KB1;MAP3K20;PKDCC;LMTK3;PRKCE;BRAF;NEK4;MAP4K4;MAPKAPK2;PAK3;MAST2;SMG1;PRKD1;CAMK2D;MAP3K5;ACVR1;OXSR1;MAP4K2;SIK2;PLK1;PTK2;GRK4;SIK3;PPP4R1;TGFBR2;SGK3;CDK19;MERTK;HIPK2;PRKAB1;TGFBR1;ABI1;MAPKAPK5;ACVR2A;FER;INCENP;MAP4K3;VRK3;MAPK1;CDC42BPA;BMPR1A;TP53RK;TAOK2;GSK3B;LATS1;MAP3K10;CDK13;PRKG2;DYRK2;ROCK2;STK11;PDK2;MAPK8;PPP3CB;SBK1;TRIB2;MAST4;CSK;AKT2;FYN;MAML1;MAP3K1;CSNK2A2;SRPK2;EEF2K;CDK14;TBCK;CAB39;WNK3;CDK9;WNK1;CDK5R1;YWHAZ;MAPK9;ROCK1;DDR2;PAK4;PNCK;PRKCB;FAM20B;DYRK3;MARK1;MAPK6;CTBP1;AKT3;PRKCA;STK4;CAMK4;ABI2;FGFR2;ERC1;MARK3;EPHB3;TAF1
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.7161269024975806,1.8708744002349775,0.0,0.05703422053231939,0.34,17/34,21.99%,WNT7A;SHANK1;BTBD3;CTNNA2;WASL;PAK3;SHANK3;DVL1;FARP1;TAOK2;TMEM106B;CTNND2;LRP4;PTEN;SDC2;PHACTR1;EPHB3
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),0.8133685299056541,1.8613017148493978,0.0,0.06197610611821638,0.35,3/16,4.85%,PDK4;PPARGC1A;SOX9
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.5483430294674585,1.8492263041217734,0.0,0.06748032776885382,0.39,66/156,24.68%,STK32C;PRKX;RPS6KA4;CAMKV;STK38L;RPS6KB2;RPS6KA3;CSNK1G3;CSNK2A1;AKT1;CAMK2A;DYRK1A;UHMK1;TTBK2;CSNK1E;RPS6KA2;MORC3;RPS6KB1;PRKCE;MAPKAPK2;MAST2;SMG1;PRKD1;CAMK2D;PLK1;TGFBR2;SGK3;HIPK2;TGFBR1;MAPKAPK5;VRK3;MAPK1;GSK3B;LATS1;MAP3K10;DYRK2;ROCK2;MAPK8;SBK1;NDNF;MAST4;AKT2;CSNK2A2;SRPK2;CAB39;WNK1;CDK5R1;MAPK9;ROCK1;PNCK;PRKCB;DYRK3;MARK1;AKT3;PRKCA;STK4;GALNT1;CAMK4;MARK3;TAF1;GALNT2;CSNK1D;MGAT5B;MARK2;TNKS;GAS6
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.5991621159959549,1.8469468272728684,0.0,0.06589180781195991,0.41,50/118,23.85%,CHRNA4;ETV5;ANK2;CSPG5;SNAP91;ASCL1;PSD2;ADGRB3;ADGRL3;OLIG2;PDGFRA;VCAN;SLC35F1;MEGF10;VSTM2B;LRRC4C;ADGRA1;ASTN1;SHC3;MAPK4;CA10;CLIP3;LY6H;OLIG1;HAPLN2;PLPPR4;ELAVL3;TMEM178A;FYN;OPCML;CTNND2;NRXN2;BRINP1;GRIA2;CDO1;CLVS2;ARNT2;PHYHIPL;SLC6A1;CHST1;FAIM2;TMEM59L;ATP2B2;CNTFR;CNP;CNTN2;LHFPL3;SLCO1C1;CACNG7;TCEAL7
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.708706669903782,-1.8430217828297757,0.0,0.003418481565419269,0.04,65/191,13.30%,RPL19;RPS13;RPL12;RPS14;RPL23;RPS21;RPL41;RPS27;RPS4X;RPS23;RPL27A;RPL10;WARS1;RPL39;RPLP1;RPL8;RPL34;RPL29;RPL15;RPL7A;RPL35;RPS27A;RPL24;RPL11;RPL38;RPL35A;RPS8;RPS7;RPS25;RPL27;RPS15;RPL9;RPL18A;RPLP2;RPL3;RPL23A;RPL30;RPS6;RPS26;RPL18;RPS9;RPS12;RPL5;TMA7;EEF1B2;GARS1;RPL13;RPL21;RPS28;RPL32;RPL7;RPS24;RPS16;RPS3A;RPS18;TRMT112;RPL13A;RPL26L1;RPL14;MRPL51;RPS11;RPL6;RPL10A;RPS20;MRPL27
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.7076289318832222,-1.8420963418366318,0.0,0.00364638033644722,0.05,59/161,12.92%,RPL19;RPS13;RPL12;RPS14;RPL23;RPS21;RPL41;RPS27;RPS4X;RPS23;RPL27A;RPL10;RPL39;PATL2;RPLP1;RPL8;RPL34;RPL29;RPL15;RPL7A;RPL35;RPS27A;RPL24;RPL11;RPL38;RPL35A;RPS8;RPS7;RPS25;RPL27;RPS15;RPL9;RPL18A;RPLP2;HELZ2;RPL3;RPL23A;RPL30;RPS6;RPS26;RPL18;RPS9;RPS12;RPL5;RPL13;RPL21;RPS28;RPL32;RPL7;RPS24;RPS16;RPS3A;RPS18;RPL13A;RPL14;RPS11;RPL6;RPL10A;RPS20
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,-0.75691922879723,-1.84125379480521,0.0,0.003281742302802498,0.05,33/81,11.96%,GBP2;IFI44L;SAMD9;ISG15;IFITM3;WARS1;CMPK2;USP18;IRF1;BST2;IFI44;IL7;MX1;PARP14;EPSTI1;IFIT3;B2M;IFIT2;SAMD9L;HELZ2;HLA-C;HERC6;PSMB9;TRIM21;IFI35;DDX60;SP110;STAT2;CASP8;PSME1;PROCR;LPAR6;RSAD2
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),0.7571549769217572,1.8408093635787879,0.0,0.06754052431458875,0.41,3/13,13.28%,PPARGC1A;ELOVL5;MLXIPL
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.8236530718472678,1.8356612031452806,0.0,0.07096871759419289,0.43,1/16,0.01%,CPA1
prerank,PanglaoDB_Augmented_2021__Motor Neurons,0.6679046891145165,1.8343384650412127,0.037037037037037035,0.068515135055059,0.43,16/61,9.33%,SPSB4;MEX3A;TENM3;CSPG5;EFNA2;MEIS3;MPP2;ZIC2;LYPD6;MID1;PCGF2;CSNK1E;CBARP;CDK5R2;RBFOX2;HSPA12A
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.6166622563114502,1.830055526102453,0.0,0.06981978443264306,0.47,26/66,19.82%,LIMD1;NPNT;RANBP3L;SOX9;BMP2;MEN1;TRPM4;ZHX3;BMPR1B;IGF1;HGF;GDF10;PRKD1;ACVR1;PTK2;ACVR2A;BMPR1A;YAP1;SEMA4D;BMP7;SUFU;RORB;CRIM1;IL6R;DDR2;REST
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.655662896828176,1.8280469276272602,0.0,0.06847487939403958,0.48,31/71,21.99%,EPHA7;EPHA6;NCK2;EFNA5;EPHA4;EFNA2;AP2B1;GRIN1;GIT1;ANKS1B;NCSTN;EPHA2;EFNB1;WASL;EPHA5;ITSN1;EFNB2;PAK3;ANKS1A;PTK2;ROCK2;PTPN11;ARHGEF7;FYN;CDK5R1;GRIN2B;ROCK1;SDC2;ACTR3;CRK;EPHB3
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.6611399195674836,1.82205094887238,0.0,0.07129277566539924,0.51,18/65,11.86%,VAPB;SGMS1;ST6GALNAC5;CERS3;ELOVL7;VAPA;ACER3;HACD2;PLPP1;ELOVL6;B4GALT6;SPNS2;PLPP2;LARGE1;PPM1L;ELOVL5;PRKD1;PLPP3
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.7391781866043358,1.8214111271191307,0.0,0.06999654338057379,0.51,7/15,15.83%,GRAMD1C;SMAD2;TGFBR2;TGFBR1;OSBPL7;ABCA2;SMO
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.7086418452003475,1.8179305985830578,0.0,0.07104350022600972,0.52,17/34,20.58%,ADGRB3;CDKL5;CSMD3;NEDD4L;TNIK;SARM1;DCC;LRP8;CAMSAP2;KIAA0319;GSK3B;SEMA4D;BMP7;RAP2A;RTN4IP1;SDC2;MARK1
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.6818714669519831,-1.8134415138094626,0.0,0.0049723368224280275,0.08,44/161,10.32%,RPL19;RPL12;RPS14;RPL23;RPL41;RPS27;RPL27A;RPL10;RPL39;RPLP1;RPL8;RPL34;RPL29;RPL15;RPL7A;RPL35;RPL24;RPL11;RPL38;RPL35A;RPS7;RPS25;RPL27;RPS15;RPL9;RPL18A;RPLP2;RPL3;RPL23A;RPL30;RPS6;RPL18;RPS9;RPL5;RPL13;RPL21;RPS28;RPL32;RPL7;RPS24;RPS16;EMG1;POP5;RPL13A
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.5946069275623326,1.8124917812115608,0.0,0.07345316280677497,0.55,56/128,23.64%,MAPK10;GABRG1;CADM2;LSAMP;EGFR;PSD2;ADGRB3;AMER2;RBFOX1;ZEB2;CHL1;CTNNA2;NTRK2;CDH20;SLITRK2;CAMK2A;PPFIA2;NRXN1;NPAS3;FAM107A;LRRC4C;ADGRA1;ASTN1;KCNA2;GDF10;GPM6B;CA10;RGS7BP;KIF1B;BICD2;MAGI2;SLC4A4;TRPM3;PTPRZ1;PLPPR4;ELAVL3;ACSBG1;RUFY3;SLC39A12;OPCML;GRIN2B;NTRK3;GRIA2;CLVS2;VSTM2A;PHYHIPL;SLC6A1;P2RY1;FAIM2;RFX4;ATP2B2;GRM5;CNTN2;DPP6;TTC21B;SLCO1C1
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.544053034219948,1.8025769149244302,0.0,0.08402362846279196,0.58,40/104,21.79%,CHRNA4;ADCY1;ABCC8;PCDH8;SNAP91;NR4A2;CAMKV;CACNA1B;LONRF2;CHD5;CADPS2;NOL4;KIF5A;SRCIN1;NRXN1;ADGRA1;KCNQ2;ASTN1;CDK5R2;OLFM3;MAPK4;CELF3;SLITRK1;TMEM196;ERC2;LY6H;TENM1;MYT1;ELAVL3;CSRNP3;CTNND2;DPYSL5;NOVA2;GRIA2;UNC13A;CLVS2;VSTM2A;PHYHIPL;TMEM59L;CNTFR
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.725885991103613,1.8009967315103792,0.0,0.08112626196407499,0.58,10/25,19.16%,LIMD1;RANBP3L;SOX9;MEN1;TRPM4;GDF10;SEMA4D;SUFU;RORB;CRIM1
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.7439507269482045,1.797648585582626,0.0,0.08101451780159004,0.59,6/26,10.50%,SNAP91;PICALM;AP2B1;ITSN1;PIP5K1C;SGIP1
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.7218878563621073,1.7930589792508105,0.0,0.08090998293991057,0.6,13/28,14.54%,SMG9;MEIS3;RAB18;PBX1;FREM2;ATF6;BMPR1B;MEIS2;PBX2;PBX3;HIPK2;SH3PXD2B;ZDHHC16
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.7949826841741536,1.7929059391972988,0.0,0.07838154597303837,0.6,7/14,13.63%,HDAC9;SMARCAD1;HDAC2;ELK4;HDAC4;SIRT1;SIRT2
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.5512217029336487,1.7918229488068456,0.0,0.07600634761021903,0.6,39/118,18.80%,EPHA7;KLHL17;SMG9;ADGRL3;CDH2;MEIS3;GRIN1;NFIB;CTNNA2;RAB18;ZIC2;PBX1;RAPGEF2;PCDH18;POMK;SOX6;UGP2;NF1;MEIS2;SHANK3;PBX2;PBX3;CA10;ADGRL2;TGFBR2;CNTN4;RAB3GAP1;NIPBL;SCYL2;SYNJ1;PTPN11;TBC1D23;EML1;MKKS;BBS2;PTEN;CDK5R1;GRIN2B;FBXW11
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.5621754991214851,1.789894113694234,0.0,0.07491460116711739,0.61,43/143,15.19%,SLC24A3;CHRNA4;CACNG2;DLGAP1;PCDH8;CADM2;SNAP91;ATP2B3;TSHZ1;PSD2;ADGRB3;AMER2;RBFOX1;GRIN1;CACNA1B;PDE1B;PPM1E;PRKG1;KIF5A;CTNNA2;NRIP3;KCNMA1;CAMK2A;HIVEP2;PKP4;VSTM2B;NRXN1;GNG4;MRPS35;ADGRA1;KCNQ2;ASTN1;OLFM3;KCNA2;CELF3;SLITRK1;TMEM196;CA10;LY6H;SEZ6L;ELAVL3;SLC32A1;SLC22A15
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.8135946559389847,-1.78938516408897,0.0,0.0067317790826717915,0.12,15/38,7.63%,IFI6;GBP2;IFIT1;ISG15;IFITM3;IRF1;BST2;HLA-A;HLA-B;MX1;STAT1;IFIT3;IFIT2;HLA-C;IFI35
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.8135946559389847,-1.78938516408897,0.0,0.0067317790826717915,0.12,15/38,7.63%,IFI6;GBP2;IFIT1;ISG15;IFITM3;IRF1;BST2;HLA-A;HLA-B;MX1;STAT1;IFIT3;IFIT2;HLA-C;IFI35
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.6426064510265815,1.784347499455642,0.0,0.08110710582193473,0.62,20/60,17.39%,PDK4;ATP6V0D2;FOXO1;AP3S1;ATP6V1A;RHOQ;AKT1;PIK3CA;PIK3R1;IRS1;ATP6V1C1;SOS1;FER;GAB1;ATP6V1B2;GSK3B;PDK2;PHIP;AKT2;IDE
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.6912189556306967,1.7751408196678187,0.0,0.08965606636709299,0.7,15/35,14.54%,SMG9;ASCL1;MEIS3;CHD7;RAB18;PBX1;FREM2;ATF6;BMPR1B;MEIS2;PBX2;PBX3;HIPK2;SH3PXD2B;ZDHHC16
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),0.8220571299432218,1.775007089954808,0.0,0.08723292943825264,0.7,4/15,5.80%,ITGA1;PPP1R15B;BMP2;PLEK
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.5810112524995342,1.7741862649954085,0.0,0.08544899667072972,0.7,35/105,12.72%,PPARGC1A;MAPK10;PCDH19;PDZRN4;ABCC8;CNTN1;ANK2;SOWAHA;ETV1;ERBB4;SNAP91;ESRRG;PLEKHA6;LONRF2;NFIB;PCDH17;LIMCH1;CADPS2;NOL4;THSD7A;NTRK2;PBX1;LMO3;FRZB;PPFIA2;NRXN1;ADGRA1;GUCY1A2;ATP9A;MAPK4;TMEM196;ADGRL2;RGS7BP;CNTN4;ASXL3
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.5657179666726792,1.76875842159491,0.0,0.08973915818022282,0.72,41/96,20.44%,SEMA5B;CNTN1;ANK2;SNAP91;LSAMP;ADGRB3;ADGRL3;RBFOX1;CACNA1B;PCDH17;SLC35F1;CTNNA2;NRXN1;KCNQ2;CPT1C;ASTN1;GUCY1A2;UNC5D;MAPK4;PAK3;RGMA;RUNX1T1;ZNF423;GPM6B;ASXL3;MAGI2;TRPM3;ELAVL3;PURG;CSRNP3;OPCML;BRINP1;LRCH2;NOVA1;FMN2;NTRK3;NOVA2;FAT3;GRIA2;UNC13A;CLVS2
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.7257636420533111,1.7636871907444116,0.0,0.09721742136190806,0.77,9/24,18.17%,WNT7A;SHANK1;WASL;PAK3;SHANK3;MTMR2;FYN;CTNND2;PTEN
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),0.8187192280776355,1.7619568835672774,0.027777777777777776,0.09674319003819143,0.79,1/12,0.32%,SLC26A7
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),0.6793259755408115,1.7608911585515956,0.0,0.09721742136190806,0.79,11/33,20.25%,PAPOLA;IWS1;QKI;SAFB2;KHDRBS3;SLTM;DHX9;JMJD6;SRPK2;KHDRBS2;PTCD2
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.5434329599017471,1.760259514727929,0.0,0.09540872515052372,0.79,39/123,14.95%,CADM2;SNAP91;ATP2B3;LSAMP;GLS;ADGRB3;AMER2;RBFOX1;CACNA1B;KCNA4;UNC79;CACNG3;CTNNA2;KCNMA1;CDH20;PPFIA2;VSTM2B;NRXN1;ASTN1;OLFM3;NLK;HSPA12A;SGIP1;SYNE1;PAK3;CELF3;SLITRK1;TMEM196;CA10;GRM1;CACNA2D3;KIF1B;CNTN4;MAGI2;NAPB;SEZ6L;VWC2L;TRPM3;ELAVL3
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,0.5915778997325092,1.7546129896521678,0.0,0.10031070295069604,0.81,37/94,22.91%,SHISA7;PCDH8;CSPG5;SNAP91;CAMKV;PSD2;GRIN1;MPP2;KIF5A;VSTM2B;FBLL1;ADGRA1;KCNQ2;ASTN1;CDK5R2;CELF3;SLITRK1;CLIP3;LY6H;NCDN;ELAVL3;SLC32A1;ADGRB2;PIANP;OPCML;TMEM198;BRINP1;GRIA2;PNCK;NGB;CLVS2;SLC6A9;FAIM2;TMEM59L;B4GALNT4;GRM5;CNTN2
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.7075223498264914,1.7520009493672979,0.0,0.10110611821638436,0.82,13/32,19.82%,BRINP3;ASCL1;ZEB1;BMP2;MMD;TCF4;KCTD11;ZC4H2;NBL1;IMPACT;BRINP1;CPNE1;REST
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.6414923507696783,1.7466697788885726,0.0,0.10693916349809886,0.84,25/43,22.98%,CADM2;CDH2;NECTIN3;CDH11;CDH20;CADM1;CDH4;SMAD7;PIP5K1C;CDH9;AFDN;TJP1;CDH13;NECTIN2;CDH18;CSK;CDH8;ZNF703;CDH6;CDH19;NECTIN1;CDH10;CTNNB1;DCHS1;TBCD
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.5588781278939625,1.7442096879185711,0.0,0.10797339138492766,0.85,19/83,9.57%,LPIN3;TBC1D4;ADCY1;HDAC9;FOXO1;PDE3B;KAT2B;NR4A2;PRKACB;RHOQ;NFKB1;RAB31;DENND4C;PRKAR1B;AKT1;RAB8B;PIK3R1;IRS1;RPS6KB1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.597212759954316,1.7427066212719178,0.0,0.1105848167991704,0.87,8/47,10.21%,PLD6;PPARGC1A;MCU;DCN;BOK;MFF;SPIRE1;PRKN
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.7542619000363788,1.7386798536605739,0.0,0.11547048822985813,0.9,4/18,5.59%,PPARGC1A;SOX4;RPS6KA4;ARRB1
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.8837677027160857,-1.7385655127960722,0.0,0.0226596492336363,0.35,3/17,4.87%,SLC28A2;RPE65;B2M
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.6531954334624634,-1.7382066577680175,0.0,0.02114900595139388,0.35,44/188,10.32%,RPL19;RPL12;RPS14;RPL23;RPL41;RPS27;RPL27A;RPL10;RPL39;RPLP1;RPL8;RPL34;RPL29;RPL15;RPL7A;RPL35;RPL24;RPL11;RPL38;RPL35A;RPS7;RPS25;RPL27;RPS15;RPL9;RPL18A;RPLP2;RPL3;RPL23A;RPL30;RPS6;RPL18;RPS9;RPL5;RPL13;RPL21;RPS28;RPL32;RPL7;RPS24;RPS16;EMG1;POP5;RPL13A
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.6563242892827704,1.7343764333344371,0.0,0.12249395091600415,0.93,21/50,19.83%,TIAM2;EPHA4;PLXNA2;CDH2;ARHGAP35;KIF13B;PLXNA1;NTRK2;ROBO1;LRRC4C;CHODL;PAK3;SLIT2;SLITRK1;GSK3B;RUFY3;LRP4;PTEN;PLXNA4;ARHGDIA;MCF2
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.6308061949120534,1.7341027653561982,0.0,0.12047335353083508,0.93,17/56,16.90%,CDKL1;TBC1D1;TBC1D5;USP6NL;CDKL5;ARHGAP35;EVI5L;TESK1;KCTD17;CEP97;TBC1D22B;ODAD3;TBC1D24;TAPT1;TBC1D10A;YAP1;CEP120
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.5671162968504114,1.7311835420996864,0.0,0.12301742933872212,0.93,31/59,24.63%,CSNK2A1;AKT1;DYRK1A;NLK;PRKD1;CAMK2D;ACVR1;OXSR1;TGFBR2;HIPK2;TGFBR1;MAPK1;CDC42BPA;GSK3B;MAP3K10;DYRK2;ROCK2;MAPK8;SBK1;CSNK2A2;WNK3;WNK1;CDK5R1;ROCK1;DYRK3;PRKCA;GALNT1;TAF1;GALNT2;MARK2;TNKS
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.5582504825924329,1.7237359699741845,0.0,0.13573753171285277,0.96,48/121,21.31%,SHISA7;FEZF2;KCNQ3;GABRG1;CADM2;SNAP91;ATP2B3;NR4A2;PSD2;ADGRB3;AMER2;RBFOX1;CACNA1B;CACNG3;CTNNA2;CDH20;CAMK2A;VSTM2B;NRXN1;ADGRA1;KCNQ2;ASTN1;OLFM3;CELF3;SLITRK1;TMEM196;CA10;GRM1;ADRB2;LY6H;SEZ6L;PDE2A;ELAVL3;SLC32A1;SATB2;KCNC2;OPCML;CCM2;BRINP1;GRIN2B;YWHAZ;POU3F1;GRIA2;NGB;CLVS2;VSTM2A;SLC6A1;FAIM2
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.5535310408060957,1.7231204526416473,0.0,0.13430406728885816,0.96,41/117,21.31%,GABRG1;CADM2;SNAP91;ATP2B3;LSAMP;PDE10A;PSD2;ADGRB3;AMER2;RBFOX1;DPF1;CAMK2A;PPFIA2;VSTM2B;NRXN1;PPP1R1B;LRRC4C;ADGRA1;ASTN1;OLFM3;CELF3;SLITRK1;TMEM196;CA10;RGS7BP;LY6H;GABRB1;PLPPR4;ELAVL3;CSRNP3;KCNC2;NPY;OPCML;BRINP1;ABHD2;GRIA2;CLVS2;VSTM2A;PHYHIPL;SLC6A1;FAIM2
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.6600340608250361,1.7228367438206793,0.0,0.13256921094805646,0.96,10/32,16.66%,EPHA7;TESK1;PPP2R5A;PDGFA;RAP2C;PDGFC;TAOK2;RAP2A;IMPACT;PPP2R5E
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,-0.6625519972656556,-1.7225321523395076,0.0,0.028715245149521857,0.45,54/147,17.02%,IFI44L;IFIT1;ISG15;IFITM3;WARS1;CMPK2;USP18;IRF1;BST2;HLA-A;IFI44;HLA-B;SELP;IL7;MX1;PARP14;STAT1;EPSTI1;IFIT3;P2RY14;B2M;IFIT2;SAMD9L;HELZ2;HERC6;PNP;PSMB9;TRIM21;GPR18;IFI35;DDX60;VAMP5;RNF213;SP110;STAT2;CASP8;C1R;PSME1;VAMP8;CIITA;RSAD2;OAS3;APOL6;MT2A;TNFAIP2;CCL2;SOCS3;BPGM;CD274;LY6E;PSMA3;EIF2AK2;RIPK2;IL15RA
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.5834207061128054,1.7220425277296483,0.0,0.13089631376228333,0.96,44/105,21.35%,ABCC8;ANK2;CADM2;SNAP91;ATP2B3;PSD2;ADGRB3;RBFOX1;KCTD16;MYBPC1;NTRK2;CAMK2B;CAMK2A;PPFIA2;VSTM2B;ADGRA1;ASTN1;CDK5R2;OLFM3;SEMA3C;MAPK4;CELF3;NKAIN2;SLITRK1;TMEM196;CA10;RGS7BP;LY6H;PLPPR4;ELAVL3;SLC32A1;LRFN5;KCNC2;OPCML;CTNND2;BRINP1;GRIA2;CLVS2;VSTM2A;PHYHIPL;SLC6A1;CHST1;FAIM2;TMEM59L
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.6277234058363228,1.71914764789735,0.0,0.1323521385558608,0.96,11/53,7.56%,SHISA7;CACNG2;DLGAP1;SHANK1;DLGAP4;GRIN1;NPTXR;CACNG3;CAMK2B;DLG3;CAMK2A
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.5391630518881131,1.7161482856544026,0.0,0.13643962239412613,0.96,24/85,16.17%,WNT7A;MAP3K11;TPD52L1;SH3RF3;MARVELD3;EGFR;DUSP10;MBIP;SH3RF1;MEN1;PLCB1;ITCH;DUSP19;HMGB1;PRKN;MAP4K4;MAP3K5;MAP4K2;TNFRSF19;HIPK2;TAOK2;DUSP22;MAP3K10;RAP2A
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.6191656419624033,1.711599501949265,0.0,0.14500225559064253,0.96,15/44,24.15%,NUP42;NUP37;NUP188;EP300;NUP153;OGT;NDC1;RUBCNL;NUP205;HIF1A;NUP214;RANBP2;NUP98;NUP54;PRDM16
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.6483970029818579,-1.7102900768118654,0.0,0.03410438079382989,0.56,86/271,17.87%,PIF1;RPL19;RPS13;RPL12;RPS14;RPL23;RPS21;RPL41;RPS27;RPS4X;RPS23;RPL27A;RPL10;WARS1;RPL39;RPLP1;RPL8;RPL34;GCNT1;RPL29;RPL15;RPL7A;RPL35;RPS27A;RPL24;RPL11;RPL38;RPL35A;RPS8;RPS7;RPS25;RPL27;RPS15;RPL9;RPL18A;RPLP2;RPL3;RPL23A;RPL30;RPS6;RPS26;RPL18;RPA3;RPS9;RPS12;RPL5;EEF1B2;RPL13;RPL21;RPS28;RPL32;RPL7;RPS24;RPS16;TYMS;RPS3A;RPS18;RPL13A;RPL14;MRPL51;RPS11;RPL6;RPL10A;POLR2L;POLR2I;BLM;RPS20;MRPL27;INHA;APOE;PTMA;POLE3;DRG1;BRCA1;RPS19;RPL36;POLR2J;RPL31;MRPS33;RRAGC;GTPBP2;IGF2BP3;RPL28;MRPL36;PAX8;RPS2
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.6238299556306484,1.7098011246347748,0.0,0.14615019011406843,0.96,16/59,11.43%,SPSB4;PLEKHG4B;EPHA7;MEX3A;SEMA5B;CCKBR;CAMKV;CXCL12;CACNA1B;SALL3;PHC1;KCNQ2;UNC5D;NLGN4X;ADAMTS19;ZNF423
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.7429646620349131,1.709571676682876,0.0,0.1447105222895287,0.96,10/19,14.98%,ZFPM2;PARVA;NRP2;ROBO1;SEMA3C;ACVR1;TGFBR2;SMAD4;BMPR1A;NRP1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.6595824260714556,1.7087778928821087,0.0,0.1439445045326316,0.96,18/41,21.96%,FLT1;ERBB4;CSF1R;EPHA4;EGFR;PDGFRA;TEC;DYRK1A;ABL2;PKDCC;PTK2;ABI1;FER;FYN;TTL;DDR2;ABI2;FGFR2
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),0.8244723698253275,1.708450125943393,0.0,0.14227692459631622,0.96,3/9,9.46%,VEGFD;CXCL12;VEGFC
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),0.7038461195310751,1.704057727035721,0.0,0.14764895869339786,0.96,3/14,12.88%,ANK2;VAPA;TAPT1
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.5208253598495218,1.7030313732636717,0.0,0.1474713499428328,0.97,51/211,14.28%,POU6F2;EPHA7;CHST8;LIG4;KLHL17;IL1RAPL2;SOX8;SOX4;NR4A2;SMG9;ADGRL3;CDH2;MEIS3;GRIN1;ZIC5;SOX9;NFIB;PSPN;RPS6KA3;MYRF;VCAN;CHD7;RAB18;ZIC2;PBX1;PCDH18;ADAM23;MBP;POMK;NPAS2;HAPLN1;SOX6;PKD2;PRKN;UGP2;NF1;MEIS2;PBX2;ZBTB16;PBX3;CA10;ADGRL2;TGFBR2;CNTN4;RAB3GAP1;NCKAP1;NIPBL;SCYL2;HAPLN2;PDGFC;PTPRZ1
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.6020358100705173,1.7023144216947403,0.0,0.14729912327561825,0.97,16/42,19.16%,RBPMS2;BMP2;UBE2D1;SMAD5;BMPR1B;SMAD7;SMURF1;NBL1;HIPK2;ACVR2A;VWC2L;SMAD4;BMPR1A;LEMD3;UBE2D3;CRIM1
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.7425632858342528,1.700792659298634,0.0,0.14858304399193112,0.97,12/19,22.85%,LIG4;SOX8;BMP2;CHD7;ZNF568;MBNL1;FUT8;TGFBR1;ARNT2;STIL;FGFR2;PTPRR
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),0.8395600044048204,1.6993249180911316,0.0,0.14925733514975295,0.97,1/12,0.68%,NUDT21
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.6113101265518974,1.6992061541063532,0.0,0.1473759749921099,0.97,14/38,15.87%,PCSK5;SALL1;PRKX;SOX4;MME;PYGO2;CEP290;C1GALT1;NF1;ZBTB16;NIPBL;TGFBR1;PYGO1;BMP7
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),0.8335887311554832,1.6988243283576665,0.0,0.14582613204286207,0.97,5/12,9.83%,WNT7A;SALL1;HDAC2;MAP3K20;GLI3
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.7350842730790342,1.6927015732659907,0.0,0.1560955779613735,0.97,3/20,4.76%,PDK4;MITF;ADIPOR2
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),0.623349927953581,1.6914241445284826,0.0,0.1563580193570688,0.97,12/38,15.87%,LIG4;PCSK5;SOX8;BMP2;CHD7;ZNF568;PKD2;MBNL1;DVL1;FUT8;TGFBR1;BMP7
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.6895841779149223,1.6908039782199078,0.03333333333333333,0.15661327057753954,0.97,8/21,16.05%,PLD6;GDAP1;CHCHD3;MFF;MIGA2;OPA1;MIGA1;THG1L
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.610445287144717,1.6900402470741307,0.0,0.15817537205369905,0.97,16/60,9.02%,VAPB;SLC24A3;ATP13A5;SNCA;ANK2;NPTN;HTR2C;ATP2B3;CXCL12;GRIN1;STIM2;ATP2C1;CALCB;ATP13A4;TMTC2;SLC10A7
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.76982563936532,1.6875851109427036,0.029411764705882353,0.16021431040442446,0.97,8/13,12.96%,RARB;PCSK5;SALL1;RBPMS2;PDGFRA;GLI3;PKDCC;NIPBL
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.5619698391202993,1.6870994821800418,0.0,0.15964123928902796,0.97,32/107,18.79%,PDK4;LPIN3;ATP6V0D2;TBC1D4;HDAC9;FOXO1;PDE3B;KAT2B;AP3S1;ATP6V1A;RHOQ;RAB31;DENND4C;AKT1;RAB8B;PIK3R1;IRS1;ATP6V1C1;RPS6KB1;SOS1;FER;GAB1;ATP6V1B2;GSK3B;PDK2;PHIP;AKT2;INSIG2;IDE;MYO5A;BCAR1;CPEB1
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.8560499133028542,1.685062369037056,0.0,0.16034561705145872,0.97,6/12,8.27%,PDK4;PID1;FOXO1;SOX9;FOXO3;IRS1
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.7927633944166316,1.6804729084581527,0.023809523809523808,0.16925802334547582,0.98,3/9,9.72%,FUT9;NFAT5;ZDHHC21
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.8410455393184774,-1.678946007961649,0.013888888888888888,0.06928122639249719,0.8,2/17,2.02%,SULT1C3;SULT1C2
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.646456762117501,1.6778058172259411,0.0,0.17302239801878824,0.98,3/38,4.21%,CPA1;MGLL;LTC4S
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.6344009332173863,-1.6748477106523656,0.0,0.07081654442889602,0.8,48/179,12.57%,RPL19;RPL12;RPS14;RPL23;RPL41;RPS27;RPL27A;RPL10;RPL39;RPLP1;RPL8;RPL34;RPL29;RPL15;RPL7A;RPL35;RPL24;RPL11;RPL38;RPL35A;RPS7;RPS25;RPL27;RPS15;RPL9;RPL18A;RPLP2;RPL3;RPL23A;RPL30;RPS6;RPL18;RPS9;RPL5;RPL13;RPL21;RPS28;RPL32;RPL7;RPS24;RPS16;EMG1;POP5;RPL13A;RPL26L1;RPL14;RPL6;RPL10A
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.5264120157401428,1.6746259800551115,0.0,0.1791230988593156,0.98,43/164,15.18%,CPA1;PDK4;POSTN;PID1;TIAM2;STARD13;ESYT3;MITF;DNM3;PCDH7;ABCA1;LSAMP;DCN;CXCL12;LTC4S;RBFOX1;ACER3;LYVE1;PDGFRA;PLEK;PDE1C;GPM6A;RAPGEF2;LRRC66;SPRED1;BBS10;ROR1;EXT1;HGF;CDH9;MEIS2;PLPP3;SGCD;ENAH;LRATD1;PAPSS2;COL15A1;SLC4A4;HS2ST1;CDC42BPA;GNAI1;NEO1;OSBPL8
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.4829840182433258,1.673880816000952,0.0,0.1797922187656028,0.98,72/278,18.75%,NUDT21;PPARGC1A;RARB;SNRPF;WDR33;HDAC9;PAPOLA;NR2F6;TRIM24;KAT2B;EAF2;CSTF3;SOX5;ZBTB1;INTS13;NR4A2;MLLT3;ESRRG;RORA;SNAPC1;NOTCH2;NFKB1;IWS1;INTS7;MAML2;PIR;THRB;RNGTT;NR2E1;COPS2;INTS6;NR1D2;NR1D1;CDK12;PRRX1;TAF4;NRBF2;TRIP11;PKNOX1;NR3C1;GLIS3;INTS8;NELFA;SNAPC3;TBL1XR1;RREB1;TAF8;HNF4G;DTX1;CDK13;YAP1;POU2F1;CCNT2;PCID2;SETD2;SCAF8;NR3C2;ZNF141;MAF;CBFB;MAML1;TAF2;RPRD1B;RORB;RBPJ;SNAPC5;ESRRB;CDK9;TAF4B;TAF3;HDAC10;MED27
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,0.5730664541637859,1.6729560503836178,0.0,0.18020790301231737,0.99,30/73,20.44%,SPSB4;MEX3A;PCDH8;CSPG5;SNAP91;EFNA2;CAMKV;CACNA1B;RHBDL3;PPM1E;MPP2;KIF5A;FBLL1;KCNQ2;ASTN1;CDK5R2;CELF3;IGDCC3;MYT1;GRM8;PURG;DPYSL5;VGF;DRD2;LRCH2;LIN28B;OGDHL;UNC13A;POU3F2;CLVS2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.6510086167053339,1.6716238035083772,0.0,0.1820191238510905,0.99,13/48,13.72%,FLT1;ERBB4;CSF1R;EPHA4;EGFR;PDGFRA;TEC;DYRK1A;ABL2;PKDCC;PTK2;ABI1;FER
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.7521226857434279,1.6715506015334554,0.0,0.17985222951952992,0.99,7/20,8.72%,CHST11;CSPG5;CSGALNACT1;DCN;VCAN;UGDH;CHPF2
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.6055984140796333,1.670938921993817,0.0,0.179566295927289,0.99,33/88,19.17%,ADAMTS3;MEX3A;TENM3;MPDZ;SALL1;CDH2;MEIS3;SOX9;CACNA2D1;LYPD6;MID1;PCGF2;GLRB;RBFOX2;HSPA12A;GLI3;GPR161;DZIP1;ZFHX4;SLIT2;ADGRL2;ENAH;NCKAP1;PTPRG;YAP1;DDAH1;SMO;LIFR;LRP4;LRCH2;IGDCC4;BCAR1;CHST3
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.6504177481731153,1.6699152132518218,0.02631578947368421,0.17996527303274143,0.99,10/23,25.18%,FBXL17;KLHL15;UGGT1;VCP;ZYG11B;CUL3;RNF185;DERL1;BAG6;AUP1
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),0.55656240109311,1.6680265196362294,0.0,0.1812490315505918,0.99,13/75,8.84%,EPHA7;EPHA6;FLT1;ERBB4;CSF1R;EPHA4;EGFR;PDGFRA;HNRNPU;EPHA2;NTRK2;EPHA5;ROR1
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),0.5766864847144585,1.6678996364340382,0.0,0.1796312808346165,1.0,14/46,17.69%,PPARGC1A;PID1;FOXO1;SOX8;NR4A2;ZNF516;EP300;CLIP3;SIRT1;BBS9;OSBPL8;AKT2;MKKS;BBS2
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.8279866338357232,1.6678538846998237,0.0,0.17848681629815477,1.0,9/14,12.88%,TRPS1;SOX5;SOX9;BMP2;KAT2A;BMPR1B;SOX6;ZBTB16;TAPT1
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.7681396734409927,1.6668115550515212,0.0,0.17648701108777154,1.0,6/16,15.55%,WNT7A;SNCA;IL1RAPL2;SLITRK2;SLITRK1;LRFN5
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.7681396734409927,1.6668115550515212,0.0,0.17648701108777154,1.0,6/16,15.55%,WNT7A;SNCA;IL1RAPL2;SLITRK2;SLITRK1;LRFN5
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.6285357620564896,1.6664728942546063,0.0,0.1754140428921384,1.0,13/39,23.78%,NUP42;NUP37;NUP188;EP300;NUP153;OGT;NDC1;NUP205;HIF1A;NUP214;RANBP2;NUP98;NUP54
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.7970520161072367,1.6654757282847488,0.02631578947368421,0.17540949789815238,1.0,7/15,15.04%,MAP3K11;SASH1;MAP3K7;DUSP19;MAP3K5;MAP3K4;MAP3K10
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.7685412585967787,1.6649985222606085,0.0,0.17519820402880024,1.0,8/22,9.83%,PCSK5;KAT2B;SALL1;CHD7;KAT2A;BMPR1B;MAP3K20;GLI3
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.890449325008335,1.66417378847957,0.0,0.17499135845143451,1.0,2/7,2.40%,ACE2;SNCA
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),0.5926601125526858,1.6632434499055562,0.0,0.1755989673349464,1.0,24/58,15.87%,MAPK10;MAP3K11;BTRC;ARHGEF6;IRAK2;TAB3;MAP2K4;NFKB1;MAPK11;UBE2N;MAP3K7;MAP3K20;TAB1;GPS1;MAP3K5;MAP4K2;CRKL;TNFRSF19;MAP4K3;CUL1;MAPK1;TAOK2;MAP3K10;MAPK8
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.5301943656589048,1.661992796519015,0.0,0.1777976345319844,1.0,35/134,15.47%,MAP3K11;FLT1;PRKX;ERBB4;CSF1R;EPHA4;PASK;EGFR;CDKL5;PDGFRA;TEC;TNIK;NTRK2;CAMK2B;AKT1;DAPK2;CAMK2A;DYRK1A;UHMK1;CDK12;EIF2AK4;MAPKAPK2;SMG1;PRKD1;CAMK2D;OXSR1;SIK2;PTK2;PIKFYVE;MAPKAPK5;FER;TAOK2;GSK3B;MAP3K10;STK11
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.6873236772301634,1.6600347656115153,0.0,0.18014983387063777,1.0,7/26,12.96%,WNT7A;SALL1;HDAC2;MAP3K20;GLI3;MBNL1;NIPBL
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.6113229119258116,1.659263887502521,0.0,0.17950853156522015,1.0,18/48,18.56%,LRP12;NR4A2;ASTN2;ADGRL3;CDKL5;SH3RF1;GPM6A;NTRK2;RAPGEF2;ASTN1;AUTS2;KIAA0319;DNAAF4;NRP1;USP9X;NDNF;PEX13;CDK5R1
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.6225836604098843,1.6582510913480388,0.0,0.17926892499135844,1.0,11/41,16.75%,PDK4;PID1;ACACB;BCO2;MKLN1;PANK2;PRKN;SSH1;ABCA2;PDK2;RNF41
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.5746847515671931,1.6574344524177735,0.0,0.1784565338663144,1.0,27/89,19.43%,KAT2B;ZBTB1;DR1;SOX9;BAHD1;SMARCAD1;HNRNPC;ARID1B;KAT2A;MBD2;SMARCA2;HDAC2;KDM5A;MBD3;HDAC4;SIRT1;SMARCD2;BAZ2B;RSF1;RBBP4;SATB2;SMARCC1;KDM4C;JARID2;ATRX;BAZ1A;NPM2
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.7055677251504866,1.6574250537817483,0.0,0.17670696000487993,1.0,10/28,9.79%,CHST8;CHST11;CSGALNACT1;UGDH;CANT1;BMPR1B;EXT1;EXT2;IGF1;EXTL3
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.7803207674323317,1.6567834662063177,0.027777777777777776,0.1763127602951886,1.0,8/13,18.17%,LHX6;ARHGAP35;NTRK2;RAPGEF2;B4GALT6;B4GALT5;NPY;PTEN
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),0.8764636427285976,1.6564986790427383,0.0,0.17461744529235024,1.0,1/10,2.75%,ZBTB1
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.9050571142853275,-1.6556442491228776,0.0,0.09899922613454204,0.91,2/12,2.02%,SULT1C3;SULT1C2
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.6233823414073938,1.6540365713447653,0.0,0.17869487926522146,1.0,8/34,10.80%,RCN3;ABCA1;TVP23B;TMEM167A;TANGO6;RAB8B;GOLPH3;MTTP
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.7392336998488189,1.652345106460327,0.0,0.18159480594016789,1.0,5/18,14.35%,DGKB;DGKH;DGKZ;GPAM;DGKG
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),0.7327318520215316,1.6485727474864582,0.03333333333333333,0.1895285429541497,1.0,3/16,3.61%,MTHFS;PRODH;GLS
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.4984728087343708,1.6480869160080875,0.07142857142857142,0.18831374582325153,1.0,45/112,18.66%,MAPK10;PCDH19;SEMA5B;MPDZ;ANK2;PDZRN3;ADGRL3;RGCC;VCAN;PRDX6;COL25A1;CDH11;CACNA2D1;PRKG1;MEGF10;PBX1;FRZB;PCDH18;COL23A1;PRICKLE2;ASTN1;GUCY1A2;GFRA1;MAPK4;RUNX1T1;SLIT2;ZNF423;PLPP3;ADGRL2;RGS7BP;MEST;ASXL3;PLPPR4;LRFN5;LHX2;CSRNP3;TMEM178A;WASF3;LIFR;OPCML;LRP4;DRD2;BRINP1;LRCH2;FAM13C
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.7009195140494888,1.6466933591554067,0.0,0.1897969473927893,1.0,7/26,8.72%,CHST11;CSPG5;CSGALNACT1;DCN;VCAN;UGDH;CHPF2
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.747508662566223,1.6465430365740166,0.030303030303030304,0.18877855639003238,1.0,6/16,14.08%,ADCY1;RPS6KA4;EPHA5;LRP8;PRKD1;CRTC2
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.5993003448098015,1.6463716890176625,0.0,0.18742818172475964,1.0,39/93,19.98%,RNF150;AMOTL1;TENM3;MPDZ;ANK2;RASSF8;PDE10A;PARVA;FLRT2;LIMCH1;CDH11;CACNA2D1;PPFIBP1;PCDH18;GUCY1A2;ITSN1;GPR161;DZIP1;RUNX1T1;SLIT2;ALDH7A1;ADGRL2;APBB2;ENAH;NCKAP1;FARP1;PTPRG;TJP1;PTPN14;PYGO1;BMPR1A;LIFR;EML1;RBMS3;ZNF462;LRCH2;CHST3;FBLN1;NOVA2
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.7301097245349585,1.6456935858382427,0.030303030303030304,0.18731713865981925,1.0,11/18,21.58%,RBM24;RIDA;FTO;ROCK2;PUM1;CELF1;YTHDF2;LIN28B;ROCK1;GIGYF2;YTHDF3
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.681367274696476,1.644675523032591,0.0,0.18858459081885173,1.0,8/29,16.88%,ITGA1;PPP1R15B;PPP1R1B;PPP6R3;PPP4R4;MAGI2;GSK3B;PPP1R12A
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.520084727745717,1.6439043510925777,0.0,0.1888064656976004,1.0,50/110,20.44%,RNF150;MAPK10;RCN3;PDZRN4;PDZRN3;RAB27A;CADM2;SNAP91;LSAMP;ADGRB3;RBFOX1;PDGFRA;CDH11;KCTD16;CACNA2D1;PRKG1;FRZB;PCDH18;NRXN1;CPEB4;ASTN1;OLFM3;UNC5D;SGIP1;PAK3;CELF3;RUNX1T1;ZNF423;TMEM196;GMPPA;MEST;CNTN4;SGCD;ASXL3;MAGI2;TRPM3;PLPPR4;HEPH;CSRNP3;NDNF;OPCML;INTS6L;LRCH2;NOVA1;FAM13C;FMN2;GNB3;FGF14;GRIA2;CLVS2
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),0.6140058022371846,1.6434140394786656,0.0,0.1885172605539608,1.0,13/41,21.58%,RBM24;CPEB3;RIDA;FTO;TNRC6B;ROCK2;PUM1;CELF1;CNOT8;YTHDF2;ROCK1;GIGYF2;YTHDF3
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.5999753102749206,1.6428411167489896,0.0,0.18923873916826583,1.0,28/53,22.05%,CSNK2A1;AKT1;CAMK2A;DYRK1A;NLK;PRKD1;CAMK2D;ACVR1;OXSR1;TGFBR2;HIPK2;TGFBR1;MAPK1;CDC42BPA;GSK3B;MAP3K10;DYRK2;ROCK2;MAPK8;SBK1;CSNK2A2;WNK3;WNK1;CDK5R1;ROCK1;DYRK3;PRKCA;TAF1
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.7421567844271835,1.6412790804493629,0.02631578947368421,0.19210827195618072,1.0,3/12,9.48%,PDK4;ADIPOR2;PANK2
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.5587136134225813,1.6344912714484654,0.0,0.20448613544089475,1.0,16/62,11.60%,SHISA7;CACNG2;ADCY1;KCTD13;NPTN;BAIAP3;CACNG3;MPP2;NRXN1;TSHZ3;CLSTN2;EIF2AK4;ADRA1A;SHANK3;NLGN3;RIMS3
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.6053981673772384,1.6338854476955194,0.0,0.20456506142035105,1.0,7/47,8.40%,ACAP2;ANKRD50;CMTM6;EPS15;EHD4;DENND1A;SNX27
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.6263969259951414,1.6332382438361395,0.0,0.20480470100241963,1.0,13/40,23.78%,NUP42;NUP37;NUP188;EP300;NUP153;OGT;NDC1;NUP205;HIF1A;NUP214;RANBP2;NUP98;NUP54
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.6081695043097339,-1.631088408254952,0.0,0.15288751839246562,0.98,79/326,14.33%,RPL19;RPS13;RPL12;PRSS23;RPS14;RPL23;CP;RPS21;RPL41;RPS27;RPS4X;RPS23;RPL27A;RPL10;WARS1;RPL39;USP6;RPLP1;RPL8;RPL34;RPL29;RPL15;RPL7A;RPL35;TMEM208;RPS27A;RPL24;RPL11;RPL38;RPL35A;RPS8;RPS7;RPS25;RPL27;RPS15;IGFBP5;RPL9;RPL18A;RPLP2;RPL3;RPL23A;RPL30;TIMP1;RPS6;RPS26;RPL18;RPS9;RPS12;RPL5;GPC3;GGCX;RPL13;RPL21;RPS28;RPL32;RPL7;RPS24;RPS16;RPS3A;ST3GAL6;RPS18;PHEX;UBL5;RPL13A;SEC11C;CCN1;F5;CTSH;RPL14;MRPL51;RPS11;RPL6;RPL10A;RPS20;MRPL27;CST3;SPCS1;APOE;UBE2S
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.7772983632872954,1.6284533619201793,0.0,0.21885971552879138,1.0,10/17,15.76%,TRPS1;SOX5;SOX9;LOXL2;BMPR1B;SOX6;PKDCC;ZBTB16;TGFBR1;PTPN11
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.5457372997393183,1.6248006479156663,0.0,0.2271062712142934,1.0,15/68,14.62%,PPARGC1A;LEPR;HADH;PLAC8;ESRRG;ADIPOR2;ELOVL6;ZNF516;ADRB1;ADRB2;OGT;PRKAB1;PDGFC;ALMS1;ADIPOR1
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.7577079305080495,1.6246177502267716,0.0,0.2255760329812078,1.0,6/18,17.81%,SNCA;GRK3;PLEK;MRAP;ADA;RPGRIP1L
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.6774125757723759,1.6235532556700367,0.0,0.22579530122765742,1.0,11/22,20.95%,LIMD1;WTIP;EGFR;PUM2;TNRC6B;DHX9;FXR1;PUM1;MAP2K2;DDX6;FMR1
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.6776343459858285,1.622017141080165,0.0,0.22834427929484966,1.0,7/17,19.22%,PDK4;SLC12A2;KCNH2;PDK2;SLC12A8;CLCN3;SLC12A9
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),0.7039715596849615,1.6214272622789037,0.03125,0.22822947014962222,1.0,5/19,3.17%,PPARGC1A;LEPR;PID1;SDHAF4;COX10
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.47543752649214804,1.6206369925864517,0.0,0.22765717411835792,1.0,106/352,21.77%,VAPB;FMNL3;PPARGC1A;LIMD1;LIG4;MICAL1;WTIP;CSPG5;VAPA;MTX2;USP6NL;SORT1;RHOT1;TRAPPC12;EPS15;PLIN5;TRAPPC8;RAB31;AFG1L;TMCC1;GABPB1;GABPA;BRWD1;BIN1;TNIK;CHMP1A;RAB18;PEX11A;NRF1;WASL;FMNL2;PEX14;TFB1M;TRIP11;FGD4;HPS3;BRWD3;PKD2;PYROXD2;PRKN;ZMYM3;SYNE1;GOLPH3;MAST2;KIF5C;DYM;PRKD1;ZRANB1;PEX2;TTC17;RAB30;PEX16;PIKFYVE;RAB3GAP1;MTERF1;CHMP2B;TJAP1;OPA1;CLASP1;NDP;ABCD3;PEX7;STRIP1;TMED3;TRAPPC11;HACE1;PHIP;ARHGEF7;AGTPBP1;RAB1A;ARFGEF1;PRPF40A;TMED5;NECTIN2;TMEM135;MAST4;TTC29;PCLO;WASF3;PEX6;YTHDF2;WDR81;SEC23IP;ATAD3C;TOR1B;TOR1AIP2;ARMC2;PDZD8;NSFL1C;LARP4;MIEF2;STX7;UBXN2B;PAK4;SIRT5;PTCD2;ATXN7;PLAAT3;DYRK3;MARK1;CAPZB;GORASP2;CHMP6;YTHDF3;SIPA1L3;ABI2
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.764730735464016,-1.620115148301077,0.0,0.17527487299058797,0.98,5/25,6.36%,GBP2;GBP7;RPL39;HLA-A;STAB2
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.8321020004779671,1.6173611426255632,0.0,0.2346889312564812,1.0,5/10,14.98%,VEGFD;PIK3CA;VEGFC;GAB1;NRP1
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.6350486153047943,1.6171213461508953,0.0,0.23332181126857932,1.0,12/41,19.82%,HDAC9;RCOR1;SMARCAD1;HDAC2;ELK4;HDAC4;SIRT1;TBL1XR1;SIRT2;MIER3;HDAC10;REST
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.8550134648390039,1.6169631315153723,0.0,0.23197572389587595,1.0,3/9,4.71%,DLGAP1;DLGAP4;NPTXR
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.589104542900652,1.6151801300258484,0.0,0.23450919962109118,1.0,13/37,15.76%,NCK2;EGFR;SOX9;CBL;AKT1;PIK3CA;PIK3R1;SHC3;BRAF;SOS1;PTK2;GAB1;PTPN11
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.7723440822202933,1.614391864683252,0.037037037037037035,0.23508940074788676,1.0,10/18,17.09%,RHOQ;AKT1;PIK3R1;IRS1;IGF1;OCLN;OSBPL8;PTPN11;ARPP19;AKT2
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.7570815854403289,1.613178553206641,0.0,0.23726898476748387,1.0,6/14,15.56%,PDK4;RORA;PRKN;SIRT1;ADIPOR1;PDK2
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.881604232619984,1.611055691915324,0.02,0.24057684271349783,1.0,1/9,0.50%,NAF1
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.8115713397563307,1.6090080176567372,0.0,0.24455582440373316,1.0,4/14,7.18%,CACNA1G;ANK2;CACNA2D1;TRPM4
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),0.9279795713251382,1.6074225580746282,0.0,0.24761849088062463,1.0,1/6,2.75%,ZBTB1
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.7175620523026824,1.6070100093751147,0.0,0.2469464425835329,1.0,6/18,11.57%,WNT7A;SHANK1;GRIN1;NRXN1;SHANK3;NLGN3
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.6037343081665841,1.6068167887896414,0.0,0.24529787042185786,1.0,16/33,27.95%,SMCR8;TBC1D12;SEC22B;RALB;PIP4K2C;PIKFYVE;RAB3GAP1;UBQLN2;MTM1;LRSAM1;SCFD1;SH3GLB1;RAB1B;RAB5A;PIP4K2B;IFT20
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.7111737191307379,-1.6067264414722942,0.0,0.21093517554969685,1.0,11/43,6.48%,GBP2;TRIM22;GBP1;IRF1;HLA-A;HLA-B;STAT1;B2M;HLA-C;IFNGR2;TRIM21
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),0.6940851670992974,1.6050783421002148,0.05128205128205128,0.24898850363193717,1.0,4/17,4.71%,DLGAP1;HTR2C;DLGAP4;NPTXR
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),0.8513581348497701,1.6025248265337682,0.05263157894736842,0.2548485259987161,1.0,4/8,12.77%,SOX9;PLIN5;AKT1;ACADVL
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.5447881364527435,1.6015458673764695,0.0,0.2571780011914305,1.0,53/116,21.31%,MAPK10;CNTN1;ANK2;SNAP91;LSAMP;PNMT;ADGRB3;RBFOX1;CACNA1B;PCDH17;SERPINE1;KCTD16;CACNA2D1;SLC12A2;FAM171B;RAPGEF2;NRXN1;ADGRA1;ASTN1;GUCY1A2;DOC2B;SHC3;ITSN1;UNC5D;MAPK4;CELF3;PSD3;TMEM196;RGS7BP;KIF1B;ERC2;ASXL3;STX1A;CDC42BPA;PLPPR4;CSRNP3;NPY;PCLO;LIFR;OPCML;LRP4;BRINP1;LRCH2;FAM13C;NOVA2;GRIA2;UNC13A;CLVS2;VSTM2A;ARNT2;PHYHIPL;P2RY1;FAIM2
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.7241579631609726,1.6012507489660261,0.029411764705882353,0.2570099998539456,1.0,10/21,17.32%,ADCY1;PDE3A;PDE7B;PDE7A;SOX9;RAPGEF2;EPHA5;AHR;PDE2A;PDE4D
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),0.7665788165753463,1.6010086235202245,0.0,0.2558925692351202,1.0,4/11,17.00%,KEAP1;PKD2;LATS1;SUFU
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.49319782879235313,1.6000995512076444,0.0,0.25654597303836846,1.0,23/115,11.86%,TYR;POSTN;HMCN1;STARD13;SASH1;MITF;RASSF8;EPS8;EGFR;PARVA;SOX9;NRP2;LOXL2;PPFIBP1;MEN1;PRRX1;PRICKLE2;RASAL2;FAP;GLI3;PRKN;ECM1;PLPP3
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),0.7442620529727559,1.600064979930252,0.02857142857142857,0.25491078346067203,1.0,2/17,1.74%,MTHFS;SLC19A1
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.6174210063792934,1.599895785826462,0.047619047619047616,0.25369751738963675,1.0,15/39,15.16%,PPARGC1A;PID1;PRMT6;RHOT1;FZD5;MFF;INF2;PRKN;GOLPH3;EP300;FBXW7;STOX1;PDE2A;GSK3B;CYRIB
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.8108065124677934,1.5998497240146563,0.03125,0.25197168393800656,1.0,1/11,0.06%,VAPB
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),0.802877664838888,1.5991778924915012,0.0,0.25342217000962247,1.0,4/11,6.66%,WNT7A;FZD5;SMAD2;TASOR
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.5385696216504532,1.5990614961539433,0.0,0.2522433228088165,1.0,18/70,13.72%,LPIN3;TBC1D4;HDAC9;FOXO1;PDE3B;KAT2B;SORT1;RHOQ;RAB31;DENND4C;AKT1;RAB8B;PIK3R1;IRS1;RPS6KB1;SIRT1;OGT;FER
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),-0.8538104176199633,-1.5983942377164133,0.0,0.24066110220551654,1.0,2/14,1.58%,H1-4;H1-2
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),0.6235467488961842,1.5983305257965699,0.0,0.25276529554096094,1.0,18/32,28.73%,KCTD13;ARHGAP35;KANK1;SPRY4;ARHGAP24;ABL2;SPRY3;KCTD10;SYNGAP1;CUL3;TNFAIP1;ARHGAP44;CCDC125;MAPKAP1;LZTR1;TGFB2;RIPOR2;RASIP1
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.6201168843899808,1.5982201371682476,0.0,0.2513488827793967,1.0,8/30,18.80%,BICDL1;RHOT1;TRAK1;PEX14;TRAK2;BICD2;RAB1A;FBXW11
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),0.6228421880492298,1.5973947591210398,0.0,0.2521257072425273,1.0,7/42,15.87%,TYR;MAPK10;MEN1;CLOCK;MAP4K3;PRIMPOL;MAPK8
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.6182500660587178,1.5971786132096948,0.0,0.2513673979788943,1.0,10/26,18.87%,CNOT9;CNOT2;STRN3;GPAM;DNAAF4;LATS1;YAP1;CBFB;RUNX1;AXIN1
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.5304337884374083,1.5971739120716406,0.0,0.2497351421478625,1.0,42/114,20.96%,MAPK10;ABCC8;CNTN1;EFNA5;CADM2;SNAP91;LSAMP;ADGRB3;RBFOX1;CACNA1B;STXBP5;PCDH17;UNC79;NOL4;PIR;CAMK2B;NRXN1;LRRC4C;ADGRA1;ASTN1;UNC5D;MAPK4;PAK3;CELF3;TMEM196;RGS16;CA10;CNTN4;ASXL3;LY6H;SEZ6L;ELAVL3;CSRNP3;NPY;CTNND2;CXXC4;NOVA1;NOVA2;GRIA2;CLVS2;VSTM2A;PHYHIPL
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),0.8046461643111169,1.595884351503051,0.0,0.2522635282048995,1.0,3/10,4.85%,ANKRD2;SOX8;SOX9
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),0.8672325391963875,1.5946624993544976,0.023255813953488372,0.2543855858969927,1.0,2/7,6.56%,GLS;KYNU
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.6920231790283511,1.5937831536577012,0.0,0.2557375479138091,1.0,8/18,16.05%,PLD6;GDAP1;CHCHD3;MFF;MIGA2;OPA1;MIGA1;THG1L
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.6802692194803477,1.5934878140430482,0.0,0.25485731600064754,1.0,13/25,22.96%,AMOTL1;FAT4;AMOT;TJP1;LATS1;YAP1;MOB1A;CASP3;MOB1B;NPHP4;STK4;DCHS1;TEAD1
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.8206820838486919,1.5929476870153285,0.0,0.25496644470387203,1.0,9/13,12.88%,SOX5;SOX9;BMP2;LOXL2;BMPR1B;SOX6;PKDCC;ZBTB16;TAPT1
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.7755054913254713,1.5921745012447923,0.05555555555555555,0.2556818181818182,1.0,6/10,15.60%,WNT7A;SOX8;CDH2;TAPT1;PEF1;NRG1
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),0.7267134931066139,1.5895466521600157,0.03225806451612903,0.2629097221178557,1.0,8/23,13.73%,SHISA7;CACNG2;SHANK1;CACNG3;SHANK3;NLGN3;ADRB2;SHISA9
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.6681192268902381,1.5894756050556422,0.0,0.2615268656143181,1.0,9/21,13.43%,SHANK1;CPEB3;LLPH;CAMK2B;CAPRIN2;LRP8;SHANK3;CAPRIN1;DLG5
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.6165552930834091,1.5885362430748895,0.038461538461538464,0.263023820985285,1.0,15/26,29.63%,DROSHA;SMAD2;PUS10;PUM2;PRKRA;AGO3;PUM1;ZC3H7A;LIN28B;SMAD3;ZC3H7B;DICER1;SMAD1;AGO2;AGO1
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.6676822823787855,-1.588422940576722,0.011904761904761904,0.2761039190757836,1.0,19/77,13.16%,IFI6;IFI44L;IFIT1;ISG15;IFITM3;IRF1;BST2;MX1;STAT1;IFIT3;IFIT2;APOBEC3G;PQBP1;STAT2;NLRP1;RSAD2;OAS3;SKP2;TLR3
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.7472557239709703,1.5883570722899452,0.02857142857142857,0.26248703767715176,1.0,6/14,12.84%,FTO;NFKB1;PLIN5;FBXW7;MEST;SIRT1
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.7642484401298408,1.5881872972064315,0.0,0.26136756434025704,1.0,9/12,20.89%,RAPGEF2;ADRA1A;ZDHHC21;ADRB1;ADRB2;PDE4D;DRD2;LMBRD2;ADCY9
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.5806151184035158,1.5880044959223698,0.0,0.2606129669039101,1.0,24/64,19.21%,LIG4;TIAM2;SOX8;NPTN;PLXNA2;CDKL5;PLXNA1;MME;NTRK2;ROBO1;SPEN;CHODL;CAPRIN2;SHANK3;SLIT2;NAP1L1;SLITRK1;CAPRIN1;FZD3;KDM1A;DRD2;PLXNA4;SS18L1;ARHGDIA
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.6694098828267278,-1.5875455802681926,0.0,0.2717955804628736,1.0,21/62,15.55%,GBP2;GBP7;TRIM22;GBP3;GBP1;IRF1;HLA-A;HLA-B;STAT1;B2M;HLA-C;IFNGR2;TRIM21;RPL13A;CIITA;OAS3;MT2A;CCL2;SP100;CX3CL1;WNT5A
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),0.6701012598305044,1.5866590458973953,0.03125,0.26301096390006024,1.0,6/24,8.26%,ANKRD2;SOX8;RANBP3L;RBM24;SOX9;PLCB1
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.5413529311101801,1.5853858060515416,0.0,0.26491747321119946,1.0,17/59,12.65%,KCTD8;RGS5;RGS3;MGLL;GIT1;RGS6;PLEK;CAMK2A;GNG4;CAMKMT;PLCB1;RIC8B;MRAP;RGS16;GRK4;PPEF1;RGS12
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.6416069766276958,1.5851934701066395,0.03225806451612903,0.26404021541488637,1.0,10/19,28.21%,KLHL15;UGGT1;VCP;CUL3;RNF185;DERL1;BAG6;AUP1;DNAJB14;UGGT2
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.7827313577976761,1.5837750092785627,0.03125,0.2674050954636953,1.0,2/10,0.82%,PLD6;PID1
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),0.8522922978390743,1.5836235697358694,0.0,0.26618243673476816,1.0,4/8,12.54%,PPP1R15B;TMEM33;BOK;NCK1
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.5978658897475885,1.5822448845259223,0.03333333333333333,0.26938269198305453,1.0,11/29,17.09%,PDK4;RORA;AKT1;IRS1;PRKN;SIRT1;OGT;ADIPOR1;RUBCNL;PDK2;AKT2
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,-0.7146333011786064,-1.581572400514913,0.0,0.2884691999500468,1.0,8/31,9.63%,SLC28A2;SLC3A1;ADH4;SLC18A2;VIL1;ALDOB;FMO5;ADH6
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),0.8567839120462564,1.581378548025752,0.0,0.2702981484108542,1.0,2/7,0.82%,PPARGC1A;PID1
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),0.6482460100919092,1.581185897258738,0.0,0.26941517575121876,1.0,7/27,18.07%,ITGA1;PPP1R15B;PPP2R5A;CAMTA1;MAGI2;SPPL3;PTBP1
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),0.4827014153439455,1.5807786455773492,0.0,0.2687645054565207,1.0,33/100,14.45%,TRPS1;PCSK5;SOX5;SOX4;MMP16;ITGB8;SOX9;RAB33B;BMP2;RPS6KA3;VCAN;CDH11;CHD7;ETS2;FRZB;ADAMTS4;BMPR1B;SLC10A7;TRIP11;EXT1;HAPLN1;IGF1;SOX6;PKDCC;GDF10;ANKH;DYM;ZBTB16;WWOX;TGFBR1;PAPSS2;HAPLN2;SH3PXD2B
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.5381722084836653,1.5805214388668116,0.0,0.2679002804575307,1.0,18/56,15.76%,NCK2;ERBB4;EGFR;SOX9;CBL;AKT1;PIK3CA;PIK3R1;SHC3;BRAF;NRG2;SOS1;PTK2;GAB1;MAPK1;CPNE3;NRG1;PTPN11
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.4769896248118642,1.5799262665704208,0.0,0.26836402303631796,1.0,52/133,21.31%,MAPK10;GDAP1;ANK2;PRKX;CADM2;SNAP91;ATP2B3;LSAMP;ADGRB3;AMER2;RBFOX1;CACNA1B;KCTD16;KIF5A;CALCB;PPFIA2;NRXN1;DGKH;ADGRA1;ASTN1;OLFM3;DGKZ;TLN2;MAPK4;NKAIN2;SLITRK1;TMEM196;CA10;RGS7BP;KIF1B;ERC2;ASXL3;LY6H;MAGI2;PLPPR4;ELAVL3;CPNE3;LRFN5;RUFY3;CSRNP3;CCDC92;OPCML;BRINP1;NOVA1;FAM13C;GRIA2;CLVS2;VSTM2A;PHYHIPL;ZDHHC2;SLC6A1;FAIM2
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.5427443773324075,1.5798140615949128,0.07692307692307693,0.2674025252741022,1.0,14/49,14.48%,LEPR;SNCA;TAB3;SMCR8;QSOX1;AKT1;PIK3CA;ATG7;HGF;SMG1;EIF4E;SIRT2;BCL2;EIF4G3
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.5085846347606199,1.5780499895472904,0.0,0.271774288544686,1.0,28/100,14.88%,PPARGC1A;LEPR;MAPK10;ABCC8;CNTN1;SOWAHA;ETV1;SNAP91;PLEKHA6;PCDH17;BAIAP3;NOL4;FRZB;NRXN1;LCORL;ADGRA1;ASTN1;UNC5D;MAPK4;CELF3;TMEM196;RGS7BP;CNTN4;ASXL3;LY6H;EHF;BCHE;PLPPR4
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.5371949975534224,1.5775211892614815,0.0,0.27134462495679224,1.0,18/103,13.95%,SDC4;NR2F6;MYO5B;NPNT;ARHGEF16;HID1;PLEKHA6;CEP170B;CADPS2;LGR4;SEC23B;MAOA;WASL;PIP4K2C;GCLC;ARHGEF10L;MYH14;TMEM117
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.7157925606651289,1.57537774702937,0.0,0.2766131049800146,1.0,6/13,14.73%,SOX9;BMP2;ACVR1;TGFBR2;MDM4;BMPR1A
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.5283236644416045,1.5753574663888767,0.0,0.2752000850860167,1.0,21/75,15.04%,WNT7A;MAP3K11;SASH1;TPD52L1;SH3RF3;PRMT1;BMP2;MBIP;SH3RF1;MID1;PLCB1;DUSP19;HMGB1;MAP3K5;MAP4K2;MAP3K4;TNFRSF19;HIPK2;TAOK2;DUSP22;MAP3K10
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.8024273051256916,1.5749422583097676,0.0967741935483871,0.2753962362514379,1.0,4/9,12.73%,SNCA;CBL;PTPRJ;CBLB
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.6882029257319514,-1.5748114630212842,0.012048192771084338,0.31235154417745215,1.0,18/49,16.18%,RPL10;RPL7A;RPL24;RPL11;RPL35A;MRPL20;RPL3;RPL23A;RPL5;RPL7;RPL26L1;RPL14;RPL6;RPL10A;EBNA1BP2;WDR12;RPF2;GTF3A
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),0.7181478337732613,1.5744741086623477,0.07894736842105263,0.27622428200003,1.0,7/14,18.55%,SNCA;EGFR;AKT1;WASL;ZDHHC21;DDAH1;DNM2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),0.6643062155885514,1.5741631418444986,0.03571428571428571,0.2754668771779038,1.0,5/23,7.56%,ANK2;CXCL12;GRIN1;STIM2;CAMK2A
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.6783972161722752,1.5731436174748137,0.0625,0.27691284858891874,1.0,3/16,6.86%,ADCY1;PRKACB;PRKAR1B
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),0.5937221298892722,1.5730421804477381,0.0,0.2757439587719574,1.0,6/30,10.35%,MTHFS;PRODH;GLS;KYAT1;ALDH4A1;GCLC
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.8328629857509907,-1.5728643779160163,0.0,0.31101109524835174,1.0,2/10,9.07%,EIF2S3B;EIF2S2
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),0.6193426105833217,1.5718547551280448,0.06896551724137931,0.2774833420361695,1.0,8/40,18.43%,DNASE1L2;STT3B;UBE2G1;DFFB;PRKN;IDE;PPP1R8;HNRNPD
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.4289050307095568,1.5718099698460852,0.0,0.27601517620529026,1.0,106/362,18.80%,ZNF93;LIMD1;ZFPM2;TNFSF4;PTPRK;BTRC;FOXP1;YAF2;ZNF706;HDAC9;KCTD1;FOXO1;SOX8;SALL1;EED;DACH1;SPINDOC;PRMT6;ASCL1;PSPC1;ZEB1;SOX9;BMP2;PHF10;RCOR1;BAHD1;SMAD2;ZNF746;LOXL2;DPF1;PHC1;TLE2;CHMP1A;ZIC2;RFX3;MEN1;COPS2;HIC2;NR1D2;SP3;NR1D1;TSHZ3;PLCB1;SPEN;SFMBT2;MBD2;PEX14;ZHX3;SMARCA2;HDAC2;RBFOX2;ZNF568;NR3C1;GLI3;CLOCK;GCLC;SCMH1;ZNF148;RUNX1T1;RBM15B;ZNF423;ZBTB16;ZHX2;FOXN3;ZNF24;HDAC4;SIRT1;NIPBL;MLXIPL;AHR;ZNF91;SIRT2;SOX13;ZBTB38;VGLL4;ZNF282;SMAD4;TRIM28;KAT7;PHC2;MAP3K10;SAMD1;PHC3;RSF1;PIAS4;NRG1;POU2F1;USP47;BMP7;TFDP2;UIMC1;DPF3;KAT6B;ZNF703;JARID2;MTERF3;ZBTB21;KDM1A;ZBTB18;RORB;RBPJ;MDM2;CDK5R1;PPM1F;HDAC10;FBXW11
prerank,GO_Biological_Process_2021__phenol-containing compound biosynthetic process (GO:0046189),0.950963734740566,1.571022608916707,0.02,0.2773254862008114,1.0,1/5,0.07%,TYR
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),0.8929213997401271,1.5702599222309046,0.018867924528301886,0.2781130839379401,1.0,3/6,9.46%,VEGFD;CXCL12;VEGFC
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.521045468645333,1.56861765356382,0.0,0.28091784047701346,1.0,29/84,16.11%,LRRN1;CAPN13;SPON1;PCDH19;CLIC5;MYO5B;NPNT;PDZRN3;HID1;PRIMA1;SLC12A2;PBX1;AHCYL2;FRZB;DLG3;AMOT;PPP1R1B;ZBTB7C;NDRG2;ARHGAP32;ZNF423;ASXL3;TNFRSF19;MYH14;MCF2L;NEBL;NEO1;BMP7;HEPH
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.850028082096312,1.5670707695387907,0.0,0.2839957625069625,1.0,3/9,7.34%,PDE3B;PLIN5;AKT1
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),0.8781435538284953,1.5654949219808894,0.0,0.2876432982563671,1.0,2/7,5.95%,WNT7A;EPHA2
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.5595815342449236,1.5649105968304287,0.0,0.2878632774070036,1.0,14/35,22.06%,PDE12;RBM24;CPEB3;RIDA;FTO;ZC3H12D;ROCK2;PUM1;CELF1;YTHDF2;ROCK1;GIGYF2;YTHDF3;DIS3L2
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.727035571165166,1.564275669046212,0.03333333333333333,0.2883786162235375,1.0,6/13,14.73%,SOX9;BMP2;SMAD2;ACVR1;MDM4;BMPR1A
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.6533375578254467,1.5636568410419913,0.0,0.28888872317391356,1.0,8/22,18.80%,BICDL1;KIF5A;TRAK1;TRAK2;FYCO1;KIF13A;RAB1A;FBXW11
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.700746281095352,-1.5634657079835907,0.0,0.35716295395500525,1.0,11/41,7.99%,RPS14;RPS27;RPL10;RPL24;RPL11;RPS15;MRPL20;RPL3;RPL23A;RPL5;RPS28
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.5426750746775161,1.5633070572655725,0.0,0.2881170851271093,1.0,10/64,14.06%,VAPB;VAPA;TRAM1;TMEM33;TMCC1;RAB18;STX18;REEP4;VCPIP1;STX1A
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),0.6945444191208716,1.562584298158579,0.029411764705882353,0.2890142034055518,1.0,2/18,1.74%,MTHFS;SLC19A1
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.5463436172152056,1.5619655305681956,0.0,0.28970791565848597,1.0,13/55,18.60%,CPNE2;ADCY1;SYT3;ITPKB;PKD2;SLC25A24;BRAF;CAMK2D;SYT9;CPNE3;TRPM2;CPNE1;ADD1
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.5528826057166267,1.561483046607365,0.0,0.2898143227863448,1.0,4/31,9.85%,DNA2;INTS7;MAP3K20;CLOCK
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.4926524623778819,1.5570370720901685,0.0,0.3007964769861017,1.0,30/129,18.46%,PDK4;ATP6V0D2;FOXO1;ATP6V1A;RHEB;FOXO3;SESN1;CPEB4;KPTN;ATP6V1C1;RALB;PIK3R4;EIF2AK4;ATG7;PIK3C3;PRKD1;MAP3K5;TFEB;SIK2;VPS41;SIRT1;RPTOR;MAPK1;ATP6V1B2;SESN3;MAPK8;IMPACT;ATF2;RRAGD;ATG5
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.7188479171677922,1.5537032475477324,0.02702702702702703,0.3110957483581058,1.0,8/13,20.46%,FTO;HNRNPU;TFE3;SIRT1;RREB1;SOX13;BMP7;VSTM2A
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.5910650953333253,1.5512888182598341,0.0,0.3168144202029239,1.0,13/31,18.87%,RNF6;NCOA2;RNF14;SAFB2;EP300;GPAM;DNAAF4;LATS1;CBFB;KDM4C;KDM1A;RUNX1;AXIN1
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.6482451468813765,-1.5508351619455762,0.012048192771084338,0.4165695471460591,1.0,19/84,13.16%,IFI6;IFI44L;IFIT1;ISG15;IFITM3;IRF1;BST2;MX1;STAT1;IFIT3;IFIT2;APOBEC3G;PQBP1;STAT2;NLRP1;RSAD2;OAS3;SKP2;TLR3
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.7193332574014332,1.5505015658443264,0.05263157894736842,0.31830406447859844,1.0,5/15,9.87%,AJAP1;EPHA4;GIT1;SERPINE1;RTN4RL1
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.5969954894674601,1.550073084339309,0.0,0.318080300960806,1.0,21/33,31.50%,KAT2B;TSPAN14;MAML2;ROBO1;EP300;YAP1;MAML1;RBPJ;TSPAN5;CREBBP;MESP1;JAG1;POGLUT1;TGFB2;MAML3;ROBO2;IL6ST;DLL1;SRC;NOTCH4;ZMIZ1
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.4529137707879837,1.5489161460023666,0.0,0.32030087617788067,1.0,82/354,14.28%,POU6F2;CHST8;LIG4;DNM3;IL1RAPL2;EFNA5;SOX8;FAT4;CSPG5;ERBB4;LSAMP;PCDHB2;ASCL1;FBXL17;BTBD3;ADGRL3;CDH2;RBFOX1;ATXN10;ZIC5;SCD5;NOTCH2;PSPN;RPS6KA3;ZEB2;FZD5;VCAN;BTBD1;CHD7;RBM45;DPF1;GPM6A;FGF17;ZIC2;ROBO1;NR2E1;ARHGAP26;MOBP;DOC2A;ADAM23;DYRK1A;NRXN1;GLRB;MBP;TRAK1;KCNQ2;NPAS2;RBFOX2;GFRA1;HAPLN1;SOX6;PKD2;PRKN;SDK1;TRAK2;NAV3;NF1;EP300;SHANK3;MBNL1;DVL1;ZBTB16;NLGN3;GPM6B;SLITRK1;IGF2BP2;ZC4H2;CNTN4;HDAC4;MERTK;LY6H;NCKAP1;NBL1;PCDHB13;TGFBR1;FARP1;HAPLN2;PDGFC;TENM1;OPHN1;NDP;PTPRZ1
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),0.492496906376807,1.5486038599181895,0.0,0.3197892293068148,1.0,9/67,11.73%,RANBP17;SNRPF;NUP188;PPP1R10;SPRN;AKT1;IPO8;NXT2;NUP153
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.7374929334863491,1.548016712816278,0.04878048780487805,0.32011975780509627,1.0,6/12,17.09%,PPARGC1A;AKT1;IRS1;SIRT1;ARPP19;AKT2
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.6234862514550258,1.547590178717979,0.0,0.3199841983111945,1.0,18/35,27.46%,EFNA5;KLHL42;FAM107A;MEMO1;BICD2;CLASP1;CDK2AP2;GSK3B;TRIM36;ROCK1;MACF1;PRKAA1;MARK2;TAOK1;CYLD;CLASP2;AURKA;MAP6
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.4956447479303206,1.54744484180766,0.0,0.3190205808103561,1.0,58/175,18.98%,EPHA7;EPHA6;SEMA5B;SLIT1;EFNA5;NPTN;EPHA4;EFNA2;EMB;PLXNA2;CXCL12;ALCAM;ARHGAP35;NFIB;NOTCH2;NRP2;PSPN;PLXNA1;EPHA2;KIF5A;EFNB1;ROBO1;NRXN1;PIK3CA;EPHA5;PIK3R1;SHC3;GFRA1;UNC5D;EFNB2;SEMA3C;DCC;KIF5C;SHANK3;SLIT2;SOS1;BSG;PTK2;CNTN4;ENAH;GAB1;OPHN1;MAPK1;NRP1;VASP;SEMA6C;PTPN11;SEMA4D;SMO;LYPLA2;PTPRO;CYFIP1;FYN;NTN4;PLXNA4;CDK5R1;SEMA3D;UNC5A
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),0.48720404041258186,1.5466156337049388,0.0,0.32118434868811513,1.0,34/119,19.72%,EPHA7;NAF1;EPHA6;SERINC5;FLT1;ERBB4;CSF1R;EPHA4;DCUN1D1;EGFR;PDGFRA;EPHA2;CCT4;NTRK2;UBE2N;EPHA5;ROR1;FBXW7;DKC1;DCUN1D5;PLK1;MAP3K4;MERTK;MAPKAPK5;MAPK1;DCUN1D4;PTGES3;POT1;DCUN1D2;HNRNPD;AXIN1;NTRK3;HMBOX1;DDR2
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.5654970726680979,1.5446287269585055,0.0,0.3272530099365637,1.0,29/63,22.89%,CSF1R;CADM2;MARVELD3;CDH2;NECTIN3;CDH11;CDH20;CADM1;PKP4;CDH4;TLN2;SDK1;CDH9;NLGN4X;AFDN;OCLN;TJP1;CDH13;NECTIN2;CDH18;CSK;CDH8;CTNND2;CDH6;CDH19;NECTIN1;CDH10;DCHS1;SMAD3
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.8324683001354654,1.5446037950010412,0.029411764705882353,0.32270782924300034,1.0,2/8,10.98%,KIF5A;KIF5C
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.8324683001354654,1.5446037950010412,0.029411764705882353,0.32270782924300034,1.0,2/8,10.98%,KIF5A;KIF5C
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.8324683001354654,1.5446037950010412,0.029411764705882353,0.32270782924300034,1.0,2/8,10.98%,KIF5A;KIF5C
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),0.7092480095588782,1.5444148305822913,0.06896551724137931,0.32202710817944474,1.0,7/15,18.70%,PDGFRA;PDGFA;PTPRJ;FER;PDGFC;NRP1;BCAR1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.7451848169551593,1.5434941868203662,0.02564102564102564,0.32183849537617965,1.0,7/14,20.73%,KCTD13;FHDC1;ARRB1;FAM171A1;CUL3;TNFAIP1;PHACTR1
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.7451848169551593,1.5434941868203662,0.02564102564102564,0.32183849537617965,1.0,7/14,20.73%,KCTD13;FHDC1;ARRB1;FAM171A1;CUL3;TNFAIP1;PHACTR1
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.6896830825101288,1.5427382160434537,0.06060606060606061,0.32223156207774256,1.0,5/13,14.73%,SOX9;BMP2;ACVR1;MDM4;BMPR1A
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.49791072094248034,1.5425631265730644,0.0,0.3214773372456217,1.0,28/107,13.34%,TIAM2;TENM3;ZNF804A;NPTN;FUT9;PLXNA2;CDKL5;ARHGAP35;TOX;PLXNA1;NTRK2;ROBO1;CAMK2B;RAPGEF2;CARMIL1;ABL2;CHODL;ROR1;CAPRIN2;GRIP1;EP300;PRKD1;DVL1;SLIT2;SLITRK1;CAPRIN1;MAGI2;RAP1A
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),0.6225920572471694,1.5424100357443797,0.0,0.32037957418185553,1.0,9/28,19.27%,LIMD1;WTIP;PUM2;TNRC6B;PRKRA;AGO3;PUM1;CNOT8;ZC3H7A
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.5244869830569784,1.5422510719420286,0.0,0.3196404185764618,1.0,22/61,19.82%,MOSMO;BRINP3;ASCL1;ZEB1;BMP2;MMD;BIN1;TCF4;KCTD11;EIF2AK4;ZC4H2;CNTN4;NBL1;DTX1;YWHAG;BMP7;IMPACT;BRINP1;CPNE1;CDK5R1;ROCK1;REST
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.6374163584995606,1.5413976988049714,0.0,0.3206438879561503,1.0,12/27,21.01%,SHISA7;CAMK2B;CAMK2A;SLC4A10;RAB3GAP1;NCDN;SHISA9;DRD2;NETO1;SYNGR1;GRIK2;ZDHHC2
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.7676219504955064,1.5409182624010898,0.029411764705882353,0.3218112685793294,1.0,6/12,13.85%,AK3;RHOQ;RAB23;EFL1;GNAI3;OPA1
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),0.7445094377701065,1.5403278596488514,0.02564102564102564,0.3224521197030366,1.0,3/10,6.30%,DROSHA;SMAD2;PUS10
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),0.6013815638428393,1.538609383993908,0.045454545454545456,0.3272843762324676,1.0,10/35,23.78%,NUP42;NUP37;NUP188;NUP153;NDC1;NUP205;NUP214;RANBP2;NUP98;NUP54
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.49197106549277914,1.5385923957834673,0.0,0.3258489184419743,1.0,42/141,17.47%,PLD6;ELAPOR2;SOX8;SOX5;SHANK1;CPEB3;MCU;VHL;DCN;SOX9;BMP2;RPS6KA3;MFF;LLPH;CAMK2B;TRPM4;NRXN1;SPIRE1;PLCB1;BMPR1B;NCOA3;SOX6;ZNF268;PRKN;LRP8;GRIP1;SHANK3;DVL1;ACVR1;ZBTB16;SIRT1;TAPT1;B4GALT5;RREB1;DLG5;CLASP1;BMPR1A;ARHGEF7;BMP7;TFRC;ZNF703;SLC6A6
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.5987639695503966,1.5383607893411646,0.038461538461538464,0.3249354336698883,1.0,20/37,28.18%,PLPP1;PLPP2;PIP4P2;PLPP3;MTMR10;SYNJ1;PLPPR4;MTMR2;PTEN;MTM1;MTMR12;SACM1L;PLPPR2;OCRL;MTMR6;SYNJ2;MTMR9;SGPP2;SGPP1;TPTE2
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.7317820094354158,1.5372927849783615,0.06896551724137931,0.32741136776927815,1.0,12/15,24.33%,ASTN2;NCAM2;NRXN1;ASTN1;NLGN4X;NLGN3;CNTN4;NRXN2;CDK5R1;NLGN1;NLGN4Y;NLGN2
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.7396091020768956,1.5372876214064117,0.06666666666666667,0.3259940025408397,1.0,4/15,5.73%,CSPG5;CSGALNACT1;DCN;VCAN
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),0.7192908657503063,1.535874765173515,0.0,0.32995257577744136,1.0,2/13,0.82%,PPARGC1A;PID1
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),0.8219568798848834,1.5348896372904384,0.0425531914893617,0.3302899571910979,1.0,2/8,0.89%,PDK4;PDP1
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),0.8219568798848834,1.5348896372904384,0.0425531914893617,0.3302899571910979,1.0,2/8,0.89%,PDK4;PDP1
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.5909019435980698,1.5345421927582217,0.0,0.32996006501386327,1.0,8/33,14.88%,DGKB;PLPP1;DGKH;PLPP2;DGKZ;PLPP3;DGKG;PLPPR4
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),0.7233099091537348,1.533348754397529,0.05,0.33251653611581433,1.0,6/13,19.94%,SHISA7;SLC4A10;RAB3GAP1;SHISA9;SYNGR1;GRIK2
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.7904208727498143,1.5330928174041025,0.10256410256410256,0.33193391293694513,1.0,6/7,20.95%,RBM24;CPEB3;CPEB4;CPEB1;CPEB2;FMR1
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.4788094390329671,1.5329267021175839,0.0,0.33111109981496917,1.0,50/138,23.15%,TAFA1;WNT7A;LRP12;FUT9;NR4A2;ASTN2;LHX6;ASCL1;ADGRL3;OLIG2;CDKL5;ADNP2;FZD5;SH3RF1;GPM6A;NTRK2;RAPGEF2;DTNB;ASTN1;AUTS2;DOCK7;NLGN4X;KIAA0319;OLIG1;OPHN1;DNAAF4;NRP1;USP9X;YAP1;LHX2;FZD3;NDNF;EML1;PEX13;YTHDF2;RUNX1;CDK5R1;ATOH8;CASP3;ACSL3;POU3F2;MARK1;MYT1L;ATP2B2;MYEF2;THOC2;CTNNB1;WNT8A;FGF13;ELP3
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.6939111897494097,-1.532895913507143,0.0,0.5325994278923222,1.0,5/39,3.95%,P2RY10;CD24;IGHG1;TAGAP;CD9
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.6935862909207949,-1.529311180226961,0.0,0.5431449255698884,1.0,6/35,4.64%,GBP2;P2RY10;GPR183;IL1R1;TAGAP;CD5
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by hormone (GO:0001990),0.8989655530788059,1.5289059603096176,0.0,0.3441252655739507,1.0,1/5,0.09%,ACE2
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.505916926296639,1.5288141898293628,0.0,0.343258511925337,1.0,18/70,14.87%,PRMT6;TMEM33;USP6NL;RHOT1;PDE4DIP;RAB33B;ZEB2;MFF;PRKN;GOLPH3;EP300;STX18;CAMSAP2;STOX1;PTK2;TJP1;MAPK1;PDE2A
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),-0.8622429379166219,-1.528196872698621,0.015873015873015872,0.5205468386016725,1.0,4/12,8.03%,FLG2;ABCA12;FLG;HRNR
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),-0.8622429379166219,-1.528196872698621,0.015873015873015872,0.5205468386016725,1.0,4/12,8.03%,FLG2;ABCA12;FLG;HRNR
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.6869885259708388,1.5274227328637418,0.0,0.3462715124359414,1.0,7/21,17.49%,PNLDC1;CNOT9;CNOT6L;CNOT2;CNOT4;PAN3;CNOT8
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.7402729772227997,1.5270282475881507,0.05,0.3466082278969185,1.0,8/13,20.03%,EPHA2;OCLN;TJP1;ROCK2;CBFB;RUNX1;ROCK1;NPHP4
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),-0.8305356178686645,-1.5261255218945409,0.029411764705882353,0.5217362531399897,1.0,1/9,0.19%,PIF1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.7264612115493825,1.5258156869986375,0.041666666666666664,0.34902254484003536,1.0,7/12,20.94%,KAT2B;NAA25;EP300;NAA30;NAA50;CREBBP;NAA16
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.7072009835823161,1.5253747155095165,0.06976744186046512,0.3491061663823927,1.0,5/12,19.43%,RGCC;IGF1;SIRT2;PHIP;NPM2
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.4963713652848014,1.524580006145902,0.0,0.35022080038375525,1.0,25/95,14.68%,TIAM2;CCDC88C;RRAD;RHEB;MAPK11;RAB18;RAPGEF2;CCNA2;SHOC2;G3BP1;RALB;SHC3;IGF1;RUNDC3A;ARHGAP32;MRAS;NF1;PRKD1;SOS1;NRAS;CRKL;RRAS2;RREB1;MAPKAPK5;TRIM28
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),-0.9004207632452257,-1.5239461058315786,0.0,0.5231570274602722,1.0,2/6,6.50%,CCDC39;DNAAF1
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),0.6381643272105509,1.5237878336687902,0.09090909090909091,0.35148444942797163,1.0,19/32,30.26%,EFNA5;FAM107A;BICD2;CLASP1;MAPRE1;CDK2AP2;GSK3B;TRIM36;SKA2;ROCK1;GAS2L1;PRKAA1;MARK2;TAOK1;CYLD;CLASP2;MAP6;TPPP;CAMSAP3
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.4939806878606708,1.5235380862278898,0.0,0.3512422138597844,1.0,34/103,23.91%,ATP6V0D2;SMCR8;DCN;QSOX1;ATP6V1A;RHEB;SESN1;AKT1;PIK3CA;EXOC8;ATP6V1C1;MAP3K7;GNAI3;SMG1;SIRT1;PRKAB1;EXOC4;RPTOR;SNX5;UBQLN1;ATP6V1B2;SESN3;MAPK8;UBQLN2;RRAGD;CDK5R1;CASP3;WAC;RB1CC1;PAFAH1B2;SESN2;ERN1;PRKAA1;SH3GLB1
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.6692680218900007,1.5212769366759855,0.0,0.35641161089615647,1.0,8/22,13.60%,CHST8;CHST11;CSGALNACT1;CANT1;BMPR1B;IGF1;HS3ST4;CHST14
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.7896730992390404,1.5207269146436668,0.0425531914893617,0.35677622345586985,1.0,2/10,9.19%,DNM3;FGD4
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.6343489715806517,1.5195479718770513,0.02857142857142857,0.3593933632907017,1.0,11/24,27.92%,ARFIP1;STXBP5;DISP1;GAPVD1;NDFIP1;PPM1F;NDFIP2;SCFD1;LLGL1;LLGL2;DNAJA1
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),0.5350332658821043,1.5193065920356177,0.03571428571428571,0.3587361580294791,1.0,23/54,21.75%,UBE2G1;UBE2T;KBTBD7;RNF146;NEDD4L;MARCHF6;RNF6;KBTBD6;UBE2E3;UBE2D1;UBR5;ITCH;PRKN;UBE2E1;CDC34;UBE2E2;BFAR;HACE1;CUL3;UBE2D3;FBXO38;PELI1;UBE2H
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.5622417619997527,1.5184263992569804,0.0,0.3597816157226803,1.0,26/52,24.03%,EGFR;PPP1R10;RGCC;EYA2;TOX;UBE2N;NPAS2;HMGB1;HGF;SIRT1;EYA3;DHX9;OTUD4;TRIM28;APLF;USP9X;UIMC1;POT1;BRCC3;ATRX;H2AX;FGF2;EYA4;MECP2;EYA1;ERCC6
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),0.6150063589479697,1.5176123603052105,0.043478260869565216,0.3596279098883811,1.0,10/33,23.78%,NUP42;NUP37;NUP188;NUP153;NDC1;NUP205;NUP214;RANBP2;NUP98;NUP54
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.6150063589479697,1.5176123603052105,0.043478260869565216,0.3596279098883811,1.0,10/33,23.78%,NUP42;NUP37;NUP188;NUP153;NDC1;NUP205;NUP214;RANBP2;NUP98;NUP54
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.4872849802979558,1.5173687444348127,0.0,0.35859884914906165,1.0,19/86,13.34%,EPHA7;EPHA6;FLT1;ERBB4;CSF1R;EPHA4;EGFR;PDGFRA;AGAP2;MMD;EPHA2;NTRK2;RAPGEF2;EPHA5;ROR1;DUSP19;PTK2;MERTK;RAP1A
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.49165125620148936,1.5168377437026737,0.0,0.3591728012659869,1.0,52/120,19.59%,PDP1;PTPRK;BTRC;PTPN4;PPP1R15B;EYA2;PPM1E;DUSP10;PTPN13;PPP2R1B;PPP2R5A;PPM1A;PTPN9;PPP2R2B;PPM1L;PTPRJ;TAB1;PTPRB;PPEF1;SSH1;PPP4R1;NCK1;PPP2R2C;EYA3;DUSP6;PTPRG;PTPRZ1;PTPN14;DUSP22;PPTC7;MTMR2;STK11;PTPN11;PPP2R2A;UBASH3B;PPP3CB;PTPRO;PPP2R5E;PPP1R12A;PPP1CC;RPRD1B;PTEN;MTM1;PPM1D;LHPP;PPP1CB;PPM1F;PTPRE;FBXW11;DUSP18;DUSP12;SSH2
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),0.6403497953419769,1.5164600249334177,0.02702702702702703,0.3590613866020355,1.0,8/13,25.56%,PARD3;MYRF;ATPSCKMT;RIMS2;HCRT;RNF10;NLGN2;DICER1
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.7193091576772261,1.5154452742967528,0.045454545454545456,0.36204069164543123,1.0,12/23,17.09%,RHOQ;AKT1;PIK3R1;IRS1;IGF1;BRAF;CLIP3;OCLN;OSBPL8;PTPN11;ARPP19;AKT2
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.7920823644393856,1.5148281755765625,0.05128205128205128,0.3625196353333236,1.0,5/8,15.47%,AKT1;DAPK2;PIK3CA;MAP3K7;STK11
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),0.8009051938469288,1.5145463467002414,0.02702702702702703,0.3622470685208327,1.0,3/8,9.82%,TOP3B;TOP1MT;HMGB1
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),0.712974762313442,1.5134684482943919,0.027777777777777776,0.36436046580926607,1.0,4/15,13.20%,MYRF;B4GALT6;PRDM8;B4GALT5
prerank,GO_Biological_Process_2021__purine nucleobase transport (GO:0006863),-0.990457756425458,-1.5132322585170095,0.0,0.59373627188861,1.0,1/5,0.04%,SLC28A2
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.6310326828693782,1.5131689922348013,0.06666666666666667,0.3637861065008193,1.0,7/25,9.73%,WNT7A;SOX5;SOX9;NFIB;BMP2;BMPR1B;SOX6
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.7411736476124562,1.5125638944111224,0.02564102564102564,0.36338693712095027,1.0,7/11,16.17%,RAP2B;TNIK;RAPGEF2;MAP4K4;RAP1A;RAP2C;RAP2A
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.7411736476124562,1.5125638944111224,0.02564102564102564,0.36338693712095027,1.0,7/11,16.17%,RAP2B;TNIK;RAPGEF2;MAP4K4;RAP1A;RAP2C;RAP2A
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.5748630086649152,1.5124328821513264,0.041666666666666664,0.36245589549269874,1.0,16/39,14.54%,SMG9;MEIS3;RAB18;PBX1;FREM2;ATF6;CEP290;BMPR1B;MEIS2;PBX2;PBX3;RAB3GAP1;NIPBL;HIPK2;SH3PXD2B;ZDHHC16
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.7936927567197423,1.5115197279653985,0.03571428571428571,0.3647480696209934,1.0,6/8,17.86%,TNFSF4;SH3RF1;HMGB1;HLA-DRA;CBFB;RUNX1
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.5615906703155318,1.5110840568492352,0.0,0.36542098905921694,1.0,17/60,21.58%,NCK2;PPP1R15B;C8ORF88;RPS6KB2;UHMK1;EIF4EBP2;EIF2AK4;RPS6KB1;NCK1;EIF3H;EIF4G3;IMPACT;EIF3E;YTHDF2;DNAJC3;FMR1;YTHDF3
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.5596888491819283,1.5109478746197094,0.0,0.3643476791638076,1.0,17/60,15.56%,PDK4;PPARGC1A;LEPR;FOXO1;SOX4;MCU;ADIPOR2;PIK3R1;NR1D1;IRS1;SIRT1;MLXIPL;CRTC2;ADIPOR1;HECTD4;STK11;PDK2
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.6412340553057186,-1.5104752428271524,0.0125,0.5981466205748998,1.0,16/62,13.86%,GBP2;GBP7;ISG15;RPL39;HLA-A;SELP;AQP1;RPL30;STAB2;NLRP1;IL12A;OAS3;TLR3;DEFB109B;PGLYRP1;SLC11A1
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.5642674909530735,1.5097290956285836,0.0,0.36595673186270666,1.0,15/69,7.29%,VAPB;SLC24A3;ATP13A5;ANK2;NPTN;HTR2C;ATP2B3;CXCL12;STIM2;NEDD4L;ATP2C1;CALCB;SLC12A2;KCNMA1;ATP13A4
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.7701681292493514,1.5090855842135114,0.05263157894736842,0.3661136075584745,1.0,1/9,1.01%,ACACB
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),0.5677825364947494,1.508497210050317,0.0,0.36756077463989295,1.0,14/32,24.93%,SOX9;H2BC18;ANP32B;NAP1L1;RSF1;RBBP4;KAT6B;ATRX;ASF1A;H2AX;SPTY2D1;MACROH2A1;NAP1L3;HAT1
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.5497988070718247,1.5079480712685216,0.07142857142857142,0.3685684003985279,1.0,16/56,15.04%,WNT7A;MAP3K11;TPD52L1;SH3RF3;MBIP;SH3RF1;PLCB1;DUSP19;HMGB1;MAP3K5;MAP4K2;TNFRSF19;HIPK2;TAOK2;DUSP22;MAP3K10
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.514593206033328,1.5078950144596914,0.0,0.36721833299780066,1.0,27/79,20.95%,RBM24;RBFOX1;HNRNPU;PRDX6;MBNL2;QKI;CELF2;RBFOX2;NSRP1;KHDRBS3;CELF3;MBNL1;RBM15B;U2AF2;JMJD6;FXR1;CELF1;SRPK2;PTBP1;TRA2A;PCBP4;KHDRBS2;NOVA1;SMU1;REST;NOVA2;FMR1
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),0.6546864734799975,1.5078867925036301,0.02564102564102564,0.3659490817250802,1.0,6/14,20.27%,CSF1R;PLEK;CARMIL1;CYFIP1;ARF6;PLEKHA1
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.6249872843937394,1.507717058745028,0.03125,0.36525469000408506,1.0,11/26,16.83%,SOX4;NR4A2;TOX;CHD5;NTRK2;MDGA2;CEND1;ZC4H2;OPHN1;AGTPBP1;NPY
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.5972865967761075,1.5076923904279291,0.0,0.3641426456664512,1.0,8/34,16.42%,YAF2;EED;PHC1;PCGF2;MGA;PHC3;TFDP2;RBBP4
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),-0.7394742518771913,-1.5073208265593274,0.031746031746031744,0.6171042921894865,1.0,3/19,6.75%,GC;RPE65;RBP2
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.5200197737062886,1.5066813359425733,0.05555555555555555,0.3661271262265071,1.0,41/93,24.33%,DLGAP1;KCTD13;USP46;NRG3;DLGAP4;HOMER1;CDH2;CACNA1B;NPTXR;BAIAP3;SLC12A2;CAMK2A;EIF4EBP2;LRRC4C;CLSTN2;DGKZ;LRP8;BTBD9;NLGN4X;NLGN3;RIMS3;IQSEC2;GRM1;OPHN1;GRM8;GRID1;DRD2;PTEN;GRIK2;RIMS2;UNC13A;HCRT;NPTX1;FMR1;NLGN1;NPTX2;GRIK1;GRM5;NLGN4Y;PXK;NLGN2
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),0.6636250545628781,1.5056673009253037,0.03125,0.36760774581164657,1.0,5/19,14.70%,PPARGC1A;RPS6KA4;ARRB1;SMAD4;KAT7
prerank,GO_Biological_Process_2021__regulation of angiotensin levels in blood (GO:0002002),0.8735062562180448,1.5055734109778118,0.022727272727272728,0.3652597402597403,1.0,2/7,6.09%,ACE2;MME
prerank,GO_Biological_Process_2021__angiotensin maturation (GO:0002003),0.8735062562180448,1.5055734109778118,0.022727272727272728,0.3652597402597403,1.0,2/7,6.09%,ACE2;MME
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),0.5697008089831119,1.5054841693923242,0.034482758620689655,0.36423665910966835,1.0,15/34,19.82%,EPHA7;SNCA;PICALM;FOXO3;ZNF746;EFNB2;SARM1;NF1;MAP3K5;GSK3B;FYN;SRPK2;CDK5R1;GRIN2B;REST
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),0.855363855346669,1.5045448035813214,0.0,0.36618562046318703,1.0,1/6,6.30%,PUS10
prerank,GO_Biological_Process_2021__drug transport (GO:0015893),0.9515415011832273,1.504375032923751,0.0,0.36537261258136183,1.0,2/5,3.20%,SLC19A1;ABCC2
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),0.5131122054253822,1.5042091608939825,0.0,0.3645653301071552,1.0,21/60,21.29%,VPS37B;PARD3;EGFR;ZDHHC18;ZDHHC11;RAB3IP;NECTIN3;VPS37A;ZDHHC21;BRAF;GOLGA7;AFDN;PIKFYVE;RAB3GAP1;TAOK2;CHM;FRMPD1;RAB10;ZDHHC14;ZDHHC2;GORASP2
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),-0.8490771268737227,-1.5025235172037845,0.0,0.6483442110414691,1.0,1/11,0.18%,SPAG17
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.7990834658900329,1.501311820354175,0.025,0.3733148980297269,1.0,6/9,13.63%,HDAC9;RCOR1;SMARCAD1;HDAC2;HDAC4;SIRT2
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.46466582775974496,1.5012975037339105,0.0,0.37200960118346915,1.0,48/141,24.06%,TMEM235;GABRG1;SLIT1;CADM2;PSD2;ADGRB3;AMER2;RBFOX1;SOX9;HMG20A;NTRK2;CDH20;CAMK2A;VSTM2B;LUZP2;NRXN1;FAM107A;ADGRA1;ASTN1;MAPK4;SYNE1;GPM6B;CA10;RGS7BP;LY6H;SLC4A4;PTPRZ1;PLPPR4;ACSBG1;TMEM178A;SLC39A12;OPCML;S1PR1;BRINP1;NFATC3;SLC6A11;GRIA2;PHYHIPL;SLC6A1;FAIM2;ATP2B2;CNTFR;GRM5;CNTN2;TEAD1;SLCO1C1;TCEAL7;HTRA1
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.6524508480725607,1.5010113311205335,0.0,0.37166186312991467,1.0,8/26,22.04%,LPIN3;CSNK2A1;SLC44A5;SLC44A1;CSNK2A2;PCYT1B;CEPT1;CHPT1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.6387883574924558,1.500882912095659,0.03125,0.3709114673349464,1.0,7/23,20.58%,ZNF804A;HOMER1;CTNNA2;AKT1;GSK3B;PTEN;MARK1
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.6365866776048507,1.5008421152458153,0.03333333333333333,0.36862164320535895,1.0,7/21,21.01%,ZDHHC18;ZDHHC11;ZDHHC21;GOLGA7;CLIP3;ZDHHC14;ZDHHC2
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.6365866776048507,1.5008421152458153,0.03333333333333333,0.36862164320535895,1.0,7/21,21.01%,ZDHHC18;ZDHHC11;ZDHHC21;GOLGA7;CLIP3;ZDHHC14;ZDHHC2
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),0.728438114234251,1.5007274314490382,0.05128205128205128,0.3679562470378197,1.0,3/11,15.06%,CCT4;DKC1;CCT3
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),0.7154925541646182,1.5005794086702966,0.075,0.36736199565318267,1.0,5/12,14.31%,ELOVL7;HACD2;ELOVL6;ELOVL5;HACD1
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.7535084273148014,1.5002938688603387,0.075,0.36697088063573485,1.0,6/9,20.89%,RAPGEF2;ADRA1A;ADRB1;ADRB2;DRD2;ADCY9
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),-0.7091824137165532,-1.5000929378074375,0.0,0.6413389415011704,1.0,7/23,14.84%,ACOT2;ACOT1;ACOT6;GLYAT;ACSM6;ACSM5;ACSM3
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),-0.7091824137165532,-1.5000929378074375,0.0,0.6413389415011704,1.0,7/23,14.84%,ACOT2;ACOT1;ACOT6;GLYAT;ACSM6;ACSM5;ACSM3
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.7972776847805254,1.4993844703913022,0.09302325581395349,0.3692939325747582,1.0,2/8,0.82%,PPARGC1A;PID1
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),0.5581845474856844,1.498552162959225,0.0,0.37054667315026923,1.0,10/33,18.97%,PDE3B;EGFR;GIT1;AGAP2;HDAC4;SIRT2;MDM4;SF3B3;ADGRB1;FMN2
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.46540498254601337,1.4981216716261987,0.0,0.37152819947496757,1.0,33/119,18.75%,PPARGC1A;RARB;HDAC9;NR2F6;KAT2B;NR4A2;ESRRG;RORA;DR1;NOTCH2;MAML2;THRB;NR2E1;NR1D2;NR1D1;TAF4;NRBF2;NR3C1;TBL1XR1;TAF8;HNF4G;YAP1;NR3C2;MAML1;TAF2;RORB;RBPJ;ESRRB;CDK9;TAF4B;TAF3;HDAC10;MED27
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.5894047301206633,1.4974109705928,0.05,0.37230671736375165,1.0,17/39,26.93%,SMARCAD1;HNRNPC;ARID1B;MBD2;SMARCA2;HDAC2;MBD3;SMARCD2;RBBP4;SMARCC1;SPTY2D1;VPS72;ERCC6;ARID1A;MTA2;CHD3;PBRM1
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.8604702558095738,-1.4966940065359893,0.0,0.6589589373922744,1.0,4/9,8.81%,CENPE;KIF2C;NUF2;MIS12
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.8408272576384042,1.4964122484795335,0.08108108108108109,0.373718073957783,1.0,5/7,14.98%,SLIT1;ALCAM;NRP2;SLIT2;NRP1
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.8408272576384042,1.4964122484795335,0.08108108108108109,0.373718073957783,1.0,5/7,14.98%,SLIT1;ALCAM;NRP2;SLIT2;NRP1
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.7283458097640344,1.4959384502472286,0.029411764705882353,0.3739630141721396,1.0,6/14,13.85%,AK3;RHOQ;RAB23;EFL1;GNAI3;OPA1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.6890331546772543,1.4957014474243304,0.027777777777777776,0.3743355194632938,1.0,5/15,13.63%,PARD3;SPRED2;SPRED1;SMAD7;SIRT2
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,-0.627211009533618,-1.4949569854384028,0.0,0.6590224728072276,1.0,25/90,18.13%,SPAG17;RSPH4A;CFAP52;USP18;AQP1;TEKT1;ANGPTL2;ENKUR;DNAAF1;VWA3A;ZBBX;RGS22;DYNLRB2;CFAP77;AK7;CFAP126;CXCL17;TEKT2;APOBEC4;CFAP100;CFAP99;LRRIQ1;C1ORF87;DRC1;S100B
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.5694402884811341,1.4948416437573475,0.0,0.3759932057970484,1.0,8/39,14.39%,ACE2;ANK2;ATP2B3;CASQ1;TMEM65;STIM1;ASPH;ATP2B4
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.6477821876897134,1.4946384224861624,0.03125,0.3755223431088356,1.0,9/24,12.00%,RANBP17;NUP42;XPO1;RANBP3L;RANBP3;XPO6;STYX;XPO7;SMURF1
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.831046293087849,1.4945873151135898,0.05263157894736842,0.37441498990303274,1.0,5/10,9.73%,NUDT21;SOX5;RBM24;SOX9;SOX6
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.5691739012545115,-1.4940591690043474,0.0,0.6519490234154384,1.0,84/320,17.88%,RPL19;RPS13;RPL12;RPS14;RPL23;RPS21;RPL41;RPS27;RPS4X;RPS23;RPL27A;RPL10;WARS1;RPL39;RPLP1;RPL8;RPL34;RPL29;RPL15;RPL7A;FIP1L1;RPL35;RPS27A;RPL24;RPL11;RPL38;RPL35A;RPS8;RPS7;RPS25;RPL27;RPS15;RPL9;RPL18A;RPLP2;RPL3;RPL23A;RPL30;RPS6;RPS26;RPL18;RPS9;RPS12;RPL5;RPL13;RPL21;RPS28;RPL32;RPL7;RPS24;RPS16;RPS3A;RPS18;RPL13A;RPL14;MRPL51;RPS11;RPL6;CPSF3;RPL10A;POLR2L;POLR2I;TSPAN32;RPS20;MRPL27;SLU7;PTMA;MCM3AP;PRPF4;DRG1;RPS19;RPL36;POLR2J;NCBP2;NXF5;RPL31;MRPS33;RRAGC;IGF2BP3;RPL28;MRPL36;PAX8;RPS2;RBM8A
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),-0.8204195586174019,-1.4935646577787542,0.05172413793103448,0.6434309642622346,1.0,2/9,9.63%,ADH4;ADH6
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),0.7313156902549572,1.493471442465593,0.058823529411764705,0.3772035948842033,1.0,3/10,15.06%,CCT4;DKC1;CCT3
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.6774968135502805,-1.492493906994095,0.05063291139240506,0.6385723564203195,1.0,7/45,12.81%,PIF1;CETN2;RPS27A;ANXA1;DDX11;UBC;BLM
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.6835092900470751,1.491383603116995,0.11764705882352941,0.38289685040971105,1.0,3/14,6.86%,ADCY1;PRKACB;PRKAR1B
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),0.6781713881116184,1.4911314118579821,0.027777777777777776,0.38266297059846804,1.0,6/23,14.20%,CLDN12;SLC12A2;MBP;JAM2;OCLN;TJP1
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),-0.8565822814668103,-1.4911014207606166,0.0,0.6354747935324702,1.0,1/10,0.18%,SPAG17
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),0.611815885363267,1.4908424444301989,0.0,0.3821149685088503,1.0,11/26,21.06%,WNT7A;SHANK1;GRIN1;NRXN1;SHANK3;NLGN4X;NLGN3;MTMR2;PTEN;RIMS2;NLGN1
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.6610382984541764,1.4906132004403805,0.02857142857142857,0.381381741666359,1.0,11/15,29.63%,DROSHA;PUM2;PRKRA;AGO3;PUM1;ZC3H7A;ZC3H7B;TSN;DICER1;AGO2;AGO1
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),0.6934165694804413,1.490268069665784,0.045454545454545456,0.38096684990466423,1.0,7/17,22.72%,FZD5;FRAT2;DVL1;GSK3B;AXIN1;CTNNB1;WNT8A
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.6163906263032279,1.4894490710775488,0.034482758620689655,0.38286783821242765,1.0,18/31,26.01%,SNCA;DYRK1A;TTBK2;TRIM54;NAV3;CAMSAP2;CLIP3;CLASP1;MAPRE1;HDGFL3;KATNB1;CIB1;ATXN7;TBCD;FGF13;FKBP4;TAOK1;CLASP2
prerank,GO_Biological_Process_2021__negative regulation of systemic arterial blood pressure (GO:0003085),0.8279729971514551,1.489159618445166,0.05405405405405406,0.3825754806030472,1.0,3/6,12.21%,ADRB1;PRCP;ADRB2
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),-0.7823798608328857,-1.4891579832640973,0.046153846153846156,0.6264266925055358,1.0,2/15,1.21%,IFI6;GATA1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.7823798608328857,-1.4891579832640973,0.046153846153846156,0.6264266925055358,1.0,2/15,1.21%,IFI6;GATA1
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.6473243860602063,1.4887711076951204,0.0,0.38290618867399445,1.0,11/21,21.06%,SHANK1;CPEB3;LLPH;CAMK2B;PPFIA2;SHANK3;DLG5;TANC2;ARF6;FMR1;NLGN1
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),0.6325713103016032,1.4886388227188028,0.03125,0.3819963518354209,1.0,7/26,7.36%,CHRNA4;CACNA1G;CACNG2;CACNB4;CACNA1I;CACNA1B;KCNH2
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),0.7805437400748106,1.488177123985193,0.0,0.3822650733297121,1.0,4/12,14.45%,LIMD1;WTIP;DLG5;VGLL4
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),0.7415526316237251,1.4876776207760556,0.023809523809523808,0.3825936240685723,1.0,5/12,17.00%,KEAP1;PSMD10;PKD2;FAF1;SUFU
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.748798914373327,1.487574824827092,0.02857142857142857,0.38181605550654746,1.0,7/14,18.17%,WNT7A;SHANK1;WASL;PAK3;SHANK3;CTNND2;PTEN
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),-0.9388662835854403,-1.487444378904993,0.0,0.6288954239889788,1.0,2/7,0.58%,GBP2;GBP7
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.841719678069198,1.4869274132225438,0.025,0.3829999543465359,1.0,6/7,14.97%,FOXO1;RHEB;RFX3;AKT1;CLOCK;GSK3B
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,-0.6466048102229469,-1.4867948203236114,0.01282051282051282,0.6220862453236936,1.0,19/57,14.44%,RSPH4A;CCDC39;CFAP52;DCDC2B;CCDC181;TEKT1;DNAAF1;ECT2L;CFAP73;VWA3A;ANKUB1;EFHB;CFAP77;CFAP126;CXCL17;TEKT2;APOBEC4;CFAP100;FAM161A
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),0.6802774668189702,1.4863205230232073,0.0,0.3842983333459751,1.0,6/14,18.31%,INTS7;ERI1;TOE1;INTS6;INTS8;INTS6L
prerank,GO_Biological_Process_2021__regulation of mast cell chemotaxis (GO:0060753),0.9027165700589175,1.4857559256703599,0.08888888888888889,0.38498098859315594,1.0,3/5,9.46%,VEGFD;RIN3;VEGFC
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.7368425332270852,-1.4854537847085394,0.015625,0.6214039823362139,1.0,2/18,9.07%,EIF2S3B;EIF2S2
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.6876443592279807,-1.485146339104858,0.0,0.613288023678273,1.0,8/39,10.15%,ANKRD53;CENPE;RAB11A;KIF2C;NUF2;SPDL1;MIS12;CHMP2A
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.7929364457342023,-1.4847746570721576,0.014705882352941176,0.6042898698642577,1.0,7/18,6.81%,RPL10;RPL24;RPL11;MRPL20;RPL3;RPL23A;RPL5
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),0.8253090742131497,1.4847123349597562,0.08695652173913043,0.38771882500783394,1.0,1/6,1.93%,FOXP1
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),0.8500372517932848,1.4842241863162724,0.05128205128205128,0.3880243165662243,1.0,1/6,0.06%,VAPB
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),0.46050233916639743,1.4840758283098598,0.0,0.38754536144146384,1.0,48/145,18.45%,TIAM2;TBC1D4;ARHGEF16;TBC1D1;PICALM;TBC1D5;RSU1;SNX18;USP6NL;ARAP1;CDKL5;RGS6;TBC1D12;EVI5L;DOCK9;RANGAP1;EPHA2;ARHGEF26;ARHGAP24;RAPGEF2;PKP4;MTSS2;TBC1D22B;DOCK7;ADRB1;MAP4K4;NF1;RGS16;RGS10;AFDN;RAB3GAP1;TBC1D8B;RAP1A;RAP1GDS1;GSK3B;SCRIB;TBC1D10A;SNX13;SEMA4D;ARHGEF7;GARNL3;RALGAPB;RABGAP1L;ITGA6;RALGAPA1;TBCK;RAB11FIP2;ALS2
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.619340517323471,1.4837210111028984,0.05714285714285714,0.38778949187694434,1.0,4/23,5.72%,SLC26A7;SLC19A1;ABCC2;SLC25A18
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.9097761940513726,1.483244237477629,0.0,0.38833125049855083,1.0,3/5,8.26%,INTS13;LHFPL2;PLCB1
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),-0.9487979669760238,-1.4826844792994964,0.0,0.61019296209126,1.0,2/6,4.67%,APIP;BHMT
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),0.6419548899927869,1.4826269126624636,0.0,0.3891678983965951,1.0,8/18,22.69%,EXOSC6;INTS7;TOE1;INTS6;INTS8;INTS6L;USB1;INTS14
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.4925503510146628,1.4820547190092026,0.0,0.38993996898556144,1.0,34/99,23.38%,HDAC9;RPS6KA4;PRMT6;PRMT1;EYA2;RCOR1;PHC1;KAT2A;CCNA2;UBE2N;HDAC2;SUPT3H;EP300;USP3;HDAC4;SIRT1;TBL1XR1;SIRT2;INCENP;EYA3;MIER3;USP22;PADI2;NAA50;KAT6B;HDAC10;PHF20L1;ATXN7;CREBBP;NSD1;EYA4;HUWE1;EHMT1;EYA1
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),-0.7329161395108916,-1.4819404554234694,0.0,0.6065565083800479,1.0,1/23,0.03%,IFI6
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.5003371809807311,1.4815965024967455,0.0,0.39023310050331755,1.0,28/81,21.58%,FOXO1;EGFR;AGAP2;NEDD4L;CSNK2A1;SEC22B;ITCH;ATG7;PRKN;SMURF1;SIRT2;MDM4;VCP;GSK3B;NSF;FAF1;HACE1;WDR91;RNF41;SF3B3;IDE;ADGRB1;MDM2;AXIN1;FMN2;FURIN;ZDHHC2;CHMP6
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.6938890796761844,-1.4804273081535613,0.0,0.6101815773176849,1.0,16/37,15.55%,GBP2;GBP7;GBP3;IFITM3;GBP1;BST2;STAT1;TRIM21;RPL13A;CIITA;SLC11A1;CCL2;SHFL;SP100;CX3CL1;WNT5A
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.5162998367197534,1.4803879556712982,0.0,0.3940703742499713,1.0,33/64,29.52%,CDKL1;TBC1D1;TBC1D5;USP6NL;TRAPPC12;CDKL5;TBC1D12;TBC1D22B;STX18;ODAD3;TBC1D24;PIKFYVE;ALMS1;TBC1D10A;UBQLN2;ATG5;TSG101;STIL;RABGAP1;TBC1D17;RAB1B;CYLD;TBC1D15;RAB5A;TBC1D10B;C10ORF90;ATG3;STAM;IFT20;SDCCAG8;GSN;ATXN2;SENP6
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.43313794284027074,1.480321734749117,0.0,0.39322973949659046,1.0,59/207,19.52%,VEGFD;EPHA7;LEPR;PID1;CCDC88C;EFNA5;NPTN;PPP1R15B;ERBB4;CSF1R;EGFR;SOX9;BMP2;LIMCH1;ARRB1;TESK1;FGF17;PTPN13;TNIK;NTRK2;MEN1;AKT1;PPP2R5A;PDGFA;RALB;VEGFC;PRKN;HGF;SLIT2;BST1;PLPP3;PTK2;CLIP3;OCLN;CRKL;SIRT1;ACVR2A;FER;WDFY2;ROCK2;PHIP;SEMA4D;BMP7;RAP2A;IMPACT;FXR1;PPP2R5E;TFRC;AKT2;FYN;PTEN;CIB1;CCND3;AXIN1;NTRK3;FKBP8;FAS;FBLN1;MOB1B
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.8820724181888668,-1.4802189789773832,0.0,0.602473191089492,1.0,2/9,1.58%,H1-4;H1-2
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),0.5795620712249915,1.480015971300406,0.0,0.39327530877218997,1.0,17/38,15.87%,MAPK10;MAP3K11;ARHGEF6;IRAK2;TAB3;MAP2K4;UBE2N;MAP3K7;TAB1;GPS1;MAP3K5;MAP4K2;CRKL;TNFRSF19;MAP4K3;MAP3K10;MAPK8
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),0.7263262079062824,1.479652635735213,0.0625,0.3938476859390552,1.0,3/15,11.21%,WNT7A;ACTA2;SLC4A7
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.5897529992788725,1.478473872429501,0.07142857142857142,0.3962266794966415,1.0,7/24,14.62%,PDK4;ZBTB20;ADIPOR2;AKT1;ASXL3;MLXIPL;ADIPOR1
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.5927877570054794,1.4783981261757193,0.0,0.3955060842711397,1.0,8/29,7.41%,HMCN1;TENM3;FAT4;ALCAM;NECTIN3;CRB1;TENM2;CADM1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),0.8651183395308863,1.4783604708913476,0.06666666666666667,0.3943835093457703,1.0,2/5,5.11%,RGCC;BMP2
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),0.7923751470706086,1.477911045762668,0.06060606060606061,0.39448283418102814,1.0,1/8,0.11%,PDK4
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),-0.7271646973827103,-1.4777288574605127,0.02702702702702703,0.6121435710719305,1.0,2/19,1.21%,POU4F1;GATA1
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),0.7417403228422506,1.4775585796531086,0.02564102564102564,0.39452387375236037,1.0,1/10,0.14%,TCAP
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),-0.8540495649430367,-1.4773024537118822,0.0,0.6057108239527407,1.0,1/8,0.72%,SLC3A1
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.5996218689485181,1.4769904483380336,0.10714285714285714,0.39496734619577556,1.0,9/28,17.86%,RAB27A;GRIN1;ZBTB20;RGCC;AKT1;HDAC2;MLXIPL;ADGRB1;RUNX1
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),0.7806131380091232,1.4765586780972528,0.075,0.3948920035850955,1.0,5/8,19.30%,LEPR;EIF2AK4;SGIP1;UCN;GNB3
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.736059562721909,1.476244885405705,0.058823529411764705,0.39510303775848393,1.0,4/13,19.90%,TMEM33;RAB18;REEP4;RAB10
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),0.8455842456549252,1.4757251294658669,0.0,0.39518028999217714,1.0,2/6,6.39%,ANAPC1;CDC27
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),0.8455842456549252,1.4757251294658669,0.0,0.39518028999217714,1.0,2/6,6.39%,ANAPC1;CDC27
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),0.7922753681626162,1.47517205182922,0.0,0.3962956225895622,1.0,3/10,7.66%,EGFR;TEC;DYRK1A
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),0.7624476453534136,1.4748272323939497,0.03225806451612903,0.3964436008328041,1.0,1/11,1.88%,SERINC5
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),0.79629098919801,1.4747641384118657,0.046511627906976744,0.39432060444884903,1.0,4/7,18.70%,HGF;SIRT2;NRP1;BCAR1
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),0.79629098919801,1.4747641384118657,0.046511627906976744,0.39432060444884903,1.0,4/7,18.70%,HGF;SIRT2;NRP1;BCAR1
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),0.619123792563115,1.4743961454023606,0.045454545454545456,0.3943609288444432,1.0,5/22,11.20%,CSPG5;SOX4;MYRF;NF1;PRDM8
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.8125242623853575,-1.473590536345765,0.015625,0.6217946659436904,1.0,2/10,3.85%,MX1;STAT1
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.6325808787267221,1.47351991919419,0.03125,0.39708288139027614,1.0,8/21,12.92%,EPHA4;CDKL5;ABHD17B;CTNNA2;CAMK2B;SLITRK2;ABHD17A;PDLIM5
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.6527474295881552,1.4730526051517219,0.03333333333333333,0.39670263196879163,1.0,6/19,22.81%,ACAD8;AUH;BCKDHB;HIBCH;ACADSB;ACAT1
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.6527474295881552,1.4730526051517219,0.03333333333333333,0.39670263196879163,1.0,6/19,22.81%,ACAD8;AUH;BCKDHB;HIBCH;ACADSB;ACAT1
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),0.7092113610173634,1.4724708966579492,0.09375,0.39756662855522173,1.0,5/12,14.98%,SOX8;SOX4;ASCL1;NF1;NRP1
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.49752758994576257,1.4714600747871747,0.047619047619047616,0.4010771002890991,1.0,37/95,23.71%,PIP5K1B;CSF1R;PGAP1;PLEK;PTPN13;PLEKHA2;PIK3CA;PIK3R1;PLCB1;PIK3R4;PIP4P2;PIP5K1C;PIK3C3;PLEKHA8;PIP4K2C;PIKFYVE;PLBD1;MTMR10;SYNJ1;MTMR2;PITPNM3;PLCB3;RAB4A;PI4KB;PLEKHA3;PTEN;MTM1;MTMR12;PITPNM1;PLEKHA1;PLAAT3;SACM1L;FGF2;OCRL;MTMR6;PIK3C2B;SYNJ2
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),0.6322341329996967,1.4708720815115623,0.0,0.4015933252972643,1.0,8/31,15.39%,CLDN12;PARD3;MARVELD3;STRN;AFDN;OCLN;DLG1;PARD6G
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.5482799136907913,1.4707240246344462,0.0,0.4008433565532231,1.0,16/78,14.62%,PPARGC1A;LEPR;ACACB;HADH;PLAC8;ESRRG;ADIPOR2;ELOVL6;ZNF516;ADRB1;ADRB2;OGT;PRKAB1;PDGFC;ALMS1;ADIPOR1
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.47069886748934653,1.4706041034869264,0.0,0.4004262352545971,1.0,55/160,23.96%,TMEM235;GABRG1;SOX8;SOWAHA;ELOVL7;PSD2;AMER2;OLIG2;KIF13B;MYRF;SRCIN1;NTRK2;PEX5L;MOBP;ADAMTS4;CAMK2A;VSTM2B;NRXN1;FAM107A;PPP1R1B;MBP;ADGRA1;ASTN1;NDRG2;ANLN;MAPK4;GPM6B;CA10;RGS7BP;KIF1B;SGK3;LY6H;OLIG1;HAPLN2;SEMA4D;TMEM178A;SLC39A12;EML1;OPCML;KLHL2;POU3F1;GRIA2;PLEKHH1;PHYHIPL;SLC6A1;FAIM2;ATP2B2;FGFR2;MOG;CREB5;GRM5;CNTN2;PRR18;SLCO1C1;GALC
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),-0.7830085362039219,-1.4690983393525703,0.0,0.6491696492731192,1.0,2/16,5.95%,IFI6;CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.5712538343415867,1.4689683788998789,0.038461538461538464,0.4050907945175685,1.0,7/31,12.26%,VEGFD;CSF1R;CXCL12;SERPINE1;VEGFC;HMGB1;PTK2
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.6829530378783979,1.4689489470874824,0.06060606060606061,0.4039560864096762,1.0,9/19,17.84%,DCUN1D1;DNAJB2;ITCH;PRKN;DCUN1D5;TGFBR1;UBQLN1;HIF1A;DCUN1D2
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),0.7268818703389902,1.4688148265087908,0.07142857142857142,0.40315358590471706,1.0,3/9,15.83%,GRAMD1C;OSBPL7;SMO
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),-0.8999621140382211,-1.4685695221817694,0.0,0.644147110973157,1.0,4/8,6.81%,RPL23;RPL11;RPS7;RPL5
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.4749673913979629,1.4678453479243854,0.0,0.40576764392390813,1.0,25/81,24.23%,ANXA11;CPNE2;ADCY1;SYT3;HOMER1;ITPKB;KCNMA1;PKD2;SLC25A24;BRAF;CAMK2D;STIM1;PEF1;SYT9;CPNE3;TRPM2;CPNE1;ADD1;ADAM9;NLGN1;PPP3CA;SLC25A13;PRKAA1;KCNIP2;SYT5
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.6947673913016014,1.4676728241301134,0.05,0.4052346180435534,1.0,5/12,17.09%,GRAMD1C;RORA;OSBPL7;SMO;INSIG2
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.6235349024758682,1.4674791556714284,0.037037037037037035,0.4045429650134578,1.0,10/25,15.56%,PDK4;RORA;PANK2;PRKN;ACADVL;SIRT1;TTC39B;ARV1;ADIPOR1;PDK2
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.48726833114989665,1.4667144275048818,0.0,0.4064869861143205,1.0,29/100,20.03%,EPHA7;EPHA6;CASS4;FLT1;ERBB4;CSF1R;EPHA4;EGFR;PDGFRA;EPHA2;NTRK2;EPHA5;ROR1;SHC3;MTSS1;PTK2;MERTK;ABI1;ACVR2A;FER;PTPRG;LIFR;FYN;TRIO;BCAR1;MPZL1;NTRK3;DDR2;CNKSR1
prerank,PanglaoDB_Augmented_2021__T Cells Naive,-0.7107228790614271,-1.4664073915981515,0.0,0.6499672949717171,1.0,8/25,10.76%,P2RY10;TAGAP;CD5;DPEP2;GMFG;GPR171;ARHGAP9;TRAF3IP3
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.47471337489516885,1.466137242177363,0.0,0.40702765009869935,1.0,47/145,19.00%,TENM3;ZNF804A;NPTN;FUT9;EPHA4;CDH2;CDKL5;ARHGAP35;TOX;KIF13B;KANK1;CSMD3;SRCIN1;CTNNA2;NTRK2;CAMK2B;RAPGEF2;AKT1;PPFIA2;ABL2;LRRC4C;ROR1;HDAC2;PTPN9;RTN4RL1;EFNB2;DCC;PAK3;EP300;SHANK3;PRKD1;CAMSAP2;PDLIM5;MAGI2;RAP1A;TANC2;GSK3B;PTPRO;RUFY3;NDNF;RETREG3;ITGA6;PTEN;CIB1;CDK5R1;RTN4IP1;NTRK3
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.8483821369307609,-1.4653069372646805,0.0,0.6512054315784959,1.0,1/9,0.03%,IFI6
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.767880645097652,1.464695363360867,0.05714285714285714,0.4117318043173557,1.0,1/13,0.34%,LPIN3
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.6075925979279388,1.4638263225527175,0.03571428571428571,0.41438592919138784,1.0,5/23,4.46%,CACNA1G;CACNA1I;MAIP1;MCU;CACNA1B
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),-0.7480615720744878,-1.4637547925231364,0.046153846153846156,0.6561071559794113,1.0,4/17,3.85%,IFITM3;IRF1;BST2;STAT1
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.6869315931753341,1.463586709245283,0.07142857142857142,0.41383809421271245,1.0,7/15,24.42%,INTS7;TOE1;INTS6;INTS8;INTS6L;INTS14;INTS11
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.7433453185794777,1.4627935828657723,0.034482758620689655,0.415359446036708,1.0,10/16,19.69%,FMNL3;RHOQ;PLEK;FMNL2;NCKAP1;DLG1;STRIP1;ROCK2;ARF6;ROCK1
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),0.5883910547607286,1.4623489903707827,0.07407407407407407,0.4154459696568929,1.0,10/31,23.22%,SMCR8;SESN1;KPTN;SIK3;SESN3;STK11;RRAGD;DYRK3;GPR137B;SESN2
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),0.7154494437385484,1.4622707915271833,0.08571428571428572,0.41463625403623544,1.0,6/10,23.22%,SESN1;EIF2AK4;SESN3;IMPACT;RRAGD;SESN2
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.5764594082239882,1.4620624739096453,0.037037037037037035,0.41414621500172827,1.0,11/32,17.36%,TCAP;CACNA1G;BMP2;NOTCH2;SMAD5;SGCD;SMAD4;BMPR1A;NRG1;BMP7;MAML1
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),0.8724866793219042,1.4616156321892289,0.0,0.41491661720874723,1.0,1/6,4.01%,TMEM33
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.901678847576122,1.4614967117165516,0.0,0.41401031968154506,1.0,3/6,8.12%,SPIRE2;SNX18;SPIRE1
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),-0.8139020874258664,-1.4610512836527114,0.07352941176470588,0.6713303275950329,1.0,2/10,4.37%,RPE65;PDE6B
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.746378221421622,1.4607360731432604,0.07692307692307693,0.41571524684247546,1.0,5/11,9.70%,AKT1;PIK3R1;PLCB1;IRS1;IGF1
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),0.7766262723796363,1.4604641161297762,0.08333333333333333,0.4157994310441394,1.0,3/7,10.21%,SPSB4;MARCHF7;PRKN
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.8900025310048089,1.4598114305274383,0.07692307692307693,0.4182163843760802,1.0,6/6,11.03%,ZSWIM6;SALL1;ERBB4;LHX6;RAPGEF2;SHANK3
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),0.830416419039676,1.459542811300946,0.07317073170731707,0.4180866232505461,1.0,2/7,11.27%,TRUB1;DKC1
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),0.7772507632577428,1.4592683491519427,0.047619047619047616,0.4180606989706242,1.0,4/9,19.86%,ZSWIM6;ZSWIM5;NRP1;ZSWIM4
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),0.6805903819944147,1.4591912669816034,0.0967741935483871,0.41710903165275787,1.0,6/13,24.02%,NUP153;NDC1;NUP205;NUP98;NUP54;AHCTF1
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.8847828287941683,1.4587012658118876,0.0,0.41754754219766205,1.0,7/7,11.55%,SOX5;SOX9;LOXL2;BMPR1B;SOX6;PKDCC;ZBTB16
prerank,GO_Biological_Process_2021__renal filtration cell differentiation (GO:0061318),-0.9054531525315861,-1.4586857444150931,0.0,0.6713705203972717,1.0,1/5,0.13%,CD24
prerank,GO_Biological_Process_2021__glomerular epithelial cell differentiation (GO:0072311),-0.9054531525315861,-1.4586857444150931,0.0,0.6713705203972717,1.0,1/5,0.13%,CD24
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.6910288726563321,1.4586045011716475,0.11904761904761904,0.41670456819546275,1.0,4/17,11.20%,CACNA1G;CACNA2D1;PIK3CA;CAMK2D
prerank,GO_Biological_Process_2021__lung epithelium development (GO:0060428),0.8939648535425899,1.4583560113553062,0.06666666666666667,0.4163253141577144,1.0,2/6,3.91%,RCN3;ASCL1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),0.7372650843332731,1.4578615956632648,0.12121212121212122,0.4160804101734718,1.0,3/11,15.06%,CCT4;DKC1;CCT3
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),0.7372650843332731,1.4578615956632648,0.12121212121212122,0.4160804101734718,1.0,3/11,15.06%,CCT4;DKC1;CCT3
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.5336632177025603,1.457822615497223,0.03333333333333333,0.414996867438645,1.0,13/43,23.67%,STT3B;RHBDD1;HSPH1;ERP44;DNAJB2;PRKN;HSPA4;TOR1B;BAG3;DERL1;HSPA1A;DNAJB5;ERN1
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.7596752860653918,1.4574709190902817,0.05128205128205128,0.41492900462827875,1.0,4/12,16.88%,ITGA1;PPP1R15B;MAGI2;PPP1R12A
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),0.8771324256359183,1.455934821934054,0.06976744186046512,0.41858900078624656,1.0,2/6,6.79%,PLIN5;ABHD5
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.5893263984048376,1.455596125132704,0.0,0.4185122066897644,1.0,21/38,24.33%,CACNG2;HOMER1;CDH2;CACNG3;NRXN1;TSHZ3;DGKZ;SHANK3;NLGN3;GRM1;OPHN1;GRM8;DRD2;UNC13A;NLGN1;CACNG8;GRIK1;GRM5;CACNG4;CACNG7;NLGN2
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),0.5147495790845942,1.4552737569659755,0.05263157894736842,0.41803491185620467,1.0,18/35,26.90%,FOXO1;KAT2B;ZDHHC18;KAT2A;ZDHHC21;CLOCK;EP300;ZDHHC5;ZDHHC16;CREBBP;ZDHHC14;ZDHHC2;ZDHHC13;ZDHHC17;GTF2B;PORCN;GLUL;KAT6A
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),0.893507788521152,1.4550786948526793,0.0,0.4175100877306005,1.0,2/5,4.85%,SOX8;SOX9
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),0.7053972120454338,1.4547419399212893,0.09090909090909091,0.4176859262410593,1.0,7/16,21.58%,NEDD4L;FAP;FAF1;MDM2;FURIN;ZDHHC2;CHMP6
prerank,GO_Biological_Process_2021__uridine transport (GO:0015862),-0.9752420437850128,-1.4545126075592625,0.0,0.6794093524180309,1.0,1/5,0.04%,SLC28A2
prerank,GO_Biological_Process_2021__nucleoside transport (GO:0015858),-0.9752420437850128,-1.4545126075592625,0.0,0.6794093524180309,1.0,1/5,0.04%,SLC28A2
prerank,GO_Biological_Process_2021__pyrimidine nucleoside transport (GO:0015864),-0.9752420437850128,-1.4545126075592625,0.0,0.6794093524180309,1.0,1/5,0.04%,SLC28A2
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.7723647775031606,1.4536784951698576,0.02564102564102564,0.4199494237346872,1.0,2/8,10.41%,SNCA;PTPRJ
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.4869977765659895,1.4534690406688788,0.0,0.4196221350621133,1.0,20/63,23.26%,LPIN3;HADH;ECHDC1;AUH;BDH2;PEX2;NUDT19;HSD17B4;ACADVL;ACADM;ABCD3;PEX13;ABHD2;FAAH;ACOX1;PCCA;AIG1;SCP2;ACAT1;ECHDC2
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.46958962784461006,1.453363116370938,0.0,0.41924703746606046,1.0,33/63,31.52%,KAT2B;YJEFN3;EGFR;TSPAN14;ARRB1;MAML2;AKT1;EP300;FBXW7;DTX1;YAP1;MAML1;YTHDF2;RBPJ;TSPAN5;CREBBP;MESP1;RFNG;POFUT1;LLGL1;JAG1;POGLUT1;TGFB2;LLGL2;HIF1AN;MAML3;IL6ST;DLL1;PRAG1;SRC;NOTCH4;ZMIZ1;EGF
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.4283138948702181,1.4530370334624805,0.0,0.4195647291466712,1.0,41/147,20.89%,PPARGC1A;RARB;HDAC9;NR2F6;KAT2B;NR4A2;ESRRG;RORA;NOTCH2;MAML2;THRB;NR2E1;NR1D2;NR1D1;TAF4;NRBF2;TFB1M;TAF1B;NR3C1;TBL1XR1;TAF8;HNF4G;UBTF;YAP1;RSF1;NR3C2;MAML1;TAF2;RORB;RBPJ;ESRRB;CDK9;TAF4B;TAF3;HDAC10;MED27;RRN3;GTF2F2;CREBBP;NAT14;NR4A1
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.5216089723710912,1.4529321348061852,0.05,0.4188963320454874,1.0,13/48,15.56%,PDK4;LEPR;SOX4;MCU;ADIPOR2;IRS1;TENT4B;MLXIPL;CRTC2;ADIPOR1;HECTD4;STK11;PDK2
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.4987041260362035,1.4522069024671478,0.0,0.42014619928982183,1.0,29/96,23.78%,TCAP;PPARGC1A;MITF;PARD3;SHANK1;PICALM;SOX9;CD247;WASL;PEX14;OCLN;NDC1;MDM4;YAP1;NUP205;WASF3;WASF1;MDM2;FAS;SLC7A9;PPP2R1A;CREBBP;REPS2;TEAD1;CAPZA1;NUP98;VAMP3;LIN7A;NUP54
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),-0.6851260555004782,-1.4521957196644812,0.041666666666666664,0.6899680872625431,1.0,7/28,12.90%,EPN1;KLF2;ITGA5;CEACAM1;THBS1;PIK3CB;FGF1
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.5942567066027142,1.4518025611042193,0.038461538461538464,0.4207041055409522,1.0,10/40,19.96%,HDAC9;RCOR1;HDAC2;HDAC4;SIRT1;TBL1XR1;SIRT2;MIER3;HDAC10;SIRT5
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.7691008457034356,1.4513931554346826,0.08333333333333333,0.4207218255119358,1.0,6/9,22.03%,RAP2B;RAPGEF2;RAP1A;RAP2C;RAP2A;RAP1B
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),0.5245137746376762,1.4513420433584947,0.1111111111111111,0.41991103753160985,1.0,14/46,18.57%,PRODH;SLC6A13;SNCA;PICALM;ZNF746;EFNB2;SARM1;MAP3K5;GSK3B;FAF1;FYN;CELF1;SLC6A6;GRIN2B
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.7447386770019091,-1.4509224530070732,0.014285714285714285,0.6915408286760791,1.0,1/17,0.03%,IFI6
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),0.7819386895796743,1.4503078381798113,0.047619047619047616,0.4224583045281714,1.0,3/8,17.72%,KDM5A;KDM1B;KDM1A
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.7731678201157879,-1.449643100838347,0.016129032258064516,0.693001686280112,1.0,1/14,0.13%,CD24
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),0.8289891869283404,1.4494153989879768,0.0,0.42547774187069487,1.0,5/7,14.23%,SOX4;MDGA2;SOX6;ZC4H2;SOX13
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.7526266076138755,-1.4486829151438751,0.027777777777777776,0.6934433682139723,1.0,4/16,7.99%,RPS14;RPS27;RPS15;RPS28
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),-0.7612250126118232,-1.448640289044843,0.015384615384615385,0.6851502495471208,1.0,1/11,0.13%,CD24
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.5900569670371185,-1.4476520971758295,0.04819277108433735,0.6838330523464706,1.0,5/47,4.79%,GBP2;GBP3;GBP1;IL1R1;ANXA1
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),0.686597309533356,1.4475847173853977,0.09090909090909091,0.4309488678281596,1.0,2/12,4.69%,TCAP;PDGFRA
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.7216040379713111,1.447338612787666,0.09523809523809523,0.43065146554659617,1.0,5/11,14.31%,ELOVL7;HACD2;ELOVL6;ELOVL5;HACD1
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.6307465015487081,1.4468546467725605,0.11428571428571428,0.4311255745346398,1.0,7/20,14.01%,HS3ST5;UGDH;EXT1;EXT2;EXTL3;HS3ST4;HS2ST1
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.8322749675156534,-1.446680011606371,0.045454545454545456,0.6832236341513513,1.0,4/9,10.27%,EPN1;KLF2;THBS1;PIK3CB
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.7291821537828262,1.4465246654969701,0.06060606060606061,0.4312612820217383,1.0,8/9,24.33%,NRXN1;NLGN4X;NLGN3;NRXN2;LRP4;NLGN1;NLGN4Y;NLGN2
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.622679792671669,1.4453623703126501,0.0,0.4349402072949995,1.0,8/21,21.51%,EFNA5;LIMCH1;GPM6B;PTK2;CLASP1;ROCK2;ROCK1;MACF1
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.7217064605424827,1.4448557758148441,0.08695652173913043,0.43540028417318427,1.0,4/12,13.60%,CSPG5;DCN;VCAN;CHST14
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),0.7451301695724255,1.4444548656060086,0.11363636363636363,0.43431704721877357,1.0,1/8,0.09%,ACE2
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),0.7451301695724255,1.4444548656060086,0.11363636363636363,0.43431704721877357,1.0,1/8,0.09%,ACE2
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),0.8640539332553453,1.4439031915967093,0.023255813953488372,0.4352495089071181,1.0,2/5,9.85%,LMO3;CLOCK
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),-0.8801371711386046,-1.443900590159434,0.037037037037037035,0.6976370476628319,1.0,2/7,9.63%,ADH4;ADH6
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.6922747678349551,-1.4428942888797265,0.04225352112676056,0.6970077979265468,1.0,8/24,18.79%,CD24;FLG;GPR87;TRIM29;B3GNT3;CCL2;DMKN;DUOXA1
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),0.8795291602271129,1.4428009899830134,0.02631578947368421,0.43788051198336786,1.0,3/6,4.58%,EPS8;CXCL12;ARHGAP35
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.6777019444284605,1.4427674870251859,0.125,0.43700646689867406,1.0,7/12,24.83%,AKT1;IRS1;IGF1;DYRK2;AKT2;IRS2;EPM2AIP1
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.8212206764996344,-1.442226403446306,0.016129032258064516,0.6948959098315132,1.0,4/14,8.86%,AKR1C1;DUOX1;STAT1;TYMS
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),0.4733905121958025,1.4419182511329953,0.05555555555555555,0.439526317595532,1.0,14/85,18.07%,NUDT21;PPARGC1A;SNRPF;CSTF3;RIDA;DHX15;CPSF6;U2AF1;ZC3H12D;U2AF2;AGO3;CELF1;YTHDF2;PTBP1
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.5059363089184036,1.4414076118069858,0.0,0.4404841521513699,1.0,20/57,19.16%,ELAPOR2;RBPMS2;BMP2;SMAD2;UBE2D1;SMAD5;BMPR1B;SMAD7;ZNF423;SMURF1;NBL1;HIPK2;ACVR2A;VWC2L;SMAD4;BMPR1A;LEMD3;RBPJ;UBE2D3;CRIM1
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),0.732946719590055,1.441183427451348,0.10344827586206896,0.43970385517181065,1.0,4/11,12.52%,EXOSC6;FBLL1;DKC1;TENT4B
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.7670716622449557,1.4409884428567845,0.05128205128205128,0.4382477426285726,1.0,3/7,21.66%,ATG7;ATG2B;RB1CC1
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.7670716622449557,1.4409884428567845,0.05128205128205128,0.4382477426285726,1.0,3/7,21.66%,ATG7;ATG2B;RB1CC1
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),0.838682907859597,1.4408245296938758,0.0,0.43785052022949306,1.0,1/6,1.44%,LIG4
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.47323125519919856,1.4395139719390435,0.0,0.4418636211017129,1.0,28/76,23.98%,NUP42;NUP37;NUP188;HSPH1;CHORDC1;CAMK2B;CAMK2A;MAPKAPK2;EP300;CAMK2D;NUP153;SIRT1;RPTOR;NDC1;MAPK1;GSK3B;DNAJB6;PTGES3;NUP205;NUP214;BAG2;CREBBP;BAG3;RANBP2;HSPA1A;NUP98;NUP54;FKBP4
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),0.7925137761943095,1.439500918786704,0.10810810810810811,0.44081156486099454,1.0,1/8,0.61%,WNT7A
prerank,MSigDB_Hallmark_2020__Apical Junction,0.46373656653810397,1.4388020578519347,0.0,0.44193515677534356,1.0,47/157,18.92%,CERCAM;ARHGEF6;CNTN1;AMH;CADM2;EGFR;HADH;RSU1;PARVA;ITGA10;COL9A1;MAPK11;VCAN;NECTIN3;CDK8;CDH11;KCNH2;ADAM23;WASL;IRS1;CDH4;MAP3K20;NF1;SLIT2;PBX2;NLGN3;MAP4K2;PTK2;PPP2R2C;EXOC4;TJP1;DLG1;GNAI1;TIAL1;TAOK2;VASP;CRAT;PARD6G;NECTIN2;CDH8;AKT2;NRXN2;TUBG1;PTEN;MPZL1;TMEM8B;CDH6
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.6473043445705001,1.4387308078712981,0.05128205128205128,0.44111829010374776,1.0,8/16,24.52%,NCK2;CBL;FBXW7;CBLB;TSG101;CHMP6;ERRFI1;SOCS4
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.502067302305629,1.4384994983063548,0.0,0.44071897684064987,1.0,21/78,14.01%,CHST11;B4GALT3;SDC4;HS3ST5;CSPG5;CSGALNACT1;DCN;GPC5;VCAN;UGDH;ST3GAL1;B4GALT6;ABCC5;CHPF2;SLC10A7;EXT1;EXT2;B4GALT2;B4GALT5;CHST14;HS2ST1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),0.5055452107500539,1.438308026450652,0.0,0.4402756898564525,1.0,33/106,21.35%,MTCL1;SLC19A1;MPDZ;SALL1;EGFR;MEIS3;ALCAM;SOX9;CEP170B;FMNL2;RBFOX2;SHC3;HSPA12A;CAMK2N1;DZIP1;PSD3;TNFRSF19;FARP1;TJP1;SH3PXD2B;YAP1;DDAH1;ADGRB2;LIFR;LRP4;BCAR1;CHST3;CASKIN2;ARNT2;LEF1;DOCK1;SDC3;TMEM59L
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.562424677669381,1.4380532654104474,0.09375,0.43983448892865135,1.0,6/28,14.95%,ATP6V0D2;ATP6V1A;RAB31;ATP6V1C1;PIKFYVE;ATP6V1B2
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.4230681606706058,1.4378683393931193,0.0,0.4392127914392681,1.0,134/385,22.96%,WNT7A;PPARGC1A;FLI1;BTRC;YAF2;MITF;FOXO1;SOX8;SALL1;ERBB4;SOX4;PICALM;MLLT3;ACTA2;EGFR;ZXDA;ESRRG;VHL;MSANTD1;RORA;SOX9;NFIB;BMP2;NFKB1;MYRF;FOXO3;ZXDC;RNF6;SMAD2;ZIC2;TFE3;RFX3;ETS2;AKT1;ARID1B;KCNH2;DYRK1A;NPAS3;KAT2A;NR1D2;CEP290;SP3;NR1D1;PLCB1;PPM1A;ZNF516;SMARCA2;NPAS2;SMAD5;HDAC2;TCF4;RNF14;KDM5A;ELF1;IGF1;GLI3;CLOCK;NEK4;SUPT3H;MED13;EP300;MAP3K5;TFEB;ZNF423;ACVR1;ZBTB16;HDAC4;SETD3;HIPK2;TBL1XR1;TGFBR1;MLXIPL;RREB1;AHR;SNX5;EHF;JMJD6;NDP;SMAD4;TRIM28;TRIP4;USP22;YAP1;RSF1;TRIM16;LHX2;PHIP;BMP7;PPP3CB;TRIM44;PCID2;CXXC1;HIF1A;SMARCC1;KAT6B;APBB1;BCL10;RUNX1;RORB;ESRRB;HNRNPD;DNM2;FBXW11;AXIN1;ATOH8;SS18L1;MAP2K2;MAP3K2;HIVEP3;REST;POU3F1;WAC;MED4;NFATC2;CREBBP;MESP1;NAT14;MLLT11;ARNT2;ZNF318;NAA16;LEF1;BRD4;RNF10;CAMK4;NSD1;EPC1;CTNNB1;FGF2;NFATC1;MECOM;CREB5;SMAD3;TEAD1
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),0.6019450284543003,1.4376915079722252,0.0967741935483871,0.4388672164337563,1.0,8/25,18.22%,SMCR8;QSOX1;AKT1;SEC22B;PIK3CA;SMG1;UBQLN4;MTM1
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.8245122687545996,-1.4376849971294625,0.045454545454545456,0.7269380940148986,1.0,3/10,10.67%,H1-4;H1-2;ATAD2
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.6354687959818559,-1.437587177389647,0.01282051282051282,0.7191849217071833,1.0,11/50,12.20%,IFIT1;ISG15;IFITM3;BST2;MX1;STAT1;TRIM21;APOBEC3G;HEXIM1;RSAD2;OAS3
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.6941084245433,-1.437410829103394,0.046153846153846156,0.7123015381370175,1.0,6/27,7.71%,HLA-A;HLA-B;B2M;HLA-C;ERAP2;ERAP1
prerank,GO_Biological_Process_2021__scaRNA localization to Cajal body (GO:0090666),0.841789208318217,1.436989522990726,0.06818181818181818,0.43931396981863624,1.0,2/5,11.27%,CCT4;DKC1
prerank,GO_Biological_Process_2021__RNA localization to Cajal body (GO:0090670),0.841789208318217,1.436989522990726,0.06818181818181818,0.43931396981863624,1.0,2/5,11.27%,CCT4;DKC1
prerank,PanglaoDB_Augmented_2021__Thymocytes,-0.668101517314185,-1.4365352829754932,0.043478260869565216,0.712287249812815,1.0,12/32,16.56%,P2RY10;TAGAP;CD5;DPEP2;GMFG;TSHR;ARHGAP9;TRAF3IP3;TMC8;CXCR4;ARHGAP30;MYO1F
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.80920966891752,-1.436528658465951,0.03225806451612903,0.7042840222868283,1.0,2/11,5.69%,PRAME;KLF2
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),0.42285155507829125,1.4358545139629075,0.0,0.44245231070989316,1.0,80/176,25.06%,SPSB4;RNF150;BTRC;SPSB2;KEAP1;ANAPC1;UBE2G1;KLHL8;RNF11;RNF217;ARRB1;RNF146;NEDD4L;RNF6;CBL;CDC27;RNF144A;FEM1C;UBE2D1;UBR3;PSMD11;ITCH;RNF14;FBXO11;CNOT4;UBE3C;PRKN;KLHL15;PSMF1;KCTD10;PSMD14;FBXL14;FBXO21;PLK1;SMURF1;TRIP12;UBE2E1;BUB3;CDC34;FBXO45;MIB1;UBQLN1;ARIH1;ANAPC16;BFAR;HACE1;WDR91;UBQLN2;UBQLN4;RNF166;NDFIP1;CUL3;WDR81;UBE2L5;MDM2;FBXO8;UBA6;RBBP6;RNF185;UBE3B;UBE2H;TAF1;NDFIP2;PSMD13;UBA1;RNF149;UBE2G2;BAG6;RCHY1;FBXL7;AMFR;AREL1;PSMC2;FBXO10;USP33;RNF20;UBE2K;RLIM;BIRC6;FBXL4
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.6797558672313746,1.4354612973343512,0.04878048780487805,0.4425084390435991,1.0,5/16,12.96%,PRKCSH;PHF2;PKD2;NF1;NIPBL
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.5629976041068913,-1.4354108565297323,0.022727272727272728,0.7058784601305744,1.0,5/82,6.16%,IFI6;CD24;POU4F1;BCL2L2;SELENOK
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),0.7488072425909011,1.4353605559996276,0.16279069767441862,0.44193419460767364,1.0,3/6,17.69%,SPX;MKKS;BBS2
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.6922768403514683,1.4352374047352858,0.10344827586206896,0.4414075066917118,1.0,4/12,15.06%,GNL3L;CCT4;DKC1;CCT3
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.6814422186500555,1.4351535266786393,0.11764705882352941,0.4406144419789704,1.0,4/15,9.75%,ADCY1;PRKACB;PRKAR1B;PRRC1
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.6820033834893107,1.4348402074938345,0.125,0.4406742791756559,1.0,7/11,24.83%,AKT1;IRS1;IGF1;DYRK2;AKT2;IRS2;EPM2AIP1
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.5051382395585977,1.4344266371111205,0.037037037037037035,0.4409122224794426,1.0,4/46,10.35%,MTHFS;SLC19A1;ME2;GCLC
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),-0.8541942511490723,-1.4342124303979045,0.01639344262295082,0.708279327769682,1.0,1/9,1.21%,GATA1
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),0.4843492699487767,1.4339817604416312,0.0,0.44194995258024383,1.0,35/75,24.66%,USP13;KEAP1;RNF217;RNF144A;CSNK1E;DNAJB2;SMAD7;RNF14;PSMD10;PRKN;FBXW7;DVL1;COP1;PIAS1;PLK1;OSBPL7;SIRT2;VCP;ARIH1;GSK3B;ZYG11B;TRIB2;MDM2;BAG2;HECTD1;RNF185;FMR1;RNFT1;HSPA1A;TAF1;CSNK1D;BAG6;RCHY1;PSMC2;SUMO2
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.6466209149414324,1.4337074637004603,0.034482758620689655,0.44165119868932573,1.0,7/19,22.29%,FLT1;PDGFRA;ABL2;GNA13;NTRK3;FGFR2;FGF2
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),-0.7119203816618267,-1.4336759916748198,0.0958904109589041,0.7047422691561743,1.0,10/20,18.63%,RNF212B;SYCE2;MEIOB;IHO1;MEI4;STAG3;RAD21L1;REC8;RNF212;TEX11
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.7415869871372402,-1.4330557981216776,0.04411764705882353,0.7022810902825204,1.0,2/18,1.21%,IFI6;GATA1
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.6843626166178359,1.4328848574772497,0.08888888888888889,0.4440112296825186,1.0,5/11,14.57%,WNT7A;SMAD2;CHD7;TGFBR2;SMAD4
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,0.48722029609993134,1.4323511647659921,0.0,0.4447255129937467,1.0,28/93,21.60%,MAPK10;EGFR;RPS6KA3;SMAD2;FGF17;PPP2R1B;AKT1;UBE2N;PLCB1;RALB;MAP3K7;EIF4E;NCK1;PIKFYVE;RPTOR;MAPK1;GSK3B;PTPN11;MAPK8;PTEN;CAB39;UBE2D3;ARHGDIA;MAPK9;PAK4;PRKCB;ACTR3;CAMK4
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),0.7281558620723574,1.432094542637036,0.030303030303030304,0.4443784081209394,1.0,4/13,13.55%,RAD54B;RAD52;NSMCE2;SMC6
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.6257757934317543,-1.431592836732908,0.012987012987012988,0.7077856980725106,1.0,16/46,16.56%,P2RY10;TAGAP;HSD11B1;SPON2;CD5;DPEP2;THEMIS;GMFG;GPR171;ARHGAP9;TRAF3IP3;KLRD1;CXCR4;ARHGAP30;FHL2;MYO1F
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.4998965527313913,1.4312197515714447,0.0,0.44706816891451195,1.0,29/49,31.00%,SMCR8;DCN;SESN1;RALB;MAP3K7;PIP4K2C;GNAI3;ADRB2;RAB3GAP1;SIRT1;FYCO1;SESN3;WAC;BAG3;PAFAH1B2;LRSAM1;CALCOCO2;SESN2;SH3GLB1;SPTLC2;PIP4K2B;RUFY4;HTT;LARP1;BNIP3L;TBK1;EPM2A;UVRAG;PIP4K2A
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),0.8066952283075894,1.430778109136829,0.13513513513513514,0.4476829335853102,1.0,1/6,1.88%,SERINC5
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),0.7434966327037695,1.4304950526591478,0.09090909090909091,0.44772563783970626,1.0,2/8,8.89%,BMP2;HDAC2
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.542817751539397,1.4300231463828976,0.058823529411764705,0.44881678751888515,1.0,17/41,18.89%,EGFR;EYA2;UBE2N;UBR5;NPAS2;RAD52;SIRT1;TRIP12;EYA3;DHX9;TRIM28;KAT7;UIMC1;BRCC3;WRNIP1;CDK9;H2AX
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),0.7267101471123547,1.4296890920244438,0.14285714285714285,0.4488131627447728,1.0,5/9,13.21%,BMP2;SMAD7;ACVR1;TGFBR2;TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.7146689061729288,1.429685229015305,0.05128205128205128,0.44785260417995765,1.0,5/9,17.09%,SNCA;AKT1;IRS1;PRKCE;AKT2
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.5856823492257086,1.429392830444553,0.05128205128205128,0.4476775452446793,1.0,7/27,8.72%,CHST11;CSPG5;CSGALNACT1;DCN;VCAN;UGDH;CHPF2
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.5054577128485492,1.4289248142274087,0.0,0.4480662177423887,1.0,17/61,21.02%,ASIC4;SLC24A3;SLC6A13;SLC12A2;TRPM4;PKD2;SLC4A4;ASIC3;ATP1A4;SLC6A6;SLC24A4;SLC6A11;SLC6A12;SLC6A7;SLC9A9;SLC6A9;SLC6A1
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.6496887566951404,1.4288335705853112,0.02857142857142857,0.4476322156930522,1.0,4/13,12.87%,TOP3B;TOP1MT;HMGB1;MTERF1
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.6840264257507601,1.4283281667564114,0.12903225806451613,0.4482348247892497,1.0,6/17,14.29%,CHRNA4;SNCA;SYT3;KCNA2;PRKN;SYT9
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.7459389236806967,1.4281691896817967,0.06451612903225806,0.44775935352039864,1.0,3/10,8.12%,SPIRE2;CARMIL1;SPIRE1
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.534238524844095,1.4280489569072532,0.10526315789473684,0.44702845186943596,1.0,18/56,19.92%,CRADD;SOX4;PRMT1;RGCC;CNOT9;SDE2;CNOT6L;CNOT2;CNOT4;RFWD3;EP300;MDM4;TFDP2;CNOT8;MDM2;PCBP4;FBXO31;WAC
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.6495711765485795,-1.427862304259888,0.028985507246376812,0.7297558541758188,1.0,15/44,15.34%,P2RY10;ARHGAP15;TAGAP;EPSTI1;CD5;DPEP2;THEMIS;GMFG;GPR171;ARHGAP9;RHOH;TRAF3IP3;TMC8;SP100;ARHGAP30
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.5825013505807465,1.427610267754737,0.06060606060606061,0.44779971707493865,1.0,8/27,14.98%,VEGFD;FLT1;PIK3CA;VEGFC;MAPKAPK2;PRKD1;GAB1;NRP1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",0.5857318546275824,1.4275299405115602,0.08695652173913043,0.4471574053323103,1.0,7/23,24.03%,EAF2;KAT7;CCNT2;SCAF8;SETD5;ZMYND11;ERCC6
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),0.46245017265518384,1.4274205810546452,0.0,0.44664582840613465,1.0,13/64,19.09%,RANBP17;TSPAN17;NUP188;PPP1R10;SPRN;AKT1;IPO8;NXT2;NUP153;TNPO1;NUP214;TSPAN10;IPO5
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.5039177736881664,1.4272689621229138,0.043478260869565216,0.446008852576316,1.0,9/47,10.80%,RCN3;PCSK5;ABCA1;TVP23B;TMEM167A;TANGO6;RAB8B;GOLPH3;MTTP
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.5216171839086082,1.4268241299239517,0.06666666666666667,0.4462661717713438,1.0,20/63,18.07%,VAPB;BET1;VAPA;TRAPPC6B;SEC22B;SEC23B;PPP6R3;PEF1;TRAPPC10;COL7A1;SEC24B;NSF;TRAPPC9;RAB1A;TFG;CUL3;CD59;SEC23A;SEC23IP;CNIH1
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),-0.8179065446483829,-1.4267897503054472,0.07017543859649122,0.7318969031562655,1.0,1/8,0.28%,GC
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.5147437672371384,1.4265673662651686,0.0,0.44656473028201943,1.0,22/67,18.87%,SPSB4;DCUN1D1;FAM107A;UBE2D1;UBE2N;SMAD7;PSMD10;MARCHF7;FBXW7;DCUN1D5;PLK1;PEF1;COMMD1;UBQLN1;DCUN1D4;BIRC2;NDFIP1;CUL3;KDM1A;BCL10;DCUN1D2;AXIN1
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),0.6959475103200424,1.4259641899681066,0.075,0.4476650911495514,1.0,4/13,11.03%,SHISA7;ADCY1;EIF2AK4;SHANK3
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),0.7839334644536694,1.4259058444633903,0.07692307692307693,0.4469049009764762,1.0,3/8,12.84%,LEPR;NR1D1;SIRT1
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),0.5487877495717084,1.425493865336445,0.047619047619047616,0.4473684801199492,1.0,7/29,16.41%,CHRNA4;MME;OR3A2;KCNA2;TTC8;WHRN;ASIC3
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),-0.8327726640111918,-1.4251410991364164,0.034482758620689655,0.7381664688314004,1.0,2/9,3.05%,ENPP2;PDXDC1
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.47557336892230706,1.4244722844766653,0.0,0.4505177090153562,1.0,32/92,23.00%,TENM3;MPDZ;EGFR;PARVA;EPHA2;CACNA2D1;MID1;PCGF2;RBFOX2;PLOD2;PKDCC;SLIT2;ADGRL2;ENAH;NCKAP1;PTPRG;TJP1;YAP1;DDAH1;LIFR;LRP4;SNX7;BCAR1;CHST3;CASKIN2;TSPAN12;MESP1;DOCK1;PLS3;ADCY6;TEAD1;ERRFI1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.6932506384190085,-1.424392457524877,0.05063291139240506,0.7363827881492545,1.0,11/30,20.10%,NDUFA6;NDUFS5;NDUFA2;NDUFC1;NDUFB10;NDUFB3;NDUFA1;NDUFB7;NDUFA12;NDUFB9;NDUFB11
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),0.44543356059682204,1.424271698012723,0.0,0.4501753265909389,1.0,29/100,15.87%,MTCL1;RCN3;PICALM;RSU1;SNX18;USP6NL;ARAP1;CDKL5;RGS6;BMP2;EVI5L;DOCK9;PLIN5;RAPGEF2;PKP4;ADRB1;MAP4K4;NF1;RGS16;RGS10;AFDN;RAB3GAP1;RAP1A;RAP1GDS1;GSK3B;SNX13;SEMA4D;ARHGEF7;MAPK8
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.8018714295194507,1.4239288743231555,0.045454545454545456,0.45075432356187906,1.0,2/6,10.69%,UHRF2;HELLS
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),0.3903310844929932,1.4235501653062461,0.0,0.45120566292174835,1.0,121/312,23.59%,SPSB4;RNF150;VPS37B;BTRC;KCTD13;FEM1B;SPSB2;KEAP1;ANAPC1;TRIM9;FBXL17;UBE2G1;KLHL8;RNF11;RNF217;KBTBD7;ARRB1;RNF146;NEDD4L;MARCHF6;RNF6;CBL;PSMA1;KLHL42;CDC27;RNF144A;KBTBD6;FEM1C;KCTD17;ATE1;VPS37A;UBE2D1;UBR3;PSMD11;ITCH;RNF14;PSMD10;FBXO11;CLOCK;CNOT4;UBE3C;PRKN;RMND5A;KLHL15;FBXW7;PSMF1;KCTD10;PSMD14;PCNP;ZRANB1;FBXL14;COP1;FBXO21;PLK1;SMURF1;UBAP1L;AGAP3;SIRT1;TRIP12;TBL1XR1;UBE2E1;BUB3;CDC34;FBXO45;SIRT2;MIB1;UBQLN1;SPOPL;VCP;ARIH1;USP9X;ANAPC16;BFAR;FAF1;HACE1;WDR91;BIRC2;UBQLN2;KCTD5;UBQLN4;RNF166;NDFIP1;PSME4;CUL3;WDR81;UBE2L5;MDM2;NFE2L2;RAD23B;FBXW11;UBE2D3;NSFL1C;UBXN2B;OTUD7A;GID8;FBXO8;ANKRD9;MVB12B;TNFAIP1;PTPN23;UBA6;RBBP6;RNF185;PSMD1;UBE3B;TSG101;PELI1;UBE2H;TAF1;NDFIP2;CTNNB1;PSMD13;UBA1;RNF149;PSMB5;HUWE1;UBE2G2;BAG6;RCHY1;FBXL7;PCBP2
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.6006937101322994,1.4230578775843308,0.10344827586206896,0.45173833909066485,1.0,8/24,15.04%,MAP3K11;SASH1;DUSP10;MAP3K7;DUSP19;MAP3K5;MAP3K4;MAP3K10
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.8355447269241975,1.4226886109956114,0.04081632653061224,0.4522271929591322,1.0,2/6,7.55%,CNOT6L;CNOT2
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.7597991249821361,-1.4224332484082596,0.03225806451612903,0.7464582534202786,1.0,3/16,6.50%,SPAG17;CCDC39;DNAAF1
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),0.7966847127296837,1.4219681040842578,0.1111111111111111,0.45341873664613586,1.0,3/6,17.23%,CAMK2A;NAIF1;ATF2
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.4479660021880955,1.4219487458101696,0.0,0.4524953850453406,1.0,71/211,18.98%,EPHA7;WNT7A;EPHA6;SEMA5B;SLIT1;EFNA5;PARD3;NPTN;EPHA4;EFNA2;EMB;CXCL12;ARHGAP35;NOTCH2;NRP2;PSPN;EPHA2;KIF5A;EFNB1;CTNNA2;ROBO1;SLITRK2;NRXN1;PIK3CA;EPHA5;PIK3R1;B4GALT6;SHC3;GFRA1;UNC5D;AUTS2;EFNB2;DOCK7;SEMA3C;DCC;PAK3;KIF5C;SHANK3;SLIT2;NLGN3;SLITRK1;SOS1;BSG;PTK2;CNTN4;ENAH;B4GALT5;GAB1;OPHN1;MAPK1;PLPPR4;TAOK2;NRP1;USP9X;VASP;SEMA6C;PTPN11;SEMA4D;LYPLA2;PPP3CB;PTPRO;CYFIP1;FYN;ADGRB1;NTN4;APBB1;DRD2;PTEN;CDK5R1;SEMA3D;UNC5A
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.5456741998984135,1.421789494807895,0.045454545454545456,0.4519887670876991,1.0,20/47,20.95%,RBM24;RBFOX1;HNRNPU;MBNL2;CELF2;RBFOX2;NSRP1;KHDRBS3;CELF3;MBNL1;RBM15B;FXR1;CELF1;PTBP1;KHDRBS2;NOVA1;SMU1;REST;NOVA2;FMR1
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),0.7686489482581619,1.4217429672556905,0.12121212121212122,0.45107235759020897,1.0,4/9,12.89%,CAMK2B;CAPRIN2;LRP8;CAPRIN1
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.4564128104648763,1.4212329222782605,0.0,0.452132946114007,1.0,40/107,19.42%,INSC;TENM3;MPDZ;ANK2;PDZRN3;PCDH7;ADGRL3;MEIS3;PARVA;OLFML2A;CDH11;CACNA2D1;PBX1;FRZB;SLITRK2;PCDH18;PRICKLE2;RBFOX2;ITSN1;HSPA12A;GFRA1;DZIP1;RUNX1T1;SLIT2;ZNF423;ALDH7A1;ADGRL2;ENAH;NCKAP1;FARP1;PTPRG;TJP1;YAP1;CSRNP3;LIFR;EML1;LRP4;FAM13C;CHST3;FBLN1
prerank,GO_Biological_Process_2021__lens fiber cell differentiation (GO:0070306),0.839689991419735,1.4211061816241046,0.02040816326530612,0.45183539928329836,1.0,1/6,0.61%,WNT7A
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.9684167247956716,-1.4206971911666806,0.0,0.7537615112486872,1.0,1/5,0.13%,CD24
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.675200977958344,1.420526422845951,0.09090909090909091,0.4532173849764404,1.0,7/15,22.29%,ZFPM2;ERBB4;IGF1;BMPR1A;RBPJ;FGFR2;FGF2
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.6227055262036143,-1.4204121726365821,0.02702702702702703,0.7481939217082396,1.0,13/54,13.04%,P2RY10;TAGAP;IL7;GPR18;DPEP2;GMFG;ARHGAP9;RHOH;ZBTB32;TRAF3IP3;TMC8;RCSD1;SP140
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),0.6096001616642964,1.4197659304105268,0.058823529411764705,0.45508373587941914,1.0,4/18,11.05%,EPHA7;FOXO3;NF1;FBXW7
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),-0.8930265966731268,-1.419120930623448,0.05263157894736842,0.7506717401459506,1.0,1/6,0.13%,CD24
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),0.7236515006769119,1.4180609745520156,0.14285714285714285,0.4609369395222038,1.0,3/13,16.72%,TNFSF4;NECTIN2;TFRC
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.49718789085056,1.4172088206176934,0.0,0.4624945945125082,1.0,24/93,19.19%,MTCL1;AMOTL1;TENM3;MPDZ;AMH;EGFR;MEIS3;PARVA;BOK;EPHA2;MID1;PCGF2;RBFOX2;GPR176;B4GALT2;ENAH;NCKAP1;TJP1;YAP1;DDAH1;LRP4;BCAR1;CHST3;CASKIN2
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),0.8019490977638368,1.417154230364168,0.06521739130434782,0.4617726035127624,1.0,1/7,1.18%,ELAPOR2
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),0.7713939326286204,1.4170166367785622,0.1,0.4615397079156585,1.0,5/7,22.03%,CBARP;RAP1A;REST;FMR1;RAP1B
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.6118337104440825,1.41696212786113,0.11764705882352941,0.4607418580802611,1.0,11/23,16.68%,SEMA5B;SLIT1;ALCAM;NRP2;AUTS2;SLIT2;NLGN3;NRP1;USP9X;PPP3CB;CYFIP1
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.43356866587549164,1.41677088206679,0.0,0.4608751199418255,1.0,15/189,6.56%,CPA1;CPO;LVRN;CAPN13;ADAMTS3;PCSK5;VHL;MMP16;CTSK;NCSTN;CTSV;ATG4C;MME;SDE2;KLKB1
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.6411720845549705,1.4167570948713117,0.10810810810810811,0.4599209271469149,1.0,9/19,20.64%,KCTD13;HOMER1;CLSTN2;RIMS3;CDKN2AIP;GRIK2;RIMS2;PTPN23;HCRT
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),-0.8631190411298111,-1.4166103722576278,0.017241379310344827,0.756536266439326,1.0,1/6,3.62%,PARP14
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),-0.8631190411298111,-1.4166103722576278,0.017241379310344827,0.756536266439326,1.0,1/6,3.62%,PARP14
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.6064481905642433,1.4158621193274703,0.15789473684210525,0.4624656837678866,1.0,5/25,7.36%,CACNA1G;ANK2;NEDD4L;CACNA2D1;KCNH2
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),-0.6789536543326609,-1.4158322732139828,0.06060606060606061,0.7559467348931723,1.0,2/21,2.02%,SULT1C3;SULT1C2
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.7004749794734766,1.4157594253687786,0.09375,0.46199322217510447,1.0,7/18,14.01%,HS3ST5;CSGALNACT1;UGDH;EXT1;EXT2;EXTL3;HS2ST1
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.4669571277118135,1.4153748034615512,0.0,0.462202826746553,1.0,35/97,23.32%,CACNG2;CACNB4;C4ORF50;AMER2;PDE1B;CACNG3;KCNT1;CTNNA2;KCNH2;MOBP;NRXN1;NR3C1;RUNDC3A;KCNA2;CELF3;SLC4A10;NAPB;SEZ6L;KCNC2;SLC24A4;OTUD7A;ZNF493;GRIA2;CABP1;PRKCB;VSTM2A;MYT1L;ATP2B2;MOG;CACNA1E;CNTN2;DPP6;FGF13;RPH3A;SV2B
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.6579483883659444,-1.4144976964162235,0.04411764705882353,0.7600639012622767,1.0,10/38,9.51%,RPS14;RPS27;RPS7;RPS25;RPS15;RPS6;RPS28;RPS24;RPS16;EMG1
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),0.4110622706165295,1.414370071546455,0.0,0.464807071661328,1.0,101/341,18.27%,SPSB4;UHRF2;BTRC;KCTD13;NUP42;TRIM24;PDZRN3;SPSB2;KEAP1;DCUN1D1;NUP37;MSL2;TSPAN17;VHL;FBXL17;NUP188;UBE2G1;KLHL8;UBE2T;ARRB1;NEDD4L;RANGAP1;MARCHF6;RNF6;CBL;DTX4;SDE2;RAD18;CDC27;RNF144A;UBE2E3;TRPM4;FBXL3;LMO7;UBE2D1;RNF182;UBE2N;UBE2Z;UBR3;PEX14;RNF26;TMEM129;ITCH;RNF14;TRIM54;ATG7;FBXO11;CNOT4;RFWD3;PRKN;ZNF451;FBXW7;KCTD10;PCNP;PEX2;RNF25;PIAS1;NUP153;DCUN1D5;PLK1;SMURF1;MKRN3;NSMCE2;PEX5;SIRT1;VCPIP1;UBE2E1;CDC34;FBXO45;COMMD1;MIB1;CUL2;STX1A;DTX1;CUL1;NDC1;HIF3A;TRIM28;VCP;ARIH1;DCUN1D4;USP9X;ANAPC16;PIAS4;HACE1;NUP205;KLHL24;TRIM44;MIB2;MARCHF3;RNF41;HIF1A;UBR1;TRIM35;CUL3;PEX13;BCL10;DCUN1D2;NUP214;MDM2;NFE2L2
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),0.6961469829175526,1.4143304963887826,0.08571428571428572,0.46393428456477753,1.0,3/12,11.19%,SOX4;PKD2;DVL1
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),0.7120028479631917,1.4139594804138005,0.07692307692307693,0.46417839549239853,1.0,5/14,13.28%,PID1;PDE12;GIT1;HDAC4;MLXIPL
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),-0.8527369709544635,-1.4139161866934002,0.014492753623188406,0.7581744834138108,1.0,2/9,2.71%,RPL39;HLA-A
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),-0.9007691134072957,-1.4134320545495416,0.03225806451612903,0.754648797130556,1.0,1/6,2.40%,ENPP2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.6961936493068399,-1.413343857743812,0.1282051282051282,0.7484279273134444,1.0,4/26,10.62%,CETN2;RPS27A;RPA3;UBC
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),-0.7648372355227638,-1.4126660592830529,0.1095890410958904,0.7466460972557928,1.0,4/13,11.73%,RNF212B;MEIOB;IHO1;MEI4
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),-0.8374482660055819,-1.4118335091508094,0.05357142857142857,0.7467688378224003,1.0,2/6,8.81%,CENPE;MIS12
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.6440243997590392,1.411603006481215,0.06666666666666667,0.4725957095593163,1.0,3/20,8.12%,SPIRE2;SNX18;SPIRE1
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.6286239492475107,1.4111632162391696,0.06666666666666667,0.47290038529690676,1.0,3/17,16.51%,ACACB;ABCD3;CPT1A
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),0.6922041213982545,1.4111554522412373,0.09302325581395349,0.4719392056519943,1.0,3/11,21.51%,FAM110C;SEMA4D;MACF1
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.5464406900528558,1.410853179785636,0.0,0.4720467814526074,1.0,13/30,18.36%,SEMA5B;ALCAM;NRP2;LLPH;EIF2AK4;AUTS2;NLGN3;NRP1;USP9X;PPP3CB;IMPACT;CYFIP1;CPNE1
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),0.6829714872891397,1.4101584007587884,0.06451612903225806,0.47361021508009704,1.0,3/11,10.11%,CHRNA4;MME;KCNA2
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),-0.7543532732248723,-1.4100684497496718,0.04477611940298507,0.7546053878408364,1.0,8/14,19.70%,MT1H;MT1G;MT2A;MT3;MT1A;MT1E;MT1F;GLRA1
prerank,GO_Biological_Process_2021__tyrosine metabolic process (GO:0006570),0.847680071279561,1.4082097717696989,0.0625,0.47838827263300127,1.0,1/7,0.07%,TYR
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.5573038997506373,1.407957832115846,0.11538461538461539,0.4784821956223587,1.0,13/40,19.21%,TIAM2;PLXNA2;CDKL5;PLXNA1;NTRK2;ROBO1;CHODL;SLIT2;SLITRK1;SEMA4D;RUFY3;PLXNA4;ARHGDIA
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.6010724400586329,1.4078459975870508,0.037037037037037035,0.47791067177346835,1.0,11/26,17.09%,PID1;RHOQ;AKT1;PIK3R1;IRS1;IGF1;OCLN;OSBPL8;PTPN11;ARPP19;AKT2
prerank,GO_Biological_Process_2021__pteridine-containing compound biosynthetic process (GO:0042559),0.9053336685875786,1.4074035830003608,0.02564102564102564,0.4780051765999359,1.0,2/5,6.27%,MTHFS;QDPR
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.5321695281849843,1.4061289277684617,0.03125,0.4818009679919812,1.0,4/33,8.33%,SGMS1;ST6GALNAC5;CERS3;B4GALT6
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.6073503231660249,1.4059054700036528,0.041666666666666664,0.4821206360179745,1.0,5/18,10.21%,MCU;DCN;MFF;SPIRE1;PRKN
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),0.7376499126586308,1.4056523188032137,0.1590909090909091,0.4822449811748781,1.0,6/10,16.96%,LIMD1;WTIP;PUM2;DHX9;FXR1;PUM1
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),-0.8638815187971711,-1.4054498983949268,0.05660377358490566,0.7778784788791945,1.0,1/6,3.85%,STAT1
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),-0.8638815187971711,-1.4054498983949268,0.05660377358490566,0.7778784788791945,1.0,1/6,3.85%,STAT1
prerank,GO_Biological_Process_2021__organic hydroxy compound catabolic process (GO:1901616),-0.7807941949297349,-1.405284240250762,0.12,0.772255793776872,1.0,1/7,0.87%,ADH4
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.5778102105015218,1.4051703465261076,0.037037037037037035,0.4827561513365825,1.0,13/32,20.24%,PID1;KANK1;IRS1;RPS6KB1;PIP4K2C;SIK2;NCK1;SIRT1;OGT;SNX5;PTPN11;PTPRE;PRKCB
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),0.8667748701027618,1.4049649630263268,0.045454545454545456,0.48253084328457196,1.0,3/5,9.82%,ZBTB1;TRPM4;HMGB1
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),0.7973962064677923,1.4047394240413178,0.06521739130434782,0.4813128651268168,1.0,3/7,6.79%,CACNG2;CACNG3;GPHN
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),0.7973962064677923,1.4047394240413178,0.06521739130434782,0.4813128651268168,1.0,3/7,6.79%,CACNG2;CACNG3;GPHN
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),0.7710415238536917,1.4043771482377285,0.07142857142857142,0.4817449848277633,1.0,5/9,17.05%,LRCH1;AKT1;WASL;PADI2;CD200R1
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.7986500353373795,1.404373789624201,0.07142857142857142,0.480794797480963,1.0,3/6,10.21%,ARFIP1;ATP9A;PRKN
prerank,PanglaoDB_Augmented_2021__Interneurons,0.45230430444551756,1.4040934730110182,0.0,0.4811496865907662,1.0,66/265,12.82%,VEGFD;PDP1;CACNG2;DLGAP1;ADCY1;PTPN4;PCDH8;DNM3;ETV1;CACNA1I;CADM2;SNAP91;ATP2B3;LHX6;TRIM9;CAMKV;PSD2;ADGRB3;RORA;AMER2;RBFOX1;CACNA1B;CDKL5;GABRA5;NPTXR;ILDR2;NOL4;SLC35F1;KIF5A;CTNNA2;NRIP3;LMO3;KCNMA1;GABRA4;CAMK2A;HIVEP2;PPFIA2;VSTM2B;NRXN1;GNG4;ADGRA1;KCNQ2;ABCC5;CDH4;ASTN1;CDK5R2;OLFM3;TMEM132D;HSPA12A;FBXO11;KCNA2;MAPK4;ADARB1;CELF3;RGMA;PSD3;SLITRK1;TMEM196;CA10;GRM1;OXR1;RGS10;ADGRL2;RGS7BP;ERC2;LY6H
prerank,GO_Biological_Process_2021__sulfation (GO:0051923),-0.7985229982822162,-1.403850271221367,0.0625,0.7781878586990292,1.0,2/9,2.02%,SULT1C3;SULT1C2
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),0.7156936972606941,1.4038056578442837,0.0425531914893617,0.4814267824849223,1.0,3/11,9.98%,IRAK2;PIK3R4;PIK3C3
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.4019680745018317,1.4035952406821541,0.0,0.4814359203757549,1.0,48/182,15.23%,NUDT21;BRINP3;NPNT;SOX5;RANBP3L;RBM24;ASCL1;VHL;CDH2;RGCC;ZEB1;SOX9;BMP2;MMD;NFKB1;RPS6KA3;MAPK11;SMAD2;LOXL2;CTNNA2;LMO3;TRPM4;FRZB;RAPGEF2;AKT1;PLCB1;ZHX3;BMPR1B;TCF4;KCTD11;IGF1;SOX6;ZNF268;PKDCC;HGF;PRKD1;ACVR1;ZBTB16;ZC4H2;TGFBR2;NBL1;TGFBR1;RAP1A;ACVR2A;WDFY2;SMAD4;BMPR1A;YAP1
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),0.7469340960077369,1.4035790337689455,0.1282051282051282,0.4804937757174853,1.0,2/6,15.74%,PLOD2;MTHFR
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),-0.6283406869808275,-1.403497792205255,0.05333333333333334,0.7752298092218495,1.0,9/43,14.28%,SPAG17;RSPH4A;CCDC39;TEKT1;DNAAF1;CFAP73;ZBBX;TEKT2;CFAP100
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),0.7831347607266036,1.4034955012640555,0.125,0.4788100132806957,1.0,3/5,15.14%,TOX;OTUD4;USP9X
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),0.7831347607266036,1.4034955012640555,0.125,0.4788100132806957,1.0,3/5,15.14%,TOX;OTUD4;USP9X
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.6576369215557955,1.4030753924383417,0.08333333333333333,0.4792781045351654,1.0,9/17,22.29%,ZFPM2;ERBB4;TGFBR1;VGLL4;BMPR1A;RUNX1;RBPJ;FGFR2;FGF2
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),0.7129458690990584,1.4016216387593152,0.05,0.4831800227532813,1.0,6/10,24.33%,SHANK1;NRXN1;PCLO;NRXN2;NLGN1;NLGN2
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),-0.7357830005251206,-1.4014634560040358,0.05555555555555555,0.7851151288823266,1.0,2/14,8.31%,TNNT1;CHRM2
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.6978868419763973,1.4012206963335836,0.058823529411764705,0.4839015988874509,1.0,6/13,22.29%,ZFPM2;ERBB4;BMPR1A;RBPJ;FGFR2;FGF2
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.4513116751281318,1.4010340086167934,0.0,0.48352974330756365,1.0,26/134,11.86%,VAPB;LPIN3;SGMS1;LCMT2;PCSK5;CERS3;ELOVL7;VAPA;ACER3;HACD2;PLPP1;ELOVL6;GPHN;CSNK2A1;SLC44A5;SPNS2;PLPP2;LARGE1;GSTM2;PPM1L;ASL;ESD;GOLPH3;ELOVL5;PRKD1;PLPP3
prerank,GO_Biological_Process_2021__detection of light stimulus involved in sensory perception (GO:0050962),-0.896375732753394,-1.4008840421367739,0.0967741935483871,0.7760408951043798,1.0,1/5,0.50%,RPE65
prerank,GO_Biological_Process_2021__detection of light stimulus involved in visual perception (GO:0050908),-0.896375732753394,-1.4008840421367739,0.0967741935483871,0.7760408951043798,1.0,1/5,0.50%,RPE65
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.6999967488604337,1.400753304320403,0.03225806451612903,0.48345960893489415,1.0,8/17,19.22%,USP6NL;PDE4DIP;RAB33B;STX18;CAMSAP2;MAPK1;MYO5A;MAP2K2
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),0.7882947960530484,1.4005549449174859,0.15,0.48323989138622425,1.0,2/6,7.08%,LIMD1;MEN1
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.6548817979323028,1.4004733415636028,0.06666666666666667,0.48253493179823975,1.0,8/16,19.28%,PDP1;PPM1E;DUSP10;PPM1A;DUSP6;PPM1D;PPM1F;DUSP18
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.4372065815678323,1.3997772864756668,0.0,0.4842957685272479,1.0,57/194,19.96%,VEGFD;EPHA7;EPHA6;LEPR;EFNA5;FLT1;NPTN;ERBB4;CSF1R;EPHA4;EGFR;ZBTB20;PDGFRA;SOX9;BMP2;LIMCH1;ARRB1;EPHA2;TESK1;FGF17;TNIK;NTRK2;AKT1;EPHA5;ROR1;RALB;VEGFC;IGF1;HGF;PTK2;CLIP3;MERTK;CRKL;SIRT1;MLXIPL;ACVR2A;SLC4A4;WDFY2;NRP1;ROCK2;PTGES3;SEMA4D;RAP2A;FXR1;TFRC;HIF1A;AKT2;ITGA6;BCL10;CIB1;CCND3;AXIN1;NTRK3;FAS;DDR2;NIBAN1;ARNT
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.7040499151681796,-1.3997015277152294,0.034482758620689655,0.779210383136494,1.0,2/26,4.84%,PIF1;NOP10
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),0.4814086753482324,1.3986657044610422,0.0,0.4876142770301679,1.0,11/72,6.67%,NUDT21;SNCA;ZBTB1;MCU;HOMER1;PRMT1;BOK;EHD4;UGDH;MPP2;CPSF6
prerank,GO_Biological_Process_2021__protein import (GO:0017038),0.4710162599939492,1.3983193210504365,0.05263157894736842,0.48813183268904503,1.0,22/79,19.09%,GDAP1;RANBP17;NUP188;PPP1R10;SPRN;AKT1;IPO8;RAB8B;PEX14;NXT2;PEX2;NUP153;SAMM50;TOMM22;PEX16;PEX5;ABCD3;HSPA4;TNPO1;PEX13;NUP214;IPO5
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),0.6728561972780495,1.398303254973053,0.03125,0.48731160104806814,1.0,2/17,3.43%,SAMHD1;STT3B
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.582261997554829,1.3979574094390113,0.0,0.4878277615920201,1.0,13/29,20.10%,ADGRB3;CDKL5;NEDD4L;TNIK;RAPGEF2;CAPRIN2;SARM1;CAPRIN1;GSK3B;SEMA4D;RAP2A;SS18L1;SDC2
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)",0.855279387802544,1.3978871045138719,0.041666666666666664,0.48704819158346024,1.0,2/5,6.60%,PDE12;TOE1
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.6052575555732023,1.3973887758509693,0.10714285714285714,0.48844836486159415,1.0,11/23,24.91%,ABHD17B;ABHD17A;HDAC4;SIRT1;SIRT2;LYPLA2;HDAC10;SIRT5;LYPLAL1;ABHD17C;ABHD10
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.45929711789700234,1.3970266441127344,0.0,0.48862801668604466,1.0,39/107,22.17%,WNT7A;TENM3;FUT9;SOX4;NR4A2;LHX6;ASCL1;OLIG2;ADNP2;FZD5;UGDH;TENM2;NTRK2;PBX1;DTNB;EPHA5;NLGN4X;PBX2;PBX3;TGFBR1;OLIG1;TENM1;OPHN1;LHX2;FZD3;RUNX1;RORB;WNK1;CDK5R1;ATOH8;CASP3;ACSL3;POU3F2;MYT1L;TDP2;ATP2B2;MYEF2;THOC2;CTNNB1
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),0.499655552107422,1.3969104326022495,0.0,0.4880351307536542,1.0,19/65,19.33%,ATP6V0D2;ATP6V1A;RHEB;SESN1;KPTN;ATP6V1C1;EIF2AK4;PRKD1;MAP3K5;TFEB;RPTOR;MAPK1;ATP6V1B2;SESN3;MAPK8;IMPACT;ATF2;RRAGD;FAS
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),0.617319699025009,1.3964699907227247,0.058823529411764705,0.48887522908256104,1.0,3/16,9.02%,SLC15A3;SLC15A2;SLC10A7
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),-0.8098205950761509,-1.3963128581368167,0.03571428571428571,0.8026370552878843,1.0,2/7,6.50%,CCDC39;DNAAF1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.5870689647782572,-1.3960834008452232,0.0379746835443038,0.7977568687300381,1.0,11/59,10.72%,PSMB6;HLA-A;HLA-B;B2M;HLA-C;PSMB9;PSMA8;PSMA7;PSME1;PSMC3;VAMP8
prerank,GO_Biological_Process_2021__positive regulation of membrane depolarization (GO:1904181),0.8001771385028685,1.3958733550591012,0.1794871794871795,0.48982201339293563,1.0,2/5,7.18%,DCN;TRPM4
prerank,GO_Biological_Process_2021__GDP-mannose metabolic process (GO:0019673),-0.8490434338509498,-1.3958729433023676,0.07272727272727272,0.7931318326168243,1.0,1/6,2.74%,GMPPB
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),0.49518096512062243,1.3957480970189395,0.0,0.48915713064202165,1.0,19/66,19.33%,ATP6V0D2;ATP6V1A;RHEB;SESN1;KPTN;ATP6V1C1;EIF2AK4;PRKD1;MAP3K5;TFEB;RPTOR;MAPK1;ATP6V1B2;SESN3;MAPK8;IMPACT;ATF2;RRAGD;FAS
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.7266129132599013,1.3955234236191485,0.13157894736842105,0.4890419327496209,1.0,4/11,8.11%,TMEM33;BOK;ATF6;PIK3R1
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),-0.8184954997796388,-1.3934183314677746,0.029850746268656716,0.807702415565751,1.0,2/9,4.87%,ARG2;B2M
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.5810763404235187,1.3931040573577722,0.08,0.4973381117536712,1.0,7/19,16.12%,CDIP1;AEN;EP300;SIRT1;HIPK2;DYRK2;MSH2
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),0.6857331464664966,1.3930246632718402,0.13513513513513514,0.4965538796514952,1.0,6/11,20.46%,HNRNPU;TFE3;RREB1;SOX13;BMP7;VSTM2A
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.6830095216627998,-1.3917233450334805,0.04054054054054054,0.8155737352520283,1.0,10/36,16.36%,IFIT1;ISG15;IFITM3;BST2;MX1;APOBEC3G;RSAD2;OAS3;SHFL;EIF2AK2
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.7788284805553315,1.3917079450558194,0.1276595744680851,0.5000167671837837,1.0,4/7,15.10%,LIG4;APTX;SIRT1;APLF
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),0.6555475437259057,1.3913757098563764,0.10810810810810811,0.5004615262809285,1.0,6/14,21.42%,AIFM2;COQ3;COQ9;COQ2;PDSS2;FDXR
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.7082161471583817,1.391238870103925,0.075,0.500109545281072,1.0,4/14,15.18%,ABCA1;ABHD5;TTC39B;OSBPL8
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.4986217524186476,1.3910626528464243,0.08695652173913043,0.5000113831159211,1.0,23/66,22.80%,KAT2B;DR1;CHD5;MBIP;ZZZ3;KAT2A;MAP3K7;SUPT3H;EP300;KAT7;TRIM16;NAA50;KAT6B;EP400;ATF2;APBB1;KAT14;PHF20L1;CREBBP;LEF1;ING3;EPC1;BEND3
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.8091478612822255,-1.390795849193959,0.12307692307692308,0.817980729096166,1.0,3/9,3.46%,IFIT1;ISG15;MX1
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),0.627434021490606,1.3905441284080686,0.12121212121212122,0.5012458232515267,1.0,2/16,4.69%,TCAP;PDGFRA
prerank,PanglaoDB_Augmented_2021__Podocytes,0.43159310704252074,1.3900389507952668,0.0,0.5023678801466731,1.0,48/163,17.64%,CLIC5;ADCY1;STARD13;MPDZ;FAT4;RASSF8;DACH1;EGFR;PARVA;ILDR2;NFIB;KANK1;LIMCH1;CADPS2;EHD4;ARHGAP24;LOXL2;QKI;THSD7A;EFNB1;LGR4;MID1;PRICKLE2;RASAL2;RBFOX2;HSPA12A;PLOD2;PLPP3;WSB2;ADGRL2;MERTK;APBB2;ENAH;NCKAP1;MAGI2;PTPRG;TJP1;NEBL;CDC42BPA;CDH13;YAP1;DDAH1;PARD3B;PTPRO;TRIB2;LIFR;GOLIM4;NTN4
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),0.8213091221142366,1.389661229932378,0.10256410256410256,0.5029118192149775,1.0,3/5,15.74%,HDAC2;SIRT1;MTHFR
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),0.7392739071258733,1.389601326719766,0.16666666666666666,0.5022004915656576,1.0,4/7,9.73%,SOX5;PDGFRA;SOX9;SOX6
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.6670217153769167,1.3895528134573452,0.10256410256410256,0.5015275207905492,1.0,7/14,25.05%,ACER3;ITPKB;ISYNA1;IP6K2;IPPK;FGF2;IPMK
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.520218577346488,1.3893515763281001,0.0,0.5013208091660668,1.0,10/35,15.71%,EPHA7;TENM3;EFNA5;FUT9;MEGF10;SMAD7;PTK2;AFDN;PTPRG;ADA
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.5058957363703054,1.3890461752169165,0.0,0.501221687058189,1.0,25/76,19.60%,TIAM2;TBC1D4;ARHGEF16;TBC1D1;TBC1D5;USP6NL;TBC1D12;EVI5L;RANGAP1;EPHA2;ARHGEF26;ARHGAP24;MTSS2;TBC1D22B;DOCK7;TBC1D8B;SCRIB;TBC1D10A;GARNL3;RALGAPB;RABGAP1L;RALGAPA1;TBCK;NTRK3;RAP1GAP2
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.4061073419260986,1.3887246729253426,0.0,0.5015139297971337,1.0,71/246,18.56%,EPHA7;TIAM2;MAP3K11;KLF11;ARHGEF6;PAWR;AIFM2;SNCA;FOXO1;TPD52L1;PHLDA1;CRADD;SOX4;ARHGEF16;ARHGEF12;BMP2;BOK;NCSTN;FOXO3;ARHGEF26;BIN1;KCNMA1;FRZB;DAPK2;ADAMTSL4;ATF6;TNFRSF10B;UBE2Z;RPS6KA2;CTNNBL1;FAP;FGD4;ITSN1;ATG7;MAP3K20;HMGB1;C3ORF38;ZNF268;NF1;TP53BP2;GNA13;SLIT2;TRADD;MAP3K5;SOS1;CLIP3;SIRT1;TGFBR1;MCF2L;SIRT2;DUSP6;JMY;IP6K2;SCRIB;LATS1;MAP3K10;FAF1;ARHGEF7;MAPK8;CCAR1;CSRNP3;ITGA6;TRIO;TRIM35;APBB1;BCL10;SRPK2;PNMA3;AIFM1;DNM2;CDK5R1
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.6276965579499729,1.388709868584289,0.11764705882352941,0.5007052008245425,1.0,6/15,17.00%,PCSK5;BMPR1B;GLI3;MBNL1;NIPBL;ZNF141
prerank,PanglaoDB_Augmented_2021__Neutrophils,-0.5958377332709333,-1.3886736536668625,0.06060606060606061,0.8288108555359017,1.0,15/41,14.32%,CD24;DOCK8;ARG2;TAGAP;CLEC12A;IGSF6;CXCL2;CEACAM1;P2RY13;DPEP2;NR1I3;CD14;OAS3;SLC11A1;SPI1
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),0.6957684114503264,1.3886678016559217,0.09302325581395349,0.4998994180412868,1.0,6/10,16.14%,RAP2B;RAPGEF2;AFDN;RAP2C;TJP1;RAB1A
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.6853376801048608,-1.3884565798612607,0.07462686567164178,0.8245907532933202,1.0,4/19,11.48%,P2RY10;LPAR4;GPR18;LPAR6
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),0.825625207375518,1.388349778155297,0.06896551724137931,0.5004045815919304,1.0,3/7,14.72%,KIF5A;PPFIA2;TANC2
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",0.7719072594144464,1.3876568409543535,0.08888888888888889,0.49952908239856936,1.0,3/6,11.07%,ELOVL7;ELOVL6;ELOVL5
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",0.7719072594144464,1.3876568409543535,0.08888888888888889,0.49952908239856936,1.0,3/6,11.07%,ELOVL7;ELOVL6;ELOVL5
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",0.7719072594144464,1.3876568409543535,0.08888888888888889,0.49952908239856936,1.0,3/6,11.07%,ELOVL7;ELOVL6;ELOVL5
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",0.7719072594144464,1.3876568409543535,0.08888888888888889,0.49952908239856936,1.0,3/6,11.07%,ELOVL7;ELOVL6;ELOVL5
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),0.7006096673823137,1.3876436049138685,0.08888888888888889,0.4987341299128371,1.0,3/9,13.74%,RPS6KA4;CCNA2;INCENP
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.6595925549910118,1.3874582817048557,0.07407407407407407,0.49846659140022925,1.0,2/17,6.11%,ACE2;CBL
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),0.8174191773963788,1.387423005399493,0.018867924528301886,0.49778112338269614,1.0,1/6,1.44%,LIG4
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),-0.6885583337436476,-1.3872726471615655,0.0684931506849315,0.828471636980564,1.0,1/19,0.13%,CD24
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),0.800631330982315,1.3870357508856663,0.05,0.4983873755338247,1.0,3/7,14.98%,SPRED1;TGFBR1;NRP1
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.4381924618701903,1.387011819112752,0.0,0.49760015384739054,1.0,37/126,16.98%,CLDN12;HMCN1;TENM3;FAT4;NPTN;IGSF11;EMB;PCDHB2;ADGRL3;CDH2;ALCAM;NECTIN3;CDH11;CRB1;ATP2C1;TENM2;ROBO1;CDH20;CADM1;SLITRK2;LRRC4C;CDH4;UNC5D;SDK1;CDH9;ACVR1;SLITRK1;BSG;TGFBR2;CNTN4;PCDHB13;TENM1;CDH13;LRFN5;NECTIN2;CDH18;CDH8
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.6853533232690542,1.3869795008677008,0.06451612903225806,0.4967810231593502,1.0,3/14,2.41%,WNT7A;ELAPOR2;SLIT1
prerank,MSigDB_Hallmark_2020__Allograft Rejection,-0.5562841206938862,-1.3867611076082098,0.011764705882352941,0.8264479280111026,1.0,23/108,16.74%,GBP2;WARS1;RPL39;GCNT1;HLA-A;IL7;STAT1;IGSF6;RPL9;B2M;TIMP1;IFNGR2;RPS9;RPS3A;IL12A;KLRD1;TLR3;SPI1;CCL2;BRCA1;IL18;RPS19;RIPK2
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.6293557183884857,1.3866087982968678,0.06666666666666667,0.49721252294400464,1.0,7/15,23.90%,XPO1;NXT2;RBM15B;NUP205;NXT1;NUP98;ANP32A
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.6618340092820627,1.3863180993333974,0.12121212121212122,0.4973657115654058,1.0,9/14,29.63%,DROSHA;PRKRA;DHX9;AGO3;CELF1;TSN;DICER1;AGO2;AGO1
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.6025861932998646,1.3861075967186536,0.09090909090909091,0.49696578806318187,1.0,6/22,14.62%,PDK4;ADIPOR2;ELOVL5;ACADVL;MLXIPL;ADIPOR1
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),0.7373647793167272,1.3860213877652847,0.15384615384615385,0.4965672827294056,1.0,4/7,21.82%,PLOD2;JMJD6;PLOD1;P3H4
prerank,GO_Biological_Process_2021__inhibition of cysteine-type endopeptidase activity (GO:0097340),0.8608129325928597,1.38595619185542,0.13157894736842105,0.4959292953084804,1.0,1/5,1.28%,CARD18
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),0.6926458995142769,1.3851505546877143,0.13636363636363635,0.49797305302551914,1.0,4/11,13.65%,ABCA1;STARD4;RELCH;ARV1
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.6871502374018333,-1.3851236737888288,0.07894736842105263,0.8345238633641708,1.0,7/20,18.13%,P2RY10;SPON2;TYMS;KLRD1;TUBB;CCNB1;S100B
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.8554215443565993,-1.3848062551853177,0.07462686567164178,0.830634474085274,1.0,4/7,7.71%,HLA-A;B2M;ERAP2;ERAP1
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),0.7915617082704048,1.3847210951448528,0.08695652173913043,0.4987065110639255,1.0,1/7,0.33%,LAMB4
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.6048862379777847,1.384677032395184,0.13333333333333333,0.4979312011022234,1.0,6/22,21.12%,VPS37B;VPS37A;UBAP1L;MVB12B;PTPN23;TSG101
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid transport (GO:0015812),0.7899878517918606,1.3843645850386543,0.13725490196078433,0.49801289944760907,1.0,5/5,21.02%,SLC6A13;SLC6A6;SLC6A11;SLC6A12;SLC6A1
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),0.7395198452774989,1.3842957239500233,0.07894736842105263,0.4973097494860553,1.0,5/9,15.15%,PPP1R3D;AKT1;PPP1R3F;PPP1R3G;RUBCNL
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.4348100797312919,1.3834271177653426,0.0,0.4993331932928265,1.0,46/128,19.59%,PDP1;PTPRK;BTRC;PTPN4;PLPP1;PPM1E;DUSP10;PTPN13;PPP2R1B;PPP2R5A;PPM1A;PLPP2;PTPN9;PPM1L;PTPRJ;TAB1;ACP6;PTPRB;PLPP3;PPEF1;SSH1;PPP4R1;DUSP6;PTPRG;PTPRZ1;PTPN14;PLPPR4;MTMR2;STK11;PPP2R2A;PPP3CB;PTPRO;PPP2R5E;PPP1R12A;PPP1CC;PTEN;MTM1;PPM1D;LHPP;PPP1CB;PPM1F;PTPRE;FBXW11;DUSP18;DUSP12;SSH2
prerank,GO_Biological_Process_2021__positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),0.7805779144656331,1.3821901943551382,0.2222222222222222,0.5028112226522181,1.0,3/6,17.32%,ADRA1A;ADRB1;PDE4D
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),-0.8338459386690845,-1.381985099430976,0.014925373134328358,0.8472119805593118,1.0,2/8,4.87%,ARG2;B2M
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.4660967428231168,1.3819040623569372,0.0,0.5030874307545022,1.0,30/87,16.02%,WNT7A;PTPRK;PDE3A;SOX5;PARD3;SOX9;SMAD2;CBL;SMAD5;NLK;SMAD7;MAP3K7;NR3C1;SOX6;TGFBRAP1;GDF10;ACVR1;SMURF1;PTK2;TGFBR2;CRKL;SIRT1;WWOX;TGFBR1;SMAD4;BMPR1A;PDE2A;DUSP22;USP9X;PXN
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.5588871847916357,1.3818351094165662,0.07142857142857142,0.5025497084757031,1.0,12/31,17.09%,PPARGC1A;LIG4;SMCR8;DOC2B;STX18;KATNBL1;ADRB2;RAB3GAP1;FYCO1;SYNJ1;GSK3B;AKT2
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),0.606544683595653,1.3809678583455747,0.08823529411764706,0.5045499631794887,1.0,2/17,4.08%,LAMB4;QSOX1
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),0.7907236483148028,1.380811008839596,0.07317073170731707,0.5043153733148981,1.0,4/9,14.35%,DGKB;DGKH;DGKZ;DGKG
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.702630160867722,-1.3803744648844924,0.05084745762711865,0.8557244342900194,1.0,2/27,4.84%,PIF1;NOP10
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.6909686470637137,1.3799084892521787,0.10256410256410256,0.5064741223811016,1.0,7/12,23.30%,USP13;UBQLN1;UBQLN2;NFE2L2;RNF185;RNFT1;BAG6
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.5383149056811546,1.3795630820601616,0.07142857142857142,0.5070443571584914,1.0,7/31,7.83%,KAT2B;SMCR8;EVI5L;TESK1;CEP97;SEC22B;KAT2A
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),0.5767949091672947,1.3794912101832266,0.043478260869565216,0.506403700911079,1.0,5/31,2.66%,NUDT21;SNRPF;WDR33;PAPOLA;CSTF3
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),0.7996226489327418,1.3793474885528587,0.10810810810810811,0.5060669630618496,1.0,2/6,7.77%,DENND4C;DENND1A
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),0.3726674805023156,1.3789953361274483,0.0,0.5063002987209317,1.0,186/669,18.39%,ZNF300;LPIN3;WNT7A;PPARGC1A;PID1;ZFPM2;MEOX2;ETV5;RARB;NCK2;NRIP1;ZGLP1;MITF;VEZF1;FOXO1;KAT2B;EAF2;SOX8;UBP1;SALL1;ETV1;SOX4;TFAP2C;NR4A2;EGFR;RPS6KA4;PLAC8;ASCL1;DCN;RORA;MEIS3;DR1;GRIN1;RGCC;RHOQ;MLLT10;SOX9;NFIB;BMP2;NFKB1;CCDC62;PHF10;RPS6KA3;ZEB2;ARRB1;FZD5;FOXO3;HNRNPU;SERPINE1;CDK8;SMAD2;ZNF407;ZNF746;MAML2;THRB;GABPB1;GABPA;DPF1;HCLS1;PBX1;TFE3;RFX3;MEN1;NFAT5;LMO7;KAT2A;NRF1;WASL;ATF6;NR1D2;SP3;PIK3R1;NR1D1;NCOA2;CDK12;SMARCA2;NPAS2;SMAD5;HDAC2;BMPR1B;SMAD7;TCF4;NCOA3;MRTFA;ELF1;IGF1;NR3C1;PKD2;GLIS3;AUTS2;HMGB1;GLI3;CLOCK;CAPRIN2;ZNF268;FOXJ3;PRKN;HGF;TCF12;LMO1;ZNF451;MED13;MEIS2;EP300;AKIRIN2;RGMA;PRKD1;DVL1;PBX2;TFEB;ACVR1;SS18;ZNF24;ELK4;HDAC4;NCK1;ASXL3;SIRT1;OGT;SETD3;WWOX;HIPK2;TBL1XR1;MLXIPL;RREB1;MAP2K5;SLC30A9;AHR;SIRT2;METTL23;ACVR2A;DHX9;HNF4G;SMARCD2;CRTC2;EHF;JMJD6;ZBTB38;KMT2C;EPCAM;SMAD4;CDH13;KAT7;BMPR1A;BCL9;CDK13;YAP1;RSF1;POU2F1;PHIP;CCNT2;TFDP2;HSF2;PPP3CB;DPF3;CSRNP3;SATB2;AATF;THAP3;ATAD2B;HIF1A;KAT6B;PPP1R12A;POGZ;ITGA6;ATF2;ABHD14B;MAML1;KDM1B;KDM1A;APBB1;ATRX;RUNX1;ZBTB18;RPRD1B;RORB;RBPJ;SSBP2;DCAF6;YY1;ZNF462;NFE2L2;NFIA;NFATC3;ESRRB;CDK9
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.47757383851735,1.3789889193359302,0.10526315789473684,0.5054303669361879,1.0,13/62,15.79%,SPIRE2;SNX18;SEPTIN6;SEPTIN8;SPIRE1;SEPTIN11;ANLN;PLK1;SEPTIN7;INCENP;TRIM36;ROCK2;ESPL1
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),-0.6657040876543007,-1.3788965493716492,0.04838709677419355,0.8630258342627306,1.0,4/24,6.50%,SPAG17;RSPH4A;CCDC39;DNAAF1
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.6503561652664204,1.3787457698856465,0.10810810810810811,0.5053304866125663,1.0,5/12,15.60%,SOX8;CDH2;TAPT1;PEF1;NRG1
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),-0.7888432793592489,-1.3787221361894555,0.12280701754385964,0.8577643962981957,1.0,1/8,3.46%,RAB7B
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),0.634937454316788,1.37821854034399,0.08108108108108109,0.5067291620302193,1.0,3/14,9.50%,ST6GALNAC5;B4GALT6;LARGE1
prerank,GO_Biological_Process_2021__regulation of striated muscle cell differentiation (GO:0051153),0.7576380489397547,1.3780052106711813,0.17647058823529413,0.5066274030152357,1.0,2/6,3.77%,HDAC9;RBM24
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.7309897640739182,-1.377648942554517,0.1,0.8591585494909391,1.0,5/12,11.26%,SFRP4;GPC3;RSPO3;RNF213;SFRP1
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.6543727919043402,1.377117784525757,0.1111111111111111,0.5087822317964158,1.0,7/18,17.49%,LIMD1;WTIP;HELZ;TNRC6B;AGO3;CELF1;CNOT8
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.5447674612437232,1.3770808159393526,0.1111111111111111,0.5080148522751563,1.0,14/35,19.72%,NPNT;BMP2;ZHX3;BMPR1B;IGF1;HGF;PRKD1;ACVR1;ACVR2A;BMPR1A;YAP1;BMP7;IL6R;DDR2
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),0.5419985208546738,1.3766530937680326,0.0,0.508638903193493,1.0,4/33,7.36%,ACE2;ANK2;KCNMA1;KCNH2
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),0.7974504085977423,1.3756585516579056,0.08333333333333333,0.5118026827826901,1.0,3/5,19.08%,KCNMA1;SHANK3;CLCN3
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),0.5408028555018269,1.3751315242373487,0.06896551724137931,0.512484108338655,1.0,9/31,14.45%,SOX8;SOX5;ITGB8;SOX9;ZNF516;TRIP11;SOX6;ZBTB16;SH3PXD2B
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.6690126582278478,1.3750656411848128,0.11764705882352941,0.5118801553197724,1.0,11/11,33.14%,NLGN4X;NLGN3;LRP4;PTEN;NLGN1;CNTN2;NLGN4Y;NLGN2;IL1RAPL1;CEL;PTPRD
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.8465983525765444,-1.374850995500126,0.047619047619047616,0.8759969681653383,1.0,4/7,5.94%,HLA-A;HLA-B;B2M;HLA-C
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.6678720829098939,1.3745862069863992,0.058823529411764705,0.5126248353434666,1.0,2/16,0.82%,LEPR;PID1
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.4016627223051943,1.374569853564048,0.0,0.5118915286010484,1.0,40/162,21.18%,NUDT21;PPARGC1A;SNRPF;HNRNPH1;CSTF3;DROSHA;HNRNPU;DHX15;RNGTT;HNRNPC;CPSF6;SNRPN;CDK12;CELF2;U2AF1;SYNCRIP;ADARB1;CELF3;MBNL1;DKC1;HNRNPH3;TENT4B;ZMAT5;U2AF2;ADARB2;MTPAP;SF3B3;RBM6;CELF1;SRPK2;TSEN2;PTBP1;HNRNPD;NOVA1;SMU1;LIN28B;USB1;PPP2R1A;PPIG;ALKBH5
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.49407845020880153,1.374465978846645,0.09090909090909091,0.5112588903204182,1.0,14/45,15.87%,AMH;BMP2;SMAD2;SMAD5;BMPR1B;SMAD7;RGMA;ACVR1;SMURF1;ACVR2A;SMAD4;BMPR1A;USP9X;BMP7
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),0.6237077740546918,1.3744338107181246,0.06976744186046512,0.5104323098060517,1.0,1/16,0.50%,NAF1
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),0.6829207820741926,1.3739584295831628,0.08571428571428572,0.5115332775015834,1.0,3/12,4.26%,HDAC9;PCSK5;SORT1
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),0.821322804069694,1.3737769382454255,0.06,0.5112301048971091,1.0,1/5,13.40%,NAPB
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),0.7508232461504158,1.3734863308191503,0.1111111111111111,0.5114156590640306,1.0,2/8,7.81%,CAMK2B;NRXN1
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),0.7853573130409182,1.3729132456274078,0.12121212121212122,0.5127042305213148,1.0,4/8,10.89%,SPRED2;DYRK1A;SPRED1;EP300
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.6460550302426651,1.3723176984033243,0.11428571428571428,0.5136968544763221,1.0,5/15,24.42%,INTS7;INTS6;INTS8;ZCCHC8;INTS11
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),-0.8837756015339893,-1.3719552209775931,0.016666666666666666,0.8925167012800367,1.0,2/6,9.81%,NLRP1;CASP8
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.5613282748166961,1.371823993892309,0.19047619047619047,0.5146214714155978,1.0,10/20,17.09%,PPP1R3D;PASK;AKT1;IRS1;PPP1R3F;IGF1;PPP1R3G;GSK3B;DYRK2;AKT2
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.6327055182726794,-1.3717241015517465,0.1,0.8874669078429734,1.0,2/30,1.58%,H1-4;H1-2
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),-0.877102669495851,-1.371614874006146,0.018867924528301886,0.882449720154991,1.0,1/5,8.94%,HES1
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.6022955583552698,1.3715091739989957,0.09090909090909091,0.5149293517517941,1.0,5/17,17.19%,TCAP;BMP2;ACVR1;NRG1;ALPK2
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.7697158547189011,-1.3713077009635328,0.058823529411764705,0.8786884140126083,1.0,5/11,18.76%,ANXA1;PIK3CB;RSAD2;MADCAM1;ZP3
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),0.613150757040076,1.3713006653610231,0.0967741935483871,0.5149137650840164,1.0,4/26,7.36%,CACNA1G;ANK2;CACNA2D1;KCNH2
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.5621920459509121,1.3710888522783813,0.08333333333333333,0.5145763180364571,1.0,2/25,2.93%,VAPB;PDE12
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.4076103142639461,1.371069029440273,0.0,0.5137579166583346,1.0,45/202,16.37%,ATP6V0D2;LEPR;USP13;FOXO1;TAB3;KEAP1;SMCR8;DCN;ATP6V1A;RHEB;BOK;FZD5;FOXO3;AKT1;DAPK2;ABL2;ATF6;EXOC8;ATP6V1C1;TICAM1;HMGB1;PIP4K2C;PRKN;HGF;EP300;EIF4E;FBXW7;PRKD1;TFEB;PRKAB1;DRAM2;EXOC4;OSBPL7;SIRT2;RPTOR;BCL2;SNX5;UBQLN1;TPCN1;EIF4G3;ATP6V1B2;GSK3B;STK11;MAPK8;UBQLN2
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.5710400495462676,1.3710265688684276,0.10344827586206896,0.5129743012324046,1.0,8/20,18.04%,ELAPOR2;SMAD2;BMPR1B;ZNF423;ACVR2A;SMAD4;BMPR1A;RBPJ
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.6569127138065171,1.3706218150245548,0.12121212121212122,0.5136987764022799,1.0,9/11,24.33%,WNT7A;NRXN1;NLGN4X;NLGN3;NRXN2;LRP4;NLGN1;NLGN4Y;NLGN2
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.44856837108198366,1.3699940340732786,0.058823529411764705,0.5149005596539742,1.0,22/78,17.13%,TENM3;ZNF804A;NPTN;FUT9;ARHGAP35;TOX;NTRK2;CAMK2B;RAPGEF2;ABL2;ROR1;CAPRIN2;LRP8;EP300;PRKD1;CAPRIN1;MAGI2;RAP1A;BMP7;NDNF;RETREG3;ITGA6
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),0.7623213029959618,1.3691205733103096,0.05405405405405406,0.5168646418482528,1.0,4/7,18.45%,PICALM;RIN3;RAB22A;ALS2
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.5287016374160862,1.3690697162574046,0.03571428571428571,0.5160810718920175,1.0,11/38,18.80%,KAT2B;DR1;PHF14;MBIP;KAT2A;MAP3K7;SUPT3H;KAT7;TRIM16;KAT6B;KAT14
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,0.4642479969207336,1.368881454571734,0.0,0.5157455803641388,1.0,30/150,13.80%,GSTT2;TYR;PDK4;ABCC2;MARCHF6;EPHA2;SERPINE1;UGDH;MPP2;KYNU;ETS2;PGD;LEAP2;MAOA;SMOX;CA2;CYFIP2;GSR;NDRG2;IGF1;GCLC;ASL;ELOVL5;AHCY;SLC35D1;ABCC3;ABHD6;PDLIM5;PAPSS2;CYP2J2
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),0.5683845720668739,1.3685249687609435,0.07692307692307693,0.5163642971879384,1.0,10/30,20.55%,PICALM;EPS8;PEX11A;RIN3;HP1BP3;RPTOR;RAB22A;PTEN;RAP1GAP2;NEB
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.6719917252763794,1.3683877652418004,0.11428571428571428,0.5158391267891389,1.0,5/16,11.12%,KCTD13;ARHGAP35;KANK1;ABL2;KCTD10
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.7538976251292226,-1.3681931814672592,0.05714285714285714,0.8986808204202211,1.0,5/13,18.02%,GATA1;ZNF593;MSX2;HEY2;DDIT3
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),-0.8243396040763717,-1.3676648055785636,0.08620689655172414,0.8964814663034961,1.0,2/7,3.85%,IFIT1;STAT1
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),0.6892626751258337,1.3674968457246717,0.12903225806451613,0.5179756876927459,1.0,4/11,14.87%,PDE3A;OCLN;TJP1;PDE2A
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),0.5635941448535539,1.3674033115871465,0.1111111111111111,0.5175128358611619,1.0,6/23,12.54%,PID1;KANK1;IRS1;RPS6KB1;PIP4K2C;NCK1
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),0.5464513720805645,1.3672455392078007,0.1111111111111111,0.5170830508931096,1.0,9/35,11.55%,WNT7A;SOX5;ITGB8;SOX9;NFIB;BMP2;TRIP11;SOX6;ZBTB16
prerank,GO_Biological_Process_2021__positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870),0.7250206231996926,1.3670105324382589,0.20930232558139536,0.5171273531763083,1.0,4/5,26.45%,RBM24;TENT4B;LARP4B;TENT4A
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),-0.7190580986720495,-1.3669559999672163,0.078125,0.8968222487076369,1.0,2/18,6.27%,RPS13;RPS26
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.831456149269624,-1.3665588640390127,0.03125,0.882729945810869,1.0,3/8,10.67%,H1-4;H1-2;ATAD2
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.831456149269624,-1.3665588640390127,0.03125,0.882729945810869,1.0,3/8,10.67%,H1-4;H1-2;ATAD2
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.831456149269624,-1.3665588640390127,0.03125,0.882729945810869,1.0,3/8,10.67%,H1-4;H1-2;ATAD2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),0.4873529454245917,1.3659728008842709,0.05555555555555555,0.519373848492679,1.0,18/55,23.22%,CCT4;HCLS1;TESK1;AKT1;PIK3R1;UBR5;DKC1;PLK1;TRIM28;KAT7;CCT3;YAP1;TFRC;IPO5;ZPR1;BAG3;SMAD3;SESN2
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.6446137727862875,-1.3652271098533566,0.06557377049180328,0.8879300757282628,1.0,2/31,4.84%,PIF1;NOP10
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.5738001102688245,1.3652019344673356,0.1388888888888889,0.5218329631939834,1.0,3/21,8.76%,ATP6V0D2;ATP6V1A;ATP6V1C1
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),0.7816430037417053,1.3649075840328937,0.14,0.5218693899624232,1.0,3/5,11.03%,CTNNA2;CAMK2B;SHANK3
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),0.7265219679379411,1.364485859177523,0.10714285714285714,0.5229076180886397,1.0,2/12,17.16%,DNA2;TICRR
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),0.5064941451301088,1.364413548276968,0.0,0.5224420460519515,1.0,11/34,27.61%,PPP2R5A;PPP6R3;CAMTA1;SPPL3;ARPP19;PPP1R8;PTBP1;PPP6R1;ENSA;PPP1R16B;HTT
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),0.6439916166916281,1.3636646061832531,0.0967741935483871,0.5241314203376835,1.0,3/13,16.02%,PIK3R1;PTK2;PXN
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),0.563609189828557,1.3623205602149544,0.1111111111111111,0.5284016126459092,1.0,6/22,12.54%,PID1;KANK1;IRS1;RPS6KB1;PIP4K2C;NCK1
prerank,GO_Biological_Process_2021__aldehyde biosynthetic process (GO:0046184),-0.8489470542381827,-1.3619723551526655,0.05263157894736842,0.910266932333629,1.0,1/5,2.86%,CACNA1H
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),0.5606774743051177,1.3617052533873029,0.06060606060606061,0.529484963705496,1.0,9/19,19.00%,ACAP2;NTRK2;RAPGEF2;AKT1;MAGI2;RAP1A;WASF1;CIB1;NTRK3
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),0.850393751080027,1.361642178083615,0.08888888888888889,0.5287944404749153,1.0,2/5,11.24%,ROBO1;SLIT2
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),0.6930885478293567,1.3612708699344143,0.17647058823529413,0.5290364301225363,1.0,7/12,23.71%,INPP5A;SYNJ1;PTEN;NUDT3;OCRL;IMPA2;SYNJ2
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),0.7760806818491244,1.3609600265610708,0.05555555555555555,0.5292157271780555,1.0,2/6,3.76%,LIG4;EXOSC6
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),0.7151566746630433,1.3606178525985748,0.1111111111111111,0.5298272184874735,1.0,6/11,19.70%,NPTN;CAMK2B;SHANK3;DRD2;NETO1;SYNGR1
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),0.6320395868946362,1.3598986989946553,0.08333333333333333,0.53164041281912,1.0,6/16,14.45%,LIMD1;WTIP;IQCJ-SCHIP1;MOB3B;DLG5;VGLL4
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),0.5010692040687686,1.3598703257368947,0.06666666666666667,0.53017336149676,1.0,18/57,21.86%,CD247;PIK3CA;WASL;PIK3R1;CYFIP2;PRKCE;WIPF2;PTK2;NCK1;NCKAP1;ABI1;MAPK1;CYFIP1;FYN;DOCK1;ACTR3;CRK;WIPF3
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.5010692040687686,1.3598703257368947,0.06666666666666667,0.53017336149676,1.0,18/57,21.86%,CD247;PIK3CA;WASL;PIK3R1;CYFIP2;PRKCE;WIPF2;PTK2;NCK1;NCKAP1;ABI1;MAPK1;CYFIP1;FYN;DOCK1;ACTR3;CRK;WIPF3
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.5327969058058535,1.359836384429253,0.047619047619047616,0.5296122524872097,1.0,12/29,20.59%,SOX9;BMP2;ANKH;ECM1;ACVR1;ZBTB16;PTPN11;LRP4;RBPJ;S1PR1;DDR2;SGMS2
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.5727632561321642,-1.359808824319226,0.0641025641025641,0.9228101025808122,1.0,14/61,16.17%,PSMB6;HLA-A;HLA-B;B2M;HLA-C;PSMB9;PSMA8;PSMA7;PSME1;PSMC3;VAMP8;PSMC4;MFSD6;PSMA3
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.4786689512989733,1.3597853180598274,0.08695652173913043,0.5289302417125641,1.0,12/62,10.94%,ACACB;ANO5;CADM2;LRP1B;RBFOX1;SYCP2L;COL9A1;KBTBD12;SLC35F1;NT5C1A;ADRA1A;RGMA
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),-0.8849942394684169,-1.3596264188251688,0.07272727272727272,0.9121041566912441,1.0,1/5,3.85%,STAT1
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),-0.8849942394684169,-1.3596264188251688,0.07272727272727272,0.9121041566912441,1.0,1/5,3.85%,STAT1
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),-0.8204809676461448,-1.3588865600294056,0.12727272727272726,0.912677235695525,1.0,4/8,16.16%,ADH4;MT3;APOE;SCARF1
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.5886942488335328,1.358460788983632,0.04,0.5323840331399985,1.0,17/27,29.07%,TLE2;PYGO2;MEN1;EP300;PYGO1;BCL9;ASH2L;CREBBP;LEF1;CTNNB1;CDC73;TCF7L2;TLE1;TRRAP;BCL9L;TLE3;TLE4
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),0.7649134815975658,1.3583815374402115,0.23809523809523808,0.5317609519399461,1.0,3/7,19.43%,LIG4;MSH2;XRCC4
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.7087667125426582,1.3582342149284252,0.08571428571428572,0.5313229681779383,1.0,3/13,11.20%,ANK2;GSTM2;CAMK2D
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),0.7627989739150631,1.3580149762849998,0.13157894736842105,0.5313739682966234,1.0,4/7,14.56%,PPP1R3D;AKT1;PPP1R3F;PPP1R3G
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.64094894128123,-1.3574517556291588,0.07936507936507936,0.9184320472426437,1.0,5/19,15.85%,PARP14;STAT1;IFNGR2;CDC37;SOCS3
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.5788096801132686,1.3568491427819611,0.13333333333333333,0.5346501755086343,1.0,9/18,25.72%,NUP153;AFDN;TSPAN33;NDC1;NUP205;NUP98;AHCTF1;GSDMD;ADAM10
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.701016612712456,1.3565842254648854,0.18181818181818182,0.534635056602143,1.0,4/10,13.70%,SMAD2;ACVR1;TGFBR1;ACVR2A
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.6975260141761912,1.3560863084267263,0.15151515151515152,0.5356513085272806,1.0,5/9,24.02%,NUP153;NDC1;NUP205;NUP98;AHCTF1
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),0.5962430796531313,1.3556996189940727,0.12903225806451613,0.53587696373134,1.0,8/20,28.53%,SERINC5;OSBPL8;PLAAT3;PTDSS2;OSBPL5;SERINC1;SLC27A1;ABHD12
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),-0.7888580361128739,-1.3546977422269877,0.045454545454545456,0.9338333590936408,1.0,4/8,15.69%,CENPE;NUF2;MIS12;CENPH
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.3870828030188666,1.3544520150989046,0.0,0.5392769805811098,1.0,67/178,24.33%,CHRNA4;DLGAP1;KCNQ3;CACNB4;GABRG1;SNCA;HTR2C;PCDHB2;HOMER1;PRKACB;GRIN1;CACNA1B;PDE7B;GABRA5;RPS6KA3;KIF5A;PRKAR1B;GABRA4;DOC2A;NRXN1;GLRB;MBP;KCNQ2;RPS6KA2;GPR176;NLGN4X;LPAR3;NLGN3;GRM1;PCDHB13;EXOC4;GABRB1;DLG1;MAPK1;HRH1;CACNB3;NPY;APBA3;APBA1;NRXN2;GABRG3;GRIN2B;NOVA1;GRIK2;GRIA2;HCRT;NPTX1;CHRM3;SLC6A1;NLGN1;CAMKK1;CAMK4;NPTX2;GRIK1;GRM5;CNP;CACNA1E;GABRB3;KCNC4;NLGN4Y;PMP22;GLRA3;KCNIP2;GABRR2;SYT5;GABBR2;NLGN2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.615735438993808,1.3543634481700084,0.07407407407407407,0.5387415114229464,1.0,7/19,18.04%,ZFPM2;SMAD7;TGFBR1;SMAD4;BMPR1A;NRG1;RBPJ
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.4717616962417488,1.3538420979043944,0.043478260869565216,0.5392929203610961,1.0,20/64,19.16%,RBPMS2;BMP2;SPRY4;UBE2D1;SPRY3;SMAD5;BMPR1B;SMAD7;SLIT2;SMURF1;NBL1;HIPK2;ACVR2A;VWC2L;ATP2B4;SMAD4;BMPR1A;LEMD3;UBE2D3;CRIM1
prerank,GO_Biological_Process_2021__proline metabolic process (GO:0006560),0.8777009617900629,1.3533890167037532,0.11363636363636363,0.540263997970975,1.0,2/5,8.59%,PRODH;ALDH4A1
prerank,GO_Biological_Process_2021__nose development (GO:0043584),0.7803966523655818,1.3529440831927757,0.15384615384615385,0.5409315562640943,1.0,2/6,9.83%,CHD7;GLI3
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),0.7811964565621557,1.3527753363598196,0.18421052631578946,0.5405168606214233,1.0,2/7,4.28%,PRMT6;PRMT1
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),0.8040040923566698,1.3527317435404806,0.11627906976744186,0.5397139740631043,1.0,2/5,7.22%,CXCL12;RAPGEF2
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.7306084572009591,1.3527013639390526,0.07317073170731707,0.5381156008225798,1.0,3/7,14.50%,GABPA;PRKN;MAPK1
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.7306084572009591,1.3527013639390526,0.07317073170731707,0.5381156008225798,1.0,3/7,14.50%,GABPA;PRKN;MAPK1
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.5832063327055135,1.3526972967532407,0.02857142857142857,0.5373797340311605,1.0,6/20,14.50%,SNCA;GABPA;PRKN;SIRT2;ATP2B4;MAPK1
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-0.8338098473691141,-1.3526756914554334,0.04411764705882353,0.9464087849822521,1.0,1/7,0.35%,TOMM7
prerank,PanglaoDB_Augmented_2021__Neurons,0.41432015323742594,1.352583896665843,0.0,0.536973652937412,1.0,71/259,18.26%,DGKB;CACNG2;GNL3L;DLGAP1;TMEM191C;CACNB4;DNM3;CADM2;SNAP91;ATP2B3;PSD2;ADGRB3;RORA;AMER2;RBFOX1;CACNA1B;NWD2;ZCCHC7;UNC79;NOL4;CACNA2D1;KIF5A;CTNNA2;CTTNBP2;KCNMA1;PPFIA2;VSTM2B;LUZP2;NRXN1;PPP1R1B;CBARP;ADGRA1;KCNQ2;ASTN1;CDK5R2;CHODL;OLFM3;TRIP11;SAFB2;IGF1;ADAM12;CAMK2N1;SGIP1;SYNE1;CELF3;FBXW7;RIMS3;SLITRK1;TMEM196;CA10;RGS7BP;ERC2;SACS;LY6H;SLC30A9;STX1A;NBEA;KMT2C;GNAI1;ELAVL3;SLC32A1;PTPN11;CSRNP3;CACNB3;NPY;PCLO;OPCML;VGF;RERE;MYO5A;BRINP1
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.5483293970060192,1.3522799268149481,0.06666666666666667,0.5373715263353175,1.0,11/37,19.08%,RAB27A;ALS2CL;TMCC1;EXOC8;RNF26;DNAJC13;HOOK1;CHMP2B;RAB22A;ALS2;CLCN3
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.7699432079871303,-1.3516085285656645,0.07692307692307693,0.9498132780155113,1.0,7/12,19.20%,RPL39;CXCL2;RPL30;PGLYRP1;RPS19;ROMO1;CXCL14
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),-0.8138025056419143,-1.3511730634583445,0.07547169811320754,0.9479791229064175,1.0,2/8,6.50%,CCDC39;DNAAF1
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.5930490337149723,1.3511306995018513,0.07407407407407407,0.5408257098603367,1.0,10/25,17.23%,ZFPM2;FOXO1;RORA;ANKRD26;RUNX1T1;SIRT1;SIRT2;YAP1;TRIB2;TRIO
prerank,GO_Biological_Process_2021__histidine metabolic process (GO:0006547),0.8271217775285535,1.3510545238878635,0.09302325581395349,0.5393273323894711,1.0,4/5,13.57%,CARNMT1;CARNS1;FTCD;AMDHD1
prerank,GO_Biological_Process_2021__histidine catabolic process (GO:0006548),0.8271217775285535,1.3510545238878635,0.09302325581395349,0.5393273323894711,1.0,4/5,13.57%,CARNMT1;CARNS1;FTCD;AMDHD1
prerank,PanglaoDB_Augmented_2021__Decidual Cells,-0.7785773445805239,-1.3508190975471839,0.13793103448275862,0.9452165226798541,1.0,3/8,9.02%,P2RY10;CD5;GPR171
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.6689787858842589,1.3502461936784425,0.125,0.541403524070784,1.0,10/10,33.14%,NLGN4X;NLGN3;LRP4;PTEN;NLGN1;NLGN4Y;NLGN2;IL1RAPL1;CEL;PTPRD
prerank,PanglaoDB_Augmented_2021__T Cells,-0.570887888943732,-1.3500066116216423,0.07792207792207792,0.9459655950609095,1.0,17/55,18.16%,P2RY10;CD163L1;TAGAP;IFIT3;CD5;THEMIS;GMFG;GPR171;ARHGAP9;RHOH;TRAF3IP3;CD160;CXCR4;ARHGAP30;GIMAP2;PTPN22;SKAP1
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),0.8248627587764992,1.3498297778565636,0.125,0.5417621520629303,1.0,3/7,8.60%,NFKB1;CAMK2A;CA2
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.4978451891842416,1.3496579917575795,0.06666666666666667,0.5413242780378971,1.0,18/58,21.86%,CD247;PIK3CA;WASL;PIK3R1;CYFIP2;PRKCE;WIPF2;PTK2;NCK1;NCKAP1;ABI1;MAPK1;CYFIP1;FYN;DOCK1;ACTR3;CRK;WIPF3
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.4179172950106131,1.3493321255609303,0.0,0.5413877882498994,1.0,27/98,16.02%,PTPRK;AMH;PARD3;BMP2;SMAD2;CBL;SMAD5;NLK;BMPR1B;SMAD7;MAP3K7;TGFBRAP1;GDF10;RGMA;ACVR1;SMURF1;PTK2;TGFBR2;SIRT1;TGFBR1;ACVR2A;SMAD4;BMPR1A;DUSP22;USP9X;BMP7;PXN
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.7537333960938001,-1.3491344666261373,0.1016949152542373,0.9468396989588761,1.0,2/10,10.85%,STAT1;IL12A
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.5237148416629394,1.3490854427434242,0.03225806451612903,0.5412455108330034,1.0,14/31,18.57%,CHRNA4;GABRG1;GRIN1;GABRA5;MPP2;GABRA4;AKT1;NLGN3;RAB3GAP1;GSK3B;INSYN1;DRD2;GABRG3;GRIN2B
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),0.6932019915157083,1.3488332847644342,0.175,0.5413382747871677,1.0,3/10,20.59%,SGMS1;ABCA2;SGMS2
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.47022634405497143,1.348730322186832,0.1111111111111111,0.5408158298593614,1.0,29/67,23.37%,KEAP1;RNF217;RNF144A;CSNK1E;DNAJB2;SMAD7;RNF14;PSMD10;PRKN;DVL1;COP1;PIAS1;PLK1;SIRT2;UBQLN1;VCP;ARIH1;GSK3B;ZYG11B;UBQLN2;TRIB2;MDM2;NFE2L2;BAG2;HECTD1;HSPA1A;TAF1;CSNK1D;RCHY1
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.6552984157315231,1.348577821982181,0.1111111111111111,0.5407042927054934,1.0,5/12,20.44%,AGMO;PEX7;FAR1;AGPS;PLAAT3
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.6264864452209419,1.3483019975667063,0.11428571428571428,0.5409434235479863,1.0,4/18,6.67%,NUDT21;CPEB3;ZC3H14;CPSF6
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),0.8210071620722659,1.3480021475522088,0.14285714285714285,0.5411818373564687,1.0,2/5,7.83%,PAG1;KAT2A
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.6258997226630876,1.3473422952870764,0.07142857142857142,0.5426129248588892,1.0,7/13,29.63%,DROSHA;PRKRA;AGO3;LIN28B;DICER1;AGO2;AGO1
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),0.784873445838679,1.3466824786572646,0.1111111111111111,0.5444466231308291,1.0,3/7,6.56%,KYAT1;QDPR;KYNU
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.4964249839438011,1.3465961339662649,0.0,0.5437791168595323,1.0,34/73,25.91%,SHISA7;CACNG2;CACNB4;ANK2;SHANK1;HOMER1;GRIN1;CACNG3;CAMK2B;DLG3;CAMK2A;CAMK2D;SHISA9;DLG1;JPH1;CACNB3;PDE4D;GRIN2B;CTSS;NETO1;FGF14;GRIA2;SLMAP;NLGN1;CACNG8;PRRT1;FGF13;CACNG4;CACNG7;NLGN2;STAC;KCNE2;DAPK1;CACNB2
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),0.8551526898485764,1.3461702111731677,0.06818181818181818,0.5444175596266851,1.0,2/5,12.54%,PPP1R15B;NCK1
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.6253548276913946,1.3457222535722548,0.08695652173913043,0.5448804997284085,1.0,10/17,24.33%,WNT7A;DVL1;NLGN4X;NLGN3;PCLO;LRP4;PTEN;NLGN1;NLGN4Y;NLGN2
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.7717407798717251,1.3453301070393608,0.06666666666666667,0.5453998456077565,1.0,1/7,0.65%,CLDN12
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),-0.7590649025998184,-1.3448033446379137,0.14705882352941177,0.9778191318685615,1.0,3/9,17.27%,GATA1;ZNF385A;ZFPM1
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),0.5942866326840145,1.3445682015797038,0.1111111111111111,0.5475908285732162,1.0,10/24,30.59%,PHF2;KDM5A;KDM4C;KDM1B;KDM1A;JMJD1C;KDM6A;KDM7A;KDM3A;PHF8
prerank,GO_Biological_Process_2021__catecholamine biosynthetic process (GO:0042423),0.7951764596193363,1.3444999900081729,0.16216216216216217,0.5469236087106809,1.0,2/7,3.64%,SNCA;PNMT
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),0.7595235328046082,1.34447708782635,0.12195121951219512,0.5463158879728052,1.0,5/8,19.76%,CPEB3;DPH5;DPH1;DPH3;CPEB2
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.4328377869816666,1.3444134191898423,0.0625,0.5456525224386679,1.0,12/81,7.56%,SLC24A3;CHRNA4;CACNA1G;ANK2;CACNA1I;STIM2;CACNA1B;CACNG3;CACNA2D1;ATP2C1;TRPM4;CAMK2A
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),0.5153647807628613,1.3443254895194412,0.03571428571428571,0.5451058245566809,1.0,5/33,9.84%,RAD54B;LIG4;RAD51B;HMGB1;RAD52
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),0.6815952327763507,1.344125838383453,0.16216216216216217,0.5451048109117177,1.0,4/9,25.17%,BDH2;OXCT1;ACAT1;HMGCLL1
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.6078913374425076,1.3438973105244991,0.03125,0.5451323936072874,1.0,6/25,11.03%,SHISA7;ADCY1;EPHA4;FAM107A;EIF2AK4;SHANK3
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),0.7533913360829946,1.3438804060351057,0.21951219512195122,0.5443319055109478,1.0,4/7,14.70%,KAT2B;KAT2A;EP300;KAT7
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.7936762187325922,1.3432407600758862,0.10526315789473684,0.5453868828895311,1.0,6/8,15.76%,SOX4;ASCL1;NRP2;NF1;NRP1;FZD3
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),0.668215791908965,1.3429133567585698,0.05555555555555555,0.5455847380383507,1.0,2/13,5.21%,LAMB4;FLRT2
prerank,GO_Biological_Process_2021__urea cycle (GO:0000050),-0.7807610160497047,-1.3427426726656342,0.1,0.9889977939809348,1.0,1/7,2.67%,ARG2
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.5113154775740762,1.3426286456320218,0.08695652173913043,0.5460378499827169,1.0,8/42,15.79%,SNX18;SEPTIN6;ANLN;PLK1;INCENP;TRIM36;ROCK2;ESPL1
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),0.6626063985413339,1.3425524951474102,0.21212121212121213,0.5454394069753067,1.0,7/13,19.16%,PID1;CSPG5;MFF;MYH14;WASF1;MTM1;NUBPL
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.5186972378673574,1.3424906491896944,0.0,0.5448427086996963,1.0,21/38,26.93%,ARAP1;RHOQ;TENM2;GPM6A;WASL;PIK3R1;TENM1;NRP1;TRPM2;FXR1;ARF6;FMR1;CAPZB;NLGN1;ARHGAP44;MYO10;BCAS3;RAB5A;FXR2;RALA;PPP1R16B
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),0.4011432126034662,1.3422943085637007,0.0,0.5448420898509729,1.0,71/231,23.55%,TCAP;BET1;PPARGC1A;MITF;PARD3;SHANK1;PICALM;MCU;CXCL12;SOX9;PDE4DIP;BOK;CD247;TRAPPC6B;TLE2;PYGO2;MEN1;SEC22B;WASL;PEX14;PPP6R3;EP300;TRADD;SAMM50;AFDN;OCLN;PEF1;TRAPPC10;DHX9;OPA1;TSPAN33;COL7A1;CUL1;SH3PXD2B;MDM4;SEC24B;PYGO1;BCL9;GSK3B;YAP1;NSF;TRAPPC9;RAB1A;TFG;WASF3;WASF1;CUL3;ASH2L;CD59;SEC23A;SEC23IP;CNIH1;MDM2;AXIN1;FAS;SLC7A9;PPP2R1A;CREBBP;LEF1;REPS2;CTNNB1;WDCP;CDC73;TEAD1;CAPZA1;CSNK1D;SCFD1;FBXL7;VAMP3;LIN7A;PPP6R1
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.8005471647302583,-1.3421281078767922,0.11320754716981132,0.9882459526903148,1.0,1/7,7.31%,GARS1
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),0.5710438993727455,1.3419530609983352,0.0,0.5453501686106802,1.0,5/29,5.59%,PPARGC1A;SNCA;RPS6KA4;IWS1;ARRB1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.7523373882326584,-1.3417128394633395,0.15151515151515152,0.985767263769956,1.0,4/14,6.81%,RPL23;RPL11;RPS7;RPL5
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),0.49107462108374983,1.3412700165345774,0.037037037037037035,0.546731588233848,1.0,6/28,24.03%,INTS7;MAP3K20;CLOCK;H2AX;CDC5L;ERCC6
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.6650214838298658,-1.3410572725338115,0.06666666666666667,0.9858575264996277,1.0,11/24,23.74%,RPL7A;RPL35;RPL7;DDX18;RPL10A;WDR12;RPF2;NIFK;SNU13;RRP15;LAS1L
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.4466723338918824,1.3410165901613356,0.05,0.5467000556064864,1.0,30/101,21.77%,FMNL3;LIMD1;MICAL1;WTIP;CSPG5;RHOBTB3;BRWD1;BIN1;TNIK;FMNL2;FGD4;BRWD3;ZMYM3;MAST2;ZRANB1;STRIP1;PHIP;PRPF40A;NECTIN2;MAST4;LRCH3;PCLO;WASF3;PDZD8;LARP4;PAK4;MARK1;CAPZB;SIPA1L3;ABI2
prerank,GO_Biological_Process_2021__water transport (GO:0006833),-0.8123287011624701,-1.340868347694129,0.14754098360655737,0.9813509872344908,1.0,4/6,16.11%,CFTR;AQP1;PDPN;AQP11
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.7075491619071622,1.3406234927906193,0.2,0.5471188251695919,1.0,5/12,18.27%,PLXNA2;NRP2;PLXNA1;NRP1;PLXNA4
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),0.6340468608143961,1.3403264692552042,0.15151515151515152,0.5475644819366658,1.0,3/12,16.81%,RHOT1;OPA1;HIF1A
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.6427895208780745,1.339972867170566,0.17142857142857143,0.548036909512886,1.0,8/17,21.69%,PARD3;CYTH3;GOLPH3;CLASP1;OPHN1;RAP2A;FERMT1;SIPA1L3
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.5123402573130946,1.3388788807315672,0.05263157894736842,0.5509734318453268,1.0,30/58,28.42%,CDKL1;TBC1D1;TBC1D5;USP6NL;CDKL5;EPHA2;TBC1D22B;ODAD3;TBC1D24;FER;TBC1D10A;TRPM2;FXR1;ATG5;ARF6;FMR1;CAPZB;RABGAP1;TBC1D17;CYLD;MYO10;TBC1D15;RAB5A;FXR2;PPP1R16B;TBC1D10B;ATG3;IFT20;TWF1;SDCCAG8
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.7938522042485362,-1.3386189433491775,0.14545454545454545,0.994335743805012,1.0,3/9,10.85%,APLNR;THBS1;IL12A
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),0.6705023711924609,1.3378671310420642,0.12903225806451613,0.5535378126810684,1.0,2/10,3.89%,MAIP1;MCU
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.47761425225017956,1.3375546554103679,0.045454545454545456,0.5540275576003909,1.0,19/46,24.03%,EGFR;SPRED2;EYA2;UBE2N;SPRED1;NPAS2;SIRT1;EYA3;DHX9;TRIM28;UIMC1;FXR1;BRCC3;H2AX;FMR1;SPRED3;EYA4;EYA1;ERCC6
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),0.7356588894850069,1.3371533044897852,0.041666666666666664,0.5545158972258273,1.0,8/11,17.48%,PEX5L;PEX14;PEX2;PEX16;PEX5;PEX7;PEX6;PEX13
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.42942237229312413,1.3369469983049527,0.05555555555555555,0.5543621497201525,1.0,18/62,15.87%,ELAPOR2;BMP2;ZEB2;SMAD2;MEN1;BMPR1B;GDF10;EP300;ZNF423;ACVR1;KIAA0319;HIPK2;TGFBR1;ACVR2A;SMAD4;BMPR1A;STK11;BMP7
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.7292657794750528,1.336944864939842,0.07142857142857142,0.5535690708221266,1.0,3/8,11.20%,NEDD4L;PRKCE;CAMK2D
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),0.8031164756752782,1.3364092108758712,0.11764705882352941,0.554833711915461,1.0,2/5,8.62%,SLC19A1;ABCC5
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.4940125270789729,1.3362487087823793,0.04,0.554291854064585,1.0,16/51,18.70%,CASS4;MCU;PARVA;PLEK;ATP2C1;THSD7A;TNIK;MKLN1;AUTS2;FER;GAB1;CDC42BPA;NRP1;RAP2A;S1PR1;BCAR1
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),0.7311388546975782,1.33612574372165,0.1,0.5538623290524431,1.0,5/8,13.92%,RORA;SMAD2;TGFBR2;TGFBR1;ABCA2
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.44261741204020705,1.3359297712172051,0.05,0.5536829468688584,1.0,19/71,16.90%,EPS8;ARAP1;ARHGAP35;RHOQ;TENM2;GPM6A;KCTD17;PIK3CA;WASL;PIK3R1;AUTS2;ANLN;OCLN;TAPT1;NCKAP1;TENM1;NRP1;CYFIP1;CEP120
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.5265051502711353,1.3355517688428318,0.041666666666666664,0.5543602504477894,1.0,22/60,24.52%,USP13;KEAP1;SMCR8;BOK;DAPK2;ABL2;PIP4K2C;PRKN;EP300;DRAM2;OSBPL7;RPTOR;WDR91;RRAGD;ROCK1;DCAF12;TPCN2;GPR137B;RAB39B;WDR24;IFI16;USP33
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.6021522037168807,-1.3352947981498549,0.043478260869565216,1.0,1.0,12/37,15.34%,P2RY10;IL5;TAGAP;CD5;THEMIS;GMFG;GPR171;TRAF3IP3;KLRD1;LTBR;CXCR4;ARHGAP30
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),0.4503696122551932,1.3352004259124228,0.0,0.5550907914187584,1.0,14/60,18.05%,LIMD1;NUP42;WTIP;NUP37;NUP188;PUM2;IPO8;NUP153;DHX9;NDC1;NUP205;FXR1;PUM1;NUP214
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),0.7005738844676446,1.3344954106257965,0.1,0.5568107153243788,1.0,1/14,0.41%,TXNIP
prerank,MSigDB_Hallmark_2020__Inflammatory Response,-0.5331037450572087,-1.3342504376178643,0.05555555555555555,1.0,1.0,28/118,17.02%,SLC28A2;GPR183;IRF1;BST2;IL1R1;APLNR;SELENOS;BEST1;RASGRP1;ITGA5;TIMP1;IFNGR2;GPC3;ADM;PDPN;TACR1;EMP3;CD14;TLR3;CCL2;CX3CL1;LY6E;SCARF1;EIF2AK2;IL18;CALCRL;RIPK2;IL15RA
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.47949960316325113,1.334050323481335,0.0625,0.5573982167363939,1.0,31/68,23.37%,KEAP1;RNF217;RNF144A;CSNK1E;DNAJB2;SMAD7;RNF14;PSMD10;PRKN;FBXW7;DVL1;COP1;PIAS1;PLK1;SMURF1;PTK2;SIRT2;VCP;ARIH1;GSK3B;ZYG11B;TRIB2;PTEN;MDM2;AXIN1;BAG2;HECTD1;HSPA1A;TAF1;CSNK1D;RCHY1
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),0.7181919238524237,1.3336733703432526,0.08333333333333333,0.5577918207010493,1.0,5/11,15.78%,SNCA;DYRK1A;CLIP3;MAPRE1;ARHGEF7
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.6720697475212362,1.3329961019746783,0.17857142857142858,0.5592812669265875,1.0,4/11,11.57%,WNT7A;DVL1;NLGN4X;NLGN3
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.6953782444928065,1.3322551466949522,0.125,0.5611772953656957,1.0,2/9,5.29%,PLXNA2;PLXNA1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),0.8525858370689415,1.3318944688652987,0.09090909090909091,0.5614818833762859,1.0,1/5,5.23%,BOK
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.6340844601549135,1.3313878481561403,0.11538461538461539,0.5624137058844091,1.0,4/19,4.66%,CPA1;ACE2;GIPC2;ANXA4
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.5337201298307095,-1.331259223277788,0.0,1.0,1.0,29/140,18.73%,IFI6;TRIM22;IFIT1;ISG15;IFITM3;RPL39;BST2;MX1;B2M;TRIM21;APOBEC3G;NLRP1;MASP2;CIITA;KLRD1;SKP2;TLR3;FES;PGLYRP1;SLC11A1;SHFL;SP100;RIPK2;NLRP9;TRIM61;ALPK1;S100B;CLEC5A;PGLYRP2
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),0.7415843208145185,1.3308624989866211,0.2222222222222222,0.5634247244764046,1.0,3/7,11.20%,KDM5A;PRKD1;CAMK2D
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.6675032265264925,1.3308571657278583,0.11764705882352941,0.5626356142180343,1.0,4/13,13.20%,ST6GALNAC5;ST3GAL1;B4GALT6;B4GALT5
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),-0.7577261450385748,-1.330561816873341,0.09333333333333334,1.0,1.0,5/11,19.44%,IFITM3;BST2;CIITA;LY6E;TRIM5
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),0.704271619511654,1.3299472845103835,0.08333333333333333,0.5650847596924334,1.0,3/7,15.92%,SLC15A2;ZDHHC5;BIRC2
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.6501297934411848,1.3296701415672405,0.05555555555555555,0.5653002962264916,1.0,6/19,11.45%,EGFR;RGCC;AKT1;PSMD10;PKD2;STOX1
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),0.8099886015750485,1.3295817710209417,0.11627906976744186,0.5648915214476727,1.0,1/6,3.61%,GLS
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),-0.6987360041248679,-1.32937575556355,0.22033898305084745,1.0,1.0,7/12,27.38%,PFDN6;APOE;CLU;CRYAB;VBP1;PFDN1;LDLR
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),0.7622965609944268,1.3293312630527327,0.075,0.5648359261188519,1.0,3/6,18.18%,MAP3K4;IMPACT;YY1
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),0.6391106295330155,1.3292307895592688,0.11764705882352941,0.5644018918621372,1.0,5/13,20.95%,C8ORF88;EIF4EBP2;EIF2AK4;EIF3E;FMR1
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.6832623812172928,-1.3291505016453382,0.14925373134328357,1.0,1.0,4/18,9.17%,PSMB6;PSMB9;PSMA8;PSMA7
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.6015248615019708,-1.3291272640770342,0.06944444444444445,1.0,1.0,5/29,5.32%,CFTR;DUOX1;STAT1;IGFBP5;AQP1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),0.7423177589794864,1.3289823518215118,0.15217391304347827,0.5645631697200139,1.0,3/8,7.99%,ZEB1;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),0.7257207193646094,1.3289395960446075,0.10638297872340426,0.5639419460527659,1.0,2/10,3.88%,NUDT21;CPEB3
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.5360128867650698,1.328882726211067,0.16666666666666666,0.5633493732603198,1.0,19/46,26.92%,MSL2;CHD5;ZZZ3;KANSL2;EP300;OGT;KAT7;TRIM16;EP400;ATF2;APBB1;LEF1;ING3;EPC1;BEND3;KANSL3;HAT1;HCFC1;TRRAP
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),0.5158756291222076,1.3284447356891713,0.08,0.5638610438990667,1.0,6/29,16.86%,OTUB2;CYREN;UBR5;KLHL15;TRIP12;UBQLN4
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),0.6661302124919473,1.3280791565119916,0.10344827586206896,0.5643175898004901,1.0,4/13,12.22%,LPIN3;AGMO;GPAM;GK
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.5837564388920415,1.3280674778467725,0.10714285714285714,0.5635660393101064,1.0,7/19,25.23%,PTPRK;RCC2;TAOK2;ARHGEF7;TRIP6;WHAMM;THSD1
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),-0.8344578186727265,-1.328045037219739,0.14,1.0,1.0,1/6,1.27%,LMOD1
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.5744176134441524,1.3276982291134296,0.0967741935483871,0.5639949521929537,1.0,10/25,14.72%,EPHA4;HOMER1;CDKL5;ABHD17B;SRCIN1;PPFIA2;ABHD17A;SHANK3;PDLIM5;TANC2
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),0.6739386616227132,1.327656669212163,0.1,0.5633528923156069,1.0,6/10,24.88%,PSMD11;PSMD10;PSMG2;OTUD6B;PSMD13;PSMG1
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.5550797801248407,-1.3274072272001698,0.1125,1.0,1.0,7/62,6.50%,CD24;AGPAT2;USP18;IL7;STAT1;IFNGR2;SIGIRR
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),-0.7382849174643453,-1.3271505957456953,0.1206896551724138,1.0,1.0,3/11,5.24%,DOCK8;RASGRP1;BTN3A1
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),0.7220501987359238,1.326604126689664,0.18181818181818182,0.5649545731928495,1.0,1/9,4.22%,AP2B1
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),0.7220501987359238,1.326604126689664,0.18181818181818182,0.5649545731928495,1.0,1/9,4.22%,AP2B1
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.6986295209618634,1.326601097640262,0.12195121951219512,0.564233932638537,1.0,6/10,18.80%,CTNNA2;SHANK3;MKKS;BBS2;PTEN;FBXW11
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),-0.82840476498859,-1.3260706497260302,0.10526315789473684,1.0,1.0,1/6,1.19%,CENPE
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.5062644365479566,1.3260600871335102,0.07142857142857142,0.5653239599523923,1.0,11/47,14.98%,ACE2;WNT7A;EPHA2;SLITRK2;NRXN1;CLSTN2;PTPRJ;MAP4K4;NLGN3;DLG5;NRP1
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.7681277877266087,1.3259851839203867,0.14285714285714285,0.5647641565565271,1.0,5/8,15.87%,NPNT;SALL1;PKD2;SLIT2;BMP7
prerank,GO_Biological_Process_2021__negative regulation of fibroblast migration (GO:0010764),0.7839274493098382,1.3252813907485317,0.125,0.5663279525448123,1.0,1/5,1.95%,MACIR
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.6068216311230287,1.32501833060555,0.09090909090909091,0.5663245916338508,1.0,1/17,0.34%,LPIN3
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.43584261276924935,1.3249957167399296,0.0625,0.5657921654662557,1.0,51/110,28.30%,PIP5K1B;SOCS6;ITPKB;PTPN13;PLEKHA2;EFR3A;PIK3CA;PIK3R1;SOCS7;PIK3R4;PIP5K1C;PIK3C3;PLEKHA8;PIP4K2C;SMG1;TTC7B;PIKFYVE;SYNJ1;IP6K2;MTMR2;PITPNM3;PIGP;RAB4A;PI4KB;PLEKHA3;PTEN;MTM1;MTMR12;PITPNM1;PLEKHA1;PGAP4;SACM1L;PIGQ;FGF2;TTC7A;OCRL;MTMR6;PIK3C2B;SYNJ2;PIGU;SOCS4;FIG4;DPM1;MTMR9;RAB5A;SLC27A1;PI4KA;PIP4K2B;RUFY1;TPTE2;PIGZ
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),-0.7001545050359412,-1.3246405486657808,0.046875,1.0,1.0,4/15,13.09%,KIF20B;FBXO43;CAV2;BORA
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.4908424647997854,1.3241668148592327,0.08,0.5678765460857542,1.0,11/32,15.32%,SPIRE2;NCK2;BIN1;CARMIL1;SPIRE1;PRKCE;NCK1;NCKAP1;FER;TENM1;VASP
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.578269660095116,1.3238170347034774,0.11764705882352941,0.5685042640238145,1.0,15/24,31.00%,PIP4P2;MTMR10;SYNJ1;MTMR2;PTEN;MTM1;MTMR12;SACM1L;OCRL;MTMR6;SYNJ2;MTMR9;TPTE2;MTMR3;MTMR7
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),0.5587532952694269,1.3235203018782389,0.11764705882352941,0.5686297033208839,1.0,4/22,14.18%,TRUB1;METTL8;DKC1;ZC3H13
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell migration (GO:0090521),0.7973542415975335,1.3234985535343673,0.14285714285714285,0.5679917976619407,1.0,4/5,19.69%,KANK1;TESK1;ANLN;ROCK1
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),-0.8111813650555642,-1.3232407858012916,0.10526315789473684,1.0,1.0,3/9,9.20%,ACMSD;MST1;PGP
prerank,MSigDB_Hallmark_2020__Protein Secretion,0.46647350289191414,1.322854017976463,0.07692307692307693,0.5690897646696126,1.0,23/90,19.38%,BET1;SGMS1;ARFIP1;TMX1;AP3S1;ABCA1;EGFR;AP2B1;RPS6KA3;SEC22B;AP3B1;RAB9A;KIF1B;DOP1A;RAB22A;MAPK1;AP1G1;SCRN1;ARFGEF1;SCAMP1;CLCN3;STX7;STX12
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.6019063291178383,-1.322794342695226,0.057971014492753624,1.0,1.0,6/43,8.04%,LDHC;GAPDHS;ENO4;SLC16A3;ALDOB;PDHX
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.511792141204338,1.3226879876341215,0.08695652173913043,0.5688465526868569,1.0,5/30,13.83%,PLD6;PIWIL4;DROSHA;TENT4B;PRKRA
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.5610699947252086,1.3226184837899453,0.13333333333333333,0.5683419546949929,1.0,5/19,16.51%,ACACB;PLEKHA8;ARV1;ABCD3;CPT1A
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.43666935315085537,1.322608926656064,0.0,0.5676031949770621,1.0,33/97,22.67%,EPHA7;PDE3B;EFNA5;PRKX;EPHA4;PLXNA2;RSU1;CXCL12;PLXNA1;EPHA2;TFE3;PKP4;ABL2;PTPRJ;PTK2;CDH13;ROCK2;PTPN11;SEMA4D;PPP1R12A;YTHDF2;PLXNA4;PPP1CB;FRMD5;ARHGDIA;FBLN1;ROCK1;PPP2R1A;ZDHHC2;PRKCA;EPHB3;EPB41L4B;PPP3CA
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),0.8157874108250289,1.321969528753978,0.11363636363636363,0.5686173801054826,1.0,4/6,16.81%,ROBO1;SLIT2;PADI2;HIF1A
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),0.7402786879957461,1.3218347200213127,0.1388888888888889,0.5684283053053308,1.0,2/8,8.66%,ATP6V1A;CPEB4
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.40224848905690896,1.321750400237326,0.0,0.5680833554970905,1.0,44/164,19.33%,VEGFD;LEPR;EFNA5;NPTN;ERBB4;CSF1R;EGFR;SOX9;BMP2;LIMCH1;ARRB1;TESK1;FGF17;TNIK;NTRK2;AKT1;DYRK1A;PPP2R5A;UBE2N;RALB;ATG7;VEGFC;HGF;CAMTA1;PTK2;CLIP3;CRKL;RAB3GAP1;SIRT1;ACVR2A;WDFY2;ROCK2;SEMA4D;RAP2A;SPPL3;FXR1;TFRC;AKT2;PTBP1;CIB1;CCND3;AXIN1;NTRK3;FAS
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),0.6132709186463894,1.3217020852288794,0.15789473684210525,0.5674530128811132,1.0,5/12,20.43%,NCSTN;MME;DYRK1A;IDE;MGAT3
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),-0.6231081371430816,-1.3213940360324616,0.1232876712328767,1.0,1.0,5/27,12.27%,CCDC39;MMP21;APLNR;DNAAF1;SRF
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),0.5371513075726345,1.3212513198891416,0.06451612903225806,0.5679420960792323,1.0,10/27,30.07%,RAB33B;VTI1A;TRAPPC10;NSF;GOLGA5;COG5;COG3;COG1;COPA;COG6
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.5825198424637175,1.3206362843744626,0.13333333333333333,0.569130773281301,1.0,5/19,22.95%,PICALM;PRKD1;MTMR2;ARF6;LRSAM1
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),0.7170251139575884,1.3205958465450902,0.20588235294117646,0.5685274801244383,1.0,4/6,26.45%,RBM24;TENT4B;LARP4B;TENT4A
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.6542638285589062,1.319339246036584,0.15384615384615385,0.5716539716833368,1.0,7/11,28.21%,UGGT1;VCP;RNF185;DERL1;BAG6;AUP1;UGGT2
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.7434859605785951,1.31917299263779,0.1111111111111111,0.5715660416559413,1.0,2/7,5.43%,PARD3;MYRF
prerank,GO_Biological_Process_2021__regulation of barbed-end actin filament capping (GO:2000812),0.7272196458827165,1.3189485827114873,0.18421052631578946,0.5715816306154573,1.0,1/5,7.38%,CARMIL1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),0.6122174301899908,1.3187878987556862,0.14285714285714285,0.5711845843942343,1.0,1/23,0.34%,LPIN3
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.5552263772264648,1.3184658182928584,0.1111111111111111,0.571123378421996,1.0,7/16,19.86%,ELOVL7;HACD2;ELOVL6;ELOVL5;HACD1;ACSBG1;ACSL3
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.6843817042785131,1.3180067646811566,0.125,0.5720653712573865,1.0,8/10,29.00%,NCKAP1;CYFIP1;WASF3;WASF1;ABI2;WHAMM;GSN;FCHSD2
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.6955576683567675,1.3179464212502991,0.25,0.5714124103139678,1.0,6/11,26.49%,ARHGAP35;B4GALT6;B4GALT5;PTEN;SPTBN4;EPHB1
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.6744556292088539,1.3173872366321169,0.15,0.5723002343022509,1.0,8/10,32.09%,SOX4;PKD2;NF1;ZPR1;SOX12;RELN;DLL1;GLI2
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.4761614526240552,1.3169747151693854,0.1,0.5727758430120955,1.0,9/41,19.66%,LAMB4;PARVA;SRCIN1;PIK3R1;FER;NRP1;PXN;NTN4;TMEFF2
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),0.8236751226189702,1.3168237709744983,0.2,0.5723547765022651,1.0,3/5,15.70%,ROBO1;SLIT2;PADI2
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),0.7710290375397226,1.3162223968190114,0.08108108108108109,0.5736722107329623,1.0,4/6,22.71%,RBPMS2;NFATC3;NFATC2;NFATC1
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),0.8139244139445054,1.3161611497743613,0.15384615384615385,0.5731745238983047,1.0,3/7,13.20%,MYRF;B4GALT6;B4GALT5
prerank,GO_Biological_Process_2021__intestinal lipid absorption (GO:0098856),-0.7695240971221332,-1.316154205065345,0.16666666666666666,1.0,1.0,1/7,1.50%,AKR1C1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),0.6876988131413183,1.3160899111034534,0.19444444444444445,0.5726781416162936,1.0,3/9,9.89%,BMP2;SOX6;EFNB2
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),0.5786391121736078,1.3155063876439388,0.05555555555555555,0.5740408785966487,1.0,3/23,7.87%,TCAP;KCNH2;PIK3CA
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.8233942173190514,-1.3154872102319248,0.14285714285714285,1.0,1.0,3/6,5.94%,HLA-A;HLA-B;HLA-C
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.8233942173190514,-1.3154872102319248,0.14285714285714285,1.0,1.0,3/6,5.94%,HLA-A;HLA-B;HLA-C
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),0.7905623387864501,1.3152345374391672,0.10256410256410256,0.5741546532197394,1.0,1/5,15.88%,SLC16A10
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.4847665658406841,1.3152241443354453,0.11764705882352941,0.5734558703415736,1.0,14/70,15.00%,RANBP17;NUP42;XPO1;RANBP3L;NUP188;U2AF1;RANBP3;XPO6;EIF4E;NUP153;XPO7;SMURF1;U2AF2;THOC7
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),-0.8010005079570227,-1.3148099659529247,0.1791044776119403,1.0,1.0,3/6,11.96%,HLA-A;ANXA1;RSAD2
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.38362378673304126,1.3145047700208041,0.0,0.5751671638279874,1.0,99/339,20.53%,POU6F2;PPARGC1A;LIMD1;USP13;BACH1;YAF2;MITF;WTIP;SOX4;RPS6KA4;ESRRG;VHL;PSPC1;RORA;BMP2;RNF6;NFXL1;CHD7;ZNF212;HCLS1;HMG20A;RFX3;COPS2;NFYC;NR1D2;SP3;NCOA2;GPBP1L1;ZNF280D;ZNF516;SMARCA2;ZNF117;NLK;MAGED1;RNF14;ZNF33A;NR3C1;SOX6;CLOCK;ZNF268;TGFBRAP1;CREM;SUPT3H;ZNF737;ZNF736;EP300;FOXN2;DVL1;PRDM8;TFEB;ZNF423;HP1BP3;FOXN3;ZNF519;APBB2;TGFBR1;MLXIPL;RREB1;AHR;ZNF680;MYT1;SOX13;ZBTB38;ZNF282;KAT7;TRIP4;ZFAT;DMTF1;CCAR1;CXXC1;HIF1A;KAT6B;SUFU;ZNF141;ATF2;ZNF703;APBB1;ATRX;RORB;SSBP2;SOX21;NFIA;ESRRB;ELAVL2;HNRNPD;UTP4;DNM2;HDAC10;ASCC1;NSD2;SPIN3;RALY;REST;PRDM2;SPTY2D1;NFATC2;ZNF646;PPP2R1A;CREBBP
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.4542353392425318,1.3143778127622663,0.0,0.5748739549127204,1.0,21/53,22.98%,CLDN12;CDH2;CDH11;CDH20;PKP4;SMAD7;PIP5K1C;TLN2;CDH9;TJP1;CDH18;CDH8;ZNF703;CTNND2;CDH6;CDH19;PRKCA;CDH10;CTNNB1;DCHS1;TBCD
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.5384304818402329,1.3142905878919784,0.043478260869565216,0.5744550879954619,1.0,9/27,15.60%,ERBB4;EGFR;PIK3CA;PIK3R1;NRG2;SOS1;GAB1;CPNE3;NRG1
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),0.6912174309978353,1.3142020202270246,0.0967741935483871,0.5741130628790497,1.0,6/12,20.25%,IWS1;SAFB2;SLTM;DHX9;SRPK2;PTCD2
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.5796264022926156,-1.3139154848015149,0.13333333333333333,1.0,1.0,11/33,24.26%,GAPDHS;ENO4;ENOSF1;ALDOB;HK2;LDHA;GPI;NEU1;PGAM1;ENO1;GAPDH
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),0.6428358745315621,1.3138597286867912,0.16666666666666666,0.5744023881608766,1.0,7/13,13.62%,SLC43A1;NEDD4L;BIN1;KCNH2;CBARP;CAMK2D;COMMD1
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),0.7454060853357134,1.3131669008783917,0.17647058823529413,0.576000628639077,1.0,4/8,18.02%,SOX8;SOX9;RPGRIP1L;RORB
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),0.5735768532273784,1.3129656057519499,0.14705882352941177,0.5760352306879836,1.0,6/21,18.24%,LIG4;MEN1;MAP3K20;YAP1;KDM1A;MDM2
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.3986343830184005,1.3122072100333315,0.0,0.5777025940722996,1.0,8/77,7.34%,ACE2;WNT7A;PID1;ACACB;SNCA;TBC1D5;ARRB1;AKT1
prerank,GO_Biological_Process_2021__T cell apoptotic process (GO:0070231),0.7584792159893378,1.3120487643604724,0.17777777777777778,0.5774338503395293,1.0,3/5,19.33%,AKT1;GLI3;FAS
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),-0.6942883293969528,-1.3120367091887297,0.10666666666666667,1.0,1.0,4/14,10.98%,SLC18A2;CEACAM1;GSTP1;CIITA
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),0.6794231215833404,1.3119452013160675,0.2857142857142857,0.5770655750995115,1.0,5/7,27.68%,CEND1;OPHN1;AGTPBP1;FAIM2;GRID2
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),0.7574940467540834,1.3119395407909025,0.2222222222222222,0.5763979623295213,1.0,2/6,13.85%,HNRNPU;DHX9
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),0.5544504763741003,1.3117162494752153,0.14705882352941177,0.5765068061636234,1.0,4/23,3.67%,VAPA;TRAM1;EGFR;MAIP1
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.7212401582863335,-1.3116037205113182,0.17543859649122806,1.0,1.0,4/13,8.81%,ZWILCH;SPDL1;MTBP;MIS12
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.7819270491752737,-1.3113631382859563,0.13043478260869565,1.0,1.0,3/9,10.62%,ISG15;RPS27A;UBC
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),0.5975028474038778,1.311117838397323,0.1,0.5777385500036164,1.0,5/21,12.34%,CCDC88C;KIF5A;HOOK1;KIF5C;KIF1B
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.47480715705385657,1.3110632253361965,0.07692307692307693,0.5772471349942833,1.0,14/35,21.71%,RHEB;LGR4;TFE3;NR1D1;DOCK7;ZNF423;ABHD6;STK11;PGAM5;RBPJ;NOVA1;LNPEP;NOVA2;PLCL1
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),0.39830499440495754,1.3105677577504082,0.0,0.5781262378658717,1.0,42/136,18.48%,ADAP1;EFNA5;RCC2;EPHA4;PICALM;LRCH1;PLXNA2;RSU1;SNX18;USP6NL;ARAP1;CDKL5;RGS6;EVI5L;PLXNA1;DOCK9;PRKG1;NTRK2;RAPGEF2;PKP4;EPHA5;FGD4;ADRB1;MAP4K4;NF1;RGS16;RGS10;PTK2;AFDN;RAB3GAP1;RAP1A;RAP1GDS1;GSK3B;SNX13;SEMA4D;ARHGEF7;ARFGEF1;ITGA6;RAB11FIP2;PLXNA4;ALS2;WNK1
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.5931863166410706,-1.3102267619871668,0.1044776119402985,1.0,1.0,7/46,16.68%,H1-4;H1-2;POLR2L;POLR2I;BLM;POLQ;POLR2J
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.4351328472125978,1.3102052385889098,0.0,0.5785804079518159,1.0,34/97,23.37%,GNL3L;SASH1;SOX4;DCUN1D1;ARRB1;AKT1;FAM107A;UBE2D1;UBE2N;DNAJB2;SMAD7;PSMD10;PRKN;FBXW7;OGT;TGFBR1;COMMD1;U2AF2;UBQLN1;SPOPL;BIRC2;NDFIP1;CUL3;ADGRB1;BCL10;AXIN1;PRMT3;BAG2;N4BP1;DERL1;HSPA1A;NDFIP2;HUWE1;RCHY1
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.7382449326704014,1.310046233532363,0.26666666666666666,0.5785864413109726,1.0,3/8,12.84%,PRKAR1B;PKIA;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),0.8006726385620784,1.3098274939162846,0.1282051282051282,0.578369256015576,1.0,3/6,12.90%,OTUB2;UBR5;TRIP12
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.7254781810734364,-1.3091765171887,0.15873015873015872,1.0,1.0,2/11,4.33%,SFRP2;P2RY12
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),0.6686596344603659,1.3091305312690482,0.125,0.5797625940938043,1.0,4/11,18.46%,ATG7;AGTPBP1;TTL;ATG5
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.3863607654458591,1.309083934843216,0.0,0.5792228807096887,1.0,31/123,17.07%,EPS8;RAP2B;MAPK11;RAPGEF2;ARHGAP5;CCNA2;SHOC2;G3BP1;RALB;SHC3;IGF1;MRAS;NF1;GNA13;PRKD1;SOS1;NRAS;CRKL;RRAS2;NCKAP1;RREB1;RAP1A;MAPKAPK5;RAP2C;CDH13;TRIM28;ROCK2;HACE1;RAP2A;CYFIP1;WASF1
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.5418463929756927,1.3088981723966897,0.15384615384615385,0.5791539495720073,1.0,9/29,14.78%,WNT7A;SNCA;PIP5K1C;NLGN4X;NLGN3;TBC1D24;STX1A;OPHN1;SYNJ1
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.40453647834689177,1.3088776385052434,0.0,0.5784436571033529,1.0,67/226,19.83%,TIAM2;MAP3K11;KLF11;ARHGEF6;PAWR;AIFM2;SNCA;FOXO1;PHLDA1;CRADD;SOX4;ARHGEF16;ARHGEF12;BMP2;BOK;NCSTN;FOXO3;ARHGEF26;BIN1;KCNMA1;FRZB;DAPK2;ADAMTSL4;ATF6;TNFRSF10B;UBE2Z;RPS6KA2;CTNNBL1;FGD4;ITSN1;ATG7;MAP3K20;HMGB1;C3ORF38;ZNF268;NF1;GNA13;SLIT2;TRADD;MAP3K5;SOS1;CLIP3;SIRT1;MCF2L;DUSP6;JMY;IP6K2;SCRIB;LATS1;MAP3K10;FAF1;ARHGEF7;MAPK8;CCAR1;CSRNP3;ITGA6;TRIO;TRIM35;APBB1;BCL10;PNMA3;AIFM1;DNM2;FAS;CASP3;REST;MCF2
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.44714922672530977,1.308702558838946,0.13333333333333333,0.578203385909873,1.0,8/61,7.88%,POSTN;SDC4;ACTA2;EGFR;PARVA;EPHA2;MME;FBLIM1
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),0.6382290722594322,1.3085157800979081,0.2,0.5781360070357519,1.0,2/11,12.84%,POLD3;SIRT1
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),-0.6929386512069852,-1.3082207195949742,0.10714285714285714,1.0,1.0,2/18,6.67%,SELENOS;THBS1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.7528650136055554,1.3082117854592148,0.0975609756097561,0.5783883501000497,1.0,4/8,13.62%,NEDD4L;PRKCE;CAMK2D;COMMD1
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.658219548943501,1.3081799175118638,0.06666666666666667,0.5778299107563712,1.0,4/13,13.60%,CSPG5;DCN;VCAN;CHST14
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),0.4938165854634772,1.3081515285231518,0.11538461538461539,0.5772483609390672,1.0,12/60,12.17%,TSEN15;LCMT2;TRUB1;RPP40;TRMT1;FARS2;ZBTB8OS;THUMPD1;TRIT1;NSUN6;CDKAL1;CTU1
prerank,MSigDB_Hallmark_2020__heme Metabolism,0.4087084405533398,1.307968375588597,0.0625,0.5773294524000867,1.0,38/163,15.91%,TYR;BACH1;ACKR1;BTRC;SNCA;VEZF1;KAT2B;PICALM;DCUN1D1;ARHGEF12;EPOR;FOXO3;RCL1;CDC27;YPEL5;SLC7A11;GMPS;SMOX;CA2;FBXO34;NR3C1;TRAK2;GCLC;TNRC6B;SEC14L1;XPO7;CDR2;BSG;FTCD;MINPP1;NNT;ARL2BP;ADIPOR1;SLC30A1;SYNJ1;GAPVD1;RBM38;TFDP2
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.557617336071614,-1.3077119570846105,0.06976744186046512,1.0,1.0,5/60,10.89%,SLC28A2;SLC18A2;SYN3;GAD1;SNAPIN
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.715412662158376,1.3073537933496793,0.1891891891891892,0.5792446308265234,1.0,7/9,23.30%,KAT2B;KAT2A;EP300;SIRT1;KAT7;CREBBP;BAG6
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),0.6730799220764754,1.3069911874384517,0.1794871794871795,0.5797382609556597,1.0,4/9,26.34%,GALK2;PGM2;CHST1;GALE
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.672446301039221,1.3069648305370618,0.17647058823529413,0.5791816312554728,1.0,1/16,0.51%,ATP6V0D2
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),0.6481702658268105,1.306849706784498,0.2,0.5788944145708204,1.0,2/10,8.59%,PRODH;ALDH4A1
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),-0.6939228126717493,-1.3067733067199014,0.1694915254237288,1.0,1.0,2/15,3.85%,DUOX1;STAT1
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.4907272565604513,1.3064827005438135,0.06060606060606061,0.5794596339098259,1.0,11/42,13.43%,WNT7A;SNCA;SLIT1;IL1RAPL2;SLITRK2;NRXN1;CLSTN2;NLGN3;SLITRK1;PDLIM5;DLG5
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.5707241571837636,1.306320421915361,0.14705882352941177,0.5791241790528863,1.0,7/20,21.41%,SHANK1;MARVELD3;CGNL1;TJP1;PCLO;NLGN1;NECTIN1
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.5339615094264076,1.3062328272647756,0.10526315789473684,0.578668191721979,1.0,3/35,1.97%,SLC26A7;CLIC5;ANO5
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.38262712421442224,1.3058137666590903,0.0,0.5791346038636557,1.0,27/153,18.22%,VAPB;BET1;ANK2;VAPA;TRAPPC12;PGAP1;VTI1A;TRAPPC8;TRAPPC6B;SEC22B;TRIP11;DCTN5;DYNLL2;PEF1;COL7A1;SEC24B;TMED3;NSF;TRAPPC11;RAB1A;TFG;TMED5;CUL3;CD59;SEC23A;CNIH1;MIA2
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.42561716491228935,1.3054901967570787,0.0,0.5796967085493002,1.0,37/89,23.37%,XPO1;KEAP1;RNF217;RNF144A;CSNK1E;DNAJB2;SMAD7;RNF14;PSMD10;PRKN;DVL1;COP1;PIAS1;PLK1;OGT;EIF3H;COMMD1;SIRT2;VCP;ARIH1;GSK3B;ZYG11B;TRIB2;UBQLN4;MDM2;FHIT;RAD23B;BAG2;WAC;N4BP1;HECTD1;HSPA1A;TAF1;GNA12;CSNK1D;BAG6;RCHY1
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.545673449735289,-1.3049991683177542,0.0945945945945946,1.0,1.0,4/52,3.29%,GC;AKR1C1;HSD11B1;DHCR24
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),0.5071074538098552,1.30463541711893,0.05555555555555555,0.5819260721969138,1.0,8/29,10.20%,HDAC9;FOXO1;ASCL1;RHEB;NOTCH2;AKT1;CLOCK;DOCK7
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.5359542430746247,1.3045288393164798,0.2,0.5814205632357393,1.0,14/47,18.45%,CRADD;SOX4;PRMT1;RGCC;CNOT9;CNOT6L;CNOT2;CNOT4;EP300;MDM4;TFDP2;CNOT8;MDM2;PCBP4
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.5590555553323254,-1.3045059509130141,0.1095890410958904,1.0,1.0,22/56,17.64%,RPL11;RPL38;RPL35A;RPS7;RPS25;RPS15;RPS6;RPL5;RPS28;RPL7;RPS24;RPS16;EMG1;RPL26L1;RPL14;RBIS;EBNA1BP2;WDR12;RPF2;GTF3A;RPS19;MRPL36
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589),-0.8599743590400135,-1.304265309407797,0.10526315789473684,1.0,1.0,1/5,3.54%,APLNR
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.681731581855727,-1.3041842878185765,0.22666666666666666,1.0,1.0,6/14,21.05%,RPL35;RPL7;DDX18;WDR12;RPF2;NIFK
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),0.5729263497541544,1.303840354703833,0.13513513513513514,0.5830874173048833,1.0,7/18,18.59%,HNRNPU;RANGAP1;MORC3;SYNE1;TAF8;ARL2BP;TAF3
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),0.8199570562734487,1.3038004403763097,0.14285714285714285,0.582461254380205,1.0,2/5,12.81%,TMEM33;RAB3GAP1
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),0.7882639489122183,1.3037795903681408,0.15789473684210525,0.5817885139274385,1.0,2/5,13.53%,AK3;ENTPD4
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),0.5923583951623491,1.3036711077336351,0.08571428571428572,0.5813337423737532,1.0,7/18,14.28%,SOX8;SOX9;MYRF;SOX6;PRDM8;SOX13;PTPRZ1
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.651134461223846,1.3035678446792496,0.21621621621621623,0.5810001152206475,1.0,11/14,24.33%,CACNG2;CACNG3;NRXN1;TSHZ3;SHANK3;NLGN3;NLGN1;CACNG8;CACNG4;CACNG7;NLGN2
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.8005233615379796,1.303392475720321,0.125,0.5809789819637775,1.0,2/6,4.30%,BTRC;RORA
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.7071735794577925,-1.303060063810192,0.1694915254237288,1.0,1.0,5/11,23.18%,SFRP1;INHA;ID2;XBP1;MMP14
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),0.8058575272476652,1.3026184609154685,0.21153846153846154,0.5824425017751359,1.0,1/5,1.44%,LIG4
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),0.7250277727680381,1.302499167894283,0.17073170731707318,0.5822044048300835,1.0,4/7,22.60%,ISYNA1;ITPK1;IPPK;IMPA2
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),0.7768758630113417,1.3021147243158417,0.16666666666666666,0.5826595968749442,1.0,2/6,9.05%,DACH1;SMAD7
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.6439493592951266,1.3019874880064588,0.1875,0.5821116763755967,1.0,5/9,22.98%,SMAD7;PIP5K1C;ZNF703;CTNNB1;TBCD
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),0.37804882413794644,1.301820172271976,0.1,0.5821131382037779,1.0,41/239,18.11%,UHRF2;CHRNA4;DNASE1L2;BACH1;LIG4;SAMHD1;TOP3B;ZBTB1;DNA2;POLD3;LTO1;UBE2T;SMARCAD1;RAD18;PDS5B;MEN1;DFFB;UBE2N;CSNK1E;TOP1MT;STN1;RAD51B;HMGB1;RAD52;HELLS;USP3;CDC34;EXD2;PDS5A;TRIM28;VCP;PRIMPOL;PTGES3;MSH2;POT1;PSME4;TICRR;ORC5;SRPK2;ASF1A;SMUG1
prerank,GO_Biological_Process_2021__intestinal cholesterol absorption (GO:0030299),-0.7728334789610997,-1.3017998594232176,0.18032786885245902,1.0,1.0,1/6,1.50%,AKR1C1
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),0.7124569158824505,1.3012583271134808,0.1951219512195122,0.5833997227088896,1.0,3/5,19.58%,SETD3;SETD2;SETD5
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.5995603258318251,-1.3008630343927634,0.0821917808219178,1.0,1.0,8/35,18.97%,RPS14;GATA1;ATP5IF1;INHA;ID2;RPS19;ZFPM1;SLC25A5
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle contraction (GO:0045986),0.7836828282209862,1.300327084124418,0.13953488372093023,0.5855626345356003,1.0,3/5,12.21%,KCNMA1;DOCK4;ADRB2
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.4432678217682921,1.300305728596833,0.0,0.5848714023618966,1.0,22/70,19.26%,STARD13;EPS8;NOTCH2;KANK1;KBTBD7;EPOR;SPRY4;DENND4C;KBTBD6;DENND1A;SHOC2;SPRY3;IGF1;CRKL;OGT;OPHN1;SYNGAP1;RALGPS1;ARHGAP17;LRRC59;ARHGDIA;ARF6
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.49583044074277105,1.3000053384639843,0.13793103448275862,0.5850117609368282,1.0,12/43,16.31%,PARD3;ACER3;MYRF;MBP;B4GALT6;GAL3ST1;NF1;ZNF24;SBF2;B4GALT5;SIRT2;ACSBG1
prerank,GO_Biological_Process_2021__glandular epithelial cell development (GO:0002068),0.7832551173340129,1.2999301902541802,0.14285714285714285,0.5846544412086295,1.0,1/5,4.29%,CDH2
prerank,GO_Biological_Process_2021__positive regulation of cell activation (GO:0050867),-0.7922482380848263,-1.2998777847214367,0.1,1.0,1.0,2/6,3.05%,SOX15;SELP
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6569344022298933,1.299852523345783,0.08108108108108109,0.5842743369976864,1.0,5/16,9.74%,EGFR;RGCC;AKT1;PSMD10;PKD2
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),0.725569524614647,1.2997478487802039,0.1891891891891892,0.5841077826857387,1.0,2/7,3.76%,LIG4;EXOSC6
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),0.7036973704796021,1.2993950415475441,0.24324324324324326,0.5845315441692199,1.0,4/7,27.65%,CSF1R;TJP1;NLGN2;PARD6A
prerank,GO_Biological_Process_2021__establishment of centrosome localization (GO:0051660),0.7977208184174416,1.299392507251316,0.125,0.5838230210853785,1.0,3/5,15.98%,PARD3;DLG1;PARD3B
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),0.6860664803556509,1.2993416801327233,0.20512820512820512,0.5834457641346861,1.0,5/8,13.00%,AKT1;WASL;PLCB1;SLIT2;NBL1
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),-0.7095235893918544,-1.2991596408630988,0.18032786885245902,1.0,1.0,7/9,27.38%,PFDN6;APOE;CLU;CRYAB;VBP1;PFDN1;LDLR
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.33237300013292764,1.2988333668472647,0.0,0.584456560492303,1.0,141/445,21.75%,SPSB4;UHRF2;BTRC;KCTD13;SASH1;TRIM24;PDZRN3;SPSB2;SH3RF3;KEAP1;MSL2;TSPAN17;VHL;FBXL17;UBE2G1;KLHL8;RNF11;UBE2T;RNF217;ARRB1;RNF146;NEDD4L;MARCHF6;RNF6;CBL;PSMA1;DTX4;KLHL42;SDE2;RAD18;CDC27;SH3RF1;PHC1;RNF144A;UBE2E3;FBXL3;RUSC1;FBXO30;LMO7;UBE2D1;RNF182;UBE2N;UBE2Z;UBR3;PEX14;UBR5;RNF26;TMEM129;PSMD11;ITCH;RNF14;TRIM54;PSMD10;MARCHF7;FBXO11;RNF208;CNOT4;RFWD3;UBE3C;PRKN;RMND5A;FBXW7;PSMF1;KCTD10;PSMD14;PCNP;FBXL14;PEX2;RNF25;FBXO21;PLK1;SMURF1;MKRN3;PEX5;SIRT1;VCPIP1;TRIP12;UBE2E1;CDC34;FBXO45;COMMD1;MIB1;UBE2E2;FBXO28;CUL2;BCL2;DTX1;CUL1;HIF3A;BLMH;VCP;ARIH1;USP22;TRIM36;USP9X;ANAPC16;BFAR;HACE1;BIRC2;KLHL24;TRIM44;MIB2;MARCHF3;RNF41;HIF1A;FBXW2;RNF166;PSME4;UBR1;CBFB;TRIM35;CUL3;PEX13;BCL10;UBE2L5;MDM2;NFE2L2;FBXW11;FBXO31;LNPEP;UBE2D3;KLHL2;OTULIN;WAC;ANKRD9;MKRN1;TNFAIP1;UBA6;RBBP6;RNF185;PSMD1;UBE3B;FBXO15;PELI1;RNF10;DERL1;DTX2;RNFT1;SHPRH;HERC2;UBE2H
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),0.7910085712937461,1.2983164080617438,0.17073170731707318,0.5854179503749681,1.0,3/5,15.60%,TMEM167A;TMEM167B;TRAPPC11
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.48076007114648744,1.2983104386781634,0.10526315789473684,0.5847352308742412,1.0,16/52,16.05%,LCMT2;TRUB1;TRMT1;TFB1M;APOBEC3F;THUMPD1;TRIT1;ADARB1;NSUN6;CDKAL1;RBM15B;NSUN3;PUS7L;CTU1;JMJD6;THG1L
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),0.706306348171544,1.2982221061062633,0.13953488372093023,0.5843352670967312,1.0,2/7,14.70%,PHF14;KAT7
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),0.5895838450370472,1.298138858895538,0.17142857142857143,0.583819277454231,1.0,4/12,23.10%,SMCR8;SEC22B;MTM1;SCFD1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.38183882393396074,1.2980212692525508,0.0,0.5835615934683187,1.0,53/241,17.69%,SPAG16;FHDC1;MACIR;ARHGEF6;DNM3;RAP2B;PARVA;CILK1;EXOC2;SEPTIN6;RAB3IP;EHD4;CYS1;TNIK;RFX3;RAPGEF2;CARMIL1;RAB8B;RAB23;SSX2IP;EXOC5;TTBK2;CEP290;EXOC8;FGD4;EXOC6;MTSS1;MAP4K4;DZIP1;GOLPH3;TTC8;DYNLL2;SEPTIN7;KIAA0586;RAP1A;EXOC4;BBS9;RAP2C;OPHN1;CEP20;CDH13;RP2;NRP1;LZTFL1;ARHGEF7;CDC14A;RAB1A;RAP2A;PTPRO;CYFIP1;ATAT1;MKKS;BBS2
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),0.6635546319086499,1.2979131722787884,0.21621621621621623,0.5833278696891823,1.0,3/9,18.17%,DUSP6;LATS1;PTEN
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),-0.7638586433082082,-1.2978819532677572,0.21311475409836064,1.0,1.0,2/9,4.33%,MST1;P2RY12
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),-0.783358620248849,-1.297690224486184,0.11864406779661017,1.0,1.0,3/6,16.71%,IL5;KIF9;FSCN1
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),0.5786567724512561,1.2976433742606228,0.14285714285714285,0.583444409353264,1.0,3/17,5.33%,RHBDD1;NFKB1;NCSTN
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),0.4031191698857911,1.2974976373210614,0.0,0.5832346713417272,1.0,39/126,16.54%,WNT7A;ACAP2;PDE3A;FLT1;SOX5;EGFR;SOX9;BMP2;NTRK2;RAPGEF2;AKT1;MTSS2;BMPR1B;SMAD7;RPS6KB1;NR3C1;SOX6;HGF;MAPKAPK2;PRKD1;ACVR1;TGFBR2;CRKL;WWOX;MAGI2;TGFBR1;MAP2K5;RAP1A;SIRT2;ACVR2A;SMAD4;BMPR1A;PDE2A;NRP1;DUSP22;CPNE3;PTPN11;BMP7;NDNF
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),0.5420915970548791,1.2967130209444808,0.12,0.5854674995079693,1.0,12/24,26.01%,TTBK2;TRIM54;NAV3;CAMSAP2;CLASP1;HDGFL3;KATNB1;CIB1;ATXN7;FGF13;TAOK1;CLASP2
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),0.6111650550658025,1.296448158307715,0.10256410256410256,0.5856275250976588,1.0,4/19,11.20%,TCAP;KCNH2;PIK3CA;CAMK2D
prerank,GO_Biological_Process_2021__fluid transport (GO:0042044),-0.7923814840800552,-1.2962388718636262,0.078125,1.0,1.0,4/7,16.64%,AQP1;PDPN;AQP11;SLC4A11
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),0.4951123174765875,1.2962084558608022,0.15,0.5854855395337442,1.0,10/39,14.32%,SORT1;EPS15;ALS2CL;WASL;EXOC8;RNF26;DNAJC13;HOOK1;CHMP2B;RAB22A
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),-0.7877865770865438,-1.2961838626902866,0.11864406779661017,1.0,1.0,1/6,6.50%,DNAAF1
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.5028529353319645,1.2959656341324437,0.15789473684210525,0.5859232572808394,1.0,17/43,18.97%,SPIRE2;EGFR;EYA2;FAM168A;UBE2N;SPIRE1;NPAS2;HMGB1;SIRT1;EYA3;DHX9;TRIM28;UIMC1;BRCC3;HDAC10;H2AX;FMN2
prerank,GO_Biological_Process_2021__cardiac muscle cell myoblast differentiation (GO:0060379),0.7779499497022397,1.2958851004268495,0.22857142857142856,0.5853877586292036,1.0,3/5,19.82%,NRG1;RBPJ;REST
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.5146137076783293,1.2957103937881753,0.09375,0.5852465646504971,1.0,13/29,14.87%,ZFPM2;SALL1;SOX4;ROBO1;SMAD7;SLIT2;ACVR1;TGFBR2;TGFBR1;MDM4;SMAD4;BMPR1A;PDE2A
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.420614753739084,1.2951737319638117,0.2,0.5863064913013885,1.0,32/115,19.58%,KAT2B;ZBTB1;DR1;SOX9;LOXL2;SMARCAD1;HMGN4;BRWD1;HMG20A;KAT2A;SMARCA2;HDAC2;KDM5A;HP1BP3;HDAC4;SIRT1;SMARCD2;BAZ2B;RSF1;PADI2;RBBP4;SATB2;SETD2;SMARCC1;KDM4C;JARID2;CHD1;ATRX;HDAC10;BAZ1A;NPM2;SETD5
prerank,GO_Biological_Process_2021__forelimb morphogenesis (GO:0035136),0.7724124132590292,1.2948695450589554,0.13636363636363635,0.5858847061791578,1.0,1/5,0.61%,WNT7A
prerank,GO_Biological_Process_2021__embryonic forelimb morphogenesis (GO:0035115),0.7724124132590292,1.2948695450589554,0.13636363636363635,0.5858847061791578,1.0,1/5,0.61%,WNT7A
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),-0.7441045864627525,-1.294767976514583,0.16666666666666666,1.0,1.0,2/10,9.93%,BUD23;TRMT112
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.6042090167325893,-1.294392900256702,0.14084507042253522,1.0,1.0,14/33,24.72%,CD24;IGHG1;P2RY13;CD14;SPI1;POU2F3;TUBB;PTAFR;IL4R;ALOX5;CDHR2;IRAG2;NFAM1;GFI1B
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),0.772230216976467,1.2941995777040947,0.18604651162790697,0.5874693455126331,1.0,2/5,15.23%,LMO3;YAP1
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.5734209537401783,1.2941059294153259,0.23333333333333334,0.5871656456156092,1.0,12/21,26.01%,TTBK2;TRIM54;NAV3;CAMSAP2;CLASP1;HDGFL3;KATNB1;CIB1;ATXN7;FGF13;TAOK1;CLASP2
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.5628683985981499,-1.2937740224657444,0.11392405063291139,1.0,1.0,17/50,19.11%,RPE65;ADH4;AKR1C1;PLB1;RBP2;GPC3;CYP2D6;ADH6;RDH11;BCO1;APOM;APOE;RDH13;RBP1;SCPEP1;CYP3A4;RETSAT
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.5913449601308922,1.2937155974878696,0.13793103448275862,0.5876661126009083,1.0,7/22,22.17%,CDH2;MAPK11;CTNNA2;NRG1;OLFM2;MESP1;CTNNB1
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.6590414599918031,1.2937020925125498,0.125,0.5869731101096336,1.0,4/15,15.05%,PICALM;EPS15;SGIP1;HIP1
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),0.7049661154211588,1.2935910656168046,0.12195121951219512,0.5866023629596968,1.0,2/6,14.67%,FYCO1;KIF13A
prerank,GO_Biological_Process_2021__cellular nitrogen compound catabolic process (GO:0044270),-0.744922929649221,-1.2934084643271042,0.10526315789473684,1.0,1.0,5/7,22.69%,PM20D1;CYP2D6;NIT1;CYP3A4;CYP3A5
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.5015150440551893,1.2932731241946227,0.03571428571428571,0.5868729794026148,1.0,13/32,21.50%,RCN3;RHBDD1;MARCHF6;KYNU;GLRB;PRKN;UBXN6;KAT7;VCP;TRPM2;DRD2;RNF185;DERL1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.6927699160965063,-1.2929421896825521,0.1780821917808219,1.0,1.0,3/20,10.62%,CETN2;RPS27A;UBC
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",0.769949439336129,1.2926886380614921,0.11764705882352941,0.5880340243458114,1.0,2/6,14.01%,HS3ST5;HS2ST1
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),0.8433231719240649,1.2922803484228074,0.11627906976744186,0.5883251461760539,1.0,4/5,14.13%,ASCL1;TOX;CHD5;OPHN1
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),0.7859890581005392,1.2916563680284587,0.058823529411764705,0.5897097088051403,1.0,3/8,9.41%,FOXO1;ATP6V1A;ATG7
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),-0.6615328028483729,-1.291649749385335,0.10526315789473684,1.0,1.0,1/18,0.44%,POU4F1
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.7182169233986603,1.2911906031144753,0.16666666666666666,0.5905446077951221,1.0,3/11,15.18%,PLIN5;ABHD5;OSBPL8
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),0.686939172056229,1.2902529513180319,0.23529411764705882,0.5925719832919293,1.0,6/11,23.71%,INPP5A;SYNJ1;PTEN;OCRL;IMPA2;SYNJ2
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),0.686939172056229,1.2902529513180319,0.23529411764705882,0.5925719832919293,1.0,6/11,23.71%,INPP5A;SYNJ1;PTEN;OCRL;IMPA2;SYNJ2
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.5256028880815502,1.2902125959186839,0.1,0.5919712854550536,1.0,6/24,12.84%,FOXP1;CNOT9;CNOT2;CLOCK;STRN3;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.5852147354177039,1.2901595070783423,0.15384615384615385,0.5914173106533978,1.0,6/19,16.77%,SPRY4;CGNL1;SPRY3;SLIT2;CYRIB;SYNGAP1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.6084921472226945,1.2900354299188097,0.2,0.5910004357996319,1.0,7/13,20.95%,RBM24;CPEB3;CPEB4;DHX9;CPEB1;CPEB2;FMR1
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),-0.7879171762568741,-1.290021322258629,0.18181818181818182,1.0,1.0,3/7,10.62%,RPS27A;B2M;UBC
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),-0.7879171762568741,-1.290021322258629,0.18181818181818182,1.0,1.0,3/7,10.62%,RPS27A;B2M;UBC
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),0.7719557193901423,1.2900117470177361,0.09090909090909091,0.5904262695037741,1.0,3/5,21.96%,PTPRK;KLF9;FGFR2
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.5017939368613081,1.2898829211598535,0.034482758620689655,0.5902599209192921,1.0,13/34,18.87%,PARD3;SPRED2;SPRED1;SMAD7;STOX1;PLK1;SIRT2;RPTOR;MAPK1;BMP7;CAB39;WNK3;AXIN1
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.5207464523357426,1.2897295471295005,0.08823529411764706,0.5903420770032152,1.0,10/39,13.43%,WNT7A;LIG4;MME;SLITRK2;NRXN1;SPEN;CLSTN2;NLGN3;NAP1L1;DLG5
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),0.7295234609175424,1.2896209998519623,0.21739130434782608,0.5899058501781781,1.0,3/6,22.16%,SNCA;NDFIP1;NDFIP2
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.5971966014628971,1.2896164860334585,0.1111111111111111,0.5892455928102316,1.0,5/18,16.17%,PDGFA;RAP2C;PDGFC;TAOK2;RAP2A
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.6813687671628141,1.2894773871658594,0.07317073170731707,0.5889465103129139,1.0,7/9,31.00%,RALB;PIP4K2C;RAB3GAP1;LRSAM1;SH3GLB1;PIP4K2B;PIP4K2A
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.5436441131037458,1.2894035129740913,0.11764705882352941,0.5885583102958563,1.0,12/28,20.64%,KCTD13;SNCA;HOMER1;CLSTN2;RIMS3;SCRIB;NSF;CDKN2AIP;GRIK2;RIMS2;PTPN23;HCRT
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),0.5192684001391067,1.2892879414284935,0.1111111111111111,0.5881934319446654,1.0,16/31,22.62%,CCDC88C;BTRC;SNCA;FBXL3;NR1D1;PRKN;EP300;PEX2;PLK1;SIRT1;CUL3;MDM2;FBXW11;CREBBP;DERL1;CDC73
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,-0.6302456543039385,-1.2889765026539493,0.0821917808219178,1.0,1.0,6/17,10.76%,P2RY10;TAGAP;CD5;THEMIS;GPR171;TRAF3IP3
prerank,GO_Biological_Process_2021__tryptophan metabolic process (GO:0006568),-0.7445544712256082,-1.288533652243518,0.1875,1.0,1.0,2/8,1.98%,KMO;ACMSD
prerank,GO_Biological_Process_2021__indolalkylamine catabolic process (GO:0046218),-0.7445544712256082,-1.288533652243518,0.1875,1.0,1.0,2/8,1.98%,KMO;ACMSD
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),0.6037065956054833,1.2884368995358269,0.17647058823529413,0.5900470267497743,1.0,4/9,30.06%,ELOVL5;MLXIPL;ABCD2;SLC45A3
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.6807091597212904,1.2883430408629686,0.16666666666666666,0.5890258292906778,1.0,7/10,25.73%,SESN1;RPTOR;SESN3;UBR1;RRAGD;SESN2;UBR2
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.6807091597212904,1.2883430408629686,0.16666666666666666,0.5890258292906778,1.0,7/10,25.73%,SESN1;RPTOR;SESN3;UBR1;RRAGD;SESN2;UBR2
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),0.6470989182012421,1.2883128544734956,0.225,0.5883942117697296,1.0,4/12,12.69%,TRAPPC8;PIK3R4;PIK3C3;PEX5
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.5032810878810292,1.287860606251811,0.10714285714285714,0.5893025754985936,1.0,14/34,24.64%,FOXO3;SESN1;CPEB4;KPTN;PIK3R4;PIK3C3;SIK2;SESN3;IMPACT;SESN2;PRKAA1;SH3GLB1;IFI16;PICK1
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),0.5535912881624385,1.2875993342147938,0.07407407407407407,0.5895629692717225,1.0,7/28,15.39%,PARD3;MARVELD3;STRN;AFDN;OCLN;DLG1;PARD6G
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),0.728370436850788,1.2874574593355825,0.21951219512195122,0.5892443568908144,1.0,2/6,22.73%,KDM1B;MECP2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.6686527971981768,1.2870114411485158,0.1891891891891892,0.589970865636265,1.0,3/11,11.34%,PRODH;GSKIP;MAP3K5
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.5962383005485362,1.2865434391389754,0.1891891891891892,0.5910286520604767,1.0,9/13,33.51%,ATG7;UBA3;UBA6;UBA1;SAE1;DESI2;SENP6;DESI1;UBA2
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.7378460903524093,-1.2864571407719612,0.21428571428571427,1.0,1.0,4/9,8.81%,ZWILCH;SPDL1;MTBP;MIS12
prerank,GO_Biological_Process_2021__mammary gland duct morphogenesis (GO:0060603),0.8415398033114669,1.286262834785655,0.13513513513513514,0.5911306968694537,1.0,3/5,14.99%,CSF1R;EPHA2;SCRIB
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.7390464085963665,-1.286135278195331,0.13793103448275862,1.0,1.0,3/10,10.62%,RPS27A;B2M;UBC
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.6024308571016926,-1.2854826956681298,0.12857142857142856,1.0,1.0,6/23,16.61%,GAPDHS;ENO4;ALDOB;HK2;LDHA;GPI
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),0.7133211593351836,1.2854330333448265,0.2857142857142857,0.5931812866970545,1.0,2/8,14.75%,ADO;BLMH
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),0.6276861900201129,1.2850310584081068,0.21621621621621623,0.594032730528792,1.0,5/10,22.37%,NT5C1A;MACROD1;NME4;ERH;NT5C3A
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.7060009596547552,1.2846711974004088,0.13333333333333333,0.5943298675486284,1.0,4/8,19.11%,PLIN5;LMO3;SIRT1;ASXL2
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.7255114557810913,1.2846461296100353,0.20833333333333334,0.5936993988777953,1.0,4/7,13.63%,BOK;FAP;TP53BP2;SIRT2
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.667692273105265,1.284524130252659,0.20454545454545456,0.5934230761091164,1.0,5/10,15.76%,BOK;FAP;TP53BP2;SIRT2;FZD3
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.6601910109807834,-1.2844408702040602,0.08823529411764706,1.0,1.0,5/16,11.37%,HLA-A;HLA-B;CEACAM1;IL12A;KLRD1
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),0.5160208479172557,1.2842220304865708,0.10344827586206896,0.5934116168249286,1.0,4/26,7.91%,MICAL1;PAWR;EPS8;FAM107A
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),0.5977997827989676,1.2838491596417119,0.16666666666666666,0.593994045542916,1.0,5/17,13.92%,YJEFN3;NFKB1;TTC39B;ARV1;ABCA2
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.5065901277136432,1.2837621763000808,0.13636363636363635,0.5937183265275034,1.0,20/44,21.51%,STXBP6;EXOC2;RAB31;EXOC5;EXOC8;ARFRP1;EXOC6;GOLPH3;EXOC6B;GOLGA7;GGA2;EXOC4;COMMD1;KIF13A;NSF;BBS2;GGA1;RAB10;OSBPL5;MACF1
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.41218490692841847,1.2835391679520904,0.0,0.5937504632884388,1.0,10/46,25.84%,INTS7;MAP3K20;CLOCK;MDM4;ATRX;H2AX;CDC5L;SESN2;ERCC6;MYO6
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.5190712909693899,1.2831447770356286,0.1724137931034483,0.5945497451181583,1.0,14/28,27.35%,PRDX6;DYRK1A;PIK3R1;HNRNPLL;CELF3;U2AF2;TRA2A;ZPR1;RBM20;HSPA1A;NUP98;ERN1;SETX;SLC38A2
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.5661231772243325,1.283107587768259,0.12,0.5940772694574975,1.0,9/18,17.32%,PDE3A;PDE3B;PRKAR1B;PEX5L;RAPGEF2;CDC34;GNAI1;PDE2A;PDE4D
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),0.7242818495861914,1.2830919853119842,0.2926829268292683,0.593474629618757,1.0,5/6,27.41%,LY6H;ATP2B4;ROCK2;CHRM3;LYPD1
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),-0.7859787582936493,-1.282400469119767,0.21818181818181817,1.0,1.0,3/7,16.16%,MT3;APOE;SCARF1
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),-0.7859787582936493,-1.282400469119767,0.21818181818181817,1.0,1.0,3/7,16.16%,MT3;APOE;SCARF1
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),0.6933937226553132,1.2823752916231463,0.05555555555555555,0.5951235450156713,1.0,4/13,14.35%,TNFSF4;CD22;AHR;SAMSN1
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.40877898171432225,1.2823491038394532,0.0625,0.5945429057250695,1.0,22/99,14.40%,VAPB;SGMS1;ESYT3;CERS3;ELOVL7;VAPA;ACER3;HACD2;PLPP1;ESYT2;ELOVL6;SPNS2;PLPP2;GAL3ST1;PPM1L;ELOVL5;PRKD1;PLPP3;ARV1;ABCA2;HACD1;HEXB
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.6495842928703461,1.2816642726073302,0.08571428571428572,0.5959035572179019,1.0,3/10,11.67%,CSGALNACT1;UGP2;FUT8
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),0.6771025910170402,1.2816589348401186,0.2,0.5945921885040726,1.0,5/6,31.82%,ATP2B4;ROCK2;SIRPA;PTGIS;KHSRP
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),0.6771025910170402,1.2816589348401186,0.2,0.5945921885040726,1.0,5/6,31.82%,ATP2B4;ROCK2;SIRPA;PTGIS;KHSRP
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),-0.7579137231472677,-1.2816278804460808,0.16923076923076924,1.0,1.0,1/7,0.41%,TLCD1
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),0.5892514817928729,1.2815209557461054,0.25,0.594492678339355,1.0,4/18,15.17%,MTHFS;PLOD2;GCLC;GGCT
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),0.645159790663323,1.2810615944533026,0.16129032258064516,0.5950661001308577,1.0,5/15,18.01%,TAFA1;NF1;FZD3;KDM1A;DRD2
prerank,GO_Biological_Process_2021__regulation of mitotic spindle checkpoint (GO:1903504),-0.7842654734779426,-1.2807994025349347,0.22413793103448276,1.0,1.0,3/6,17.31%,ANAPC15;DUSP1;CCNB1
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid segregation (GO:0033047),-0.7842654734779426,-1.2807994025349347,0.22413793103448276,1.0,1.0,3/6,17.31%,ANAPC15;DUSP1;CCNB1
prerank,GO_Biological_Process_2021__cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.7280760402046982,1.280732251911257,0.13636363636363635,0.5954214821382948,1.0,2/5,9.80%,AKT1;TICAM1
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.5150346544553878,1.280721681975123,0.1111111111111111,0.5947800812498028,1.0,8/32,12.34%,AP3S1;KIF5A;TRAK1;AP3B1;TRAK2;KIF5C;RAB21;KIF1B
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.43357392176921916,1.2801194307776813,0.06666666666666667,0.5961731301092315,1.0,16/59,19.14%,SERINC5;CSF1R;PLEK;PRDX6;PLCB1;DGKH;ACP6;PIGX;ABHD6;SYNJ1;CPNE3;PLCB3;PIGP;AGK;CPNE1;FAR1
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),0.7629176210618603,1.2791104867844791,0.2391304347826087,0.598384030418251,1.0,1/7,0.50%,NAF1
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),0.8471941550785782,1.2789602635900592,0.10810810810810811,0.5982593945429916,1.0,2/5,6.27%,KYAT1;QDPR
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,-0.6196982021867357,-1.2785895508835525,0.13333333333333333,1.0,1.0,18/34,18.99%,FMO6P;CP;CFTR;DUOX1;AQP1;TEKT1;TMC4;TRIM29;CXCL17;FMO2;CLCA4;ERBB3;IL20RA;PPL;C1ORF87;FUT2;DUOXA1;POF1B
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.6056939979518574,-1.2785258542606996,0.08955223880597014,1.0,1.0,7/21,10.76%,P2RY10;IL5;TAGAP;CD5;THEMIS;GPR171;TRAF3IP3
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.4563020645857173,1.2783877185118466,0.0,0.5991912775159552,1.0,15/98,7.29%,VAPB;SLC24A3;ATP13A5;ANK2;NPTN;HTR2C;ATP2B3;MAIP1;MCU;CXCL12;STIM2;ATP2C1;CALCB;KCTD17;ATP13A4
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),0.6289723044747862,1.2778301380086938,0.24242424242424243,0.6001210965177718,1.0,5/12,16.66%,IWS1;CPSF6;NUP153;DHX9;SETD2
prerank,PanglaoDB_Augmented_2021__Reticulocytes,0.4348669607073422,1.2772180209233541,0.09090909090909091,0.6018016481650856,1.0,21/92,18.07%,XPO1;RCC2;STT3B;NUP188;DHX15;UBAP2L;TTI1;RFWD3;NUP153;ZDHHC5;INCENP;UGGT1;DHX9;DCAF1;NDC1;STIP1;NEU3;NUP205;TFRC;SF3B3;PTBP1
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),0.66817522734682,1.2769276060822323,0.24242424242424243,0.6021464460796017,1.0,1/10,1.88%,SERINC5
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),-0.7390817996438191,-1.2768412275267906,0.18055555555555555,1.0,1.0,4/9,19.44%,IFITM3;CIITA;LY6E;TRIM5
prerank,GO_Biological_Process_2021__delamination (GO:0060232),-0.7474259077650701,-1.276699797329845,0.23076923076923078,1.0,1.0,3/5,14.32%,ABCA12;AKNA;SPI1
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.6329678925111137,1.2766228281330576,0.1794871794871795,0.602447561251983,1.0,4/11,15.23%,EVI5L;TESK1;CEP97;YAP1
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),-0.7654470492462166,-1.2765961567750772,0.1864406779661017,1.0,1.0,2/7,7.75%,ENPP2;ANGPTL3
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),0.6580387608431988,1.2762757657542927,0.12903225806451613,0.6028766352725337,1.0,4/10,11.68%,UGDH;CARNS1;UGP2;SLC35D1
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.5669584067142858,1.276204587113987,0.0975609756097561,0.6024696365676835,1.0,7/18,20.76%,RBM24;IGF1;EFNB2;NRG1;MAML1;ATP11A;MESP1
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",0.7661141169927285,1.276171592963012,0.26666666666666666,0.6018924135759584,1.0,1/5,5.77%,RAB31
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),0.6870091097717955,1.2760143142589428,0.1891891891891892,0.601168629528181,1.0,1/6,10.06%,GSTM2
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),0.6870091097717955,1.2760143142589428,0.1891891891891892,0.601168629528181,1.0,1/6,10.06%,GSTM2
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),0.8076946333482202,1.2759733799065414,0.25,0.6005734122291557,1.0,2/5,9.81%,LLPH;AUTS2
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.6226661907576503,1.275771081989703,0.10256410256410256,0.59996125485118,1.0,2/13,10.96%,CPEB3;TNRC6B
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.6226661907576503,1.275771081989703,0.10256410256410256,0.59996125485118,1.0,2/13,10.96%,CPEB3;TNRC6B
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.7745127562023674,-1.2754545287474888,0.15,1.0,1.0,3/7,14.92%,SELENOS;GSTP1;CCL2
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),-0.6514897940399952,-1.2752300355446995,0.11428571428571428,1.0,1.0,3/17,17.21%,ANKRD53;BORA;TPX2
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.45164789786001114,1.2750795831090271,0.10526315789473684,0.6014517801590045,1.0,20/58,18.20%,ADCY1;ABCA1;CNR1;ADGRB3;ADGRL3;CALCB;LGR4;RAPGEF2;ADRA1A;GPR161;ADRB1;GNA13;LPAR3;ADGRL2;ADRB2;GNAQ;ADGRB2;ADGRB1;DRD2;S1PR1
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.5377653181190778,1.274771335608147,0.14814814814814814,0.6016866868831103,1.0,12/24,26.92%,KAT2B;KAT2A;EP300;KAT7;NAA50;KAT6B;ATAT1;PHF20L1;CREBBP;BAG6;KAT6A;TRRAP
prerank,GO_Biological_Process_2021__stress granule disassembly (GO:0035617),0.7543144093969125,1.2747318663151972,0.2564102564102564,0.6011365568225638,1.0,4/5,24.56%,VCP;KLC1;DYRK3;ZFAND1
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),0.5142921725156373,1.2746670878625606,0.09090909090909091,0.6006935266329138,1.0,10/37,23.78%,NUP42;NUP37;NUP188;NUP153;NDC1;NUP205;NUP214;RANBP2;NUP98;NUP54
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),0.6606723047609606,1.274383798594042,0.20833333333333334,0.6010977493608639,1.0,2/7,0.82%,PDK4;PID1
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),0.5513477435034644,1.2743296903567856,0.19047619047619047,0.6006557244623454,1.0,6/23,19.46%,OTUB2;VCPIP1;OTUD4;USP25;USP34;OTUD7A
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.7732730108328459,1.2741029549648908,0.21428571428571427,0.600869108969083,1.0,3/6,16.64%,PPARGC1A;SIRT1;ARPP19
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.45811798011845717,1.2739991924972782,0.12,0.6004704676483665,1.0,13/41,18.04%,RARB;PCSK5;SALL1;PBX1;PDGFA;GLI3;PKDCC;PBX2;PBX3;TGFBR2;BMPR1A;TBC1D23;RBPJ
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),-0.7279327812226655,-1.2736633984044647,0.18181818181818182,1.0,1.0,3/8,6.50%,CCDC39;BBOF1;DNAAF1
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.717141502092917,1.273301171386189,0.14893617021276595,0.6022635052517771,1.0,5/8,18.71%,HDAC9;HDAC4;SIRT1;SIRT2;HDAC10
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",0.7786503964670582,1.2728991381609842,0.225,0.6028953115671055,1.0,1/6,4.32%,RHOT1
prerank,GO_Biological_Process_2021__inner ear receptor cell development (GO:0060119),0.7083077271899147,1.2728938859145573,0.1875,0.6022435328518979,1.0,2/7,13.96%,SLC4A7;WHRN
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.7931771430782439,1.2726485210892315,0.15217391304347827,0.6023910586288942,1.0,2/5,15.18%,ABHD5;OSBPL8
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),0.6984033672001034,1.2721684600633605,0.16279069767441862,0.6034192006819272,1.0,3/7,28.15%,TMCC1;SH3GLB1;SLC25A46
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.6557218191002153,1.271965661899617,0.15789473684210525,0.6031880050836145,1.0,9/12,22.71%,INPP5A;NFAT5;HRH1;PPP3CB;ADGRB2;NFATC3;NFATC2;PPP3CA;NFATC1
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.5436804911462911,1.2717516792655092,0.13333333333333333,0.603354967281181,1.0,3/25,4.23%,SLC26A7;SLC19A1;SLC26A3
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),0.696261624330726,1.271564943756348,0.16666666666666666,0.603312500696899,1.0,2/5,27.59%,ARF6;AIF1L
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.5252963459524885,1.271497321270407,0.09375,0.6030195111501038,1.0,9/32,10.63%,NCK2;CASS4;CSF1R;EPHA4;RAP2B;SRCIN1;DLG3;SH3BP5L;LRP8
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),0.7514329310020839,1.271284794059858,0.21739130434782608,0.603227840918363,1.0,3/6,20.73%,TAOK2;NRP1;PHACTR1
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.47013529071544474,1.2711906095036958,0.05263157894736842,0.6028313714332078,1.0,18/53,14.10%,FLT1;DCN;PDGFRA;SOX9;EPOR;CBL;HCLS1;NTRK2;PIK3CA;PIK3R1;PDGFA;ROR1;IGF1;HGF;PTK2;SIRT1;PDGFC;GAB1
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.5755751399367004,-1.2710914476923194,0.1780821917808219,1.0,1.0,18/25,35.05%,C1R;CPB2;CLU;C1QB;C1S;ZP3;SUSD4;CR1;C2;C3;PHB2;SERPING1;C1QBP;C6;C5;CD46;CR1L;PROS1
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),-0.7981317554239997,-1.2710699038801057,0.14285714285714285,1.0,1.0,4/5,18.76%,C1R;C1QB;C1S;ZP3
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),0.5550742291536827,1.2709092142316505,0.12,0.6031435437084716,1.0,9/25,16.15%,SNCA;KANK1;DYRK1A;SLIT2;SSH1;CLIP3;MAPRE1;CYRIB;ARFGEF1
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.7792997120534639,1.2705937052380962,0.1388888888888889,0.6034758434058978,1.0,3/5,16.02%,NCK2;NCK1;PXN
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.4293792899355141,1.2705247553990937,0.0,0.6029557419766546,1.0,9/72,7.18%,SLC24A3;CACNA1G;ATP2B3;MAIP1;MCU;GRIN1;CACNA2D1;ATP2C1;TRPM4
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),0.7575385453770398,1.270123430232552,0.175,0.603536542222219,1.0,2/6,9.87%,EPHA4;RTN4RL1
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.5973948238184589,-1.2701165856320242,0.14545454545454545,1.0,1.0,7/21,20.76%,ADH4;CYP2D6;ADH6;RDH11;CYP3A4;RETSAT;LRAT
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.705445703754639,-1.2700398886294744,0.1111111111111111,1.0,1.0,7/11,20.76%,ADH4;CYP2D6;ADH6;RDH11;CYP3A4;RETSAT;LRAT
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),0.6802203979207413,1.2699040112679432,0.16666666666666666,0.603805174168661,1.0,2/7,7.66%,NCSTN;DYRK1A
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),0.8115690019081174,1.2687350671903916,0.11363636363636363,0.6065787308574515,1.0,2/5,14.83%,DNA2;PRIMPOL
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.7137657389367615,1.2684928691319388,0.175,0.6066780784137795,1.0,2/8,13.47%,ABCA1;TTC39B
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.438847515691106,1.2680560516522894,0.047619047619047616,0.6073351043763153,1.0,37/94,25.84%,ABCC8;NPNT;SOWAHA;EFNA2;ARHGEF16;SOX9;CADPS2;PRIMA1;LYPD6;PCGF2;EFNB2;MAPK4;RGS16;ENAH;MYH14;HNF4G;JPH1;YAP1;DDAH1;BMP7;PCLO;CXXC4;LRP4;SHROOM3;BCAR1;TSPAN12;MARK1;CNTFR;CTNNB1;EPB41L4B;TEAD1;CACNG4;HS6ST2;CPE;NR2F1;ARFGEF3;MYO6
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),0.7600207732957385,1.2679994692200103,0.09375,0.6068348594564962,1.0,2/7,5.39%,NFKB1;PLIN5
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.7693482377375216,1.2676932965133916,0.14285714285714285,0.6071191881233049,1.0,1/5,2.25%,MITF
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),0.5126031245390843,1.2676187532954604,0.15384615384615385,0.6067438132370948,1.0,4/26,7.91%,MICAL1;PAWR;EPS8;FAM107A
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),0.6375905556207395,1.2672499195167544,0.15625,0.6072745378829029,1.0,4/14,12.39%,NPTN;EMB;BSG;CNTN4
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),0.6246216379993981,1.267158783118966,0.21739130434782608,0.6068381322854831,1.0,2/13,4.69%,PCSK5;PDGFRA
prerank,GO_Biological_Process_2021__hyperosmotic response (GO:0006972),-0.8301616951897006,-1.2670079825270226,0.26666666666666666,1.0,1.0,3/5,13.16%,AQP1;RCSD1;TLR3
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.724308486816924,-1.2668871613263384,0.21428571428571427,1.0,1.0,4/12,7.71%,HLA-A;B2M;ERAP2;ERAP1
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),0.48062212967840723,1.2667094708485576,0.18518518518518517,0.6074497631284923,1.0,11/40,12.88%,SDC4;ARHGAP35;CNOT6L;KCTD17;CNOT2;G3BP1;RALB;PIP4K2C;STX18;RAB3GAP1;TAPT1
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),0.509137715690826,1.2664280548774323,0.13793103448275862,0.6077524535434724,1.0,11/31,22.89%,HCLS1;RAB23;PIK3R1;UBR5;TRIM28;SUFU;IPO5;CABP1;ZPR1;BAG3;SMAD3
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.4688086777619681,1.2663650097407548,0.125,0.6072554587451197,1.0,25/57,30.51%,SMCR8;RHEB;PIK3CA;TTI1;GOLPH3;SIRT1;MAPKAPK5;RPTOR;UBR1;TBCK;RRAGD;DYRK3;GNA12;MIOS;PRKAA1;WDR24;SH3BP4;GAS6;UBR2;RICTOR;FBXO9;WDR59;TNFAIP8L1;EPM2A;TMEM127
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),0.686211466868052,1.2663232877626174,0.2222222222222222,0.6067390434260557,1.0,3/9,13.21%,PDGFRA;TGFBR2;TGFBR1
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.4054136038985061,1.2660519454962622,0.0,0.6070210810168348,1.0,27/104,16.81%,ANKRD2;PPARGC1A;ETV5;PTPRK;SNCA;FOXO1;KEAP1;EGFR;PDGFRA;ADNP2;FOXO3;PRDX6;AKT1;GSR;PKD2;RAD52;SLC25A24;PRKD1;AGAP3;SIRT2;FER;MAPK1;PDK2;MAPK8;PXN;ERMP1;HIF1A
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),-0.6115461698718417,-1.2659855151279245,0.17567567567567569,1.0,1.0,5/24,12.90%,CCDC39;DNAAF1;PDPN;FGF7;FGF1
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.43133628916654515,1.2659835424446746,0.09090909090909091,0.6066489635951166,1.0,26/105,16.82%,MPDZ;PDZRN3;HTR2C;EGFR;PLEKHA6;SOX9;CEP170B;CADPS2;CGNL1;LGR4;CHMP1A;FRZB;PRICKLE2;ATP9A;PLPP3;ADGRL2;SLC4A10;NCKAP1;ARHGEF10L;MYH14;FARP1;TJP1;NEO1;DDAH1;PARD3B;TMEM178A
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.5381297831355291,1.2657662886425642,0.08333333333333333,0.6066856750509334,1.0,9/27,23.54%,EED;AEBP2;TASOR;RBBP4;JARID2;PPHLN1;PPM1D;EPC1;MACROH2A1
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),0.5054208606742985,1.2644988801514707,0.125,0.6106354636109281,1.0,7/35,15.39%,PARD3;MARVELD3;STRN;AFDN;OCLN;DLG1;PARD6G
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),0.7763072846128813,1.2644350310762138,0.20930232558139536,0.6102200111118551,1.0,2/5,8.60%,CAMK2A;CA2
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),-0.7063279938219502,-1.2638506548663597,0.19696969696969696,1.0,1.0,1/13,0.78%,RPL23
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),-0.5376200064855293,-1.2633719639322938,0.10256410256410256,1.0,1.0,9/58,12.43%,SULT1C3;ACOT2;SULT1C2;ACOT1;ACOT6;GLYAT;ACSM6;HINT1;ACSM5
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),0.7592875873538594,1.2630723853105639,0.21621621621621623,0.6136087034495326,1.0,2/6,6.83%,TXNIP;ZFYVE19
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.5414839790592061,1.2630573259304605,0.22857142857142856,0.6130284753924454,1.0,7/22,14.29%,CHRNA4;SNCA;SYT3;KCNA2;PRKN;STX1A;SYT9
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),0.6708612548237847,1.2625031620467022,0.24390243902439024,0.6139310602873396,1.0,2/11,5.11%,TCAP;BMP2
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.4614775748101621,1.2623951976512549,0.09523809523809523,0.6136761021443655,1.0,16/60,21.02%,ASIC4;SLC24A3;SLC6A13;NEDD4L;SLC12A2;PKD2;SLC4A4;ASIC3;ATP1A4;SLC6A6;SLC24A4;SLC6A11;SLC6A12;SLC6A7;SLC6A9;SLC6A1
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.3804228958882326,1.2622360627348792,0.0,0.6136444650881439,1.0,64/186,20.83%,SPSB4;BTRC;KCTD13;RCN3;FEM1B;SPSB2;TRIM9;FBXL17;UBE2G1;RHBDD1;SOCS6;KBTBD7;ARRB1;NEDD4L;MARCHF6;PSMA1;KLHL42;KBTBD6;FEM1C;KCTD17;ATE1;NR1D1;PSMD11;ITCH;PSMD10;CLOCK;PRKN;RMND5A;FBXW7;PSMF1;KCTD10;PSMD14;PCNP;COP1;UBXN6;SMURF1;AGAP3;SIRT1;TBL1XR1;CDC34;FBXO45;SIRT2;SPOPL;VCP;BFAR;FAF1;HACE1;BIRC2;KCTD5;RNF41;PSME4;CUL3;MDM2;NFE2L2;RAD23B;FBXW11;UBE2D3;NSFL1C;UBXN2B;GID8;ANKRD9;TNFAIP1;RNF185;PSMD1
prerank,GO_Biological_Process_2021__regulation of sensory perception (GO:0051931),0.6430952474845044,1.2619682944681692,0.23684210526315788,0.6138961496280987,1.0,2/8,6.67%,MGLL;SPX
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.5504726633792956,-1.261908672072443,0.125,1.0,1.0,2/56,0.09%,IFI6;EPN1
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.6813274386326054,-1.2616337528868928,0.1746031746031746,1.0,1.0,1/13,0.44%,POU4F1
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),0.5514270998500634,1.261487125463846,0.1282051282051282,0.6149961948441036,1.0,10/23,20.44%,MFF;PEX11A;PEX14;PEX2;PEX16;ABCD3;PEX7;TMEM135;PEX6;PLAAT3
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),0.7708811548651827,1.261375649659101,0.2,0.6146604275224439,1.0,4/6,9.74%,NPNT;SALL1;BMP2;PKD2
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.3622832534219076,1.2610837528537144,0.0,0.6151119708037572,1.0,66/293,19.48%,TXNIP;ATP6V0D2;TBC1D4;RCN3;ARFIP1;ARL5A;ABCA1;TBC1D1;TVP23B;TBC1D5;LRP1B;USP6NL;ATP6V1A;TBC1D12;CMTM6;TMEM167A;EVI5L;RAB31;CHMP1A;RAB18;TANGO6;RAB8B;RAB23;CEP290;SNX27;ATP6V1C1;ARFRP1;SLC10A7;TBC1D22B;AP3B1;GOLPH3;FAM91A1;MTTP;SCFD2;RAB21;GOLGA7;GGA2;TBC1D8B;CHMP2B;NAPB;STX1A;NDC1;RAB22A;KIF13A;ATP6V1B2;TBC1D10A;TMED3;NSF;SNX13;STX8;RAB1A;TMED5;RAB28;RABGAP1L;TFRC;BBS2;SEC23IP;OLFM2;TBCK;MIA2;DNM2;SCAMP1;STX7;ARF6;STX12;GGA1
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),-0.6135351816891548,-1.2607272051113716,0.1864406779661017,1.0,1.0,5/18,18.49%,LIPI;HSD11B1;MT3;HSD17B14;CYP3A4
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.7191443941508116,1.26071187198974,0.2222222222222222,0.6155827269324383,1.0,4/7,13.63%,RCC2;RAD18;SMC6;SIRT2
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.6803575322242259,-1.260396531044181,0.11940298507462686,1.0,1.0,4/14,11.48%,P2RY10;LPAR4;GPR18;LPAR6
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.6406593754012593,1.2603728887773318,0.22580645161290322,0.6159921249192204,1.0,3/16,11.20%,ANK2;GSTM2;CAMK2D
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.5410478310131713,1.2602124299282844,0.047619047619047616,0.6159382148044116,1.0,8/27,25.23%,PTPRK;RCC2;TAOK2;ARHGEF7;ITGA6;TRIP6;WHAMM;THSD1
prerank,GO_Biological_Process_2021__glyceraldehyde-3-phosphate metabolic process (GO:0019682),-0.7358465736058113,-1.2600026792497463,0.0967741935483871,1.0,1.0,2/7,9.14%,ALDOB;GLYCTK
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),0.6800664648806969,1.2598731817648174,0.10344827586206896,0.6164267446643794,1.0,4/11,15.25%,QDPR;AKT1;FTCD;PRKG2
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.4172472961643346,1.2595883740020626,0.0625,0.6166132834781083,1.0,44/119,21.39%,BICDL1;TENM3;LRP12;ETV1;VAPA;ASCL1;PRMT1;ATXN10;UGDH;TENM2;GPM6A;NTRK2;PBX1;RAPGEF2;UHMK1;EPHA5;GPRIN1;B4GALT6;HMGB1;DOCK7;PBX2;GPM6B;TBC1D24;PBX3;CNTN4;NCDN;B4GALT5;TENM1;OPHN1;HDGFL3;GSK3B;TBC1D23;NPY;RUNX1;WNK1;CDK5R1;UNC5A;ROCK1;SAMD14;POU3F2;MYT1L;TDP2;NLGN1;CNTNAP2
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.3858120884059418,1.2591855338165407,0.08333333333333333,0.6173406480626895,1.0,21/97,12.20%,ACKR1;CNTN1;ANK2;ADGRL3;PCDH17;CHL1;PRIMA1;MEGF10;NTRK2;FRZB;NRXN1;FAM107A;INTS6;PPP1R1B;ASTN1;NDRG2;MAPK4;ZNF423;GPM6B;RGS16;RGS7BP
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),0.7055994180480365,1.2590248107017405,0.21621621621621623,0.6172855712303892,1.0,5/8,24.48%,TOX;PBX1;KAT7;PTPRC;NFIL3
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.41096008172017595,1.2590212855618037,0.06666666666666667,0.6166505037702756,1.0,38/105,26.36%,TBC1D5;SORT1;BAIAP3;VTI1A;EPS15;RHOBTB3;ARFRP1;PIK3C3;HOOK1;RAB9A;PIKFYVE;SNX5;AP1G1;TBC1D10A;CCDC91;SNX16;STX8;WDR91;TBC1D23;WDR81;GGA1;PTPN23;ERC1;MON2;PHETA1;VAMP3;KIF16B;SNX1;CORO7;TBC1D17;VPS54;RIC1;VPS50;VPS51;VPS26B;HOOK3;STX5;RAB5A
prerank,GO_Biological_Process_2021__mitochondrial ribosome assembly (GO:0061668),0.805519753070798,1.2587465256891346,0.10526315789473684,0.6170758420669519,1.0,2/5,17.60%,MRPS2;MTERF3
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),0.7871368327630431,1.2586519632865614,0.10256410256410256,0.6166618815791995,1.0,2/7,14.83%,DNA2;PRIMPOL
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),-0.6918178938847002,-1.258597139280355,0.1935483870967742,1.0,1.0,3/11,12.55%,LIPI;PNPLA3;FABP3
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),0.7217374987036078,1.2585126498018229,0.2,0.6163883644872239,1.0,2/8,6.47%,LOXL2;LOXL1
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),-0.5683930616090351,-1.2582296930849952,0.1282051282051282,1.0,1.0,10/40,14.27%,RPE65;ADH4;AKR1C1;PLB1;RBP2;GPC3;RDH11;BCO1;APOM;APOE
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.630019087653528,1.2579344157227026,0.2222222222222222,0.6171712528262113,1.0,6/11,19.16%,PID1;MFF;MYH14;WASF1;MTM1;NUBPL
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),0.7351540332140595,1.2578802175463426,0.2894736842105263,0.6166191573136866,1.0,1/7,8.11%,GMPS
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.5051746057191208,1.2578697842274058,0.12,0.6160483099675755,1.0,15/41,22.60%,ITPKB;ISYNA1;INPP5A;PLCB1;MINPP1;ITPK1;SYNJ1;IP6K2;PLCB3;IPPK;PTEN;FGF2;NUDT3;OCRL;IMPA2
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.5997057534151128,1.2574176574757812,0.25,0.6169085888342366,1.0,5/11,25.96%,SMCR8;ADRB2;FYCO1;CALCOCO2;SETX
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),0.5937057902425911,1.2571716425379218,0.15625,0.6169735004267867,1.0,8/17,20.95%,CBARP;PKD2;GSTM2;UBQLN1;DRD2;GPR35;SLC6A9;FMR1
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.5351952957881156,1.2571266058412787,0.21739130434782608,0.6164040375851867,1.0,8/28,15.77%,EPHA7;SLIT1;ROBO1;PDGFA;SEMA3C;SLIT2;SEMA6C;SEMA4D
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.5020504742371009,1.2571157293665396,0.13636363636363635,0.615835734545708,1.0,6/24,10.21%,MCU;DCN;MFF;SPIRE1;INF2;PRKN
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),0.741867713367039,1.2562841755809013,0.21951219512195122,0.617167442794355,1.0,3/6,11.03%,SHISA7;GPHN;SHANK3
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),0.7071933809781654,1.2562047048059557,0.15384615384615385,0.6161906650219943,1.0,6/8,24.91%,ABHD17B;ABHD17A;LYPLA2;LYPLAL1;ABHD17C;ABHD10
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),0.7071933809781654,1.2562047048059557,0.15384615384615385,0.6161906650219943,1.0,6/8,24.91%,ABHD17B;ABHD17A;LYPLA2;LYPLAL1;ABHD17C;ABHD10
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.7369563054957128,1.2561387618456619,0.1794871794871795,0.6157234816641414,1.0,2/8,3.89%,CASS4;MCU
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),0.6580122843223709,1.2560524313103176,0.2894736842105263,0.615355742873743,1.0,3/9,19.31%,CAMK2B;NRXN1;YWHAZ
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.6504466025613092,-1.2556978780008903,0.19298245614035087,1.0,1.0,6/12,22.69%,HSD17B8;CYP2D6;HSD17B7;HSD17B14;CYP3A4;CYP3A5
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),0.6892898690960555,1.2553475041790296,0.2777777777777778,0.6167795957294656,1.0,5/8,30.38%,TGFBR2;TRPM2;CAMK4;GAS6;AXL
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),-0.8417075765815709,-1.2545921748630462,0.13725490196078433,1.0,1.0,3/5,13.86%,RPS23;COL5A1;SLC11A1
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",0.7659339648208812,1.2545572302028032,0.16666666666666666,0.6189672991220047,1.0,5/7,18.73%,CSGALNACT1;EXT1;EXT2;HS2ST1;NDST1
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.4088926291486896,1.2541917946267722,0.0625,0.6197168714451812,1.0,16/64,18.05%,NUP42;NUP37;NUP188;GIT1;ZBTB20;IGF1;EP300;NUP153;HDAC4;OGT;MLXIPL;SLC4A4;NDC1;NUP205;HIF1A;NUP214
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),0.7475769139905748,1.2539460084430591,0.08823529411764706,0.6199744293874737,1.0,4/8,13.21%,PDGFRA;TGFBR2;NIPBL;TGFBR1
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.42240910244810437,1.2539377534929503,0.0,0.6194082560239956,1.0,10/85,8.05%,SLC26A7;SLC24A3;CHRNA4;SLC15A3;SLC26A3;GRIN1;SLC15A2;SLC25A18;SLC12A2;GLRB
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.5688379102595368,-1.2539248925019582,0.10126582278481013,1.0,1.0,4/42,6.67%,IFI6;DHCR24;AQP1;THBS1
prerank,GO_Biological_Process_2021__beta-catenin destruction complex assembly (GO:1904885),0.7489933144871324,1.2535173716070942,0.17142857142857143,0.6200963780685329,1.0,2/5,18.87%,GSK3B;AXIN1
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),0.4216840802427651,1.2534612649417798,0.08695652173913043,0.6196094645995572,1.0,18/74,14.92%,VPS37B;GDAP1;PARD3;TRAM1;ZDHHC18;ZDHHC11;RAB3IP;VPS37A;RAB8B;PEX14;ZDHHC21;PEX2;GOLGA7;PEX16;PIKFYVE;PEX5;ABCD3;TAOK2
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),0.7301608029808986,1.2533804593226672,0.175,0.6192212358022396,1.0,4/8,20.95%,CBARP;DRD2;GPR35;FMR1
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),0.4035499527303542,1.2528076460718438,0.0625,0.620415033795743,1.0,24/83,17.81%,WNT7A;FOXO1;PRMT1;NEDD4L;IL17D;CSNK2A1;AKT1;SEC22B;ITCH;ATG7;PRKN;SMURF1;MAP2K5;ABCA2;VCP;GSK3B;NSF;ROCK2;HACE1;MAPK8;RAB1A;RNF41;IDE;BCL10
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.5518129187474379,-1.2527410148065414,0.18181818181818182,1.0,1.0,4/34,8.77%,RPS14;RPS8;RPS28;RPS16
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.6050866540157191,1.2523342136198832,0.18518518518518517,0.6213139071552716,1.0,9/21,21.53%,EVI5L;KANK1;ARHGAP24;TESK1;CEP97;SLIT2;YAP1;CAPZB;ARHGAP44
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.5682747687326076,-1.251973887404619,0.14473684210526316,1.0,1.0,8/38,12.45%,GBP2;GPR183;IRF1;IGSF6;SAMD9L;FPR3;CIITA;APOL6
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.42006505420455154,1.251521707298134,0.0,0.6230876893780648,1.0,13/59,14.39%,ACE2;ANK2;ATP2B3;CASQ1;TMEM65;CELF2;ASB3;SMAD7;CAMK2D;STIM1;ASPH;CYP2J2;ATP2B4
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.4898871808841768,1.2515005379636857,0.14285714285714285,0.6224834409245056,1.0,13/37,20.43%,CHRNA4;CHD7;FAM107A;NF1;TTC8;NIPBL;CHMP2B;METTL23;HLA-DRA;CYFIP1;SETD5;DGCR2;MGAT3
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.5449550947897389,1.251328871410628,0.125,0.6221914967162115,1.0,14/29,30.51%,SESN1;KPTN;SIRT1;MAPKAPK5;SESN3;STK11;UBR1;SESN2;PRKAA1;SH3BP4;UBR2;TNFAIP8L1;EPM2A;TMEM127
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.4761419341029759,1.251309155937922,0.07692307692307693,0.6216087749098466,1.0,9/42,16.03%,ESYT3;ST6GALNAC5;ESYT2;B4GALT6;LARGE1;ABCA2;HEXB;NEU3;STS
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.7598308657715104,1.2510677748560248,0.1282051282051282,0.6216675704933031,1.0,3/5,20.94%,NAA25;NAA30;NAA16
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.5617786795109265,1.2509619418369273,0.14814814814814814,0.6213579275998483,1.0,10/24,24.93%,FOXO1;KAT2B;CLOCK;EP300;SIRT1;NAA50;CREBBP;NAA16;GTF2B;HAT1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),0.7962431939348391,1.2506675972091335,0.14285714285714285,0.62157178407008,1.0,3/5,18.27%,HIF1A;RBPJ;NFE2L2
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.500029528821947,1.2505840239201504,0.07317073170731707,0.6211467721881434,1.0,7/30,28.48%,RHBDD1;PRKN;BAG3;HSPA1A;ERN1;DNAJB14;DAXX
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.6257948930218146,1.2505436639094651,0.2,0.6205679851069869,1.0,3/13,11.64%,ABCA1;STARD4;RELCH
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.6146887815791808,1.2504403586600084,0.14285714285714285,0.6203572057471188,1.0,6/21,11.61%,LIG4;PDE3A;MME;RFX3;SPEN;NAP1L1
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),0.6013989054415723,1.249501896469347,0.20930232558139536,0.6226158584761246,1.0,6/13,17.36%,CACNA1G;NOTCH2;SMAD5;SMAD4;BMPR1A;MAML1
prerank,MSigDB_Hallmark_2020__UV Response Dn,0.4018128498172582,1.249496688962152,0.0,0.622018066232117,1.0,62/132,25.49%,MGLL;MMP16;ANXA4;NFIB;NOTCH2;NFKB1;SERPINE1;ATP2C1;KCNMA1;DYRK1A;NR1D2;IRS1;CELF2;PEX14;SMAD7;NR3C1;PRKCE;SYNE1;PLPP3;BCKDHB;ADGRL2;RASA2;TGFBR2;APBB2;PDLIM5;NIPBL;MAGI2;MAP2K5;ACVR2A;TJP1;ATP2B4;DLG1;CDC42BPA;BMPR1A;NRP1;CDK13;TOGARAM1;DDAH1;SCAF8;FYN;ATRX;RUNX1;DMAC2L;PTEN;PRDM2;SDC2;AKT3;PRKCA;COL11A1;PHF3;SMAD3;MIOS;RBPMS;ADD3;SYNJ2;PMP22;CDKN1B;SFMBT1;ATP2B1;SIPA1L1;RXRA;ATXN1
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle cell differentiation (GO:2000726),0.7376873868931874,1.2492552348749757,0.20454545454545456,0.621941234047359,1.0,3/5,14.57%,BMP2;SOX6;SMAD4
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.641196462495879,-1.2491579576856073,0.19718309859154928,1.0,1.0,3/24,10.62%,CETN2;RPS27A;UBC
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.5550342402078802,-1.2488424995369583,0.14705882352941177,1.0,1.0,9/43,11.48%,P2RY10;P2RY12;HTR2B;LPAR4;GPR18;CHRM2;TACR1;FPR3;LPAR6
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),0.7147193738888584,1.2487733787848083,0.2564102564102564,0.6226338311754249,1.0,3/5,20.52%,MGLL;ABHD6;FAAH
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),0.7243021033711552,1.2487074208601876,0.1875,0.6222491355035803,1.0,3/7,14.79%,UBXN6;CHMP2B;VCP
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),0.6765567323704424,1.2481942207227825,0.21052631578947367,0.6232087767423085,1.0,1/8,7.68%,PCGF2
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.3954424473131998,1.247959849814992,0.07692307692307693,0.6232652986089664,1.0,45/128,20.18%,PID1;NCK2;SNCA;PARD3;PPP1R15B;SMCR8;SPRED2;PPM1E;TESK1;PTPN13;MEN1;GSKIP;AKT1;SPRED1;SMAD7;DUSP19;PRKN;TAB1;CAMK2N1;NF1;DVL1;SLIT2;PLPP3;OCLN;NCK1;CRKL;MLXIPL;SIRT2;SAMSN1;YWHAG;GNAQ;SEMA4D;UBASH3B;IMPACT;TRIB2;PDE4D;PTEN;CIB1;PPM1F;NTRK3;FKBP8;FBLN1;NIBAN1;DNAJC3;SNX25
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.6334991258197661,-1.2479505279861243,0.20270270270270271,1.0,1.0,4/18,6.81%,RPL23;RPL11;RPS7;RPL5
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.49922478015039184,-1.2478426593538237,0.12222222222222222,1.0,1.0,15/120,9.07%,EIF2S3B;RPS14;RPS27;RPL10;RPL24;RPL11;RPL38;RPS15;MRPL20;RPL3;RPL23A;SNRPD2;RPL5;RPS28;EIF2S2
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),0.6745561407932981,1.2475990500191476,0.2692307692307692,0.6238772372245559,1.0,2/8,11.30%,TRPM4;ECM1
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),0.7313939524127245,1.2475304481580296,0.1568627450980392,0.6228606431759297,1.0,4/6,26.67%,PIK3R1;MAP4K4;ARF6;DUSP3
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),0.7313939524127245,1.2475304481580296,0.1568627450980392,0.6228606431759297,1.0,4/6,26.67%,PIK3R1;MAP4K4;ARF6;DUSP3
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.35691731696163254,1.2474984113973315,0.0,0.6223251945451965,1.0,84/229,24.33%,CHRNA4;DLGAP1;KCNQ3;CACNB4;GABRG1;SNCA;HTR2C;PCDHB2;HOMER1;PRKACB;GRIN1;CACNA1B;PDE7B;GABRA5;RPS6KA3;KIF5A;PRKAR1B;GABRA4;DOC2A;NRXN1;GLRB;MBP;KCNQ2;RPS6KA2;GPR176;DVL1;NLGN4X;LPAR3;NLGN3;TBC1D24;GRM1;KIF1B;ERC2;PCDHB13;NAPB;EXOC4;GABRB1;STX1A;DLG1;MAPK1;SLC32A1;HRH1;GRID1;CACNB3;NPY;APBA3;CDH8;LIN7C;APBA1;NRXN2;DRD2;GABRG3;PTEN;GRIN2B;NOVA1;GRIK2;GRIA2;UNC13A;HCRT;DNAJC5;NPTX1;CHRM3;SLC6A1;NLGN1;CAMKK1;CAMK4;ERC1;PTPRN2;NPTX2;GRIK1;GRM5;CNP;CACNA1E;GABRB3;KCNC4;LIN7A;NLGN4Y;PMP22;GLRA3;KCNIP2;GABRR2;SYT5;GABBR2;NLGN2
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.40846567955800256,1.2473728231314423,0.058823529411764705,0.6221724157699187,1.0,36/118,20.05%,PICALM;MLLT3;NRG3;STK38L;CD22;RAB33B;HNRNPU;RAPGEF2;SLITRK2;ABL2;FAM107A;BBS10;ITCH;CAMK2D;CAMSAP2;DCUN1D5;SGK3;RAP1A;RPTOR;OPHN1;TJP1;CDH13;TAOK2;LATS1;HIP1;ROCK2;STK11;PTPN11;SEMA4D;TFRC;RAB4A;BCAR1;SETD5;ROCK1;PAK4;NCLN
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.5956215659205546,1.2472228973294133,0.275,0.6221724344767289,1.0,6/9,24.52%,CBL;CBLB;TSG101;CHMP6;ERRFI1;SOCS4
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.45822454847401073,1.2469464424696368,0.12,0.6221914967162115,1.0,15/49,15.87%,AMH;SOX9;BMP2;SMAD2;SMAD5;BMPR1B;SMAD7;RGMA;ACVR1;SMURF1;ACVR2A;SMAD4;BMPR1A;USP9X;BMP7
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.36466603875882025,1.2463733282581044,0.0,0.623237868179011,1.0,66/276,19.48%,RANBP17;TBC1D4;ARFIP1;NUP42;XPO1;ARL5A;TBC1D1;RANBP3L;MAIP1;TBC1D5;NUP188;PPP1R10;USP6NL;TBC1D12;EVI5L;KIF13B;AP1S3;RAB31;CACNG3;RAB18;SPRN;AKT1;IPO8;RAB23;TRAK1;SNX27;RANBP3;XPO6;ARFRP1;NXT2;TBC1D22B;AP3B1;TRAK2;FAM91A1;NUP153;XPO7;SCFD2;RAB21;SMURF1;GGA2;CLIP3;TBC1D8B;NAPB;STX1A;RAB22A;KIF13A;TBC1D10A;TMED3;NSF;SNX13;STX8;RAB1A;TMED5;RAB28;RABGAP1L;TNPO1;AKT2;KATNB1;SEC23IP;NUP214;TBCK;IPO5;STX7;ARF6;STX12;GGA1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),-0.752488079357778,-1.2463406128840995,0.1864406779661017,1.0,1.0,2/7,5.51%,ENPP2;VIL1
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),0.7495091817317516,1.2461771216537783,0.2830188679245283,0.6233508833639293,1.0,2/5,14.62%,ADIPOR2;ADIPOR1
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),0.7550705844422807,1.2461743395286988,0.1951219512195122,0.6227421422668943,1.0,4/5,19.58%,MGLL;ABHD6;LYPLA2;ABHD2
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),0.5965855589683338,1.2458804230399478,0.14285714285714285,0.6229692360871069,1.0,7/26,11.20%,CACNA1G;ANK2;CACNA2D1;BIN1;TRPM4;KCNH2;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),0.5689744226540826,1.2456694427627506,0.16129032258064516,0.6229495272921328,1.0,7/15,19.43%,DNA2;EGFR;STN1;DHX9;KAT7;FAF1;NPM2
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.47145768912056957,1.2456000940658551,0.10526315789473684,0.6225133460177018,1.0,11/34,24.68%,SMCR8;RHEB;PIK3CA;GOLPH3;SIK3;RPTOR;RRAGD;MIOS;GPR137B;WDR24;GAS6
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),0.7267336421974051,1.245594619480455,0.23404255319148937,0.6219077882881126,1.0,2/7,22.73%,KDM1B;MECP2
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),0.7304217195039209,1.2450428721912834,0.22580645161290322,0.6232307500057946,1.0,2/9,3.47%,GAS2;EPS8
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),0.511790436908178,1.244581096066595,0.14814814814814814,0.6236261615751446,1.0,4/31,4.38%,ACE2;PID1;RAB27A;GRIN1
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),0.5453385943369058,1.2443917389140409,0.23076923076923078,0.6235116168898942,1.0,13/27,16.15%,SHANK1;IQCJ-SCHIP1;KANK1;PIK3CA;PRKN;SHANK3;SLIT2;SSH1;CLASP1;TJP1;SMAD4;CYRIB;ARFGEF1
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.6690308989227192,1.2440596425346857,0.2391304347826087,0.6238117870722434,1.0,2/9,7.71%,PDP1;ABL2
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),0.4447080144559994,1.2439776287832198,0.08333333333333333,0.6234902386472807,1.0,10/44,17.00%,MOSMO;BTRC;FBXL17;RORA;GLI3;HERC4;DLG5;VCP;SMO;SUFU
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),0.4917486002044546,1.2435649496183836,0.10714285714285714,0.6241471276294879,1.0,16/37,22.17%,SOX9;BMP2;LOXL2;TASOR;HGF;TGFBR1;DLG5;TRIM28;GSK3B;ROCK2;BMP7;HIF1A;RBPJ;ROCK1;LEF1;CTNNB1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.7421036647094555,1.243491328557785,0.17391304347826086,0.6237131607027459,1.0,5/5,25.81%,ZDHHC21;DOCK4;CHRM3;ATP2B1;DOCK5
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.504863460494183,1.2434499841226438,0.16,0.6232424958660701,1.0,11/44,16.12%,LEPR;HDAC9;SOX4;TOX;CHD7;PBX1;PTPRJ;HDAC4;DCAF1;KAT7;MSH2
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),0.7275743258132157,1.2432314571421945,0.2702702702702703,0.6234664792914498,1.0,3/7,12.90%,OTUB2;UBR5;TRIP12
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),0.6329287543803641,1.2432102516166668,0.2222222222222222,0.6229594956132901,1.0,2/11,5.04%,EPHA4;NFIB
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),0.6264833032247478,1.2431769611570471,0.24444444444444444,0.6225096287976652,1.0,2/10,2.04%,SLC19A1;SLC6A13
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),-0.7694337142972327,-1.243006294603621,0.1864406779661017,1.0,1.0,3/6,20.85%,HES1;HEY2;ENG
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),0.7041454139467866,1.2427240897175782,0.23809523809523808,0.623388018825281,1.0,2/6,9.94%,FEM1B;RFWD3
prerank,GO_Biological_Process_2021__positive regulation of autophagosome maturation (GO:1901098),0.6890193038949507,1.2425273282524745,0.2702702702702703,0.6234055471270711,1.0,3/6,14.22%,SMCR8;ADRB2;FYCO1
prerank,GO_Biological_Process_2021__skeletal myofibril assembly (GO:0014866),0.7527458020127795,1.242486173446575,0.2222222222222222,0.622881908345845,1.0,1/5,0.14%,TCAP
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),0.6517211531209027,1.2424123307591624,0.23529411764705882,0.6225084087321564,1.0,3/8,25.17%,BDH2;ACAT1;HMGCLL1
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),0.6833671193429209,1.2424067850965905,0.28205128205128205,0.6219493843641608,1.0,3/6,27.03%,ABCD3;ACOX1;ABCD2
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),0.5875817125096295,1.2423836353038535,0.18181818181818182,0.6214286423093526,1.0,7/12,32.58%,SORT1;SLC2A8;SLC2A9;SLC2A10;PPARD;SLC45A1;SLC2A1
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.6530230452567886,1.2421152113027185,0.17777777777777778,0.6214107831985825,1.0,6/10,31.71%,NDFIP1;PPM1F;NDFIP2;DNAJA1;CORO2B;SNX3
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),0.4036360373778716,1.2419237041929223,0.058823529411764705,0.6213929582026371,1.0,20/84,15.23%,VEGFD;WNT7A;EGFR;SOX9;BMP2;NOTCH2;NRP2;AKT1;VEGFC;IGF1;PRKD1;ECM1;NRAS;SIRT1;TGFBR1;RREB1;TGM1;CDH13;NRP1;YAP1
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),0.6000926976842744,1.2405845016049115,0.3191489361702128,0.6255681323436671,1.0,4/10,19.43%,LIG4;HMGB1;DCAF1;XRCC4
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),0.6325146239953551,1.2403525700964178,0.14705882352941177,0.6254907724078073,1.0,2/9,8.94%,RNF26;ITCH
prerank,GO_Biological_Process_2021__negative regulation of phospholipase activity (GO:0010519),-0.7908708349389062,-1.240135714884666,0.23076923076923078,1.0,1.0,2/6,7.75%,ANXA1;ANGPTL3
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.71664830333805,1.2399944041126711,0.12195121951219512,0.6261542639869635,1.0,4/9,17.84%,PPP2R5A;PIK3R1;WDR91;WDR81
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.7085608839634872,1.2396779219744392,0.225,0.6266684930948189,1.0,2/6,9.25%,FOXO1;EIF2AK4
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),0.585119230619229,1.2395081972569504,0.13333333333333333,0.6264609310003562,1.0,4/13,14.68%,EGLN3;PLOD2;ASPH;PLOD1
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),0.7280334470925506,1.2394068725223728,0.1794871794871795,0.6261614388990815,1.0,2/7,3.33%,ZFPM2;SOX4
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),0.7342668847154799,1.2392395806303687,0.2,0.6262868036502426,1.0,2/6,8.93%,SOX9;BMPR1B
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),0.8002366769042661,1.2390510673510844,0.2608695652173913,0.6261539129423367,1.0,3/5,16.22%,TRIP11;FAM91A1;TBC1D23
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.43753186724047866,1.2389566003196575,0.14285714285714285,0.625873974798102,1.0,17/61,23.48%,LAMB4;PARVA;EPHA2;SRCIN1;PIK3R1;FER;OPHN1;NRP1;PXN;NTN4;YTHDF2;TMEFF2;SIPA1L3;ABI2;EPHB3;TBCD;VAMP3
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),0.6672991143153985,1.2388752949752941,0.20454545454545456,0.6255945663381516,1.0,1/7,0.76%,LEPR
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),-0.7203555907633061,-1.238858168819878,0.24615384615384617,1.0,1.0,3/8,17.78%,APOM;APOE;ABCA5
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.3560616987339499,1.2387996334341684,0.0,0.6252973084761667,1.0,90/304,19.05%,PTPRK;SEMA5B;AMOTL1;CASS4;SASH1;MITF;FLT1;ZMYND8;PRKX;RCC2;ERBB4;DACH1;CSF1R;EPHA4;RAP2B;EGFR;PLXNA2;CXCL12;FAM110C;PDGFRA;BMP2;PLXNA1;KANK1;LIMCH1;FOXO3;SERPINE1;DUSP10;SRCIN1;CTNNA2;FGF17;ROBO1;CAMK2B;AKT1;CARMIL1;AMOT;CAMK2A;TTBK2;FAM107A;PDGFA;SMAD7;IGF1;ZNF268;SEMA3C;HGF;PTPRJ;NAV3;ADARB1;MAP4K4;NF1;SLIT2;TRADD;ACVR1;PTK2;AFDN;SGK3;MAGI2;TGFBR1;DLG5;RAP2C;FER;PDGFC;MAPRE1;TJP1;CDH13;DUSP22;CYRIB;CPNE3;ROCK2;HACE1;SEMA6C;SEMA4D;SMO;RAP2A;ARID2;CCAR1;RUFY3;RNF41;AKT2;ITGA6;ZNF703;DRD2;PTEN;PLXNA4;CIB1;SRGAP2B;PPM1F;SEMA3D;BCAR1;NTRK3;FRMD5
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),0.4774746312567263,1.238582250378715,0.15,0.6254779780049333,1.0,16/51,23.16%,NAF1;RGCC;CCT4;HGF;DKC1;MAP3K4;MAPKAPK5;MAPK1;CCT3;PTGES3;POT1;HMBOX1;CTNNB1;FGF2;TNKS2;POLG2
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),-0.7666685446932844,-1.2381012663448612,0.16666666666666666,1.0,1.0,3/7,17.09%,MT3;CCS;SOD3
prerank,GO_Biological_Process_2021__CD40 signaling pathway (GO:0023035),-0.7718603982769051,-1.2380725516707314,0.16393442622950818,1.0,1.0,1/5,5.74%,ITGA5
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.5103441921864378,1.2380716620007308,0.1,0.6262269368482153,1.0,12/32,17.34%,SOCS6;ITPKB;EFR3A;PIK3CA;PIK3R1;SOCS7;PIK3C3;PIP4K2C;SMG1;TTC7B;IP6K2;PI4KB
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.5655265855465772,1.2380397820073765,0.15384615384615385,0.6256916903976676,1.0,3/24,5.75%,ACE2;SNCA;NEDD4L
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),0.7432625904908385,1.2380163571351488,0.1794871794871795,0.6251391435785971,1.0,2/7,9.87%,EPHA4;RTN4RL1
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),-0.7733995734747023,-1.237979984162587,0.23809523809523808,1.0,1.0,6/7,21.60%,RPE65;RBP2;BCO1;RBP1;LRAT;RLBP1
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),0.6593837879217462,1.2377911886174788,0.21875,0.625264408623794,1.0,3/10,5.39%,PCSK5;SNCA;PLIN5
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.638259467701344,1.2377369287933426,0.19047619047619047,0.6249143154724004,1.0,6/13,34.32%,LEPROTL1;VTA1;CHMP6;STAM;CHMP5;CHMP7
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.5958243533299624,1.2374514027002388,0.25,0.625222124311719,1.0,9/16,29.53%,NAPB;GRID1;CDH8;GRIK2;GRIA2;UNC13A;GRIK1;GRID2;GRIK5
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.538326913062497,-1.2373731604024651,0.17333333333333334,1.0,1.0,7/37,12.20%,ISG15;USP18;PARP14;SIGIRR;GSTP1;STAT2;OAS3
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),0.7722143560726662,1.2373730385168837,0.21052631578947367,0.6243235376345515,1.0,2/5,13.85%,HNRNPU;DHX9
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),0.7722143560726662,1.2373730385168837,0.21052631578947367,0.6243235376345515,1.0,2/5,13.85%,HNRNPU;DHX9
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),0.735310811243254,1.237294124159782,0.15151515151515152,0.6238846091107167,1.0,3/7,21.60%,FOXP1;UBASH3B;CAMK4
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),0.663602891748708,1.2371894728790278,0.2916666666666667,0.6235010672191221,1.0,5/7,28.37%,DROSHA;PRKRA;TSN;DICER1;AGO2
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.4902858277606899,1.2371889930097,0.047619047619047616,0.6229183559413473,1.0,19/42,25.81%,CASS4;CSPG5;CDKL5;TESK1;CARMIL1;CAPRIN2;CRKL;CAPRIN1;RREB1;NRP1;ARHGEF7;CIB1;SS18L1;DOCK1;CRK;TRIOBP;CUX1;NEDD9;DOCK5
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),0.6189859993600888,1.237044054354051,0.21951219512195122,0.6228450592127621,1.0,3/12,11.45%,AIFM2;PRKN;STOX1
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),0.7126401400119442,1.2369110102810494,0.20512820512820512,0.6221914967162115,1.0,2/6,23.64%,SLC16A10;SLCO1C1
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),0.7126401400119442,1.2369110102810494,0.20512820512820512,0.6221914967162115,1.0,2/6,23.64%,SLC16A10;SLCO1C1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.43344615351574406,1.2368267916545181,0.0625,0.6217932130532763,1.0,25/78,14.50%,PIP5K1B;FLT1;EGFR;DCN;PDGFRA;SOX9;EPOR;CBL;HCLS1;PTPN13;NTRK2;PIK3CA;PIK3R1;DIPK2A;PDGFA;ROR1;IGF1;PIP5K1C;PIP4K2C;HGF;PTK2;SIRT1;PDGFC;GAB1;MAPK1
prerank,GO_Biological_Process_2021__regulation of skeletal muscle satellite cell proliferation (GO:0014842),0.7323871975942501,1.236768842610871,0.21052631578947367,0.6213414094968609,1.0,4/6,26.49%,CFLAR;FGF2;AKIRIN1;EPHB1
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),0.7416375986345637,1.2365520486861292,0.2894736842105263,0.6213421995407451,1.0,1/5,10.77%,GOLPH3
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),0.7010069030364797,1.2363851253310467,0.22857142857142856,0.6210541341264622,1.0,4/11,15.47%,SESN1;KPTN;SESN3;STK11
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),-0.6548074240682651,-1.2362768706686087,0.24285714285714285,1.0,1.0,2/11,3.44%,AGPAT2;IL7
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.6341313810651121,-1.2352733580082518,0.19696969696969696,1.0,1.0,3/22,10.62%,RPS27A;RPA3;UBC
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.550739092940069,-1.235212656775609,0.12790697674418605,1.0,1.0,19/50,26.77%,NDUFA6;NDUFS5;NDUFA2;NDUFC1;NDUFB10;TMEM126A;NDUFB3;DMAC1;NDUFA1;NDUFB7;NDUFA12;NDUFB9;NDUFB11;TMEM126B;NDUFAF3;NDUFAF8;OXA1L;NDUFB2;NDUFA3
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.550739092940069,-1.235212656775609,0.12790697674418605,1.0,1.0,19/50,26.77%,NDUFA6;NDUFS5;NDUFA2;NDUFC1;NDUFB10;TMEM126A;NDUFB3;DMAC1;NDUFA1;NDUFB7;NDUFA12;NDUFB9;NDUFB11;TMEM126B;NDUFAF3;NDUFAF8;OXA1L;NDUFB2;NDUFA3
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),0.7150054135131505,1.2348924283786165,0.3,0.6241736869571402,1.0,2/6,16.66%,IWS1;SETD2
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),0.7150054135131505,1.2348924283786165,0.3,0.6241736869571402,1.0,2/6,16.66%,IWS1;SETD2
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),-0.6483939860759114,-1.234892423254278,0.1746031746031746,1.0,1.0,5/12,20.61%,SFRP1;INHA;ID2;TNFRSF21;BANK1
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.7058143065821006,-1.2344260617397942,0.2459016393442623,1.0,1.0,1/9,1.09%,IFIT1
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),0.49270535930658593,1.2342005012136805,0.21739130434782608,0.6251620290356031,1.0,10/33,18.80%,BICDL1;MYO5B;PPFIA2;WASL;TRAK1;TRAK2;TANC2;RAB1A;MYO5A;FBXW11
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),0.6260536277884513,1.2339472524169883,0.225,0.6251772676590565,1.0,3/10,11.24%,SLIT1;EPHA4;SLIT2
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),-0.6808173378324383,-1.2337811236451228,0.23333333333333334,1.0,1.0,3/12,12.34%,IFIT1;PLN;ATP5IF1
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),0.4428627255221818,1.2337570828291993,0.0,0.6248869889905713,1.0,19/62,19.69%,ARAP1;RGCC;LIMCH1;PPM1E;CGNL1;TESK1;CARMIL1;PIK3R1;ARHGEF10L;TGFBR1;CLASP1;TJP1;ALMS1;NRP1;ROCK2;PXN;PPM1F;TMEFF2;ROCK1
prerank,GO_Biological_Process_2021__positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568),0.7642406888399174,1.2331818541126465,0.18181818181818182,0.6260335148457495,1.0,3/5,15.68%,MYORG;IGF1;PHIP
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),-0.6784983964231932,-1.2330245881000286,0.2033898305084746,1.0,1.0,3/10,17.19%,TIMM10;TIMM8B;ROMO1
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),-0.6337817240954248,-1.2329887662569166,0.18840579710144928,1.0,1.0,3/13,9.24%,IFITM3;TRIM21;HEXIM1
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.690812152465988,1.2328160706671656,0.23809523809523808,0.6264604535952031,1.0,5/8,21.77%,NCKAP1;CYFIP1;WASF3;WASF1;ABI2
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.608965609918098,-1.2325563277262759,0.1643835616438356,1.0,1.0,6/23,17.23%,ARG2;SELENOS;GSTP1;CX3CL1;CD274;PTPN22
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),-0.7501292624435385,-1.2324133713928653,0.22641509433962265,1.0,1.0,2/7,21.50%,VAMP8;TFR2
prerank,GO_Biological_Process_2021__glial cell migration (GO:0008347),-0.816599546413755,-1.2322824923250366,0.2037037037037037,1.0,1.0,3/5,14.92%,CD9;P2RY12;CCL2
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.5968709964792862,-1.2321260907235654,0.14285714285714285,1.0,1.0,4/27,8.77%,RPS14;RPS21;RPS8;RPS16
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),-0.5555210859772515,-1.2320015315764938,0.17142857142857143,1.0,1.0,10/37,19.77%,ANAPC15;KIF20B;FBXO43;CAV2;BORA;DUSP1;CCNB1;TOM1L1;AURKAIP1;OBSL1
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.3830764055729672,1.2312634088623957,0.07692307692307693,0.6305602590712366,1.0,35/86,24.15%,RBPMS2;SPRED2;BMP2;SMAD2;UBE2D1;SPRED1;PPM1A;SMAD5;BMPR1B;SMAD7;ZNF451;ACVR1;SMURF1;TGFBR2;SIRT1;NBL1;HIPK2;MAGI2;TGFBR1;ACVR2A;VWC2L;SMAD4;BMPR1A;WFIKKN1;LEMD3;UBE2D3;CRIM1;SNX25;SKIL;HSPA1A;SPRED3;SMAD3;TRIM33;SLC2A10;PRDM16
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,-0.54263048541498,-1.2312038020287737,0.21621621621621623,1.0,1.0,10/41,17.83%,IL1R1;TMEM40;IER3;S100A10;GPR87;TRIM29;LTBR;B3GNT3;IL18;KLF4
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),0.6521339359217395,1.2308134332997167,0.2857142857142857,0.6313582222663583,1.0,3/9,15.25%,QDPR;AKT1;PRKG2
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.6742514693854299,-1.23081017869416,0.3114754098360656,1.0,1.0,1/10,3.56%,STX19
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.49920791245136276,1.2307187693033486,0.08333333333333333,0.6310457052855114,1.0,14/40,22.60%,ITPKB;ISYNA1;INPP5A;PLCB1;MINPP1;ITPK1;SYNJ1;IP6K2;PLCB3;IPPK;PTEN;NUDT3;OCRL;IMPA2
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.5173383490686169,1.2307004740192948,0.2,0.630537183439743,1.0,13/30,25.40%,USP13;OTUB2;PSMD14;ZRANB1;OTUD4;USP25;UIMC1;ABRAXAS2;BRCC3;OTUD7A;STAMBPL1;USP33;CYLD
prerank,GO_Biological_Process_2021__protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),0.7945835669332524,1.229936242661521,0.21428571428571427,0.6319221660719948,1.0,3/5,19.46%,ZRANB1;USP9X;OTUD7A
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),-0.7191511931672501,-1.2298518193084391,0.18309859154929578,1.0,1.0,4/9,18.73%,HLA-A;HLA-B;PGLYRP1;PGLYRP2
prerank,GO_Biological_Process_2021__venous blood vessel development (GO:0060841),-0.8248850527469713,-1.2297715369352864,0.2037037037037037,1.0,1.0,2/6,6.64%,APLNR;CCBE1
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),0.7905894366952306,1.2295488802524095,0.14583333333333334,0.6322878380906776,1.0,3/5,16.21%,EIF2AK4;NCK1;IMPACT
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),-0.7902767562306088,-1.2295155645206155,0.25806451612903225,1.0,1.0,1/6,3.44%,IL7
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),-0.6230313452351551,-1.2290913968466355,0.15151515151515152,1.0,1.0,5/18,16.40%,CD24;HHLA2;PDCD1LG2;CD274;IL18
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),0.7049879527141663,1.2289487814603253,0.21621621621621623,0.6332409561560618,1.0,2/5,14.67%,FYCO1;KIF13A
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.6962197637785376,1.2288154763102077,0.24324324324324326,0.6330705891067109,1.0,4/7,29.63%,DHX9;AGO3;AGO2;AGO1
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),0.5917062297838823,1.2285141647828983,0.25,0.6334519958419368,1.0,5/12,18.04%,BMP2;NOTCH2;ACVR1;BMPR1A;RBPJ
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.6660401602606616,-1.2284450850845465,0.2153846153846154,1.0,1.0,2/14,6.27%,RPS13;RPS26
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.5712226333074856,-1.2283174034557727,0.17647058823529413,1.0,1.0,17/23,35.05%,C1R;CPB2;CLU;C1QB;C1S;SUSD4;CR1;C2;C3;PHB2;SERPING1;C1QBP;C6;C5;CD46;CR1L;PROS1
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),0.5122928248009594,1.2283107343971966,0.27586206896551724,0.6336016584190169,1.0,14/27,18.80%,CCDC88C;BTRC;NFKB1;MAPK11;MAP3K7;MAP3K20;MAP3K5;CUL1;MAPK1;KAT7;TAOK2;MAPK8;CCM2;FBXW11
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.46266482606076736,1.228161918259336,0.10344827586206896,0.6334136721136044,1.0,8/30,14.69%,PCSK5;SALL1;MME;PYGO2;CEP290;C1GALT1;TGFBR1;PYGO1
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.4222912409035472,1.2275193180316928,0.06666666666666667,0.6349113673579065,1.0,21/69,16.02%,PTPRK;PARD3;SMAD2;CBL;SMAD5;NLK;SMAD7;MAP3K7;TGFBRAP1;GDF10;ACVR1;SMURF1;PTK2;TGFBR2;SIRT1;TGFBR1;SMAD4;BMPR1A;DUSP22;USP9X;PXN
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.4681249010532879,1.2274920360447135,0.14814814814814814,0.6343857694412787,1.0,12/44,17.34%,CSF1R;PDGFRA;PIK3CA;PIK3R1;PLCB1;IRS1;RPS6KB1;IGF1;PIK3C3;OGT;PLCB3;PI4KB
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.5234785552333008,1.2269613577997969,0.1935483870967742,0.6354902732995983,1.0,8/18,19.82%,ZNF706;LOXL2;CNOT2;KAT2A;NCOA3;ZC3H13;ESRRB;REST
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.4155638218037596,1.22677109892819,0.10526315789473684,0.635495864480389,1.0,19/89,13.60%,CHST11;B4GALT3;CSPG5;CSGALNACT1;DCN;TPK1;VCAN;UGDH;ST3GAL1;B4GALT6;CHPF2;SLC10A7;GSTM2;GCLC;ESD;B4GALT2;B4GALT5;PAPSS2;CHST14
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),0.5418525923847209,1.2267190248032482,0.23529411764705882,0.6351302517047418,1.0,2/16,9.35%,FEM1B;PPP1R3F
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.5297584812394007,1.2266784420264458,0.23076923076923078,0.6346063645122917,1.0,12/18,32.84%,DROSHA;TENT4B;PRKRA;LIN28B;DIS3L2;DICER1;AGO2;DDX17;PARN;KHSRP;XPO5;SND1
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),0.8154157270012752,1.2266207179040245,0.2,0.6341716471889403,1.0,1/5,4.54%,ATP6V1A
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.5907009197039658,1.2265984491489743,0.17647058823529413,0.633667206835269,1.0,8/13,35.05%,CLIP3;APBA1;BAG3;BORCS5;DYNC1I1;CAMSAP3;CDC42;COPG1
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.7514293834452349,-1.226586628767091,0.14492753623188406,1.0,1.0,4/8,23.82%,ABCA12;APOE;DBI;PRELID1
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.6632348379227936,-1.2264870409623863,0.1791044776119403,1.0,1.0,4/14,23.57%,ORMDL2;ORMDL1;SPHK1;SIRT3
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),0.7005228749373922,1.2262964376437242,0.2972972972972973,0.63407949661101,1.0,3/7,21.06%,NPAS2;SGIP1;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.5195417986185323,1.2262913016769117,0.18181818181818182,0.6335232649256357,1.0,8/23,16.81%,HDAC2;NCOA3;SHANK3;FBXW7;NLGN3;ADRB2;NRP1;HIF1A
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,0.38325318154096466,1.2262664267989072,0.058823529411764705,0.6330559391034916,1.0,30/103,21.35%,ABCC8;SOWAHA;SNAP91;CACNA1B;ALCAM;UNC79;NOL4;VWA5B2;NRXN1;ADGRA1;ASTN1;CDK5R2;OLFM3;UNC5D;CELF3;TMEM196;CA10;ASXL3;LY6H;ELAVL3;CSRNP3;NPY;OPCML;CTNND2;GRIA2;UNC13A;CLVS2;VSTM2A;PHYHIPL;TMEM59L
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.43534171140665623,1.2260997261746998,0.11538461538461539,0.6330636889154927,1.0,9/51,9.86%,PNLDC1;PDE12;EXOSC6;DCP1B;CNOT9;CNOT6L;CNOT2;EXOSC1;CNOT4
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),-0.6514433316593878,-1.2259397571942954,0.18032786885245902,1.0,1.0,3/12,12.90%,THBS1;SEMA5A;FGF1
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,-0.5862466999442525,-1.2258432945483397,0.2054794520547945,1.0,1.0,9/23,22.39%,GC;SLC18A2;ALDOB;ADH6;SEMA4G;C3P1;F11;F10;CDHR2
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),0.5054227613696688,1.2258229432048646,0.13043478260869565,0.6334925832427583,1.0,12/35,14.73%,TCAP;SOX9;BMP2;FLRT2;TBX19;CHD7;ACVR1;PTK2;NIPBL;TGFBR1;MDM4;BMPR1A
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),-0.7676790464979265,-1.2251393242080804,0.22950819672131148,1.0,1.0,3/6,17.09%,MT3;CCS;SOD3
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.44164827856015304,1.2251041121657233,0.09090909090909091,0.6349901833878424,1.0,22/52,26.33%,MITF;CSF1R;SOX9;NFKB1;CDK8;MED13;TNRC6B;AGO3;TRIM28;CBFB;PTEN;PPM1D;MED27;MED4;LEF1;CTNNB1;MECP2;TCF7L2;MED30;SETX;MED23;RELA
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),0.5954816134711122,1.2249156881944434,0.2727272727272727,0.6348735531245037,1.0,3/16,9.05%,TCAP;BMP2;SMAD7
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.6748005294379965,1.2249055205562114,0.30952380952380953,0.6343371115542249,1.0,3/7,24.64%,MTMR2;FYN;PICK1
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.4672384701219659,1.2248088822066194,0.15384615384615385,0.6340988823182726,1.0,11/42,16.53%,ABCC8;HTR2C;PASK;HADH;CHD7;RFX3;CLOCK;RAP1A;STX1A;PPP3CB;KCNC2
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),0.6726043674377765,1.2247887888825437,0.24390243902439024,0.6336165090379883,1.0,5/8,32.58%,SORT1;SLC2A10;SLC27A1;ZDHHC7;SLC2A1
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.5228562074673369,1.2241755196824557,0.1935483870967742,0.6347582010933343,1.0,8/24,14.98%,ARAP1;RHOQ;TENM2;GPM6A;WASL;PIK3R1;TENM1;NRP1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.6949310716826711,-1.2239728224697637,0.23076923076923078,1.0,1.0,5/7,25.39%,CEACAM1;KLRD1;MICA;HLA-F;HLA-E
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),0.7386169257446147,1.2239022560530024,0.1956521739130435,0.635025940146232,1.0,3/6,21.91%,FOXP1;BCL10;IRS2
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.5449203858359356,-1.2238601923211645,0.18181818181818182,1.0,1.0,17/46,18.76%,ISG15;IL1R1;HLA-A;RASGRP1;BTN3A1;IL12A;CD14;TLR3;PDCD1LG2;INHA;SLC11A1;CD274;IL18;PTPN22;ZFPM1;DDIT3;ZP3
prerank,GO_Biological_Process_2021__cerebral cortex cell migration (GO:0021795),0.7232304446061566,1.2231147973701804,0.3684210526315789,0.6367741099204978,1.0,4/5,26.61%,LHX6;PEX13;FGF13;RELN
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.6221054935011849,1.2231106625676333,0.2222222222222222,0.6362388483794272,1.0,6/12,18.20%,TGFBR1;BMPR1A;NRG1;BMP7;RBPJ;S1PR1
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),0.6270182647720801,1.2229579910594368,0.2222222222222222,0.6360175879474669,1.0,3/8,14.07%,CARMIL1;MAPKAPK2;SNX5
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.3951406948619868,1.2228905236257823,0.06666666666666667,0.6356750926012591,1.0,40/111,26.01%,BET1;FHDC1;USP6NL;TRAPPC12;VTI1A;TRAPPC8;SEC22B;TRIP11;SYNE1;GOLPH3;DYM;PRKD1;RAB30;VCPIP1;TJAP1;CLASP1;TMED3;TRAPPC11;HACE1;ARHGEF7;RAB1A;ARFGEF1;TMED5;SEC23IP;NSFL1C;YWHAZ;UBXN2B;GORASP2;GOLGA5;STX17;CSNK1D;HUWE1;STK25;VMP1;VPS51;COG3;BCAS3;BAG5;STX5;CLASP2
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.46541901285489906,1.2228620620769775,0.15789473684210525,0.6351596063157375,1.0,10/45,18.24%,LIG4;EEF1D;INTS7;MAP3K20;CLOCK;SIRT1;NIPBL;YAP1;KDM1A;MDM2
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.6863438950675167,-1.2228456845833469,0.18032786885245902,1.0,1.0,2/11,7.91%,IFIT1;PQBP1
prerank,PanglaoDB_Augmented_2021__Spermatocytes,0.5842467605414505,1.2225450182159676,0.17142857142857143,0.6355296228584609,1.0,2/17,3.15%,PRNT;GCNA
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.548036060209724,1.2221822970880245,0.19230769230769232,0.6359163091437751,1.0,5/27,6.57%,HDAC9;CDH2;MAPK11;CTNNA2;MEGF10
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.5463770659674516,-1.2221228770184545,0.2077922077922078,1.0,1.0,9/46,16.17%,PSMB6;BHMT;PSMB9;PSMA8;PSMA7;PSME1;PSMC3;PSMC4;PSMA3
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),0.6637478728407598,1.2219262134974616,0.29411764705882354,0.6353729335627906,1.0,6/9,30.74%,POT1;ATRX;TERF2IP;DAXX;H3-3A;TERF2
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),0.6637478728407598,1.2219262134974616,0.29411764705882354,0.6353729335627906,1.0,6/9,30.74%,POT1;ATRX;TERF2IP;DAXX;H3-3A;TERF2
prerank,GO_Biological_Process_2021__negative regulation of cardiocyte differentiation (GO:1905208),0.6936726666210861,1.2217719546607633,0.2608695652173913,0.635292084341514,1.0,3/6,9.73%,EGFR;BMP2;SOX6
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.5449260373517745,-1.2216237175006908,0.13513513513513514,1.0,1.0,3/42,3.38%,FTH1;CP;FTL
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.5074691265481324,1.221549900715719,0.20689655172413793,0.6354358594488196,1.0,14/29,25.81%,CASS4;CSPG5;TESK1;CARMIL1;CRKL;RREB1;NRP1;ARHGEF7;CIB1;DOCK1;CRK;TRIOBP;NEDD9;DOCK5
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.44176954644019717,1.221310113353299,0.16666666666666666,0.635441360000319,1.0,16/64,18.45%,CRADD;SOX4;PRMT1;RGCC;CNOT9;CNOT6L;CNOT2;CNOT4;EP300;HIPK2;MDM4;TFDP2;CNOT8;ATRX;MDM2;PCBP4
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.5344157054983223,1.2211620832638588,0.2,0.635395139404726,1.0,5/18,12.89%,CDKL5;CAMK2B;CAPRIN2;LRP8;CAPRIN1
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),0.6903631113092388,1.2209740463271959,0.32432432432432434,0.6353317788241187,1.0,2/6,23.54%,OGT;MACROH2A1
prerank,GO_Biological_Process_2021__positive regulation of memory T cell differentiation (GO:0043382),0.7444181773300027,1.2208227006964611,0.2777777777777778,0.634689651504913,1.0,1/5,1.50%,TNFSF4
prerank,GO_Biological_Process_2021__regulation of memory T cell differentiation (GO:0043380),0.7444181773300027,1.2208227006964611,0.2777777777777778,0.634689651504913,1.0,1/5,1.50%,TNFSF4
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),0.7115987172486634,1.2205138430770466,0.2777777777777778,0.6349706065206744,1.0,5/7,27.01%,PRKN;VAT1;TFRC;HUWE1;ADCK1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),0.6849676721442356,1.2204458691376512,0.2926829268292683,0.6346332673229871,1.0,1/6,1.50%,TNFSF4
prerank,GO_Biological_Process_2021__regulation of macrophage proliferation (GO:0120040),0.662703886150718,1.2204065438268321,0.2894736842105263,0.6342107934313257,1.0,3/6,14.50%,CSF1R;PTK2;MAPK1
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.5505280614592301,1.2203015013449956,0.2222222222222222,0.6339089797490829,1.0,7/18,23.54%,TASOR;PLK1;NIPBL;MSH2;PPHLN1;WAPL;MACROH2A1
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.49274325756308385,1.2201752761642426,0.10714285714285714,0.6336761604017468,1.0,8/29,16.30%,NAF1;CCT4;DKC1;MAP3K4;MAPKAPK5;MAPK1;PTGES3;POT1
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.739681921716495,1.2201109909680163,0.3170731707317073,0.633255642999616,1.0,1/5,4.64%,PGAP1
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),0.5355412413811176,1.2199054281756394,0.17647058823529413,0.6332288348884071,1.0,7/19,16.56%,USP49;KAT2A;SUPT3H;USP3;USP22;UIMC1;BRCC3
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.43259487872455243,1.21969103029517,0.13793103448275862,0.6332874271613811,1.0,10/54,15.56%,PDK4;FOXO1;FAM107A;RALB;ATG7;TFEB;VPS41;SIRT1;RPTOR;PDK2
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),0.6474488432545273,1.219373799873692,0.17647058823529413,0.6337040860880164,1.0,2/10,10.84%,TENM3;NF1
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),-0.5805889669689365,-1.2192213700443266,0.17333333333333334,1.0,1.0,4/30,6.50%,CCDC39;MMP21;ENKUR;DNAAF1
prerank,GO_Biological_Process_2021__negative regulation of trophoblast cell migration (GO:1901164),-0.7754179006039962,-1.2191604534451264,0.2727272727272727,1.0,1.0,2/5,12.13%,TIMP1;NODAL
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),0.6192625364939696,1.2191416352246,0.2702702702702703,0.6338132813557945,1.0,5/11,22.46%,ACTA2;ADRA1A;ROCK2;ROCK1;TPCN2
prerank,MSigDB_Hallmark_2020__Coagulation,-0.5092590534742734,-1.2190551071121298,0.14814814814814814,1.0,1.0,15/85,14.55%,PRSS23;F8;SPARC;MST1;CD9;ANXA1;TIMP1;THBS1;C1R;MASP2;CTSH;VWF;A2M;CPB2;CLU
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.5154830211549617,-1.218966098894767,0.1511627906976744,1.0,1.0,18/62,18.39%,IFIT1;IFITM3;GBP1;TAGAP;MX1;IFIT3;CLEC12A;IGSF6;P2RY13;DPEP2;CD14;SPI1;CXCR4;LY6E;ADA2;MYO1F;CD44;PTAFR
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),0.6053689854979369,1.2188564583942485,0.19444444444444445,0.6341436210237527,1.0,1/11,0.57%,MTHFS
prerank,PanglaoDB_Augmented_2021__Principal Cells,0.43680399659820424,1.2188377676240745,0.12,0.6336058256285195,1.0,9/61,8.70%,ACE2;CAPN13;MYO5B;NPNT;ARHGEF16;FAM110C;PLEKHA6;MAOA;ZBTB7C
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),0.5448629776435185,1.218530316911904,0.21875,0.6339017770166232,1.0,8/24,14.20%,SHANK1;ARAP1;CGNL1;PIK3R1;PRKN;SHANK3;CLASP1;TJP1
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.617238304059248,1.2182826785855634,0.1875,0.6339085309065551,1.0,5/9,10.21%,SNCA;STXBP6;RAB33B;ATP9A;PRKN
prerank,GO_Biological_Process_2021__glycerol ether metabolic process (GO:0006662),0.7876275622559336,1.218256430220658,0.2549019607843137,0.633423247665877,1.0,1/5,1.16%,AGMO
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),0.692195814450566,1.2180896357627933,0.2894736842105263,0.6334643101784032,1.0,3/8,18.04%,SNAPC1;SNAPC3;SNAPC5
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),0.7569346021461837,1.217968129877402,0.25,0.633234311825613,1.0,5/5,24.33%,NRXN1;SHANK3;NRXN2;PTEN;NLGN2
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.6087204409941902,-1.2179387134017872,0.18055555555555555,1.0,1.0,2/24,4.87%,ARG2;B2M
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),0.5742713884585697,1.217216594483549,0.1875,0.634629234697239,1.0,4/13,24.76%,TASOR;TRIM28;PPHLN1;ZNF304
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),0.6851786781262893,1.2171865731277385,0.22580645161290322,0.6341111979440629,1.0,1/7,9.70%,IGF1
prerank,GO_Biological_Process_2021__positive regulation of DNA ligation (GO:0051106),0.7337787100428586,1.217036077931929,0.28888888888888886,0.633898129731642,1.0,2/5,15.10%,HMGB1;APLF
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.5236293197038773,-1.2168746814686389,0.2077922077922078,1.0,1.0,8/54,10.62%,PSMB6;RPS27A;PSMB9;PSMA8;PSMA7;PSME1;PSMC3;UBC
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.5854231211353578,-1.2166785318492086,0.15492957746478872,1.0,1.0,7/23,14.32%,HLA-A;HLA-B;RASGRP1;IL12A;KLRD1;CD160;SPI1
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.4852575061300877,-1.2162273630874414,0.13414634146341464,1.0,1.0,19/88,16.54%,SLC28A2;SLC51B;SPON2;PDZK1;AQP1;VIL1;CEACAM1;RBP2;ALDOB;NR1I3;SLC51A;ADH6;TMC4;GPX2;ABCG2;ART3;CA1;AQP11;GSTM3
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),-0.6602398949375239,-1.2162022126300835,0.21311475409836064,1.0,1.0,3/8,18.49%,HSD11B1;HSD17B14;CYP3A4
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),-0.7492772188400085,-1.2161184827728604,0.22580645161290322,1.0,1.0,1/7,1.98%,ACMSD
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.5669596906981643,1.215982779248614,0.2,0.6360483548651918,1.0,13/20,32.53%,PIK3C3;HOOK1;SNX16;STX8;WDR91;WDR81;PTPN23;KIF16B;HOOK3;RAB5A;RAB7A;AKTIP;LMTK2
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),0.47951317699458085,1.2158672289433972,0.2222222222222222,0.635833976140632,1.0,10/30,18.25%,WNT7A;MLLT3;FBXL17;GPM6A;PSMD11;EPCAM;SETD2;PUM1;JARID2;SOX21
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),0.6374701547792676,1.215709374436705,0.20588235294117646,0.6358053054615186,1.0,2/8,7.34%,FUT9;AKT1
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),0.5186574781034247,1.2154990242589292,0.24242424242424243,0.63579351861412,1.0,6/18,20.26%,SYT3;NEDD4L;RASAL1;SMURF1;RIMS2;UNC13A
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),0.6323786073627938,1.2153483506946132,0.2702702702702703,0.6355630970592422,1.0,1/8,0.74%,ANKRD2
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),0.698042263451408,1.215255562246632,0.3181818181818182,0.635433904327825,1.0,3/7,11.65%,AKT1;WASL;JAM2
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),0.35665608661247034,1.214696508369595,0.0,0.6369839920909682,1.0,35/146,19.43%,RAD54B;SEM1;LIG4;SAMHD1;DNA2;CYREN;SMARCAD1;UBE2N;APTX;RAD51B;HMGB1;RAD52;RFWD3;PSMD14;NSMCE2;EXD2;SMC6;EYA3;REV3L;VCP;APLF;PIAS4;MAPK8;UIMC1;DCLRE1C;EME2;BRCC3;AP5S1;APBB1;PALB2;YY1;CIB1;H2AX;NSD2;XRCC4
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),0.604876210679468,1.214674169245466,0.20588235294117646,0.6364679463415754,1.0,4/16,11.28%,MCU;DAPK2;SLIT2;BST1
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.5198031586623267,1.21446785933306,0.2903225806451613,0.6367238250473796,1.0,3/27,4.23%,ACE2;CAPN13;SLC26A3
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.6280384463771329,1.2143941070157114,0.30952380952380953,0.6364433529744344,1.0,4/12,12.26%,TCAP;CDH2;PIK3CA;PTK2
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",0.40586993441825175,1.2134903695725783,0.23529411764705882,0.63850595210827,1.0,5/66,2.66%,NUDT21;SNRPF;WDR33;PAPOLA;CSTF3
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),0.7228069837802813,1.213385823836544,0.20833333333333334,0.6381408380712004,1.0,4/5,27.67%,DCAF1;PRKCB;PRKCA;PKN1
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.5929225454326945,1.2133540680688475,0.3225806451612903,0.637692831256392,1.0,5/14,22.47%,SEC23B;SEC24B;RAB1A;SEC23A;SAR1A
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.5333252399897775,1.2132747211394979,0.2222222222222222,0.6374291800987733,1.0,7/21,21.48%,PARD3;MYRF;JAM2;SIRT2;PTPRZ1;ZPR1;RNF10
prerank,"GO_Biological_Process_2021__phototransduction, visible light (GO:0007603)",-0.7020282249085329,-1.2132611340419186,0.23728813559322035,1.0,1.0,1/7,4.37%,PDE6B
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),0.6375799411572036,1.2130261422827693,0.21875,0.6375828654841431,1.0,1/10,1.65%,INSC
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),-0.7416579276775586,-1.2128639026785142,0.27586206896551724,1.0,1.0,2/6,9.20%,MST1;PGP
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),0.7379340972789781,1.2127882123899714,0.2631578947368421,0.6377029653174003,1.0,1/6,5.39%,PLIN5
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.6794164281217683,1.2124792091774694,0.2564102564102564,0.6379893276875216,1.0,4/7,22.17%,STARD13;CCM2;RBPJ;CTNNB1
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.5559124814875861,-1.2123673785574305,0.19718309859154928,1.0,1.0,7/28,14.84%,ACOT2;ACOT1;ACOT6;GLYAT;ACSM6;ACSM5;ACSM3
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.6454277902691721,1.2123313670547773,0.1875,0.6380589766100114,1.0,3/9,13.63%,PARD3;NF1;SIRT2
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),-0.5959181394108791,-1.2122984114422266,0.19402985074626866,1.0,1.0,8/22,19.70%,MT1H;MT1G;MT2A;MT3;MT1A;MT1E;MT1F;GLRA1
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.7401595632670719,1.2122947094667447,0.34285714285714286,0.6377629024967427,1.0,6/7,24.84%,ASCL1;NRP2;NRP1;FZD3;CTNNB1;UNC5C
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),-0.7796229880212151,-1.2119057418912602,0.14285714285714285,1.0,1.0,1/6,2.68%,SLC51B
prerank,GO_Biological_Process_2021__fructose catabolic process (GO:0006001),-0.8000105046265943,-1.2117075597400457,0.1864406779661017,1.0,1.0,2/5,9.14%,ALDOB;GLYCTK
prerank,GO_Biological_Process_2021__fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),-0.8000105046265943,-1.2117075597400457,0.1864406779661017,1.0,1.0,2/5,9.14%,ALDOB;GLYCTK
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.5658046913501436,1.2110906134677204,0.15384615384615385,0.6411036475157356,1.0,6/17,23.78%,RGPD3;KPNA4;CBLB;IPO5;RANBP2;NUP54
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),0.757325087271888,1.2110413926330093,0.23076923076923078,0.6408220708099697,1.0,4/5,17.86%,HMGB1;GLI3;CBFB;RUNX1
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,-0.5287838531951401,-1.2110349000177072,0.17567567567567569,1.0,1.0,17/59,20.59%,GC;HSD11B1;PDZK1;BHMT;AQP1;GLYAT;ALDOB;ADH6;SORD;APOE;GSTZ1;ABCC6P1;SOD3;CYP3A4;C3P1;F11;SLC22A1
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),0.5868415471318305,1.2107607313317277,0.2962962962962963,0.6409719465718027,1.0,7/17,18.59%,HNRNPU;AKT1;MORC3;TAPT1;TAF8;ARL2BP;TAF3
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),0.4402631111173906,1.2104129271874462,0.17391304347826086,0.6413699931279815,1.0,10/43,13.63%,ACE2;PID1;BCO2;SNCA;PLIN5;PRKN;BST1;TGFBR2;PIKFYVE;SIRT2
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.47641859060107894,-1.2098938258827334,0.18518518518518517,1.0,1.0,14/111,11.73%,GBP2;PSMB6;GBP3;GBP1;IL1R1;RPS27A;PSMB9;PSMA8;PSMA7;PSME1;PSMC3;UBC;SFRP1;HYAL1
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,0.5302358532692979,1.2097256740079296,0.21739130434782608,0.6424954585904348,1.0,8/33,18.56%,SLIT1;NRP2;ETS2;AMOT;NF1;OPHN1;NRP1;CDK5R1
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.49053469404395933,1.2091645239627773,0.24242424242424243,0.6437347450214098,1.0,7/27,16.76%,ATP2B3;MAIP1;MCU;CACNA2D1;ADRA1A;JPH1;CACNB3
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),0.6913883559823617,1.2088590361898797,0.2682926829268293,0.6438816367753764,1.0,1/8,5.12%,ADO
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),0.3904650515400394,1.2088433480495822,0.07692307692307693,0.6433515534540666,1.0,17/72,15.65%,PRODH;GLS;CARNMT1;KYAT1;QDPR;ACAD8;CARNS1;KYNU;ALDH4A1;DDO;AUH;ALDH7A1;BCKDHB;FTCD;AMDHD1;BLMH;DDAH1
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),0.6347075411533923,1.2082192514069003,0.2608695652173913,0.6447518754139367,1.0,7/12,30.74%,UBE2N;POT1;ATRX;TERF2IP;DAXX;H3-3A;TERF2
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.48966128851777624,1.2080522331540748,0.12903225806451613,0.6448151440941607,1.0,7/23,17.00%,MOSMO;BTRC;GLI3;GPR161;HERC4;VCP;SUFU
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.5385150655177804,1.2079975406330303,0.22857142857142856,0.6444337890548971,1.0,10/21,18.57%,CHRNA4;GRIN1;MPP2;AKT1;NLGN3;RAB3GAP1;GSK3B;INSYN1;DRD2;GRIN2B
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),0.5376090915828411,1.2070168530663437,0.18181818181818182,0.6467179223085305,1.0,6/18,24.41%,SLC6A13;SFXN1;SLC47A1;SLC6A6;SLC6A1;SH3BP4
prerank,GO_Biological_Process_2021__medium-chain fatty acid catabolic process (GO:0051793),0.6815232170831662,1.206939463674547,0.24324324324324326,0.646401346532964,1.0,3/5,29.72%,ACADM;ABHD2;ABHD3
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),0.7256629401408994,1.2065930167238519,0.3023255813953488,0.6467586018441532,1.0,2/5,17.07%,NTRK2;WASF1
prerank,MSigDB_Hallmark_2020__Spermatogenesis,-0.49983082456205796,-1.206587596788277,0.10126582278481013,1.0,1.0,19/85,18.36%,LDHC;GAPDHS;CFTR;ZC2HC1C;NEFH;KIF2C;MEP1B;RPL39L;GAD1;CCNB2;TEKT2;CDKN3;PARP2;ART3;PCSK1N;GSTM3;NOS1;SCG3;CCT6B
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),-0.5811726773359874,-1.2064888206953812,0.2463768115942029,1.0,1.0,9/21,20.98%,MT1H;MT1G;MT2A;SLC39A7;MT3;MT1A;MT1E;MT1F;SLC39A6
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.604712660886183,-1.2062501689094756,0.19402985074626866,1.0,1.0,1/22,0.19%,PIF1
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),0.6966372692812574,1.2058243813070622,0.2608695652173913,0.6487888705605411,1.0,3/8,5.67%,USP13;MITF;LRMDA
prerank,GO_Biological_Process_2021__positive regulation of receptor binding (GO:1900122),-0.7622834399938209,-1.2056621923637139,0.27419354838709675,1.0,1.0,2/5,7.15%,B2M;BDNF
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.7225158049001417,1.2056253709958296,0.24390243902439024,0.6488156269509061,1.0,3/6,21.06%,ROCK1;PHACTR1;NLGN1
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.5706818440700624,1.2049444235054256,0.2,0.650218288283225,1.0,9/13,21.53%,KBTBD7;ARHGAP24;KBTBD6;AUTS2;OGT;ALS2;ARHGAP17;ARF6;ARHGAP44
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),0.5459883137450584,1.2048744519038046,0.21428571428571427,0.649867365322775,1.0,4/18,13.60%,ZNF93;PIWIL4;APOBEC3F;ZNF91
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),0.6983364409450961,1.2047526976879033,0.27906976744186046,0.649549738253381,1.0,5/6,27.87%,INTS13;PLK1;TOR1AIP2;NUP54;NUTF2
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),0.6434196140317794,1.2042656109946268,0.2894736842105263,0.650311023130303,1.0,6/8,28.70%,CNTNAP2;CNTN2;KCNIP2;PICK1;SPTBN4;NRCAM
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.578858845177199,-1.2042333208678029,0.1917808219178082,1.0,1.0,13/30,18.76%,ISG15;IL1R1;HLA-A;RASGRP1;BTN3A1;IL12A;CD14;TLR3;SLC11A1;IL18;PTPN22;ZFPM1;ZP3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),0.7666794565523585,1.2041493729349324,0.2777777777777778,0.65009150899287,1.0,3/5,19.39%,FOXO1;ATP2B4;MLIP
prerank,PanglaoDB_Augmented_2021__B Cells,-0.5075580143806647,-1.2041185579360298,0.1411764705882353,1.0,1.0,16/71,15.34%,P2RY10;CD24;IGHG1;TAGAP;IFIT3;CD5;GMFG;ARHGAP9;RHOH;TRAF3IP3;CD14;TMC8;RCSD1;SP140;CXCR4;ARHGAP30
prerank,GO_Biological_Process_2021__regulation of aldosterone biosynthetic process (GO:0032347),0.6821045069406042,1.2038328698211136,0.3170731707317073,0.6503943358998926,1.0,2/5,19.82%,BMP2;REST
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.5398243953360171,1.2036602612822749,0.16129032258064516,0.6503869936074271,1.0,6/21,5.43%,SOX8;SOX4;CDH2;SOX9;NFIB;MYRF
prerank,GO_Biological_Process_2021__regulation of response to wounding (GO:1903034),-0.7520678966304736,-1.2035540924451544,0.2692307692307692,1.0,1.0,4/5,24.30%,VIL1;ALOX5;TNFRSF12A;CADM4
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),-0.6688810173059105,-1.2032803938785357,0.203125,1.0,1.0,4/8,17.83%,SIGIRR;GSTP1;OAS3;KLF4
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),0.7461253191561221,1.2031991848990509,0.2926829268292683,0.6511124582469902,1.0,1/6,3.71%,SERPINB9
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),0.5114171658803396,1.202951032370378,0.1875,0.6513323170775801,1.0,5/18,19.69%,PLEK;TESK1;SIRT1;BMP7;ROCK1
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.6084563421070615,-1.2023931206599936,0.22058823529411764,1.0,1.0,3/21,10.62%,RPS27A;RPA3;UBC
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.6551748482069722,1.2020431733011048,0.23076923076923078,0.6535351737037967,1.0,2/9,11.99%,MAOA;SMS
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.41324630268715284,1.2020360860757624,0.07142857142857142,0.6529891961150717,1.0,26/90,16.52%,HDAC9;NUP42;KAT2B;NUP37;NUP188;RANGAP1;LOXL2;LOXL1;TRPM4;PLOD2;ZNF451;EP300;PIAS1;NUP153;HDAC4;NSMCE2;SIRT1;SIRT2;STX1A;NDC1;PLOD1;TRIM28;PIAS4;VCPKMT;NUP205;ATPSCKMT
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.5781474755425058,-1.2018726816864005,0.2222222222222222,1.0,1.0,7/20,24.26%,GAPDHS;ALDOB;HK2;GPI;PGAM1;ENO1;GAPDH
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.5781474755425058,-1.2018726816864005,0.2222222222222222,1.0,1.0,7/20,24.26%,GAPDHS;ALDOB;HK2;GPI;PGAM1;ENO1;GAPDH
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.5750576378375511,1.201864841581573,0.2,0.6527362691708211,1.0,5/18,17.32%,ANK2;CASQ1;GSTM2;CAMK2D;PDE4D
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.6010152064652289,-1.201407308115187,0.25806451612903225,1.0,1.0,3/16,11.26%,FTH1;GSTP1;SFRP1
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),0.5360430997812565,1.2012920357072472,0.14285714285714285,0.653732428250642,1.0,4/15,13.08%,VEZF1;RAB23;ZNF148;KLRG1
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),-0.7422746494259744,-1.2011377668340477,0.21153846153846154,1.0,1.0,1/6,6.50%,SIGIRR
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),0.4113900945298599,1.2009757709036262,0.047619047619047616,0.6539653905979952,1.0,18/52,19.76%,EGLN3;RORA;RGCC;CPEB4;HP1BP3;SIRT1;HIPK2;SIRT2;UBQLN1;MDM4;BMP7;NDNF;HIF1A;MDM2;CPEB1;FMN2;AK4;CPEB2
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),0.6899951489361345,1.2006787230221905,0.16129032258064516,0.6541817755856754,1.0,3/8,10.03%,CNOT9;CNOT2;STRN3
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),0.670927174803647,1.2005586190447062,0.2,0.6540257538277315,1.0,1/6,2.58%,SOX8
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.5196421984058303,1.2004301885454565,0.24324324324324326,0.6538376664629474,1.0,3/15,12.52%,CPEB3;TNRC6B;TENT4B
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),-0.7876450182793209,-1.200369805966255,0.26229508196721313,1.0,1.0,1/5,15.24%,SLU7
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),0.622176572378026,1.2003552904646826,0.23333333333333334,0.6534884008024869,1.0,5/11,20.53%,IL17D;CBFB;RUNX1;PRKCB;CREBBP
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),0.4550428872115966,1.200247384529992,0.11538461538461539,0.65320425752245,1.0,11/33,27.97%,ANK2;STIM2;CAMK2A;DLG1;DRD2;WNK3;ORAI1;ATP2B1;CACNB2;SCN3B;MYLK
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),0.409968650611857,1.2002152124240821,0.1875,0.6527432402453685,1.0,23/74,19.83%,PID1;PPP1R15B;GIT1;HNRNPU;TESK1;PTPN13;MEN1;PRKN;SLIT2;PLPP3;OCLN;HDAC4;CRKL;SIRT1;BMP7;IMPACT;PTEN;CIB1;NTRK3;FKBP8;FBLN1;ROCK1;NIBAN1
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),0.7054123077192498,1.2001290853312303,0.20512820512820512,0.6524118583524898,1.0,1/6,0.76%,LEPR
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.6461457761700206,1.1999634814736688,0.2222222222222222,0.652338554698141,1.0,5/8,20.10%,DCUN1D1;DCUN1D5;DCUN1D4;DCUN1D2;UBA3
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.5363106244020489,1.1998532910598891,0.3142857142857143,0.6520402202973036,1.0,7/17,27.63%,PPP1R1B;PPP4R4;GSK3B;ROCK2;ROCK1;STYXL1;IKBKB
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),0.6162862386970356,1.1994518257726272,0.25,0.6527065187271642,1.0,3/10,24.18%,PDS5A;WAPL;GMNN
prerank,GO_Biological_Process_2021__positive regulation of protein localization to synapse (GO:1902474),0.7154479798256401,1.1991698452879687,0.375,0.6531148251295947,1.0,2/5,11.19%,WNT7A;DVL1
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.6099351296656916,-1.199056746280269,0.21428571428571427,1.0,1.0,6/16,21.54%,ENPP2;PDXDC1;SPHK1;ASAH2;SGPL1;ASAH1
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),0.6852538074672707,1.1988131434080374,0.3142857142857143,0.6534101604076757,1.0,1/6,2.50%,XPO1
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.5992377758095694,1.1987798493643937,0.10714285714285714,0.6529676630830481,1.0,1/14,1.01%,ACACB
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),0.4025994021397205,1.1987302961805057,0.18181818181818182,0.6525899589476616,1.0,18/58,19.09%,BRINP3;PTPRK;BMP2;CHMP1A;MEN1;RPS6KA2;CAMK2N1;TP53BP2;PLK1;HECA;ANGEL2;SCRIB;LATS1;BMP7;TRIM35;PTEN;BRINP1;IPO5
prerank,GO_Biological_Process_2021__positive regulation of macrophage proliferation (GO:0120041),0.6877154114782774,1.1986142290979298,0.34210526315789475,0.6525169310340413,1.0,3/5,14.50%,CSF1R;PTK2;MAPK1
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.4759841593395622,1.1985658110605886,0.16666666666666666,0.652156208497826,1.0,11/25,24.93%,RNF6;DCC;KIAA0319;RUFY3;LRP4;PTEN;ARHGDIA;MCF2;FGF13;PTPRS;TRIM46
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),0.5873684860195831,1.1983379048343528,0.21621621621621623,0.6522274461262999,1.0,5/9,29.63%,DHX9;AGO3;DICER1;AGO2;AGO1
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.5123126737289156,1.198224152574284,0.16216216216216217,0.6520271880996937,1.0,8/22,15.61%,ARAP1;CNOT9;CBL;AKT1;FBXW7;HIP1;SHKBP1;NEU3
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.4086206839694413,1.1981930199354296,0.15384615384615385,0.6515561025779463,1.0,21/81,20.95%,CDC25A;PTPRK;ZBTB1;EGFR;RHBDD1;SDE2;MEN1;AKT1;EIF2AK4;EP300;MAP3K4;MAP4K3;PRIMPOL;USP47;MAPK8;MSH2;KDM1A;YY1;N4BP1;CREBBP;FMR1
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.5076886405954536,1.1980390359871351,0.1875,0.6514523468179269,1.0,15/29,21.77%,EPHA4;SRCIN1;CAMK2B;PPFIA2;CAPRIN2;LRP8;SHANK3;CAPRIN1;PDLIM5;TANC2;PTEN;CDK5R1;NLGN1;ARHGAP44;ABI2
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.7182995419002196,1.1979340614171177,0.3611111111111111,0.6511735944850359,1.0,3/6,16.02%,PIK3R1;PTK2;PXN
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),0.36694306668305077,1.1978862869074445,0.0625,0.6507520975909457,1.0,42/135,18.38%,ANKRD2;LIMD1;ZFPM2;FOXO1;SOX8;ABCA1;RANBP3L;EGFR;ASCL1;RORA;SPRED2;SOX9;HNRNPU;MEN1;TRPM4;SPRED1;ANKRD26;SMAD7;EIF2AK4;GDF10;MEIS2;RUNX1T1;ZBTB16;ANP32B;CNTN4;SIRT1;TGFBR1;SIRT2;DTX1;ADIPOR1;YAP1;PTPN11;SEMA4D;BMP7;TRIB2;SUFU;TRIO;YTHDF2;RORB;PTBP1;PTEN;ESRRB
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),0.5245792988929135,1.197446768779349,0.23529411764705882,0.6516031450431993,1.0,6/17,20.26%,SYT3;NEDD4L;RASAL1;SMURF1;RIMS2;UNC13A
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),0.5158210104246488,1.197434832304404,0.22857142857142856,0.6511184451312498,1.0,6/21,24.00%,AP2B1;PIK3R4;SMURF1;SNX25;SH3GLB1;KIF16B
prerank,GO_Biological_Process_2021__negative regulation of lipase activity (GO:0060192),0.6755933573557109,1.1971555916133396,0.375,0.6514440204011088,1.0,3/7,5.39%,HDAC9;SORT1;PLIN5
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.7039509093557801,1.1971314531922268,0.3142857142857143,0.6509761002679021,1.0,3/6,14.98%,ALCAM;SLIT2;NRP1
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.5646587442799472,1.1969116046886485,0.2564102564102564,0.6510160263751049,1.0,2/14,6.38%,TAFA5;PRKG1
prerank,GO_Biological_Process_2021__cellular response to iron ion (GO:0071281),-0.778130378592211,-1.1967907830630067,0.20754716981132076,1.0,1.0,1/5,4.87%,B2M
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.4770404645335399,1.1963209197975966,0.21739130434782608,0.6522275632184167,1.0,6/34,8.15%,PPARGC1A;FOXO1;SOX4;ZBTB20;PIK3R1;NR1D1
prerank,GO_Biological_Process_2021__heparin metabolic process (GO:0030202),0.7232816291620746,1.1962667847707784,0.3333333333333333,0.6518550711757034,1.0,2/5,9.02%,CSGALNACT1;SLC10A7
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),-0.7384202719375846,-1.1959522813844696,0.23943661971830985,1.0,1.0,1/5,5.94%,TIMP1
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.5381260126694777,-1.1958882532232102,0.2125,1.0,1.0,11/47,22.89%,LIPI;ACMSD;HSD17B8;ACSM6;ACSM5;ACSM3;XBP1;OXSM;SDS;ALOX5;PARK7
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.36898705488612804,1.1958404492712686,0.0,0.6527319939635621,1.0,22/129,9.82%,PDK4;PID1;TNFSF4;BRINP3;NRIP1;ADCY1;LCOR;EGFR;RORA;GIT1;SOX9;ADNP2;NFKB1;CCDC62;SERPINE1;ABL2;NR1D1;IRS1;NCOA3;NR3C1;TICAM1;HMGB1
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),0.6158351394359403,1.1957706629100018,0.26666666666666666,0.6523912870726646,1.0,2/12,9.82%,PIP4P2;HMGB1
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),0.5705121823551109,1.195704299765728,0.27586206896551724,0.6520037871306018,1.0,2/24,2.04%,SLC26A7;SLC6A13
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.6399563412279411,1.1956136417659469,0.24390243902439024,0.6517430697303584,1.0,1/9,3.10%,ABCA1
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.3990404591887664,1.195457234575583,0.0,0.6517663913509443,1.0,45/153,20.93%,LPIN3;DGKB;PLD6;PIP5K1B;PTPN13;ABHD5;CSNK2A1;PLEKHA2;PIK3CA;SLC44A5;PIK3R1;DGKH;PIK3R4;PIP5K1C;DGKZ;PIK3C3;PLEKHA8;PIP4K2C;ACP6;GPAM;PIKFYVE;ETNK1;DGKG;SYNJ1;CPNE3;MTMR2;PITPNM3;SLC44A1;RAB4A;PI4KB;CSNK2A2;PLEKHA3;PTEN;AGK;MTM1;CPNE1;MTMR12;FAR1;DGKE;PITPNM1;PLEKHA1;PCYT1B;PTDSS2;CEPT1;SACM1L
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),-0.6900352147675497,-1.1954052657126777,0.22950819672131148,1.0,1.0,1/10,0.13%,CD24
prerank,GO_Biological_Process_2021__regulation of dopamine uptake involved in synaptic transmission (GO:0051584),0.8013169980729417,1.1953741477723059,0.2647058823529412,0.6514905446764562,1.0,2/5,18.01%,SNCA;DRD2
prerank,GO_Biological_Process_2021__negative regulation of lens fiber cell differentiation (GO:1902747),0.7293466388035417,1.1951925069035274,0.2549019607843137,0.6514825709194272,1.0,2/5,7.99%,SPRED2;SPRED1
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.5063728006831177,-1.195113976989046,0.16455696202531644,1.0,1.0,15/60,16.56%,GATA1;CLEC12A;AQP1;CEACAM1;THBS1;DPEP2;GMFG;VAMP5;NR1I3;RSAD2;TSPAN32;RHD;CA1;BPGM;MYO1F
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),0.7568292624801347,1.1949143866756375,0.2631578947368421,0.6516632291420124,1.0,3/6,21.97%,ERC2;PCLO;ERC1
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),0.7071782366127077,1.1949080723498717,0.25,0.6506113110965853,1.0,3/6,13.63%,PARD3;NF1;SIRT2
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),0.7071782366127077,1.1949080723498717,0.25,0.6506113110965853,1.0,3/6,13.63%,PARD3;NF1;SIRT2
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),0.5649548321079588,1.1944434402188109,0.2903225806451613,0.6515762463343108,1.0,5/15,21.58%,RPS6KB2;UHMK1;RPS6KB1;YTHDF2;YTHDF3
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.6187434541790143,1.1943886306860751,0.225,0.6511138754163054,1.0,3/13,15.29%,PPP1R15B;NCK1;BFAR
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.40975838467554876,1.1942606158070646,0.0625,0.6508087988497974,1.0,11/67,12.73%,RANBP17;RGPD3;NUP188;PPP1R10;SPRN;AKT1;IPO8;NXT2;KPNA4;NUP153;CBLB
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),0.6531344500755303,1.1941110508091828,0.2777777777777778,0.6508796303892187,1.0,4/8,17.69%,LEPR;SIRT1;MKKS;BBS2
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.5353475385128501,1.1940342276622555,0.23529411764705882,0.650497083546825,1.0,7/17,15.98%,MTCL1;PARD3;CRB1;DLG3;DLG1;SCRIB;PARD3B
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),0.6891771114297826,1.1938672608490102,0.2857142857142857,0.6505211999050471,1.0,4/6,22.29%,SPRED2;SPRED1;SPRED3;FGF2
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated immunity (GO:0002716),-0.7357095019683055,-1.1938357105769137,0.29310344827586204,1.0,1.0,4/5,25.39%,KLRD1;MICA;HLA-F;HLA-E
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.5731486969044541,1.1932395056190335,0.16216216216216217,0.651512770350084,1.0,4/15,9.25%,SHANK1;CPEB3;KAT2A;EIF2AK4
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.5126739091952819,-1.1925843650738972,0.2,1.0,1.0,14/57,13.04%,P2RY10;DOCK8;TAGAP;P2RY14;GPR18;DPEP2;GMFG;ARHGAP9;RHOH;TRAF3IP3;TMC8;RCSD1;STAG3;SP140
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),0.5085638765394694,1.1925570133748526,0.28,0.6530172933533395,1.0,10/29,22.40%,NAF1;CCT4;MAP3K4;MAPKAPK5;MAPK1;CCT3;POT1;HMBOX1;CTNNB1;TNKS2
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.5072222789610613,1.1923050139152982,0.23076923076923078,0.6531483903453961,1.0,10/31,22.40%,NAF1;CCT4;MAP3K4;MAPKAPK5;MAPK1;CCT3;POT1;HMBOX1;CTNNB1;TNKS2
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.7238233288260697,1.1922661408213964,0.28888888888888886,0.6527811256955789,1.0,4/5,27.63%,ROCK2;PPP1R12A;ROCK1;IKBKB
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),0.7424525979711419,1.1921111257584818,0.34285714285714286,0.6520017307964897,1.0,3/6,17.43%,DPH5;DPH1;DPH3
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),0.7424525979711419,1.1921111257584818,0.34285714285714286,0.6520017307964897,1.0,3/6,17.43%,DPH5;DPH1;DPH3
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),-0.8002949687388511,-1.192100780636779,0.2459016393442623,1.0,1.0,1/5,3.46%,RAB7B
prerank,GO_Biological_Process_2021__positive regulation of cholesterol storage (GO:0010886),-0.7095007761389555,-1.191885680112735,0.2631578947368421,1.0,1.0,3/5,26.86%,MSR1;EHD1;SREBF2
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),0.5050189090032922,1.191853905778634,0.20833333333333334,0.6521642799795474,1.0,8/21,20.59%,SOX9;ANKH;ECM1;ROCK2;S1PR1;ROCK1;DDR2;SGMS2
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.7100217669370368,1.1918369951350318,0.23076923076923078,0.6516593152583127,1.0,2/5,20.00%,IMMP2L;MIPEP
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),-0.4968695970355136,-1.1909856046408724,0.21518987341772153,1.0,1.0,13/71,16.52%,FTH1;CP;MT1H;FTL;MT1G;ABCG2;MT2A;SLC39A7;MT3;SLC11A1;MT1A;NUBP1;MT1E
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.379948749384694,1.1908206947910278,0.0,0.6537755297806784,1.0,46/138,22.29%,PPARGC1A;SNCA;PASK;SOX4;DNA2;EGFR;CPEB3;ZCCHC4;PRMT1;RGCC;ZEB2;PLIN5;AKT1;NR1D1;IRS1;STN1;RPS6KB1;IGF1;PKD2;STARD4;HGF;ELOVL5;SIRT1;MLXIPL;DHX9;KAT7;DYRK2;FAF1;DDAH1;FXR1;ARPP19;HIF1A;EIF3E;AKT2;HNRNPD;LARP4;NPM2;NIBAN1;ARNT;SLC6A9;ABCB10;FMR1;YTHDF3;IRS2;LARP4B;FGF2
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),0.578506808222542,1.190521286447879,0.2631578947368421,0.654199654888913,1.0,3/11,20.70%,OSBPL8;PLAAT3;OSBPL5
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),-0.7490623163778964,-1.1905093583754915,0.22033898305084745,1.0,1.0,4/5,25.07%,CAV2;CAV3;EMP2;FLOT1
prerank,GO_Biological_Process_2021__regulation of extracellular exosome assembly (GO:1903551),0.7653626403226712,1.190313148663867,0.2765957446808511,0.6542825340543063,1.0,1/5,2.32%,SDC4
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),-0.6772039702760477,-1.1903087966724546,0.3188405797101449,1.0,1.0,5/12,24.49%,CLU;USP19;AQP11;ALOX5;NUPR1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.4053193027682382,1.1898536958949157,0.10714285714285714,0.6548138581565082,1.0,17/57,18.75%,EGFR;RGCC;AKT1;PSMD10;RPS6KB1;PKD2;MEIS2;EIF4E;ANKRD17;TGM1;CCPG1;USP22;USP2;SRPK2;MDM2;TTL;CCND3
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),0.5441641325843797,1.1898137435098717,0.30303030303030304,0.6544015294854033,1.0,4/18,15.06%,NAF1;CCT4;DKC1;CCT3
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.605017503707844,1.1898011053851743,0.2857142857142857,0.6539280814499241,1.0,8/12,17.45%,ERBB4;CSF1R;EPHA2;AKT1;SCRIB;LATS1;AKT2;ZNF703
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),0.7431327272327666,1.1894943288983402,0.3023255813953488,0.6543349711125376,1.0,3/7,15.83%,NFIB;NRP1;SMO
prerank,GO_Biological_Process_2021__lung development (GO:0030324),-0.5878163751520399,-1.1892682110769708,0.2714285714285714,1.0,1.0,5/23,12.90%,CCDC39;DNAAF1;PDPN;FGF7;FGF1
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),0.6100745590747823,1.1890088476742686,0.27586206896551724,0.654879987324815,1.0,2/13,3.24%,PLD6;PIWIL4
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.5922138397087569,1.188801325451334,0.17142857142857143,0.6552238503453607,1.0,10/13,26.56%,PPP1R15B;PPP2R2B;NCK1;PPP2R2C;PPTC7;PPP2R2A;PPM1F;PPP3CA;PPP2CB;PPP2R2D
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.697023264804147,-1.1887829952262403,0.29411764705882354,1.0,1.0,1/7,2.67%,ARG2
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.4239581470231484,1.1887032868961664,0.17391304347826086,0.654920592173918,1.0,13/43,15.78%,CASS4;EFNA5;RCC2;CSPG5;KANK1;SPRY4;TESK1;CARMIL1;PTK2;CRKL;RREB1;NRP1;ARHGEF7
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.5560074677348765,1.188513190464534,0.2692307692307692,0.6549716114190954,1.0,5/14,26.79%,GPAM;SERAC1;LPCAT1;SLC27A1;CDS2
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.3743070323348687,1.188422662440052,0.0,0.6546844024488714,1.0,37/112,23.98%,AIFM2;NUP42;NUP37;NUP188;HSPH1;CHORDC1;CAMK2B;CAMK2A;NPAS2;PRKN;NEK4;MAPKAPK2;EP300;SMG1;CAMK2D;NUP153;SIRT1;RPTOR;NDC1;MAPK1;GSK3B;DNAJB6;ROCK2;PTGES3;NUP205;NUP214;BAG2;CREBBP;DYRK3;BAG3;RANBP2;HSPA1A;VASH1;NUP98;NUP54;AMFR;FKBP4
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),-0.7479186000443471,-1.188059073282961,0.28,1.0,1.0,1/6,6.67%,THBS1
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.5856409523172321,1.1877619485174036,0.2727272727272727,0.6559027510431291,1.0,5/9,23.18%,DNAJB2;SACS;DNAJB6;HSPA1A;DNAJA4
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.42233326332139054,1.1873488843637634,0.23809523809523808,0.6558955806520907,1.0,14/50,23.78%,NUP42;NUP37;NUP188;PUM2;IPO8;NUP153;NDC1;NUP205;PUM1;NUP214;FMR1;RANBP2;NUP98;NUP54
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.42233326332139054,1.1873488843637634,0.23809523809523808,0.6558955806520907,1.0,14/50,23.78%,NUP42;NUP37;NUP188;PUM2;IPO8;NUP153;NDC1;NUP205;PUM1;NUP214;FMR1;RANBP2;NUP98;NUP54
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.709703654339427,-1.1872487786272372,0.30303030303030304,1.0,1.0,4/11,14.55%,LRPAP1;SRF;APOE;CLU
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),0.6969355817385875,1.1869300030923773,0.2558139534883721,0.6565585063481674,1.0,2/5,19.00%,CDH13;NTRK3
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),-0.6231258350597,-1.186624992709902,0.2753623188405797,1.0,1.0,3/15,21.40%,SHFL;OGFOD1;CLN3
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),-0.7091602079174337,-1.1863019127446988,0.27419354838709675,1.0,1.0,2/9,1.98%,KMO;ACMSD
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.40578244528755963,1.1860018678371664,0.09090909090909091,0.6589044693817006,1.0,31/144,12.82%,POU6F2;CHRNA4;KCTD8;PCDH8;GALNT14;RBPMS2;SNAP91;ATP2B3;CAMKV;PSD2;ADGRB3;RBFOX1;CACNA1B;SLC35F1;KIF5A;GPHN;VSTM2B;FBLL1;ADGRA1;KCNQ2;ASTN1;CDK5R2;OLFM3;MAPK4;GRIP1;CELF3;SLITRK1;TMEM196;CA10;ERC2;LY6H
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),0.5371414137740795,1.185615682227116,0.3125,0.6594110067356486,1.0,2/17,1.16%,LPIN3;AGMO
prerank,GO_Biological_Process_2021__parallel actin filament bundle assembly (GO:0030046),0.7268764919791859,1.1855758206511378,0.2619047619047619,0.6590148879207456,1.0,2/5,8.12%,SPIRE2;SPIRE1
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),0.6322906652520024,1.1854585079955917,0.25,0.6586957601969594,1.0,3/10,24.64%,MTMR2;FYN;PICK1
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.6341343125358603,1.1853543370944997,0.3076923076923077,0.6584534422665873,1.0,5/11,22.09%,ADCY1;EPHA2;PDE4D;ADCY9;ADCY6
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.39951535771144536,1.1853360699538862,0.14285714285714285,0.6580437567353246,1.0,15/75,18.30%,KAT2B;EED;TFAP2C;AEBP2;PHF2;TASOR;KAT2A;TAF1B;EP300;HDAC4;RBBP4;JARID2;KDM1B;PPHLN1;PPM1D
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),0.6233998284460467,1.185190180598526,0.28125,0.6579242323108314,1.0,3/9,6.18%,CSF1R;PDE1B;PIR
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.466661512101664,1.1849591875076844,0.15789473684210525,0.6580028318835112,1.0,6/27,19.86%,ACACB;SPX;RPS6KB1;ABCD3;CPT1A;ACSL3
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.5422643537603759,-1.1848862135900222,0.2235294117647059,1.0,1.0,4/38,6.67%,IFI6;DHCR24;AQP1;THBS1
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),-0.7314565875066192,-1.1848741995301086,0.25,1.0,1.0,4/6,25.74%,TIMP1;SVBP;TIMP2;DDRGK1
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.6338652394962175,-1.184818407436387,0.2909090909090909,1.0,1.0,4/12,15.85%,STAT1;IFNGR2;CDC37;SOCS3
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),0.6580300778578563,1.1843365007427111,0.2894736842105263,0.6591462880288993,1.0,2/13,6.79%,PLIN5;ABHD5
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.47671451400768045,1.1843291312282542,0.23333333333333334,0.6586461294645862,1.0,12/31,28.70%,SLC19A1;SLC6A13;SLC47A1;SLC6A6;SLC29A1;LRSAM1;LRRC8A;SLC12A6;GLUL;SLC27A1;SLC22A2;LRRC8D
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),0.512577877236645,1.1843160964582853,0.25806451612903225,0.6582075132863809,1.0,7/20,20.21%,SYT3;DOC2B;RIMS3;SYT9;PPP3CB;ARHGAP17;RIMS2
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.5570025450844244,1.1843085452373523,0.3142857142857143,0.6577240468189792,1.0,4/15,15.06%,NAF1;CCT4;DKC1;CCT3
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),0.7662382576548268,1.1842642245388644,0.25,0.65730200068701,1.0,5/6,22.17%,ASCL1;NRP2;NRP1;FZD3;CTNNB1
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),0.3984762193439416,1.1841790599667812,0.058823529411764705,0.6570473141959292,1.0,16/72,16.53%,ABCC8;EFNA5;SOX4;HADH;MCU;RFX3;EPHA5;NR1D1;IRS1;DOC2B;CLOCK;PRKN;RAP1A;STX1A;PPP3CB;KCNC2
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),0.6188444143298096,1.183889441145766,0.32558139534883723,0.6573684546326777,1.0,3/10,5.80%,BMP2;NFKB1;PLEK
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.6160309128162053,-1.1838018677150743,0.3125,1.0,1.0,4/14,15.43%,ATP5ME;ATP5F1E;ATP5PD;ATP5MC3
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.5904768249792072,1.1837230712469489,0.2972972972972973,0.6573713418004817,1.0,8/15,23.67%,USP13;BOK;PIK3R1;NCK1;RNF185;RNFT1;BAG6;ERN1
prerank,GO_Biological_Process_2021__icosanoid secretion (GO:0032309),-0.7787333424017584,-1.183631701787557,0.25806451612903225,1.0,1.0,1/6,4.79%,ANXA1
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),0.6821649197601658,1.1831557060542714,0.2631578947368421,0.6582057887355062,1.0,4/9,25.74%,OTUB2;VCPIP1;OTUD7A;USP30
prerank,GO_Biological_Process_2021__C-terminal protein lipidation (GO:0006501),0.6805868471924963,1.1831529486815107,0.2682926829268293,0.6576943623262322,1.0,2/5,18.46%,ATG7;ATG5
prerank,GO_Biological_Process_2021__cilium movement involved in cell motility (GO:0060294),-0.7622344991375412,-1.1828936253828763,0.3125,1.0,1.0,3/7,21.91%,TEKT1;TEKT2;TEKT3
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),0.5190967906683244,1.1826754865775762,0.2413793103448276,0.658542358616751,1.0,13/24,26.01%,PIK3CA;TTBK2;TRIM54;NAV3;CAMSAP2;CLASP1;HDGFL3;KATNB1;CIB1;ATXN7;FGF13;TAOK1;CLASP2
prerank,GO_Biological_Process_2021__regulation of growth hormone secretion (GO:0060123),0.7339587354717636,1.1825474440508406,0.25,0.6583180636924365,1.0,2/5,18.01%,CHD7;DRD2
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),0.6482150732872085,1.1824963851326973,0.3181818181818182,0.6579584642963368,1.0,2/8,3.13%,SNCA;STXBP6
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),0.7212262632133106,1.1823879503396337,0.2857142857142857,0.6576144827802252,1.0,4/5,27.55%,FTO;JMJD6;ALKBH5;ALKBH3
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),0.6923007669848649,1.1820864235633801,0.358974358974359,0.6576048033376026,1.0,3/5,30.24%,BEND3;KMT5B;SETD4
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),0.6923007669848649,1.1820864235633801,0.358974358974359,0.6576048033376026,1.0,3/5,30.24%,BEND3;KMT5B;SETD4
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,-0.5056104943995822,-1.1819485208970595,0.17721518987341772,1.0,1.0,16/74,12.07%,CD24;CRYBA1;OVOL2;IL1R1;KIF20B;ST6GAL1;ITGA5;CEACAM1;FMO5;PGR;TMC4;EMILIN2;F5;TRIM29;CXCL17;GPX2
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.5942001939726345,-1.1818124671620494,0.1917808219178082,1.0,1.0,5/22,17.23%,ARG2;SELENOS;GSTP1;CX3CL1;PTPN22
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),0.6211853685707717,1.1815848194440437,0.35135135135135137,0.6585841697515348,1.0,2/10,6.34%,AK3;NT5C1A
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.565418365517279,-1.1815447104553503,0.22727272727272727,1.0,1.0,7/29,15.69%,CENPE;MIS12;CENPN;CENPV;ITGB3BP;OIP5;CENPH
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),-0.7319296788549134,-1.1814626890959865,0.2545454545454545,1.0,1.0,3/6,21.09%,PLN;SLC8B1;TRDN
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.591898151042582,-1.1810832993526417,0.2,1.0,1.0,3/23,6.18%,CENPE;ANAPC15;ANAPC11
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.42045105174473635,1.1810778869548804,0.21739130434782608,0.6596070664511728,1.0,13/57,14.98%,VEGFD;BMP2;NRP2;AKT1;VEGFC;HMGB1;PRKD1;ECM1;NRAS;SIRT1;TGFBR1;CDH13;NRP1
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.6549639568939317,-1.1810336119239957,0.21739130434782608,1.0,1.0,2/12,2.63%,IFITM3;BST2
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),0.547137751329953,1.1807361937517773,0.1891891891891892,0.6599682663133233,1.0,2/14,4.85%,SOX8;SOX9
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.5780595015460767,-1.1803597239096433,0.22535211267605634,1.0,1.0,7/21,24.26%,GAPDHS;ALDOB;HK2;GPI;PGAM1;ENO1;GAPDH
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),0.5675106012313651,1.1801951367404608,0.2647058823529412,0.6609435451696475,1.0,9/16,33.01%,RAB23;GSK3B;LATS1;SUFU;CABP1;POLR1A;ILRUN;UFM1;CTNNA1
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),0.5734450358049239,1.1801839567490573,0.21951219512195122,0.6604493232429162,1.0,3/14,16.57%,ERI1;TENT4B;MTPAP
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",0.6367863461273977,1.1800079286165794,0.3333333333333333,0.66061445601352,1.0,1/12,0.91%,CHRNA4
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),0.6321460862101888,1.1799884295228633,0.2894736842105263,0.6601511606264459,1.0,3/9,19.86%,SPX;RPS6KB1;ACSL3
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),0.5348881347092007,1.179975905622681,0.21875,0.6596736324234621,1.0,8/19,26.93%,PPP1R1B;PPP4R4;GSK3B;ARPP19;PPP1R8;ENSA;STYXL1;PPP1R16B
prerank,GO_Biological_Process_2021__negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),-0.7366964842171315,-1.1795077248809949,0.3684210526315789,1.0,1.0,1/5,6.50%,SIGIRR
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.3316038454773108,1.1789556886951864,0.0,0.6620342125677585,1.0,50/215,16.53%,PDK4;PID1;TNFSF4;BRINP3;PTPRK;NRIP1;PDE3A;FOXO1;LCOR;EGFR;CPEB3;SLC26A3;RORA;GIT1;PDGFRA;SOX9;ADNP2;NFKB1;CCDC62;GUCY1B1;SERPINE1;RAPGEF2;AKT1;ABL2;NR1D1;IRS1;CPEB4;NCOA3;PKD2;TICAM1;HMGB1;PRKD1;SLIT2;SSH1;AGAP3;RAP1A;AHR;FER;RPTOR;ATP2B4;MAPK1;VCP;IP6K2;PDE2A;ROCK2;PDK2;MAPK8;PXN;IMPACT;KCNC2
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),0.5181268018647267,1.178908391755619,0.19047619047619047,0.6617350372548234,1.0,3/13,12.37%,CA2;BRAF;CLIP3
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.43233460979909993,1.1788779163706875,0.09090909090909091,0.6612723036778007,1.0,15/48,18.87%,FOXO1;NEDD4L;CSNK2A1;SEC22B;ITCH;ATG7;PRKN;SMURF1;VCP;GSK3B;NSF;HACE1;RNF41;IDE;AXIN1
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),-0.6782841960128528,-1.1788317810287539,0.3114754098360656,1.0,1.0,4/8,28.44%,CYP3A4;AKR7A2;CYP3A5;MGST1
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),-0.6782841960128528,-1.1788317810287539,0.3114754098360656,1.0,1.0,4/8,28.44%,CYP3A4;AKR7A2;CYP3A5;MGST1
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),-0.6782841960128528,-1.1788317810287539,0.3114754098360656,1.0,1.0,4/8,28.44%,CYP3A4;AKR7A2;CYP3A5;MGST1
prerank,GO_Biological_Process_2021__carbohydrate transport (GO:0008643),-0.7285449617962443,-1.1780631728972863,0.3103448275862069,1.0,1.0,2/6,16.11%,AQP1;AQP11
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.7058661957510562,1.1779421244725832,0.23529411764705882,0.6633133485106738,1.0,4/9,15.76%,IRS1;SIRT1;SNX5;PTPN11
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),0.6083194846755586,1.1774771966175384,0.2857142857142857,0.6634438164463679,1.0,2/12,7.42%,MCU;DAPK2
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),0.6083194846755586,1.1774771966175384,0.2857142857142857,0.6634438164463679,1.0,2/12,7.42%,MCU;DAPK2
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),-0.6250546485152009,-1.1773095015081718,0.29850746268656714,1.0,1.0,5/10,18.63%,SYCE2;STAG3;RAD21L1;REC8;TEX11
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),-0.6250546485152009,-1.1773095015081718,0.29850746268656714,1.0,1.0,5/10,18.63%,SYCE2;STAG3;RAD21L1;REC8;TEX11
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.3621540942667847,1.1772264980259868,0.0,0.6635609284670052,1.0,45/124,22.17%,WNT7A;PARD3;SHANK1;BTBD3;ALCAM;GPM6A;CTNNA2;TNIK;SLITRK2;WASL;EIF2AK4;DOCK7;DCC;MAP4K4;PAK3;SHANK3;DVL1;SLITRK1;CNTN4;NCKAP1;NBL1;FARP1;PLPPR4;TAOK2;TMEM106B;BMP7;IMPACT;TRIO;ADGRB1;CTNND2;APBB1;LRP4;DRD2;PTEN;CPNE1;ALS2;DNM2;ROCK1;RAB10;SDC2;NLGN1;CNTNAP2;FGFR2;EPHB3;CTNNB1
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.6155992407237377,-1.177215118359178,0.3,1.0,1.0,4/15,15.43%,ATP5ME;ATP5F1E;ATP5PD;ATP5MC3
prerank,GO_Biological_Process_2021__glycosylceramide metabolic process (GO:0006677),0.7109892346658904,1.1771961596016074,0.34210526315789475,0.6631282749092473,1.0,1/5,8.85%,GAL3ST1
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),0.7240838226361611,1.1768775638320412,0.3191489361702128,0.6630213305849122,1.0,5/5,27.61%,NRXN1;SHANK3;NRXN2;CNTNAP2;HTT
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),0.7240838226361611,1.1768775638320412,0.3191489361702128,0.6630213305849122,1.0,5/5,27.61%,NRXN1;SHANK3;NRXN2;CNTNAP2;HTT
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.5579351049462817,-1.1768240876008642,0.26153846153846155,1.0,1.0,5/23,6.81%,RPL23;RPL11;RPS7;EFNA1;RPL5
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.5058762178723542,1.1767048641199989,0.19047619047619047,0.6631680470311011,1.0,5/17,18.04%,SOX9;TRPM4;ECM1;LRP4;RBPJ
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.6101805645711899,1.1766636499884,0.21052631578947367,0.662751819200639,1.0,5/10,25.05%,ITPKB;IP6K2;IPPK;FGF2;IPMK
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),0.6632994900571632,1.1765954650572665,0.3235294117647059,0.6624546022756868,1.0,3/6,10.21%,UBE2T;RNF6;PRKN
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),-0.7170249441347633,-1.1762739630568535,0.2833333333333333,1.0,1.0,2/8,9.42%,AKR1C1;GSTP1
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.6858884714638563,1.1762073063423153,0.2653061224489796,0.6631041362460062,1.0,4/6,23.91%,WASL;ATP10A;DNM2;SH3GLB1
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.6263680622002585,1.175913418894115,0.2631578947368421,0.6633833159801932,1.0,9/11,36.72%,OPHN1;SCRIB;RAP2A;RAB10;CAMSAP3;ZDHHC7;CDC42;EZR;RHOA
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.5081486476396703,1.1756465914212515,0.21212121212121213,0.6634701466976687,1.0,8/17,26.35%,TMTC2;LARGE1;CRPPA;TMTC4;FKRP;TMTC1;DPM1;TMTC3
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),-0.6793294237297041,-1.1756432186199108,0.2647058823529412,1.0,1.0,4/10,7.42%,ANXA1;FLG;THBS1;F13A1
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),0.6672059190608763,1.1755790720304213,0.3333333333333333,0.6632470481047077,1.0,4/7,26.78%,SPX;RPS6KB1;ACSL3;SLC27A1
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.5668415448665483,1.1751903365535785,0.23076923076923078,0.6636728953079339,1.0,8/21,24.63%,DACH1;RGCC;PDGFA;HGF;POT1;HMBOX1;FGF2;TNKS
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,0.4258299842990072,1.1750096442703462,0.16666666666666666,0.6637003896552808,1.0,15/80,12.29%,CHRNA4;SEMA5B;ABCC8;EBF4;EFNA2;PNMT;HID1;PLEKHA6;KCNH2;FBLL1;GAL3ST1;TMEM74B;RNF208;CELF3;FTCD
prerank,GO_Biological_Process_2021__regulation of glucokinase activity (GO:0033131),0.7010062659282724,1.1749163873000048,0.2857142857142857,0.6633893108557998,1.0,2/5,19.47%,PRKN;DUSP12
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),0.6982331257733234,1.1747978300341528,0.25,0.6621798710921142,1.0,2/5,23.54%,NSMCE2;MACROH2A1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),0.6982331257733234,1.1747978300341528,0.25,0.6621798710921142,1.0,2/5,23.54%,NSMCE2;MACROH2A1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),0.6982331257733234,1.1747978300341528,0.25,0.6621798710921142,1.0,2/5,23.54%,NSMCE2;MACROH2A1
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),-0.6114259698443534,-1.1746459218600367,0.3013698630136986,1.0,1.0,5/19,16.43%,MEIOB;MOV10L1;SYCP3;BTBD18;BRDT
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.5636715484627592,-1.174490007885876,0.26666666666666666,1.0,1.0,6/22,21.67%,POU4F1;CASP8;FES;ID2;CD74;IL34
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),-0.5998937333538907,-1.1744833790252076,0.18461538461538463,1.0,1.0,7/24,19.91%,TRIM22;IFITM3;TRIM21;CIITA;LY6E;TRIM5;CD74
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",-0.7201203702682211,-1.174167678160071,0.203125,1.0,1.0,2/7,2.71%,IRF1;HLA-A
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.5459579834576028,-1.1739432125271319,0.2727272727272727,1.0,1.0,9/25,23.32%,AGPAT2;IL7;PARP14;CXCR4;WNT5A;CD74;C1QTNF4;PARP9;NLRC5
prerank,GO_Biological_Process_2021__positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),0.7065934630547589,1.1738463801725778,0.325,0.6641600740890503,1.0,3/5,13.63%,RCC2;HNRNPU;SIRT2
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),0.5178021122603295,1.1734951886749683,0.25,0.6645683214124278,1.0,7/19,19.26%,PICALM;RIN3;ABCA2;MTMR2;NEU3;UBQLN2;ARF6
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.5613379786315094,-1.1734086718048167,0.15942028985507245,1.0,1.0,9/27,25.07%,ISG15;IRF1;OAS3;TLR3;RIPK2;POLR3G;RIOK3;DHX58;FLOT1
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),0.4778423683372183,1.1733995394068846,0.25806451612903225,0.6644631260499123,1.0,3/28,8.76%,ATP6V0D2;ATP6V1A;ATP6V1C1
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),-0.6107087808679977,-1.1733980923882956,0.3114754098360656,1.0,1.0,3/15,12.62%,PRSS3;AMN;MMAB
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),-0.6107087808679977,-1.1733980923882956,0.3114754098360656,1.0,1.0,3/15,12.62%,PRSS3;AMN;MMAB
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),0.6883642210540757,1.173395819634457,0.2631578947368421,0.6639627773104169,1.0,1/6,3.76%,EXOSC6
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.5076584119379259,-1.1733836000566342,0.2222222222222222,1.0,1.0,18/53,16.56%,GATA1;SELP;TAGAP;SPON2;CD9;PDE6B;CLEC12A;F13A1;DPEP2;GMFG;ARHGAP9;VWF;TSPAN32;SLC11A1;SPI1;CXCR4;PLK3;MYO1F
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),0.7520993528093861,1.1730116982284573,0.29545454545454547,0.6645311833108484,1.0,3/5,23.61%,DCC;FGF13;PTPRS
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.47078351511056593,1.1729343337174853,0.19230769230769232,0.6642069657378842,1.0,8/29,11.05%,CASS4;CSF1R;EPHA4;SRCIN1;NTRK2;DLG3;LRP8;FBXW7
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.6136073059679581,1.1727728594182547,0.30303030303030304,0.6639708844089324,1.0,4/7,32.25%,SMAD7;SNX25;PMEPA1;GREM1
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",0.526261033316277,1.1727698363924801,0.225,0.6634870049794004,1.0,6/15,30.74%,NEIL2;POT1;SMUG1;TERF2IP;TDG;TERF2
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),0.462308512540261,1.1726199024846367,0.21875,0.6633830943045128,1.0,5/30,14.44%,ANK2;KCNMA1;KCNH2;GABBR1;DLG1
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),-0.7331363732116667,-1.1725228589007133,0.2807017543859649,1.0,1.0,3/6,16.89%,SLC8A3;CAV3;C12ORF57
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),0.6145953228128114,1.1724632443272072,0.2564102564102564,0.6632210381155775,1.0,3/12,8.26%,RANBP3L;RBM24;PLCB1
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),0.7172211817956586,1.1723020170942657,0.325,0.663175739969007,1.0,1/6,1.93%,FOXP1
prerank,GO_Biological_Process_2021__polyol transport (GO:0015791),-0.7929209563032823,-1.1722842382881211,0.2765957446808511,1.0,1.0,2/5,16.11%,AQP1;AQP11
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),0.583598267820434,1.1719587017446251,0.2619047619047619,0.6638290779312443,1.0,5/8,21.94%,PRKN;UBQLN1;FYN;REST;LANCL1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),0.5728596007741023,1.1719237827252926,0.3142857142857143,0.6634779977254048,1.0,4/10,18.17%,BTRC;PLK1;RAB1A;PTEN
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.40416939162318116,1.1711969545301109,0.16666666666666666,0.6647840620393435,1.0,29/106,15.87%,TCAP;ZFPM2;HDAC9;PCSK5;KAT2B;SALL1;ERBB4;SOX4;SMG9;SOX9;BMP2;FLRT2;TBX19;CHD7;KAT2A;PKD2;NF1;ACVR1;PTK2;TGFBR2;SGCD;PDLIM5;NIPBL;TGFBR1;SH3PXD2B;ZDHHC16;DNAAF4;PTPN11;BMP7
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),0.5219818134716779,1.170737769318358,0.2564102564102564,0.665550902270604,1.0,6/17,11.44%,PID1;PICALM;RHOQ;PPP2R5A;PKDCC;MRAP
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.6232135395581783,1.170565606056453,0.26666666666666666,0.6655040344423752,1.0,1/10,3.66%,EGFR
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.4297141546238481,1.1704260075436106,0.21428571428571427,0.6653122440883689,1.0,45/105,22.37%,PID1;EFNA5;WTIP;EPHA4;ADGRB3;CDH2;ARHGAP35;KIF13B;NEDD4L;EPHA2;SRCIN1;TNIK;PPFIA2;FMNL2;LRRC4C;INF2;SARM1;ZMYM3;PAK3;NF1;SHANK3;ZRANB1;PDLIM5;CLASP1;TANC2;GSK3B;STRIP1;CYRIB;PHIP;SEMA4D;RAP2A;RUFY3;CDK5R1;PDZD8;LARP4;TSPAN12;SDC2;CAPZB;ARHGAP44;ABI2;FGFR2;EPHB3;CTNNB1;FGF2;VASH1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte migration (GO:0002686),0.6960134040560602,1.1703990366570385,0.3,0.6648309707949143,1.0,2/5,17.05%,SLIT2;CD200R1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),0.6603789633692735,1.17037042305218,0.35714285714285715,0.6644228024664254,1.0,3/6,16.81%,PRKN;FBXW7;HIF1A
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.36767365656514406,1.170116947984443,0.0,0.6644926485111846,1.0,38/140,19.00%,RCN3;CASS4;ERBB4;EGFR;FAM110C;PDGFRA;EPHA2;MYORG;HCLS1;FGF17;NTRK2;AKT1;PIK3CA;STRN;PIK3R1;IRS1;PDGFA;HGF;PTPRJ;NRG2;PTK2;SIRT1;MAGI2;TGFBR1;GAB1;HIP1;OSBPL8;NRG1;PTPN11;RNF41;AKT2;FYN;PHLPP2;DRD2;PTEN;CPNE1;CIB1;NTRK3
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.5121016810758975,1.1695343696071485,0.2727272727272727,0.6655598631230106,1.0,7/26,15.77%,WNT7A;SLITRK2;NRXN1;CLSTN2;NLGN3;DLG5;SEMA4D
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.6106436696091481,1.169444319304459,0.3023255813953488,0.6652242899163786,1.0,6/10,22.00%,VHL;NCK1;SIRT2;IMPACT;BAG3;HSPA1A
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.5939966547689092,1.169273971447325,0.19230769230769232,0.6652067774375902,1.0,4/19,14.70%,MSL2;KANSL2;OGT;KAT7
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),0.6761778091480196,1.1691701471189018,0.2702702702702703,0.6651171711929235,1.0,4/6,30.47%,SLC25A18;SLC25A13;LRRC8D;SLC25A12
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),0.707021400481665,1.1691092149052564,0.3333333333333333,0.66488356522236,1.0,5/8,27.73%,RPS6KA4;CDK9;FMR1;MACROH2A1;MAPK3
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.6970484541757129,-1.1684940022058552,0.29508196721311475,1.0,1.0,1/9,3.22%,SLC18A2
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.47321273458632906,-1.168484119810471,0.17105263157894737,1.0,1.0,3/63,2.03%,GBP2;GBP3;GBP1
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),0.43282387870337025,1.1683295591590834,0.21052631578947367,0.666508238276299,1.0,12/73,7.29%,VAPB;SLC24A3;ATP13A5;ANK2;NPTN;HTR2C;ATP2B3;CXCL12;STIM2;ATP2C1;CALCB;ATP13A4
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),-0.7084043751231096,-1.168134869249336,0.3050847457627119,1.0,1.0,3/8,14.27%,PPIB;CAV2;APOE
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.5350538303649888,1.1680444508312915,0.1935483870967742,0.6667488818437419,1.0,6/19,16.90%,ZMYND10;ARHGAP35;KCTD17;TAPT1;SEPTIN7;CEP120
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),0.5134708449030642,1.1675955799482094,0.23076923076923078,0.6674637515161059,1.0,12/21,30.73%,TRIM24;PIK3R4;SMURF1;IDE;SNX25;LRSAM1;SH3GLB1;KIF16B;NEDD4;CLN6;MTOR;UVRAG
prerank,GO_Biological_Process_2021__arachidonate transport (GO:1903963),-0.7862705640601758,-1.167425417003069,0.3103448275862069,1.0,1.0,1/5,4.79%,ANXA1
prerank,GO_Biological_Process_2021__arachidonic acid secretion (GO:0050482),-0.7862705640601758,-1.167425417003069,0.3103448275862069,1.0,1.0,1/5,4.79%,ANXA1
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),0.7119378258692619,1.167371806212662,0.22727272727272727,0.6675452560389287,1.0,3/5,18.17%,NLGN4X;MTMR2;PTEN
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),-0.5647309667788867,-1.167365722999163,0.24242424242424243,1.0,1.0,4/25,12.27%,CCDC39;APLNR;DNAAF1;SRF
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),-0.7671371742753259,-1.1672503657705278,0.25862068965517243,1.0,1.0,2/5,10.85%,CEACAM1;IL12A
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),-0.6061623725737009,-1.1669904628224268,0.2537313432835821,1.0,1.0,6/16,19.46%,CD9;CEACAM1;PDPN;PRKCQ;CELA2A;ALOX12
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),-0.5480531317997821,-1.166887106602649,0.25675675675675674,1.0,1.0,5/35,8.40%,FLG2;OVOL2;OVOL3;RBP2;FGF7
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.4849079337628416,1.166672449815212,0.14285714285714285,0.668818522884914,1.0,10/28,19.21%,CSF1R;PDGFRA;NOTCH2;HCLS1;ABL2;TJP1;NRP1;TRPM2;NTRK3;ARHGDIA
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),-0.5575702675157503,-1.1665340059315958,0.24193548387096775,1.0,1.0,5/29,12.27%,CCDC39;APLNR;DNAAF1;HES1;SRF
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell differentiation (GO:0035886),-0.7325679697993759,-1.166170476032955,0.25862068965517243,1.0,1.0,4/6,20.85%,APLNR;HES1;HEY2;ENG
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),0.5758769839869337,1.166077192212974,0.3055555555555556,0.6695159329747462,1.0,3/9,16.52%,MGLL;SPX;ATPSCKMT
prerank,GO_Biological_Process_2021__venous blood vessel morphogenesis (GO:0048845),-0.734942157356472,-1.1660626487628873,0.3442622950819672,1.0,1.0,2/6,20.85%,CCBE1;ENG
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.5941661339674581,1.165946683640764,0.3076923076923077,0.6693806609790492,1.0,6/11,27.17%,RALB;PIP4K2C;RAB3GAP1;LRSAM1;SH3GLB1;PIP4K2B
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,0.3967599842367289,1.1658731480175646,0.18181818181818182,0.6691309620635382,1.0,22/98,12.19%,POSTN;MPDZ;ANK2;PDZRN3;FAT4;DCN;CXCL12;PDGFRA;CDH11;CACNA2D1;PRKG1;FRZB;PCDH18;PRRX1;GUCY1A2;GFRA1;PKDCC;RUNX1T1;SLIT2;ZNF423;PLPP3;ADGRL2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.4107982447515376,1.1658201150386127,0.15384615384615385,0.6687814067473822,1.0,12/53,16.42%,YAF2;EED;PPP1R10;PHC1;ZFYVE19;PCGF2;MGA;PHC3;ESPL1;BMP7;TFDP2;RBBP4
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),-0.7130715575639144,-1.1655928227561916,0.3584905660377358,1.0,1.0,3/6,9.93%,BUD23;EMG1;TRMT112
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),0.6905034247068762,1.1654348291717322,0.375,0.6693909482354071,1.0,4/6,26.33%,NFKB1;ROCK2;ROCK1;RELA
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.7181254673001296,-1.1651445248633745,0.288135593220339,1.0,1.0,1/5,8.04%,PDHX
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.7249536111289779,-1.1641401626176693,0.26666666666666666,1.0,1.0,3/7,15.55%,WNT9B;WNT3;WNT5A
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication initiation (GO:0030174),0.7367537546751013,1.1639666155030965,0.3888888888888889,0.6729304126593604,1.0,3/5,17.38%,KAT7;TICRR;WRNIP1
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),-0.6505903446628604,-1.1639646872509357,0.25806451612903225,1.0,1.0,1/11,4.45%,PDZK1
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),0.431671526179889,1.1637357084245101,0.16666666666666666,0.6729645629205055,1.0,12/51,20.33%,CCDC88C;CRIPT;HOOK1;CAMSAP2;CLIP3;KATNAL1;CLASP1;DLG1;SLAIN2;CIB1;KATNAL2;PCM1
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),0.6772864317303966,1.1637251910228585,0.3170731707317073,0.6724990140259566,1.0,3/5,28.53%,PRKN;ADAM9;D2HGDH
prerank,GO_Biological_Process_2021__anterograde dendritic transport (GO:0098937),0.7035938853789493,1.163547899603454,0.3902439024390244,0.6719263329525308,1.0,2/5,10.98%,KIF5A;KIF5C
prerank,GO_Biological_Process_2021__anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971),0.7035938853789493,1.163547899603454,0.3902439024390244,0.6719263329525308,1.0,2/5,10.98%,KIF5A;KIF5C
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial cell proliferation (GO:1905563),0.6413164159484233,1.1634647908823916,0.30612244897959184,0.6716334995802676,1.0,1/5,2.66%,FLT1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),0.4352080914322116,1.1633897867495608,0.12,0.6712556916553767,1.0,15/47,19.26%,ARHGEF16;EGFR;EPHA2;AKT1;PIK3R1;PTPN9;PRKCE;CLIP3;ZDHHC5;ATP2B4;DLG1;GNAI1;WNK3;CIB1;ARF6
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),0.6709174548578012,1.1632404137950982,0.3076923076923077,0.6712197997790494,1.0,2/6,9.43%,SASH1;MARCHF7
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),0.4767724486916158,1.163216116824068,0.21212121212121213,0.6707859943238671,1.0,3/29,5.75%,NAF1;RBM24;HNRNPU
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),0.599486285876815,1.1632125115658762,0.3333333333333333,0.6703102145502721,1.0,7/14,18.24%,DYRK1A;PSMD10;MARCHF7;PRKN;SIRT1;KDM1A;MDM2
prerank,GO_Biological_Process_2021__mesoderm morphogenesis (GO:0048332),0.6553175650343706,1.1630166823654056,0.3953488372093023,0.6703886299928598,1.0,2/6,6.05%,SMAD2;TBX19
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.48887288612004753,1.1623333866531589,0.19444444444444445,0.6718851282920141,1.0,6/26,23.67%,RHBDD1;PRKN;ABCB10;BAG3;HSPA1A;ERN1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.7503793493376494,-1.1622915441376576,0.31666666666666665,1.0,1.0,2/5,17.23%,IFI35;PTPN22
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),-0.6959453015409569,-1.162278477699871,0.3484848484848485,1.0,1.0,1/7,6.57%,DND1
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.6969589748811621,1.1622764855852654,0.34782608695652173,0.6715513040928188,1.0,2/7,4.38%,RAB27A;GRIN1
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.49175080265583193,1.1621459290500864,0.15,0.6715011924455873,1.0,10/28,24.93%,RNF6;DUSP10;DCC;KIAA0319;BBS2;PTEN;FGF13;PTPRS;CDKN1B;TRIM46
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),0.5605529342208754,1.1620985535165582,0.2857142857142857,0.6711964356065009,1.0,3/11,8.27%,PPARGC1A;PLIN5;IRS1
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),-0.7493385120694598,-1.161972626487867,0.36363636363636365,1.0,1.0,3/5,23.37%,PODXL;FSCN1;ATP8B1
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),0.5232409730677066,1.161954356287295,0.3,0.6710476699242687,1.0,5/13,28.48%,VCP;CPEB2;ZFAND1;GSTO2;DAXX
prerank,GO_Biological_Process_2021__neuron fate specification (GO:0048665),-0.7303455465712774,-1.1619419530966397,0.29411764705882354,1.0,1.0,1/5,0.44%,POU4F1
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),-0.6712574812602565,-1.161828964311678,0.3050847457627119,1.0,1.0,3/9,17.12%,KLRD1;TUBB;MICA
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.44269551715775707,1.1617375644559542,0.25,0.6711252074976487,1.0,12/40,14.98%,VEGFD;YJEFN3;PARVA;LOXL2;ROBO1;AKT1;VEGFC;EFNB2;SLIT2;JMJD6;CDH13;NRP1
prerank,GO_Biological_Process_2021__positive regulation of muscle contraction (GO:0045933),-0.7443166095067322,-1.1617374007695458,0.2909090909090909,1.0,1.0,3/6,22.98%,SRF;SPHK1;ENO1
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),0.6466135735580816,1.1617120294149,0.4146341463414634,0.6706943060667061,1.0,1/8,5.39%,PLIN5
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),0.3939779524119027,1.1615012517124923,0.18181818181818182,0.6707437676750396,1.0,8/63,9.03%,DNASE1L2;HNRNPH1;PDE12;DNA2;HNRNPU;HNRNPC;LSM8;RBFOX2
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),0.6077517392435735,1.1612892601525897,0.2702702702702703,0.6709482542317268,1.0,3/9,18.02%,CEP290;AGTPBP1;RORB
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.5592275937959782,1.160979957900264,0.3170731707317073,0.671391965614151,1.0,3/10,7.36%,NEDD4L;CACNA2D1;KCNH2
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),0.65416106515804,1.1609065991839633,0.35,0.6711451497321933,1.0,3/7,28.16%,CYREN;ERCC6;NUDT16L1
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),0.42249667596714374,1.160699688609258,0.21428571428571427,0.6711660037727675,1.0,15/38,26.83%,ADCY1;GUCY1B1;GMPS;PANK2;SLC25A16;PAPSS2;PANK3;PANK1;ADCY9;PAPSS1;ADCY6;ACAT1;ACOT7;SLC26A2;ADCY2
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),0.5935462617076126,1.1606714835288372,0.3333333333333333,0.6707510011824488,1.0,2/8,5.96%,SOX9;IL17D
prerank,GO_Biological_Process_2021__contact inhibition (GO:0060242),0.6889920778833142,1.160467564136275,0.4,0.6708564024384152,1.0,4/6,15.83%,FAP;PTPRJ;YAP1;SMO
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),-0.7031839945771312,-1.1603205949744737,0.31666666666666665,1.0,1.0,3/10,9.54%,IFIT1;MX1;NLRP1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.6634910064019308,1.1601025520292516,0.37209302325581395,0.6709966062281997,1.0,5/8,18.38%,IGF1;CAMTA1;SPPL3;PTBP1;CIB1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.6634910064019308,1.1601025520292516,0.37209302325581395,0.6709966062281997,1.0,5/8,18.38%,IGF1;CAMTA1;SPPL3;PTBP1;CIB1
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),0.5558897594004815,1.1600938046636267,0.16666666666666666,0.6705268491107117,1.0,2/13,9.00%,MTHFS;DDO
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),0.6556783800978089,1.1595873269908943,0.3125,0.6713325218080809,1.0,4/7,31.25%,UBR5;YAP1;NEDD4;SRC
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.5325919937830419,1.15943930253587,0.29411764705882354,0.6711991557785643,1.0,6/17,26.33%,FOXP1;NECTIN2;BCL10;PRKCB;PTPRC;RELA
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",-0.7281021294668102,-1.1594171019555701,0.25757575757575757,1.0,1.0,2/7,2.71%,IRF1;HLA-A
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),-0.7022708292070654,-1.1592800913100165,0.2692307692307692,1.0,1.0,3/7,17.70%,B2M;BDNF;GREM2
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),-0.5799407517605257,-1.159098061062096,0.2676056338028169,1.0,1.0,2/18,14.27%,ABCA12;APOE
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),-0.5754850911567696,-1.1587349192845386,0.24615384615384617,1.0,1.0,3/18,6.67%,DUOX1;P2RY12;THBS1
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.40332418916749047,1.1584469089722924,0.15384615384615385,0.6734719379698454,1.0,24/86,15.76%,ZFPM2;HDAC9;PCSK5;KAT2B;SALL1;ERBB4;SOX4;SMG9;SOX9;BMP2;KAT2A;PIK3CA;PKD2;NF1;FBXW7;ACVR1;TGFBR2;PDLIM5;TGFBR1;SH3PXD2B;ZDHHC16;DNAAF4;STK11;PTPN11
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),0.6496057082434226,1.1583350069232046,0.34375,0.6733512037161518,1.0,2/9,9.94%,FEM1B;RFWD3
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.5673963833591987,1.158141803814225,0.32432432432432434,0.6736077794796,1.0,8/11,31.50%,PLPP1;RNF14;ARID1A;DAXX;DDX17;KDM3A;PMEPA1;ZMIZ1
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),-0.7376435059529683,-1.157991207382176,0.27941176470588236,1.0,1.0,3/6,14.12%,TOMM7;ATP5IF1;HK2
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),0.590488405987851,1.1579091042951788,0.35135135135135137,0.6737523229202156,1.0,4/12,12.87%,FASTKD1;FOXO3;TFB1M;MTERF1
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),0.46144887101104975,1.1578129337157528,0.3157894736842105,0.6734642715980443,1.0,11/35,18.62%,RGCC;LIMCH1;PPM1E;TESK1;CARMIL1;ARHGEF10L;TGFBR1;NRP1;ROCK2;PXN;PPM1F
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.539312070219841,1.1577060541416855,0.25,0.6732602611420225,1.0,5/18,17.72%,TAFA1;TOX;NAP1L1;PTPRZ1;KDM1A
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),-0.6152352745327729,-1.1575510270649627,0.3125,1.0,1.0,2/12,1.98%,KMO;ACMSD
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.660151371070408,-1.1571337584483903,0.2537313432835821,1.0,1.0,3/10,17.23%,NLRP1;RIPK2;PTPN22
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),-0.5703315672929568,-1.1568337702667946,0.2608695652173913,1.0,1.0,4/20,10.57%,ANXA1;RHOBTB2;THBS1;RHOH
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.6657859392220706,1.1567563622549817,0.2978723404255319,0.6752432385453674,1.0,4/6,24.71%,PRKN;CPNE1;HSPA1A;UBE2K
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.5658916784634271,-1.1566173269165965,0.2753623188405797,1.0,1.0,4/22,11.26%,SFRP2;OVOL2;EFNA1;SFRP1
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),-0.7401703705774685,-1.1565947878963678,0.3448275862068966,1.0,1.0,2/6,10.27%,ANXA1;PIK3CB
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.49146314215880327,-1.1564524189779248,0.24390243902439024,1.0,1.0,9/56,16.55%,LIPI;HSD17B8;AGPAT4;ACSM6;MVK;ACSM5;ACSM3;XBP1;FADS1
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.3925948701347381,1.1564411236683867,0.21052631578947367,0.6756228038899216,1.0,32/84,19.66%,PTPRK;MITF;ZMYND8;DACH1;EPHA4;RAP2B;KANK1;LIMCH1;FOXO3;SERPINE1;DUSP10;ROBO1;SMAD7;PTPRJ;NAV3;ADARB1;NF1;SLIT2;AFDN;MAGI2;DLG5;RAP2C;DUSP22;RAP2A;ARID2;RNF41;DRD2;PTEN;SRGAP2B;FRMD5;FBLN1;TMEFF2
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),-0.6420322779462118,-1.1560832478701952,0.29333333333333333,1.0,1.0,6/12,20.23%,TIMP1;SPINK13;NODAL;DUSP1;ZP3;WEE2
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),0.5956438586817351,1.1559992242236998,0.2558139534883721,0.6762382634418731,1.0,1/8,3.21%,CSF1R
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),0.5181646572118572,1.1559909023743324,0.2857142857142857,0.6757548908447024,1.0,3/15,23.19%,SIK3;RRAGD;GPR137B
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),-0.6885401255201242,-1.1558350554990913,0.3050847457627119,1.0,1.0,2/7,14.90%,PSMC3;PSMC4
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),0.7574005559716109,1.1557700245325546,0.2777777777777778,0.6759943953385018,1.0,2/5,17.80%,CSNK2A1;CSNK2A2
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),0.6525646413010991,1.1556560732328967,0.2702702702702703,0.6759143572575315,1.0,4/8,20.12%,GRIN1;CPEB4;CDK5R1;GRIA2
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3445198856488671,1.155507037428915,0.0,0.6758621701356957,1.0,108/375,20.95%,POU6F2;PPARGC1A;LIMD1;USP13;BACH1;YAF2;MITF;WTIP;SOX4;RPS6KA4;ESRRG;VHL;PSPC1;RORA;BMP2;FOXO3;RNF6;NFXL1;CHD7;ZNF212;HCLS1;HMG20A;RFX3;NFYC;CCNA2;NR1D2;SP3;NCOA2;PDGFA;GPBP1L1;ZNF280D;ZNF516;SMARCA2;ZNF117;NLK;MAGED1;RNF14;ZNF33A;NR3C1;SOX6;CLOCK;ZNF268;TGFBRAP1;CREM;SUPT3H;ZNF737;ZNF736;EP300;FOXN2;EIF4E;DVL1;PRDM8;ANKRD17;TFEB;ZNF423;HP1BP3;FOXN3;ZNF519;APBB2;TGFBR1;MLXIPL;RREB1;AHR;ZNF680;MAPKAPK5;MYT1;SOX13;ZBTB38;ZNF282;KAT7;TRIP4;ZFAT;DMTF1;CCAR1;CYFIP1;CXXC1;HIF1A;KAT6B;SUFU;ZNF141;ATF2;ORC5;ZNF703;APBB1;ATRX;RORB;SSBP2;SOX21;NFIA;ESRRB;ELAVL2;HNRNPD;UTP4;DNM2;HDAC10;ASCC1;NSD2;SPIN3;REST;PRDM2;SPTY2D1;NFATC2;ZNF646;PPP2R1A;CREBBP;RBBP6;ARNT2;ZNF195
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),0.36420013480443214,1.1552245128350447,0.07142857142857142,0.6761010860387806,1.0,26/108,19.45%,TNFSF4;BTRC;IRAK2;KEAP1;ANXA4;ARRB1;MEN1;PEX14;HDAC2;ITCH;SMAD7;EIF2AK4;PSMD10;PKD2;HDAC4;SIRT1;MAP2K5;COMMD1;HAVCR2;MAP3K10;BMP7;SUFU;KDM1A;TAF3;TAX1BP1;OTULIN
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),0.3584403901118054,1.1552024912325851,0.0,0.6756472298297393,1.0,72/302,22.21%,CHRNA4;BACH1;FOXP1;SAMHD1;FOXO1;ZBTB1;RBM24;UBE2T;BOK;EPHA2;RAD18;PDS5B;MEN1;CSNK1E;UBR5;APTX;RAD51B;RAD52;RFWD3;NEK4;MAPKAPK2;USP3;DCUN1D5;SIRT1;VCPIP1;TRIP12;NIPBL;SMC6;FBXO45;UBE2E2;BCL2;PDS5A;ZBTB38;ZDHHC16;TRIM28;VCP;TAOK2;APLF;YAP1;DYRK2;STK11;USP47;MSH2;AATF;UBQLN4;PSME4;TICRR;ATF2;ASH2L;APBB1;MACROD1;ASF1A;CDKN2AIP;YY1;CIB1;FBXO31;H2AX;FMN2;WAC;NFATC2;WDR48;UBA6;RBBP6;FMR1;ZBTB40;XRCC2;ETAA1;SHPRH;HERC2;TAF1;BCL2L1;TANK
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.5318025134093641,1.154754599286105,0.18181818181818182,0.6762180893136335,1.0,4/9,23.68%,SIRT1;KLF15;SETD5;PRKAA1
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.5134839390420084,-1.1545503427355601,0.22857142857142856,1.0,1.0,8/52,11.87%,AGPAT2;ENPP2;AGPAT4;PLB1;ANGPTL3;PNPLA3;PGP;PLAAT4
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.38173117493023984,1.1545448934256377,0.2631578947368421,0.6763594397424696,1.0,21/63,23.75%,CHRNA4;CACNA1B;CACNG3;CACNA2D1;ATP2C1;CAMK2A;PKD2;SLC30A9;MMGT1;SLC30A1;TRPM2;CACNB3;NDFIP1;FYN;CACNG8;SLC39A8;ATP2B2;NDFIP2;CACNA1E;RAMP1;CACNG7
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),0.6637147757466553,1.154495229262912,0.30952380952380953,0.6760721969138064,1.0,4/8,23.03%,GABRB1;HRH1;DRD2;GABRB3
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),0.467852569771618,1.1544928962566672,0.25806451612903225,0.6755920320012255,1.0,10/29,20.33%,WNT7A;RAPGEF2;NF1;RUFY3;LRP4;PTEN;ARHGDIA;REST;MCF2;PCM1
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),0.671923016640157,1.1544691566748457,0.35135135135135137,0.6751401476410719,1.0,1/7,17.16%,TICRR
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.519308349236484,-1.1544645015601538,0.2857142857142857,1.0,1.0,12/39,16.56%,P2RY10;TAGAP;CD5;DPEP2;THEMIS;GMFG;GPR171;ARHGAP9;TRAF3IP3;CXCR4;ARHGAP30;MYO1F
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.6222384078639366,1.1542539344648652,0.24390243902439024,0.6747343780277573,1.0,7/9,22.71%,NFAT5;PPP3CB;ADGRB2;NFATC3;NFATC2;PPP3CA;NFATC1
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.6222384078639366,1.1542539344648652,0.24390243902439024,0.6747343780277573,1.0,7/9,22.71%,NFAT5;PPP3CB;ADGRB2;NFATC3;NFATC2;PPP3CA;NFATC1
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),-0.6779344964236931,-1.154033894790948,0.2923076923076923,1.0,1.0,2/10,11.73%,IHO1;MEI4
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),0.67515953132284,1.1539332949699561,0.39473684210526316,0.6749312592963967,1.0,4/7,19.69%,ZDHHC21;ROCK2;PPP1R12A;ROCK1
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),0.576806672787043,1.1535399104522646,0.3333333333333333,0.6752654661702637,1.0,7/13,32.11%,SLC25A18;SLC25A14;SLC25A13;LRRC8D;SLC25A12;SLC1A2;SLC13A5
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.5764172340125909,-1.1534278683049572,0.2923076923076923,1.0,1.0,3/24,7.15%,PIF1;ANXA1;DDX11
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.5306200031023935,-1.1532991237108037,0.28735632183908044,1.0,1.0,18/53,20.76%,COX7C;NDUFA6;NDUFS5;COX4I1;NDUFA2;NDUFC1;NDUFB10;UQCRQ;UQCRFS1;COX5B;UQCR10;NDUFB3;NDUFA1;NDUFB7;NDUFA12;NDUFB9;NDUFB11;COX6C
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.5163899068063336,-1.153251389893656,0.27631578947368424,1.0,1.0,8/43,16.17%,PSMB6;PSMB9;PSMA8;PSMA7;PSME1;PSMC3;PSMC4;PSMA3
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.5531903639817353,-1.1532053723414961,0.3055555555555556,1.0,1.0,2/30,5.19%,IFI6;IFIT2
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),0.36089835086971744,1.1530871237048639,0.05263157894736842,0.6762592337452105,1.0,17/84,10.88%,ACE2;TNFSF4;ACKR1;FOXP1;HDAC9;NPTN;BTN3A3;RPS6KA4;RGCC;DTX4;LGR4;CADM1;KAT2A;RNF26;LURAP1;MAPKAPK2;MAST2
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),0.7050277474425187,1.153026760881408,0.3142857142857143,0.6759874266995147,1.0,2/5,24.76%,OGT;ZNF304
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),0.6006942328148044,1.1529979315308398,0.3157894736842105,0.6756336159168537,1.0,3/8,18.39%,CDK12;CDK13;CDK9
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),0.6801044757393516,1.1529852579401847,0.34615384615384615,0.6751979750113493,1.0,1/6,3.10%,ABCA1
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),0.6826391318589996,1.1529728723638313,0.41025641025641024,0.6747218128286896,1.0,3/6,29.08%,FZD3;BCL2L1;PAK2
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),-0.7677599306765461,-1.1529309923362756,0.26865671641791045,1.0,1.0,2/6,19.68%,CD63;EMP2
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.4239183264704151,-1.152663975046565,0.10416666666666667,1.0,1.0,64/376,17.02%,IFI6;GBP2;PSMB6;TRIM22;IFIT1;ISG15;IFITM3;GBP1;DUOX1;IL5;IRF1;BST2;IL1R1;HLA-A;HLA-B;RPS27A;IL7;MX1;STAT1;IFIT3;ANXA1;B2M;IFIT2;CXCL2;HLA-C;TIMP1;CEACAM1;PSMB9;PSMA8;IFNGR2;TRIM21;F13A1;IFI35;INPP5D;PSMA7;STAT2;PIK3CB;PSME1;PSMC3;UBC;IL12A;CIITA;RSAD2;OAS3;LTBR;MT2A;MT3;TXNDC17;CEBPD;SPI1;IL3RA;PSMC4;CCL2;SP100;CX3CL1;CA1;IL20RA;SOCS3;PSMA3;IL18;FSCN1;RIPK2;CTR9;IL15RA
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),0.672668699549106,1.1526471936431117,0.3902439024390244,0.6749999451910239,1.0,2/5,31.72%,UBQLN4;RUBCN
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),0.6846195958954175,1.152225385208663,0.32608695652173914,0.6757706192217251,1.0,4/6,26.79%,GPAM;TAMM41;SLC27A1;CDS2
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),-0.7262449148592921,-1.1520285137427388,0.34375,1.0,1.0,1/7,10.85%,IL12A
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.41221782827577913,1.151763581463824,0.1,0.6766223063119428,1.0,17/72,11.74%,EFNA5;CSF1R;EPS8;ARHGAP35;PDGFRA;RHOQ;NOTCH2;RHOBTB3;TESK1;ABL2;PIK3CA;FAM107A;EPHA5;PDGFA;PAK3;BST1;GPM6B
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),0.6933945487919269,1.151733513900772,0.39215686274509803,0.6762285219232805,1.0,3/5,29.63%,AGO3;AGO2;AGO1
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.43299793439770334,1.1517185520320774,0.16666666666666666,0.6757669723536032,1.0,25/64,23.37%,DCUN1D1;FAM107A;UBE2D1;SMAD7;PSMD10;FBXW7;PIAS1;DCUN1D5;HDAC4;COMMD1;UBQLN1;DCUN1D4;PIAS4;BIRC2;NDFIP1;CUL3;BCL10;DCUN1D2;AXIN1;WDR48;DERL1;NDFIP2;TANK;HUWE1;RCHY1
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.36660969332390275,1.1513688357368388,0.25,0.6762482061504522,1.0,24/114,18.63%,PAPOLA;HNRNPH1;FTO;FASTKD1;DROSHA;HNRNPU;RNGTT;HNRNPC;LSM8;CELF2;RBFOX2;SYNCRIP;ADARB1;DKC1;HNRNPH3;DHX9;AGO3;TP53RK;ADARB2;RBM6;PPP1R8;PTBP1;HNRNPD;NOVA1
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.520097439676965,1.1513609297539857,0.3,0.6757872905561519,1.0,9/30,8.03%,ADCY1;PDE3A;HTR2C;PDE7B;PDE7A;SOX9;GUCY1B1;RAPGEF2;EPHA5
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.6234881465132505,1.1511111568896348,0.2571428571428571,0.6758587857036548,1.0,2/9,11.16%,PGAP1;STX18
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),-0.7513340919872014,-1.1509809788662786,0.3076923076923077,1.0,1.0,2/5,11.26%,THBS1;SFRP1
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.4824178699212573,-1.1506688401162948,0.25,1.0,1.0,20/66,25.07%,ISG15;IRF1;STAT1;PQBP1;CD14;OAS3;POLR2L;TLR3;RIPK2;PTPN22;DDX41;POLR1C;POLR3G;POLR2K;NFKB2;HSPD1;RIOK3;DHX58;GAPDH;FLOT1
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),0.6431747878075907,1.1501332912470779,0.3055555555555556,0.6781238743883394,1.0,3/8,20.94%,NAA25;NAA30;NAA16
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),-0.656193501475697,-1.1499656965026555,0.3,1.0,1.0,1/8,0.51%,SAMD9
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),0.5374962729096512,1.1499180957661608,0.2413793103448276,0.6782480966807739,1.0,2/13,3.71%,TRIM24;SERPINB9
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.551394305152733,1.149862674145319,0.2702702702702703,0.6778414971878987,1.0,2/14,6.05%,SMAD2;TBX19
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),0.548654276551939,1.1498160915324607,0.25925925925925924,0.6774626600499397,1.0,4/17,12.81%,TENM3;CEP290;NF1;RAB3GAP1
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),0.7118351376513541,1.1486060087176075,0.36363636363636365,0.6800328052749317,1.0,3/5,20.95%,RPS6KA4;CDK9;FMR1
prerank,GO_Biological_Process_2021__dopamine uptake (GO:0090494),0.6956688064423855,1.1484780543598805,0.3157894736842105,0.6797615898132074,1.0,1/5,2.40%,SNCA
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),0.6641816475409517,1.1475188865876338,0.3125,0.6817431034653274,1.0,3/6,26.33%,NFKB1;LIN28B;RELA
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.5322674171036706,-1.1475095860816735,0.27586206896551724,1.0,1.0,18/52,20.76%,COX7C;NDUFA6;NDUFS5;COX4I1;NDUFA2;NDUFC1;NDUFB10;UQCRQ;UQCRFS1;COX5B;UQCR10;NDUFB3;NDUFA1;NDUFB7;NDUFA12;NDUFB9;NDUFB11;COX6C
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),0.5810317069940075,1.1474593726068638,0.36666666666666664,0.6814303968459433,1.0,5/11,18.17%,MYRF;B4GALT6;B4GALT5;ABCA2;PTEN
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),-0.62649298962056,-1.1474109002987136,0.3076923076923077,1.0,1.0,8/13,18.93%,MT1H;AQP1;MT1G;MT2A;MT3;MT1A;MT1E;MT1F
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),-0.6350444127770881,-1.14701290381266,0.2647058823529412,1.0,1.0,1/12,3.89%,MYOF
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.5478276592949516,1.1469608532251607,0.3055555555555556,0.6824188748282229,1.0,2/14,5.39%,NFKB1;PLIN5
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.6848123663449109,1.1463966046495064,0.36363636363636365,0.6832434957302566,1.0,6/8,29.69%,RREB1;CLASP1;PTEN;FERMT1;CLASP2;MTOR
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.33463457933749724,1.146333668679782,0.25,0.6829303978287523,1.0,48/222,15.83%,PPARGC1A;LEPR;TNFSF4;SOX8;SOX5;ABCA1;HADH;PLAC8;ESRRG;RGCC;ADIPOR2;SOX9;BMP2;SERPINE1;SMAD2;LOXL2;ELOVL6;RFX3;TRPM4;CADM1;KAT2A;PLCB1;ZNF516;BMPR1B;NCOA3;ADRA1A;SOX6;LURAP1;ADRB1;ACVR1;ZBTB16;ADRB2;TGFBR2;SIRT1;TAPT1;OGT;PRKAB1;B4GALT5;TGFBR1;RREB1;PDGFC;ALMS1;SMAD4;ADIPOR1;BMPR1A;TRIM16;PTPN11;SMO
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),0.6807587910689235,1.1462381517607625,0.3488372093023256,0.6826312565893311,1.0,3/7,23.16%,DNA2;PRIMPOL;POLG2
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.5875823199947703,-1.1461599816015526,0.3492063492063492,1.0,1.0,7/22,17.68%,IFIT1;PLN;TIMP1;ATP5IF1;MT3;PHPT1;NOS1
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.5574898410883949,-1.1459649497717244,0.3230769230769231,1.0,1.0,10/23,20.98%,MT1H;MT1G;TMC8;MT2A;SLC39A7;MT3;MT1A;MT1E;MT1F;SLC39A6
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.5096152580260532,-1.1457424000383303,0.2631578947368421,1.0,1.0,4/45,4.87%,FTH1;CP;FTL;B2M
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.4440360693614099,1.145398337177962,0.20689655172413793,0.6842917425229287,1.0,4/35,2.85%,SPAG16;MTCL1;NCKAP5;ZNF207
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),-0.6714630510461461,-1.1450868055015253,0.3728813559322034,1.0,1.0,6/9,30.57%,MCMDC2;DONSON;MCM5;ORC3;MCM3;MCM4
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),-0.647440187305834,-1.1449324623070474,0.34375,1.0,1.0,1/9,0.68%,SFRP2
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),-0.6682536239670224,-1.1449161780083004,0.2962962962962963,1.0,1.0,3/9,19.58%,FBXO43;TOM1L1;AURKAIP1
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),0.5966454629934117,1.1448474407359157,0.4,0.6851937867265814,1.0,4/10,16.81%,TRAK1;TRAK2;OPA1;HIF1A
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.4231876563523812,1.1446508500904686,0.11764705882352941,0.6851500654982605,1.0,20/80,15.23%,TENM3;EFNA5;PARVA;NRP2;EPHA2;CDH11;LOXL1;MID1;PCDH18;FBLIM1;ROR1;VEGFC;GLI3;EFNB2;GPR161;SLIT2;ADGRL2;ENAH;PTPN14;YAP1
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.5818526948001772,1.1445963390098017,0.34375,0.6848097636794155,1.0,4/11,24.76%,TASOR;TRIM28;PPHLN1;ZNF304
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),0.5943708711018225,1.144484368619538,0.3333333333333333,0.6846316256962643,1.0,2/11,13.76%,CCDC88C;COL15A1
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),0.7487052808219752,1.144243475550126,0.27906976744186046,0.6851135202652692,1.0,1/5,7.62%,SEC22B
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter transport (GO:0051590),0.6854367096920599,1.1439825383031468,0.3333333333333333,0.6855140136614211,1.0,2/5,10.21%,BAIAP3;PRKN
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),-0.5998092212043393,-1.1438299518601664,0.30357142857142855,1.0,1.0,4/12,15.12%,GPR183;MSMP;CCL2;CX3CL1
prerank,PanglaoDB_Augmented_2021__Ionocytes,-0.5182303740767124,-1.1437914949129682,0.30864197530864196,1.0,1.0,18/59,18.42%,SPAG17;FMO6P;MROH9;CFTR;CFAP52;TEKT1;ZBBX;AK7;CXCL17;CHST9;APOBEC4;LRRIQ1;IL20RA;C1ORF87;FUT2;ATP12A;CAPN9;SLC9A7
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),0.5817260290783965,1.1433926474456282,0.2857142857142857,0.6867476294905573,1.0,2/14,5.51%,ADCY1;GUCY1B1
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),0.7123022908230708,1.1433773885590937,0.2894736842105263,0.6863536511050312,1.0,1/5,13.07%,HIPK2
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),0.4741608630938989,1.1432272537132775,0.2962962962962963,0.6862824845836684,1.0,12/30,19.35%,PICALM;NEDD4L;TTBK2;LEPROTL1;GPM6B;COMMD1;GSK3B;LATS1;LZTFL1;ROCK2;NSFL1C;UBXN2B
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.6509276341244278,-1.1432038233540274,0.3333333333333333,1.0,1.0,3/11,17.31%,ANAPC15;DUSP1;CCNB1
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),0.3284767958946859,1.143150726209249,0.0,0.6860101379856711,1.0,54/258,19.01%,CHRNA4;BACH1;LIG4;WDR33;ZBTB1;DNA2;PRMT6;POLD3;UBE2T;FTO;FAAP100;RAD18;PDS5B;MEN1;UBE2N;CSNK1E;NEIL2;ASCC3;APTX;RAD51B;RAD52;RFWD3;USP3;SIRT1;VCPIP1;SLC30A9;EXD2;COMMD1;EYA3;PDS5A;TRIM28;VCP;PRIMPOL;APLF;PIAS4;USP47;MAPK8;UIMC1;DCLRE1C;MSH2;EME2;BRCC3;SETD2;PSME4;TICRR;WRNIP1;APBB1;ASF1A;SMUG1;RAD23B;CIB1;H2AX;ASCC1;NSD2
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.3815542314002599,1.1431032168463053,0.20833333333333334,0.6856174833426701,1.0,16/61,13.37%,WNT7A;DNM3;PCDHB2;ADGRL3;CDH2;FZD5;GPM6A;NRXN1;SDK1;SHANK3;DVL1;NLGN4X;NLGN3;SLITRK1;PCDHB13;FARP1
prerank,GO_Biological_Process_2021__regulation of glial cell differentiation (GO:0045685),0.6837881517386973,1.1431004244398144,0.35,0.6851449695705526,1.0,2/5,10.84%,EPHA4;NF1
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.3362228180956539,1.1425638281434918,0.0,0.686159488705996,1.0,59/206,18.87%,LIMD1;CCDC88C;BTRC;SOX4;MLLT3;EGFR;AMER2;GPC5;SOX9;BMP2;NFKB1;KANK1;ZEB2;RNF146;CSNK1G3;PSMA1;INVS;TLE2;LGR4;GSKIP;TRPM4;FRZB;LYPD6;CSNK1E;PPM1A;UBR5;PSMD11;TMEM170B;PSMD10;GLI3;CAPRIN2;PRKN;PSMF1;DVL1;PSMD14;DACT3;TMEM131L;SCYL2;TBL1XR1;SOX13;BICC1;VCP;GSK3B;LATS1;STK11;GNAQ;USP47;PTPRO;PSME4;CUL3;ZNF703;CTNND2;TMEM198;LRP4;CDK14;RBMS3;WNK1;USP34;AXIN1
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.45028831049627116,1.1423534920982048,0.16666666666666666,0.6863563329764111,1.0,13/29,26.14%,ZDHHC18;ZDHHC11;ZDHHC21;GOLGA7;CLIP3;ZDHHC5;ZDHHC16;ZDHHC14;ZDHHC2;ZDHHC13;ZDHHC17;PORCN;GLUL
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),-0.7450855112169777,-1.1421543163012466,0.3225806451612903,1.0,1.0,1/6,4.45%,PDZK1
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),-0.7330762402693911,-1.1420594376305169,0.2698412698412698,1.0,1.0,3/6,23.82%,PRKCQ;CD274;PRELID1
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),0.5688595286058722,1.1418955867328404,0.22580645161290322,0.687315133859608,1.0,3/10,14.45%,SOX8;ZNF516;SH3PXD2B
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),0.7506714576988481,1.1415885953945717,0.2826086956521739,0.6874975500764376,1.0,1/5,7.03%,ROBO1
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),0.7110251468225683,1.1414208145210272,0.35714285714285715,0.6872790944796648,1.0,2/5,17.05%,LRCH1;CD200R1
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),0.6565889092116362,1.1407417345081317,0.4,0.6886890136203142,1.0,2/6,12.84%,BMP2;SIRT1
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.598898009839023,-1.1406192762827312,0.3088235294117647,1.0,1.0,4/11,28.22%,UAP1;GNPDA1;GFPT2;UAP1L1
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.598898009839023,-1.1406192762827312,0.3088235294117647,1.0,1.0,4/11,28.22%,UAP1;GNPDA1;GFPT2;UAP1L1
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.6032382727729815,-1.1405060918665169,0.3384615384615385,1.0,1.0,5/14,17.23%,GBP1;CEACAM1;CD160;PHPT1;PTPN22
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),0.5297935621047386,1.1404364742811413,0.2727272727272727,0.6891101552064798,1.0,3/15,11.19%,SPRY3;GRIP1;DVL1
prerank,GO_Biological_Process_2021__response to vitamin D (GO:0033280),-0.7368023553145443,-1.1404295239478126,0.4166666666666667,1.0,1.0,3/5,22.47%,SFRP1;FES;ALPL
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.6477665707371987,1.1395882672592386,0.3888888888888889,0.6908900309342562,1.0,2/7,14.10%,PRKD1;GAB1
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.5164940174528841,1.1395833376091946,0.24,0.6904168185843013,1.0,12/29,21.77%,EPHA2;PIK3CA;PIK3R1;AUTS2;SLIT2;OCLN;NCKAP1;FER;CYFIP1;CAPZB;ACTR3;ABI2
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.5799687568624832,1.1395760881772843,0.2903225806451613,0.6899442540267486,1.0,6/15,20.24%,FOXP1;CD22;ELF1;CBFB;RUNX1;PRKCB
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",0.6363728623072921,1.1393167299700868,0.2727272727272727,0.6900575023536694,1.0,6/7,36.36%,SH3RF1;HLA-DRA;TARM1;AGER;CD55;TWSG1
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.36084356831033093,1.1392696069259485,0.07142857142857142,0.6896788604449565,1.0,35/103,22.29%,PASK;SOX4;DNA2;EGFR;CPEB3;ZCCHC4;PRMT1;RGCC;HSPH1;NFKB1;AKT1;IRS1;STN1;RPS6KB1;IGF1;HGF;SIRT1;DHX9;KAT7;DYRK2;FAF1;FXR1;EIF3E;AKT2;HNRNPD;LARP4;NPM2;NIBAN1;SLC6A9;ABCB10;FMR1;YTHDF3;IRS2;LARP4B;FGF2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),-0.7142619194480605,-1.139090428965477,0.328125,1.0,1.0,1/6,9.42%,GSTP1
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),0.39640621493897976,1.1388613053916097,0.13636363636363635,0.6902835348750234,1.0,17/56,16.41%,SNCA;SMCR8;PPM1E;HNRNPU;GSKIP;AKT1;PPP2R5A;SPRED1;DUSP19;TAB1;CAMK2N1;NF1;DVL1;YWHAG;GNAQ;UBASH3B;TRIB2
prerank,GO_Biological_Process_2021__negative regulation of skeletal muscle cell differentiation (GO:2001015),0.67420734493793,1.1386043529577365,0.4583333333333333,0.6904361357118335,1.0,2/5,26.49%,AKIRIN1;EPHB1
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),0.5211416711276777,1.1383497535839813,0.32432432432432434,0.6905620024625466,1.0,5/18,13.92%,ACER3;PLPP1;PLPP2;PLPP3;ABCA2
prerank,GO_Biological_Process_2021__regulation of macrophage apoptotic process (GO:2000109),-0.7421164272385448,-1.1383316412964797,0.3548387096774194,1.0,1.0,1/5,4.51%,SELENOS
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424),0.7165544917563356,1.13830306558175,0.375,0.6901973029885975,1.0,2/5,15.92%,SLC15A2;BIRC2
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),-0.6921507691145803,-1.1382084076497354,0.2978723404255319,1.0,1.0,1/6,0.80%,DOCK8
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),0.6558487867904417,1.1382079030961085,0.30303030303030304,0.6900052838242455,1.0,2/9,7.21%,DNASE1L2;DFFB
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),0.3825857254474634,1.1379901870079112,0.23529411764705882,0.6901444226892594,1.0,20/70,23.72%,NUDT21;WDR33;PAPOLA;CSTF3;CPSF6;U2AF1;TENT4B;U2AF2;THOC7;MTPAP;SCAF8;RPRD1B;THOC2;GRSF1;CDC73;RPRD2;PAPOLG;MAGOH;CPSF7;CPSF2
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.6545897352756853,-1.1378451546035906,0.32786885245901637,1.0,1.0,2/10,3.05%,GCNT1;SELP
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.4738043947513833,1.1378098445206204,0.10526315789473684,0.6899923813286117,1.0,16/31,24.33%,NRG3;CACNA1B;EIF4EBP2;LRRC4C;LRP8;BTBD9;NLGN4X;NLGN3;IQSEC2;GRID1;GRIK2;NLGN1;GRIK1;NLGN4Y;PXK;NLGN2
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),0.4002994255520463,1.1375263490011618,0.16666666666666666,0.6902106469987919,1.0,5/62,6.09%,GSTT2;LVRN;PCSK5;CARNMT1;MME
prerank,GO_Biological_Process_2021__aspartate metabolic process (GO:0006531),0.7156600487337128,1.1374112238207787,0.5142857142857142,0.6900851850042832,1.0,1/5,9.00%,DDO
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),-0.5851944045588906,-1.1373961131918884,0.328125,1.0,1.0,1/15,3.56%,STX19
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),0.5333351230364534,1.1373843343399126,0.29411764705882354,0.6896562951657311,1.0,6/12,19.42%,HNRNPU;AGO3;EPCAM;YAP1;KDM1A;FBLN1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.4855957697733874,1.1370410175267192,0.25,0.6900326362093313,1.0,11/25,18.87%,BTRC;DCUN1D1;UBE2N;FBXW7;DCUN1D5;PLK1;DCUN1D4;RAB1A;DCUN1D2;PTEN;AXIN1
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),0.6305937037399156,1.1369105907133992,0.3235294117647059,0.689841639960864,1.0,2/7,11.28%,FUT9;BST1
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),-0.7307164665132864,-1.1368705955322764,0.42,1.0,1.0,1/5,4.87%,B2M
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),0.48062542954600457,1.136785348656158,0.26666666666666666,0.6896509025149014,1.0,9/27,17.72%,FOXP1;RNF6;NCOA2;RNF14;SAFB2;EP300;SIRT1;KDM4C;KDM1A
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),0.5673133905552248,1.1366909368997322,0.3170731707317073,0.6893946024782346,1.0,8/15,22.29%,AJAP1;SERPINE1;SLC12A2;CLASP1;PTEN;SERPINE2;CRK;FGF2
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.6640830603090154,-1.1366713548440606,0.35714285714285715,1.0,1.0,2/11,3.85%,IRF1;STAT1
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.4857317576371472,-1.1365836951098285,0.3157894736842105,1.0,1.0,16/69,17.31%,PSMB6;ANAPC15;RPS27A;PSMB9;ANAPC11;PSMA8;PSMA7;PSME1;PSMC3;UBC;SKP2;CDC26;UBE2S;PSMC4;PSMA3;CCNB1
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),0.5660614281501508,1.136309388980969,0.2926829268292683,0.6898621889334855,1.0,5/11,26.59%,DR1;TAF1B;TAF1;GTF2B;TAF12
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.38813664481520155,1.1362894245220558,0.23076923076923078,0.6894220434159813,1.0,22/84,16.21%,NPY1R;ADCY1;ABCA1;CNR1;PRKACB;ADGRB3;ADGRL3;CALCB;LGR4;GPR161;GNAI3;GNA13;LPAR3;VIPR1;ADGRL2;ADRB2;GABBR1;GNAI1;PDE2A;GRM8;GNAQ;ADGRB2
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),0.4204206832673517,1.1361752906023925,0.18518518518518517,0.6891270050728225,1.0,10/61,12.17%,LCMT2;TRUB1;TRMT1;TYW3;PUS10;THUMPD1;TRIT1;NSUN6;CDKAL1;CTU1
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),0.5847399383782856,1.1361739616671294,0.3333333333333333,0.6886616931180131,1.0,1/9,5.03%,TOX
prerank,GO_Biological_Process_2021__arginine catabolic process (GO:0006527),-0.7144617322417997,-1.1360323507097814,0.35294117647058826,1.0,1.0,1/5,2.67%,ARG2
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),0.44087620865625204,1.1358141461022004,0.22580645161290322,0.6889317156727602,1.0,11/40,16.17%,LEPR;NCK2;TNFSF4;SOX4;KIF13B;CHD7;EIF2AK4;NCK1;SCRIB;ADA;PPP3CB
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),0.5492739172547225,1.1356936394445776,0.2777777777777778,0.6887293811951978,1.0,3/11,13.21%,SALL1;NF1;TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.3951230635446924,1.1356320517507859,0.2692307692307692,0.6884749110922079,1.0,16/52,24.33%,SOX4;MCU;DOC2B;IGF1;GOLPH3;SYTL4;APBB1;ARF6;ADAM9;PTPN23;MYOM1;IRS2;FRMD4A;TCF7L2;LRRC8A;NLGN2
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),0.5207540244467572,1.1354468688858064,0.30952380952380953,0.6885219285841477,1.0,1/13,3.76%,EXOSC6
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),0.5039817294518651,1.1354392081514135,0.25,0.6880847583553191,1.0,7/22,13.85%,GDAP1;DNM3;MFF;TMCC1;PEX11A;PRKN;OPA1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),0.6964338089743536,1.135141406466132,0.41304347826086957,0.6884196391772828,1.0,3/6,23.54%,RGCC;PTEN;MACROH2A1
prerank,GO_Biological_Process_2021__negative regulation of ceramide biosynthetic process (GO:1900060),-0.7529035377062463,-1.1348874880326967,0.3275862068965517,1.0,1.0,3/5,19.49%,ORMDL2;ORMDL1;SPHK1
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),0.6316373614357546,1.1348520525940002,0.35714285714285715,0.688675668744355,1.0,1/6,9.55%,SFXN1
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),-0.640650353415279,-1.1347668058975957,0.3333333333333333,1.0,1.0,5/13,14.07%,GATA1;CTSL;RDX;CTSH;BRD8
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),-0.5678343762976498,-1.1345320257769274,0.273972602739726,1.0,1.0,4/20,12.43%,GC;PDPN;AMN;ABCG2
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),0.6622211792154213,1.1341744695371563,0.3541666666666667,0.6900021171503806,1.0,2/7,19.33%,AKT1;FAS
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.47234288077510594,1.134147432301777,0.17391304347826086,0.6896042750726702,1.0,10/28,17.24%,MTCL1;PARD3;CRB1;DLG3;OPHN1;DLG1;SCRIB;PARD3B;RAP2A;LIN7C
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),-0.5818235234333815,-1.1341444872614626,0.323943661971831,1.0,1.0,5/21,12.90%,CCDC39;DNAAF1;PDPN;FGF7;FGF1
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),0.6622104149678126,1.134102953075659,0.45,0.6892200072192575,1.0,2/6,15.20%,ADARB1;ADARB2
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),-0.4574665381842581,-1.133521388925635,0.23255813953488372,1.0,1.0,8/118,8.31%,GBP2;ISG15;GBP1;FSIP2;RPL11;PAQR3;RAB11A;TRAM1L1
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),0.5213784651130058,1.133243689865486,0.2702702702702703,0.6906867737508212,1.0,5/15,19.58%,MGLL;PRDX6;ABHD6;LYPLA2;ABHD2
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),0.5054427210289963,1.1331291189738968,0.27586206896551724,0.690588803748059,1.0,5/22,18.07%,BMP2;PPP2R5A;CAMTA1;SPPL3;PTBP1
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),0.6034995874832985,1.1331224508353037,0.35135135135135137,0.6901656053873289,1.0,4/10,28.91%,BLMH;MTHFR;TST;NOX4
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.6055210223823694,-1.1328825551193027,0.3783783783783784,1.0,1.0,3/14,17.23%,RAB7B;IFI35;PTPN22
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),0.6650254693412053,1.1326750699455386,0.39473684210526316,0.6908484555616313,1.0,3/7,18.46%,EIF2AK4;ATG7;ATG5
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.43838039248543303,1.1325391591113654,0.2413793103448276,0.6908285558354945,1.0,11/38,23.67%,DNA2;RIDA;ZC3H12D;AGO3;PPP1R8;YTHDF2;HNRNPD;ZPR1;HSPA1A;DIS3L2;ERN1
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),-0.7097810004756313,-1.1317108306359527,0.3582089552238806,1.0,1.0,1/6,3.46%,RAB7B
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),0.6944814093933852,1.1315412096455761,0.42857142857142855,0.6929647404037249,1.0,2/6,4.76%,PPARGC1A;ADIPOR2
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),0.5641184365875554,1.1313352490665978,0.3170731707317073,0.6931641081991105,1.0,7/11,31.25%,ATP9A;DNAJC13;MAPK1;MAP2K2;MAPK3;USP7;SRC
prerank,"GO_Biological_Process_2021__fructose 1,6-bisphosphate metabolic process (GO:0030388)",-0.7227158167849407,-1.1311147853479935,0.4098360655737705,1.0,1.0,1/5,6.97%,ALDOB
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),0.5279098013707032,1.1308877564507458,0.16129032258064516,0.6936874842474773,1.0,4/16,15.61%,ST6GALNAC5;ABCA2;HEXB;NEU3
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.5772410286178059,1.130866045657479,0.34285714285714286,0.6933027998617352,1.0,6/13,24.37%,HNRNPU;EPCAM;KAT7;KDM1A;N4BP2L2;PTPRC
prerank,GO_Biological_Process_2021__skin development (GO:0043588),-0.5064516786682711,-1.1308321019844552,0.3,1.0,1.0,7/44,8.03%,FLG2;DHCR24;ABCA12;COL5A1;ANXA1;FLG;HRNR
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),0.6644943296687928,1.1304922643948496,0.3958333333333333,0.6939160619501736,1.0,2/6,4.29%,TCAP;CDH2
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),0.36427992242989327,1.1300574439166764,0.14285714285714285,0.6943472765659152,1.0,22/78,16.41%,SNCA;SMCR8;PPM1E;DUSP10;SRCIN1;TESK1;GSKIP;AKT1;SH3BP5L;SPRED1;DUSP19;TAB1;CAMK2N1;ADARB1;NF1;PTPRB;DVL1;YWHAG;GNAQ;UBASH3B;PTPRO;TRIB2
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),0.3915890953509251,1.1297727931045094,0.21052631578947367,0.6945968070771695,1.0,18/67,18.57%,PPARGC1A;EGLN3;SNCA;PICALM;INPP5A;ZNF746;AKT1;EFNB2;SARM1;PRKN;DCC;MAP3K5;RRAS2;GSK3B;CD200R1;FYN;SIGMAR1;GRIN2B
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),0.3794970775321725,1.1293884671218726,0.17391304347826086,0.6951174905862278,1.0,21/70,19.26%,PID1;ARHGEF16;PICALM;EGFR;RHOQ;EPHA2;AKT1;PPP2R5A;PIK3R1;PTPN9;PRKCE;MRAP;CLIP3;ZDHHC5;ATP2B4;DLG1;STX8;WNK3;CIB1;STX7;ARF6
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,0.38941144649869314,1.1293747400694996,0.18181818181818182,0.6946814570167652,1.0,32/137,17.51%,WNT7A;SPON1;ETV5;WDR33;HDAC9;ETV1;SNAP91;BTBD3;SOX9;BMP2;MMD;CBL;CSF2RA;ZNF277;STRN;PRRX1;USP12;CA2;ANKH;KIF5C;RGS16;TMEM158;DUSP6;MTMR10;NRP1;PRKG2;PTBP2;TSPAN13;TRIB2;RABGAP1L;AKT2;MAP3K1
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.3744806242807286,1.1293444840432258,0.17647058823529413,0.6943234665899142,1.0,23/92,15.46%,EFNA5;ARHGAP35;IQCJ-SCHIP1;RHOQ;RHOBTB3;TESK1;FAM107A;EPHA5;PDGFA;PAK3;BST1;GPM6B;KATNBL1;PTK2;BICD2;CLASP1;TJP1;MAPK1;TAOK2;CDK2AP2;GSK3B;TRIM36;ROCK2
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),0.6348481344048782,1.1291974631915216,0.36363636363636365,0.6937894199022427,1.0,2/8,12.52%,GIT1;HDAC4
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),0.6348481344048782,1.1291974631915216,0.36363636363636365,0.6937894199022427,1.0,2/8,12.52%,GIT1;HDAC4
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),0.6579312748726087,1.1289700369053879,0.3488372093023256,0.6937935126881297,1.0,2/5,24.76%,ATRX;ZNF304
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.43993100699484905,-1.1288862367643129,0.2857142857142857,1.0,1.0,23/117,16.36%,POU4F1;ISG15;IFITM3;BST2;IL1R1;SELP;MX1;STAT1;PTPN7;ANXA1;TIMP1;TRIM21;SIGIRR;CASP8;CIITA;SRF;SLC11A1;CXCR4;SHFL;SP100;DPYSL3;CD274;EIF2AK2
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),0.5524566497226653,1.1285101660510697,0.3170731707317073,0.6945701888321434,1.0,4/12,10.32%,SLC19A1;SLC25A41;ABCC5;SLC25A24
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.5345260715369478,-1.1281851091597495,0.3188405797101449,1.0,1.0,3/26,10.53%,TOMM7;UBL5;ARIH2
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.6757344277601306,-1.127991162177563,0.3389830508474576,1.0,1.0,2/9,3.05%,GCNT1;SELP
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),0.6942124200473326,1.1277242521970894,0.30612244897959184,0.695924895048936,1.0,2/6,11.57%,TSHZ3;NLGN3
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),0.6753646563452306,1.1275451716962304,0.2702702702702703,0.6959532862574688,1.0,3/7,25.79%,SMS;MTHFR;MSRA
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.6336853490688977,-1.127429054579551,0.3389830508474576,1.0,1.0,1/11,2.68%,SLC51B
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.5140829463036909,-1.1272634057186075,0.2876712328767123,1.0,1.0,6/32,12.20%,ISG15;USP18;TRIM21;STAT2;A2M;OAS3
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),0.5439895480790957,1.1270862725048658,0.30303030303030304,0.6967141439703695,1.0,3/10,15.70%,ARID1B;SERTAD2;PADI2
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),0.6450885736638939,1.1266419807821912,0.32558139534883723,0.6974097842877697,1.0,4/7,28.70%,UGDH;LETM1;LRRC8A;LRRC8D
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),0.6691255333990831,1.126591676460013,0.37777777777777777,0.6969879497455449,1.0,1/5,5.19%,NFKB1
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),0.3899305534348502,1.1264688125976963,0.15384615384615385,0.6967462289558911,1.0,27/93,23.78%,WDR33;NUP42;NUP37;NUP188;IWS1;AGFG1;U2AF1;FYTTD1;SMG1;EIF4E;RBM15B;NUP153;U2AF2;NDC1;THOC7;SMG7;NUP205;PCID2;NUP214;ALKBH5;RANBP2;THOC2;NXT1;MAGOH;NUP98;CPSF2;NUP54
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),-0.7488592048370036,-1.1263891304145957,0.3220338983050847,1.0,1.0,1/5,7.95%,PDPN
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),0.5331936079901387,1.1263787079396559,0.24242424242424243,0.6965432780372964,1.0,2/13,4.51%,YAE1;LTO1
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),0.5738100576176636,1.1260561674517346,0.32432432432432434,0.696801704810166,1.0,5/10,19.69%,ZDHHC21;ROCK2;PPP1R12A;ADD1;ROCK1
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),-0.6714728811474818,-1.1258677336546765,0.3392857142857143,1.0,1.0,1/8,7.63%,IFI35
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.4426829947895775,1.1257803124724244,0.25925925925925924,0.6970981918853868,1.0,10/41,15.60%,ZBTB1;SALL1;PRKCSH;ARHGAP35;SOX9;PHF2;PKD2;NF1;TGFBR1;NRG1
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),0.6451710872646284,1.1257070930684967,0.34210526315789475,0.6962582606045606,1.0,5/5,35.50%,PAPSS2;PAPSS1;SLC26A2;SLC35B3;SLC35B2
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),0.6451710872646284,1.1257070930684967,0.34210526315789475,0.6962582606045606,1.0,5/5,35.50%,PAPSS2;PAPSS1;SLC26A2;SLC35B3;SLC35B2
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),0.6162369225927395,1.1256794818326796,0.37142857142857144,0.6959029975385781,1.0,2/6,10.74%,CARMIL1;MAPKAPK2
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),-0.7337097185472621,-1.1253759652111661,0.2692307692307692,1.0,1.0,1/6,10.72%,VAMP8
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.5588583701725713,-1.1253589738657224,0.3148148148148148,1.0,1.0,4/24,11.26%,SFRP2;PARP14;SH3BP5;SFRP1
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.48179630938035456,1.1251896529297596,0.2413793103448276,0.696786558176176,1.0,9/25,17.32%,RAP2B;RAPGEF2;AFDN;RAP1A;RAP2C;TJP1;PDE2A;RAB1A;PDE4D
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),0.5460837158147627,1.1250214361001825,0.2571428571428571,0.696635545751216,1.0,3/11,9.70%,CARD18;GIT1;IGF1
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),-0.5699940899175067,-1.1249180981177764,0.38095238095238093,1.0,1.0,1/14,2.03%,GBP1
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),0.6324485248893218,1.1246020395661,0.4,0.6972369710947284,1.0,3/7,7.87%,CXCL12;ARHGAP35;PIK3CA
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.49116755308295795,1.1243930823909372,0.21428571428571427,0.6972769834902253,1.0,10/24,14.73%,ZFPM2;SOX4;ROBO1;SMAD7;SLIT2;ACVR1;TGFBR2;TGFBR1;SMAD4;BMPR1A
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),0.6796419092221788,1.1243897343953577,0.35555555555555557,0.6968203515429494,1.0,1/6,2.50%,XPO1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),0.6108769219419308,1.1242915957175739,0.35135135135135137,0.6965679139754201,1.0,3/6,34.05%,GSK3B;PARD6A;BICD1
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),0.6412050438757108,1.1240864336343899,0.3125,0.696659151326458,1.0,1/9,0.57%,MTHFS
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.3714728598774913,1.1237613368638102,0.16666666666666666,0.697017140765743,1.0,8/58,8.05%,SLC26A7;CLIC5;ANO5;GABRG1;GABRA5;SLC12A2;GABRA4;GLRB
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.47022517227228616,1.1235586186670052,0.3333333333333333,0.6971079655096662,1.0,5/26,13.28%,ZBTB20;PLIN5;AKT1;ELOVL5;MLXIPL
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),0.6563897456534847,1.1233382219685182,0.37209302325581395,0.6971986716834279,1.0,4/7,9.74%,NPNT;SALL1;BMP2;PKD2
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.4187585410981635,1.12278346372479,0.2,0.6982785561748007,1.0,13/52,12.39%,HMCN1;TENM3;NPTN;IGSF11;EMB;CDH2;NECTIN3;ROBO1;CADM1;CDH4;SDK1;BSG;CNTN4
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),0.42862713285885484,1.1226512221078355,0.21428571428571427,0.6981782556555386,1.0,10/55,14.18%,LCMT2;ZCCHC4;TYW3;METTL8;FBLL1;TFB1M;NSUN6;RBM15B;NSUN3;ZC3H13
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.49759231302982476,-1.1226474087124443,0.29333333333333333,1.0,1.0,15/59,16.62%,P2RY10;DOCK8;GPR183;BST2;TAGAP;DPEP2;GMFG;ARHGAP9;TRAF3IP3;SPI1;IL3RA;CXCR4;ARHGAP30;MYO1F;SERPINF1
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),-0.5774673406860132,-1.122487736692619,0.24242424242424243,1.0,1.0,1/17,0.13%,CD24
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),0.6055000833415465,1.122397287243953,0.3939393939393939,0.6983820881809513,1.0,2/9,15.87%,LRP8;BMP7
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.5905896741520397,-1.1221523194944532,0.3333333333333333,1.0,1.0,6/20,16.68%,ITGA5;COL8A1;NODAL;DUSP1;LAMB1;COL4A2
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),0.6048925508128999,1.1217539036058999,0.37209302325581395,0.699433776032665,1.0,6/7,34.13%,ESPL1;WAPL;TERF2IP;TERF2;ERCC1;ERCC4
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.41392705477270514,1.121581404373855,0.21052631578947367,0.6993076191133737,1.0,4/22,11.05%,EGFR;ARRB1;AKT1;FBXW7
prerank,GO_Biological_Process_2021__megakaryocyte development (GO:0035855),-0.7040017830461979,-1.1215765257420616,0.38181818181818183,1.0,1.0,2/5,24.14%,ZNF385A;THPO
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),0.41832852432326656,1.1213399729594467,0.2222222222222222,0.699535603854333,1.0,4/31,12.69%,TUB;RAB27A;PIP4P2;MERTK
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.3299150850487269,1.1209467501001962,0.0,0.7001802091355823,1.0,37/170,19.70%,VAPB;VAPA;USP6NL;TRAPPC12;TRAPPC8;ALS2CL;TMCC1;EXOC8;RNF26;TRIP11;DNAJC13;HOOK1;SYNE1;GOLPH3;DYM;PRKD1;REEP4;RAB30;CHMP2B;TJAP1;CLASP1;RAB22A;TMED3;TRAPPC11;HACE1;ARHGEF7;RAB1A;ARFGEF1;TMED5;LEMD3;SEC23IP;TOR1B;ALS2;TOR1AIP2;NSFL1C;UBXN2B;SYNGR1
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),0.5529867939795015,1.120838701313051,0.41935483870967744,0.699574292980012,1.0,6/12,32.66%,SLC37A1;SLC37A2;SLC25A14;SLC37A3;SLC25A3;XPR1
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),0.5529867939795015,1.120838701313051,0.41935483870967744,0.699574292980012,1.0,6/12,32.66%,SLC37A1;SLC37A2;SLC25A14;SLC37A3;SLC25A3;XPR1
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.4656628174262684,-1.1207832099228583,0.3125,1.0,1.0,10/74,12.69%,P2RY10;CD24;ACKR4;LPAR4;GPR18;TACR1;FPR3;JPH3;LPAR6;CAV3
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),0.432618492345721,1.1207666060422474,0.25925925925925924,0.6992719243148294,1.0,8/32,16.72%,TESK1;AKT1;PLK1;KAT7;GSK3B;LATS1;YAP1;TFRC
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),0.4444508922874937,1.1200417352550365,0.3103448275862069,0.7008601113062818,1.0,2/35,1.50%,TNFSF13B;TNFSF4
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.44894448570123185,1.119988455049225,0.2857142857142857,0.7004817439450952,1.0,15/30,24.07%,FZD5;CAMK2A;PLCB1;NLK;MAP3K7;TNRC6B;AGO3;FZD3;PLCB3;PPP3CB;LEF1;CTNNB1;PPP3CA;NFATC1;TCF7L2
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),0.3888838744228793,1.1198499813002005,0.3,0.7004184858664537,1.0,9/52,7.18%,NUDT21;ACACB;SAMHD1;SNCA;GLS;HOMER1;GRIN1;CPSF6;TRPM4
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.5687513763404652,1.1196872929333597,0.3170731707317073,0.7002546965083671,1.0,2/11,1.84%,MEOX2;STARD13
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),0.5835660084306818,1.1196695108411576,0.38636363636363635,0.6998271802006985,1.0,4/9,35.17%,ATRX;INO80;SSBP1;WIZ
prerank,GO_Biological_Process_2021__aromatic compound biosynthetic process (GO:0019438),-0.6628760410655242,-1.119643517807334,0.3898305084745763,1.0,1.0,1/6,1.98%,ACMSD
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),0.5193989202544558,1.119306861070626,0.2894736842105263,0.700266883174302,1.0,4/15,5.95%,FOXP1;CSF1R;EFNA2;EPHA2
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),0.5296383428143436,1.1192004438530214,0.24,0.7000281952139767,1.0,3/15,6.18%,CSF1R;PDE1B;PIR
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),-0.6276685885199305,-1.1187543185101125,0.39655172413793105,1.0,1.0,1/9,0.44%,POU4F1
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell apoptotic process (GO:0010664),0.6321625692397403,1.1186147947638383,0.38461538461538464,0.701132042862081,1.0,3/5,21.10%,PPP1R10;BMP7;BAG3
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),0.5907132304713895,1.1185777373105288,0.25806451612903225,0.7007677439240052,1.0,3/10,8.59%,PRODH;GLS;ALDH4A1
prerank,GO_Biological_Process_2021__tyrosine phosphorylation of STAT protein (GO:0007260),0.6597990622748857,1.118279334173748,0.37735849056603776,0.7010678994088111,1.0,2/5,27.76%,FER;JAK2
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),-0.6231750323994922,-1.118254549262843,0.3333333333333333,1.0,1.0,2/9,5.95%,CD9;CEACAM1
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),0.43632239359855585,1.1180392367974894,0.2777777777777778,0.7012049089782851,1.0,6/29,7.42%,SGMS1;TPD52L1;CRADD;NR4A2;CSNK2A1;DAPK2
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.5604157758117686,1.117905518235119,0.36363636363636365,0.7010414567448787,1.0,3/15,7.17%,NEDD4L;SLC12A2;KCNMA1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),-0.5256129831823304,-1.1175701785119736,0.2898550724637681,1.0,1.0,8/25,14.92%,SPARC;STAT1;THBS1;IL12A;ATP5IF1;CAV2;APOE;CCL2
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),-0.5354724635031496,-1.1171506382245688,0.33766233766233766,1.0,1.0,3/23,17.78%,ABCA12;APOE;ABCA5
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),-0.6789747797841852,-1.1168492836670214,0.36923076923076925,1.0,1.0,3/7,22.84%,TRMT10C;TRMT10B;TRMT10A
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),0.6826885987480935,1.1168271227465634,0.391304347826087,0.703366480572354,1.0,1/5,17.95%,RPRD1B
prerank,GO_Biological_Process_2021__elastic fiber assembly (GO:0048251),-0.7012405475617617,-1.1162926903001926,0.4,1.0,1.0,1/6,13.54%,FBLN5
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),0.48083751058958724,1.1162720741591552,0.28,0.7041765226230855,1.0,7/27,17.07%,SPIRE2;FAM107A;WASL;SPIRE1;TTC17;WASF3;WASF1
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),0.634820838456389,1.1162558201941837,0.3170731707317073,0.7032975328434311,1.0,3/7,20.22%,RAB23;SUFU;CABP1
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),0.634820838456389,1.1162558201941837,0.3170731707317073,0.7032975328434311,1.0,3/7,20.22%,RAB23;SUFU;CABP1
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),0.577236754679674,1.115990050129366,0.32608695652173914,0.7033951696459593,1.0,3/11,5.73%,CSPG5;DCN;VCAN
prerank,GO_Biological_Process_2021__regulation of blood-brain barrier permeability (GO:1905603),0.6081191533219267,1.1159308835148716,0.3488372093023256,0.7031810869738627,1.0,2/7,14.20%,OCLN;TJP1
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),0.3697747069198005,1.1158160320825616,0.16666666666666666,0.7030793806783167,1.0,9/73,8.79%,ITGA1;PTPRK;NPNT;RCC2;ITGB8;LYVE1;ITGA10;PPFIA2;MKLN1
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.5982439970005734,1.1155939154591852,0.3235294117647059,0.703102282740847,1.0,6/10,15.87%,NPNT;SALL1;BMP2;PKD2;SLIT2;BMP7
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),-0.634882429064065,-1.115466619721531,0.3968253968253968,1.0,1.0,2/8,13.34%,GATA1;MT3
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),-0.4924124296921731,-1.1154114359035627,0.24675324675324675,1.0,1.0,6/44,11.48%,P2RY10;RASGRP1;LPAR4;GPR18;PIK3CB;LPAR6
prerank,PanglaoDB_Augmented_2021__Mller Cells,0.35845718370923024,1.1152023953287085,0.125,0.7035729900686879,1.0,23/127,8.60%,POSTN;MAPK10;MPDZ;ANK2;PDZRN3;CXCL12;ANXA4;PDGFRA;COL9A1;PCDH17;PRDX6;CDH11;CACNA2D1;CRB1;MEGF10;NTRK2;FRZB;SLITRK2;PCDH18;FAM107A;PRRX1;PRICKLE2;CA2
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),0.5439452072528537,1.1151879366759072,0.34146341463414637,0.7031604309016473,1.0,3/10,10.56%,COPS7B;COPS2;GPS1
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),-0.6341462550128285,-1.115185537247191,0.328125,1.0,1.0,3/9,20.23%,ZWILCH;WEE1;WEE2
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.35127831668609344,1.1149989800867555,0.16666666666666666,0.7032205091280153,1.0,41/145,18.98%,BICDL1;WNT7A;LRP12;EPHA4;SHANK1;VAPA;PRMT1;ATXN10;GPM6A;TNIK;RAPGEF2;UHMK1;WASL;GPRIN1;HMGB1;DOCK7;MAP4K4;PAK3;SHANK3;CAMSAP2;GPM6B;TBC1D24;CNTN4;NCDN;NCKAP1;NBL1;WHRN;OPHN1;HDGFL3;TAOK2;GSK3B;BMP7;TBC1D23;NPY;TRIO;CTNND2;PTEN;ALS2;DNM2;CDK5R1;UNC5A
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),0.6147714402036762,1.114620642184926,0.3611111111111111,0.7037399032941185,1.0,3/9,18.01%,PNMT;PRKN;DRD2
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.48979861740927044,1.1145649155093338,0.2702702702702703,0.7034148841106022,1.0,4/19,9.70%,PICALM;BIN1;NTRK2;IGF1
prerank,GO_Biological_Process_2021__glycolipid transport (GO:0046836),-0.6639390375899032,-1.1142872721343469,0.3442622950819672,1.0,1.0,2/6,22.00%,CLN3;CPTP
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.5012892666740264,1.1140174736474107,0.21428571428571427,0.7042930970780984,1.0,6/17,17.07%,ARFIP1;CTNNA2;NCKAP1;CYFIP1;WASF3;WASF1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),-0.6555534804770828,-1.1139222817595957,0.4090909090909091,1.0,1.0,2/7,20.85%,GPER1;ENG
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),-0.6429743898739317,-1.1138794338051756,0.43333333333333335,1.0,1.0,2/10,8.99%,SFRP2;NRARP
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.6765271813300333,-1.1135181420424884,0.34545454545454546,1.0,1.0,2/9,15.43%,ATP5PD;ATP5MC3
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),-0.6952778351235636,-1.11344380807231,0.423728813559322,1.0,1.0,2/8,16.06%,SHFL;OGFOD1
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),0.45403725982846665,1.1133256349311258,0.3225806451612903,0.70554195893166,1.0,8/20,32.47%,HSD17B4;OSBPL7;OSBPL1A;SCP2;CYP39A1;CYP7B1;HSD3B7;OSBPL9
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),-0.5312084417127233,-1.1133208632371991,0.31645569620253167,1.0,1.0,1/27,0.19%,PIF1
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.5819495766320425,1.1129498515431429,0.3333333333333333,0.7060833199398503,1.0,3/8,4.67%,APOLD1;VEZF1;ZEB1
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),-0.646572824950455,-1.11291316806185,0.3770491803278688,1.0,1.0,1/7,4.51%,SELENOS
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.49502498932770833,-1.1128055644884673,0.35526315789473684,1.0,1.0,5/32,13.86%,FTH1;CP;CUTC;MT3;SLC11A1
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.5810480111808781,-1.1127430084511853,0.3181818181818182,1.0,1.0,3/16,13.16%,IFIT1;PQBP1;TLR3
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),0.6838494447240339,1.1127016970615184,0.2857142857142857,0.7062774497057472,1.0,4/6,26.15%,CSGALNACT1;CHST14;DSEL;DSE
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),-0.6533745813027966,-1.1126028257954064,0.42592592592592593,1.0,1.0,3/6,15.12%,MSMP;CCL2;CX3CL1
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),-0.6451952435785949,-1.112460848329169,0.36666666666666664,1.0,1.0,1/6,1.84%,SOX15
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),0.4730947082751913,1.112359848648095,0.2916666666666667,0.7068052854613531,1.0,6/27,10.21%,MARVELD3;DUSP10;MEN1;ITCH;DUSP19;PRKN
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),0.4017457777840566,1.1122493919819108,0.2413793103448276,0.7065413610993851,1.0,13/49,14.16%,KAT2B;ASCL1;BMP2;NOTCH2;NCSTN;MAML2;DTX4;PBX1;ITCH;EP300;ZNF423;MIB1;DTX1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),0.6603415631441653,1.1119673131291152,0.34285714285714286,0.7068213002423147,1.0,4/7,14.73%,PPP1R10;CAMK2A;CAMK2D;BMPR1A
prerank,GO_Biological_Process_2021__citrulline metabolic process (GO:0000052),0.6516828754828102,1.111696499614014,0.38,0.7071008839069676,1.0,2/6,29.43%,DDAH1;CAD
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.49560385800307183,-1.11162728138728,0.32894736842105265,1.0,1.0,5/62,9.81%,IFI6;GATA1;THBS1;GSTP1;CASP8
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.42526197395603665,1.1116003244058292,0.2692307692307692,0.7068496116128375,1.0,9/30,21.10%,PPARGC1A;RPS6KA4;ARRB1;UBE2N;NIPBL;KDM1A;CDK9;FMR1;CTBP1
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),-0.7152225396055926,-1.1114530048821352,0.27450980392156865,1.0,1.0,2/5,18.97%,SLC25A4;SLC25A5
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.43816639256710244,-1.111134266476786,0.26136363636363635,1.0,1.0,11/101,10.73%,LDHC;ACOT2;AKR1C1;ACOT1;SLC16A3;ACOT6;GLYAT;ANGPTL3;PDHX;ADH6;ACSBG2
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),0.588343448279786,1.1111164335739985,0.41379310344827586,0.707412399246777,1.0,6/13,21.17%,IGF1;CAMK2D;ROCK2;ROCK1;PRKCA;PDE9A
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),-0.728644171212703,-1.1109953829646493,0.3728813559322034,1.0,1.0,2/5,22.60%,SLX4;MUS81
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.5695101307193514,-1.1108197185495008,0.3492063492063492,1.0,1.0,5/18,12.92%,RPL23;RPS7;RPS15;HEXIM1;RPS20
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta clearance (GO:1900222),-0.7627594289120676,-1.110582447637326,0.3620689655172414,1.0,1.0,2/5,12.27%,LRPAP1;SRF
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),0.6116058753499836,1.1105307560341584,0.42857142857142855,0.7087014479686775,1.0,2/8,19.86%,MTTP;ACSL3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.43560081208346646,1.1099588728149945,0.19047619047619047,0.7098041570062654,1.0,17/47,21.01%,ARHGEF16;EGFR;EPHA2;ATP2C1;AKT1;PIK3R1;PTPN9;PRKCE;CLIP3;ZDHHC5;ATP2B4;DLG1;WNK3;CIB1;ARF6;ACSL3;ZDHHC2
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),0.6834219013583877,1.1093298080955025,0.4418604651162791,0.7109546942204449,1.0,1/7,3.24%,PIWIL4
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),0.39339925185938757,1.109267630001684,0.2608695652173913,0.7106771825731284,1.0,24/65,20.27%,SNCA;SHANK1;KANK1;DYRK1A;PIK3CA;TTBK2;TRIM54;PRKN;NAV3;SHANK3;SLIT2;CAMSAP2;SSH1;CLIP3;CLASP1;MAPRE1;SMAD4;HDGFL3;CYRIB;ARFGEF1;KATNB1;CIB1;SSH2;ATXN7
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),0.7644507913988489,1.109221508899134,0.42857142857142855,0.7103139886460321,1.0,1/5,4.43%,PARVA
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.579410459577061,-1.1091383696623478,0.33783783783783783,1.0,1.0,4/16,17.27%,CEACAM1;TLR3;INHA;ZFPM1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),0.6438836224387965,1.1090046131770939,0.40425531914893614,0.7104671261954325,1.0,3/6,25.00%,PLK1;GNAI1;EPB41
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.33975960284739937,1.10863006023135,0.2,0.7109883181975302,1.0,16/90,14.53%,ADCY1;PRKACB;MAPKBP1;CD247;CALCB;PRKAR1B;RNF26;ITCH;GPR176;ADRB1;VIPR1;ADRB2;SIRT2;FER;SAMSN1;HAVCR2
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.4780980005120289,-1.1086278537780214,0.3116883116883117,1.0,1.0,11/62,16.36%,PSMB6;GATA1;PSMB9;PSMA8;PSMA7;PSME1;PSMC3;SPI1;PSMC4;PSMA3;EIF2AK2
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.5498580302608755,-1.108309654708591,0.35294117647058826,1.0,1.0,5/20,15.12%,ANXA1;CXCL2;PPIB;CCL2;CX3CL1
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),0.6204740708118314,1.1082523823433947,0.4146341463414634,0.7113739135365361,1.0,1/9,1.75%,ADCY1
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),-0.6429017267880436,-1.1081849470654346,0.35384615384615387,1.0,1.0,5/12,14.07%,GATA1;CTSL;RDX;CTSH;BRD8
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),-0.6792774871828899,-1.108123371082344,0.4,1.0,1.0,3/6,18.49%,HSD11B1;HSD17B14;CYP3A4
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.6447312243912129,-1.108055554779861,0.31343283582089554,1.0,1.0,4/9,11.37%,HLA-A;HLA-B;CEACAM1;KLRD1
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),0.5705656793117996,1.1080350998993964,0.45454545454545453,0.7114157580872036,1.0,1/12,3.73%,IREB2
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),0.4606730418027042,1.1076443777419396,0.34375,0.7119231153746381,1.0,4/22,11.70%,CSTF3;PDE12;TOE1;ZC3H12D
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),-0.5716610450471902,-1.1076074569092371,0.3384615384615385,1.0,1.0,2/18,6.48%,TRIM22;TRIM21
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.51302975522601,1.1075756255645481,0.4,0.711597241147528,1.0,4/17,11.45%,CDC25A;RCC2;RAD51B;STOX1
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),0.5679005424287147,1.1075495155320982,0.358974358974359,0.7112105955718291,1.0,1/9,3.76%,EXOSC6
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),0.40564119590801917,1.1074526152227413,0.19047619047619047,0.7110078654396755,1.0,9/35,16.84%,PLPP1;UBR5;RBFOX2;RNF14;NR3C1;TRIP4;YAP1;PADI2;NR3C2
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.5247909575803598,1.1067453337668909,0.29411764705882354,0.7124185516395262,1.0,6/13,14.44%,ANK2;CACNA2D1;CAMK2B;STIM1;BCL2;DLG1
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,0.37104662731009325,1.106612955161118,0.26666666666666666,0.7122275306709837,1.0,40/114,21.79%,PCDH19;SEMA5B;PCDH8;CSPG5;SNAP91;ASCL1;CAMKV;ADGRL3;MEIS3;SOX9;RHBDL3;SLC35F1;SALL3;MEGF10;NPAS3;ADGRA1;KCNQ2;ASTN1;CDK5R2;MAPK4;CELF3;GPM6B;SLITRK1;LY6H;TMTC4;PTPRZ1;ELAVL3;CSRNP3;OPCML;CTNND2;DPYSL5;SOX21;POU3F4;GRIA2;POU3F2;CLVS2;ARNT2;PHYHIPL;TMEM59L;CNTFR
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),0.39926457680643296,1.1065140894506746,0.35,0.7119513104883989,1.0,12/56,17.21%,GNL3L;TRAPPC12;TESK1;AKT1;PRKN;PLK1;KAT7;GSK3B;YAP1;TM9SF4;TFRC;FYN
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.5229948971131309,1.106351921413604,0.3076923076923077,0.7118949994383537,1.0,4/18,9.72%,ACE2;TRPM4;ADRA1A;ZDHHC21
prerank,GO_Biological_Process_2021__modulation by symbiont of host autophagy (GO:0075071),0.6767600830612133,1.1063343265979808,0.3902439024390244,0.711509621646456,1.0,2/5,18.46%,ATG7;ATG5
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.6584128048812039,-1.1062986337366545,0.4032258064516129,1.0,1.0,4/12,18.76%,ANXA1;RHOH;MADCAM1;ZP3
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),0.6143419501755522,1.1061913884846362,0.36585365853658536,0.711453657909031,1.0,5/7,22.03%,PRKN;RAP1A;SLC30A1;FMR1;RAP1B
prerank,GO_Biological_Process_2021__translocation of molecules into host (GO:0044417),0.6336674387026126,1.1061327813024107,0.391304347826087,0.7107092364418538,1.0,5/6,35.48%,THOC7;THOC2;THOC3;THOC1;THOC5
prerank,GO_Biological_Process_2021__viral mRNA export from host cell nucleus (GO:0046784),0.6336674387026126,1.1061327813024107,0.391304347826087,0.7107092364418538,1.0,5/6,35.48%,THOC7;THOC2;THOC3;THOC1;THOC5
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),0.6288748476528171,1.1060762932820338,0.36585365853658536,0.7103985229275037,1.0,2/8,5.19%,PID1;NFKB1
prerank,GO_Biological_Process_2021__dopamine transport (GO:0015872),-0.7555314896461719,-1.105669429840605,0.3793103448275862,1.0,1.0,1/5,3.22%,SLC18A2
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.4671991048818933,1.1054845400373077,0.38461538461538464,0.7113641764604217,1.0,10/25,18.87%,FEM1B;DCUN1D1;UBE2N;SMAD7;FBXW7;DCUN1D5;PLK1;DCUN1D4;DCUN1D2;AXIN1
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.5908446031028746,1.1052656748661804,0.3333333333333333,0.7110343836536855,1.0,5/9,24.59%,SLC12A2;CA12;SLC12A8;SLC12A9;SLC12A6
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.5908446031028746,1.1052656748661804,0.3333333333333333,0.7110343836536855,1.0,5/9,24.59%,SLC12A2;CA12;SLC12A8;SLC12A9;SLC12A6
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),-0.6233685793736343,-1.1052240655241767,0.375,1.0,1.0,2/5,18.97%,FZD9;SLC25A5
prerank,GO_Biological_Process_2021__cellular hyperosmotic response (GO:0071474),-0.7594627088352534,-1.1050178444751615,0.3968253968253968,1.0,1.0,2/5,12.82%,AQP1;RCSD1
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.5786403037318706,-1.1050149937677942,0.3424657534246575,1.0,1.0,3/15,10.85%,HLA-A;HLA-B;IL12A
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),0.5643148200815198,1.1045817940988991,0.3333333333333333,0.7121676453952676,1.0,3/13,10.21%,SNCA;MAOA;PRKN
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),0.6001663916597793,1.1045261667845734,0.4186046511627907,0.7118691130797272,1.0,5/9,29.91%,CEP290;RORB;ARL3;CDHR1;RP1
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),0.3819675312141456,1.104144943790227,0.2222222222222222,0.7124552981576541,1.0,4/60,2.66%,NUDT21;WDR33;PAPOLA;CSTF3
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.48231882053326314,-1.1038327683488651,0.34146341463414637,1.0,1.0,18/54,22.31%,IRF1;IL1R1;IL7;STAT1;CD9;IFNGR2;STAT2;CD14;A2M;LTBR;IL3RA;SOCS3;IL15RA;CD44;TNFRSF21;CRLF2;IL4R;TNFRSF12A
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),-0.6851569607234614,-1.1036264024410873,0.3548387096774194,1.0,1.0,2/8,13.34%,SLC51B;MT3
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.40358010519085463,1.1036165942999305,0.2,0.7133313158958433,1.0,11/36,21.42%,FEM1B;UBE2N;NPAS2;RFWD3;NEK4;SMG1;FXR1;WRNIP1;CDK9;FMR1;ETAA1
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.504476610358335,1.103409797586648,0.3870967741935484,0.7134560902859529,1.0,8/23,26.66%,PRELID2;MTTP;OSBPL8;PITPNM1;OSBPL5;SCP2;PRELID3B;TNFAIP8L3
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),0.4930947336615983,1.103212919176766,0.36,0.71359280120311,1.0,5/16,19.69%,SOX9;TRPM4;ECM1;ROCK2;ROCK1
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),0.7075822364766556,1.1031325161148666,0.3673469387755102,0.7133184792507236,1.0,2/5,24.37%,PTPRJ;PTPRC
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),0.5921714521448852,1.1030557096648606,0.4,0.7131290349590895,1.0,1/10,4.32%,RHOT1
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),-0.6666349118108932,-1.1028492405129322,0.4406779661016949,1.0,1.0,5/7,30.57%,MCMDC2;MCM5;ORC3;MCM3;MCM4
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),0.39793238074489096,1.1027885036726124,0.23076923076923078,0.7134105247302774,1.0,18/50,24.42%,NUP37;NUP188;RANGAP1;REEP4;CHMP2B;LBR;SIRT2;NDC1;PPP2R2A;NUP205;NSFL1C;UBXN2B;PPP2R1A;CHMP6;NUP98;IST1;AHCTF1;RCC1
prerank,GO_Biological_Process_2021__regulation of hormone secretion (GO:0046883),-0.6937005006325783,-1.1027474950277432,0.40350877192982454,1.0,1.0,2/5,19.87%,ANXA1;SNX6
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),-0.698333037420514,-1.1025360672949582,0.4117647058823529,1.0,1.0,5/6,26.99%,S100A10;EMP2;ANXA2;FLOT1;RFTN1
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),0.593989260042317,1.102288299280377,0.42857142857142855,0.7143791830026958,1.0,3/7,7.36%,NEDD4L;BIN1;KCNH2
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),0.5536619918760364,1.1021280723746958,0.3548387096774194,0.7143581927773583,1.0,4/18,5.80%,FLT1;CSF1R;MLLT3;PLEK
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.4699011568480275,1.1020498120812579,0.2903225806451613,0.7141324334986257,1.0,10/25,22.17%,PRKX;CSF1R;PKD2;MTSS1;SLIT2;ACVR1;SCRIB;CCM2;MESP1;CTNNB1
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.3614623499089249,1.101645963069433,0.14285714285714285,0.7146895088925014,1.0,31/120,23.00%,CLDN12;MPDZ;NR2F6;EGFR;RORA;CEP170B;BOK;PLIN5;LGR4;AKT1;ALDH4A1;RBFOX2;FKBP5;PKDCC;ADGRL2;B4GALT2;TSPAN9;YAP1;DDAH1;SNX7;BCAR1;CHST3;CASKIN2;TSPAN12;PLS3;KCTD3;ADCY6;EPB41L4B;TMEM47;TEAD1;ERRFI1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.38804188107513055,1.1015183188892448,0.15384615384615385,0.7145721107281832,1.0,13/50,13.91%,CDC25A;RCC2;EGFR;RGCC;CDC27;AKT1;PLCB1;RAD51B;ANKRD17;STOX1;NSMCE2;UBE2E2;RPTOR
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),-0.7115837027290034,-1.1008702271480177,0.3898305084745763,1.0,1.0,1/5,9.99%,GAD1
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),0.47810936062114373,1.1006090021303712,0.3,0.7161743495751693,1.0,4/31,10.35%,GSTT2;GSR;GSTM2;GCLC
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.5287859058747422,1.1001574615198126,0.3111111111111111,0.7171136736429992,1.0,5/13,22.83%,HOMER1;GRM1;GRM8;HOMER2;GRM5
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.6118228179585268,-1.1001121334897899,0.3230769230769231,1.0,1.0,3/11,9.23%,CD9;CEACAM1;RDX
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.379091763953549,1.1000939601798496,0.25,0.7167668139768695,1.0,35/107,18.54%,PTPRK;MACIR;MITF;ZMYND8;DACH1;EPHA4;RAP2B;MARVELD3;KANK1;LIMCH1;FOXO3;SERPINE1;DUSP10;ROBO1;SMAD7;PTPRJ;NAV3;ADARB1;NF1;SLIT2;AFDN;MAGI2;DLG5;RAP2C;PTPRG;CLASP1;ADIPOR1;BMPR1A;DUSP22;RAP2A;ARID2;RNF41;DRD2;PTEN;SRGAP2B
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.5449011743780725,1.1000223991797795,0.2894736842105263,0.7165163997388332,1.0,4/13,12.84%,BAHD1;LOXL2;HP1BP3;SIRT1
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),0.5352338870606905,1.1000170345466893,0.34210526315789475,0.7156448896801371,1.0,5/13,21.42%,COQ3;COQ9;COQ2;PDSS2;FDXR
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),0.5352338870606905,1.1000170345466893,0.34210526315789475,0.7156448896801371,1.0,5/13,21.42%,COQ3;COQ9;COQ2;PDSS2;FDXR
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),0.6647800538641968,1.0999298587203379,0.34210526315789475,0.7153237497867566,1.0,2/5,19.82%,BMP2;REST
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.4291762995938248,1.0998166174582409,0.2692307692307692,0.7151706216295832,1.0,12/41,18.62%,EFNA5;EPHA5;NR1D1;CSNK1E;PRKN;DVL1;CAMK2D;FER;PARD6G;KDM1A;TTL;PPM1F
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),0.6011620825266544,1.0994970876330736,0.4166666666666667,0.7154244994549177,1.0,2/10,9.83%,LIG4;GLI3
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.49098520232372145,-1.0994958408855664,0.3157894736842105,1.0,1.0,11/37,16.26%,DOCK8;HLA-A;IL7;ANXA1;PNP;RHOH;PRKCQ;PDCD1LG2;CCL2;CD274;XBP1
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),-0.6624950620894324,-1.0991519704511912,0.36,1.0,1.0,4/8,26.33%,THBS1;WNT5A;HSPD1;TNIP2
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.3622990905682041,1.0991220083408848,0.18181818181818182,0.7158933065307147,1.0,30/85,18.92%,DNM3;PCDHB2;ADGRL3;CDH2;FZD5;CDH11;GPM6A;CDH20;PKP4;NRXN1;FBLIM1;TLN2;SDK1;CDH9;SHANK3;NLGN3;SLITRK1;PCDHB13;FARP1;OPHN1;TJP1;VASP;CDH18;CDH8;ITGA6;CTNND2;NRXN2;DRD2;PTEN;CDH6
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.6042212543805896,-1.0991176702297412,0.3548387096774194,1.0,1.0,4/11,8.81%,ZWILCH;SPDL1;MTBP;MIS12
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.4343565712748192,1.098963837805102,0.2857142857142857,0.7158118137351651,1.0,15/42,22.73%,RGCC;EPHA2;AKT1;HMGB1;PRCP;NF1;PRKD1;SIRT1;ATP2B4;HIF1A;AKT3;PRKCA;FGF2;VASH1;MECP2
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.4931462327150488,-1.09893967920889,0.29411764705882354,1.0,1.0,3/39,7.31%,WARS1;PARS2;GARS1
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.5555473051010527,1.0987517312283983,0.42857142857142855,0.716005114013237,1.0,4/13,16.86%,SMCR8;ADRB2;FYCO1;UBQLN4
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),-0.6662585697371044,-1.0987132401531807,0.3389830508474576,1.0,1.0,1/7,2.06%,PATL2
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),0.6535134510733008,1.0981660086739349,0.34375,0.7170098141255421,1.0,5/6,32.84%,TENT4B;LIN28B;DIS3L2;PARN;SND1
prerank,PanglaoDB_Augmented_2021__Platelets,-0.44729404524130445,-1.0980045961504392,0.29545454545454547,1.0,1.0,25/91,21.06%,HLA-A;SELP;SPARC;CD9;P2RY12;CLEC12A;THBS1;P2RY13;F13A1;DPEP2;GMFG;F5;LGALS8;VWF;LTBR;SPI1;CXCR4;MYO1F;ARHGAP10;CXCL14;ALOX12;OST4;CRLF2;CTSA;ILK
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.6105830547541329,-1.0976558023996181,0.3709677419354839,1.0,1.0,1/11,2.68%,SLC51B
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),0.5925019717387057,1.0976318847525484,0.46153846153846156,0.7178582107435125,1.0,2/8,4.07%,ABCA1;PRKACB
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.5765770561505053,1.0976117498547,0.3076923076923077,0.7174776829756512,1.0,7/10,27.16%,DNAJB2;SACS;DNAJB6;HSPA1A;DNAJA4;BAG5;SNCAIP
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.543824787741671,1.0974128647965447,0.4166666666666667,0.7175026941298469,1.0,6/13,15.60%,SOX8;FBXL17;CDH2;TAPT1;PEF1;NRG1
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.4593776460546085,-1.0972019587222481,0.3,1.0,1.0,25/78,18.39%,P2RY10;KMO;HLA-A;HLA-B;TAGAP;FTL;RAB7B;CLEC12A;IGSF6;ANXA1;HLA-C;PDPN;CD14;TLR3;PDCD1LG2;SLC11A1;SPI1;CXCR4;ARHGAP30;PPL;MYO1F;GPR68;SCIMP;S100B;PTAFR
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.33126170991204223,1.097100996674796,0.25,0.7179086859787197,1.0,56/185,20.33%,NCK2;MAP3K11;ARHGEF12;STK38L;NOTCH2;CDC27;BIN1;ARHGAP5;MID1;WASL;KPTN;RASAL2;FGD4;ITSN1;PKD2;DOCK4;ANLN;NF1;DYNLL2;STAU1;SOS1;PLK1;RASA2;CKAP5;KIF1B;NCK1;RAB3GAP1;PDLIM5;FARP1;ABI1;INCENP;CLASP1;OPHN1;MAPRE1;ALMS1;DLG1;CDC42BPA;TAOK2;LATS1;KIF15;ARHGEF7;ESPL1;PXN;ARFGEF1;WASF1;KLC1;TRIO;KATNB1;ALS2;BCAR1;ARHGDIA;ARF6;SSH2;ROCK1;MARCKS;PCM1
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.5844884404427466,-1.0970789369137715,0.3220338983050847,1.0,1.0,1/12,0.80%,DOCK8
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.578387311519224,1.0963861365239391,0.34375,0.719587407835822,1.0,6/14,13.85%,AKT1;PSMD10;IGF1;PRKN;HGF;OPA1
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.35187654582843825,1.0960775753836771,0.2,0.7198370314932914,1.0,41/158,18.38%,LIMD1;PDE3A;PDE3B;WTIP;PDE10A;RORA;CD22;MAPKBP1;PLEK;EPHA2;CGNL1;AKT1;SPRED1;NR1D1;PPM1A;SPRY3;PSMD10;PTPRJ;NF1;SLIT2;SIRT1;MAGI2;DLG5;CDC34;MAPKAPK5;BCL2;DGKG;ATP2B4;VGLL4;ADIPOR1;PDE2A;CYRIB;BMP7;UBR1;PDE4D;PHLPP2;DRD2;PTEN;MDM2;CPNE1;CIB1
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.3842030204788437,1.0960041494193333,0.32142857142857145,0.7197298068772359,1.0,12/53,16.95%,SNCA;PICALM;CD22;NEDD4L;ABL2;PRKD1;CLIP3;OPHN1;CDH13;HIP1;MTMR2;RAB4A
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),-0.6712724012651499,-1.095647394035454,0.47619047619047616,1.0,1.0,2/6,13.71%,ISG15;HERC5
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),-0.649592361113265,-1.0955519223968961,0.4444444444444444,1.0,1.0,5/9,30.57%,MCMDC2;MUS81;MCM5;MCM3;MCM4
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.6395452127567487,1.095477982234986,0.40476190476190477,0.7202635767274551,1.0,2/7,4.85%,SOX8;SOX9
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.6395452127567487,1.095477982234986,0.40476190476190477,0.7202635767274551,1.0,2/7,4.85%,SOX8;SOX9
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),0.6573299265884944,1.0952691217048902,0.40540540540540543,0.7204528635424086,1.0,1/6,2.63%,ANK2
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),0.49712168417355335,1.0952237745646114,0.4166666666666667,0.7201202650636945,1.0,4/16,16.90%,CCT4;DKC1;CCT3;CEP120
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.33512324316460856,1.0951138227302384,0.0,0.7199065575293322,1.0,57/195,21.17%,WNT7A;ADAMTS3;SASH1;KAT2B;TPD52L1;SALL1;NPTN;SHANK1;CRADD;HOMER1;GRIN1;BMP2;KANK1;TSPAN14;MAML2;MYORG;CSNK2A1;ROBO1;LMO3;NRXN1;PIK3R1;IRS1;IGF1;PKD2;EP300;SHANK3;ZRANB1;NLGN3;SIRT1;TGFBR1;DLG5;ZDHHC5;SNX5;NRP1;YAP1;TRIM16;PHIP;PTPN11;SMO;TRIM44;HIF1A;MAML1;RBPJ;CDKN2AIP;PTEN;NTRK3;ASXL2;FAS;ARNT;RIMS2;MBD5;PRKCB;TSPAN5;CREBBP;MESP1;NLGN1;PRKCA
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.4081996161492756,1.0950578515559555,0.35,0.7195746968721595,1.0,10/34,15.77%,SEMA5B;SOX8;ERBB4;CDH2;SEMA3C;TAPT1;PEF1;NRG1;SEMA6C;SEMA4D
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),0.610638648938503,1.0949010726500121,0.42857142857142855,0.7194680887545419,1.0,4/6,21.10%,DIPK2A;IGF1;BMP7;BAG3
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.6874855176670132,1.0948276891037088,0.3404255319148936,0.7191960332138235,1.0,3/5,30.80%,MTMR2;MTMR9;MTMR3
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.49474700312715725,1.094329984999754,0.34615384615384615,0.7199526264529096,1.0,6/30,18.55%,ATP6V0D2;ATP6V1A;ATP6V1C1;ATP6V1B2;TFRC;DNM2
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),-0.5632729228004425,-1.0942334604955934,0.42424242424242425,1.0,1.0,1/18,0.19%,PIF1
prerank,GO_Biological_Process_2021__regulation of gap junction assembly (GO:1903596),0.6632428838055953,1.0942235555576303,0.4418604651162791,0.7197278573705584,1.0,1/5,0.09%,ACE2
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),-0.6439974899510841,-1.0940150432401814,0.36363636363636365,1.0,1.0,2/7,12.81%,SLX4;BLM
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),0.4416309751825412,1.09367328884333,0.3181818181818182,0.7206248736822819,1.0,6/29,14.97%,RAB27A;SYT3;DOC2A;RIMS3;SYT9;GSK3B
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),0.41578363307444566,1.0934910908338453,0.2222222222222222,0.7207185216911258,1.0,10/45,17.07%,SPIRE2;MICAL1;FAM107A;WASL;SPIRE1;TTC17;ENAH;ABI1;WASF3;WASF1
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.4717207588336492,1.0933537221327854,0.2631578947368421,0.7205762345990206,1.0,3/24,2.13%,MEOX2;STARD13;HDAC9
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),0.4595661882570943,1.0925172764141773,0.25,0.722119221946391,1.0,6/29,18.43%,DNASE1L2;DFFB;ENTPD6;ENTPD4;PPP1R8;HNRNPD
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),0.49634153483845206,1.092427935831455,0.3488372093023256,0.7219055980694854,1.0,5/13,24.85%,BRAF;CLIP3;OCLN;PRKCB;RTN2
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.472809819345566,1.0916764454460084,0.3448275862068966,0.7235165306756143,1.0,7/21,17.32%,RGCC;CDC27;IGF1;NSMCE2;PHIP;ESPL1;CUL3
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.6108551224058865,1.0915901574038245,0.41304347826086957,0.7232905574065442,1.0,5/8,26.53%,IL17D;TICAM1;HIF1A;MYD88;IL17RA
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),0.6086127943224066,1.0915498669100536,0.38461538461538464,0.7229237921999105,1.0,2/9,5.69%,ERBB4;MFF
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),0.4863481382532196,1.0915245607299795,0.2727272727272727,0.7225339735563393,1.0,2/15,5.26%,SORT1;EPS15
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.5462949727907213,1.0914225268046447,0.3333333333333333,0.7222033318805513,1.0,3/11,7.30%,GABRG1;GABRA5;GABRA4
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.5064307329933383,-1.0910689435240615,0.3150684931506849,1.0,1.0,4/34,6.81%,RPL23;RPL11;RPS7;RPL5
prerank,GO_Biological_Process_2021__positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),0.6839641706446421,1.090626592598286,0.37209302325581395,0.7238444262585421,1.0,4/5,30.16%,LMO3;ASXL2;PTGIS;GPS2
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),0.5554282606123105,1.0905635004606402,0.35,0.7236072096158231,1.0,2/15,7.42%,MCU;DAPK2
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),-0.5464971517185542,-1.0904330578776464,0.3333333333333333,1.0,1.0,6/23,16.80%,ITGA5;COL8A1;NODAL;LAMB1;COL4A2;CTR9
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),0.5163978381670304,1.0904280185927642,0.37142857142857144,0.7236984390206703,1.0,3/11,18.05%,UHMK1;PTPN14;NUP214
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),0.6144547606037456,1.0903965419654007,0.4864864864864865,0.7233327537595942,1.0,5/7,17.45%,ERBB4;AKT1;LATS1;AKT2;ZNF703
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.6275830561995133,-1.0903744091917593,0.34615384615384615,1.0,1.0,3/9,6.81%,COPS9;RPL11;RPL5
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.49707269775370233,1.090073707933088,0.3125,0.7236815681439952,1.0,3/24,1.76%,BACH1;CDK18;KLF11
prerank,GO_Biological_Process_2021__lactation (GO:0007595),0.5993821223132982,1.089964652538159,0.43902439024390244,0.723503514645709,1.0,1/8,3.13%,ERBB4
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),0.5840039409458279,1.0896616140689779,0.46153846153846156,0.7237115050969027,1.0,2/10,9.87%,EPHA4;RTN4RL1
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),0.647453548441971,1.0894524342063234,0.36585365853658536,0.7234027148475817,1.0,4/7,32.54%,EEFSEC;SEPSECS;SECISBP2L;SELENOT
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),0.647453548441971,1.0894524342063234,0.36585365853658536,0.7234027148475817,1.0,4/7,32.54%,EEFSEC;SEPSECS;SECISBP2L;SELENOT
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),-0.6749328988954117,-1.0893460128288528,0.39285714285714285,1.0,1.0,2/7,10.72%,ATG14;VAMP8
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),0.5512526707308073,1.088803428254735,0.35135135135135137,0.7242756245256484,1.0,6/12,33.77%,ALMS1;ROCK2;ROCK1;FHOD1;SLC9A1;CDC42
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),-0.7216987847258582,-1.088491404763588,0.4166666666666667,1.0,1.0,2/5,22.66%,TRMT10C;TRNT1
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.46822660406027145,-1.0882740941519418,0.30666666666666664,1.0,1.0,10/58,16.36%,PSMB6;GATA1;PSMB9;PSMA8;PSMA7;PSME1;PSMC3;PSMC4;PSMA3;EIF2AK2
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3978308325909481,1.0880708496622091,0.3,0.7257190110543393,1.0,9/35,15.87%,BMP2;SMAD7;GDF10;ACVR1;TGFBR1;ACVR2A;SMAD4;BMPR1A;BMP7
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),0.5785577855903214,1.0880047341967174,0.4,0.7254354656613458,1.0,2/10,6.09%,SERPINE1;MME
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,-0.504258500813085,-1.0874078351879781,0.391304347826087,1.0,1.0,9/32,10.76%,P2RY10;GPR183;TAGAP;CD5;DPEP2;GMFG;GPR171;ARHGAP9;TRAF3IP3
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.5139010051632968,-1.0868704816302546,0.4393939393939394,1.0,1.0,17/25,35.05%,C1R;CPB2;CLU;C1QB;C1S;SUSD4;CR1;C2;C3;PHB2;SERPING1;C1QBP;C6;C5;CD46;CR1L;PROS1
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),0.6286589901135219,1.086311615974891,0.34210526315789475,0.7288452405829903,1.0,4/6,28.30%,MSRB3;MSRB1;MSRA;FN3K
prerank,PanglaoDB_Augmented_2021__Follicular Cells,-0.48765590191019903,-1.086224178336315,0.31746031746031744,1.0,1.0,8/42,8.79%,SLC3A1;ADH4;PDZK1;BHMT;ALDOB;FMO5;ANGPTL3;TSHR
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.5014696878711795,1.0859127108400881,0.42424242424242425,0.7292820166787062,1.0,4/18,20.67%,SLC6A13;SLC47A1;SLC6A6;SLC6A9
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.5439565990512365,-1.0857662678003945,0.4225352112676056,1.0,1.0,6/15,20.53%,RASGRP1;IL12A;KLRD1;CD160;MICA;HLA-F
prerank,GO_Biological_Process_2021__regulation of hair cycle (GO:0042634),0.6541871877402121,1.0857526771612307,0.4375,0.7292412006694795,1.0,2/5,12.96%,CLOCK;NIPBL
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),-0.638655167228322,-1.0855764313738827,0.4067796610169492,1.0,1.0,4/8,25.24%,NEFH;DRC1;HAP1;IGBP1
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),-0.6750124901859758,-1.0854257196456616,0.38461538461538464,1.0,1.0,2/5,19.87%,VAMP8;SNX6
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.5243748619810236,-1.085289825084139,0.35294117647058826,1.0,1.0,7/28,13.86%,CP;FTL;B2M;CUTC;TMC8;MT3;SLC11A1
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),0.6413040226590744,1.0852037504436407,0.42857142857142855,0.7301074859791908,1.0,3/6,28.26%,GCLC;CDO1;TST
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),-0.6224458567601361,-1.0847071878788215,0.42857142857142855,1.0,1.0,3/9,21.67%,FES;CD74;IL34
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.5384913231271988,1.0846669549957935,0.34285714285714286,0.730868138336678,1.0,4/13,15.55%,SLITRK2;LRRC4C;SLITRK1;LRFN5
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),0.6427848167830925,1.0844249255799532,0.38095238095238093,0.7309309828321235,1.0,2/6,26.34%,PGM2;GALE
prerank,MSigDB_Hallmark_2020__Adipogenesis,0.37649163481817216,1.084280099446606,0.0,0.7308196315346874,1.0,40/178,19.80%,MTARC2;SLC19A1;SOWAHC;PPP1R15B;ABCA1;HADH;MGLL;LTC4S;RNF11;ADIPOR2;QDPR;ELOVL6;GPHN;CCNG2;DNAJC15;PEX14;ITSN1;MIGA2;SDHC;MRAP;GPAM;SAMM50;RREB1;DRAM2;COL15A1;MAP4K3;UBQLN1;ACADM;YWHAG;CRAT;GPD2;PGM1;LIFR;COQ3;AIFM1;DLAT;COQ9;SQOR;PTCD3;APLP2
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.4981903746551256,1.0840179335889282,0.32142857142857145,0.7309404356000452,1.0,6/17,24.18%,TRAK1;TRAK2;NECTIN2;MTM1;MARK1;MARK2
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),0.4483965111611162,1.083611825841236,0.3793103448275862,0.7315364580595812,1.0,5/27,9.70%,TCAP;ANK2;MEGF10;BIN1;IGF1
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),0.3759531525209891,1.0834187682672107,0.2857142857142857,0.7316798655420362,1.0,27/92,23.78%,WDR33;NUP42;NUP37;NUP188;AGFG1;U2AF1;FYTTD1;SMG1;KIF5C;EIF4E;RBM15B;NUP153;U2AF2;NDC1;THOC7;SMG7;NUP205;NUP214;FMR1;ALKBH5;RANBP2;THOC2;NXT1;MAGOH;NUP98;CPSF2;NUP54
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.6158172701779255,-1.0833799878582642,0.4,1.0,1.0,3/10,7.95%,ENPP2;VIL1;PDPN
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.6216564370821855,1.083286469189323,0.45454545454545453,0.731591494286902,1.0,6/8,36.72%,OPHN1;RAP2A;CAMSAP3;CDC42;EZR;RHOA
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",0.6168598862511565,1.0832243730979554,0.5428571428571428,0.7309061360238348,1.0,1/7,3.76%,EXOSC6
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),0.6168598862511565,1.0832243730979554,0.5428571428571428,0.7309061360238348,1.0,1/7,3.76%,EXOSC6
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),0.43345415643939905,1.0831430813465424,0.25,0.730749023946851,1.0,11/50,13.93%,ANXA11;SNCA;HOMER1;SLC30A4;NEDD4L;LOXL2;GPHN;KCNMA1;ATP7B;PEF1;BCL2
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),0.3733440033972636,1.082978884138223,0.34782608695652173,0.7307653916608595,1.0,12/62,10.21%,UHRF2;SH3RF3;RNF11;UBE2T;RNF146;RAD18;SH3RF1;ITCH;MARCHF7;RNF208;CNOT4;PRKN
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.3714044376863935,1.0828108192530852,0.29411764705882354,0.7308741080320834,1.0,17/58,20.95%,CDC25A;PTPRK;ZBTB1;RHBDD1;MME;SDE2;EIF2AK4;EP300;SIRT1;STK11;USP47;IMPACT;KDM1A;YY1;N4BP1;CREBBP;FMR1
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.673555885507445,-1.0825250827640978,0.38461538461538464,1.0,1.0,2/8,14.61%,B3GALT2;B3GNT3
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),-0.673555885507445,-1.0825250827640978,0.38461538461538464,1.0,1.0,2/8,14.61%,B3GALT2;B3GNT3
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.4989498764077791,-1.0821804797457333,0.3472222222222222,1.0,1.0,4/32,12.34%,TOMM7;UBL5;ARIH2;ATP5IF1
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.3698465784944493,1.0821620810496915,0.3333333333333333,0.731813514869105,1.0,18/84,14.38%,ACE2;PPARGC1A;MYO5B;TFCP2L1;LPP;ESRRG;ITGB8;CDKL5;THRB;CPEB4;ZBTB7C;FGD4;MUC20;TSC22D2;MYH14;EHF;BAZ2B;NEBL
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),-0.5215755005868654,-1.0819950311009103,0.3283582089552239,1.0,1.0,3/29,7.00%,P2RY12;THBS1;SEMA5A
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),-0.5345895114232124,-1.0818187023536467,0.3709677419354839,1.0,1.0,5/19,21.28%,M6PR;CLU;AP4M1;GNPTAB;GCC2
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.45590711724355926,-1.0817800960843333,0.2972972972972973,1.0,1.0,9/61,17.11%,ANKRD53;CETN2;KIF20B;SVIL;RAB11A;DCDC1;CENPV;PLK3;GIPC1
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.530407083223567,-1.081729342044315,0.3918918918918919,1.0,1.0,6/26,13.16%,RPS27A;CASP8;UBC;CD14;LY96;TLR3
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.530407083223567,-1.081729342044315,0.3918918918918919,1.0,1.0,6/26,13.16%,RPS27A;CASP8;UBC;CD14;LY96;TLR3
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),0.6086009320822146,1.081572212737381,0.42105263157894735,0.7328210012387245,1.0,3/8,17.13%,AMER2;SMURF1;ITGA6
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.521524477375232,1.0810215381426265,0.3225806451612903,0.7339655989530562,1.0,4/12,24.76%,TASOR;TRIM28;PPHLN1;ZNF304
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),0.5910989296798499,1.081006034408211,0.375,0.733565341165061,1.0,3/8,21.02%,SHANK1;DRD2;SLC6A1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.3411174108069856,1.0805943688381403,0.2,0.7341210393925681,1.0,25/105,17.21%,CASS4;ERBB4;EGFR;FAM110C;PDGFRA;MYORG;HCLS1;FGF17;PIK3CA;STRN;PIK3R1;IRS1;PDGFA;HGF;PTPRJ;NRG2;PTK2;TGFBR1;GAB1;HIP1;OSBPL8;NRG1;PTPN11;AKT2;FYN
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.44754552907469436,1.0805274457399652,0.25,0.7338592235491914,1.0,15/32,27.37%,RGCC;BMP2;SMAD2;LOXL2;TGFBR2;TGFBR1;SMAD4;ZNF703;LEF1;CTNNB1;SMAD3;TCF7L2;JAG1;TGFB2;BCL9L
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),0.5298736385999034,1.080476374799921,0.38235294117647056,0.7331411661310133,1.0,7/15,31.27%,KANSL2;OGT;KAT7;KANSL3;HCFC1;KAT8;JADE1
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),0.5298736385999034,1.080476374799921,0.38235294117647056,0.7331411661310133,1.0,7/15,31.27%,KANSL2;OGT;KAT7;KANSL3;HCFC1;KAT8;JADE1
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.5103141250624743,1.080237354847755,0.3055555555555556,0.7332938398060046,1.0,4/12,19.58%,MLLT3;HNRNPU;CDK9;SETD5
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),-0.6875251623246361,-1.0799941039031955,0.423728813559322,1.0,1.0,3/5,30.25%,XBP1;MMP14;SYK
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.5217299391479816,1.0799409172574947,0.36,0.7335381560588172,1.0,4/16,9.82%,TNFSF4;MAPK11;PLCB1;HMGB1
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),0.3545412252086595,1.0798810193404744,0.25,0.733254514253202,1.0,14/83,14.79%,USP13;RCN3;STT3B;RHBDD1;MARCHF6;TMEM129;DNAJB2;ECPAS;PRKN;UBXN6;DERL2;UGGT1;UBQLN1;VCP
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),0.4813650597892003,1.0798232332201332,0.34146341463414637,0.7330285285236323,1.0,3/10,7.36%,NEDD4L;BIN1;KCNH2
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),0.455799554896677,1.0796561166881025,0.32142857142857145,0.7330663330767518,1.0,11/33,14.78%,SNCA;DNM3;SNAP91;PICALM;ITSN1;PIP5K1C;NLGN4X;NLGN3;STX1A;OPHN1;SYNJ1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),0.5921116016485242,1.0790251359096636,0.3695652173913043,0.7340659615814462,1.0,4/9,26.01%,RGCC;CLASP1;SMAD3;CLASP2
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),0.4985419293601484,1.0789131878257647,0.2857142857142857,0.733851341357546,1.0,5/16,11.44%,PID1;PICALM;RHOQ;PPP2R5A;MRAP
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),0.45539217244214725,1.078629305876702,0.35714285714285715,0.734208840812509,1.0,7/31,13.85%,MFF;AKT1;PSMD10;IGF1;PRKN;HGF;OPA1
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),0.6671593641781829,1.0785065719293685,0.41304347826086957,0.7341086951353112,1.0,1/5,11.64%,GPAM
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.46669106176194247,-1.0783652250836484,0.3972602739726027,1.0,1.0,8/50,16.17%,PSMB6;PSMB9;PSMA8;PSMA7;PSME1;PSMC3;PSMC4;PSMA3
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.36061103278161344,1.0782888151479832,0.3076923076923077,0.7342942647331804,1.0,18/76,16.21%,PRODH;SNCA;PDE12;SOX4;ACER3;ADNP2;RAD18;NPAS2;SARM1;PRKN;SLC25A24;DCC;PRKD1;NCK1;RRAS2;FAF1;BMP7;IMPACT
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),0.48084892865876694,1.0779637943825884,0.25,0.7347764634865903,1.0,9/17,25.65%,PPM1E;KCNH2;RAP2A;TFRC;PPM1F;REST;GAS6;PDE4B;KCNE2
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),0.615204023858378,1.0774383980721047,0.4318181818181818,0.7355433586656475,1.0,4/8,29.69%,SMG1;RPTOR;LARP1;MTOR
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),-0.6777419968902241,-1.0773095290495986,0.423728813559322,1.0,1.0,1/5,12.20%,OAS3
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.45258979789173176,1.0772704626699652,0.2727272727272727,0.7355681070599172,1.0,6/24,14.40%,B4GALT3;ST3GAL1;B4GALT6;B4GALT2;B4GALT5;HEXB
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.5457806050736604,1.077208125639649,0.3235294117647059,0.7353078984766965,1.0,7/13,28.25%,NOTCH2;ROBO1;SLIT2;NFATC1;JAG1;TGFB2;ROBO2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.5817426953523311,-1.077132217400849,0.3508771929824561,1.0,1.0,1/10,3.05%,SELP
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),0.4573384037348499,1.0771054133144125,0.34285714285714286,0.735104946975215,1.0,6/22,20.67%,SLC43A1;SLC38A6;SLC6A6;SLC6A7;SLC7A9;SLC6A9
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),0.44332893577035715,1.0770576616156282,0.36363636363636365,0.73475424407295,1.0,5/27,12.30%,ABCA1;ATP11C;ATP9A;ATP10A;ATP8A1
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),-0.6529082602354954,-1.0767466441155393,0.3968253968253968,1.0,1.0,2/6,22.66%,TRMT10C;TRNT1
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),0.479235704137642,1.0767313213161522,0.2972972972972973,0.7350752011928473,1.0,7/21,17.55%,SORT1;CHMP1A;LEPROTL1;UBXN6;CHMP2B;VCP;VTA1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.3612170880492224,1.0765782830585229,0.3333333333333333,0.7351001509996906,1.0,22/89,19.00%,WNT7A;BTRC;PASK;SOX4;CPEB3;ZCCHC4;AKT1;CYFIP2;HDAC2;ATG7;RPS6KB1;PLK1;OGT;ASPH;VGLL4;TBC1D10A;FAF1;FXR1;EIF3E;HNRNPD;FBXW11;LARP4
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),0.6731448954187003,1.076272109753554,0.42105263157894735,0.7355114412890867,1.0,2/5,7.83%,KAT2B;KAT2A
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),0.48817838597874785,1.0762242433330282,0.36666666666666664,0.7351953918740368,1.0,5/21,11.44%,PID1;PICALM;RHOQ;PPP2R5A;MRAP
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),-0.5586738681807485,-1.0760848623240715,0.391304347826087,1.0,1.0,4/12,28.22%,UAP1;GNPDA1;GFPT2;UAP1L1
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.5250635437280464,1.0760794990865796,0.41025641025641024,0.7350726707318771,1.0,7/13,29.73%,DOCK7;CEP120;FBXW11;PCM1;HOOK3;SUN2;PAFAH1B1
prerank,MSigDB_Hallmark_2020__Angiogenesis,0.42641046249197134,1.0756004321253378,0.32142857142857145,0.7357781991779133,1.0,5/24,14.98%,POSTN;VCAN;PDGFA;PTK2;NRP1
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),0.4480151558258762,1.0752276941056402,0.36,0.7363015079124337,1.0,18/41,22.17%,RANBP3L;FBXL17;SOX9;BMP2;LOXL2;HGF;TGFBR1;DLG5;TRIM28;GSK3B;ROCK2;BMP7;HIF1A;RBPJ;ROCK1;LEF1;FGFR2;CTNNB1
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),-0.6454251670914104,-1.0751918324649161,0.4375,1.0,1.0,1/8,2.15%,GPR183
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.42071015975610604,-1.0751480914974485,0.29545454545454547,1.0,1.0,17/112,16.81%,PSMB6;RPS27A;PSMB9;PSMA8;RPA3;PSMA7;PSME1;PSMC3;UBC;POLE4;BLM;WDHD1;PNKP;PSMC4;POLE3;PSMA3;DDX23
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.34117960889223187,1.0750522131661338,0.3333333333333333,0.73646162427272,1.0,33/106,20.27%,BICDL1;LRP12;CSF1R;VAPA;PRMT1;ATXN10;PLEK;GPM6A;RAPGEF2;CARMIL1;UHMK1;GPRIN1;PKD2;HMGB1;DOCK7;GPM6B;TBC1D24;CNTN4;TTC17;NCDN;OPHN1;HDGFL3;GSK3B;TBC1D23;CYFIP1;TTC29;NPY;CDK5R1;ARMC2;UNC5A;ROCK1;SAMD14;PLEKHA1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),0.41729154120576967,1.0749085545643404,0.25,0.7364630166886069,1.0,9/37,18.97%,SPIRE2;OTUB2;SPIRE1;UBR5;TRIP12;POT1;SETD2;KDM1A;FMN2
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.4576175559630773,1.0748243379863154,0.32142857142857145,0.7362380572591624,1.0,4/21,6.86%,ADCY1;MYO5B;PRKACB;PRKAR1B
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),-0.5142288534787229,-1.0746754510847112,0.34782608695652173,1.0,1.0,3/30,3.85%,GATA1;RAB7B;STAT1
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.48290424263256704,1.0746611247887128,0.38235294117647056,0.7362848218212222,1.0,8/21,18.24%,SPRED2;DYRK1A;SPRED1;PSMD10;MARCHF7;SIRT1;KDM1A;MDM2
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),0.38587940184994945,1.0743954262207815,0.3157894736842105,0.7364558798704168,1.0,14/50,16.18%,NUP42;NUP37;NUP188;RANGAP1;TRPM4;ZNF451;PIAS1;NUP153;NSMCE2;STX1A;NDC1;TRIM28;PIAS4;NUP205
prerank,GO_Biological_Process_2021__negative regulation of sphingolipid biosynthetic process (GO:0090155),-0.6931460596751604,-1.0737204628859758,0.359375,1.0,1.0,3/5,19.49%,ORMDL2;ORMDL1;SPHK1
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.4876622575036753,1.073146244495135,0.43333333333333335,0.7390444646588281,1.0,7/23,25.15%,SORT1;RAPGEF2;GLRB;NPY;GLRA3;CPE;SORCS2
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.45484865333005403,1.073060705044775,0.32,0.7388185286845215,1.0,12/32,16.02%,STARD13;PRKX;KANK1;ZEB2;LOXL2;TESK1;PIK3CA;FAP;ANLN;CDH13;NRP1;PXN
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),0.5648206498055858,1.0728831452309273,0.36666666666666664,0.7387959790067045,1.0,2/7,7.15%,MFF;PEX11A
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),-0.6768884053422666,-1.0727151173704903,0.4576271186440678,1.0,1.0,1/7,2.99%,HLA-B
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),-0.4792690899799358,-1.0725578587416738,0.3875,1.0,1.0,8/39,18.97%,RPS14;GATA1;ATP5IF1;INHA;SPI1;RPS19;ZFPM1;SLC25A5
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),0.6467311508300897,1.0725270127350557,0.391304347826087,0.7391456335518248,1.0,1/5,25.29%,PTPN2
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.2951685491945671,1.0724703381249567,0.0,0.7388636739355867,1.0,74/291,18.94%,SPSB4;BTRC;KCTD13;FEM1B;SPSB2;STT3B;ANAPC1;TRIM9;FBXL17;UBE2G1;KBTBD7;ARRB1;NEDD4L;MARCHF6;PSMA1;KLHL42;CDC27;KBTBD6;FEM1C;KCTD17;FBXL3;UBE2D1;UBR3;TMEM129;DNAJB2;PSMD11;ITCH;PSMD10;ECPAS;CLOCK;PRKN;RMND5A;KLHL15;FBXW7;PSMF1;KCTD10;PSMD14;PCNP;FBXL14;COP1;DERL2;PLK1;SMURF1;AGAP3;SIRT1;TBL1XR1;UBE2E1;BUB3;CDC34;FBXO45;SIRT2;CUL2;UBQLN1;CUL1;SPOPL;VCP;ANAPC16;BFAR;FAF1;HACE1;BIRC2;UBQLN2;KCTD5;PSME4;UBR1;CUL3;MDM2;NFE2L2;EDEM1;RAD23B;FBXW11;FBXO31;UBE2D3;NSFL1C
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.4862941328138418,1.0724689608355187,0.35294117647058826,0.7384355953295985,1.0,8/20,18.04%,ARAP1;CNOT9;CBL;AKT1;HIP1;SHKBP1;NEU3;RBPJ
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),0.645443998732705,1.0724320290238234,0.3333333333333333,0.7380868221938585,1.0,4/7,30.91%,YY1;SIRPA;PTPRS;RELB
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.5750415002533995,-1.0724102779056988,0.38461538461538464,1.0,1.0,3/14,15.86%,SFRP2;CLU;DDIAS
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.5022330290837091,1.0722517238559315,0.3125,0.7380085011234013,1.0,4/13,18.11%,DUT;NEIL2;NT5M;SMUG1
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.48196025087915434,1.072250112132706,0.4,0.737581659885042,1.0,6/18,19.22%,SLC12A2;KCNMA1;KCNH2;SLC12A8;ATP1A4;SLC12A9
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),-0.5010560925018906,-1.0719932125301155,0.3382352941176471,1.0,1.0,2/23,8.94%,POU4F1;HES1
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.49555095925558945,-1.0719921600480087,0.3684210526315789,1.0,1.0,3/32,6.04%,GBP1;ANXA1;PNP
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),-0.6516671650607533,-1.0712054597411542,0.4067796610169492,1.0,1.0,5/6,34.08%,FUCA2;FUCA1;GBA3;GBA2;NAGA
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),-0.6516671650607533,-1.0712054597411542,0.4067796610169492,1.0,1.0,5/6,34.08%,FUCA2;FUCA1;GBA3;GBA2;NAGA
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),0.3250721643991405,1.0711037209249898,0.0,0.739886391109495,1.0,37/197,17.69%,SPAG16;FHDC1;MACIR;PARVA;CILK1;EXOC2;SEPTIN6;RAB3IP;EHD4;CYS1;RFX3;RAB8B;RAB23;SSX2IP;EXOC5;TTBK2;CEP290;EXOC8;PKD2;EXOC6;DZIP1;TTC8;DYNLL2;TTC17;SEPTIN7;KIAA0586;EXOC4;BBS9;CEP20;RP2;LZTFL1;CDC14A;RAB1A;TTC29;ATAT1;MKKS;BBS2
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.39782661473478725,1.0708303269443653,0.3076923076923077,0.740087979051808,1.0,18/54,21.13%,MITF;HNRNPH1;RBM12B;MBNL2;HNRNPLL;MBNL1;HNRNPH3;IGF2BP2;CLK1;PTBP2;RBM38;CELF1;YTHDF2;PTBP1;PCBP4;NOVA1;NOVA2;RBM20
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),-0.6553150870787873,-1.0707932314885675,0.4,1.0,1.0,4/7,19.70%,CACNA1H;SPINK13;ZP3;GLRA1
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),-0.702498873263903,-1.0707260779990455,0.5714285714285714,1.0,1.0,1/5,4.21%,CD63
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),-0.702498873263903,-1.0707260779990455,0.5714285714285714,1.0,1.0,1/5,4.21%,CD63
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.6149230830924002,1.0705282471499071,0.5,0.7404914027568336,1.0,4/10,15.76%,IRS1;SIRT1;SNX5;PTPN11
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),0.5141797514926473,1.070373854418948,0.3142857142857143,0.7404119201311482,1.0,6/13,31.25%,SMG7;MTMR2;MTMR9;PPP1R16B;MTMR3;SRC
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),0.47652973850734487,1.0702375307514311,0.34210526315789475,0.7403325291809247,1.0,5/22,12.30%,ABCA1;ATP11C;ATP9A;ATP10A;ATP8A1
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),0.5031549487906335,1.0701694509928723,0.38461538461538464,0.740062717221635,1.0,2/12,7.66%,NCSTN;DYRK1A
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.4469790070596219,1.0700573297578173,0.3125,0.7398828174156274,1.0,14/32,21.51%,RAB31;NECTIN3;ARFRP1;GOLPH3;GOLGA7;AFDN;GGA2;KIF13A;NSF;BBS2;GGA1;RAB10;GORASP2;MACF1
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),-0.6860115693515758,-1.0700155561318956,0.4603174603174603,1.0,1.0,2/7,6.50%,CCDC39;DNAAF1
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),0.6798301966934608,1.0694866963400635,0.39473684210526316,0.7406881717348827,1.0,1/5,5.19%,NFKB1
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),0.3531526199866178,1.0694618507739133,0.3333333333333333,0.740329122674986,1.0,16/82,11.45%,PPARGC1A;ETV5;SNCA;FOXO1;KEAP1;ADNP2;FOXO3;PRDX6;PIK3CA;GSR;ATG7;PKD2;RAD52;SLC25A24;PRKD1;STOX1
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.6004055178083716,-1.0692709198785129,0.41818181818181815,1.0,1.0,4/10,21.67%,CASP8;INHA;ID2;IL34
prerank,GO_Biological_Process_2021__regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547),-0.6634735170537414,-1.0690903328121648,0.39655172413793105,1.0,1.0,1/5,4.21%,CD63
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),0.5791771302101405,1.0689218674924659,0.4117647058823529,0.7414128151730287,1.0,6/11,27.80%,ITGB8;SMAD4;HIF1A;SMAD3;TGFB2;SERPINF2
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),-0.5157358363937589,-1.0687452839477245,0.4098360655737705,1.0,1.0,6/25,17.11%,KIF20B;SVIL;HTR2B;FGF1;CENPV;GIPC1
prerank,GO_Biological_Process_2021__multi-ciliated epithelial cell differentiation (GO:1903251),0.668695284423632,1.0686316376872378,0.46511627906976744,0.7417689249913585,1.0,1/5,2.07%,CEP152
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.6351726983376178,-1.0685478724684303,0.38596491228070173,1.0,1.0,2/9,13.47%,PARP14;PARP2
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),0.5271305143592493,1.0685055682859017,0.4375,0.7412409819339051,1.0,4/12,24.10%,SMARCD2;ARID2;SMARCC1;ARID1A
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),0.5271305143592493,1.0685055682859017,0.4375,0.7412409819339051,1.0,4/12,24.10%,SMARCD2;ARID2;SMARCC1;ARID1A
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),0.662490644693385,1.068422144413921,0.42857142857142855,0.7410722838021385,1.0,3/6,23.03%,GABRB1;HRH1;GABRB3
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),0.5352792804329277,1.0682220635478494,0.3783783783783784,0.7411267548686009,1.0,6/11,36.79%,JMY;ACTR3;WHAMM;ARPC5L;TRIM27;ACTR2
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),0.40806242620991906,1.0682021222655107,0.35714285714285715,0.7407800371809435,1.0,2/19,3.89%,MAIP1;MCU
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),0.3708212076429257,1.067725739959906,0.3,0.7413802780262347,1.0,19/67,20.79%,FOXO1;NEDD4L;CSNK2A1;SEC22B;ITCH;ATG7;PRKN;SMURF1;VGLL4;VCP;GSK3B;NSF;FAF1;HACE1;RNF41;IDE;AXIN1;ADAM9;FURIN
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),0.623285986015245,1.0676505985573865,0.3953488372093023,0.7410894603577987,1.0,3/6,20.24%,RBM24;MAML1;ATP11A
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.6456737816548492,1.0674810975061007,0.4897959183673469,0.7410881805763301,1.0,5/8,23.67%,DYRK1A;PIKFYVE;MAP2K2;MARK3;ERN1
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),0.3582629502764742,1.0673757055683057,0.2857142857142857,0.7409757331086628,1.0,2/57,2.93%,VAPB;PDE12
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.5184432656632343,-1.0672845489784613,0.3484848484848485,1.0,1.0,6/24,15.55%,ISG15;USP18;STAT2;OAS3;CDC37;WNT5A
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.6247559693594288,-1.0672317569834704,0.36764705882352944,1.0,1.0,2/12,12.13%,TIMP1;NODAL
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),0.42767023197967174,1.06673714471953,0.25,0.7420744654584959,1.0,7/54,12.76%,SLC19A1;SLC6A13;SLC25A41;SLC25A18;ABCC5;SFXN1;SLC13A3
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.49575166878444654,1.0667268283303506,0.37142857142857144,0.7416617692956254,1.0,3/12,18.22%,TRAK1;TRAK2;MTM1
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),0.5762669133724069,1.0667268069391462,0.375,0.7412384463679453,1.0,4/7,32.87%,MSH2;POT1;MSH3;SSBP1
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.3563331413981953,1.066678195446956,0.3076923076923077,0.7409487049902503,1.0,36/136,20.02%,FEZF2;CAVIN4;FOXP1;ASCL1;SORT1;ADNP2;ZNF407;C1D;HMG20A;ADNP;MKLN1;IGF1;ZNF451;TFEB;STOX1;FUBP1;IGF2BP2;AHR;AFF1;ZUP1;MTMR2;ROCK2;TRIM44;HIF1A;POGZ;ALPK2;TOB2;ZNF462;HNRNPD;PCBP4;NOVA1;GNB3;REST;PRDM2;NOVA2;UBAP2
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),0.5638852513338217,1.0665987680756164,0.4444444444444444,0.7406925496647632,1.0,2/9,24.09%,STIM1;KCNIP2
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),0.512097153323379,1.066564651159782,0.37209302325581395,0.7403148182615863,1.0,4/13,10.32%,SLC19A1;SLC25A41;ABCC5;SLC25A24
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.3719089009341762,1.0665106253684902,0.2692307692307692,0.7400371704696043,1.0,21/59,23.35%,CSF1R;PDGFRA;AKT1;PIK3CA;PIK3R1;PLCB1;IRS1;RPS6KB1;IGF1;PIK3C3;NF1;OGT;SIRT2;PLCB3;PI4KB;PTEN;PLEKHA1;PLCL1;IRS2;NYAP2;PIK3C2B
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),-0.5919146573957139,-1.0664698256446856,0.42105263157894735,1.0,1.0,5/10,26.33%,THBS1;WNT5A;CRLF2;HSPD1;TNIP2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),0.6422610656924421,1.066197375122415,0.4222222222222222,0.7404238165603352,1.0,3/7,16.34%,DUSP10;PTPRB;PTPRO
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.5471688761189912,1.0661177776288175,0.3333333333333333,0.7402238426518524,1.0,7/14,22.29%,ROBO1;AKT1;EFNB2;SLIT2;NRP1;NR4A1;FGF2
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.5050551496196668,1.066031753624819,0.2727272727272727,0.7400240961156361,1.0,6/10,23.59%,IGF2BP2;PCBP4;NOVA1;NOVA2;ZNF445;PCBP2
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),0.6914819069717758,1.0659711781205616,0.4444444444444444,0.7397582919586463,1.0,3/5,28.10%,VPS41;VPS39;ARL8B
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.49851373498456786,-1.065844075909883,0.3380281690140845,1.0,1.0,5/26,17.23%,GBP1;CEACAM1;CD160;PHPT1;PTPN22
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.5782486883191027,1.0655144568823558,0.35294117647058826,0.740187624596221,1.0,4/7,28.37%,TNRC6B;DDX6;EIF4E2;AGO2
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),0.5782486883191027,1.0655144568823558,0.35294117647058826,0.740187624596221,1.0,4/7,28.37%,TNRC6B;DDX6;EIF4E2;AGO2
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),0.3617409280143407,1.0654885616469958,0.3333333333333333,0.7398449795396755,1.0,25/91,23.78%,WDR33;NUP42;NUP37;NUP188;AGFG1;U2AF1;FYTTD1;SMG1;EIF4E;RBM15B;NUP153;U2AF2;NDC1;THOC7;SMG7;NUP205;NUP214;ALKBH5;RANBP2;THOC2;NXT1;MAGOH;NUP98;CPSF2;NUP54
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),0.6755047271629026,1.0654124978684019,0.4594594594594595,0.7395468125030863,1.0,1/7,2.93%,PDE12
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.2969559864609193,1.0652607166879664,0.0,0.7394803222391844,1.0,87/391,17.21%,CASS4;SASH1;FLT1;ERBB4;C18ORF32;VAPA;TAB3;EGFR;SMCR8;DCN;FAM110C;IQCJ-SCHIP1;PDGFRA;SOX9;RHEB;BMP2;BOK;EEF1D;CHD5;EPOR;CASP10;CBL;ATP2C1;MYORG;HCLS1;FGF17;NTRK2;NFAT5;RAPGEF2;PUM2;PIK3CA;UBE2N;STRN;TNFRSF10B;TRAF3IP2;PIK3R1;IRS1;PPM1A;CANT1;PDGFA;ROR1;MAP3K7;ADRA1A;DUSP19;IGF1;TICAM1;HMGB1;RUNDC3A;PRKN;HGF;PTPRJ;LURAP1;GOLPH3;EP300;CFLAR;PRKD1;ANKRD17;ECM1;TRADD;NRG2;ADRB2;PTK2;SIRT1;TNFRSF19;TGFBR1;DLG5;PDGFC;RPTOR;BCL2;GAB1;CDH13;HIP1;OSBPL8;ROCK2;NRG1;PTPN11;SEMA4D;BIRC2;TFG;TRIM44;MIB2;TFRC;NR3C2;PUM1;NDFIP1;AKT2;FYN
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),-0.510112040021336,-1.0651867514750237,0.4027777777777778,1.0,1.0,11/28,24.97%,DHCR24;MVK;SQLE;HSD17B7;FDPS;DHCR7;ACAT2;TM7SF2;MSMO1;INSIG1;HMGCR
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),0.34604397243705787,1.0651082623904817,0.34615384615384615,0.7393368379722366,1.0,13/62,12.81%,ADAP1;EFNA5;EPHA4;PLXNA2;PLXNA1;PRKG1;NTRK2;CAMK2A;EPHA5;FGD4;NF1;PTK2;RAB3GAP1
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.5891602543857248,1.0647023251950734,0.5161290322580645,0.7398647399583445,1.0,5/7,38.82%,PPTC7;SIRT5;H6PD;EGR1;CLCN2
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),0.5426035853087393,1.064248890420557,0.35135135135135137,0.7404800243371031,1.0,1/8,0.82%,PID1
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),0.5933697367056959,1.0641153709399263,0.3958333333333333,0.7404241481113552,1.0,7/8,40.45%,PHETA1;RAB11B;LMTK2;PLEKHJ1;ARFGEF2;SORL1;EHD3
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),0.6299553837446276,1.063854521193126,0.42857142857142855,0.7407308406615617,1.0,3/5,20.17%,HMGB1;AHR;FBXO38
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),0.5088014079967048,1.0636249096638029,0.3870967741935484,0.7409054410624919,1.0,7/18,18.57%,GRIN1;SMAD2;SLIT2;TGFBR2;TGFBR1;ABCA2;GRIN2B
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),0.48259701308968844,1.0634552823438235,0.35,0.7409701181882944,1.0,8/27,17.21%,EPHA4;GRIN1;CACNA1B;CACNA2D1;IGF1;ADRB2;GSK3B;FYN
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),-0.5852181428724818,-1.063364569343323,0.3389830508474576,1.0,1.0,4/9,24.70%,CASP8;ID2;IL34;TGFB1
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),0.41676012809046165,1.0628738225204604,0.36666666666666664,0.7421752313039878,1.0,18/32,37.25%,PLK1;MSH2;ATRX;XRCC4;WAPL;TNKS2;TNKS;TERF2IP;RAD21;LEMD2;TERF2;XRCC5;RB1;CHMP7;FAM47E;ATR;BOD1;RPA1
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.4364954463277995,1.062789903362026,0.3793103448275862,0.7420089544758934,1.0,8/24,18.48%,SLC30A4;NEDD4L;CAMK2D;SLC4A7;SLC4A10;SLC4A4;WNK3;WNK1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.39068412995341395,1.0626276411858324,0.3333333333333333,0.7418866813045574,1.0,12/60,15.05%,EGLN3;SNCA;CRADD;BOK;CASP10;ROBO1;TNFRSF10B;CFLAR;TRADD;ANP32B;VCP;HIP1
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.5772991730309314,1.0621540556774658,0.42105263157894735,0.7424104723890845,1.0,4/8,19.14%,CPNE3;AGK;CPNE1;FAR1
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.4039852242506692,1.0621019359260992,0.36666666666666664,0.742255285641841,1.0,8/26,15.87%,BMP2;GDF10;ACVR1;TGFBR1;ACVR2A;SMAD4;BMPR1A;BMP7
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),-0.6714934490991656,-1.0619353917074454,0.49206349206349204,1.0,1.0,3/7,25.68%,SFRP1;EIF2AK2;ATRAID
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),0.4596136995534751,1.0613498627785964,0.4090909090909091,0.7435984496925786,1.0,11/24,32.84%,EXOSC6;TENT4B;LIN28B;DIS3L2;ZCCHC8;DIS3;NUDT16L1;PARN;POP1;EXOSC9;SND1
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),0.4038278418127791,1.06119634094385,0.3333333333333333,0.7434864874159817,1.0,7/44,5.73%,SDC4;CSPG5;HMMR;DCN;GPC5;LYVE1;VCAN
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),0.36403479112440795,1.0611341704278006,0.23529411764705882,0.7432217246589015,1.0,25/64,23.43%,SNCA;MARVELD3;PPFIBP1;PPFIA2;RAB8B;FBLIM1;SDK1;PAK3;DVL1;NLGN4X;NLGN3;ELFN1;OCLN;APBB2;OPHN1;TJP1;VASP;CTNND2;LRP4;SLC6A1;GRM5;SMAD3;CAPZA1;VMP1;RAB39B
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.3712941178352305,1.0609084324320526,0.26666666666666666,0.7434703663298485,1.0,17/67,19.43%,LIG4;AEN;EEF1D;INTS7;MEN1;CLOCK;RFWD3;COP1;SIRT1;EYA3;STK11;UIMC1;MSH2;BRCC3;TICRR;H2AX;XRCC4
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),0.44810804094034534,1.0608189946377073,0.3783783783783784,0.7432059097717584,1.0,1/13,1.50%,TNFSF4
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.49103598106197893,1.0607511016898583,0.25925925925925924,0.7429308449292285,1.0,12/23,34.95%,CAMSAP2;CLASP1;MAPRE1;SKA2;GAS2L1;FKBP4;CLASP2;CAMSAP3;MAPRE3;ABL1;MAP2;PRUNE1
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),0.6232211284246212,1.060528155730015,0.44,0.7432555232283274,1.0,2/5,24.68%,JAM2;GAS6
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.4113596515716718,1.0599761999708497,0.4090909090909091,0.7439719752401479,1.0,15/42,20.69%,DNA2;EGFR;CCNA2;STN1;ANKRD17;DHX9;PDS5A;ZBTB38;KAT7;FAF1;ORC5;NPM2;WAPL;PPP2R1A;RBBP6
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.3472336412475149,1.0597718407614798,0.2727272727272727,0.7440997480499905,1.0,20/101,12.72%,MAPK10;ABCC8;PDZRN3;SOWAHA;GLS;PLEKHA6;PCDH17;NOL4;CACNA2D1;FRZB;FAP;PKDCC;CAMK2N1;CELF3;RUNX1T1;TMEM196;RGS7BP;CNTN4;PRRG2;ASXL3
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.6883334540194226,1.0591077432377318,0.4528301886792453,0.7448877120659216,1.0,2/5,26.01%,CLASP1;CLASP2
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.6883334540194226,1.0591077432377318,0.4528301886792453,0.7448877120659216,1.0,2/5,26.01%,CLASP1;CLASP2
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.4241957484410496,-1.0586131014580853,0.367816091954023,1.0,1.0,15/89,14.84%,ACOT2;ACOT1;ORMDL2;ABCA12;ST6GAL1;PM20D1;ACOT6;GLYAT;ACSM6;NIT1;GNE;PLAAT4;ACSM5;ORMDL1;ACSM3
prerank,PanglaoDB_Augmented_2021__Spermatozoa,-0.4553908089225447,-1.0585584544923092,0.375,1.0,1.0,12/77,13.41%,LDHC;CP;IL1R1;TEKT1;FMO5;FPR3;ANKUB1;ST3GAL6;CD14;FMO2;APOL6;APOBEC4
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),0.394719602185421,1.058462256884921,0.3,0.7460689890228664,1.0,8/50,10.21%,TRIM24;STT3B;UBE2G1;SOCS6;MARCHF6;ATE1;NR1D1;PRKN
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),0.5600239748823439,1.0584494923463497,0.45454545454545453,0.7457282266769915,1.0,2/8,17.23%,RHOT1;ATF2
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.372717849274465,1.0582365551513637,0.3333333333333333,0.7457135313623076,1.0,25/88,23.78%,WDR33;NUP42;NUP37;NUP188;AGFG1;U2AF1;FYTTD1;SMG1;EIF4E;RBM15B;NUP153;U2AF2;NDC1;THOC7;SMG7;NUP205;NUP214;ALKBH5;RANBP2;THOC2;NXT1;MAGOH;NUP98;CPSF2;NUP54
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.47406167401594157,1.0580434153485314,0.3333333333333333,0.745731402924547,1.0,9/28,21.58%,VPS37B;RAB27A;CHMP1A;VPS37A;CHMP2B;VTA1;STAM2;TSG101;CHMP6
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),0.6299758424280432,1.057872739549372,0.4166666666666667,0.7458360074098508,1.0,1/6,13.63%,SIRT2
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),-0.6269396297027467,-1.0577107551986105,0.46551724137931033,1.0,1.0,3/9,14.94%,CASP8;SLC25A4;FZD9
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),0.5930635702095461,1.0576028415034007,0.3939393939393939,0.7461464184682899,1.0,2/9,7.83%,KAT2B;KAT2A
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),-0.6201108674730968,-1.0575828107267058,0.42424242424242425,1.0,1.0,2/7,12.06%,F8;A2M
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.6745537690505581,-1.057560778324562,0.4918032786885246,1.0,1.0,3/7,23.82%,APOE;DBI;PRELID1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),0.510107132106553,1.0575409093533197,0.3333333333333333,0.7458282262342972,1.0,7/12,31.20%,HNRNPC;MAPKAPK2;ANGEL2;MYD88;ELAVL1;TIRAP;HNRNPA0
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,-0.4461942889015202,-1.0575290444095482,0.375,1.0,1.0,9/68,13.44%,THSD4;GC;S100A6;BHMT;ALDOB;ADH6;GRAMD2A;A2M;MATN2
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),0.5778458390917148,1.0574884454835198,0.4722222222222222,0.7455428663150512,1.0,3/8,11.47%,SOX4;NOTCH2;ACVR1
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.4034774283636661,1.0574781275064842,0.34782608695652173,0.7451712642398005,1.0,14/57,15.45%,SNCA;RAB27A;STXBP5;RGCC;BMP2;BAIAP3;CADPS2;SLC12A2;IGF1;GOLPH3;RAB9A;CLASP1;STX1A;SYTL4
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.3588434660599429,1.0573417956771751,0.42105263157894735,0.745048796392812,1.0,9/62,12.21%,ADCY1;PRKACB;CD247;CALCB;PRKAR1B;GPR176;ADRB1;VIPR1;ADRB2
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),0.35971666708181355,1.057158756277403,0.3,0.7450021202776745,1.0,28/81,22.09%,C8ORF88;RBM24;CPEB3;RIDA;FTO;CNOT9;EIF4EBP2;CPEB4;EIF2AK4;SYNCRIP;IGF2BP2;CAPRIN1;ROCK2;FXR1;EIF3E;PUM1;CELF1;CNOT8;YTHDF2;LSM14A;CPEB1;DDX6;ROCK1;CPEB2;FMR1;GIGYF2;YTHDF3;MRPL13
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),-0.5293119799879363,-1.0571230664197513,0.3387096774193548,1.0,1.0,1/18,0.19%,PIF1
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.4515339711003127,1.0570200049925986,0.38235294117647056,0.744923090217767,1.0,2/22,4.16%,MSH4;POLD3
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.5116526941295674,1.0567659389437984,0.3448275862068966,0.7446250239297044,1.0,4/12,6.10%,EFNA5;RCC2;KANK1;SPRY4
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.5116526941295674,1.0567659389437984,0.3448275862068966,0.7446250239297044,1.0,4/12,6.10%,EFNA5;RCC2;KANK1;SPRY4
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),-0.5372594897558006,-1.0565521529948803,0.3770491803278688,1.0,1.0,7/16,26.33%,THBS1;WNT5A;SPHK1;CD74;HSPD1;MYO18A;TNIP2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),0.6485607028672686,1.0565471827457336,0.5277777777777778,0.7447943656528208,1.0,1/6,9.82%,HMGB1
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),-0.4711098859683216,-1.0564719324457452,0.4375,1.0,1.0,9/43,17.68%,CD24;SELP;CXCL2;IL12A;CD14;LY96;SLC11A1;PTPN22;NOS1
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),-0.7069270419055095,-1.0563975834681625,0.4918032786885246,1.0,1.0,2/5,14.27%,LRPAP1;APOE
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),0.645831904934651,1.0563937385081688,0.4666666666666667,0.7447264039738094,1.0,3/5,30.59%,KDM6A;KDM7A;PHF8
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),0.4732921811809252,1.0560577691332007,0.35135135135135137,0.7450139940423584,1.0,1/18,0.91%,VPS37B
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.5399084569287976,-1.0560508528636356,0.43548387096774194,1.0,1.0,6/18,17.19%,SELP;AQP1;RPL30;SLC11A1;RPS19;ROMO1
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.5145685432731003,-1.0559674496795044,0.42105263157894735,1.0,1.0,1/25,0.13%,CD24
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),0.5120641407683469,1.0558630074754085,0.3888888888888889,0.7450644125526963,1.0,3/17,5.11%,SASH1;PRMT1;BMP2
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),0.6985986536145203,1.0558336820191623,0.4722222222222222,0.7443262593718741,1.0,3/5,19.75%,PEX7;FAR1;AGPS
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),0.6985986536145203,1.0558336820191623,0.4722222222222222,0.7443262593718741,1.0,3/5,19.75%,PEX7;FAR1;AGPS
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),0.2986602867746026,1.0557352934261641,0.14285714285714285,0.7441082695750422,1.0,64/223,20.41%,USP13;CDC25A;USP49;USP46;KAT2B;KEAP1;RHOT1;OTUB2;SMAD2;USP31;PSMA1;USP38;KAT2A;CCNA2;UBE2D1;INO80D;USP12;PSMD11;SMAD7;MAP3K7;PSMD10;USP24;PRKN;TAB1;SUPT3H;EP300;PSMF1;PSMD14;ZRANB1;USP3;ADRB2;VCPIP1;OGT;TGFBR1;USP40;MDM4;SMAD4;OTUD4;VCP;USP25;USP22;USP9X;USP47;USP35;BIRC2;UIMC1;USP2;ABRAXAS2;BRCC3;HIF1A;PSME4;KDM1B;PTEN;YY1;MDM2;RAD23B;USP34;ASXL2;OTULIN;OTUD7A;STAM2;MBD5;ATXN7;WDR48
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,0.33182826755729183,1.0555635739506506,0.16666666666666666,0.7441375925505077,1.0,39/165,19.01%,CDC25A;XPO1;EFNA5;HMMR;DR1;NOTCH2;HNRNPU;CDC27;SLC12A2;PDS5B;CHMP1A;CCNA2;G3BP1;RASAL2;CKS1B;MAP3K20;SYNCRIP;MEIS2;DKC1;SS18;PLK1;FOXN3;LBR;BUB3;INCENP;CUL1;UCK2;KIF15;ESPL1;HIF1A;SMARCC1;EWSR1;CUL3;ORC5;ATRX;RAD23B;HNRNPD;H2AX;NSD2
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),0.5449447529969711,1.0549913414363192,0.4782608695652174,0.7448754805817579,1.0,3/9,8.38%,PDGFRA;NR1D1;PDGFA
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),0.5728274385635541,1.054684647249513,0.43902439024390244,0.7451511469795785,1.0,1/7,9.87%,RTN4RL1
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),-0.5137770244813844,-1.0544482672447546,0.39705882352941174,1.0,1.0,2/17,7.75%,ENPP2;ANGPTL3
prerank,GO_Biological_Process_2021__response to fructose (GO:0009750),-0.6610926019955571,-1.054402787806689,0.4528301886792453,1.0,1.0,3/5,33.57%,XBP1;KHK;SLC2A5
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,0.43063853748134834,1.0542791785336092,0.3333333333333333,0.7457911416357913,1.0,11/35,22.17%,NCSTN;KAT2A;CSNK1E;HDAC2;CUL1;GNAI1;MAML1;RBPJ;AXIN1;LEF1;CTNNB1
prerank,GO_Biological_Process_2021__positive regulation of secretion (GO:0051047),-0.7169104986500476,-1.0541585455558249,0.4576271186440678,1.0,1.0,2/5,16.26%,AQP1;XBP1
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),-0.5719061026758182,-1.0539781476402654,0.36507936507936506,1.0,1.0,1/9,4.51%,SELENOS
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),0.48339090467219104,1.0539385464498023,0.36363636363636365,0.7460552807579105,1.0,7/24,17.21%,EPHA4;GRIN1;CACNA2D1;IGF1;ADRB2;GSK3B;FYN
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),0.6611954482830944,1.0538624656954614,0.46808510638297873,0.7458156336326214,1.0,2/5,21.10%,PRKN;BAG3
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5693120565225308,1.0536990105938486,0.43243243243243246,0.7457903857252277,1.0,4/12,18.48%,PAG1;AKT1;FGL1;WNK1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.5480134660458893,-1.0536221266229995,0.4266666666666667,1.0,1.0,4/16,17.23%,IFI35;RSAD2;TLR3;PTPN22
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),0.4781958249589716,1.053581413828117,0.3448275862068966,0.7457865673524292,1.0,8/24,22.89%,HCLS1;PIK3R1;UBR5;TRIM28;IPO5;ZPR1;BAG3;SMAD3
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),-0.5152126652935141,-1.053333760743766,0.4246575342465753,1.0,1.0,11/25,24.97%,DHCR24;MVK;SQLE;HSD17B7;FDPS;DHCR7;ACAT2;TM7SF2;MSMO1;INSIG1;HMGCR
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.29065849551110284,1.0528569551862281,0.0,0.747162406354704,1.0,123/523,18.38%,VEGFD;ACE2;ITGA1;NCK2;TNFSF4;EGLN3;PTPRK;KLF11;KAT2B;FLT1;CCKBR;ERBB4;CSF1R;SOX4;TFAP2C;EGFR;VHL;PRMT1;MEIS3;ACER3;RGCC;PLPP1;PDGFRA;SOX9;RAB33B;BMP2;BOK;CHD5;HCLS1;FGF17;PDS5B;CNOT6L;NTRK2;CSNK2A1;MEN1;TRPM4;FRZB;RAPGEF2;DLG3;AKT1;STRN;IRS1;PDGFA;ZBTB7C;SMARCA2;RPS6KA2;DNAJB2;HDAC2;RBFOX2;MARCHF7;VEGFC;ADRA1A;IGF1;PKD2;EFNB2;ZNF268;PTPRJ;CAMK2N1;ADARB1;MEIS2;BST1;VIPR1;STOX1;HP1BP3;NAP1L1;PIAS1;DERL2;PTK2;TGFBR2;HDAC4;SGK3;CRKL;SIRT1;MAGI2;TGFBR1;MLXIPL;ABI1;DLG5;SIRT2;FER;PDGFC;PRKRA;BCL2;TENM1;CCPG1;TJP1;AGO3;PTPN14;MDM4;EPCAM;CDH13;BMPR1A;DUSP22;CDK13;YAP1;DNAJA2;STK11;NRG1;DDAH1;PHIP;BIRC2;ARID2;CCAR1;RBBP4;TFRC;RNF41;AKT2;LIFR;CUL3;CELF1;KDM4C;ADGRB1;ZNF703;CNOT8;ASH2L;RUNX1;RPRD1B;SRPK2;DRD2;PTEN;MDM2;PPM1D;CIB1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.41268770190196835,1.0527968488583528,0.3783783783783784,0.7469868122082706,1.0,11/28,16.34%,DUSP10;PTPN13;PTPN9;PTPRJ;PTPRB;DUSP6;PTPRZ1;DUSP22;PTPN11;UBASH3B;PTPRO
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.44886837395265694,-1.0521916189145086,0.39436619718309857,1.0,1.0,21/67,22.31%,ADIRF;MYOF;CD9;SLC16A3;MT1L;TRIM29;LTBR;RRAS;B3GNT3;TAX1BP3;MT1E;S100A16;DUOXA1;RARRES1;SPHK1;PLP2;SRPX2;ILK;DNPH1;EPS8L2;TNFRSF12A
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),0.3966603056502023,1.051978291053193,0.3333333333333333,0.7482856971925413,1.0,12/47,17.07%,SPIRE2;ZNF207;CASQ1;FAM107A;WASL;SPIRE1;PRKN;CKAP5;TTC17;HDGFL3;WASF3;WASF1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.5847662445278436,1.0519612682570787,0.42857142857142855,0.747906809084702,1.0,3/6,35.06%,PJA2;TIRAP;TLR1
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.4535427837017612,1.0519240355599535,0.34615384615384615,0.7475923659175048,1.0,8/32,15.45%,SDC4;SNCA;RAB27A;STXBP5;CADPS2;RAB9A;CLASP1;SYTL4
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),0.3442117257000174,1.051803612347928,0.23076923076923078,0.7474489181615487,1.0,30/107,21.66%,VPS37B;TBC1D5;CSNK2A1;VPS37A;PIK3R4;ATG7;PIK3C3;PRKN;VPS16;DYNLL2;UBXN6;TOMM22;TMEM74;VPS41;PRKAB1;CHMP2B;UBQLN1;VCP;RUBCNL;PGAM5;VTA1;MTERF3;CSNK2A2;ATG5;HDAC10;STAM2;VPS39;TSG101;CHMP6;RB1CC1
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.36345951147571415,1.051533304525298,0.2692307692307692,0.7476041022340678,1.0,10/48,13.20%,STT3B;PRKCSH;MGAT4A;MAN1A2;ERP44;LARGE1;GOLPH3;ENGASE;FUT8;B4GALT5
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),-0.6492544029507646,-1.0513284792951334,0.4827586206896552,1.0,1.0,1/6,2.46%,DUOX1
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),0.32705053443639115,1.051234084126676,0.36363636363636365,0.7479082717376379,1.0,38/155,19.18%,PLD6;PPARGC1A;PID1;GDAP1;AIFM2;DNM3;MTX2;RHOT1;CHCHD3;MFF;AFG1L;GABPB1;GABPA;NRF1;TRAK1;TFB1M;MIGA2;PYROXD2;PRKN;TRAK2;SAMM50;TOMM22;MTERF1;MYH14;OPA1;MIGA1;IMMP2L;AGTPBP1;THG1L;WASF1;WDR81;ATAD3C;MTM1;AIFM1;DNM2;COX7A2L;NUBPL;MIEF2
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.5063797473906124,1.0511257699713,0.4358974358974359,0.7477648866527923,1.0,7/15,18.57%,GRIN1;MPP2;AKT1;RAB3GAP1;GSK3B;DRD2;GRIN2B
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),-0.5447575889986345,-1.05085450425247,0.38596491228070173,1.0,1.0,6/15,22.23%,SFRP4;THBS1;CD160;CCL2;GPER1;PLA2R1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),0.38139189263705575,1.0508474248849693,0.4074074074074074,0.7476274978235399,1.0,16/47,24.42%,NUP37;NUP188;RANGAP1;REEP4;CHMP2B;LBR;SIRT2;NDC1;PPP2R2A;NUP205;PPP2R1A;CHMP6;NUP98;IST1;AHCTF1;RCC1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),0.38139189263705575,1.0508474248849693,0.4074074074074074,0.7476274978235399,1.0,16/47,24.42%,NUP37;NUP188;RANGAP1;REEP4;CHMP2B;LBR;SIRT2;NDC1;PPP2R2A;NUP205;PPP2R1A;CHMP6;NUP98;IST1;AHCTF1;RCC1
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),0.5196432917912746,1.0508410833251047,0.42105263157894735,0.7472612574950905,1.0,2/12,4.07%,LIG4;PPP1R10
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),-0.6590500803102571,-1.0508028488541694,0.4603174603174603,1.0,1.0,3/6,19.46%,DUOX1;NOX1;ALOX12
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),0.5447113393969423,1.049987602176708,0.3333333333333333,0.7488928901305014,1.0,8/13,26.00%,CTU1;DPH3;TRMT9B;ELP3;ALKBH8;ELP1;ELP4;MTO1
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),0.39687552342636595,1.0499536787191135,0.3888888888888889,0.7485688349606755,1.0,11/55,15.03%,CDC25A;MAP3K11;CAMK2A;CCNA2;RPS6KB1;EIF4E;ACVR1;CDC34;CUL2;CUL1;LATS1
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),0.6051417892610637,1.0499019561329563,0.4523809523809524,0.7482451335628689,1.0,4/7,19.86%,ATP2C1;PKDCC;CSK;ACSL3
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),0.6190499366803635,1.0495681483810637,0.42857142857142855,0.7486537004779865,1.0,2/7,20.35%,MTHFR;CDO1
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),0.5653816534461538,1.0495267568760926,0.3888888888888889,0.7483727125340337,1.0,1/7,10.21%,PRKN
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.5279886054715436,1.0494875636519185,0.40540540540540543,0.7480284554185571,1.0,2/13,13.47%,ABCA1;TTC39B
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),-0.664848964446439,-1.0492116079279605,0.45,1.0,1.0,2/5,15.12%,P2RY12;CX3CL1
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.6405779186779329,-1.0488182556278314,0.543859649122807,1.0,1.0,2/8,15.85%,PARP14;SOCS3
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),0.5183972198131541,1.0487743521084,0.43902439024390244,0.7493154537999092,1.0,7/13,26.00%,CTU1;DPH3;TRMT9B;ELP3;ALKBH8;ELP4;MTO1
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),-0.5596323791705475,-1.0485837786196444,0.48214285714285715,1.0,1.0,2/12,12.26%,SLC25A4;SLC25A33
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),-0.5903426207638351,-1.0484035388576096,0.4482758620689655,1.0,1.0,4/9,23.83%,APLNR;HEY2;TMEM204;EDNRB
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.5567967563390956,-1.0482657158018365,0.4262295081967213,1.0,1.0,4/14,12.20%,ISG15;USP18;STAT2;OAS3
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),-0.7130622155090433,-1.0482289088491563,0.47692307692307695,1.0,1.0,1/5,0.78%,RPL23
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.5778069730100635,1.0481257687784489,0.4666666666666667,0.7503364417819297,1.0,4/9,22.04%,PEX7;FAR1;AGPS;CHPT1
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),0.5443977985332729,1.0480672923362948,0.4444444444444444,0.7500974642555837,1.0,3/11,18.02%,CEP290;RPGRIP1L;RORB
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.46730464178574704,1.0479366489605217,0.48484848484848486,0.7499327566286176,1.0,7/18,14.73%,SOX4;BMP2;ACVR1;TGFBR2;MDM4;SMAD4;BMPR1A
prerank,GO_Biological_Process_2021__protein K29-linked ubiquitination (GO:0035519),0.6691698875521847,1.0477013395008208,0.4857142857142857,0.7501380769172966,1.0,3/5,10.21%,UBE2T;ITCH;PRKN
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),-0.6585355115209326,-1.0476479470733198,0.3968253968253968,1.0,1.0,1/6,9.99%,GAD1
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),0.36039278625966037,1.047589859021731,0.34615384615384615,0.7499418420495783,1.0,15/57,16.45%,TYR;POU6F2;CRYGS;ZIC2;ATF6;RGS16;SLC4A10;DRAM2;EYA3;OPA1;RP2;CRYBB3;GRM8;RDH10;CRYBB2
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.38180791559731825,1.047162351271038,0.3076923076923077,0.7503686028614504,1.0,9/42,23.67%,PDE12;RIDA;ZC3H12D;AGO3;YTHDF2;NBAS;HSPA1A;DIS3L2;ERN1
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),0.6089451443272446,1.047147446520168,0.4772727272727273,0.7499931073920829,1.0,1/6,1.50%,TNFSF4
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),0.3937449560683229,1.0469580162387746,0.2903225806451613,0.7500292425504602,1.0,9/39,15.29%,UBE2G1;UBE2T;UBE2E3;UBE2N;TRAF3IP2;ITCH;PRKN;UBE2E2;BFAR
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),0.3431076261883701,1.0468824357625095,0.3684210526315789,0.7498018766914251,1.0,18/98,14.60%,TXNIP;SLC19A1;RCN3;ABCA1;LRP1B;CMTM6;CHMP1A;ABCA9;CEP290;SPNS2;PLEKHA8;ATP8A1;SLC22A5;DISP1;CHMP2B;ABCA2;NDC1;ABCD3
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.5539972633975883,1.0467607720366274,0.45714285714285713,0.7496063554610655,1.0,2/15,8.99%,TSEN15;ZBTB8OS
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),-0.45896805245447714,-1.0465406598117615,0.39285714285714285,1.0,1.0,3/54,4.37%,TLCD1;MYOF;COL5A1
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.42645546758325237,1.0462262843597532,0.43243243243243246,0.7505584957510906,1.0,5/28,9.83%,LEPR;LIG4;SOX4;CHD7;GLI3
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.5561314503682421,1.0453169478489643,0.42857142857142855,0.7521303661772033,1.0,7/14,28.25%,NOTCH2;ROBO1;SLIT2;NFATC1;JAG1;TGFB2;ROBO2
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),-0.6698941375814953,-1.0450816536458212,0.4482758620689655,1.0,1.0,2/6,14.69%,CHRM2;CHRM5
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),0.5668269472995585,1.0448752440482088,0.4523809523809524,0.7526805158270733,1.0,1/8,11.42%,NSUN3
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),0.5588362947785196,1.0448664763416293,0.42424242424242425,0.752294681477191,1.0,1/8,1.50%,TNFSF4
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),0.6326856388618409,1.0448345921440036,0.4878048780487805,0.7519407769606512,1.0,1/5,13.85%,DHX9
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.4297709243446517,1.0447606415476653,0.3333333333333333,0.751723736971419,1.0,10/32,19.21%,SEMA5B;PLXNA2;NRP2;SEMA3C;NRP1;SEMA6C;SEMA4D;PLXNA4;SEMA3D;ARHGDIA
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),0.3623976506464182,1.0446588591969441,0.3125,0.751601368022894,1.0,21/118,11.95%,TIAM2;STARD13;ARHGEF6;ARAP2;ARHGEF16;ARHGEF12;RHOT1;ARAP1;ARHGAP35;RHOQ;ARHGEF26;CGNL1;ARHGAP24;ARHGAP5;ARHGAP26;FGD4;ITSN1;ARHGAP32;GNA13;SLIT2;SOS1
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,0.33682113009663867,1.0445423871656492,0.1875,0.7514896183959273,1.0,18/107,9.70%,POSTN;SASH1;RGS5;DACH1;PLXNA2;DCN;CXCL12;PARVA;PDGFRA;KCNT1;CDH11;CGNL1;FRZB;LRRC66;RNF182;PPP1R1B;PRICKLE2;IGF1
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.6387692182996864,1.0440179249938082,0.46875,0.752593862124675,1.0,1/7,3.66%,EGFR
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),0.5668391834573129,1.043979365163186,0.5,0.7522617018486955,1.0,4/10,20.33%,WNT7A;DOCK7;CEP120;PCM1
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),0.4275836864252812,1.0439168201613018,0.39285714285714285,0.7519717808067717,1.0,9/35,15.46%,FMNL3;RHOQ;PLEK;RHOBTB3;FMNL2;NCKAP1;DLG1;STRIP1;ROCK2
prerank,PanglaoDB_Augmented_2021__Merkel Cells,0.4418976596472207,1.04334340104816,0.34375,0.7528018988709989,1.0,5/29,4.23%,ACE2;FLI1;EFNA2;ARHGEF16;SLC26A3
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),0.3809253967988485,1.0432070101712103,0.38235294117647056,0.7527630177793702,1.0,9/37,24.30%,ANK2;KCNMA1;KCNH2;GABBR1;WNK3;WNK1;KCNN3;KCNIP2;GABBR2
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.45380754064411544,1.0431605089663656,0.4411764705882353,0.7524523878550003,1.0,9/24,14.29%,CACNA1G;CACNA1I;SYT3;DOC2A;CBARP;DOC2B;RAB3GAP1;STX1A;SYT9
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.4389413113438409,1.0430820394013747,0.28,0.7522674661902313,1.0,6/34,10.27%,FAT4;ASCL1;BTBD3;BTBD1;TRAK1;TRAK2
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),-0.5103145090035124,-1.042305609046759,0.4166666666666667,1.0,1.0,11/26,24.97%,DHCR24;MVK;SQLE;HSD17B7;FDPS;DHCR7;ACAT2;TM7SF2;MSMO1;INSIG1;HMGCR
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",0.320063458827649,1.0421722460478164,0.3333333333333333,0.7540041186121691,1.0,44/191,23.49%,TRIM24;EAF2;SOX5;NR4A2;MLLT3;NFKB1;IWS1;FOXO3;PIR;THRB;RNGTT;COPS2;TAF4;TRIP11;TAF1B;PKNOX1;GLIS3;NELFA;MTERF1;SNAPC3;RREB1;UBTF;DTX1;GTF3C3;RSF1;CCNT2;ZNF141;MAF;CBFB;TAF2;CDK9;TAF4B;TAF3;TSC22D1;GTF2F2;MED4;NAT14;TAF1;EPC1;CDC73;TCEA1;THAP1;RO60;NCOA6
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),-0.6230833422789812,-1.0421662515248147,0.4032258064516129,1.0,1.0,1/10,3.46%,RAB7B
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),0.5584264284179321,1.0421449906323992,0.45,0.7536828860601384,1.0,3/9,16.29%,PGGT1B;PTAR1;CHM
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.535310918677265,-1.0419668950063867,0.4696969696969697,1.0,1.0,7/23,21.14%,CETN2;RPS27A;UBC;COPS6;COPS5;RBX1;UBA52
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),-0.5661225086394701,-1.0418380463062797,0.35714285714285715,1.0,1.0,1/10,0.80%,DOCK8
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),0.5353850924732817,1.0417859853303535,0.47368421052631576,0.7541234651052044,1.0,2/8,18.11%,NEIL2;SMUG1
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),-0.5568913030970131,-1.0415994200681833,0.3939393939393939,1.0,1.0,2/11,5.95%,CD24;CEACAM1
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.4667255575140571,1.0414056333458557,0.36363636363636365,0.7546156989831236,1.0,6/19,11.57%,SHISA7;GPHN;NRXN1;SHANK3;NLGN4X;NLGN3
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,-0.42237304023136973,-1.0408836051352817,0.3764705882352941,1.0,1.0,4/86,3.39%,GC;PXMP2;DHCR24;PRDX5
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),0.41694110759317343,1.0408737563246966,0.42424242424242425,0.7552949630052805,1.0,4/26,16.57%,SNRPF;ERI1;TENT4B;MTPAP
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.520232850465496,-1.0407519768870575,0.37681159420289856,1.0,1.0,2/24,1.58%,H1-4;H1-2
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),-0.6671740385973862,-1.0405382353408938,0.5272727272727272,1.0,1.0,2/5,23.86%,ATG14;SQSTM1
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.48113444870983907,-1.0405237318702927,0.4305555555555556,1.0,1.0,9/37,25.07%,ISG15;IRF1;OAS3;TLR3;RIPK2;POLR3G;RIOK3;DHX58;FLOT1
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),0.513565272209499,1.0402887891622166,0.3888888888888889,0.7561921995189614,1.0,1/12,4.69%,CILK1
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.4194938912855643,-1.0401604595165892,0.36363636363636365,1.0,1.0,10/106,10.62%,PSMB6;CETN2;RPS27A;PSMB9;PSMA8;RPA3;PSMA7;PSME1;PSMC3;UBC
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.5146109682742346,-1.0398400480643537,0.3918918918918919,1.0,1.0,1/18,6.55%,RPA3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.5146109682742346,-1.0398400480643537,0.3918918918918919,1.0,1.0,1/18,6.55%,RPA3
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),0.6068150633981055,1.039750053230035,0.45454545454545453,0.7568490748916938,1.0,2/7,5.99%,PDE3B;SERPINE1
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),-0.6796061497165617,-1.0397480146061577,0.4909090909090909,1.0,1.0,1/5,2.86%,CACNA1H
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),-0.6796061497165617,-1.0397480146061577,0.4909090909090909,1.0,1.0,1/5,2.86%,CACNA1H
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),-0.6199389610007799,-1.0395888473850967,0.391304347826087,1.0,1.0,3/8,17.23%,RAB7B;RSAD2;PTPN22
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.52771567704857,1.0395551247666708,0.45,0.7567874301116493,1.0,4/12,9.74%,NUDT21;GRIN1;CPSF6;PKD2
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),-0.5319212412708851,-1.0394918262719104,0.4225352112676056,1.0,1.0,3/18,16.38%,EEF1AKMT2;SUV39H1;CSKMT
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.4985453515418149,1.0393860944227926,0.3076923076923077,0.756881815039437,1.0,5/15,14.73%,PTPRK;NOTCH2;PRKD1;TGM1;KLF9
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),0.6158392721555354,1.0393776787720532,0.4634146341463415,0.7564772817336969,1.0,3/5,10.21%,VAPA;EIF2AK4;PRKN
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.5079559369537088,1.0390589295686588,0.4,0.756810620463187,1.0,2/13,10.96%,CPEB3;TNRC6B
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.44544057264358583,-1.0388509055534718,0.38461538461538464,1.0,1.0,15/54,18.79%,PPP1R14C;IL1R1;CXCL2;FPR3;NRN1;CTSH;CD14;CXCL17;FMO2;TNFAIP2;CEBPD;RBM47;C1QB;KLF4;DUOXA1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.5347242438598434,-1.0386368687946526,0.5230769230769231,1.0,1.0,3/15,23.21%,DTX3L;PNKP;PARP9
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),0.4349731809009629,1.0383831359119817,0.358974358974359,0.7580571252036277,1.0,12/28,27.68%,DNAJC15;PEX14;PEX2;PEX16;PEX5;PEX7;PEX6;AIFM1;GRPEL2;CHCHD4;TOMM40L;PEX12
prerank,GO_Biological_Process_2021__embryonic digestive tract morphogenesis (GO:0048557),0.6531084586273899,1.0383228840785048,0.4772727272727273,0.7578186185991211,1.0,3/5,12.96%,RBPMS2;PDGFRA;NIPBL
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.617305094326242,1.0379195578799212,0.48717948717948717,0.7582232976149326,1.0,5/8,18.48%,NEDD4L;CAMK2D;COMMD1;WNK3;WNK1
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),0.6156682587105482,1.0378511303103106,0.40476190476190477,0.7580056853650862,1.0,1/7,0.14%,TCAP
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.43821051401441297,1.037726800322885,0.40625,0.7579333283119967,1.0,8/20,19.86%,ELOVL7;HACD2;ELOVL6;ELOVL5;HACD1;ACSBG1;FAR1;ACSL3
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),0.647384953181378,1.037413887636308,0.45,0.7582441201578339,1.0,2/6,26.34%,PGM2;GALE
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),-0.6013941559243327,-1.0371446202442796,0.4827586206896552,1.0,1.0,3/11,24.34%,IFI35;DOCK2;SBNO2
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),-0.5902708186365488,-1.037074412653578,0.4666666666666667,1.0,1.0,2/7,17.68%,ART4;NOS1
prerank,GO_Biological_Process_2021__regulation of keratinocyte apoptotic process (GO:1902172),-0.6349247954525085,-1.0366755322066632,0.49019607843137253,1.0,1.0,1/5,4.59%,SFRP4
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),0.5972870753514888,1.036597355812052,0.47368421052631576,0.7597445762440288,1.0,3/9,15.76%,SOX9;TGFBR1;PTPN11
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),0.5905222858435746,1.0364834156021177,0.4523809523809524,0.7596093560391555,1.0,5/7,24.96%,ATP2B3;ATP2B4;LETM1;SLC35G1;ATP2B1
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.38928431517759143,1.0364470931992675,0.42857142857142855,0.7592572072168922,1.0,11/46,15.45%,SNCA;STXBP6;RAB27A;STXBP5;CADPS2;RAB8B;RAB9A;RAB21;CLASP1;NSF;SYTL4
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.4399165572367789,1.0363437705218792,0.37142857142857144,0.7591223896737811,1.0,11/27,17.48%,GDAP1;RAB8B;PEX14;PEX2;PEX16;PEX5;ABCD3;PEX7;ZFAND6;PEX6;PEX13
prerank,GO_Biological_Process_2021__pericardium development (GO:0060039),0.5611447529458367,1.0363233650008055,0.4411764705882353,0.7587502218900016,1.0,2/6,15.87%,BMP2;BMP7
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),0.41556761535862546,1.0362496449354814,0.43478260869565216,0.7585229336791421,1.0,8/28,16.81%,PPARGC1A;PID1;ZBTB20;IGF1;MLXIPL;SLC4A4;VCP;HIF1A
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),-0.5630420381395516,-1.035632656356738,0.4027777777777778,1.0,1.0,4/12,16.40%,MTLN;ANGPTL3;APOE;IL18
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.4517983261376796,1.0352518995635598,0.36,0.7604001151595225,1.0,3/22,5.95%,TXNIP;CERS3;EPHA2
prerank,GO_Biological_Process_2021__protein sialylation (GO:1990743),0.652433266850643,1.0352415094847747,0.42857142857142855,0.7600175525155063,1.0,1/5,6.73%,ST3GAL1
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),0.4300680819216483,1.0350708743276646,0.4,0.7600063362197113,1.0,7/31,10.21%,FOXO1;MARVELD3;DUSP10;MEN1;ITCH;DUSP19;PRKN
prerank,GO_Biological_Process_2021__protein localization to ciliary transition zone (GO:1904491),0.6365770321280375,1.0349864139102618,0.5238095238095238,0.7597685657812253,1.0,3/5,30.94%,TCTN1;NPHP4;SPATA7
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),0.5103644542855371,1.0349137714752683,0.4375,0.7595207540810159,1.0,2/9,20.44%,PLBD1;PLAAT3
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),-0.6827851553542521,-1.0346509610120664,0.5,1.0,1.0,2/5,23.95%,IDH3G;IDH2
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.44652257851732136,1.0345676397551118,0.4642857142857143,0.7597978700640298,1.0,5/29,8.95%,SNCA;GRIN1;SLC12A2;KCNH2;TMTC2
prerank,GO_Biological_Process_2021__regulation of morphogenesis of an epithelium (GO:1905330),0.5916003709277536,1.0343611577977672,0.4523809523809524,0.759869050606846,1.0,1/5,1.93%,FOXP1
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.6279167399266186,1.0338424203294379,0.46938775510204084,0.7607417371814593,1.0,3/6,25.34%,PDZD8;VMP1;PACS2
prerank,GO_Biological_Process_2021__radial glial cell differentiation (GO:0060019),-0.6827948702590632,-1.033515728995261,0.532258064516129,1.0,1.0,2/5,22.21%,HES1;GPR157
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,0.4708994215944883,1.0332039584030348,0.36585365853658536,0.7617675705552996,1.0,2/19,4.66%,ACE2;ANXA4
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),0.3429334810459245,1.033029395093056,0.2857142857142857,0.7618068008895958,1.0,25/86,22.90%,ABCC8;ARFIP1;HADH;STXBP5;SLC12A2;RFX3;IGF1;CLOCK;GOLPH3;DISP1;RAP1A;STX1A;SYTL4;PPP3CB;KCNC2;SERGEF;DPH3;APBB1;DRD2;ARF6;ADAM9;PRKCA;MYOM1;FRMD4A;CACNA1E
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.36226201246902506,1.0329871795989822,0.22727272727272727,0.7615586982316519,1.0,21/54,26.33%,CSF1R;SOX9;NFKB1;CDK8;ZNF451;MED13;TNRC6B;AGO3;TRIM28;CBFB;PTEN;PPM1D;MED27;MED4;LEF1;CTNNB1;MECP2;TCF7L2;MED30;MED23;RELA
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),0.28928621016249517,1.032966562290354,0.3333333333333333,0.7612083072628387,1.0,94/413,18.38%,VEGFD;PRODH;ACACB;TNFSF4;TUB;FLT1;PARD3;CCKBR;ERBB4;RAB27A;CSF1R;EPHA4;SOX4;EGFR;VHL;CXCL12;PRMT1;MEIS3;GRIN1;ACER3;PDGFRA;SOX9;ADNP2;RPS6KA3;MYRF;RAD18;HCLS1;FGF17;CNOT6L;NTRK2;CSNK2A1;TFE3;TRPM4;AKT1;IRS1;PDGFA;HDAC2;BMPR1B;PSMD10;MARCHF7;VEGFC;IGF1;EFNB2;ZNF268;PTPRJ;MEIS2;BST1;ANKRD17;VIPR1;STOX1;NAP1L1;DERL2;PTK2;TGFBR2;HDAC4;MERTK;CRKL;SIRT1;TGFBR1;MLXIPL;SMC6;SIRT2;FER;PDGFC;TGM1;RPTOR;BCL2;CCPG1;TJP1;EPCAM;CDK13;DNAJA2;FAF1;NRG1;PHIP;USP47;MAPK8;FXR1;CCAR1;AKT2;LIFR;CUL3;CELF1;KDM4C;ZNF703;SLC6A6;CNOT8;ASH2L;RPRD1B;SRPK2;CDKN2AIP;PTEN;MDM2;CIB1
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),0.41682141574311093,1.032920159986316,0.3333333333333333,0.760889034498957,1.0,3/25,9.80%,MACIR;IL17D;TICAM1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),0.36877596368908816,1.0329007168599886,0.30434782608695654,0.7605188771851097,1.0,17/51,19.03%,CASS4;NPNT;CSPG5;RSU1;TESK1;PLEKHA2;CARMIL1;CRKL;RREB1;CDH13;GSK3B;NRP1;ARHGEF7;NDNF;CIB1;PPM1F;UTRN
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.6598501720996152,1.0328432109175012,0.5348837209302325,0.7602617365335186,1.0,5/5,34.03%,TTBK2;MARK2;PPP2CB;ABL1;MAP2
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),-0.7068450179083259,-1.032804942423907,0.4666666666666667,1.0,1.0,4/5,27.18%,SORD;AKR1A1;XYLB;DCXR
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),-0.7068450179083259,-1.032804942423907,0.4666666666666667,1.0,1.0,4/5,27.18%,SORD;AKR1A1;XYLB;DCXR
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),-0.7068450179083259,-1.032804942423907,0.4666666666666667,1.0,1.0,4/5,27.18%,SORD;AKR1A1;XYLB;DCXR
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),0.43839362450663427,1.0324603699166743,0.44,0.7605779376716939,1.0,11/26,21.75%,ANAPC1;UBE2T;CDC27;UBE2E3;RNF26;PRKN;UBE2E2;UBE2L5;UBE2D3;ANAPC13;UBE2H
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),0.3810202647778477,1.0322814759240453,0.3684210526315789,0.7598284786569645,1.0,17/56,18.07%,BET1;TRAPPC6B;SEC22B;PPP6R3;PEF1;TRAPPC10;COL7A1;SEC24B;NSF;TRAPPC9;RAB1A;TFG;CUL3;CD59;SEC23A;SEC23IP;CNIH1
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.3810202647778477,1.0322814759240453,0.3684210526315789,0.7598284786569645,1.0,17/56,18.07%,BET1;TRAPPC6B;SEC22B;PPP6R3;PEF1;TRAPPC10;COL7A1;SEC24B;NSF;TRAPPC9;RAB1A;TFG;CUL3;CD59;SEC23A;SEC23IP;CNIH1
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),0.3810202647778477,1.0322814759240453,0.3684210526315789,0.7598284786569645,1.0,17/56,18.07%,BET1;TRAPPC6B;SEC22B;PPP6R3;PEF1;TRAPPC10;COL7A1;SEC24B;NSF;TRAPPC9;RAB1A;TFG;CUL3;CD59;SEC23A;SEC23IP;CNIH1
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.45821584343097654,1.0318579025494943,0.375,0.7604199647366724,1.0,6/21,13.41%,MCPH1;PHF13;CHMP1A;CSNK2A1;PLK1;NCAPH2
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),-0.6229702806131241,-1.0316476673044208,0.47692307692307695,1.0,1.0,1/7,6.05%,EFNA1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.5788928566531535,-1.031555369219795,0.46296296296296297,1.0,1.0,1/10,9.42%,GSTP1
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),-0.5951376437517197,-1.0314497324895713,0.45454545454545453,1.0,1.0,4/9,15.55%,SFRP2;ARIH2;WNT2B;WNT5A
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),-0.5327454084672593,-1.0308311089163804,0.43283582089552236,1.0,1.0,8/16,18.93%,MT1H;AQP1;MT1G;MT2A;MT3;MT1A;MT1E;MT1F
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.5226839011010809,-1.0307666835787175,0.48,1.0,1.0,5/15,16.40%,MTLN;ANGPTL3;APOE;XBP1;IL18
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),-0.5878020129544935,-1.0303325453139138,0.43103448275862066,1.0,1.0,2/8,12.81%,SLX4;BLM
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.4222477300110528,-1.0303180467152944,0.375,1.0,1.0,8/63,10.73%,ACOT2;ACOT1;CYP4Z1;PNPLA3;CYP2D6;AWAT1;GSTP1;ACSBG2
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),0.3695758480149984,1.0302839235386516,0.3684210526315789,0.7638176320251707,1.0,17/55,16.15%,NCK2;KANK1;HCLS1;BIN1;CARMIL1;PRKCE;PAK3;SLIT2;SSH1;NCK1;NCKAP1;FER;TENM1;LATS1;CYRIB;VASP;ARFGEF1
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),-0.5637807089477347,-1.0300796367308869,0.423728813559322,1.0,1.0,2/9,11.98%,RPS21;ERI2
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),0.6331035572948327,1.029930123794106,0.5106382978723404,0.7641513745412181,1.0,5/6,27.19%,SMAD4;BMPR1A;HIF1A;SMAD3;TGFB2
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),0.55025228122219,1.0298437519761166,0.3695652173913043,0.7639239953372797,1.0,4/10,30.80%,MTMR2;GNB3;MTMR9;MTMR3
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),0.29484723096158666,1.0298351836035389,0.4,0.7635338063901805,1.0,50/274,19.98%,NUDT21;PPARGC1A;SNRPF;USP49;WDR33;PAPOLA;HNRNPH1;CSTF3;RAVER2;PSPC1;SART1;HNRNPU;DHX15;RNGTT;HNRNPC;CPSF6;SNRPN;SPEN;LSM8;U2AF1;CTNNBL1;SYNCRIP;RBM15B;HNRNPH3;ZMAT5;SMNDC1;DHX9;U2AF2;PRCC;PRPF40B;THOC7;RBM17;CMTR2;RBM41;PRPF40A;CCAR1;SF3B3;RBM6;CELF1;RPRD1B;PTBP1;TRA2A;CWC27;ELAVL2;HNRNPD;NOVA1;SMU1;RALY;GTF2F2;NOVA2
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),-0.4363037877264662,-1.0297977964269143,0.43023255813953487,1.0,1.0,18/74,20.67%,NDUFA6;NDUFS5;NDUFA2;NDUFC1;COX20;NDUFB10;UQCRFS1;SLC25A33;SURF1;TMEM126A;NDUFB3;DMAC1;NDUFA1;NDUFB7;NDUFA12;NDUFB9;NDUFB11;COA3
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),0.6022222585234973,1.0287753929578765,0.4857142857142857,0.7657616142141116,1.0,2/6,15.87%,PRKD1;MAPK8
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.44080197292915624,-1.0286949684441344,0.3875,1.0,1.0,7/48,10.91%,ISG15;COPS9;RPL11;TRIM21;RPL5;PIAS3;SVBP
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),0.5406553372338108,1.0283892970642623,0.4827586206896552,0.7662259778522992,1.0,3/8,10.21%,UBE2T;RNF6;PRKN
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.497685721435312,-1.0282680293128397,0.3717948717948718,1.0,1.0,6/33,21.14%,RPS27A;RPA3;UBC;POLD2;RBX1;UBA52
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.42376880817630813,1.0279402295553413,0.4,0.7668628221316978,1.0,6/24,19.82%,AKT1;PRKN;SIRT1;FYN;NFE2L2;REST
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),0.3956904871357362,1.0278131004680804,0.34782608695652173,0.7667668188398775,1.0,8/36,16.42%,YAF2;EED;PHC1;PCGF2;MGA;PHC3;TFDP2;RBBP4
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),-0.5574747677192973,-1.0277616849306581,0.4492753623188406,1.0,1.0,5/11,19.68%,CEACAM1;ASB4;RRAS;HEY2;EMP2
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),0.44130921332815415,1.0276172624968118,0.3870967741935484,0.7668030462339562,1.0,9/27,24.33%,SOX4;MCU;DOC2B;UCN;DRD2;IRS2;TCF7L2;LRRC8A;NLGN2
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),0.4252950602019468,1.027588938350909,0.375,0.7664532104842843,1.0,5/23,15.03%,CXCL12;ARHGAP35;HCLS1;PAK3;LATS1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),0.564638063054822,1.0274575383750715,0.4594594594594595,0.7664286442741506,1.0,4/7,15.70%,RIN3;SLIT2;NBL1;PADI2
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),-0.5002484700259919,-1.027380954761614,0.4507042253521127,1.0,1.0,4/24,5.07%,GATA1;SOX15;ADAM21;MEA1
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.4760579774043367,-1.0273684852271938,0.4473684210526316,1.0,1.0,14/39,28.15%,VAMP8;TRIM29;LTBR;TNFAIP2;CEBPD;B3GNT3;RBM47;IL18;KLF4;CDH1;RDH12;TJP3;FBP1;CXCL16
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),0.5993354050571267,1.0272807669093709,0.4791666666666667,0.7665563230517547,1.0,3/6,16.69%,CHRNA4;NLGN3;INSYN1
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.5519026153729352,1.0272347374430923,0.41935483870967744,0.7662680194544385,1.0,3/10,8.32%,PARD3;PLPP1;DGKH
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.3947914628868373,1.0269599221852006,0.45,0.7666186710794132,1.0,10/41,16.12%,CDIP1;AEN;BOK;EPHA2;EP300;SIRT1;HIPK2;BCL2;DYRK2;MSH2
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),0.6020902714497827,1.0268972279250326,0.4634146341463415,0.7663306354649875,1.0,2/7,6.27%,KYAT1;QDPR
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),0.5847856432094366,1.0268046596148948,0.4888888888888889,0.7661137875907362,1.0,2/6,16.24%,ATG7;ATG2B
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.42305089529310813,1.0266991647144117,0.43478260869565216,0.7659376516544538,1.0,11/31,24.41%,CPEB3;GRIN1;GLRB;CPEB4;RPTOR;RRAGD;CPEB1;IPO5;SESN2;GLRA3;SH3BP4
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),0.6269986704165851,1.026670959209769,0.44,0.7655796060173234,1.0,2/5,9.82%,MBP;HMGB1
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",0.47046032361012924,1.0265377941971696,0.39285714285714285,0.7655050412178948,1.0,3/20,9.82%,DNASE1L2;DFFB;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),0.6297613794733095,1.0265229210424731,0.42857142857142855,0.7651678041411882,1.0,1/6,3.00%,STMP1
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.449109013695398,1.026402566811108,0.3,0.7650329276668716,1.0,12/23,24.33%,SNCA;PIP5K1C;NLGN4X;NLGN3;STX1A;OPHN1;SYNJ1;NLGN1;NLGN4Y;SYNJ2;SYT5;NLGN2
prerank,GO_Biological_Process_2021__bundle of His cell to Purkinje myocyte communication (GO:0086069),-0.6746553506125922,-1.026281699484404,0.5178571428571429,1.0,1.0,4/5,28.99%,CTNNA3;TBX5;PKP2;JUP
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),-0.5569506228908998,-1.026248887762291,0.43243243243243246,1.0,1.0,4/13,16.43%,MOV10L1;SYCP3;BTBD18;BRDT
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.43590975436237017,1.026222592836173,0.3181818181818182,0.7650698107904674,1.0,11/33,15.19%,EPHA2;AKT1;BMPR1B;RPS6KB1;ACVR1;TGFBR2;TGFBR1;MAP2K5;ACVR2A;BMPR1A;CPNE3
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.6336128053164755,-1.026071630432834,0.5263157894736842,1.0,1.0,2/6,18.50%,SFRP1;BTG1
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.4427660536588719,1.0259989759108825,0.48484848484848486,0.7652277359716768,1.0,5/26,12.69%,TUB;RAB27A;RAB31;PTPRJ;MERTK
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),0.6379440530714972,1.0259564240689465,0.4418604651162791,0.7649014271822241,1.0,3/6,14.39%,SNCA;NFKB1;ATP2B4
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),-0.5049241729297715,-1.0256610355303957,0.4666666666666667,1.0,1.0,1/18,2.40%,ENPP2
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),0.5407930824534039,1.0253853711902599,0.4473684210526316,0.7659160390904413,1.0,4/10,14.35%,DGKB;GAL3ST1;DGKZ;DGKG
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),-0.5573875301278538,-1.025104224651469,0.4461538461538462,1.0,1.0,3/11,13.29%,SFRP4;PLAAT4;ETV4
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),0.4016647514844504,1.025085360151612,0.42857142857142855,0.7663049902480349,1.0,15/50,19.69%,EFNA5;RCC2;LIMCH1;FAM107A;PTPRJ;MAP4K4;GPM6B;PTK2;CLASP1;NRP1;DUSP22;ROCK2;PTEN;PPM1F;ROCK1
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),0.39064949780558184,1.0248664111669326,0.34782608695652173,0.7663813956185961,1.0,9/36,19.63%,SLC6A13;SLC25A18;SLC7A11;SFXN1;SLC38A6;SLC38A10;SLC47A1;SLC6A6;SLC7A9
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.39331037357951676,-1.0248656818477837,0.3488372093023256,1.0,1.0,19/127,16.17%,GBP2;PSMB6;GBP3;GBP1;STAT1;PSMB9;PSMA8;PSMA7;PSME1;PSMC3;SFRP1;HYAL1;LTBR;TXNDC17;PSMC4;CCL2;CX3CL1;BRCA1;PSMA3
prerank,GO_Biological_Process_2021__protein geranylgeranylation (GO:0018344),0.6895997098278338,1.024835613946088,0.4722222222222222,0.7660752931148864,1.0,2/5,16.29%,PGGT1B;CHM
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),-0.6483046478021388,-1.0247771524576075,0.532258064516129,1.0,1.0,1/6,4.84%,NOP10
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.47007023956251115,1.0244936381765364,0.45161290322580644,0.766453499527643,1.0,9/21,24.31%,PIK3CA;PIK3R1;AUTS2;OCLN;NCKAP1;CYFIP1;ACTR3;ABI2;AKIRIN1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.48161952674364783,1.0241200638841301,0.4473684210526316,0.7671429735720534,1.0,3/12,7.36%,ANK2;CACNA2D1;KCNH2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.47547131242293095,1.0239664909020112,0.4444444444444444,0.767178594683237,1.0,3/14,7.36%,ANK2;CACNA2D1;KCNH2
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),0.597242855215507,1.0238497459626092,0.43902439024390244,0.7670534890430878,1.0,3/5,38.58%,DNAJA1;BAG4;LRRK2
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),0.30157739839161735,1.023637761323254,0.4,0.7671192333835557,1.0,65/231,20.41%,USP13;CDC25A;USP49;USP46;KAT2B;KEAP1;RHOT1;OTUB2;SMAD2;USP31;PSMA1;COPS7B;USP38;COPS2;KAT2A;CCNA2;UBE2D1;INO80D;USP12;PSMD11;SMAD7;MAP3K7;PSMD10;USP24;PRKN;TAB1;GPS1;EP300;PSMF1;PSMD14;ZRANB1;USP3;ADRB2;VCPIP1;OGT;TGFBR1;USP40;MDM4;SMAD4;OTUD4;VCP;USP25;USP22;USP9X;USP47;USP35;BIRC2;UIMC1;USP2;ABRAXAS2;BRCC3;HIF1A;PSME4;KDM1B;PTEN;YY1;MDM2;RAD23B;USP34;ASXL2;OTUD7A;STAM2;MBD5;ATXN7;WDR48
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),0.395485189023702,1.023498441754798,0.4,0.7670344185120699,1.0,8/76,6.35%,ADAMTS3;PCSK5;TSPAN17;MMP16;NCSTN;TSPAN14;MME;SDE2
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),0.5528574547458707,1.023491239089733,0.4375,0.766658891204196,1.0,5/11,22.37%,TPK1;DCK;SLC19A2;ERH;NT5C3A
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.46502999107495285,1.023445706776306,0.3548387096774194,0.766313818281597,1.0,6/14,23.68%,RNF26;ITCH;ELMOD2;DHX9;PCBP2;TRAF3
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),0.47694168609558374,1.023425943294313,0.3870967741935484,0.7659991526741252,1.0,2/13,1.52%,AK3;AK1
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),-0.4614026937704733,-1.0234114286807636,0.44,1.0,1.0,11/47,17.78%,CD24;AKR1C1;ANGPTL3;FABP3;CAV3;APOM;APOE;ACSM3;XBP1;IL18;ABCA5
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),0.6253066709974213,1.0230750414921108,0.4594594594594595,0.7664457301850448,1.0,3/8,15.76%,SOX9;TGFBR1;PTPN11
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),0.4435737644251965,1.0227102758467055,0.34285714285714286,0.7669318757773168,1.0,4/29,5.73%,CSPG5;DCN;ADO;VCAN
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.5369337627364463,-1.0227009386275114,0.417910447761194,1.0,1.0,4/16,19.91%,AKR1C1;GSTP1;PTGR1;CD74
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.47486944761787975,-1.0225357005597573,0.4533333333333333,1.0,1.0,2/43,1.58%,H1-4;H1-2
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),0.3085134748146836,1.02233367324539,0.16666666666666666,0.7674075194274814,1.0,65/273,16.23%,VEGFD;LEPR;SNCA;EFNA5;NPTN;ERBB4;CSF1R;EGFR;RPS6KA4;AGAP2;SOX9;BMP2;MMD;LIMCH1;ARRB1;CNOT9;HCLS1;TEC;TESK1;FGF17;TNIK;NTRK2;RAPGEF2;AKT1;PDGFA;RALB;VEGFC;DUSP19;IGF1;CAPRIN2;DOCK7;HGF;PTPRJ;GDF10;BRAF;LRP8;PRKD1;STOX1;ACVR1;PLK1;PTK2;CLIP3;CRKL;SIRT1;TGFBR1;RAP1A;ACVR2A;RAP2C;PDGFC;RPTOR;WDFY2;TENM1;ATP2B4;MAPK1;SMAD4;BMPR1A;TAOK2;NRP1;LATS1;ROCK2;PTPN11;SEMA4D;BMP7;RAP2A;FXR1
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.4890921772265211,1.0221366415467905,0.4666666666666667,0.7670984095642849,1.0,5/18,23.13%,HELLS;ATRX;PPM1D;BEND3;EHMT1
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.4890921772265211,1.0221366415467905,0.4666666666666667,0.7670984095642849,1.0,5/18,23.13%,HELLS;ATRX;PPM1D;BEND3;EHMT1
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.49488868477739933,1.0221178998428102,0.36,0.766764337913576,1.0,7/19,12.26%,FLT1;PDGFRA;AGAP2;IRS1;PIK3R4;PRKD1;PTK2
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),0.6373797770637096,1.0219691765135321,0.5434782608695652,0.7667100843855202,1.0,1/5,3.49%,ACTA2
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.5244738014284654,1.0219612314471695,0.42105263157894735,0.766316697990248,1.0,2/16,8.99%,TSEN15;ZBTB8OS
prerank,GO_Biological_Process_2021__fructose metabolic process (GO:0006000),-0.6807395284908688,-1.0218105629710144,0.5161290322580645,1.0,1.0,2/5,13.99%,ALDOB;SORD
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),0.5222929242428935,1.0217067999004068,0.34146341463414637,0.7666914834215215,1.0,3/9,12.87%,FOXO3;TFB1M;MTERF1
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),-0.650612368681174,-1.0215465959462307,0.5660377358490566,1.0,1.0,1/5,3.85%,STAT1
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),-0.650612368681174,-1.0215465959462307,0.5660377358490566,1.0,1.0,1/5,3.85%,STAT1
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.3163642884422077,1.0213512385002166,0.3333333333333333,0.767026021027089,1.0,12/123,8.12%,TCAP;SPIRE2;GAS2;CASS4;MYO5B;EPS8;MCU;CGNL1;RHOBTB3;CARMIL1;WASL;SPIRE1
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),-0.44582225993227204,-1.0210124125676825,0.4567901234567901,1.0,1.0,14/56,20.40%,GATA1;AKR1C1;CACNA1H;CTSL;RDX;SFRP1;CTSH;BRD8;RAMP3;XBP1;SFR1;PAX8;GPER1;LMO2
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),-0.5497027806951277,-1.020629590850248,0.5352112676056338,1.0,1.0,1/13,4.36%,ENTPD3
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.5716728727817458,1.020626504740349,0.4358974358974359,0.7681471191768712,1.0,6/10,18.24%,DYRK1A;PSMD10;MARCHF7;SIRT1;KDM1A;MDM2
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),0.41537243388770684,1.0206088805386568,0.41379310344827586,0.7677836697829338,1.0,7/24,19.35%,INSC;PLK1;CLASP1;ESPL1;FBXW11;NSFL1C;UBXN2B
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.44320794275272957,1.020317486319023,0.4230769230769231,0.7679081720922383,1.0,9/21,26.35%,TMTC2;LARGE1;CRPPA;TMTC4;FKRP;TMTC1;DPM1;DPY19L3;TMTC3
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),-0.5497454284139357,-1.0202660623791373,0.4520547945205479,1.0,1.0,1/16,1.21%,GATA1
prerank,GO_Biological_Process_2021__maintenance of DNA repeat elements (GO:0043570),0.571900567640472,1.0193803255092713,0.4418604651162791,0.7694746468899707,1.0,3/6,30.89%,MSH2;TCF7L2;MSH3
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.3780174582172034,1.0189991419601159,0.3448275862068966,0.7700355363803892,1.0,12/39,23.78%,BIN1;CHMP1A;SYNE1;REEP4;CHMP2B;NDC1;NUP205;LEMD3;ATXN7;CHMP6;NUP98;NUP54
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),0.5084780839882044,1.018937140741487,0.4634146341463415,0.76981095983274,1.0,3/9,15.23%,SNCA;SCRIB;NSF
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),0.5929244360713899,1.0189154867106405,0.4594594594594595,0.7694475887872774,1.0,1/6,6.03%,AFG1L
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),-0.679629744685357,-1.0189096773192903,0.4909090909090909,1.0,1.0,2/6,14.27%,SELENOS;APOE
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.5676157299383241,1.018901458988133,0.475,0.7690945139267885,1.0,1/8,0.61%,WNT7A
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.3493185503435949,1.0188343025617357,0.375,0.768811240362028,1.0,13/60,11.97%,ELAPOR2;ZNF706;SOX9;NFIB;BMP2;KANK1;IL17D;LOXL2;SPRY3;PRKN;DCC;ANP32B;KIAA0319
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),-0.5645836769629204,-1.0187878221598348,0.48148148148148145,1.0,1.0,3/11,10.57%,RHOBTB2;THBS1;RHOH
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),-0.4622371432765328,-1.0181884400459462,0.4594594594594595,1.0,1.0,11/46,17.78%,CD24;AKR1C1;ANGPTL3;FABP3;CAV3;APOM;APOE;ACSM3;XBP1;IL18;ABCA5
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),-0.5368307620101656,-1.0179959247054675,0.4225352112676056,1.0,1.0,3/17,12.13%,OVOL2;VEPH1;NODAL
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),0.5857206745466106,1.0177669962603195,0.4166666666666667,0.7709277065938234,1.0,1/7,8.02%,NR1D2
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),0.3692437286282455,1.017733797510204,0.40625,0.7705843272435521,1.0,8/44,16.30%,DNA2;POLD3;LTO1;STN1;NSMCE2;SMC6;PTGES3;POT1
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),0.4806415368355253,1.0176377580661855,0.475,0.7703601575570452,1.0,3/17,10.21%,SDC4;ATP9A;PRKN
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),0.5571276960120015,1.0175775121278245,0.5,0.7696948148069966,1.0,4/9,18.16%,PUDP;UCK2;DCK;UPP1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),0.5571276960120015,1.0175775121278245,0.5,0.7696948148069966,1.0,4/9,18.16%,PUDP;UCK2;DCK;UPP1
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.4496929946243161,-1.0175621320044885,0.4520547945205479,1.0,1.0,12/39,25.20%,IFITM3;TRIM21;HEXIM1;POLR2L;POLR2I;GTF2F1;POLR2J;POLR2K;POLR2G;ZFP36;NELFCD;NELFE
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),-0.6318227393575553,-1.0175136188979834,0.4666666666666667,1.0,1.0,2/6,20.38%,DOLK;DHDDS
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),-0.6318227393575553,-1.0175136188979834,0.4666666666666667,1.0,1.0,2/6,20.38%,DOLK;DHDDS
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),0.4365515539682388,1.0172010145279347,0.3793103448275862,0.7701538406628551,1.0,8/25,22.89%,HCLS1;PIK3R1;UBR5;TRIM28;IPO5;ZPR1;BAG3;SMAD3
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),0.6122473323255694,1.0172003708099788,0.49019607843137253,0.7697623033773123,1.0,3/6,14.70%,ARRB1;AUTS2;KAT7
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.48791049899331046,1.0168354202822578,0.5151515151515151,0.770122030258066,1.0,4/17,10.21%,SNCA;GRIN1;TMTC2;PRKN
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),-0.6392353866095464,-1.0168134073298554,0.5614035087719298,1.0,1.0,5/8,23.83%,P2RY12;CXCL17;CCL2;SFTPD;EDNRB
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.4095374611642744,1.016610371620294,0.39285714285714285,0.7703233949234216,1.0,10/33,19.09%,CPEB3;SESN1;CPEB4;RPTOR;SESN3;UBR1;FYN;RRAGD;CPEB1;IPO5
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.4879470134931625,-1.0162831042805205,0.4375,1.0,1.0,6/35,21.14%,RPS27A;RPA3;UBC;POLD2;RBX1;UBA52
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),-0.6350295803597644,-1.016257505041896,0.5409836065573771,1.0,1.0,3/6,35.29%,CD74;LGALS1;CD4
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),-0.6350295803597644,-1.016257505041896,0.5409836065573771,1.0,1.0,3/6,35.29%,CD74;LGALS1;CD4
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),0.6189215452722279,1.0158423780355512,0.5121951219512195,0.7715904923664858,1.0,1/6,4.85%,SOX9
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),0.479215033988084,1.0155975322068942,0.34375,0.771820502014783,1.0,3/21,7.36%,CACNA1G;CACNA1I;KCNH2
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.4846906802991485,-1.0154572406312978,0.4473684210526316,1.0,1.0,4/25,9.18%,AKR1C1;SLC51B;CEACAM1;SLC51A
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.5709357238448151,1.015246942251856,0.475,0.7722967728636444,1.0,5/8,21.99%,RBPMS2;PDGFRA;NIPBL;FGFR2;EPHB3
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.3993321888622523,-1.014986541012146,0.40229885057471265,1.0,1.0,4/105,3.70%,RPS14;IFIT1;SRPRA;KDELR3
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.4029685652005588,-1.0147926582714977,0.47560975609756095,1.0,1.0,27/94,23.06%,GC;CP;AKR1C1;HSD11B1;ALDOB;GPC3;NR1I3;CYP2D6;ADH6;RPP25L;MASP2;APOM;SAT2;CPB2;EID2;SLC10A1;ABCC6P1;ACAT2;CYP3A4;C3P1;F11;TFR2;CDH1;TM7SF2;MSMO1;AZGP1;AR
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),0.356880102687556,1.0147852459024331,0.22727272727272727,0.7730583495929932,1.0,10/63,15.00%,NUP188;RBFOX1;U2AF1;KIF5C;EIF4E;NUP153;CKAP5;TGFBR2;U2AF2;THOC7
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),0.5200532561061167,1.014610413448354,0.4782608695652174,0.7731690686144209,1.0,5/13,16.37%,SNAP91;WASL;SCYL2;NEU3;UBQLN2
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),0.5532722301003958,1.014597874626619,0.48717948717948717,0.7728465042201386,1.0,1/7,2.23%,SASH1
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),0.3237100613140221,1.0145833968217621,0.3333333333333333,0.772484907028133,1.0,61/263,19.48%,TBC1D4;PTPRK;ARFIP1;ANK2;ARL5A;TBC1D1;EGFR;TBC1D5;USP6NL;TBC1D12;EVI5L;SEPTIN6;TRAPPC8;SEPTIN8;RAB31;RAB18;AMOT;RAB23;SNX27;ARFRP1;ITSN1;TBC1D22B;AP3B1;CNTLN;SEPTIN11;ABHD17A;FAM91A1;SCFD2;RAB21;SMURF1;GGA2;OCLN;NIPBL;BICD2;SEPTIN7;TBC1D8B;NAPB;STX1A;RAB22A;SH3PXD2B;KIF13A;TM9SF3;TBC1D10A;TMED3;NSF;TM9SF4;SNX13;STX8;RAB1A;RAP2A;TMED5;RAB28;RABGAP1L;BBS2;SEC23IP;TBCK;RRAGD;STX7;ARF6;STX12;GGA1
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.5042898148643429,1.014083182969285,0.375,0.7732350128797102,1.0,4/13,26.61%,U2AF2;PTBP1;PCBP4;SFSWAP
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),-0.6077628555644559,-1.0140214312630513,0.47540983606557374,1.0,1.0,1/11,3.46%,RAB7B
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),-0.6184064145266386,-1.0139592553056733,0.5576923076923077,1.0,1.0,1/7,0.68%,SFRP2
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),-0.4594977910850411,-1.0139286553041447,0.4936708860759494,1.0,1.0,1/37,0.19%,PIF1
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),0.3554470699047506,1.0131420715408608,0.42105263157894735,0.7747314304567666,1.0,15/49,17.21%,PTPRK;EGFR;PDGFRA;AKT1;APTX;PKD2;AGAP3;SIRT1;FER;MAPK1;PDK2;MAPK8;PXN;HIF1A;FYN
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),-0.5242666206039698,-1.0131135633819381,0.46875,1.0,1.0,5/12,21.60%,HTR2B;PIK3CB;APOE;NOS1AP;S100A1
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),-0.5806663587134485,-1.0129932242401072,0.546875,1.0,1.0,2/10,27.10%,INHA;EIF2B4
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),0.37056249779145756,1.0129096641525208,0.42105263157894735,0.7748115496152393,1.0,15/70,18.11%,BACH1;CDC25A;CDK18;KLF11;CAMK2A;RPS6KB1;EIF4E;ACVR1;CDC34;CUL2;CUL1;LATS1;TFDP2;CUL3;CDK14
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.4524487083762625,1.0128935807339547,0.47058823529411764,0.7744791503000974,1.0,9/28,18.20%,ARHGEF6;CARMIL1;GOLPH3;CDH13;ARHGEF7;PTPRO;CYFIP1;WASF1;S1PR1
prerank,GO_Biological_Process_2021__acylglycerol acyl-chain remodeling (GO:0036155),-0.6545125503593303,-1.0128823061954888,0.4528301886792453,1.0,1.0,2/5,7.96%,DGAT2L6;PNPLA3
prerank,GO_Biological_Process_2021__action potential (GO:0001508),0.3764094429650912,1.0125604095866563,0.4473684210526316,0.7749617302849243,1.0,5/36,10.11%,CHRNA4;CACNA1G;CACNA1I;KCNH2;KCNA2
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.4228886584790538,1.0124656940306114,0.4375,0.7748650313938478,1.0,8/20,25.86%,NLGN4X;SLC30A1;MTMR2;DRD2;PTEN;PRRT1;PICK1;ATAD1
prerank,GO_Biological_Process_2021__protein localization to nucleolus (GO:1902570),-0.6664028238565615,-1.01184879804151,0.5384615384615384,1.0,1.0,2/5,23.00%,RPF2;RAN
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),-0.6565776005631441,-1.011840361800758,0.5555555555555556,1.0,1.0,2/5,12.69%,RDX;CAV3
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.3531689939120984,1.0117425240470523,0.4583333333333333,0.7759450402740612,1.0,10/53,15.34%,LEPR;TAB3;PLIN5;AKT1;HGF;EIF4E;SIRT2;BCL2;EIF4G3;MTMR2
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),-0.6394655227705459,-1.0116929602896398,0.5,1.0,1.0,1/7,16.64%,SLC4A11
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),-0.5273219527413529,-1.0116743159665624,0.3968253968253968,1.0,1.0,1/12,1.19%,CENPE
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),0.3752299800245269,1.0116628080883545,0.4117647058823529,0.7757401416656445,1.0,9/47,12.84%,FOXP1;CSF1R;EFNA2;PDE1B;EPHA2;PIR;EP300;TGFBR2;SIRT1
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),-0.6116021996240644,-1.011611361355983,0.5666666666666667,1.0,1.0,3/8,21.21%,SELENOS;DDIT3;TMCO1
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),0.49033807391884654,1.0112895864685052,0.5,0.7762504995555153,1.0,5/11,23.30%,USP13;USP25;RNF185;RNFT1;BAG6
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.40859326229398374,-1.011194119813881,0.46153846153846156,1.0,1.0,7/108,5.03%,IFI44L;MYOT;PLAG1;IL5;MX1;PDE6B;ZC2HC1C
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),0.5719201828742961,1.0110809163025911,0.5,0.7763393617054606,1.0,3/8,17.20%,PEX16;ZFAND6;PEX6
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.48339870033054805,1.0108956657126507,0.4473684210526316,0.7763889930243089,1.0,6/17,16.68%,QRICH2;PARVA;RHOQ;PDGFA;NCKAP1;CYFIP1
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),-0.6500221845238082,-1.0108635372186052,0.5263157894736842,1.0,1.0,2/5,8.86%,CMPK2;TYMS
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),0.5821024638471646,1.01082466026186,0.46875,0.7761842833704613,1.0,4/8,11.20%,CCDC88C;PARVA;PIK3CA;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),0.6325669771392872,1.0107580499685676,0.4883720930232558,0.7759700040509703,1.0,3/5,21.21%,HCLS1;RUNX1;LEF1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),-0.6058119911919558,-1.0106867681019158,0.5223880597014925,1.0,1.0,5/9,26.99%,PRKCQ;IL18;SPHK1;TGFB1;RFTN1
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.452822125786894,1.0106232082713629,0.42424242424242425,0.7758927284191438,1.0,6/24,14.39%,MEOX2;STARD13;RGCC;HMGB1;MAP2K5;ATP2B4
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),-0.5266783696416384,-1.0102402928832823,0.4838709677419355,1.0,1.0,2/18,6.04%,ANXA1;PNP
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.45608490492737275,1.0100151349109532,0.47368421052631576,0.776909287438131,1.0,1/12,0.11%,PDK4
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.43374382306247017,1.0099208697472648,0.375,0.7767925747233664,1.0,2/16,10.79%,MITF;MED13
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.41581243801530376,1.0098886831807243,0.37142857142857144,0.776490617264123,1.0,11/33,20.31%,EPHA2;AKT1;PTPRJ;SIRT1;MAGI2;PHLPP2;DRD2;PTEN;CIB1;PLEKHA1;PHLPP1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),0.4779647203693693,1.009592121539018,0.40625,0.7769300383001754,1.0,6/13,14.98%,SERPINE1;PDGFA;IGF1;SLIT2;BMPR1A;NRP1
prerank,GO_Biological_Process_2021__positive regulation of blood-brain barrier permeability (GO:1905605),0.6117025668717972,1.0095572295924093,0.48,0.776638060758533,1.0,2/5,14.20%,OCLN;TJP1
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),-0.6393161339913179,-1.0093907249334249,0.532258064516129,1.0,1.0,1/5,11.69%,CD14
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.2887529790169528,1.0093435960425472,0.42857142857142855,0.7766775774154601,1.0,29/138,18.17%,C18ORF32;VAPA;TAB3;EEF1D;CASP10;ATP2C1;UBE2N;TNFRSF10B;TRAF3IP2;PPM1A;CANT1;ROR1;MAP3K7;TICAM1;PRKN;LURAP1;CFLAR;PRKD1;ANKRD17;ECM1;TRADD;TNFRSF19;BIRC2;TFG;MIB2;TFRC;NDFIP1;BCL10;TRIM8
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.4797650373109458,1.009271207487101,0.36666666666666664,0.7764541731366493,1.0,3/14,7.71%,FLT1;PDGFRA;ABL2
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),0.40327092124559566,1.0092002691456587,0.3888888888888889,0.7763185757482336,1.0,5/28,16.12%,HDAC9;PTPRJ;HDAC4;DCAF1;MSH2
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),-0.488004125519168,-1.0090983255247057,0.48484848484848486,1.0,1.0,3/24,5.32%,CFTR;IGFBP5;AQP1
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.4524608164200757,1.0090847270575922,0.46875,0.7762706534739889,1.0,8/25,18.20%,ARHGEF6;CARMIL1;GOLPH3;CDH13;ARHGEF7;PTPRO;CYFIP1;S1PR1
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.4271085814288696,-1.0090273481555745,0.4470588235294118,1.0,1.0,25/65,28.15%,IRF1;MMP25;HELZ2;HLA-C;SIGIRR;IFI35;TMC6;VAMP8;DEF6;HLA-F;ARRDC2;IL4R;NFKB2;ZFP36;JUNB;SBNO2;PARP12;HLA-E;PRKD2;B3GALT4;PARP10;ANO9;RHBDF2;ADAM8;CXCL16
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),-0.5687765617958126,-1.0088154502343463,0.5396825396825397,1.0,1.0,1/10,3.95%,CD9
prerank,GO_Biological_Process_2021__flavin-containing compound metabolic process (GO:0042726),-0.6571907612958565,-1.0085391369105883,0.5076923076923077,1.0,1.0,2/5,29.31%,SLC52A2;RFK
prerank,GO_Biological_Process_2021__riboflavin metabolic process (GO:0006771),-0.6571907612958565,-1.0085391369105883,0.5076923076923077,1.0,1.0,2/5,29.31%,SLC52A2;RFK
prerank,GO_Biological_Process_2021__succinate transmembrane transport (GO:0071422),0.6465378143967879,1.008498623795502,0.5641025641025641,0.7772435620463188,1.0,2/5,17.90%,SLC13A3;SLC25A14
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),-0.5844656623869491,-1.0084765554955226,0.5352112676056338,1.0,1.0,2/12,5.94%,CD63;TIMP1
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),-0.5505459550623775,-1.0084692321318025,0.45588235294117646,1.0,1.0,6/16,19.46%,DUOX1;NOX1;MT3;CCS;SOD3;ALOX12
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),0.4216759481597992,1.0084140761355544,0.47058823529411764,0.7766807596137012,1.0,3/24,2.66%,WDR33;PAPOLA;CSTF3
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),0.4216759481597992,1.0084140761355544,0.47058823529411764,0.7766807596137012,1.0,3/24,2.66%,WDR33;PAPOLA;CSTF3
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),0.5234162546249101,1.008330960148078,0.4722222222222222,0.7764677301365615,1.0,5/10,15.65%,PDE3A;PTPRJ;SLIT2;PDE2A;DDAH1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.42275995255193594,-1.0083236626268404,0.46835443037974683,1.0,1.0,13/68,17.23%,ARG2;SELENOS;RASGRP1;THBS1;GSTP1;CD14;OAS3;LY96;TLR3;CLU;CX3CL1;WNT5A;PTPN22
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),0.6261662363339199,1.00816726543444,0.5238095238095238,0.7764295553379933,1.0,2/7,15.45%,PSMD10;FAF1
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.4570933424581513,1.0080383852953365,0.3870967741935484,0.7763235361302929,1.0,5/20,13.20%,B4GALT3;ST3GAL1;B4GALT6;B4GALT2;B4GALT5
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),0.6159910101090497,1.0077991197911358,0.5,0.7765084025490071,1.0,2/6,10.34%,RNF26;HOOK1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",-0.6217188884279291,-1.0075878880301938,0.5,1.0,1.0,1/6,1.39%,RPS21
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),-0.5040394345027044,-1.007570164274308,0.4626865671641791,1.0,1.0,3/14,15.12%,SEMA5A;FGF7;CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),-0.5877042650766828,-1.0074313204316745,0.4696969696969697,1.0,1.0,3/8,12.50%,CEACAM1;ASB4;RRAS
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),0.5881547770141533,1.0074294111307756,0.48717948717948717,0.7769934076222333,1.0,1/9,1.38%,RARB
prerank,GO_Biological_Process_2021__plasma membrane phospholipid scrambling (GO:0017121),0.5742128390139964,1.007170527102497,0.5,0.7771874393198035,1.0,1/6,17.22%,PLSCR2
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),0.60644148230762,1.0071581284684856,0.5106382978723404,0.7768296210089509,1.0,1/6,1.50%,TNFSF4
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),0.5309876632786523,1.0066293401730784,0.5294117647058824,0.7775749235158463,1.0,5/8,35.11%,PRKCB;VMP1;ZDHHC17;PPARG;UNC119B
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),-0.6201374890883009,-1.006158627385924,0.5185185185185185,1.0,1.0,1/5,8.94%,HES1
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),-0.6159436016896244,-1.0060036342826943,0.5147058823529411,1.0,1.0,2/8,12.67%,GTF3C6;POLR2L
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.32532357579279303,1.005889700708465,0.4375,0.7789286043937741,1.0,22/103,15.76%,NPNT;HTR2C;ERBB4;CSF1R;EGFR;PDGFRA;BMP2;NOTCH2;ARRB1;NTRK2;RAPGEF2;PDGFA;ROR1;ADRA1A;HMGB1;BRAF;FBXW7;CRKL;RAP1A;PDGFC;NRP1;PTPN11
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),0.40903182936993493,1.0057548388314266,0.5277777777777778,0.7789086858042894,1.0,6/33,12.76%,SLC19A1;SLC7A11;ABCC5;SLC38A6;SLC38A10;SLC13A3
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.4869153761041771,1.005585406121585,0.5,0.7787825384568229,1.0,4/16,9.74%,NUDT21;GRIN1;CPSF6;PKD2
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),0.44580497506100997,1.0053391343212452,0.52,0.7788302913137247,1.0,1/22,0.09%,ACE2
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle recycling (GO:1903421),0.5854367004901653,1.0053101081739957,0.5,0.7784920218993566,1.0,1/5,2.40%,SNCA
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),0.4681134389354974,1.0053007677616805,0.4666666666666667,0.7781347988988198,1.0,5/18,19.73%,AK3;GMPS;ATIC;LHPP;AK4
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),0.4840777270814409,1.0051502597540245,0.4857142857142857,0.7781442426550266,1.0,3/11,10.21%,VAPA;EIF2AK4;PRKN
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),0.48721460611312484,1.0050158366050745,0.4594594594594595,0.7780862318634535,1.0,4/14,26.61%,U2AF2;PTBP1;PCBP4;SFSWAP
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),0.4555129933200189,1.004994847249404,0.45,0.777729740640548,1.0,8/16,25.20%,SLC39A11;SLC30A4;SLC30A1;TRPM2;SLC39A12;SLC39A8;SLC30A3;SLC39A13
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),-0.6337904082329426,-1.0048884003684875,0.5,1.0,1.0,3/6,27.65%,CD274;PRELID1;ADAM8
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.5738570338565435,-1.004835898025091,0.5070422535211268,1.0,1.0,1/8,4.36%,ENTPD3
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.4679660231743043,1.0047539818154219,0.5,0.7778837532042177,1.0,10/20,35.85%,HELLS;ATRX;PPM1D;BEND3;EHMT1;PICK1;METTL4;TEX15;ATF7IP;KMT2E
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),0.3256340566367411,1.0047296016022775,0.25,0.7775565771292202,1.0,43/209,17.07%,TCAP;WNT7A;PPARGC1A;SPAG16;MICAL1;QRICH2;PAWR;MITF;PARD3;SHANK1;PICALM;EPS8;QSOX1;PARVA;RHOQ;SOX9;CD247;FBLIM1;FAM107A;WASL;CEP290;PDGFA;PEX14;SYCE1;DVL1;NLGN4X;NLGN3;GPM6B;OCLN;VCPIP1;NCKAP1;DNAJB13;OPHN1;MDM4;YAP1;VASP;TOGARAM1;POT1;RBBP4;CYFIP1;PCLO;WASF3;WASF1
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.39198334067784085,1.0045245543179155,0.46153846153846156,0.7775855154311901,1.0,17/40,27.35%,EGFR;NFKB1;DYRK1A;PIK3R1;HNRNPLL;U2AF2;MAP2K2;LIN28B;ZPR1;RBM20;HSPA1A;GRSF1;ERN1;UTP15;SETX;RELA;SLC38A2
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),-0.5129979815144118,-1.0044764973093447,0.4788732394366197,1.0,1.0,1/24,1.50%,AKR1C1
prerank,GO_Biological_Process_2021__insulin metabolic process (GO:1901142),-0.616146864503872,-1.0044455840594915,0.5192307692307693,1.0,1.0,3/5,21.00%,CEACAM1;CELA2A;PCSK2
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),-0.5940386734996869,-1.0044268789321302,0.4927536231884058,1.0,1.0,1/8,4.59%,SFRP4
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),0.4625909258880314,1.0043457517198735,0.48484848484848486,0.7775663690579422,1.0,2/11,5.16%,BMP2;NOTCH2
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.4367852636176224,1.0029643158697839,0.4722222222222222,0.7803619357205411,1.0,4/18,11.67%,PRKCSH;MGAT4A;MAN1A2;FUT8
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.3726010736289908,1.0029223359337016,0.45454545454545453,0.7800821907285787,1.0,12/63,9.46%,POSTN;ACTA2;DCN;CXCL12;PDGFRA;MSRB3;CDH11;LOXL2;LOXL1;PCDH18;GLT8D2;VEGFC
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.3226076530586362,1.0028521368242882,0.5454545454545454,0.7798890947239976,1.0,39/152,19.49%,PPARGC1A;USP13;ANK2;ZNF207;EPHA4;SOX4;VHL;PARVA;CCT4;PIK3R1;NLK;SMAD7;MFSD1;MARCHF7;MORC3;IGF1;PRKN;EP300;FBXW7;DVL1;PLPP3;RAB21;GOLGA7;PRKRA;MDM4;HIP1;CCT3;USP9X;GNAQ;PTGES3;USP2;TRIM44;PEX6;CRTAP;WDR81;PTEN;SUGT1;STX12;BAG2
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.38949473551478775,1.0026804634223774,0.4090909090909091,0.7798400729454132,1.0,12/34,22.03%,FAM110C;RAPGEF2;BBS10;RAP1A;TJP1;LATS1;ROCK2;PTPN11;ROCK1;NCLN;SPTY2D1;RAP1B
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),-0.48017928783763175,-1.0025544738736503,0.4603174603174603,1.0,1.0,3/18,7.17%,ABCA12;SFRP4;CTSL
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.3096674286144127,1.0024131351562742,0.5,0.7801074875694647,1.0,39/137,18.38%,TENM3;PAWR;PARD3;PIWIL4;FZD5;EPHA2;CDK8;SMAD2;SPRY4;LGR4;LYPD6;MID1;PUM2;PCGF2;FBLIM1;SMAD5;ROR1;RBFOX2;ALDH7A1;ADGRL2;PTK2;ENAH;NCKAP1;TAF8;PTPRG;TJP1;PTPN14;SH3PXD2B;EPCAM;SMAD4;TRIM28;YAP1;ZFX;ITGA6;LIFR;CD59;LRP4;SHROOM3;ESRRB
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.4805452981888465,1.002412043406575,0.4473684210526316,0.779723008768297,1.0,7/11,28.72%,CEP290;KIAA0586;GAPVD1;CEP120;SCFD1;DNAJA1;CORO2B
prerank,GO_Biological_Process_2021__detection of virus (GO:0009597),0.63874842955054,1.0022905298716505,0.5813953488372093,0.7796166728250116,1.0,1/5,1.88%,SERINC5
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),0.6047532513780419,1.0020351820208473,0.5178571428571429,0.7799220958652807,1.0,1/5,12.96%,NIPBL
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),0.4563230967604091,1.00182046968955,0.4117647058823529,0.7800741199909638,1.0,6/22,13.91%,RPS6KB2;AKT1;EIF4EBP2;RPS6KB1;SMG1;RPTOR
prerank,GO_Biological_Process_2021__mitochondrial respirasome assembly (GO:0097250),-0.6384839023716928,-1.0016477568970548,0.5689655172413793,1.0,1.0,3/6,20.89%,COX7A1;COX7A2;HIGD1B
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),0.3532035627858811,1.001556027922118,0.38095238095238093,0.7801112273141285,1.0,22/72,19.83%,PID1;PPP1R15B;PTPN13;MEN1;PRKN;SLIT2;PLPP3;OCLN;CRKL;SIRT1;ATP2B4;GSK3B;IMPACT;ARPP19;CRTAP;PPP1R8;PTEN;CIB1;NTRK3;FKBP8;FBLN1;NIBAN1
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.336062436899129,1.0014679211717226,0.3333333333333333,0.7798615210960848,1.0,15/92,12.20%,PDK4;PID1;CSF1R;TDRD6;LYVE1;CHL1;EPOR;NTRK2;CDH20;NRXN1;FAM107A;NDRG2;KCNA2;CA10;RGS7BP
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.43639315206885193,-1.0012570720176728,0.4788732394366197,1.0,1.0,8/55,16.17%,PSMB6;PSMB9;PSMA8;PSMA7;PSME1;PSMC3;PSMC4;PSMA3
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),0.5961858763282909,1.0012042010005457,0.5,0.7800706781004051,1.0,3/5,27.40%,PANK2;GNB3;FITM2
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.4571798933118046,1.0011747347513111,0.4722222222222222,0.7797352884851111,1.0,2/16,4.58%,ERBB4;ARHGAP35
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.3346761473255521,1.0010316482497976,0.5625,0.7796961280262601,1.0,5/58,4.59%,DNASE1L2;PDE12;DNA2;POLD3;DCP1B
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.3508015925231935,1.000792556018995,0.36,0.7798478154606209,1.0,7/47,10.89%,CDC25A;PTPRK;ZBTB1;RHBDD1;SDE2;EIF2AK4;EP300
prerank,GO_Biological_Process_2021__ammonium transmembrane transport (GO:0072488),-0.6014415630317759,-1.0007641922130757,0.53125,1.0,1.0,4/6,29.77%,RHD;RHCE;RHCG;SLC12A7
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.5402834850455617,1.0004785431512446,0.5813953488372093,0.7802568205509334,1.0,8/11,37.55%,YWHAZ;STK25;HOOK3;TBCCD1;UVRAG;CDC42;COPG1;PDCD10
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.3889848422553619,1.0,1.0,0.7782712883936783,1.0,470/1648,21.21%,POU6F2;ZNF300;ZNF93;WNT7A;ANKRD2;PPARGC1A;LIMD1;ZFPM2;MEOX2;USP13;TRPS1;BACH1;ETV5;TNFSF4;CDK18;FLI1;ZNF696;PTPRK;BTRC;KLF11;ETV3;ZGLP1;FOXP1;YAF2;ZNF706;HDAC9;MITF;KCTD1;VEZF1;FOXO1;NR2F6;ZSCAN23;EBF4;SOX8;WTIP;ZNF283;SOX5;UBP1;ZSCAN20;ZBTB1;ZNF287;ZSCAN25;KLF16;SALL1;ZNF189;ETV1;ZNF510;MAMLD1;EED;TFCP2L1;ERBB4;DACH1;SOX4;LCOR;TFAP2C;NR4A2;PICALM;MLLT3;ACTA2;SPINDOC;CHD2;EGFR;ZXDA;ZBTB37;RPS6KA4;TSHZ1;ZSCAN22;LHX6;ZNF805;PRMT6;ASCL1;ESRRG;VHL;EBF1;ZNF41;ZNF384;AEBP2;PSPC1;MSANTD1;ZNF697;RORA;MEIS3;ZIC5;ZBTB43;ZBTB20;OLIG2;ANXA4;ZEB1;SOX9;ZBTB34;TOX;NFIB;BMP2;NFKB1;CHD5;PHF10;RPS6KA3;ZEB2;MYRF;ZNF595;ARRB1;FOXO3;ZXDC;RCOR1;ZNF577;RNF6;PHF14;BAHD1;PHF2;SMAD2;NFXL1;SALL3;TBX19;ZNF746;CHD7;LOXL2;ZBTB10;ZNF212;GABPA;BRWD1;DPF1;ZNF484;HCLS1;PHC1;TLE2;ZNF582;HMG20A;CHMP1A;ZNF521;ZIC2;PBX1;TFE3;ZNF783;RFX3;ETS2;MEN1;NFAT5;NR2E1;AKT1;ARID1B;KCNH2;HIC2;JDP2;CNOT2;HIVEP2;NFYC;DYRK1A;ZNF254;ZNF211;ZNF319;NPAS3;KAT2A;NRF1;ATF6;LCORL;NR1D2;CEP290;SP3;NR1D1;NCOA2;TSHZ3;PLCB1;TRAK1;SPEN;PPM1A;PRRX1;GPBP1L1;SFMBT2;ZIK1;ZNF280D;MBD2;PEX14;ZHX3;ZNF516;ZBTB7C;SMARCA2;NPAS2;ZNF117;SMAD5;NLK;HDAC2;RBFOX2;SMAD7;KLF12;TCF4;MAGED1;ZNF568;RNF14;KDM5A;ZNF415;ELF1;SAFB2;ZNF587;BRWD3;PKNOX1;ZNF33A;IGF1;NR3C1;SOX6;GLIS3;HMGB1;GLI3;CLOCK;BBX;ZNF268;TGFBRAP1;MGA;FOXJ3;FOXP4;GCLC;TCF12;SCMH1;CREM;ZNF382;NEK4;SUPT3H;ZNF737;ZNF736;MED13;MEIS2;EP300;FOXN2;ZFHX4;ZNF148;RUNX1T1;HSF5;DVL1;PRDM8;CAMK2D;RBM15B;ZNF316;MAP3K5;PBX2;IKZF2;TFEB;ZNF615;ZNF423;ACVR1;HP1BP3;ZBTB16;ZNF717;ZNF787;ZHX2;PIAS1;ZNF644;PBX3;CAMTA1;ZNF589;FOXN3;ZNF667;ZNF24;ZNF519;ELK4;HDAC4;ZNF276;SLTM;ZNF530;APBB2;SIRT1;OGT;NIPBL;SETD3;ZNF43;HIPK2;TBL1XR1;MXD3;TGFBR1;MLXIPL;RREB1;ZNF614;OLIG1;ZNF782;AHR;ZNF680;ZNF91;SIRT2;DHX9;HNF4G;ABCA2;ZNF556;TENM1;SMARCD2;SNX5;EHF;BAZ2B;JMY;JMJD6;MYT1;NDP;ZNF561;SOX13;HIF3A;ZBTB38;ATP2B4;VGLL4;ZNF282;ZNF652;MDM4;SMAD4;PKNOX2;TIAL1;TRIM28;KAT7;KLF9;HDGFL3;TRIP4;ZNF81;PHC2;USP22;MAP3K10;ZFAT;YAP1;ZNF292;ZBTB26;ZNF471;ZFP92;PURG;SAMD1;PHC3;RSF1;PIAS4;TRIM16;NRG1;POU2F1;LHX2;PHIP;ZNF140;USP47;CCNT2;BMP7;TFDP2;UIMC1;ZNF426;ZBTB9;DMTF1;HSF2;PPP3CB;ZNF160;ZNF438;CCAR1;RFX7;DPF3;ZNF555;CSRNP3;TRIM44;ZNF44;SATB2;AATF;MED13L;ZNF57;PCID2;CXXC1;ZFX;HIF1A;SMARCC1;KAT6B;NR3C2;ZNF613;ZNF347;SUFU;ZNF141;MAF;CBFB;ATF2;KDM4C;ZNF703;JARID2;MTERF3;CHD1;ZBTB21;ZNF264;KDM1A;APBB1;ZKSCAN4;BCL10;ATRX;RUNX1;ZBTB18;RORB;RBPJ;SSBP2;CDK14;ZNF311;ZNF230;YY1;MDM2;SOX21;NFE2L2;NFIA;NFATC3;ESRRB;ELAVL2;ZNF654;HNRNPD;UTP4;DNM2;CDK5R1;PPM1F;RFXAP;HDAC10;MED27;FBXW11;AXIN1;ZNF557;ASCC1;ZNF526;NSD2;ZNF624;PHF20L1;BAZ1A;GRHL1;ATOH8;SS18L1;KLF15;SPIN3;MAP2K2;POU3F4;ZNF14;MAP3K2;MBTD1;ZNF771;SETD5;HIVEP3;HMBOX1;ZNF689;ZNF493;ZNF639;REST;POU3F1;PRDM2;WAC;ZNF774;ARNT;ZNF792;ZNF586;MED4;HBP1;PRKCB;SPTY2D1;ZNF518A;NFATC2;POU3F2;ZNF646;PPP2R1A;CREBBP;MYT1L;ZNF786;ZNF527;MTF1;MESP1;ZNF30;NAT14;ZNF567;MLLT11;ZNF354B;ARNT2;ZNF318;NR4A1;NAA16;ZNF195;TCF20;HDX;MLXIP;CTBP1;ZBTB40;ELP2;IFRD1;ARID3B;ZNF107;LEF1
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3925263634643469,1.0,1.0,0.7782712883936783,1.0,124/429,19.91%,ZNF93;LIMD1;ZFPM2;TNFSF4;PTPRK;BTRC;FOXP1;YAF2;ZNF706;HDAC9;KCTD1;FOXO1;SOX8;SALL1;EED;DACH1;PASK;SPINDOC;PRMT6;CPEB3;ASCL1;RIDA;PSPC1;ZEB1;SOX9;BMP2;PHF10;RCOR1;CNOT9;BAHD1;SMAD2;ZNF746;LOXL2;DPF1;PHC1;TLE2;CHMP1A;ZIC2;RFX3;MEN1;HIC2;NR1D2;SP3;NR1D1;TSHZ3;PLCB1;SPEN;SFMBT2;MBD2;PEX14;ZHX3;SMARCA2;HDAC2;RBFOX2;ZNF568;NR3C1;GLI3;CLOCK;GCLC;SCMH1;SYNCRIP;ZNF148;RUNX1T1;RBM15B;ZNF423;ZBTB16;ZHX2;FOXN3;IGF2BP2;ZNF24;HDAC4;SIRT1;CAPRIN1;NIPBL;MLXIPL;AHR;ZNF91;SIRT2;SOX13;PDS5A;ZBTB38;VGLL4;ZNF282;SMAD4;TRIM28;KAT7;PHC2;GSK3B;MAP3K10;SAMD1;PHC3;RSF1;PIAS4;NRG1;POU2F1;USP47;BMP7;TFDP2;UIMC1;FXR1;DPF3;KAT6B;ZNF703;CNOT8;JARID2;MTERF3;ZBTB21;KDM1A;ZBTB18;RORB;RBPJ;MDM2;LSM14A;CDK5R1;PPM1F;HDAC10;FBXW11;ATOH8;MBTD1;HMBOX1;DDX6;ZNF639;REST;WAPL
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.3222345963150539,1.0,1.0,0.7782712883936783,1.0,213/776,20.67%,ACE2;POU6F2;NUDT21;PPARGC1A;SLC24A3;LIMD1;PID1;FEZF2;USP13;BACH1;CAVIN4;FOXP1;YAF2;ZNF804A;MITF;AMH;HNRNPH1;WTIP;ANK2;RAB27A;ABCC2;SOX4;TFAP2C;PICALM;ACTA2;SERPINB9;BTN3A3;RPS6KA4;ASCL1;ESRRG;VHL;SMCR8;PSPC1;SORT1;RORA;ITGB8;RGCC;SOX9;ADNP2;BMP2;NOTCH2;RBM12B;NFKB1;MAPK11;MBNL2;RNF6;NFXL1;ZNF407;CHD7;MBIP;ZNF212;GABPA;HCLS1;C1D;HMG20A;FGF17;NTRK2;RFX3;ROBO1;AKT1;PUM2;NFYC;ADNP;NR1D2;SP3;NCOA2;GPBP1L1;SFMBT2;ZNF280D;UBR5;ZNF516;SMARCA2;ZNF117;NLK;MAGED1;RNF14;ZNF33A;IGF1;NR3C1;SOX6;TICAM1;CLOCK;ZNF268;TGFBRAP1;PRKN;CREM;CAMK2N1;BRAF;ZNF451;SUPT3H;ZNF737;HNRNPLL;ZNF736;EP300;FOXN2;TNRC6B;MBNL1;ZNF148;FBXW7;DVL1;PRDM8;HNRNPH3;TFEB;ZNF423;STOX1;HP1BP3;FUBP1;FOXN3;IGF2BP2;AFDN;ZNF519;OCLN;HDAC4;APBB2;CRKL;SIRT1;PRKAB1;TGFBR1;MLXIPL;RREB1;AHR;AFF1;ZNF680;ZUP1;MYT1;SOX13;AGO3;CLK1;ZBTB38;ATP2B4;ZNF282;MAPK1;HAVCR2;KAT7;BMPR1A;TRIP4;PDE2A;GSK3B;ZFAT;YAP1;ROCK2;PTBP2;RBM38;SMO;MAPK8;BMP7;DMTF1;CCAR1;TRIM44;CXXC1;TFRC;HIF1A;KAT6B;PUM1;SUFU;ZNF141;NDFIP1;POGZ;ALPK2;ATF2;CELF1;ZNF703;TOB2;APBB1;ATRX;YTHDF2;RUNX1;SRPK2;RORB;RBPJ;SSBP2;PTBP1;RBMS3;YY1;ZNF462;SOX21;NFE2L2;NFIA;CPNE1;ESRRB;ELAVL2;HNRNPD;PCBP4;UTP4;DNM2;PPM1F;NOVA1;HDAC10;ASCC1;NTRK3;LARP4;NSD2;ATOH8;SPIN3;MAP2K2;ZC3H7A;GNB3;MAPK9;ROCK1;REST;POU3F1;PRDM2;NOVA2;UBAP2;RIMS2;SPTY2D1;NFATC2;VSTM2A;ZNF646;PPP2R1A;CREBBP;CIAO3;ZPR1
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",0.36269128263372635,1.0,1.0,0.7782712883936783,1.0,188/735,19.07%,ZNF93;ANKRD2;LIMD1;ZFPM2;TRPS1;BACH1;ETV5;RARB;TNFSF4;PTPRK;NRIP1;BTRC;KLF11;ZGLP1;FOXP1;YAF2;MCPH1;ZNF706;HDAC9;MITF;KCTD1;SNCA;FOXO1;NR2F6;SOX8;ZBTB1;SALL1;EED;DACH1;LCOR;TFAP2C;NR4A2;SPINDOC;PRMT6;CPEB3;ASCL1;VHL;PSPC1;DR1;ZEB1;SOX9;BMP2;NFKB1;PHF10;ZEB2;FOXO3;NEDD4L;HNRNPU;RCOR1;BAHD1;SMAD2;ZNF746;LOXL2;THRB;DPF1;TENM2;PHC1;TLE2;ZNF582;CHMP1A;ZIC2;RFX3;ETS2;MEN1;NR2E1;HIC2;JDP2;CNOT2;PCGF2;ZNF254;UBE2D1;NR1D2;SP3;NR1D1;TSHZ3;PLCB1;SPEN;PPM1A;SFMBT2;MBD2;PEX14;ZHX3;SMARCA2;HDAC2;PHF21A;RBFOX2;SMAD7;KLF12;ZNF568;PSMD10;NR3C1;GLIS3;HMGB1;GLI3;CLOCK;ZNF268;PRKN;FOXP4;GCLC;SCMH1;CREM;MEIS2;EP300;ZNF148;RUNX1T1;RBM15B;ZNF423;ZBTB16;PEX2;ZHX2;ZNF589;PLK1;FOXN3;ZNF24;ELK4;JAZF1;HDAC4;SIRT1;NIPBL;WWOX;TBL1XR1;MLXIPL;RREB1;MAP2K5;ZNF614;AHR;ZNF91;SIRT2;ZNF556;DCAF1;SOX13;ZBTB38;DLG1;VGLL4;ZNF282;MIER3;MDM4;SMAD4;TRIM28;KAT7;PDE2A;PHC2;DUSP22;MAP3K10;USP9X;YAP1;SAMD1;PHC3;RSF1;PIAS4;NRG1;POU2F1;ZNF140;SEMA4D;USP47;BMP7;TFDP2;UIMC1;USP2;IMPACT;DPF3;ZNF555;KAT6B;SUFU;ZNF141;CBFB;ZNF703;JARID2;MTERF3;ZBTB21;KDM1B;KDM1A;APBB1;RUNX1;ZBTB18;RORB;RBPJ;YY1;MDM2;CDK5R1;TAF3;PPM1F;HDAC10;FBXW11;UBE2D3;ZNF557;NCOA5;ATOH8
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.3830554706282817,1.0,1.0,0.7782712883936783,1.0,417/1616,19.12%,POU6F2;ZNF300;LPIN3;ZNF93;WNT7A;ANKRD2;PPARGC1A;PID1;ZFPM2;MEOX2;TRPS1;BACH1;ETV5;RARB;NCK2;FLI1;ZNF696;NRIP1;KLF11;ETV3;ZGLP1;FOXP1;MCPH1;HDAC9;MITF;KCTD1;SNCA;VEZF1;FOXO1;NR2F6;ZSCAN23;EBF4;KAT2B;EAF2;SOX8;ZNF283;SOX5;UBP1;ZSCAN20;ZBTB1;ZNF287;ZSCAN25;KLF16;SALL1;ZNF189;ETV1;ZNF510;MAMLD1;EED;TFCP2L1;DACH1;CSF1R;SOX4;LCOR;TFAP2C;NR4A2;CHD2;EGFR;ZXDA;ZBTB37;RPS6KA4;TSHZ1;PLAC8;ZSCAN22;LHX6;ZNF805;CPEB3;ASCL1;ESRRG;VHL;EBF1;DCN;ZNF41;ZNF384;AEBP2;ZNF697;RORA;MEIS3;DR1;GRIN1;ZIC5;ZBTB43;ZBTB20;OLIG2;RGCC;ANXA4;ZEB1;RHOQ;MLLT10;SOX9;ZBTB34;TOX;NFIB;BMP2;NFKB1;CCDC62;CHD5;PHF10;RPS6KA3;ZEB2;ZNF595;ARRB1;FZD5;FOXO3;NEDD4L;HNRNPU;ZXDC;RCOR1;ZNF577;PHF14;SERPINE1;PHF2;CDK8;SMAD2;SALL3;TBX19;ZNF407;ZNF746;MAML2;LOXL2;THRB;ZBTB10;ZNF212;GABPB1;GABPA;BRWD1;DPF1;TENM2;ZNF484;HCLS1;ZNF582;ZNF521;ZIC2;PBX1;TFE3;ZNF783;RFX3;ETS2;MEN1;NFAT5;NR2E1;ARID1B;HIC2;JDP2;CNOT2;HIVEP2;NFYC;PCGF2;LMO7;ZNF254;ZNF211;ZNF319;NPAS3;KAT2A;NRF1;UBE2D1;WASL;ATF6;LCORL;NR1D2;SP3;PIK3R1;NR1D1;NCOA2;CDK12;TSHZ3;TRAK1;SPEN;PPM1A;PRRX1;ZIK1;MBD2;ZHX3;ZBTB7C;SMARCA2;NPAS2;SMAD5;HDAC2;BMPR1B;PHF21A;SMAD7;KLF12;TCF4;ZNF568;RNF14;NCOA3;MRTFA;PSMD10;ZNF415;ELF1;SAFB2;ZNF587;BRWD3;PKNOX1;ZNF33A;IGF1;NR3C1;SOX6;PKD2;GLIS3;AUTS2;HMGB1;GLI3;CLOCK;BBX;CAPRIN2;ZNF268;MGA;FOXJ3;PRKN;FOXP4;HGF;TCF12;LMO1;CREM;ZNF382;ZNF451;SUPT3H;MED13;MEIS2;EP300;AKIRIN2;RGMA;TNRC6B;ZFHX4;ZNF148;PRKD1;HSF5;DVL1;CAMK2D;ZNF316;PBX2;IKZF2;TFEB;ZNF615;ACVR1;SS18;ZBTB16;ZNF717;PEX2;ZNF787;ZHX2;PIAS1;ZNF644;PBX3;CAMTA1;ZNF589;PLK1;ZNF667;ZNF24;ELK4;JAZF1;HDAC4;NCK1;ZNF276;SLTM;ASXL3;ZNF530;SIRT1;OGT;NIPBL;SETD3;WWOX;ZNF43;HIPK2;TBL1XR1;MXD3;MLXIPL;RREB1;MAP2K5;ZNF614;OLIG1;ZNF782;SLC30A9;AHR;ZNF91;SIRT2;METTL23;ACVR2A;DHX9;HNF4G;ABCA2;ZNF556;SMARCD2;CRTC2;EHF;BAZ2B;JMY;JMJD6;MYT1;ZNF561;DCAF1;SOX13;AGO3;HIF3A;ZBTB38;ATP2B4;DLG1;KMT2C;ZNF282;MIER3;ZNF652;MDM4;EPCAM;SMAD4;PKNOX2;CDH13;TIAL1;TRIM28;KAT7;BMPR1A;KLF9;HDGFL3;BCL9;ZNF81;PDE2A;DUSP22;CDK13;USP9X;YAP1;ZNF292;ZBTB26;ZNF471;ZFP92;PURG;RSF1;PIAS4;POU2F1;LHX2;PHIP;ZNF140;SEMA4D;CCNT2;TFDP2;ZNF426;USP2;ZBTB9;DMTF1;HSF2;PPP3CB;IMPACT;ZNF160;ZNF438;RFX7;DPF3;ZNF555;CSRNP3;ZNF44;SATB2;AATF;THAP3;MED13L;ZNF57;ATAD2B;ZFX;HIF1A;SMARCC1;KAT6B;NR3C2;PPP1R12A;ZNF613;ZNF347;SUFU;ZNF141;POGZ;ITGA6;MAF;CBFB;ATF2;ABHD14B;MAML1;KDM4C;CHD1;ZBTB21;ZNF264;KDM1B;KDM1A;APBB1;ZKSCAN4;ATRX;RUNX1;ZBTB18;RPRD1B;RORB;RBPJ;SSBP2;DCAF6;ZNF311;ZNF230;PTEN;YY1;ZNF462;MDM2;SOX21;NFE2L2;PPM1D;NFIA;NFATC3;ESRRB;CDK9;ZNF654;TAF3;RFXAP;HDAC10;MED27;UBE2D3;ZNF557;ZNF526;NCOA5;ZNF624;PHF20L1;BAZ1A;GRHL1;ATOH8;SS18L1;ASXL2;KLF15
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.3357692210720024,1.0,1.0,0.7782712883936783,1.0,216/835,18.88%,PDK4;SPSB4;PDP1;CDKL1;MAPK10;MAP3K11;CDK18;EGLN3;PTPRK;BTRC;FEM1B;PTPN4;HS3ST5;SPSB2;FUT9;PASK;STT3B;KEAP1;DCUN1D1;RPS6KA4;VHL;PRKACB;QSOX1;RHBDD1;CDH2;PRKCSH;SOCS6;STK38L;CDKL5;PGAP1;CILK1;MGAT4A;BMP2;MAP4K5;KBTBD7;GRK3;CSNK1G3;PPM1E;VCAN;BTBD1;CD247;CDK8;PSMA1;KLHL42;LOXL2;DUSP10;PRKG1;LOXL1;TEC;ST3GAL1;PTPN13;COPS7B;TNIK;PPP2R1B;PRKAR1B;KBTBD6;FEM1C;CSNK2A1;MEN1;CAMK2B;FBXL3;COPS2;AKT1;FBXO30;DAPK2;ATE1;CAMK2A;DYRK1A;LMO7;DCAF17;ABL2;PPP2R5A;CDK12;CSNK1E;PPM1A;ASB3;NLK;PSMD11;BMPR1B;PIK3R4;EIF2AK4;PSMD10;ATG7;PTPN9;FBXO11;LARGE1;MORC3;PLOD2;MAP3K20;PIK3C3;PGGT1B;LMTK3;PPM1L;PRKCE;PTPRJ;TAB1;DCAF5;GPS1;BRAF;NEK4;MAP4K4;MAPKAPK2;PAK3;MAST2;PTAR1;PTPRB;FBXW7;PSMF1;PRKD1;CAMK2D;PSMD14;FBXL14;COP1;MAP3K5;ACVR1;ZBTB16;ENGASE;OXSR1;MAP4K2;SIK2;FBXO21;PLK1;WSB2;GRK4;PPEF1;SSH1;SIK3;PPP4R1;TGFBR2;SGK3;CDK19;MERTK;PARP8;SIRT1;SETD3;TULP4;HIPK2;PRKAB1;B4GALT5;TGFBR1;UBE2E1;CDC34;COMMD1;SIRT2;UBE2E2;ACVR2A;FER;CUL2;DUSP6;TGM1;PTPRG;MAP4K3;NTAQ1;CUL1;PTPRZ1;HIF3A;PTPN14;PTP4A2;MAPK1;CDC42BPA;BMPR1A;TP53RK;TAOK2;GSK3B;USP25;LATS1;CDK13;PRKG2;DYRK2;MTMR2;ROCK2;STK11;PDK2;PPP2R2A;MAPK8;RAB1A;PPP3CB;CHM;PTPRO;TRIB2;B3GALT1;PPP2R5E;CSK;HIF1A;FBXW2;PPP1R12A;AKT2;PSME4;FYN;CUL3;MAML1;DCAF7;MAP3K1;ALG5;PPP1CC;VGF;MACROD1;SRPK2;DCAF6;CDK14;PTEN;TBCK;MTM1;WNK3;PPM1D;CDK9;LHPP;ATG5;WNK1;UBXN7;PPP1CB;PPM1F;PTPRE;FBXW11;FBXO31;UBE2D3
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.3478008863314446,1.0,1.0,0.7782712883936783,1.0,127/531,18.99%,ANKRD2;ZFPM2;TRPS1;BACH1;ETV5;RARB;NRIP1;KLF11;ZGLP1;FOXP1;MCPH1;HDAC9;MITF;KCTD1;SNCA;NR2F6;SOX8;ZBTB1;SALL1;EED;DACH1;LCOR;TFAP2C;NR4A2;CPEB3;ASCL1;VHL;DR1;ZEB1;SOX9;NFIB;BMP2;NFKB1;ZEB2;FOXO3;NEDD4L;HNRNPU;SMAD2;ZNF746;LOXL2;THRB;TENM2;ZNF582;ETS2;MEN1;NR2E1;JDP2;CNOT2;PCGF2;ZNF254;UBE2D1;NR1D2;NR1D1;SPEN;PPM1A;MBD2;SMARCA2;HDAC2;PHF21A;SMAD7;KLF12;ZNF568;PSMD10;NR3C1;GLIS3;HMGB1;GLI3;ZNF268;PRKN;FOXP4;CREM;ZNF451;MEIS2;EP300;ZNF148;ZBTB16;PEX2;ZHX2;ZNF589;PLK1;ELK4;JAZF1;HDAC4;SIRT1;NIPBL;WWOX;TBL1XR1;RREB1;MAP2K5;ZNF614;SIRT2;ZNF556;DCAF1;SOX13;DLG1;ZNF282;MIER3;MDM4;SMAD4;PDE2A;DUSP22;USP9X;YAP1;ZNF140;SEMA4D;USP2;IMPACT;ZNF555;SUFU;ZNF141;CBFB;ZBTB21;KDM1B;KDM1A;APBB1;ATRX;RUNX1;ZBTB18;RBPJ;YY1;MDM2;NFATC3;TAF3;HDAC10;UBE2D3;ZNF557;NCOA5
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",0.3707826068960895,1.0,1.0,0.7782712883936783,1.0,271/886,21.03%,ZNF300;LPIN3;WNT7A;PPARGC1A;PID1;ZFPM2;MEOX2;ETV5;RARB;NCK2;FLI1;NRIP1;BTRC;ZGLP1;YAF2;MITF;VEZF1;FOXO1;KAT2B;EAF2;SOX8;UBP1;SALL1;ETV1;ERBB4;SOX4;TFAP2C;NR4A2;PICALM;MLLT3;ACTA2;EGFR;ZXDA;RPS6KA4;PLAC8;ASCL1;ESRRG;VHL;DCN;MSANTD1;RORA;MEIS3;DR1;GRIN1;RGCC;RHOQ;MLLT10;SOX9;NFIB;BMP2;NFKB1;CCDC62;PHF10;RPS6KA3;ZEB2;MYRF;ARRB1;FZD5;FOXO3;HNRNPU;ZXDC;RNF6;SERPINE1;CDK8;SMAD2;ZNF407;ZNF746;MAML2;THRB;GABPB1;GABPA;DPF1;HCLS1;ZIC2;PBX1;TFE3;RFX3;ETS2;MEN1;NFAT5;AKT1;ARID1B;KCNH2;DYRK1A;LMO7;NPAS3;KAT2A;NRF1;WASL;ATF6;NR1D2;CEP290;SP3;PIK3R1;NR1D1;NCOA2;PLCB1;PPM1A;ZNF516;SMARCA2;NPAS2;SMAD5;HDAC2;BMPR1B;SMAD7;TCF4;RNF14;KDM5A;NCOA3;MRTFA;ELF1;IGF1;NR3C1;PKD2;GLIS3;AUTS2;HMGB1;GLI3;CLOCK;CAPRIN2;ZNF268;FOXJ3;PRKN;HGF;TCF12;LMO1;ZNF451;NEK4;SUPT3H;MED13;MEIS2;EP300;AKIRIN2;RGMA;PRKD1;DVL1;MAP3K5;PBX2;TFEB;ZNF423;ACVR1;SS18;ZBTB16;ZNF24;ELK4;HDAC4;NCK1;ASXL3;SIRT1;OGT;SETD3;WWOX;HIPK2;TBL1XR1;TGFBR1;MLXIPL;RREB1;MAP2K5;SLC30A9;AHR;SIRT2;METTL23;ACVR2A;DHX9;HNF4G;RPTOR;UBTF;SMARCD2;SNX5;CRTC2;EHF;JMJD6;NDP;ZBTB38;KMT2C;EPCAM;SMAD4;CDH13;TRIM28;KAT7;BMPR1A;SERTAD2;TRIP4;BCL9;USP22;YAP1;RSF1;TRIM16;POU2F1;LHX2;PHIP;PADI2;CCNT2;BMP7;TFDP2;HSF2;PPP3CB;DPF3;CSRNP3;TRIM44;SATB2;AATF;THAP3;PCID2;ATAD2B;CXXC1;SCAF8;HIF1A;SMARCC1;KAT6B;PPP1R12A;POGZ;ITGA6;ATF2;ABHD14B;MAML1;KDM1B;KDM1A;APBB1;BCL10;ATRX;RUNX1;ZBTB18;RPRD1B;RORB;ASF1A;RBPJ;SSBP2;DCAF6;YY1;ZNF462;NFE2L2;NFIA;NFATC3;ESRRB;CDK9;HNRNPD;DNM2;RFXAP;FBXW11;AXIN1;GRHL1;ATOH8;SS18L1;ASXL2;KLF15;MAP2K2;MAP3K2;MLIP;HIVEP3;ZNF639;REST;POU3F1;PRDM2;WAC;ARNT;MED4;NFATC2;POU3F2;CREBBP;ZPR1;MTF1;MESP1;NAT14;MLLT11;ARNT2;ZNF318;NR4A1;NAA16;TCF20;MLXIP
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.5508430597894602,0.9999767310180622,0.5609756097560976,0.7779577303377766,1.0,7/8,27.69%,NRXN1;SHANK3;NRXN2;PTEN;NLGN1;NLGN2;TMEM108
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),-0.5304055986192376,-0.999698091321699,0.43243243243243246,1.0,1.0,1/12,1.50%,AKR1C1
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.3646446420399784,-0.9996640142890894,0.5053763440860215,1.0,1.0,45/290,16.71%,GBP2;POU4F1;GBP7;DOCK8;IFIT1;GBP3;GBP1;DUOX1;IL5;IRF1;IL1R1;RPS27A;IL7;STAT1;PTPN7;ANXA1;CXCL2;TIMP1;IFNGR2;SIGIRR;F13A1;INPP5D;STAT2;ST3GAL6;PIK3CB;RPL13A;UBC;IL12A;SFRP1;HYAL1;MT2A;CEBPD;IL3RA;CCL2;DUSP1;CXCR4;CX3CL1;DPYSL3;WNT5A;IL20RA;SOCS3;BRCA1;XBP1;IL18;FSCN1
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),0.39533144080611404,0.9994300021527819,0.41379310344827586,0.7787831889869979,1.0,13/24,29.97%,INSC;PLK1;CLASP1;FBXW11;NSFL1C;UBXN2B;LLGL1;LLGL2;HTT;MAP4;GJA1;PAFAH1B1;CDK5RAP2
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.4261642783971181,-0.9991607472179926,0.4942528735632184,1.0,1.0,4/61,6.67%,IFI6;DHCR24;AQP1;THBS1
prerank,GO_Biological_Process_2021__L-arginine transmembrane transport (GO:1903400),0.6197872633296578,0.9989129635788953,0.5,0.7797975348401945,1.0,4/5,38.03%,SLC47A1;SLC22A2;SLC7A2;SLC7A1
prerank,GO_Biological_Process_2021__cellular response to prostaglandin E stimulus (GO:0071380),0.6092712763683339,0.9984686987528629,0.5238095238095238,0.78044117148894,1.0,1/5,1.50%,TNFSF4
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.44091754389450344,-0.9979534766591716,0.5256410256410257,1.0,1.0,5/51,12.67%,H1-4;H1-2;TAF1D;ATAD2;POLR2L
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),0.5478433890225176,0.9978260367143218,0.47368421052631576,0.78153899915707,1.0,2/11,3.27%,VPS37B;VAPA
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),0.2875301554905064,0.9976570684868379,0.6666666666666666,0.7815750314555734,1.0,53/202,19.00%,SEMA5B;CASS4;FLT1;CSF1R;EGFR;CXCL12;FAM110C;PDGFRA;SOX9;BMP2;RAPGEF2;CARMIL1;FAM107A;PDGFA;IGF1;ZNF268;SEMA3C;HGF;PRKCE;MAP4K4;TRADD;ACVR1;PTK2;CRKL;NIPBL;TGFBR1;RREB1;FER;PDGFC;CLASP1;GAB1;MAPRE1;TJP1;CDH13;NRP1;CPNE3;ROCK2;SEMA6C;SEMA4D;ARHGEF7;SMO;CCAR1;RUFY3;HIF1A;AKT2;ITGA6;ZNF703;CIB1;PPM1F;SEMA3D;BCAR1;FERMT1;NTRK3
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),0.5575132558908962,0.9976226164556986,0.5277777777777778,0.781270247055731,1.0,5/10,13.62%,PICALM;NEDD4L;LEPROTL1;GPM6B;COMMD1
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),-0.5534078276487285,-0.9975865810880665,0.5692307692307692,1.0,1.0,2/10,11.11%,ST6GAL1;GNE
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.42373841189855316,-0.9973192877782026,0.4647887323943662,1.0,1.0,16/61,21.85%,EPN1;SPARC;STAT1;KLF2;THBS1;ISM1;PIK3CB;CD160;SERPINF1;COL4A2;KLF4;SPINK5;THBS2;NAXE;CREB3L1;ALOX5
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.4126349776807839,-0.9970098517218131,0.5116279069767442,1.0,1.0,12/86,15.84%,CETN2;KIF20B;FBXO43;KNSTRN;RAB11A;IHO1;SFRP1;CAV2;USP51;BORA;USP19;PLK3
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.4543730921949799,0.9967750451358109,0.46875,0.7828959153859932,1.0,5/16,14.52%,PDK4;PIK3CA;PTK2;BCL2;ANKRD13C
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),0.4208191391939052,0.9967299201203283,0.5172413793103449,0.7826096989109632,1.0,4/28,5.51%,ACE2;MEOX2;CXCL12;GUCY1B1
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.46121027423690636,0.9965801682218836,0.46153846153846156,0.7825884265256638,1.0,5/22,18.38%,PLD6;JAM2;NECTIN2;MKKS;CIB1
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.5717032830095805,0.9963929981106673,0.5405405405405406,0.7826711001421951,1.0,4/7,18.04%,TGFBR1;BMPR1A;NRG1;RBPJ
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),-0.6359670528473299,-0.9963398122070121,0.546875,1.0,1.0,3/7,30.25%,GSTP1;TGFB1;SYK
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),0.5467403548345998,0.9959807569925314,0.4523809523809524,0.7832352950557919,1.0,6/15,30.74%,STN1;DCLRE1C;POT1;DCLRE1A;TERF2IP;TERF2
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.44952734317949544,-0.9955224274569773,0.5,1.0,1.0,6/48,9.81%,USP18;IRF1;TRIM21;IFI35;ERAP1;CASP8
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),-0.5004243041864926,-0.9954826181545862,0.453125,1.0,1.0,6/15,22.89%,HTR2B;PIK3CB;APOE;NOS1AP;S100A1;PARK7
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.38369463215140787,-0.9953656007328725,0.4891304347826087,1.0,1.0,39/275,18.79%,IFI6;APIP;PRAME;POU4F1;GATA1;RPL10;RPS27A;DHCR24;PRDX5;IL7;IFIT3;ANXA1;AQP1;BCL2L2;HTR2B;THBS1;PDPN;RPS3A;GSTP1;UBC;SFRP1;CTSH;NAA38;MT3;MIEN1;CX3CL1;PTMA;WNT5A;FHL2;BAG1;PLK3;XBP1;RIPK2;CRYAB;GPX4;COPS5;CD44;CLEC5A;ARHGAP10
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.5711058463659688,-0.995196670778731,0.5,1.0,1.0,4/14,12.88%,DUOX1;PRDX5;PRDX4;NOX1
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),0.5342645194658617,0.9950362948196216,0.4090909090909091,0.7850448353743049,1.0,4/8,26.59%,DR1;TAF1;GTF2B;TAF12
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),0.2660002880766658,0.9949689294672442,0.5,0.7848620446583154,1.0,36/202,15.63%,VAPB;DNM3;ANK2;VAPA;PICALM;EGFR;TMEM33;AP2B1;EPS15;EPS15L1;ARRB1;CBL;TMCC1;ATP2C1;BIN1;CHMP1A;AGFG1;REPS1;WASL;ITSN1;PIP5K1C;PLEKHA8;SGIP1;RABIF;STX18;KIAA0319;SLC2A8;ADRB2;REEP4;CHMP2B;OPA1;SYT9;SYNJ1;HIP1;GAPVD1;HACE1
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),-0.6046435669195983,-0.9949335205647837,0.5084745762711864,1.0,1.0,2/8,7.00%,VIL1;SEMA5A
prerank,MSigDB_Hallmark_2020__Hypoxia,-0.37257574988472236,-0.994860147861071,0.45263157894736844,1.0,1.0,29/162,18.77%,LDHC;GAPDHS;CP;LXN;PRDX5;KDELR3;COL5A1;IER3;EFNA1;ALDOB;GPC3;ADM;CCN1;GLRX;TMEM45A;MT2A;INHA;HK2;DUSP1;CXCR4;PHKG1;LDHA;MT1E;GPI;SLC25A1;DDIT3;GYS1;BTG1;SAP30
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.46477674642235256,0.9941587154286591,0.46153846153846156,0.7863201520242011,1.0,6/17,17.07%,EPS8;NCKAP1;CDH13;HACE1;CYFIP1;WASF1
prerank,GO_Biological_Process_2021__B cell chemotaxis (GO:0035754),0.5875731508316231,0.9941462089028296,0.5227272727272727,0.7859389982907913,1.0,3/5,32.33%,GAS6;CYP7B1;HSD3B7
prerank,GO_Biological_Process_2021__negative regulation of cholesterol transport (GO:0032375),0.657196372588049,0.9941386353382461,0.5454545454545454,0.7855770544779299,1.0,2/5,13.92%,NFKB1;ABCA2
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),0.5306288740626708,0.9937238624311981,0.46875,0.7862229444204053,1.0,6/15,21.17%,IGF1;CAMK2D;ROCK2;ROCK1;PRKCA;PDE9A
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.5152167394214197,-0.9936632037150248,0.5409836065573771,1.0,1.0,5/15,16.40%,IL1R1;HLA-A;B2M;RSAD2;IL18
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),0.29709841259116154,0.9935983938052236,0.5,0.7860400258460102,1.0,41/157,19.00%,SEMA5B;CASS4;FLT1;CSF1R;EGFR;CXCL12;FAM110C;PDGFRA;BMP2;CARMIL1;FAM107A;PDGFA;IGF1;ZNF268;SEMA3C;HGF;MAP4K4;TRADD;ACVR1;PTK2;TGFBR1;FER;PDGFC;MAPRE1;TJP1;CDH13;CPNE3;ROCK2;SEMA6C;SEMA4D;SMO;CCAR1;RUFY3;AKT2;ITGA6;ZNF703;CIB1;PPM1F;SEMA3D;BCAR1;NTRK3
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),0.4075922083942679,0.9934140456058163,0.4857142857142857,0.7861394828716731,1.0,5/31,10.97%,LCMT2;TRMT1;TYW3;TRMT1L;NSUN6
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.35966777831266783,0.9932728254111931,0.3684210526315789,0.7860602043483872,1.0,16/59,16.45%,TYR;POU6F2;CRYGS;ZIC2;ATF6;RGS16;SLC4A10;DRAM2;EYA3;OPA1;WHRN;RP2;CRYBB3;GRM8;RDH10;CRYBB2
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),-0.561451808076695,-0.9927224215324884,0.48484848484848486,1.0,1.0,2/9,17.12%,TUBB;MICA
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.5525292693641002,-0.9926801425630087,0.546875,1.0,1.0,3/11,9.81%,APIP;NLRP1;CASP8
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),0.5284114956890786,0.9926310663403674,0.5675675675675675,0.7870429230603962,1.0,2/7,9.80%,PDE12;TICAM1
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.5010987449437594,0.9922885793542249,0.48148148148148145,0.7866071762221952,1.0,6/11,24.13%,PANK2;SLC25A16;PANK3;PANK1;ACAT1;ACOT7
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),0.5010987449437594,0.9922885793542249,0.48148148148148145,0.7866071762221952,1.0,6/11,24.13%,PANK2;SLC25A16;PANK3;PANK1;ACAT1;ACOT7
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.5010987449437594,0.9922885793542249,0.48148148148148145,0.7866071762221952,1.0,6/11,24.13%,PANK2;SLC25A16;PANK3;PANK1;ACAT1;ACOT7
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.4822216452861622,-0.9920812075027593,0.4,1.0,1.0,8/24,22.89%,SELENOS;CLU;CREB3;AQP11;XBP1;CREB3L1;ALOX5;PARK7
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.5115109988597116,-0.9918744878629419,0.5,1.0,1.0,2/14,7.91%,IFIT1;PQBP1
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),0.5201366470727757,0.991562059225271,0.4418604651162791,0.7878597372869189,1.0,2/13,11.05%,PLIN5;FBXW7
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),0.2768441084370815,0.9914834249764352,0.4,0.7876017361096066,1.0,45/189,18.17%,PID1;MOSMO;BTRC;SNCA;NR4A2;EGFR;DCN;BMP2;KANK1;PLIN5;ARRB1;PLEK;SPRY4;LGR4;CSNK2A1;FRZB;AKT1;IRS1;SPRY3;NLK;RPS6KB1;GLI3;PIP4K2C;PTPRJ;DCC;FBXW7;NLGN4X;ACVR1;DACT3;HERC4;NCK1;WWOX;BCL2;VGLL4;OTUD4;VCP;MTMR2;UBASH3B;SUFU;CXXC4;CSNK2A2;RPGRIP1L;YTHDF2;DRD2;PTEN
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.47536104064634743,-0.9913657756033951,0.4444444444444444,1.0,1.0,1/23,0.19%,PIF1
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),0.6362121323683808,0.9911684371103215,0.6190476190476191,0.7875735031139545,1.0,1/5,5.31%,PDE1B
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),0.6362121323683808,0.9911684371103215,0.6190476190476191,0.7875735031139545,1.0,1/5,5.31%,PDE1B
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.46273899207798797,-0.9908796946498949,0.4533333333333333,1.0,1.0,10/34,16.40%,STAT1;IGFBP5;THBS1;ELN;IL12A;NOX1;CX3CL1;OGN;ID2;IL18
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),0.42756064333973837,0.9908584367418215,0.45,0.7879525829035304,1.0,14/40,24.68%,HCLS1;CPSF6;PIK3R1;UBR5;ANP32B;DHX9;TRIM28;GSK3B;IPO5;ZPR1;BAG3;SMAD3;TCF7L2;GAS6
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),-0.3983190562309967,-0.9907732840268897,0.4875,1.0,1.0,12/77,14.14%,ANKRD53;CENPE;KNSTRN;RAB11A;KIF2C;SPDL1;TTN;MIS12;CHMP2A;TEX14;RAD21L1;REC8
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),-0.6496745930262007,-0.9904830920211356,0.5081967213114754,1.0,1.0,3/6,16.64%,MT3;LETM2;SLC4A11
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.5406848702484068,0.990256924524036,0.5806451612903226,0.7888459232683717,1.0,3/8,15.97%,TNFSF4;TGFBR2;HLA-DRA
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),-0.6055709964371725,-0.9899486663191983,0.5555555555555556,1.0,1.0,2/6,15.34%,PFN4;TMSB10
prerank,GO_Biological_Process_2021__liver development (GO:0001889),-0.5106566160492709,-0.9898477490930817,0.5645161290322581,1.0,1.0,3/23,6.50%,CCDC39;ANXA1;DNAAF1
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),0.5202484152208108,0.9897908719722662,0.4878048780487805,0.7896822902871987,1.0,2/9,12.32%,RBFOX1;CKAP5
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),0.5727643792172883,0.9897283551113387,0.525,0.7894802440905102,1.0,1/6,0.82%,PID1
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.35868704990018835,0.9895373693867456,0.4166666666666667,0.7895306621743349,1.0,12/49,14.62%,PPARGC1A;HADH;ADIPOR2;ECHDC1;AUH;BDH2;PEX2;HSD17B4;ACADVL;ACADM;ABCD3;ADIPOR1
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.5530829787023605,0.989259286531428,0.46875,0.7898518584559171,1.0,6/10,31.40%,RBBP4;ATRX;ASF1A;HAT1;H3-3A;NASP
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.4420577036563822,0.9890268742237371,0.43243243243243246,0.7900794026802325,1.0,8/21,24.03%,CDK12;KAT7;CDK13;CCNT2;SCAF8;BRD4;CDC73;ERCC6
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.5855863431902334,-0.988978787209179,0.5454545454545454,1.0,1.0,3/6,25.26%,LRRC55;NOS1AP;AKAP6
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),0.31572175882583564,0.9889646094480429,0.4117647058823529,0.7898588939613986,1.0,15/74,16.51%,MEOX2;RCN3;SOX8;SALL1;ANXA4;SOX9;BMP2;PKD2;BDH2;DVL1;HNRNPH3;ACADVL;EHF;SMO;CPT1A
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),-0.510158786322349,-0.9885410798095549,0.47619047619047616,1.0,1.0,2/13,11.26%,KCNB1;SFRP1
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),0.49894238141724107,0.9884503236218554,0.5151515151515151,0.7901641861086319,1.0,2/9,18.46%,ATG7;ATG5
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),0.49894238141724107,0.9884503236218554,0.5151515151515151,0.7901641861086319,1.0,2/9,18.46%,ATG7;ATG5
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),0.4245242852822509,0.9883711358964611,0.5151515151515151,0.7898787384117538,1.0,7/20,24.37%,TEC;BCL2;BCAR1;PRKCB;PLEKHA1;NFATC2;PTPRC
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.562513787362751,-0.9882806996072362,0.5384615384615384,1.0,1.0,1/11,3.62%,PARP14
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),-0.567031918831264,-0.9882433118915068,0.5,1.0,1.0,1/10,2.06%,PATL2
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),-0.4025737569305901,-0.9882317921563153,0.47619047619047616,1.0,1.0,6/77,3.89%,TNNT1;MYOT;UTS2;LMOD1;CACNA1H;MYOF
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),0.3329770865008587,0.9882189751854092,0.45454545454545453,0.7898543005113413,1.0,30/121,18.80%,BACH1;CDC25A;BTRC;CEP152;TPD52L1;PHLDA1;FBXL17;FBXL3;CCNA2;CEP290;NEDD1;CSNK1E;PLCB1;PLK1;CKAP5;CLASP1;MAPRE1;CUL1;ALMS1;LATS1;YWHAG;PPP2R2A;ARPP19;PPP1R12A;TAF2;TUBG1;CDK14;DNM2;PPP1CB;FBXW11
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),0.6251092185421755,0.987870721263235,0.5434782608695652,0.790202188243622,1.0,3/5,29.73%,LRP8;RELN;PAFAH1B1
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.5555588361227769,-0.9875882053844216,0.581081081081081,1.0,1.0,1/12,4.36%,ENTPD3
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),0.5308628075620168,0.9875678572564258,0.5135135135135135,0.7904381058387099,1.0,5/9,27.15%,CACNA2D1;CACNB3;PDE4B;CACNB2;SRI
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),0.5732986945588809,0.9873248577557833,0.5581395348837209,0.7905994085560506,1.0,1/6,14.18%,NDP
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),0.4248282815457093,0.9872389020894645,0.45454545454545453,0.7903330234713051,1.0,3/24,6.01%,PCSK5;BMP2;SMAD2
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.3241319201159506,0.9870970739346869,0.55,0.7902712678295419,1.0,10/75,10.84%,EPHA7;PPARGC1A;LIG4;EGLN3;AGAP2;FOXO3;NTRK2;CPEB4;PRKN;NF1
prerank,GO_Biological_Process_2021__negative regulation of lipoprotein lipase activity (GO:0051005),0.6283068170147561,0.9867963589897536,0.5227272727272727,0.7906459817541996,1.0,2/5,4.26%,HDAC9;SORT1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.5967018489920447,-0.9867637832369539,0.5645161290322581,1.0,1.0,1/8,3.60%,RPS7
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.5338340545794398,0.9865636897330231,0.5294117647058824,0.7907697536725551,1.0,7/10,33.28%,CSGALNACT1;DSEL;DSE;PXYLP1;XYLT1;CSGALNACT2;B3GAT1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.5225831901102463,0.9861904518823729,0.5,0.7911995310475668,1.0,4/8,11.20%,CACNA2D1;BIN1;SESTD1;CAMK2D
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),-0.5917263891121477,-0.9858291987167942,0.5344827586206896,1.0,1.0,2/8,17.23%,RIPK2;PTPN22
prerank,GO_Biological_Process_2021__secretion (GO:0046903),-0.5648067521253131,-0.9858265550688188,0.5238095238095238,1.0,1.0,4/10,25.25%,FBLN5;SLC22A4;VIP;RIMS1
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),0.5109850471895,0.9857973527839523,0.5454545454545454,0.7918699717684688,1.0,2/13,4.53%,TNFSF4;CD22
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),0.5238240869932892,0.9857853842312948,0.48717948717948717,0.7915203342475197,1.0,1/11,2.17%,PAPOLA
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.41657748027550484,0.9857318926848173,0.46875,0.7912636620042103,1.0,11/29,28.40%,PLCB1;TRIP12;NIPBL;SEPTIN7;B4GALT5;CLASP1;EHMT1;BAG6;CLASP2;POGLUT1;TDG
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),-0.6169612194586367,-0.9854933554733597,0.546875,1.0,1.0,2/7,12.67%,GTF3C6;POLR2L
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.3095243187546589,0.9850123077999238,0.4666666666666667,0.7924979013382055,1.0,37/186,19.78%,ASIC4;SLC24A3;CACNA1G;KCNQ3;ABCC8;SLC6A13;SLC39A11;ATP6V1A;SLC30A4;KCNA4;ATP2C1;SLC12A2;TRPM4;KCNH2;KCNQ2;PKD2;KCNH7;KCNA2;NNT;SLC4A4;TRPM3;ATP2B4;SLC30A1;TRPM2;ASIC3;KCNC2;KCNH3;ATP1A4;SLC6A6;SLC25A14;DMAC2L;SLC24A4;SLC6A11;SLC6A12;TMEM175;SLC6A7;SLC9A9
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),-0.5191183661419049,-0.9848587326247206,0.4264705882352941,1.0,1.0,2/14,6.48%,TRIM22;TRIM21
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),0.5717279865301029,0.9844507672449769,0.52,0.7934070619343612,1.0,4/5,42.03%,SLC6A7;SLC6A17;SLC6A15;SLC36A4
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),0.498257036456046,0.9838916796146259,0.5454545454545454,0.7945281073150421,1.0,4/13,12.14%,TRUB1;PUS10;DKC1;PUS7L
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),-0.5000944923313844,-0.9838884072967792,0.5147058823529411,1.0,1.0,4/16,20.23%,ZWILCH;WEE1;PLK3;WEE2
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),0.4465318590938703,0.9836309291873055,0.40625,0.7946772991819993,1.0,7/17,22.29%,ROBO1;AKT1;EFNB2;SLIT2;NRP1;NR4A1;FGF2
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),-0.5770600043730828,-0.9835037536920628,0.5737704918032787,1.0,1.0,3/10,14.94%,CASP8;SLC25A4;FZD9
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),0.5467153009993481,0.9834359039246285,0.5128205128205128,0.7948817964300875,1.0,3/8,9.82%,CXCL12;SERPINE1;HMGB1
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),-0.45741454754761035,-0.983016374700368,0.5068493150684932,1.0,1.0,6/29,17.53%,GATA1;P2RY12;PIK3CB;MYL12A;TLN1;CLIC1
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),0.48971741521550716,0.9829408577879778,0.48717948717948717,0.7957142024363831,1.0,3/12,17.86%,RGCC;HDAC2;RUNX1
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),0.6192827736309094,0.9827339301116021,0.5227272727272727,0.7957241322260333,1.0,3/5,13.21%,ACVR1;TGFBR2;TGFBR1
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.4646961123707192,0.9826133770527837,0.45454545454545453,0.7956233160874218,1.0,2/19,5.19%,ABCA1;NFKB1
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.5598011633646718,0.9824660436565458,0.4594594594594595,0.7951269533218702,1.0,3/8,14.39%,SNCA;SIRT2;ATP2B4
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.5598011633646718,0.9824660436565458,0.4594594594594595,0.7951269533218702,1.0,3/8,14.39%,SNCA;SIRT2;ATP2B4
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),0.5329647158368916,0.9823985888028025,0.5681818181818182,0.7949344143323565,1.0,1/10,0.50%,NAF1
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),-0.5997530102934718,-0.9823069470793431,0.5666666666666667,1.0,1.0,1/8,4.95%,RASGRP1
prerank,GO_Biological_Process_2021__succinate transport (GO:0015744),0.5799202728964858,0.9820664288549827,0.55,0.7953591650274605,1.0,2/6,17.90%,SLC13A3;SLC25A14
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.4326998840856929,-0.9819943734862882,0.55,1.0,1.0,9/41,19.55%,FTL;SELENOS;NDUFA6;PRDX4;GLRX;FES;TXNRD2;GPX4;ATOX1
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.4198760343021313,0.981799660765447,0.41935483870967744,0.7955441524212048,1.0,8/20,24.63%,MEN1;CAMK2N1;PLK1;LATS1;PTEN;IPO5;IPO7;CDKN1B
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),0.5786462269834053,0.9817781575878026,0.5777777777777777,0.7952044599387951,1.0,3/6,18.27%,UBQLN1;UBQLN2;NFE2L2
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.36838735527259225,-0.9816086637783393,0.5257731958762887,1.0,1.0,62/210,25.48%,ISG15;AGPAT2;IRF1;IL1R1;HLA-A;IL7;RAB7B;ANXA1;RASGRP1;BTN3A1;HTR2B;PNP;CCBE1;PQBP1;HHLA2;PRKCQ;IL12A;CD14;CXCL17;NODAL;POLR2L;NOX1;TLR3;SLC11A1;WNT5A;CD274;BRCA1;XBP1;EIF2AK2;IL18;RIPK2;NLRP9;SCIMP;PTPN22;ZFPM1;DDIT3;DDX41;ZP3;SPHK1;POLR1C;CD74;POLR3G;POLR2K;CRLF2;C1QTNF4;NFKB2;PLA2R1;AGT;HLA-DPB1;PARK7;POU2F2;HSPD1;CD6;DHX58;NFAM1;GAPDH;TGFB1;FLOT1;S100A13;HLA-E;PRKD2;IL12RB1
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.450109921081972,-0.9815176605939546,0.5584415584415584,1.0,1.0,3/26,4.45%,SLC51B;KCNB1;PDZK1
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),0.5499817812264345,0.981427811005727,0.6071428571428571,0.7955916901822525,1.0,3/8,14.51%,ANK2;NOTCH2;MDM4
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),0.5617888127782705,0.9813258423679239,0.5128205128205128,0.7954545454545454,1.0,2/7,31.72%,UBQLN4;RUBCN
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.547843914702837,-0.9813013182780358,0.5333333333333333,1.0,1.0,4/12,13.06%,RASGRP1;IL12A;KLRD1;CD160
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),-0.547843914702837,-0.9813013182780358,0.5333333333333333,1.0,1.0,4/12,13.06%,RASGRP1;IL12A;KLRD1;CD160
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.3964726518740836,0.9811308546868232,0.42857142857142855,0.7954461734438842,1.0,11/36,15.14%,BTRC;AKT1;CYFIP2;HDAC2;ITCH;CAMK2N1;PLK1;OGT;ASPH;SPOPL;TBC1D10A
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),0.5238608079047409,0.9810400066438613,0.5365853658536586,0.7953092270185833,1.0,3/7,25.62%,NSFL1C;UBXN2B;CEP85
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.47521345850050145,-0.9806316124334017,0.5,1.0,1.0,1/17,1.88%,SRPRA
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),0.5948565518040332,0.9805057391062816,0.56,0.796182222596499,1.0,2/5,6.64%,SERPINE1;SLC12A2
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),-0.5613616063908743,-0.9804506448286204,0.5151515151515151,1.0,1.0,3/10,18.89%,RDX;PRKCQ;CELA2A
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),0.5828446541489751,0.9803154927541672,0.4782608695652174,0.7963386831275049,1.0,2/6,24.32%,DHX9;DCP1A
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),0.5806594261246217,0.9800472777478626,0.5789473684210527,0.7965316818736182,1.0,3/6,20.95%,EIF3E;CDK9;FMR1
prerank,MSigDB_Hallmark_2020__p53 Pathway,0.3019783360792855,0.979987101413424,0.6,0.7962753092256536,1.0,36/170,19.33%,TXNIP;ZMAT3;AK1;TPD52L1;RAP2B;AEN;RRAD;BMP2;KIF13B;FOXO3;EPHA2;SESN1;SLC7A11;PDGFA;ABCC5;CYFIP2;FBXW7;ZBTB16;SLC35D1;RGS16;PRKAB1;PTPN14;CDH13;IP6K2;ADA;SLC19A2;BLCAP;CDKN2AIP;UPP1;MDM2;PPM1D;CDK5R1;PTPRE;CCND3;TSC22D1;FAS
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.3226505302592081,0.9799273807627873,0.5333333333333333,0.7960008525893534,1.0,14/75,15.15%,ACACB;RORA;PLPP1;ELOVL6;NFYC;NR1D2;NR1D1;NCOA2;PANK2;GPAM;TBL1XR1;CHD9;ADIPOR1;RUBCNL
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),0.37241356838132994,0.9798448046786336,0.48,0.7958365564450647,1.0,13/56,19.43%,LIG4;CYREN;UBE2N;HMGB1;PSMD14;NSMCE2;PIAS4;UIMC1;DCLRE1C;BRCC3;H2AX;NSD2;XRCC4
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.44883223905319275,0.9798246567880445,0.5428571428571428,0.7955442564460093,1.0,2/16,9.82%,FLT1;HMGB1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.4421942272201707,0.979783808012695,0.4838709677419355,0.7952613814277871,1.0,7/17,18.62%,NCK2;SMAD7;NCK1;MLXIPL;PDE4D;PTEN;PPM1F
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.47441915332260554,0.9793448108382173,0.4666666666666667,0.7959207663484605,1.0,7/21,12.26%,FLT1;PDGFRA;IRS1;PIK3R4;DGKZ;PRKD1;PTK2
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),0.4785013924944736,0.9793421467324694,0.5483870967741935,0.7955465675866605,1.0,5/17,15.25%,PLPP1;AKT1;PLPP2;PLPP3;PRKG2
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),0.5283065621239997,0.9793270644917874,0.5,0.7952184053938858,1.0,1/6,4.57%,RGCC
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),0.41846955400358715,0.9792323118466363,0.53125,0.7950458071076474,1.0,11/27,23.07%,AKT1;PSMD10;IGF1;PRKN;HGF;OPA1;VAT1;TFRC;HSPA1A;BCL2L1;HUWE1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.494029804399125,0.9791506803228047,0.43333333333333335,0.7948642424891555,1.0,1/13,1.95%,MACIR
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),-0.4956467919584878,-0.9790019281403306,0.5194805194805194,1.0,1.0,4/25,9.54%,STAT1;ANXA1;STAT2;NLRP1
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),0.6164732831762285,0.9787025448844728,0.55,0.7955587630979679,1.0,2/7,7.91%,EPHA4;FAM107A
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.5334691870762599,-0.9784015595359401,0.5245901639344263,1.0,1.0,1/13,3.62%,LHFPL5
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.5463571954283286,0.9781250950893854,0.42857142857142855,0.7965991858461486,1.0,7/10,34.04%,KDM4C;KDM1A;JMJD1C;KDM7A;KDM3A;PHF8;KDM3B
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),-0.4961344465279001,-0.977992213402144,0.5,1.0,1.0,5/23,16.38%,EEF1AKMT2;TRMT112;EEF2KMT;SUV39H1;CSKMT
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.532086569658029,-0.9777232001778005,0.46875,1.0,1.0,3/14,16.74%,STAT1;TLR3;RIPK2
prerank,GO_Biological_Process_2021__negative regulation of cytosolic calcium ion concentration (GO:0051481),0.6357459688278243,0.9774493296247956,0.5853658536585366,0.7976933263909246,1.0,4/5,32.88%,DRD2;SMAD3;ATP2B1;ATP1A2
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),-0.4853020857396572,-0.9772475402838872,0.5333333333333333,1.0,1.0,3/22,6.05%,SFRP2;P2RY12;EFNA1
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),0.44419706302120543,0.9766648409913696,0.4117647058823529,0.7992055606542762,1.0,4/22,3.21%,TNFSF4;ACKR1;FOXP1;CSF1R
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),0.30406184405500647,0.976615401924131,0.47058823529411764,0.7989405097177957,1.0,18/111,12.60%,COLEC11;SNCA;DNM3;SNAP91;PICALM;LRP1B;AP2B1;HSPH1;EPS15;GRK3;RAB31;DNAJC13;PIP5K1C;SGIP1;NLGN3;ADRB2;GRK4;PIKFYVE
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),0.5160614630820581,0.9763958200597354,0.4411764705882353,0.7990398171487163,1.0,4/10,18.16%,PUDP;UCK2;DCK;UPP1
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),0.5091592970175851,0.9760918531744468,0.4634146341463415,0.7994392819807254,1.0,4/10,19.39%,FOXO1;ATP2B4;SMAD4;MLIP
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.311709020066409,0.9760563394841665,0.4,0.7991381166824083,1.0,36/120,21.56%,CASS4;SNCA;CSF1R;EPHA4;AGAP2;MMD;SRCIN1;TNIK;RAPGEF2;DLG3;RALB;DUSP19;LRP8;MAP4K4;PAK3;STOX1;ADRB2;PTK2;TGFBR2;RAP1A;INCENP;RPTOR;TAOK2;STK11;CAB39;CIB1;ALS2;AXIN1;MAP2K2;IL6R;DDR2;PAK4;CAMKK1;ETAA1;STK4;CACUL1
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),-0.5847566968388105,-0.9757398681215583,0.5614035087719298,1.0,1.0,1/7,13.82%,KCNQ1
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),0.5504472462956931,0.9754913663303957,0.42857142857142855,0.8000552913668385,1.0,3/6,40.57%,PRPF31;ZNHIT6;FBL
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),0.5412183877487758,0.9754284713675194,0.5666666666666667,0.799863148560334,1.0,4/7,29.63%,AGO3;DICER1;AGO2;AGO1
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),0.33540907724909386,0.9752832588694021,0.4166666666666667,0.7997892446987873,1.0,10/46,15.60%,WNT7A;PDGFRA;PDGFA;IGF1;PRCP;NF1;CFLAR;TGFBR1;SYTL4;NRG1
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),0.537771843380906,0.9750530781907013,0.4888888888888889,0.7998424914383313,1.0,4/8,21.10%,IWS1;ARRB1;KAT7;CTBP1
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.4741783165779549,0.9749096791431563,0.5185185185185185,0.7998140312940999,1.0,1/17,7.68%,PCGF2
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,0.3698445698246255,0.974617541451556,0.4444444444444444,0.8002118307958994,1.0,21/51,24.32%,BMP2;RAB31;SERPINE1;PPM1A;SMAD7;MAP3K7;ACVR1;SMURF1;HIPK2;TGFBR1;TJP1;BMPR1A;CDK9;UBE2D3;FURIN;SKIL;CTNNB1;KLF10;SMAD3;TRIM33;ARID4B
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),0.48586390307601246,0.9744382962447099,0.5,0.8001741604403202,1.0,3/13,17.86%,RGCC;HDAC2;RUNX1
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.3674334369366833,0.9743127860639161,0.44,0.8001455855297471,1.0,6/43,9.35%,SDC4;HS3ST5;GPC5;UGDH;EXT1;EXT2
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.5438285708120997,-0.9743027311425589,0.5409836065573771,1.0,1.0,3/13,27.10%,INHA;FSHR;EIF2B4
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),0.5636490088017495,0.9742790735754007,0.5365853658536586,0.7998272414776301,1.0,2/6,25.82%,PRKD1;DAPK1
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),0.30702147525826534,0.974250904548898,0.5,0.7994729862295233,1.0,24/86,20.26%,SYT3;EGFR;CDKL5;ADNP2;RPS6KA3;NEDD4L;CSNK2A1;AKT1;RASAL1;PSMD10;IGF1;DERL2;SMURF1;TGFBR1;RPTOR;BCL2;SEMA4D;USP47;RUFY3;CDKN2AIP;CIB1;ZNF639;RIMS2;UNC13A
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),-0.5930136472612055,-0.9739690926347516,0.5714285714285714,1.0,1.0,2/7,15.44%,GPR183;LFNG
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),0.4877362642009031,0.9739228868164705,0.53125,0.7997614466137274,1.0,7/12,17.80%,ZNF207;RAD18;CSNK2A1;PUM2;SMC6;PUM1;CSNK2A2
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.6155655215316627,0.9739147476921542,0.5581395348837209,0.7994165949887057,1.0,3/5,33.36%,ATP8A1;TMEM30A;ATP11B
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.46763017509154325,-0.9738560594637521,0.4788732394366197,1.0,1.0,6/18,23.18%,GBP1;VAMP8;CDK5;CLN3;AR;MMP14
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.512303190647839,0.9736124658531885,0.5588235294117647,0.7997048133787081,1.0,4/11,19.69%,PICALM;ABCA2;ROCK2;ROCK1
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.4356831148820179,0.9735683288981258,0.4523809523809524,0.7994596944040029,1.0,4/20,14.81%,PPP1R36;BMP2;PPP6R3;GPATCH2
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.30867742143854177,0.973223899501712,0.6470588235294118,0.7998108411979586,1.0,35/115,18.17%,CACNB4;SNCA;DNM3;PDZRN3;PCDHB2;ADGRL3;CDH2;FZD5;GPM6A;GPHN;PPFIBP1;SLITRK2;PPFIA2;NRXN1;LRRC4C;SDK1;PAK3;SHANK3;DVL1;NLGN4X;NLGN3;SLITRK1;ZC4H2;ELFN1;APBB2;PCDHB13;FARP1;LRFN5;CYFIP1;CACNB3;CTNND2;NRXN2;LRP4;DRD2;PTEN
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),-0.43606871046870543,-0.9731667256473262,0.5194805194805194,1.0,1.0,9/41,16.27%,AKR1C1;SLC51B;SLC16A3;CEACAM1;SLC51A;SLC16A4;ABCG2;SLCO3A1;SLC10A1
prerank,GO_Biological_Process_2021__negative regulation of macrophage cytokine production (GO:0010936),-0.6207920652151537,-0.973039234856527,0.5344827586206896,1.0,1.0,2/5,24.70%,CUEDC2;TGFB1
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),-0.5575078048832138,-0.9730306906328513,0.5666666666666667,1.0,1.0,3/9,18.49%,CYP2D6;NOS1;CYP3A4
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.5201270985799695,0.9729630317462675,0.5,0.7998728079592754,1.0,5/7,37.55%,YWHAZ;STK25;CDC42;COPG1;PDCD10
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.4547476943263289,-0.9728508966555097,0.5147058823529411,1.0,1.0,4/39,10.62%,ISG15;RPS27A;RPA3;UBC
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),0.2830101147148538,0.9728239381349467,0.4166666666666667,0.7997903572348009,1.0,33/170,15.76%,TPD52L1;NPNT;FLT1;HTR2C;ERBB4;CSF1R;EGFR;PDGFRA;BMP2;NOTCH2;ARRB1;NTRK2;ROBO1;RAPGEF2;MID1;PDGFA;ROR1;ADRA1A;DUSP19;IGF1;HMGB1;PTPRJ;BRAF;FBXW7;ADRB2;CRKL;RAP1A;PDGFC;TENM1;TAOK2;NRP1;ROCK2;PTPN11
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),0.37568169483524877,0.97265786550536,0.4230769230769231,0.7997260196225678,1.0,4/38,4.98%,PPARGC1A;SDHAF4;COX10;UQCRHL
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),0.6025284420707311,0.9721650963171726,0.5918367346938775,0.8004549853442221,1.0,3/5,32.57%,GNAI1;EPB41;EPB41L2
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.39722472315155705,0.9720935575295461,0.3939393939393939,0.8002192102185229,1.0,14/42,18.57%,EPHA4;KANK1;RAPGEF2;SPRY3;HDAC2;PTPN9;RTN4RL1;EFNB2;DCC;PTPRO;FYN;PTEN;CIB1;GRIN2B
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),0.5127500790641735,0.9719483935590648,0.42857142857142855,0.8002808443245241,1.0,2/8,14.62%,VHL;ADIPOR1
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.4077708220155377,0.9718753730161772,0.5142857142857142,0.8000813745823251,1.0,11/26,21.51%,RAB31;ARFRP1;GOLPH3;GOLGA7;GGA2;KIF13A;NSF;BBS2;GGA1;RAB10;MACF1
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),-0.497836375487272,-0.9711708429534831,0.5277777777777778,1.0,1.0,1/19,0.72%,GAPDHS
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),-0.497836375487272,-0.9711708429534831,0.5277777777777778,1.0,1.0,1/19,0.72%,GAPDHS
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),0.36636985613617135,0.9711120327672602,0.5625,0.8014386478843682,1.0,7/46,11.61%,WNT7A;LIG4;ASCL1;MME;SPEN;DOCK7;NAP1L1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),0.5164829435674547,0.9704037104781885,0.4782608695652174,0.8024619140334591,1.0,2/7,10.74%,FOXP1;MAPKAPK2
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),0.44587489080324494,0.9696110580704177,0.5151515151515151,0.8038707665401158,1.0,6/15,31.36%,ATG7;ATG2B;ATG5;RB1CC1;ATG3;WIPI1
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),0.33145172269803513,0.9695641728620585,0.42857142857142855,0.8036430516518617,1.0,12/69,14.22%,RAD54B;SEM1;SAMHD1;UBE2N;RAD51B;RAD52;RFWD3;PSMD14;NSMCE2;EXD2;SMC6;REV3L
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.34425294862386585,0.9694663414763002,0.5,0.8035233170135128,1.0,18/54,20.27%,PTPRK;EGFR;PDGFRA;AKT1;PKD2;MAP3K5;AGAP3;SIRT1;FER;MAPK1;PDK2;TRPM2;MAPK8;PXN;IMPACT;NFE2L2;MAPK9;PLEKHA1
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.5163286599907884,-0.9690651594934276,0.4857142857142857,1.0,1.0,7/17,20.45%,GSTT2B;GSTP1;GSTM5;GSTM3;GSTZ1;AKR1A1;GSTK1
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.5163286599907884,-0.9690651594934276,0.4857142857142857,1.0,1.0,7/17,20.45%,GSTT2B;GSTP1;GSTM5;GSTM3;GSTZ1;AKR1A1;GSTK1
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.5629212243136311,-0.9689745418125459,0.5964912280701754,1.0,1.0,4/10,29.94%,SPINK5;PRELID1;PRDM1;METTL3
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),0.27165651789205436,0.968965628627919,1.0,0.8043282907543569,1.0,80/311,18.38%,VEGFD;PID1;ZFPM2;LIG4;TNFSF4;FOXP1;SOX8;FLT1;CCKBR;RBPMS2;ERBB4;CSF1R;SOX4;EGFR;PRMT1;MEIS3;ACER3;PDGFRA;SOX9;TOX;BMP2;HNRNPU;MEGF10;HCLS1;FGF17;CNOT6L;NTRK2;CSNK2A1;TRPM4;AKT1;IRS1;PDGFA;HDAC2;MARCHF7;VEGFC;IGF1;EFNB2;ZNF268;MEIS2;BST1;VIPR1;STOX1;NAP1L1;DERL2;PTK2;TGFBR2;HDAC4;CRKL;SIRT1;TGFBR1;MLXIPL;FER;PDGFC;DHX9;BCL2;CCPG1;TJP1;EPCAM;CDH13;BMPR1A;CDK13;YAP1;DNAJA2;NRG1;PHIP;CCAR1;AKT2;LIFR;CUL3;KDM4C;ZNF703;CNOT8;ASH2L;KDM1A;RPRD1B;SRPK2;RBPJ;PTEN;MDM2;CIB1
prerank,GO_Biological_Process_2021__positive regulation of necrotic cell death (GO:0010940),0.5813524654050846,0.9688563314465825,0.5365853658536586,0.8041814328014522,1.0,1/5,2.04%,SLC6A13
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),-0.6540993280586616,-0.9687686503484757,0.6326530612244898,1.0,1.0,4/5,33.08%,CTNNA3;PKP2;JUP;DSC2
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.48114417251282365,-0.9687182797089914,0.5254237288135594,1.0,1.0,5/20,21.10%,POLR2L;POLR2I;POLR2J;POLR2K;POLR2G
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.48114417251282365,-0.9687182797089914,0.5254237288135594,1.0,1.0,5/20,21.10%,POLR2L;POLR2I;POLR2J;POLR2K;POLR2G
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),-0.5398649240800909,-0.9684875205687823,0.52,1.0,1.0,4/11,19.90%,THBS1;CD160;CCL2;GPER1
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.38254471692745917,0.9684776387594866,0.47619047619047616,0.804545908944226,1.0,10/39,13.93%,ANK2;HOMER1;STIM2;CACNA2D1;CASQ1;CAMK2B;CAMK2A;PKD2;STIM1;BCL2
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.5230999617684798,0.9682605300556419,0.5348837209302325,0.804775585079452,1.0,4/9,13.33%,FOXP1;MBP;HMGB1;MAP2K5
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),0.45035826527365885,0.9681587804396389,0.5,0.804718325339569,1.0,4/15,13.20%,ADGRB3;B4GALT6;ANKS1A;B4GALT5
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),0.5762138132491732,0.9680898522130654,0.47368421052631576,0.8044461742578817,1.0,3/6,32.65%,PEX13;SLC25A17;HACL1
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),0.34409761015758206,0.9676443850815556,0.5384615384615384,0.8050694618177234,1.0,9/41,16.68%,WNT7A;NFKB1;FOXO3;AKT1;EIF4E;SSH1;MAPKAPK5;WDR91;CYFIP1
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.3408594404007826,0.9676233403222931,0.4117647058823529,0.8047526608254623,1.0,20/70,18.01%,WNT7A;PARD3;BTBD3;CTNNA2;SLITRK2;DOCK7;DCC;PAK3;DVL1;SLITRK1;CNTN4;FARP1;OPHN1;PLPPR4;TAOK2;TMEM106B;ADGRB1;APBB1;LRP4;DRD2
prerank,GO_Biological_Process_2021__regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),-0.6149783383016463,-0.9673828712376744,0.5471698113207547,1.0,1.0,4/5,37.58%,SLC39A14;RACK1;MAPK7;CALM1
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),-0.5387705195907803,-0.9673718362636597,0.5862068965517241,1.0,1.0,4/10,22.69%,CYP2D6;NOS1;CYP3A4;CYP3A5
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),-0.595533373652638,-0.9671237850818704,0.6065573770491803,1.0,1.0,1/7,11.87%,PLAAT4
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),0.39926199996440986,0.9669465560925593,0.48148148148148145,0.805768754386361,1.0,9/40,12.66%,ANKRD2;CHD2;CHODL;LARGE1;IGF1;SOX6;TCF12;MRAS;SGCD
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),0.5884195630407406,0.9669211603776038,0.5333333333333333,0.8054608627245312,1.0,3/7,17.20%,PEX16;ZFAND6;PEX6
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),0.6308094308341159,0.966308223278204,0.6111111111111112,0.8062880529955675,1.0,3/6,28.01%,USP47;USP15;USP7
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),0.3665673332407519,0.9662491794493542,0.5,0.8061052441378386,1.0,3/40,1.50%,TNFSF13B;NCK2;TNFSF4
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.3835948627847812,0.9661331101986628,0.39285714285714285,0.8060118753445907,1.0,5/23,12.77%,NOTCH2;EPOR;SHOC2;IGF1;CRKL
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),0.37993797880242147,0.9660795130512974,0.42857142857142855,0.8057579760422484,1.0,7/33,13.85%,RBM24;HNRNPU;HNRNPC;SYNCRIP;MAPKAPK2;ANGEL2;DHX9
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),-0.4652476357746105,-0.9660458998199309,0.5142857142857142,1.0,1.0,4/24,5.07%,GATA1;SOX15;ADAM21;MEA1
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),0.49590848504666246,0.966000449525273,0.41935483870967744,0.8055399857929771,1.0,5/13,13.00%,CXCL12;SERPINE1;HMGB1;SLIT2;NBL1
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),0.6009817358719328,0.9655703821740782,0.5208333333333334,0.8060313335739132,1.0,1/5,27.64%,STAM
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),0.6009817358719328,0.9655703821740782,0.5208333333333334,0.8060313335739132,1.0,1/5,27.64%,STAM
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),-0.4672730406024088,-0.9655667211693166,0.6197183098591549,1.0,1.0,7/31,16.40%,CD24;ANXA1;PNP;HHLA2;PDCD1LG2;CD274;IL18
prerank,GO_Biological_Process_2021__endothelial cell morphogenesis (GO:0001886),0.5999480920376181,0.9651882029287762,0.5454545454545454,0.8064191782049615,1.0,1/5,13.76%,COL15A1
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.4261119130916668,-0.9650604837638687,0.6329113924050633,1.0,1.0,2/59,1.58%,H1-4;H1-2
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),0.51884293969898,0.9648561727766864,0.4358974358974359,0.8068511811382535,1.0,1/7,2.40%,SNCA
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.47536066608791416,-0.964623715928416,0.45588235294117646,1.0,1.0,3/19,14.90%,PSMC3;SRF;PSMC4
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.4822939690053785,-0.9645233690880478,0.5294117647058824,1.0,1.0,7/21,19.91%,SFRP2;ZNF385A;CLU;DDIAS;CD44;TAF9B;CD74
prerank,GO_Biological_Process_2021__positive regulation of acrosome reaction (GO:2000344),-0.6088465696897712,-0.9643687031278566,0.5714285714285714,1.0,1.0,3/5,19.70%,CACNA1H;ZP3;GLRA1
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell proliferation (GO:0061469),0.5132617102315726,0.9643474313716721,0.5476190476190477,0.8077455168753426,1.0,3/6,26.58%,NR1D1;NR4A1;SGPP2
prerank,GO_Biological_Process_2021__response to vitamin (GO:0033273),0.5819624322355328,0.9643285527541408,0.6,0.8074293756991116,1.0,1/5,6.56%,KYNU
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.2921567974147482,0.964307057742453,0.6,0.8070957426681973,1.0,70/238,18.80%,BTRC;ERBB4;EGFR;GRIN1;PDGFRA;SOX9;NFKB1;PSPN;KBTBD7;MAPK11;PSMA1;ABHD17B;FGF17;TNIK;CSF2RA;MEN1;CAMK2B;RAPGEF2;DLG3;CAMK2A;PIK3CA;SPRED1;MBP;PIK3R1;IRS1;PDGFA;SHOC2;RASAL2;PSMD11;RASAL1;MAP3K7;SHC3;PSMD10;GFRA1;IGF1;MAP3K20;ABHD17A;HGF;BRAF;MRAS;MAP4K4;MAPKAPK2;NF1;SHANK3;PSMF1;PSMD14;MAP3K5;NRG2;SOS1;GOLGA7;PTK2;RASA2;NRAS;DUSP6;CUL1;DLG1;MAPK1;TAOK2;PRKG2;NRG1;MAPK8;SYNGAP1;PSME4;FYN;CUL3;PPP1CC;CCM2;GRIN2B;PPP1CB;FBXW11
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.4930165839581292,-0.9642784765770712,0.5441176470588235,1.0,1.0,5/17,17.23%,GBP1;CEACAM1;CD160;PHPT1;PTPN22
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),-0.5271673181474839,-0.9642524567171402,0.5492957746478874,1.0,1.0,1/14,1.84%,SOX15
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),0.524847073608501,0.9639314172358926,0.5365853658536586,0.8076866021557425,1.0,4/9,17.82%,SIRT1;JARID2;KDM1A;ATRX
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),-0.4487685203497042,-0.9638364227028906,0.5405405405405406,1.0,1.0,6/49,6.66%,IFIT1;ISG15;IFITM3;BST2;MX1;APOBEC3G
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),-0.44551857486785557,-0.9637705656803209,0.5428571428571428,1.0,1.0,2/31,1.58%,H1-4;H1-2
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),0.3685410565276291,0.963437887892581,0.5,0.8083568630318105,1.0,13/27,30.36%,ZNF207;CKAP5;CLASP1;HDGFL3;SLAIN2;TUBG1;CSNK1D;FGF13;CLASP2;TUBGCP6;TUBGCP3;TPPP;RANBP9
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),0.46279724501892205,0.9634105212770601,0.5365853658536586,0.8080143852189272,1.0,3/13,11.70%,RBM24;CPEB3;ZC3H12D
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.463800486116703,-0.9631865239660139,0.5714285714285714,1.0,1.0,1/33,0.09%,EPN1
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,0.3210759692427972,0.96311281542028,0.7142857142857143,0.8082312978509483,1.0,19/127,8.37%,POSTN;ITGA1;KAT2B;RGS5;RBPMS2;ACTA2;DCN;CXCL12;RRAD;PDGFRA;PDE4DIP;NRP2;MSRB3;CDH11;ZBTB44;PRKG1;PCDH18;LMO7;PRRX1
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.37242653269485915,0.9630661901142334,0.5384615384615384,0.8079424110172806,1.0,8/36,17.09%,PID1;BCO2;AKT1;STOX1;PPA2;BCL2;VCP;AKT2
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),0.4310562183085158,0.9629999344869523,0.46875,0.8077690476989838,1.0,10/25,17.48%,GDAP1;RAB8B;PEX14;PEX2;PEX16;PEX5;ABCD3;PEX7;PEX6;PEX13
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),0.5768070721834,0.9629349522194243,0.5227272727272727,0.8075072212466455,1.0,4/5,42.17%,PTPRC;TP53;LRRC17;LRP5
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),-0.583524261455286,-0.9628261341838299,0.49206349206349204,1.0,1.0,2/7,21.97%,SUSD4;CR1
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.4997796793306308,0.9626100501890545,0.5483870967741935,0.8078036923624459,1.0,7/13,21.06%,RAB27A;KIF5A;KIF5C;SYNJ1;TMEM230;DNM2;NLGN1
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),0.4542184646304305,0.9624214744602475,0.53125,0.8078608342352654,1.0,6/25,8.38%,QRICH2;CSPG5;PARVA;RHOQ;PLEK;PDGFA
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),0.43668943582439873,0.9619379245987961,0.5625,0.8084135249635733,1.0,7/26,18.43%,NAF1;PPP1R10;MAP3K4;MAPKAPK5;MAPK1;ATRX;HNRNPD
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),0.36911140442420176,0.9618111253891342,0.4666666666666667,0.8083111095874168,1.0,3/33,2.32%,NCK2;TNFSF4;SDC4
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),0.5606553548653466,0.9612825901484642,0.5,0.8091283518715967,1.0,3/7,13.21%,ACVR1;TGFBR2;TGFBR1
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.42936993730686424,0.9612284168770548,0.5405405405405406,0.8089196493102472,1.0,4/18,12.96%,RBPMS2;PDGFRA;ACVR1;NIPBL
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),-0.549091447664313,-0.9612200675542855,0.5753424657534246,1.0,1.0,3/11,12.48%,PNP;HINT1;NT5C
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.45635570496055133,0.9611491182254739,0.45454545454545453,0.808772973916108,1.0,5/16,18.62%,RGCC;AFDN;TJP1;EPCAM;PPM1F
prerank,"GO_Biological_Process_2021__CD4-positive, alpha-beta T cell activation (GO:0035710)",0.6021427772189718,0.9608879687114558,0.625,0.8089972883903738,1.0,2/5,9.82%,TNFSF4;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),0.37947395020210273,0.9608679450761546,0.4230769230769231,0.8086830185843112,1.0,5/29,8.99%,SOX4;MCU;BAIAP3;TRPM4;DOC2B
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.4590030890794066,-0.9608016082196547,0.5945945945945946,1.0,1.0,4/26,14.16%,PARP14;ART4;PARP2;ART3
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),0.49890163184845676,0.9606603365391494,0.5142857142857142,0.8086601569091925,1.0,5/9,33.37%,IMPACT;CTSS;TRPV1;RAB11B;SLC9A1
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.451502270188634,-0.9606004753722484,0.5540540540540541,1.0,1.0,4/24,15.71%,FBXL22;PDE6B;RBM4B;ID2
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),0.46314051769310155,0.9605483611278413,0.5666666666666667,0.8084697757429967,1.0,5/16,13.85%,GDAP1;DNM3;MFF;PRKN;OPA1
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),-0.5311451511553171,-0.9603594850750794,0.5362318840579711,1.0,1.0,3/13,10.11%,CD9;ANXA1;MMP24
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.44774262370624324,-0.9600621504351003,0.5375,1.0,1.0,8/29,18.59%,CLEC12A;IGSF6;P2RY13;CD14;SLC11A1;SPI1;MYO1F;CLEC5A
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),-0.6622780771487229,-0.9600531648773402,0.5862068965517241,1.0,1.0,1/5,7.00%,SEMA5A
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",0.2689452882551356,0.959742861635098,0.6666666666666666,0.8096986066031773,1.0,47/254,20.33%,NUDT21;SNRPF;USP49;WDR33;PAPOLA;HNRNPH1;CSTF3;RAVER2;PSPC1;SART1;HNRNPU;DHX15;HNRNPC;SNRPN;SPEN;LSM8;U2AF1;CTNNBL1;SYNCRIP;RBM15B;HNRNPH3;CLNS1A;ZMAT5;SMNDC1;DHX9;U2AF2;PRCC;PRPF40B;CDK13;RBM17;RBM41;PRPF40A;CCAR1;SF3B3;RBM6;SRPK2;PTBP1;TRA2A;CWC27;ELAVL2;HNRNPD;NOVA1;SMU1;RALY;GTF2F2;NOVA2;CD2BP2
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,-0.4034462388349715,-0.9595497969617911,0.5324675324675324,1.0,1.0,8/71,12.36%,SPAG17;FMO6P;P2RY14;CYP4Z1;DNAAF1;RGS22;DCDC1;FMO2
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),0.535815952246584,0.9592484266587886,0.5348837209302325,0.8105298776745142,1.0,3/6,21.08%,PLEKHA8;PLEKHA3;GLTP
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),0.4719158737604359,0.9591355056201193,0.5454545454545454,0.8104093557913404,1.0,5/18,16.15%,ABCC2;SLC15A2;ABCC5;ABCC3;SLC47A1
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),0.5224876617653433,0.9590853082914116,0.5365853658536586,0.8101481119957212,1.0,4/7,28.98%,PTGES3;TBXAS1;HPGDS;PTGIS
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),-0.6076173776169409,-0.9589428005814842,0.6,1.0,1.0,3/6,17.83%,SPI1;DLEC1;KLF4
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),-0.5768230003967965,-0.9589265180573828,0.5714285714285714,1.0,1.0,2/8,12.81%,DDX11;BLM
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),0.5199804741909727,0.9589265092703085,0.5555555555555556,0.8101246494503036,1.0,4/7,31.51%,BMP7;LIN7C;PHACTR4;TBX20
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),-0.5165730637098483,-0.9589045816596553,0.5245901639344263,1.0,1.0,4/10,17.68%,CACNA1H;CD9;ERVW-1;NOS1
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.3482265851904684,0.9586498339228902,0.5185185185185185,0.8103386455210982,1.0,7/29,15.77%,SEMA5B;SOX8;ERBB4;SEMA3C;NRP1;SEMA6C;SEMA4D
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),-0.44838430702263443,-0.9585432149110092,0.5441176470588235,1.0,1.0,2/28,2.39%,ACOT2;ACOT1
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),0.5735618559733668,0.9584533122506074,0.5813953488372093,0.8103590680628993,1.0,1/6,20.26%,UNC13A
prerank,GO_Biological_Process_2021__G protein-coupled receptor internalization (GO:0002031),-0.6303211587313016,-0.9583029208515068,0.6415094339622641,1.0,1.0,2/5,9.28%,ADM;ARR3
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),-0.5500213997167388,-0.958287201487062,0.5789473684210527,1.0,1.0,2/8,14.15%,DDX11;DTX3L
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.3880912291182347,-0.95808613200126,0.5657894736842105,1.0,1.0,15/83,15.12%,GBP3;IL1R1;IER3;HELZ2;HLA-C;CTSH;CD14;OAS3;LTBR;TNFAIP2;PGLYRP1;DTX3L;CEBPD;B3GNT3;RBM47
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.4364884344827394,0.9579037178271002,0.4878048780487805,0.8111350707232458,1.0,2/16,4.29%,TCAP;CDH2
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),0.5838732536950799,0.9578910735331534,0.5434782608695652,0.8107862685090729,1.0,5/5,41.63%,TJP1;CAMSAP3;PLEKHA7;FERMT2;KIFC3
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),0.4917489437959609,0.9574076965056659,0.5384615384615384,0.8116403804934306,1.0,4/11,19.58%,UBE2N;MTHFR;CDK9;SETD5
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),0.2879556561310469,0.9572267094263899,0.6,0.8116163080683987,1.0,41/188,18.80%,CDC25A;BTRC;CEP152;TPD52L1;PHLDA1;EPS8;ANAPC1;FBXL17;CDC27;FBXL3;CCNG2;CAMK2A;CCNA2;CEP290;NEDD1;CSNK1E;PLCB1;RPS6KB1;EIF4E;ACVR1;PLK1;CKAP5;CDC34;CUL2;CLASP1;MAPRE1;CUL1;ALMS1;LATS1;YWHAG;PPP2R2A;ARPP19;PPP1R12A;CUL3;TAF2;TUBG1;CDK14;DNM2;PPP1CB;CCND3;FBXW11
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.3695159452857128,0.9572229439642624,0.5217391304347826,0.8112502204238031,1.0,9/34,24.93%,CDKL5;RNF6;KIAA0319;GSK3B;RUFY3;DNM2;MACF1;PTPRS;TRIM46
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.30827313407139545,0.9570656132642147,0.5333333333333333,0.811287709177683,1.0,30/100,21.55%,AMOTL1;PRKX;RCC2;ERBB4;CSF1R;EGFR;PLXNA2;PLXNA1;SRCIN1;FGF17;AKT1;AMOT;ABL2;TTBK2;MEMO1;NRG2;SGK3;CYRIB;ROCK2;NRG1;HACE1;AKT2;PLXNA4;FRMD5;FBLN1;ROCK1;SERPINE2;MGAT3;MACF1;CRK
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.4645677719645407,-0.9567764885241704,0.5522388059701493,1.0,1.0,10/24,31.39%,CENPN;ITGB3BP;OIP5;CENPH;CENPU;NPM1;CENPX;SMARCA5;KNL1;MIS18A
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.4645677719645407,-0.9567764885241704,0.5522388059701493,1.0,1.0,10/24,31.39%,CENPN;ITGB3BP;OIP5;CENPH;CENPU;NPM1;CENPX;SMARCA5;KNL1;MIS18A
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),0.51663940133793,0.956552865001183,0.5555555555555556,0.8121312932788146,1.0,3/10,15.84%,SHANK1;NRXN1;AGTPBP1
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),-0.6281526851170497,-0.9563796366722553,0.6333333333333333,1.0,1.0,1/6,13.34%,MT3
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),0.5764263879859298,0.9563252420038882,0.5882352941176471,0.8122384179893685,1.0,3/7,3.46%,DNM3;SNAP91;PICALM
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),-0.6117533433195522,-0.9562423635371204,0.5517241379310345,1.0,1.0,1/5,5.94%,TIMP1
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),0.35222293234334445,0.9561852090380624,0.52,0.8121791129607977,1.0,9/38,15.05%,SNCA;NEDD4L;RAB31;SERPINE1;CBL;SGIP1;RAB21;CLIP3;HIP1
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.474458023696951,-0.9561588807159257,0.5507246376811594,1.0,1.0,3/23,10.98%,CFTR;PDZK1;GLRX
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),-0.4783747645085405,-0.9558761820779366,0.47692307692307695,1.0,1.0,10/25,23.87%,CTSL;PRSS3;CASP8;C1R;CTSH;RIPK2;C1RL;F11;MMP14;PLAT
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),0.45542206081581577,0.9555889356506836,0.5,0.8129774047228435,1.0,2/16,5.72%,SLC6A13;SLC25A18
prerank,GO_Biological_Process_2021__positive regulation of vasoconstriction (GO:0045907),-0.5862125586110162,-0.9553896330766837,0.6190476190476191,1.0,1.0,1/7,2.87%,SMTNL1
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),0.4894134192967333,0.954965141138753,0.5588235294117647,0.8141335850461326,1.0,5/9,35.11%,PRKCB;VMP1;ZDHHC17;PPARG;UNC119B
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),-0.4495398350471657,-0.9549528916200469,0.5205479452054794,1.0,1.0,4/27,5.07%,GATA1;SOX15;ADAM21;MEA1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),0.6205908432289045,0.9547475091840572,0.5833333333333334,0.8141784187582529,1.0,2/5,7.03%,ADAMTS3;ROBO1
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.47733015153670716,0.9546918436920341,0.47058823529411764,0.8139610528319036,1.0,2/12,6.64%,NEDD4L;SLC12A2
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),0.5515776754159304,0.954681751186999,0.5806451612903226,0.813604126700475,1.0,2/8,6.66%,FZD5;TASOR
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),0.4107980798591529,0.9544565866449272,0.48148148148148145,0.8135880221850709,1.0,1/20,0.09%,ACE2
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.4439769076319574,-0.9543659575657671,0.4927536231884058,1.0,1.0,6/29,17.30%,KCNB1;IL12A;SFRP1;RSAD2;APOE;ERP29
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),0.5364602538416133,0.9541190484578562,0.5652173913043478,0.8140082760281271,1.0,3/7,13.21%,ACVR1;TGFBR2;TGFBR1
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.526674526770405,0.9538631687709459,0.4897959183673469,0.814183909832012,1.0,2/8,21.52%,ABCC5;SLC39A8
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),0.44430396213063217,0.9537103653260828,0.5,0.8141850050919258,1.0,2/13,5.72%,PPARGC1A;SLC25A18
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.4629670794543147,0.9535505141866979,0.47058823529411764,0.8141599539406623,1.0,3/13,13.41%,ZNF207;PLK1;BUB3
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.48829988459948803,-0.9533336176498183,0.5526315789473685,1.0,1.0,1/19,4.65%,PLB1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),0.4392324242191924,0.9531274262964377,0.48717948717948717,0.8148753805068966,1.0,3/13,7.01%,VEZF1;SOX9;RFX3
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),-0.42147593097895386,-0.9529522585505408,0.56,1.0,1.0,2/42,0.85%,FTH1;CP
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),0.40401159946689236,0.9528383234302376,0.4666666666666667,0.8151112627434783,1.0,6/25,9.83%,TNFSF4;ZBTB1;SOX4;SART1;DUSP10;GLI3
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.28202901079038,0.9527570472114176,0.8571428571428571,0.8149117618206637,1.0,47/155,20.53%,NCK2;KCTD8;YJEFN3;IRAK2;RGS5;RGS3;MGLL;HOMER1;FBXL17;RORA;GIT1;RGS6;GRK3;GSKIP;GNG4;PLCB1;CDC42SE2;ELF1;RIC8B;PRKD1;BST1;ACVR1;SIK2;RGS16;GRK4;NCK1;RGS12;SIRT1;OGT;UBTF;DTX1;YWHAG;UBASH3B;PXN;CSK;LIFR;CBFB;FYN;RUNX1;CDKN2AIP;GIT2;AXIN1;FRMPD1;TSPAN12;NCLN;PPP2R1A;CREBBP
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.5504229378885832,0.9526807265067256,0.5483870967741935,0.8147037398766288,1.0,2/6,13.66%,SIRT1;MAPKAPK5
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),-0.47790113794474326,-0.9524867109929573,0.5571428571428572,1.0,1.0,2/23,3.85%,GATA1;STAT1
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.3484617186864273,0.9524854467774937,0.65,0.8147132953702942,1.0,14/41,21.71%,RHEB;LGR4;TFE3;NR1D1;DOCK7;ZNF423;ABHD6;STK11;PGAM5;RBPJ;NOVA1;LNPEP;NOVA2;PLCL1
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),0.5746649362297629,0.952437734822017,0.575,0.8144273222201294,1.0,3/6,35.17%,ATRX;INO80;WIZ
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),0.34833668866122375,0.9523915598507964,0.5,0.8141589803992071,1.0,16/52,23.78%,NUP42;NUP37;NUP188;EP300;NUP153;OGT;NDC1;NUP205;HIF1A;NUP214;COX7A2L;AK4;RANBP2;BEND3;NUP98;NUP54
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),-0.4630854722930461,-0.9521271847721295,0.5774647887323944,1.0,1.0,3/20,11.49%,ASIP;SNAPIN;PMEL
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),-0.5291072123746778,-0.9517091180007512,0.6,1.0,1.0,2/15,14.27%,FABP3;APOE
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),-0.5783544918324073,-0.9516544527276516,0.6491228070175439,1.0,1.0,1/7,9.78%,PIK3IP1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),0.36208464176980754,0.9514088826057652,0.5185185185185185,0.8159403031481481,1.0,8/29,20.95%,BAIAP3;CAMK2A;RIMS3;SLC30A1;GSK3B;RIMS2;HCRT;FMR1
prerank,GO_Biological_Process_2021__negative regulation of amino acid transport (GO:0051956),0.6358470262945475,0.9511748847579572,0.5952380952380952,0.8161749728408474,1.0,1/5,3.39%,SLC43A1
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),0.40293201518309846,0.95111517900449,0.4482758620689655,0.8160190016894401,1.0,16/27,34.66%,NCSTN;ABL2;MAPK8;MSH2;POT1;CIB1;XRCC4;BCAS3;PHACTR4;MAPK3;XRCC5;MSH3;ABL1;SSBP1;MAPK14;WRN
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),0.5228168413669017,0.9510536735497979,0.6,0.8157764458366855,1.0,1/8,1.93%,FOXP1
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),0.5636205351945416,0.9510033844630634,0.5757575757575758,0.8155947858829998,1.0,3/7,35.17%,ATRX;INO80;WIZ
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.45456789217448645,-0.9509680260756339,0.527027027027027,1.0,1.0,3/22,4.45%,SLC51B;KCNB1;PDZK1
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),-0.4779869011830176,-0.9507584165605479,0.6065573770491803,1.0,1.0,4/21,17.11%,KIF20B;SVIL;CENPV;GIPC1
prerank,GO_Biological_Process_2021__negative regulation of bone resorption (GO:0045779),0.6528472941903948,0.9503902325291791,0.65625,0.8167129859831309,1.0,2/5,23.19%,UBASH3B;GPR137B
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),-0.5362081872054857,-0.9503190118307534,0.5522388059701493,1.0,1.0,1/10,3.41%,SLC5A10
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),0.2742706895911495,0.9503015270238269,0.7142857142857143,0.8165137491079381,1.0,63/254,18.27%,PPARGC1A;SLC24A3;PID1;ZNF804A;MITF;AMH;SNCA;ANK2;RAB27A;ACTA2;SERPINB9;TBC1D5;ITGB8;RGCC;SOX9;BMP2;MAPK11;ARRB1;MBIP;GABPA;TASOR;FGF17;NTRK2;ROBO1;AKT1;UBR5;ITCH;IGF1;TICAM1;PRKN;CAMK2N1;BRAF;TNRC6B;STOX1;FUBP1;AFDN;OCLN;PRKAB1;MAGI2;SCYL2;TGFBR1;MAP2K5;AGO3;MAPK1;TRIM28;PDE2A;GSK3B;SCRIB;YAP1;NSF;ROCK2;SMO;MAPK8;BMP7;TFRC;HIF1A;ATF2;CELF1;SRPK2;RBPJ;PPHLN1;RBMS3;NFE2L2
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.33863264070778765,0.9502879150610806,0.5,0.816167521690056,1.0,10/44,22.36%,TPD52L1;CRADD;BOK;WWOX;TGFBR1;BCL2;BCL10;FAS;BCL2L1;G0S2
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),0.5657255741143095,0.9502269546947403,0.5641025641025641,0.815951398730973,1.0,1/6,8.93%,BMPR1B
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),0.3774641805250027,0.9502148472652127,0.39285714285714285,0.8156230279740151,1.0,7/30,11.87%,SNAP91;PICALM;SERPINE1;CBL;MKLN1;SGIP1;RAB21
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.4689146930790526,-0.9501170815705867,0.5970149253731343,1.0,1.0,4/24,16.08%,ANKRD53;CAV3;FES;DRG1
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),0.46930744952928727,0.9499103277684653,0.45454545454545453,0.8159952258998391,1.0,1/11,2.40%,SNCA
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),0.5613291710842954,0.9498982953851867,0.5365853658536586,0.8156671275492569,1.0,1/10,5.39%,PLIN5
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),-0.44704812500055996,-0.9497987421106638,0.5769230769230769,1.0,1.0,4/37,10.61%,SLC3A1;SLC38A4;PDPN;SLC25A45
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),0.4603833280587099,0.9497771819198496,0.5862068965517241,0.8155725388708448,1.0,6/14,24.13%,PANK2;SLC25A16;PANK3;PANK1;ACAT1;ACOT7
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),0.4245944119181583,0.949506695950193,0.5428571428571428,0.8158320230310316,1.0,3/13,2.44%,AK3;AK1;NMNAT2
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),0.5162540431652146,0.9493773115411033,0.5,0.8158237455486245,1.0,3/8,23.56%,DUSP10;HLA-DRA;SOX12
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),0.422924301255568,0.9493038111905366,0.59375,0.8155825676578812,1.0,8/21,21.17%,IGF1;CAMK2D;SMAD4;ROCK2;MLIP;ROCK1;PRKCA;PDE9A
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,0.3137509431149785,0.9492857189054281,0.5625,0.8152553797951014,1.0,14/73,9.14%,POSTN;FAT4;ACTA2;DCN;CXCL12;PDGFRA;VSTM4;MSRB3;CDH11;PRKG1;ZNF521;PCDH18;PRRX1;FAP
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),0.503587509924342,0.9491862709286849,0.65,0.8150749976097845,1.0,6/10,28.72%,STOX1;DYRK3;MACROH2A1;MLC1;SLC38A2;CORO2B
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),0.2864031629645501,0.9490814410897973,0.5555555555555556,0.8149120047611601,1.0,33/158,14.98%,EPHA7;NPNT;HTR2C;ERBB4;CSF1R;EGFR;SPRED2;PDGFRA;BMP2;NOTCH2;ARRB1;EPHA2;DUSP10;NTRK2;LMO3;RAPGEF2;SPRED1;PDGFA;SPRY3;ROR1;ADRA1A;HMGB1;CAMK2N1;BRAF;STYX;FBXW7;CRKL;RAP1A;PDGFC;DUSP6;DLG1;SMAD4;NRP1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.5177374966630741,0.9489565169293552,0.5526315789473685,0.8147749890775113,1.0,2/7,13.84%,MCU;RAP1GDS1
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.5129409096350261,-0.9487294750953661,0.6212121212121212,1.0,1.0,1/13,2.77%,KIF20B
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),0.5430219608306192,0.9485882123421163,0.5714285714285714,0.8152492002264017,1.0,2/7,19.69%,MEGF10;ROCK1
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),0.37021805354361365,0.9485058443612153,0.6,0.8149917102312877,1.0,7/51,10.21%,UBE2G1;AP2B1;CTSK;CTSV;AFG1L;FAP;PRKN
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),0.4961455461168558,0.9484036793296843,0.5,0.8148634406006476,1.0,2/10,16.62%,EXOSC6;PCID2
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),0.4918991467469027,0.9479386904645994,0.5454545454545454,0.8155690677488238,1.0,5/13,20.22%,RANGAP1;RAB23;NUP153;SUFU;CABP1
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),0.5917205702779331,0.9477623239114006,0.6,0.8156296782930562,1.0,3/6,13.13%,LHX6;RAPGEF2;SCYL2
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.4869691245437401,-0.9474903121487858,0.5538461538461539,1.0,1.0,3/15,10.71%,CEACAM1;PDPN;CCN1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),0.550234281268487,0.9474503228587308,0.5405405405405406,0.8160681121972251,1.0,1/6,1.93%,FOXP1
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),-0.5888226700491447,-0.9473870362501817,0.5573770491803278,1.0,1.0,4/7,29.07%,MVK;DHDDS;HMGCR;IDI1
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),-0.5419522167271565,-0.9472399598806375,0.5714285714285714,1.0,1.0,4/11,16.12%,AKR1C1;RDH11;BCO1;RDH13
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.402590827286995,0.9471262472041453,0.5185185185185185,0.8164460687249194,1.0,15/34,22.83%,HOMER1;GRIN1;PLCB1;CPEB4;GRM1;GRM8;GNAQ;CDK5R1;GRIN2B;GRIK2;GRIA2;FMR1;HOMER2;GRIK1;GRM5
prerank,GO_Biological_Process_2021__cochlea morphogenesis (GO:0090103),-0.6036478816410433,-0.9471123358023507,0.5818181818181818,1.0,1.0,2/5,7.98%,MYO3A;MYO3B
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.5262880492158805,-0.9468499236689641,0.515625,1.0,1.0,1/10,2.04%,CFTR
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),0.41563251406926094,0.9467402790940043,0.5862068965517241,0.8170038828239573,1.0,12/28,20.91%,DGKB;MGLL;DGKH;DGKZ;GK;ABHD6;DGKG;LYPLA2;ABHD2;DGKE;PLAAT3;GK5
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.4202867094661564,0.9467236658921968,0.5428571428571428,0.8167121069048374,1.0,9/23,20.26%,CACNB4;PDZRN3;GPHN;PPFIBP1;DVL1;ZC4H2;CACNB3;LRP4;UNC13A
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),0.575113482419499,0.9466642424348417,0.5238095238095238,0.8164634531079398,1.0,4/7,22.73%,GIT1;CKAP5;HSPA1A;MECP2
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.3818080878223009,0.9466498733920953,0.5862068965517241,0.8161636033665555,1.0,9/23,24.00%,PTPRK;ANK2;SMURF1;GGA2;ARF6;GGA1;CTNNB1;PRRT1;PIGU
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),0.3410590964288764,0.9466430851176808,0.7272727272727273,0.8158468869868176,1.0,4/61,9.48%,MTHFS;SLC19A1;TPK1;PANK2
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),0.5681237043445834,0.9464130973944039,0.5588235294117647,0.8161126410444561,1.0,3/6,38.59%,LLGL2;SLC6A17;SLC6A15
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.4109907570781475,-0.94626367692681,0.5375,1.0,1.0,12/54,23.44%,SFRP2;SELENOS;BCL2L2;CLU;DDIAS;CREB3;XBP1;HTRA2;CREB3L1;PARK7;ENO1;NOL3
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.42358214512161146,-0.9462321784057288,0.5217391304347826,1.0,1.0,4/44,10.53%,TOMM7;CASP8;UBL5;ARIH2
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),-0.5135852655159638,-0.9457272053436561,0.6212121212121212,1.0,1.0,4/14,21.60%,ITGA5;FGF1;KLF4;S100A1
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),0.5766567181756135,0.9454431966398382,0.5490196078431373,0.8179442516662366,1.0,2/5,12.56%,COX10;HCCS
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),-0.4595440237847018,-0.945358963399299,0.5230769230769231,1.0,1.0,4/25,17.62%,GATA1;MSX2;SP100;HEY2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),-0.5813886215475541,-0.9452364886052009,0.5967741935483871,1.0,1.0,2/8,10.27%,ANXA1;PIK3CB
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),-0.47687562084087637,-0.9450443577010516,0.5333333333333333,1.0,1.0,4/21,16.38%,EEF1AKMT2;BHMT;EEF2KMT;CSKMT
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),0.46420371808893257,0.9449730402393216,0.5,0.8186023380616381,1.0,3/14,20.70%,STARD3;ARV1;OSBPL5
prerank,GO_Biological_Process_2021__T cell mediated cytotoxicity (GO:0001913),-0.653338127406718,-0.9445562663751343,0.6451612903225806,1.0,1.0,4/5,19.68%,HLA-A;CTSH;MICA;EMP2
prerank,GO_Biological_Process_2021__regulation of meiotic nuclear division (GO:0040020),-0.5677774079683906,-0.9440241509650569,0.6071428571428571,1.0,1.0,1/6,4.87%,FBXO43
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),0.5037120285685579,0.943653921125716,0.5,0.8208758608487231,1.0,5/8,17.86%,TNFSF4;GLI3;TGFBR2;CBFB;RUNX1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),-0.5566667248139072,-0.9434747905147671,0.5735294117647058,1.0,1.0,2/9,9.42%,SELENOS;GSTP1
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),0.4482336940997569,0.9429679304283834,0.6428571428571429,0.8219765025848677,1.0,5/17,13.53%,DNA2;SMARCAD1;UBE2N;RAD52;EXD2
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),0.4597877245530102,0.9427945605791889,0.4888888888888889,0.8219485234038649,1.0,1/13,2.32%,SDC4
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),-0.4757915505691782,-0.9427043736418778,0.5645161290322581,1.0,1.0,5/18,15.12%,DOCK8;CXCL2;CCL2;DUSP1;CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.4180321914453635,0.942692291146561,0.5555555555555556,0.8217668653653565,1.0,10/22,21.17%,PPP1R10;RPS6KB1;MEIS2;EIF4E;USP22;USP2;CUL3;MDM2;TTL;PRKCA
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),0.4130370012029921,0.9426757332785847,0.45454545454545453,0.8214317308558972,1.0,5/22,13.32%,HNRNPU;CHMP1A;CEP97;PLK1;CHMP2B
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),-0.437891567566458,-0.9426039852138176,0.5921052631578947,1.0,1.0,4/30,18.78%,THBS1;FGF1;SLU7;HTRA2
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.32093375989581724,0.9425969116343569,0.6666666666666666,0.8212333958275161,1.0,21/82,14.39%,SNCA;TPD52L1;FLT1;CSF1R;EGFR;RGCC;ROBO1;RAPGEF2;AKT1;DIPK2A;PDGFA;RALB;PSMD10;PKD2;ADRB2;SIRT1;INCENP;PDGFC;RPTOR;TENM1;ATP2B4
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),0.5113954717627988,0.9425089739622007,0.5853658536585366,0.8211034575290629,1.0,1/8,2.40%,SNCA
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),0.3076019748554507,0.9424662658303193,0.7272727272727273,0.8208457715815572,1.0,29/122,18.80%,CDC25A;BTRC;CEP152;TPD52L1;PHLDA1;FBXL17;FBXL3;CCNA2;CEP290;NEDD1;CSNK1E;PLCB1;PLK1;CKAP5;CLASP1;MAPRE1;CUL1;ALMS1;LATS1;YWHAG;PPP2R2A;ARPP19;PPP1R12A;TAF2;TUBG1;CDK14;DNM2;PPP1CB;FBXW11
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),0.4625417776326819,0.9423770305523436,0.5,0.8205883114762491,1.0,1/12,1.93%,FOXP1
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),0.4496970513388021,0.942110071340736,0.5757575757575758,0.8208335585510906,1.0,4/17,13.21%,CACNA1G;CACNA1I;KCNA2;MYH14
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),0.3200047288713771,0.9421020051947065,0.5555555555555556,0.8204826872401103,1.0,11/79,9.87%,MACIR;AJAP1;EPHA4;RORA;MAPKBP1;SERPINE1;CTNNA2;NR1D1;RNF26;ITCH;RTN4RL1
prerank,PanglaoDB_Augmented_2021__Pericytes,-0.3743150873306724,-0.9420292143412246,0.573170731707317,1.0,1.0,14/111,7.57%,LMOD1;PDE5A;HSD11B1;APLNR;SPARC;IGFBP5;P2RY14;AQP1;COL6A2;COX7A1;ANGPTL2;ECM2;ADM;ELN
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),-0.47921655054473133,-0.9420026119701452,0.4861111111111111,1.0,1.0,1/16,3.41%,SLC5A10
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),0.33175907309537106,0.9417359761549473,0.6666666666666666,0.8209404954689544,1.0,20/61,17.23%,ZFPM2;FOXO1;RORA;FTO;BMP2;LMO3;TRPM4;FRZB;AKT1;NR1D1;ANKRD26;RUNX1T1;ZBTB16;SIRT1;SIRT2;TAF8;WDFY2;YAP1;TRIB2;TRIO
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),-0.48039311697992526,-0.941539549783161,0.5921052631578947,1.0,1.0,2/16,5.51%,SVIL;VIL1
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),-0.48039311697992526,-0.941539549783161,0.5921052631578947,1.0,1.0,2/16,5.51%,SVIL;VIL1
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.38914999766831193,0.9413189679824603,0.4642857142857143,0.8212958376314263,1.0,14/29,22.17%,PCDHB2;CDH11;ATP2C1;CDH20;CDH9;PCDHB13;CDH13;CDH18;CDH8;CDH6;CDH19;NLGN1;CDH10;DCHS1
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.3287999277449337,0.9408214807319879,0.6666666666666666,0.8221184648619597,1.0,14/96,9.54%,TCAP;ZFPM2;MITF;ADPRHL1;PNMT;RBM24;ENO3;RRAD;ADIPOR2;PRKG1;CASQ1;STRN;TRIM54;CORO6
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),0.5838405043532104,0.9403988305878102,0.6666666666666666,0.8226004519590331,1.0,3/6,3.46%,DNM3;SNAP91;PICALM
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.4394213193603144,0.9396816054932554,0.5,0.8236256540055333,1.0,5/17,18.27%,AKT1;PRKN;SIRT1;HIF1A;NFE2L2
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),0.4694353972206771,0.9393868664384499,0.5882352941176471,0.8238603344618919,1.0,7/16,17.21%,ANK2;CACNA2D1;CASQ1;CBARP;CAMK2D;UBASH3B;FYN
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),0.33651074141397097,0.9393735352798082,0.6129032258064516,0.8235431616495392,1.0,1/47,0.06%,VAPB
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.487076224157585,0.9392858905880472,0.5454545454545454,0.8233619967315944,1.0,7/17,18.73%,FUT9;CSGALNACT1;EXT1;EXT2;HS2ST1;B3GALT1;NDST1
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),0.3919634777407804,0.9390031655733053,0.4722222222222222,0.8235540876522106,1.0,9/31,19.69%,EPHA4;PICALM;BIN1;NTRK2;IGF1;ABCA2;ROCK2;CASP3;ROCK1
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.3964764492009934,0.9386866826506104,0.5652173913043478,0.8238900996934849,1.0,5/42,5.63%,CARD18;FOXP1;STMP1;GIT1;FZD5
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),0.4007567082297556,0.9385460279056338,0.6216216216216216,0.8238445741241536,1.0,2/25,4.53%,TNFSF13B;CD22
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),-0.38898462587887483,-0.9385419183112353,0.5909090909090909,1.0,1.0,2/91,3.13%,GBP2;RPL11
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),0.2893866395967963,0.9383533289178916,0.8888888888888888,0.8239515197081506,1.0,39/184,18.38%,PPARGC1A;ADCY1;IRAK2;TAB3;RPS6KA4;RGCC;NFKB1;HCLS1;ZIC2;AKT1;CAMK2A;UBE2N;EPHA5;ROR1;MAP3K7;TICAM1;CLOCK;TAB1;LRP8;EP300;CFLAR;PRKD1;TRADD;RNF25;PLPP3;HDAC4;HIPK2;FER;DHX9;CRTC2;JMY;SMO;TFRC;ATF2;KDM1A;BCL10;TRIM8;PTEN;CIB1
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),0.4222093697258784,0.9382899994217763,0.6176470588235294,0.8237536419029555,1.0,6/23,15.77%,PPP1R36;PPP1R1B;PPP4R4;GPATCH2;GSK3B;SEMA4D
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),-0.600685107033458,-0.9380749021266183,0.5846153846153846,1.0,1.0,2/6,16.26%,CEACAM1;XBP1
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),0.396764534850305,0.9380615850942355,0.4827586206896552,0.8237843845638025,1.0,7/27,15.11%,ANK2;MGLL;GRK3;CDC42SE2;CAMK2D;GRK4;YWHAG
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),-0.6179761374448947,-0.9380245643632642,0.639344262295082,1.0,1.0,2/7,19.68%,EMP3;EMP2
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),0.5234675324945443,0.9377133497622642,0.4857142857142857,0.8242125966789691,1.0,3/7,16.46%,B4GALT3;GAL3ST1;B3GALT1
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),0.5507785725596542,0.9375621090807027,0.6097560975609756,0.8242177519950706,1.0,4/6,32.54%,RAB11FIP2;PTPRN2;RAB11B;SELENOT
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),-0.6051391561976944,-0.9375564594230825,0.6551724137931034,1.0,1.0,1/5,11.69%,CD14
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),-0.6051391561976944,-0.9375564594230825,0.6551724137931034,1.0,1.0,1/5,11.69%,CD14
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.3472305535682267,0.9374834057107115,0.5,0.8239947524280835,1.0,7/26,16.31%,ELOVL7;HACD2;SCD5;ELOVL6;ELOVL5;HACD1;ACSBG1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.3889966825971531,0.9373339367732467,0.5365853658536586,0.8239915515536318,1.0,5/24,13.93%,CRADD;SORT1;TNFRSF10B;TRADD;BCL2
prerank,GO_Biological_Process_2021__succinyl-CoA metabolic process (GO:0006104),0.5340933814305606,0.9369828674988513,0.5777777777777777,0.8244864713799265,1.0,3/5,29.40%,SUCLG2;SUCLA2;OGDH
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.36740589899320164,0.9367921598632772,0.5263157894736842,0.8245421329502247,1.0,11/47,15.60%,ZSWIM6;ERBB4;EGFR;ARAP1;ZSWIM5;ABL2;MEMO1;NRG2;TGFBR1;ROCK2;NRG1
prerank,GO_Biological_Process_2021__aromatic compound catabolic process (GO:0019439),0.5762089527871708,0.9366720595822041,0.6046511627906976,0.8243868624467916,1.0,1/6,7.50%,PON2
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),0.538201844942975,0.9366037430235342,0.6222222222222222,0.8241642730651401,1.0,3/7,7.34%,EGFR;MME;AKT1
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),0.37446590880045205,0.9362447138828138,0.48148148148148145,0.8244644150244727,1.0,6/31,12.84%,LPIN3;AGMO;PNPLA4;GPAM;GK;SIRT1
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",-0.5954063697358017,-0.9361283417470515,0.5833333333333334,1.0,1.0,1/7,4.33%,P2RY12
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),0.524895294515819,0.9361169184089024,0.6046511627906976,0.8243851994984607,1.0,3/6,20.68%,PRMT1;SLC6A9;ABCB10
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),0.3890358098295352,0.9358297807633192,0.6071428571428571,0.8245923576824152,1.0,9/19,30.36%,CLASP1;SLAIN2;TUBG1;CSNK1D;CLASP2;TUBGCP6;TUBGCP3;TPPP;RANBP9
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.4263678557230554,-0.9358201029426022,0.5652173913043478,1.0,1.0,8/43,15.55%,RASGRP1;THBS1;CD14;OAS3;LY96;TLR3;CLU;WNT5A
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.30956195536674747,0.9355386580294633,0.5294117647058824,0.8249171758072554,1.0,23/90,16.41%,SNCA;RAP2B;SMCR8;AGAP2;MMD;PPM1E;GSKIP;RAPGEF2;AKT1;SPRED1;DUSP19;TAB1;CAMK2N1;NF1;DVL1;PTK2;SIRT1;RAP1A;RAP2C;YWHAG;GNAQ;UBASH3B;TRIB2
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),0.3195725855618277,0.9352884000008016,0.5909090909090909,0.8251828186719671,1.0,14/64,14.98%,VEGFD;RGCC;BMP2;NRP2;AKT1;VEGFC;NF1;PRKD1;ECM1;NRAS;SIRT1;TGFBR1;CDH13;NRP1
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),0.48404049369181623,0.9352192970705347,0.5609756097560976,0.82462901865633,1.0,2/8,8.09%,ERI1;ERI3
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",0.48404049369181623,0.9352192970705347,0.5609756097560976,0.82462901865633,1.0,2/8,8.09%,ERI1;ERI3
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),0.45102219437944113,0.9351671263524007,0.6388888888888888,0.8243734839945376,1.0,3/12,24.15%,VCP;IDE;PRDM16
prerank,GO_Biological_Process_2021__regulation of flagellated sperm motility (GO:1901317),-0.6125928116631332,-0.9351272944458977,0.6153846153846154,1.0,1.0,1/5,8.46%,TACR1
prerank,GO_Biological_Process_2021__positive regulation of cilium-dependent cell motility (GO:2000155),-0.6125928116631332,-0.9351272944458977,0.6153846153846154,1.0,1.0,1/5,8.46%,TACR1
prerank,GO_Biological_Process_2021__positive regulation of flagellated sperm motility (GO:1902093),-0.6125928116631332,-0.9351272944458977,0.6153846153846154,1.0,1.0,1/5,8.46%,TACR1
prerank,GO_Biological_Process_2021__positive regulation of cilium movement (GO:0003353),-0.6125928116631332,-0.9351272944458977,0.6153846153846154,1.0,1.0,1/5,8.46%,TACR1
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.46529187689930607,-0.9348709739325016,0.5373134328358209,1.0,1.0,7/17,26.86%,FGF1;APOE;RAN;SREBF1;SEC14L2;ERLIN2;SREBF2
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.5106467591481345,-0.9346906757255635,0.5753424657534246,1.0,1.0,3/14,11.51%,CMPK2;ENTPD3;AK7
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),-0.6180392933786492,-0.9345834920307964,0.625,1.0,1.0,1/6,6.67%,THBS1
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.47447560811857953,-0.934468076974785,0.5967741935483871,1.0,1.0,4/19,15.12%,CXCL2;PPIB;CCL2;CX3CL1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),0.428311087287605,0.9339610560230588,0.5641025641025641,0.8267470299576172,1.0,2/17,4.38%,EPHA7;GRIN1
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.2715446177267912,0.9334732321525006,1.0,0.8275150264440342,1.0,44/231,20.33%,NUDT21;SNRPF;USP49;WDR33;PAPOLA;HNRNPH1;CSTF3;RAVER2;PSPC1;SART1;HNRNPU;DHX15;HNRNPC;SNRPN;SPEN;LSM8;U2AF1;CTNNBL1;SYNCRIP;RBM15B;HNRNPH3;ZMAT5;SMNDC1;DHX9;U2AF2;PRCC;PRPF40B;RBM17;RBM41;PRPF40A;CCAR1;SF3B3;RBM6;PTBP1;TRA2A;CWC27;ELAVL2;HNRNPD;NOVA1;SMU1;RALY;GTF2F2;NOVA2;CD2BP2
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",-0.44586845165002575,-0.9333252700745293,0.5882352941176471,1.0,1.0,3/24,10.57%,RHOBTB2;THBS1;RHOH
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),0.3594333944970679,0.9332661621187935,0.6190476190476191,0.8275774602753571,1.0,11/41,16.02%,RGCC;LIMCH1;PPM1E;PLEK;TESK1;CARMIL1;ARHGEF10L;TGFBR1;NRP1;ROCK2;PXN
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),-0.5426508956198192,-0.933047809877563,0.5692307692307692,1.0,1.0,1/6,12.27%,SRF
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.3406883318808318,0.9329838867754121,0.6363636363636364,0.8278411532761684,1.0,13/61,19.45%,IRAK2;ANXA4;ARRB1;ITCH;PSMD10;SIRT1;MAP2K5;COMMD1;HAVCR2;FAF1;BMP7;TAX1BP1;OTULIN
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.2526795563023099,0.9328433051197829,1.0,0.8278111639416909,1.0,62/257,18.50%,SLC24A3;FOXP1;HDAC9;KAT2B;NPTN;EED;ABCC2;PICALM;RPS6KA4;CPEB3;RIDA;VHL;SMCR8;AEBP2;ITGB8;RGCC;BMP2;NOTCH2;NFKB1;CNOT9;TASOR;LGR4;ROBO1;SFMBT2;IGF1;PRKN;SYNCRIP;HELLS;TNRC6B;ZNF148;FBXW7;STOX1;ZC3H12D;IGF2BP2;OCLN;CRKL;SIRT1;CAPRIN1;AGO3;ATP2B4;HAVCR2;BMPR1A;YAP1;ROCK2;PTBP2;SMO;FXR1;RBBP4;HIF1A;NDFIP1;CELF1;CNOT8;JARID2;YTHDF2;RUNX1;PTBP1;PPHLN1;RBMS3;YY1;PPM1D;CPNE1;LSM14A
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),-0.45259254161268525,-0.9323775571455121,0.4925373134328358,1.0,1.0,5/27,18.77%,AQP1;LRRC19;POU2F3;SNW1;SAP30
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.45853991102188124,0.9323691987243437,0.5853658536585366,0.8283762381253204,1.0,5/11,31.04%,HMGB1;AKT3;FGF2;PDPK1;MDK
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),0.41156183004433344,0.9323455641504629,0.5833333333333334,0.8280947280522165,1.0,10/18,24.52%,CBL;SRCIN1;SH3BP5L;CBLB;DUSP22;TSG101;CHMP6;ERRFI1;PTPRC;SOCS4
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),-0.5648924391407101,-0.9319851605051568,0.5686274509803921,1.0,1.0,1/6,4.67%,BHMT
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),0.4133526287429519,0.9319153818621495,0.631578947368421,0.8285922046533065,1.0,4/21,18.11%,EXOSC6;NEIL2;POT1;SMUG1
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),0.3694578706955467,0.9317355102907313,0.48148148148148145,0.8286623835139342,1.0,2/23,2.55%,MICAL1;NCKAP5
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),0.5187503190000177,0.9315198136421328,0.5777777777777777,0.8288161658534786,1.0,1/7,5.33%,NCSTN
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),0.256650808391987,0.9314250002105945,1.0,0.8286603927165684,1.0,52/273,17.89%,SPAG16;FHDC1;MACIR;CEP152;ZMYND10;PARVA;CILK1;EXOC2;SEPTIN6;RAB3IP;EHD4;CYS1;RFX3;CEP97;RAB8B;RAB23;SSX2IP;EXOC5;TTBK2;CEP290;NEDD1;CSNK1E;BBS10;EXOC8;TRIP11;EXOC6;DZIP1;TTC8;DYNLL2;PLK1;C2CD3;CKAP5;SEPTIN7;KIAA0586;EXOC4;BBS9;CLASP1;MAPRE1;ALMS1;CEP20;RP2;YWHAG;LZTFL1;TOGARAM1;CDC14A;RAB1A;TNPO1;ATAT1;MKKS;BBS2;RPGRIP1L;TUBG1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),0.36578014587584406,0.9310244997106215,0.6956521739130435,0.8291149746519528,1.0,12/47,16.30%,NAF1;GNL3L;HNRNPU;CCT4;HNRNPC;STN1;MAP3K4;TENT4B;MAPKAPK5;MAPK1;CCT3;POT1
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),-0.5886644596209456,-0.9309028106735502,0.6229508196721312,1.0,1.0,4/5,30.57%,GINS3;MCMDC2;MCM3;MCM4
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),-0.5886644596209456,-0.9309028106735502,0.6229508196721312,1.0,1.0,4/5,30.57%,GINS3;MCMDC2;MCM3;MCM4
prerank,PanglaoDB_Augmented_2021__Leydig Cells,0.2924381542179015,0.9307950024028653,0.75,0.8294020538587948,1.0,14/101,9.70%,POSTN;SASH1;PDZRN3;EGFR;ESRRG;DCN;CXCL12;PARVA;PDGFRA;CDH11;FRZB;MAOA;PRICKLE2;IGF1
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.40037566409341996,0.9305190336590686,0.46153846153846156,0.8296554783854379,1.0,4/23,12.21%,ADCY1;LGR4;ADRB1;ADRB2
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.38625646205390624,-0.9304523753871105,0.6024096385542169,1.0,1.0,5/54,11.79%,CFTR;RPS27A;ATG14;UBC;LGALS8
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.5573877968074061,0.9303676559524647,0.4864864864864865,0.8296582325053723,1.0,3/8,6.62%,EPHA4;PICALM;BIN1
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.4184291314326273,-0.9302819213894313,0.6216216216216216,1.0,1.0,5/28,14.67%,GBP1;PDZK1;GPC3;VAMP8;CDK5
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),-0.5825963425591423,-0.9300569787814198,0.5555555555555556,1.0,1.0,2/6,24.97%,MVK;HMGCR
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.5126108649259925,0.9299479036833593,0.6060606060606061,0.8303369165471189,1.0,6/11,18.55%,RAB27A;KIF5A;KIF5C;SYNJ1;TMEM230;DNM2
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),-0.4816474665927317,-0.929874764099826,0.5409836065573771,1.0,1.0,1/15,4.33%,P2RY12
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),0.48052429291309423,0.9296558906730863,0.5,0.8306563439643289,1.0,3/8,20.76%,BMP2;NRG1;MESP1
prerank,GO_Biological_Process_2021__purine deoxyribonucleotide catabolic process (GO:0009155),0.5443447932218106,0.9295706258384012,0.5897435897435898,0.8304335478255611,1.0,2/5,6.34%,SAMHD1;NT5C1A
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),0.6158653446267862,0.9294973828281713,0.6,0.8298552396219222,1.0,4/5,31.40%,RBBP4;ASF1A;HAT1;NASP
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),0.6158653446267862,0.9294973828281713,0.6,0.8298552396219222,1.0,4/5,31.40%,RBBP4;ASF1A;HAT1;NASP
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",-0.6205157280213354,-0.9294313030354072,0.6507936507936508,1.0,1.0,1/5,2.71%,HLA-A
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),0.402654343083618,0.9292876398585237,0.6046511627906976,0.829949497827955,1.0,1/18,0.14%,TCAP
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),0.38585872056794923,0.9292745139785895,0.5,0.829619181455947,1.0,6/22,16.94%,WNT7A;SNCA;PIP5K1C;STX1A;SLC32A1;PCLO
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.5353766660107775,0.9292138326949275,0.5416666666666666,0.8293973057892385,1.0,2/6,14.98%,ABCA1;NRP1
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.3498083388594187,-0.9292013148264421,0.7263157894736842,1.0,1.0,35/335,13.86%,FTH1;FLG2;AGPAT2;BST2;MMP25;HLA-B;FTL;CD63;CLEC12A;B2M;DSC1;LRRC7;HLA-C;CEACAM1;PNP;PRSS3;HRNR;TMC6;GMFG;ALDH3B1;GLIPR1;GSTP1;PRDX4;ARHGAP9;PSMC3;VAMP8;CTSH;CD14;AGA;SVIP;NIT2;CST3;PGLYRP1;CSTB;SLC11A1
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.29450985856100037,0.9291914550269683,0.6,0.8290758244510436,1.0,17/73,19.09%,CDC25A;EGFR;RGCC;MEN1;CCNG2;AKT1;CCNA2;CDK5R2;PSMD10;PKD2;PLK1;LATS1;CCNT2;PTEN;CDK5R1;CCND3;IPO5
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),0.4394551414732243,0.9287743209980399,0.5294117647058824,0.8296108295783177,1.0,5/17,13.32%,HNRNPU;CHMP1A;CEP97;PLK1;CHMP2B
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.41491783648491287,-0.9286493876125934,0.5405405405405406,1.0,1.0,3/35,14.29%,WARS1;GARS1;NARS1
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.5595053434027688,0.9285985014793112,0.6086956521739131,0.82963851737616,1.0,2/5,25.29%,HIP1;PTPN2
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.349493058116243,-0.9284877811930493,0.7157894736842105,1.0,1.0,35/338,13.86%,FTH1;FLG2;AGPAT2;BST2;MMP25;HLA-B;FTL;CD63;CLEC12A;B2M;DSC1;LRRC7;HLA-C;CEACAM1;PNP;PRSS3;HRNR;TMC6;GMFG;ALDH3B1;GLIPR1;GSTP1;PRDX4;ARHGAP9;PSMC3;VAMP8;CTSH;CD14;AGA;SVIP;NIT2;CST3;PGLYRP1;CSTB;SLC11A1
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.3490953249710249,-0.928285342770152,0.7157894736842105,1.0,1.0,35/337,13.86%,FTH1;FLG2;AGPAT2;BST2;MMP25;HLA-B;FTL;CD63;CLEC12A;B2M;DSC1;LRRC7;HLA-C;CEACAM1;PNP;PRSS3;HRNR;TMC6;GMFG;ALDH3B1;GLIPR1;GSTP1;PRDX4;ARHGAP9;PSMC3;VAMP8;CTSH;CD14;AGA;SVIP;NIT2;CST3;PGLYRP1;CSTB;SLC11A1
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),-0.5839674888072632,-0.9280856272344505,0.5806451612903226,1.0,1.0,3/7,15.19%,PNP;ABCG2;PRPS1
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.47604933122555876,-0.9278388812720118,0.5384615384615384,1.0,1.0,4/17,15.12%,CXCL2;PPIB;CCL2;CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),-0.5508961765514844,-0.927835016668174,0.6896551724137931,1.0,1.0,2/8,14.15%,RDX;DTX3L
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),-0.5508961765514844,-0.927835016668174,0.6896551724137931,1.0,1.0,2/8,14.15%,RDX;DTX3L
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),-0.5508961765514844,-0.927835016668174,0.6896551724137931,1.0,1.0,2/8,14.15%,RDX;DTX3L
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),0.346895159358778,0.9276324653028813,0.6818181818181818,0.8311611952609025,1.0,12/51,19.92%,SDE2;RFWD3;PLK1;FOXN3;TAOK2;UIMC1;EME2;BRCC3;TICRR;ATF2;FBXO31;WAC
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),0.5143965294215593,0.9274591014169484,0.6,0.8311466870029633,1.0,2/10,2.61%,XPO1;LTV1
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.304463181052746,0.9273305593905811,0.6190476190476191,0.8310823998764292,1.0,20/118,12.19%,TENM3;ABCC8;MPDZ;ANK2;PDZRN3;MEIS3;LIMCH1;CACNA2D1;FRZB;PRICKLE2;GUCY1A2;RBFOX2;HSPA12A;GFRA1;TLN2;PKDCC;SLIT2;ZNF423;PLPP3;ADGRL2
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.35462268689888743,0.9273204741481224,0.7142857142857143,0.8307610225458887,1.0,14/40,20.79%,BTRC;RCN3;RHBDD1;CYFIP2;HDAC2;PLK1;OGT;ASPH;TBC1D10A;FBXW11;BAG2;ADAM9;WDR48;FURIN
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.5244886481421213,-0.9271722711313368,0.6,1.0,1.0,1/8,3.55%,ZNF593
prerank,GO_Biological_Process_2021__negative regulation of interleukin-17 production (GO:0032700),0.5559763097543112,0.9266246973327708,0.6363636363636364,0.8318660512066108,1.0,1/5,1.50%,TNFSF4
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),0.49455095616564004,0.9265401258110466,0.5625,0.8316606448407524,1.0,3/9,15.87%,AIFM2;PRKN;BMP7
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),0.315633856165892,0.9265006829053206,0.5,0.8313311475284288,1.0,21/90,20.74%,PPARGC1A;SNRPF;DHX15;HNRNPC;SNRPN;CDK12;U2AF1;SYNCRIP;CELF3;MBNL1;HNRNPH3;ZMAT5;SMNDC1;SF3B3;SRPK2;PTBP1;NOVA1;SMU1;USB1;PPP2R1A;PPIG
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.3991967007822183,-0.9262978724935551,0.569620253164557,1.0,1.0,13/45,15.19%,SLC3A1;CFTR;AQP1;CXCL2;EFNA1;S100A10;CTSH;TRIM29;GPX2;ONECUT1;B3GNT3;CCL2;ERBB3
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),0.4610179008826554,0.9262731528209676,0.5641025641025641,0.8313497274452638,1.0,3/10,15.38%,SORT1;AP1G1;CCDC91
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),0.4208428986255922,0.9261846000789962,0.5909090909090909,0.8311779125991793,1.0,5/13,9.15%,TNFSF4;FZD5;TRPM4;SMAD7;MAP3K7
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.45674973110884953,0.9259677107843879,0.48,0.8312213633789558,1.0,8/17,19.45%,SORT1;NTRK2;RAPGEF2;SOS1;MAGI2;RAP1A;BCAR1;CASP3
prerank,GO_Biological_Process_2021__benzene-containing compound metabolic process (GO:0042537),-0.5686582104524952,-0.9257974142595291,0.5892857142857143,1.0,1.0,1/7,1.71%,KMO
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),0.32168616948980566,0.9257062081074449,0.65,0.8315459675248327,1.0,8/56,14.87%,TNFSF4;SNCA;SERPINE1;NPAS2;AKIRIN2;TRADD;DHX9;PDE2A
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),-0.5946265384346572,-0.9256516281116881,0.6415094339622641,1.0,1.0,1/5,4.45%,PDZK1
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.49657889336840333,-0.925649427628648,0.5555555555555556,1.0,1.0,4/19,9.18%,AKR1C1;SLC51B;CEACAM1;SLC51A
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.3211295669962402,0.9255475100494365,0.5238095238095238,0.831498290207891,1.0,31/83,28.56%,PICALM;STXBP5;CD22;RAB33B;ABL2;RAB8B;ATP9A;DNAJC13;RAB21;OPHN1;MAPK1;CDH13;NRP1;HIP1;NSF;RAB4A;MAP2K2;RAB10;RIMS2;SCFD1;RUFY2;RAB12;PTPRC;ZFYVE16;RAB5A;RALA;MAPK3;RAB15;USP7;RUFY1;SEPTIN2
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.449980860793899,0.9253905855178757,0.5,0.8314919697868252,1.0,2/12,11.70%,RPP40;ZC3H12D
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),-0.6159712020497867,-0.9248356354248818,0.6086956521739131,1.0,1.0,3/5,28.71%,PRKCQ;IL12RB1;NFKBID
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),-0.4868922289578085,-0.9246463411862925,0.5857142857142857,1.0,1.0,1/15,2.03%,GBP1
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,0.31572764206525283,0.9244590966818571,0.5,0.8332945430346181,1.0,18/80,11.24%,POSTN;HMCN1;FAT4;ACTA2;DCN;CXCL12;PDGFRA;VSTM4;MSRB3;CDH11;CACNA2D1;PRKG1;PCDH18;PRRX1;FAP;SSC5D;RUNX1T1;SLIT2
prerank,MSigDB_Hallmark_2020__Pperoxisome,0.30693569738471377,0.9244187934886531,0.8095238095238095,0.8330067525170575,1.0,22/90,17.81%,ABCC8;CACNA1B;PEX11A;CADM1;PEX14;ABCC5;SEMA3C;ISOC1;ELOVL5;PEX2;NUDT19;HSD17B4;PEX5;ABCD3;CRAT;STS;MSH2;SMARCC1;PEX6;IDE;PEX13;BCL10
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.3081841406164506,0.924279772326521,0.6428571428571429,0.8328925141008359,1.0,8/63,12.69%,TUB;SNCA;RAB27A;BOK;NEDD4L;DOC2B;CLIP3;MERTK
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.408950060580729,-0.924217841887077,0.5277777777777778,1.0,1.0,8/29,28.56%,RPA3;POLE4;POLE3;MCM5;CDK2;NOC3L;ORC3;MCM3
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.48867166374379195,-0.9241889673141551,0.576271186440678,1.0,1.0,4/14,25.98%,COX20;SURF1;COA3;OXA1L
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.5590763484668633,-0.9239667119284989,0.6101694915254238,1.0,1.0,2/7,18.50%,SFRP1;BTG1
prerank,GO_Biological_Process_2021__regulation of adherens junction organization (GO:1903391),-0.5789842440893764,-0.9235732400872166,0.6031746031746031,1.0,1.0,1/5,9.23%,RDX
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),0.5903279482872213,0.9224984044567389,0.6904761904761905,0.8360615744615512,1.0,5/6,40.98%,SENP1;SENP6;SENP2;SENP7;SENP5
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,-0.38267323853337615,-0.9224396273582957,0.6081081081081081,1.0,1.0,14/67,22.31%,ADH4;CD9;MVK;SQLE;CLU;HSD17B7;FDPS;DHCR7;ACAT2;PDK3;FASN;SEMA3B;TM7SF2;TNFRSF12A
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.3260046768639143,0.9223684200141291,0.6470588235294118,0.8359956119403773,1.0,20/85,19.82%,EGLN3;SNCA;CRADD;BOK;CASP10;ROBO1;TNFRSF10B;HMGB1;CFLAR;TRADD;MAP3K5;ANP32B;SIRT1;VCP;HIP1;BCL10;AIFM1;PPM1F;FAS;REST
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),-0.44767425198975563,-0.9222406560562825,0.6527777777777778,1.0,1.0,3/20,12.55%,LIPI;PNPLA3;FABP3
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.28545881114935673,0.9222053945970445,0.75,0.8359956433993735,1.0,62/168,25.34%,ANK2;ARL5A;TSPAN17;TSPAN14;PACS1;EHD4;EPHA2;DENND4C;TNIK;RAPGEF2;DLG3;EFR3A;RAB8B;NRXN1;ABHD17A;BRAF;SHANK3;DVL1;MRAP;TTC7B;BSG;SMURF1;MAGI2;RAP1A;TSPAN33;NDC1;DLG1;SH3PXD2B;TM9SF3;SCRIB;TM9SF4;ROCK2;RAP2A;CACNB3;LIN7C;NRXN2;MYO5A;WNK3;FRMPD1;ROCK1;RAB10;TSPAN5;SLMAP;ZDHHC2;NLGN1;P2RY1;TTC7A;DPP6;FGF13;LIN7A;RAMP1;NUP54;SH3GLB1;RAB12;RAPGEF6;NLGN2;PICK1;GAS6;ARL3;CPE;SPTBN4;PACS2
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),0.3966134928444089,0.9221741743108103,0.5666666666666667,0.8357897057186546,1.0,5/24,12.97%,ARL5A;RAB33B;ARFRP1;GOLPH3;BICD2
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),0.4631326644756147,0.9219672715547497,0.5142857142857142,0.8352716781455785,1.0,3/12,13.41%,ZNF207;PLK1;BUB3
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),0.4631326644756147,0.9219672715547497,0.5142857142857142,0.8352716781455785,1.0,3/12,13.41%,ZNF207;PLK1;BUB3
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),0.4631326644756147,0.9219672715547497,0.5142857142857142,0.8352716781455785,1.0,3/12,13.41%,ZNF207;PLK1;BUB3
prerank,PanglaoDB_Augmented_2021__Germ Cells,-0.3873355812153595,-0.9219208221648807,0.6385542168674698,1.0,1.0,21/83,22.14%,LDHC;GAPDHS;TSKS;BCL2L14;WDR87;TEKT1;DNAAF1;SPATA12;MOV10L1;SORD;DEPDC4;BRCA1;AQP11;SMC1B;GSG1;TSACC;CREB3L4;SPATA24;GGNBP1;SPATA18;MS4A5
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),-0.424724782693172,-0.9216478039289275,0.6,1.0,1.0,7/29,25.79%,TAF1D;POLR2L;POLR1C;POLR2K;TTF1;TBP;CDK7
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),0.42023591003988203,0.9215035929715086,0.48484848484848486,0.8357737300432867,1.0,5/15,26.43%,METTL8;ZC3H13;CBLL1;WTAP;NSUN2
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),0.5196779722414367,0.9211258638392178,0.5476190476190477,0.8363082427584553,1.0,2/7,6.56%,NMNAT2;KYNU
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.43334381701205327,-0.9209124081028679,0.6081081081081081,1.0,1.0,4/39,10.62%,ISG15;RPS27A;RPA3;UBC
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),0.48284222026384316,0.9208970300607289,0.6060606060606061,0.8364231921924229,1.0,4/12,18.16%,PUDP;UCK2;DCK;UPP1
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),0.5315952838998408,0.9205245945724931,0.5,0.8369405500887812,1.0,2/6,2.61%,XPO1;LTV1
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),0.5328263797773817,0.9205139831143092,0.575,0.8366363779416299,1.0,1/6,6.79%,GPHN
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),0.3463064713477424,0.9204522046514353,0.6,0.8363817073773947,1.0,7/29,13.91%,EGFR;RGCC;AKT1;PLCB1;ANKRD17;UBE2E2;RPTOR
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.35719244072363526,0.9204302441036758,0.5263157894736842,0.8360452117070012,1.0,7/25,17.52%,MEN1;OGT;WDR5B;KMT2C;CXXC1;WDR82;ASH2L
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),-0.5058932725510963,-0.920082296192901,0.6271186440677966,1.0,1.0,3/13,19.62%,CD9;SP100;SPINT2
prerank,GO_Biological_Process_2021__thiamine-containing compound metabolic process (GO:0042723),0.5597314429376814,0.9198594511640186,0.5428571428571428,0.8368078724616772,1.0,2/5,17.50%,TPK1;SLC19A2
prerank,GO_Biological_Process_2021__double-strand break repair via synthesis-dependent strand annealing (GO:0045003),-0.6138827565556783,-0.9198266039980484,0.6326530612244898,1.0,1.0,4/5,37.74%,XRCC3;FANCM;RAD51;RAD54L
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),0.4263354076916926,0.9197895183800119,0.6111111111111112,0.8365698458627531,1.0,8/27,21.58%,VPS37B;CHMP1A;VPS37A;CHMP2B;VTA1;STAM2;TSG101;CHMP6
prerank,GO_Biological_Process_2021__regulation of guanyl-nucleotide exchange factor activity (GO:1905097),0.5819538359133508,0.9195633903804039,0.673469387755102,0.836799056793,1.0,1/5,14.05%,CCPG1
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),0.27364659583724704,0.9194713817074357,1.0,0.8366349460438307,1.0,48/270,14.59%,ITGA1;NCK2;PTPRK;KLF11;KAT2B;ERBB4;SOX4;MARVELD3;VHL;RGCC;PLPP1;SOX9;BMP2;CHD5;DUSP10;PDS5B;MEN1;FRZB;RAPGEF2;DLG3;STRN;ZBTB7C;SMARCA2;RPS6KA2;DNAJB2;BMPR1B;MAGED1;FAP;MORC3;ADRA1A;PKD2;ZNF268;PTPRJ;CAMK2N1;MTSS1;ADARB1;NF1;PEX2;MAGI2;ABI1;DLG5;SIRT2;PRKRA;TENM1;PTPN14;VGLL4;MDM4;CDH13
prerank,GO_Biological_Process_2021__phospholipid homeostasis (GO:0055091),-0.5388050256077523,-0.9189391143166655,0.5970149253731343,1.0,1.0,3/8,12.55%,TLCD1;ANGPTL3;FABP3
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),0.485542190992059,0.918569391019438,0.5714285714285714,0.838247493950916,1.0,2/8,1.52%,AK3;AK1
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.3726019477848574,-0.9184301562431486,0.6153846153846154,1.0,1.0,1/71,0.04%,SLC28A2
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),0.47170107752962426,0.9182225170943056,0.5365853658536586,0.8385902753773478,1.0,6/10,24.91%,ABHD17B;ABHD17A;LYPLA2;LYPLAL1;ABHD17C;ABHD10
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.41552687758750007,0.9180576831927653,0.5476190476190477,0.8385810351855355,1.0,2/15,6.64%,NEDD4L;SLC12A2
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),-0.4412531012839055,-0.9180267740478464,0.5822784810126582,1.0,1.0,1/28,0.44%,POU4F1
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),0.5237654153768673,0.9178620076436986,0.6111111111111112,0.8385799791672542,1.0,5/10,22.73%,GIT1;CKAP5;ARHGEF7;HSPA1A;MECP2
prerank,GO_Biological_Process_2021__mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),-0.6063642286021178,-0.9177940722780543,0.631578947368421,1.0,1.0,2/5,23.59%,CPSF3;ZNF473
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),-0.5712466494367618,-0.9177933719225971,0.6851851851851852,1.0,1.0,1/7,14.55%,CLU
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),-0.5501822159233652,-0.917736288495229,0.5873015873015873,1.0,1.0,2/8,17.83%,SIGIRR;KLF4
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),0.5260986321133609,0.9176811994233779,0.5526315789473685,0.8382184104198196,1.0,3/6,16.46%,B4GALT3;GAL3ST1;B3GALT1
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),0.5260986321133609,0.9176811994233779,0.5526315789473685,0.8382184104198196,1.0,3/6,16.46%,B4GALT3;GAL3ST1;B3GALT1
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),-0.6141641281474581,-0.9174621001893887,0.6290322580645161,1.0,1.0,2/5,18.93%,PDZK1;SLC22A4
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),0.5366122545801848,0.9173930464697374,0.575,0.8384706571336944,1.0,3/8,23.00%,TESK1;IMPACT;ERRFI1
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.4477626220257418,0.917244863734056,0.5789473684210527,0.8384533238834989,1.0,2/10,14.97%,UGP2;GSK3B
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),-0.5618739080557421,-0.9168855602312972,0.5967741935483871,1.0,1.0,3/6,40.22%,ADCY8;ANAPC2;CPLX2
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.4043528449957261,-0.9168749574238655,0.6790123456790124,1.0,1.0,10/70,14.96%,CD24;RASGRP1;PAQR3;HTR2B;GSTP1;PIK3CB;CAV3;FGF1;APOE;DUSP1
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),-0.5863863440908766,-0.9167033709825144,0.6545454545454545,1.0,1.0,2/7,15.02%,CTSL;CXCR4
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),-0.5863863440908766,-0.9167033709825144,0.6545454545454545,1.0,1.0,2/7,15.02%,CTSL;CXCR4
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),-0.3748887622080989,-0.9166705893827042,0.5875,1.0,1.0,12/82,15.55%,CD24;ACKR4;PLN;TACR1;FPR3;CAV2;CAV3;FZD9;CXCR4;CALB1;FIS1;WNT5A
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.37166677504202267,-0.916655754116314,0.6419753086419753,1.0,1.0,1/73,0.04%,SLC28A2
prerank,GO_Biological_Process_2021__protein sulfation (GO:0006477),0.5679421939724889,0.9164938425480785,0.6578947368421053,0.8396435736542067,1.0,1/5,2.74%,HS3ST5
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),0.34050855774678723,0.915906448137021,0.6923076923076923,0.8403597871047218,1.0,7/37,8.75%,TLL2;MMP16;CTSK;CTSV;KLKB1;ADAMTS4;EXOC8
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),0.4672783316951629,0.9158981080188645,0.5853658536585366,0.8396798251929898,1.0,2/11,9.61%,AP3S1;AP3B1
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),0.4672783316951629,0.9158981080188645,0.5853658536585366,0.8396798251929898,1.0,2/11,9.61%,AP3S1;AP3B1
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),-0.5093455900155728,-0.9158660731458768,0.6229508196721312,1.0,1.0,2/12,11.26%,KCNB1;SFRP1
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.2601051227962882,0.9156571203323355,1.0,0.839849369880145,1.0,82/332,19.84%,PPARGC1A;SLC24A3;PID1;TNFSF4;ZNF804A;MITF;AMH;KAT2B;ANK2;RAB27A;PASK;SOX4;ACTA2;EGFR;SERPINB9;RBM24;CPEB3;ZCCHC4;ITGB8;RGCC;SOX9;BMP2;MAPK11;PHF2;MBIP;GABPA;FGF17;NTRK2;ROBO1;AKT1;CADM1;DYRK1A;KAT2A;PIK3R1;UBR5;TAF1B;RPS6KB1;IGF1;TICAM1;PRKN;CAMK2N1;LURAP1;BRAF;HNRNPLL;EP300;TNRC6B;STOX1;FUBP1;AFDN;OCLN;TENT4B;PRKAB1;TGFBR1;U2AF2;AGO3;MAPK1;PDE2A;GSK3B;YAP1;ROCK2;SMO;MAPK8;BMP7;FXR1;TFRC;HIF1A;EIF3E;ATF2;CELF1;SRPK2;RBPJ;RBMS3;NFE2L2;HNRNPD;PPM1F;NTRK3;LARP4;MAP2K2;MAPK9;ROCK1;NIBAN1;POU3F1
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),0.407001835748026,0.9156253355230599,0.5675675675675675,0.8395790957900459,1.0,2/22,2.40%,FOXP1;SNCA
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),-0.5090776305259166,-0.9154339714274207,0.6065573770491803,1.0,1.0,1/11,7.00%,SEMA5A
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.4642872412480885,0.9153197893312709,0.5384615384615384,0.8399275933001484,1.0,2/12,18.27%,HGF;NFE2L2
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.3641640053934073,0.9152405745976906,0.6,0.8397388661420511,1.0,5/26,15.12%,EAF2;HNRNPU;CDK12;NELFA;CDK13
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),-0.54169050746534,-0.9148611377762272,0.5972222222222222,1.0,1.0,2/8,9.47%,PRDX5;PRDX4
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),0.2799623312646909,0.9146668800951441,0.8461538461538461,0.8407944846752924,1.0,10/119,8.15%,ACE2;TNFSF4;FOXP1;MACIR;SNCA;MGLL;RORA;SERPINE1;NR1D2;NR1D1
prerank,GO_Biological_Process_2021__regulation of translational elongation (GO:0006448),0.596921374223457,0.9142159768151672,0.5897435897435898,0.8414346646905747,1.0,1/5,22.83%,GRM5
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),0.4102478183571021,0.9141490151575259,0.6571428571428571,0.841221168897821,1.0,6/17,13.92%,RORA;PANK2;ACADVL;TTC39B;ARV1;ABCA2
prerank,GO_Biological_Process_2021__protein localization to non-motile cilium (GO:0097499),-0.5693537564438486,-0.9139252780398194,0.5789473684210527,1.0,1.0,1/5,15.72%,ARL13A
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),-0.42104745828433326,-0.9138618950584706,0.5633802816901409,1.0,1.0,3/23,6.67%,GPR183;P2RY12;THBS1
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),0.4089518397623595,0.9138250880423464,0.48484848484848486,0.8415682526398955,1.0,3/18,4.38%,SNCA;RAB27A;GRIN1
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.36865592686216947,-0.9137463232390831,0.691358024691358,1.0,1.0,17/79,24.26%,ISG15;IRF1;TRIM21;PQBP1;CD14;POLR2L;HERC5;PTPN22;DDX41;POLR1C;POLR3G;POLR2K;NFKB2;NLRX1;NLRC5;DHX58;GAPDH
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.37320704928756143,-0.913702377574318,0.691358024691358,1.0,1.0,9/79,11.33%,CD24;SFRP2;RPS27A;SFRP4;WNT9B;UBC;WNT2B;SFRP1;WNT3
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.3101252074375627,0.9136653682145186,0.631578947368421,0.8414766548294891,1.0,9/61,12.21%,ADCY1;PRKACB;CD247;CALCB;PRKAR1B;GPR176;ADRB1;VIPR1;ADRB2
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),0.4123446890483901,0.9134247137398339,0.5348837209302325,0.8416691576639715,1.0,3/16,15.43%,MPHOSPH6;C1D;URB1
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),-0.47713555981424227,-0.9131399219595924,0.6212121212121212,1.0,1.0,5/14,33.46%,BLM;MCMDC2;MCM4;RECQL;RAD51
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),0.27473469120824723,0.9131348581293103,0.75,0.8419669505651507,1.0,36/135,19.09%,NCK2;SNCA;STXBP6;PICALM;PDE4DIP;PSMG3;EPS15;SMAD2;CASQ1;BIN1;TTC12;BBS10;PSMD11;TCF4;ANLN;SGIP1;NUP153;SAMM50;ADRB2;NCK1;DHX9;NDC1;SMAD4;HIP1;NRG1;PTGES3;IMMP2L;PXN;HSPA4;NUP205;POGZ;MKKS;AIFM1;PSMG2;AXIN1;COX7A2L
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),0.45032066250317887,0.9125003995376884,0.5925925925925926,0.8429050435796392,1.0,7/21,19.69%,SLIT1;RCC2;FAM107A;DUSP22;ROCK2;PTEN;ROCK1
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),0.5745085582156215,0.9124186345468706,0.627906976744186,0.8426995736643926,1.0,3/6,21.17%,GUCY1B1;PDE2A;PDE9A
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),-0.5456478688318719,-0.9119741813066349,0.609375,1.0,1.0,1/7,1.78%,WARS1
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),0.43518377376724854,0.9115436824767665,0.6153846153846154,0.844163174040788,1.0,2/13,8.87%,PPARGC1A;ENOX2
prerank,GO_Biological_Process_2021__tachykinin receptor signaling pathway (GO:0007217),-0.5619870851177762,-0.9111353233126327,0.6037735849056604,1.0,1.0,1/6,8.46%,TACR1
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),0.44370864750051614,0.9110356305618124,0.5365853658536586,0.8449129244310436,1.0,4/9,26.33%,NF1;SMO;SRPK3;POGLUT1
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.4813749840601944,-0.9109811859299062,0.625,1.0,1.0,2/17,4.79%,DUOX1;ANXA1
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),0.5433281502020743,0.9107981361335139,0.6222222222222222,0.8450792317037336,1.0,3/8,6.62%,EPHA4;BMP2;BIN1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),-0.5332268485922215,-0.9106800154703323,0.6,1.0,1.0,2/8,12.26%,UQCRFS1;SLC25A33
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),-0.5332268485922215,-0.9106800154703323,0.6,1.0,1.0,2/8,12.26%,UQCRFS1;SLC25A33
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.41458694810239016,-0.9103966077926677,0.6153846153846154,1.0,1.0,6/34,16.40%,IGFBP5;ANXA1;SFRP1;TLR3;CCL2;IL18
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),-0.5259305898874636,-0.9103391925625983,0.5862068965517241,1.0,1.0,2/8,10.98%,MTLN;GLRX
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),0.39784810742578175,0.9103111221448389,0.5555555555555556,0.845787520179796,1.0,3/14,9.70%,CARD18;GIT1;IGF1
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),-0.5468561436009398,-0.9101930101029132,0.5254237288135594,1.0,1.0,3/6,18.06%,CASP8;SPI1;TNFRSF10A
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),-0.4803866259256464,-0.9101700158573396,0.5882352941176471,1.0,1.0,1/13,4.79%,ANXA1
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.44503191830558636,-0.910009369810469,0.6349206349206349,1.0,1.0,7/21,18.93%,MT1H;MT1G;MT2A;MT3;MT1A;MT1E;MT1F
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),-0.45498174976580485,-0.9098440850384617,0.6,1.0,1.0,4/20,17.98%,CCDC39;TEKT1;TEKT2;DRC1
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated potassium channel activity (GO:1903817),0.5765420575510052,0.9096462317965304,0.6571428571428571,0.8466525766905996,1.0,2/5,25.65%,KCNE4;KCNE2
prerank,GO_Biological_Process_2021__negative regulation of delayed rectifier potassium channel activity (GO:1902260),0.5765420575510052,0.9096462317965304,0.6571428571428571,0.8466525766905996,1.0,2/5,25.65%,KCNE4;KCNE2
prerank,"GO_Biological_Process_2021__negative regulation of complement activation, classical pathway (GO:0045959)",-0.5846955778191824,-0.9094228369545198,0.6545454545454545,1.0,1.0,2/6,21.97%,SUSD4;CR1
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",-0.5846955778191824,-0.9094228369545198,0.6545454545454545,1.0,1.0,2/6,21.97%,SUSD4;CR1
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),0.3672450458529784,0.9093593168030716,0.5882352941176471,0.8468986969148162,1.0,9/33,19.69%,SNCA;EGFR;AGAP2;SIRT2;MDM4;SF3B3;ADGRB1;FMN2;ROCK1
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),-0.5504799180541708,-0.9089444193394565,0.6153846153846154,1.0,1.0,2/5,14.14%,RAD21L1;REC8
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432),0.5227072517581555,0.9085021142785875,0.5151515151515151,0.8484209194550232,1.0,1/6,3.28%,SLC15A3
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,0.31138534695681364,0.908393525524639,0.6111111111111112,0.8482381504559637,1.0,16/69,12.66%,PPARGC1A;ITGA1;PDE3A;LSAMP;DCN;SLC26A3;GIPC2;PDGFRA;PDE1C;CDH11;FRZB;SGIP1;MTTP;PLPP3;CNTN4;SGCD
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),0.423041436100316,0.9082338602637171,0.59375,0.8478569318128033,1.0,4/11,16.08%,NR1D1;PGM2;UGP2;PGM1
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),0.423041436100316,0.9082338602637171,0.59375,0.8478569318128033,1.0,4/11,16.08%,NR1D1;PGM2;UGP2;PGM1
prerank,GO_Biological_Process_2021__regulation of complement-dependent cytotoxicity (GO:1903659),0.5533987529937625,0.9081747684560506,0.6888888888888889,0.8476584951762883,1.0,3/5,35.06%,CD59;TGFB2;CD55
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.5071117697991399,-0.9081376800560773,0.6557377049180327,1.0,1.0,3/10,25.67%,FPR3;CR1;SLA2
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.5491567588397667,0.9080479066253204,0.7297297297297297,0.8472862887381678,1.0,3/6,18.48%,MBP;MAP2K5;WNK1
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.5491567588397667,0.9080479066253204,0.7297297297297297,0.8472862887381678,1.0,3/6,18.48%,MBP;MAP2K5;WNK1
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),-0.4441288261994063,-0.9079193934153902,0.5645161290322581,1.0,1.0,1/25,0.19%,PIF1
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,-0.41981321113180126,-0.9079067763097369,0.6619718309859155,1.0,1.0,11/35,18.59%,CLEC12A;IGSF6;CXCL2;CD14;TNFAIP2;SLC11A1;SPI1;PLET1;MYO1F;PTAFR;CLEC5A
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),0.38134967444446977,0.9077169333299966,0.6875,0.8476682567497869,1.0,4/24,11.69%,AK1;DUT;GSR;AK6
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),0.42303603574677917,0.9076439656608943,0.6285714285714286,0.8475346359707412,1.0,3/14,15.61%,ACER3;HEXB;NEU3
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.44230746247196495,-0.9075067439206222,0.625,1.0,1.0,3/26,10.62%,CFTR;RPS27A;UBC
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.5139785112827373,0.9072239745047839,0.6410256410256411,0.8477423498519316,1.0,2/8,10.06%,PKD2;GSTM2
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.5139785112827373,0.9072239745047839,0.6410256410256411,0.8477423498519316,1.0,2/8,10.06%,PKD2;GSTM2
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.44405085386032533,0.9070933162801678,0.5454545454545454,0.8476973167884488,1.0,6/13,14.39%,PRKAR1B;RAPGEF2;PKIA;ADRB2;SIRT1;ATP2B4
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),-0.45818348226133476,-0.9068435175441238,0.6231884057971014,1.0,1.0,1/20,2.13%,MMP21
prerank,GO_Biological_Process_2021__kynurenine metabolic process (GO:0070189),-0.5396116441080481,-0.906385295864685,0.6666666666666666,1.0,1.0,1/8,1.71%,KMO
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),0.36843184772357396,0.9063046079667952,0.6785714285714286,0.8487936912622976,1.0,7/33,15.74%,ABCC8;TRPM4;SFXN1;PKD2;SLC22A5;TRPM3;TRPM2
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),-0.4850624779380786,-0.906256049198724,0.5797101449275363,1.0,1.0,3/13,17.22%,COX7A1;SLC25A33;COX7A2
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.3682437546125769,0.9062250411134822,0.625,0.8485875710249591,1.0,8/26,16.83%,RARB;PCSK5;SALL1;GLI3;PKDCC;NIPBL;SMO;NPY
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),0.5022983874225053,0.9061945628854119,0.625,0.8482932780959552,1.0,7/10,26.67%,FRMD5;FBLN1;CRK;CCDC125;PTPN2;SPOCK3;DUSP3
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),0.5107037862337939,0.9058769657440315,0.5217391304347826,0.848553150732869,1.0,1/6,5.16%,NOTCH2
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),-0.5906322974290292,-0.9058592389680771,0.6545454545454545,1.0,1.0,1/7,4.24%,KCNB1
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.47092685304363874,-0.9058247841299428,0.6031746031746031,1.0,1.0,2/13,15.52%,SELP;FIS1
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),-0.3662832274442953,-0.9057653143334923,0.6989247311827957,1.0,1.0,17/139,17.73%,POU4F1;RPL23;RPL11;RPS15;RPA3;RPL5;SETD9;HEXIM1;ZNF385A;BLM;RPS20;CDK5;PLK3;RPF2;BRCA1;TPX2;MAP2K6
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.3629356372604035,-0.9057385494747758,0.6483516483516484,1.0,1.0,17/103,19.53%,CENPE;RPS27;ERCC6L;ZWILCH;SPC24;KIF2C;NUF2;SPDL1;MIS12;KIF4A;CENPN;ITGB3BP;CENPH;CCNB1;DSN1;TBCE;DCTN2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),0.41701298380967167,0.9056796575827958,0.6,0.8486121951188196,1.0,4/20,11.45%,CDC25A;RCC2;RAD51B;STOX1
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),0.5759921210522274,0.9055430319035777,0.7297297297297297,0.8486471270701215,1.0,2/6,10.21%,SNCA;PRKN
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.2964885970234143,0.9054437420398569,0.75,0.8484495101934637,1.0,42/147,18.88%,ELAPOR2;ZNF706;HDAC9;HS3ST5;NPTN;MARVELD3;EGFR;RPS6KA4;RGCC;SPRED2;SOX9;RHEB;NFIB;BMP2;IL17D;LOXL2;DUSP10;SPX;LGR4;TFE3;ROBO1;SPRED1;NR1D1;SMAD7;DOCK7;ZNF423;ABHD6;PTPRG;ATP2B4;ADIPOR1;GSK3B;ROCK2;STK11;PGAM5;PTPRO;ALPK2;BBS2;LRP4;RBPJ;PTEN;NOVA1;LNPEP
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),0.45325431670025607,0.9052797232978531,0.6666666666666666,0.84839631951246,1.0,2/12,3.85%,SNCA;PRMT6
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),0.5135334340107355,0.9052018984471777,0.6216216216216216,0.8482149914738145,1.0,4/7,27.91%,AFDN;TJP1;SERPINF2;PTPRU
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.3855727818182397,-0.90519866490762,0.6351351351351351,1.0,1.0,10/52,14.27%,SFRP2;SPARC;STAT1;B2M;CEACAM1;THBS1;SFRP1;ATP5IF1;CAV2;APOE
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),-0.5721774594497967,-0.9050434710949613,0.6285714285714286,1.0,1.0,1/6,4.67%,BHMT
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),0.28711706978900964,0.9050346395841103,0.85,0.8482260053950598,1.0,24/81,20.70%,STXBP6;SORT1;EXOC2;EPS15;AP1S3;ARRB1;EXOC5;EXOC8;EXOC6;EXOC6B;RABIF;GOLGA7;EXOC4;COMMD1;AP1G1;RP2;PUM1;MYO5A;DNM2;SCAMP1;RAB10;SNAP23;CLVS2;OSBPL5
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.42684971940606664,0.9045142823415633,0.5882352941176471,0.8489174121262307,1.0,8/19,23.64%,SMAD2;SMAD7;SMAD4;BCL9;LATS1;ZNF703;SMAD3;TRIM33
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.4849700269933598,0.9044422304855738,0.631578947368421,0.8486720820371011,1.0,4/12,20.67%,HIPK2;SRPK2;DYRK3;ZPR1
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.44494348789681853,-0.9043824844133243,0.6612903225806451,1.0,1.0,7/22,18.93%,MT1H;MT1G;MT2A;MT3;MT1A;MT1E;MT1F
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),0.5024301698238706,0.9041101848185309,0.6,0.8489548311837407,1.0,3/9,30.59%,KDM4C;KDM7A;PHF8
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),0.4074637538463085,0.9040800656686224,0.5666666666666667,0.8486777080452818,1.0,8/21,24.68%,RANGAP1;UHMK1;ANP32B;PTPN14;GSK3B;BAG3;TCF7L2;GAS6
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.44901424453154526,0.903717103144619,0.5862068965517241,0.8489522308834241,1.0,5/12,13.33%,ANXA4;MAPKBP1;ARRB1;SSC5D;MAP2K5
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),-0.5056155452827787,-0.9035552390354455,0.65,1.0,1.0,5/9,16.49%,ANXA1;MSMP;CCL2;CX3CL1;RPS19
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),0.48495730347061294,0.9034376337696031,0.6388888888888888,0.8492345164325756,1.0,2/10,8.21%,PNMT;SMOX
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),0.48863672951876724,0.9032584996580563,0.5882352941176471,0.8493089600260062,1.0,2/8,8.85%,B4GALT3;GAL3ST1
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),0.3366132946005275,0.9030691922701708,0.5909090909090909,0.8494152694034692,1.0,17/59,20.73%,TCAP;KCTD13;FHDC1;ARRB1;CASQ1;MYH14;TJP1;CDC42BPA;TMOD2;ROCK2;FAM171A1;CUL3;FRMD5;ROCK1;MYOM2;TNFAIP1;PHACTR1
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),-0.5585823442903914,-0.9026503551161883,0.6491228070175439,1.0,1.0,2/7,31.28%,ITGA2;ITGB4
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,-0.379731483884893,-0.9025366714914486,0.7529411764705882,1.0,1.0,25/83,21.24%,SFRP2;LMOD1;SPON2;SPARC;COL5A1;IGFBP5;COL6A2;TIMP1;ANGPTL2;C1R;MGP;TNC;COL4A2;PAMR1;SOD3;CRYAB;ADGRL4;C1S;THBS2;TAGLN;CALD1;SRPX2;NID2;COL14A1;EDNRA
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),-0.4695231554381548,-0.9025232416994038,0.671875,1.0,1.0,1/19,0.54%,FLG2
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),0.35949312420710844,0.9025178569794428,0.6333333333333333,0.8502634874467412,1.0,7/30,15.36%,PICALM;NEDD4L;LEPROTL1;GPM6B;COMMD1;ABCA2;TM9SF4
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),0.33560410459171985,0.9024148566470507,0.7142857142857143,0.8501300627494105,1.0,7/37,8.75%,TLL2;MMP16;CTSK;CTSV;KLKB1;ADAMTS4;EXOC8
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),0.46190643131401876,0.9023799406397421,0.6666666666666666,0.8498054216629273,1.0,3/11,6.66%,SMAD2;UGDH;TASOR
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),0.34048617762234185,0.9011910173417773,0.5882352941176471,0.8518238271576956,1.0,11/44,21.51%,SYT3;CDKL5;NEDD4L;PLCB1;RASAL1;SMURF1;SEMA4D;RUFY3;RIMS2;UNC13A;MACF1
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.4197667334196924,0.900738507656042,0.6666666666666666,0.8523271573461376,1.0,5/14,24.00%,SNCA;SCRIB;NSF;VAMP3;KIF16B
prerank,GO_Biological_Process_2021__regulation of germinal center formation (GO:0002634),0.5347271205657013,0.9006337892381109,0.5789473684210527,0.8521532955511526,1.0,3/5,45.07%,BCL6;RC3H1;MEF2C
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),0.4565502139622778,0.9004516573205491,0.5405405405405406,0.8521626297700252,1.0,1/10,2.44%,PDE3B
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),0.6089917163303031,0.9004339307778628,0.6170212765957447,0.8518537323852428,1.0,4/5,36.14%,CSAD;CDO1;GHR;STAT5B
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),0.2508233223596821,0.9000451576699837,1.0,0.8523800839343539,1.0,59/238,18.39%,UHRF2;CDC25A;PTPRK;KAT2B;INTS13;FBXL17;RGCC;SOX9;BMP2;NOTCH2;TTC28;TTLL12;HNRNPU;BIN1;CHMP1A;CSNK2A1;MEN1;FBXL3;UHMK1;CKS1B;RPS6KA2;FAP;PKD2;MAP3K20;ZNF268;CAMK2N1;ADARB1;EP300;TP53BP2;ANKRD17;PLK1;APBB2;SIRT1;HIPK2;MAGI2;TGFBR1;MLXIPL;SIRT2;TGM1;CCPG1;JMY;PRCC;STK11;BMP7;BIRC2;CDC14A;RBBP4;PUM1;AKT2;ZNF703;ANKK1;APBB1;CSNK2A2;RPRD1B;SRPK2;MDM2;BRINP1;LIN52;CDK9
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.39792274232115254,0.9000163711348929,0.5757575757575758,0.8520872484094041,1.0,6/20,17.81%,SNCA;EGFR;NRP1;PTGES3;ITGA6;BCL10
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.36366023030047406,0.8999442233882027,0.6923076923076923,0.8518900023745718,1.0,4/36,11.23%,SNRPF;XPO1;NXT2;RBM15B
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),0.4095396402715249,0.8993542144614786,0.45714285714285713,0.8525507182651837,1.0,4/16,18.24%,MAP3K20;YAP1;KDM1A;MDM2
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",-0.537508589578581,-0.8991337813438329,0.5925925925925926,1.0,1.0,2/8,12.15%,ERLEC1;SVIP
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),0.3430897237653042,0.899062798991002,0.5652173913043478,0.8527742299635693,1.0,20/50,28.56%,ARFIP1;STXBP5;CAMK2A;RAB8B;RAB21;DISP1;NSF;RAB10;RIMS2;HCRT;FMR1;VAMP3;RAB12;RIC1;LLGL1;RALA;SNCAIP;LLGL2;RAB15;SEPTIN2
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),0.29588615262113543,0.8989601227342214,0.7647058823529411,0.8526721784462142,1.0,17/89,15.60%,ADCY1;PRKACB;TNIK;PRKAR1B;AKT1;TNFRSF10B;MAP3K7;IGF1;PRRC1;MAP4K4;PAK3;ADRB2;TGFBR2;TAOK2;OSBPL8;STK11;NRG1
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),0.25349645546547445,0.8989191489703141,0.5,0.852403619761709,1.0,88/418,18.46%,TXNIP;ITGA1;NCK2;PTPRK;KLF11;PDE3B;KAT2B;PDE12;ERBB4;PIWIL4;SOX4;PLXNA2;VHL;RGCC;PLPP1;ADNP2;BMP2;PLXNA1;CHD5;RAD18;PDS5B;CHMP1A;MEN1;FRZB;RAPGEF2;DLG3;STRN;GNG4;ZBTB7C;SMARCA2;NPAS2;RPS6KA2;DNAJB2;APOBEC3F;PIP4P2;ADRA1A;PKD2;CAPRIN2;ZNF268;PRKN;PTPRJ;CAMK2N1;ADARB1;TP53BP2;PRKD1;SLIT2;DACT3;ANP32B;JAM2;ST7L;NDRG3;NCK1;APBB2;SIRT1;MAGI2;ABI1;DLG5;SIRT2;PRKRA;BCL2;TENM1;PTPN14;VGLL4;MDM4;SMAD4;CDH13;SERTAD2;IP6K2;STK11;DDAH1;SEMA4D;BMP7;IMPACT;ARID2;RBBP4;NAIF1;RNF41;CELF1;ADGRB1;APBB1;DRD2;CDKN2AIP;PTEN;BRINP1;PLXNA4;PPM1D;CIB1;ATG5
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),-0.49540963831175344,-0.8987364643337742,0.6153846153846154,1.0,1.0,1/12,3.54%,APLNR
prerank,MSigDB_Hallmark_2020__Myogenesis,0.27917823995335744,0.8986280760846799,0.7142857142857143,0.8527458626295457,1.0,20/141,13.76%,TCAP;ANKRD2;AK1;TPD52L1;ENO3;PDE4DIP;CASQ1;BIN1;CAMK2B;KCNH2;DAPK2;LARGE1;IGF1;ADAM12;MRAS;PKIA;VIPR1;SGCD;SIRT2;COL15A1
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.539253123711085,-0.8985992202206166,0.6285714285714286,1.0,1.0,1/7,4.37%,COL5A1
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),0.3122740705008175,0.8985080645235294,0.6666666666666666,0.8526360210745282,1.0,14/42,20.59%,BMP2;TRPM4;BMPR1B;PKDCC;ANKH;ECM1;ACVR1;GPM6B;ACVR2A;BMPR1A;BMP7;S1PR1;DDR2;SGMS2
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),-0.5364796666721107,-0.8981245096886907,0.5857142857142857,1.0,1.0,2/10,7.75%,RASGRP1;ANGPTL3
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.3756949428639214,-0.898042562680489,0.6666666666666666,1.0,1.0,14/56,20.15%,LIPI;HSD17B8;ACSM6;CYP2D6;ACSBG2;ACSM5;ACSM3;XBP1;FADS1;GPX4;CYP3A4;ALOX12;ASAH2;OXSM
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),-0.5345605962083513,-0.8976886728939512,0.578125,1.0,1.0,1/11,2.34%,EEF1AKMT2
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),0.30382087593258283,0.8976727056610518,0.75,0.8538969792188715,1.0,24/77,19.00%,NCK2;SNCA;EGFR;CNOT9;HCLS1;AKT1;SMAD7;CAPRIN2;DOCK7;BRAF;PRKD1;STOX1;NCK1;MLXIPL;RPTOR;TENM1;ATP2B4;LATS1;TFRC;PDE4D;PTEN;PPM1F;AXIN1;NTRK3
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.44150580622990276,0.8975440907089752,0.625,0.8538659577898192,1.0,3/15,13.92%,ACER3;QDPR;ABCA2
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),0.3512964827159253,0.8975349401047505,0.6774193548387096,0.8535499594100553,1.0,8/27,23.06%,CEP290;BBS10;TTC8;C2CD3;TOGARAM1;RPGRIP1L;PCM1;CSNK1D
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),-0.5455473314209558,-0.8975060834113282,0.6865671641791045,1.0,1.0,2/10,10.31%,SFRP2;MEOX1
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),0.5181593388756482,0.8971493293467472,0.6097560975609756,0.8539147797702931,1.0,1/6,2.04%,SLC6A13
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),-0.5899189536972738,-0.8970035706296416,0.6716417910447762,1.0,1.0,1/5,10.15%,CHMP2A
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.4069603671345093,-0.8964759143884405,0.6764705882352942,1.0,1.0,8/45,15.55%,RASGRP1;THBS1;CD14;OAS3;LY96;TLR3;CLU;WNT5A
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),0.37668431617947495,0.896435397617014,0.6363636363636364,0.8548646644899432,1.0,5/20,19.35%,INSC;PLK1;FBXW11;NSFL1C;UBXN2B
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),-0.5428627375439361,-0.8963243567006567,0.6363636363636364,1.0,1.0,3/7,19.70%,PDCD1LG2;CD274;BTN2A2
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),-0.528555624981713,-0.8962782213607325,0.5714285714285714,1.0,1.0,2/6,22.34%,CAV2;VPS35
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),0.5516139025538573,0.8962712391540164,0.6170212765957447,0.8547700434375749,1.0,1/5,2.63%,ANK2
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.5371625002034959,-0.8961677932689543,0.6376811594202898,1.0,1.0,1/9,4.31%,ETFB
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.40385409238499115,-0.8954519427916032,0.6708860759493671,1.0,1.0,4/38,6.81%,RPL23;RPL11;RPS7;RPL5
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,-0.41652989223623405,-0.8948595125806994,0.6176470588235294,1.0,1.0,8/40,18.98%,GATA1;GMFG;EMP3;DOK1;FES;BLVRB;CCS;DPM3
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),0.4182557141959156,0.8947358685963757,0.6363636363636364,0.8572995793041235,1.0,8/20,17.48%,GDAP1;RAB8B;PEX14;PEX2;PEX16;PEX5;ABCD3;PEX13
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.434003218785332,-0.8946367462027643,0.6764705882352942,1.0,1.0,1/35,0.09%,EPN1
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.2756846489280727,0.8945665904585007,0.5714285714285714,0.857259350253867,1.0,42/172,18.70%,NRG3;EGFR;ADNP2;RAB33B;RPS6KA3;CSNK2A1;FRZB;AKT1;FAM107A;GNG4;SMARCA2;DNAJB2;ITCH;PSMD10;CAPRIN2;PTPRJ;CAMK2D;SLIT2;DACT3;ST7L;DCUN1D5;DERL2;NDRG3;SGK3;APBB2;SIRT1;TGFBR1;RPTOR;BCL2;VGLL4;SMAD4;SERTAD2;IP6K2;TAOK2;STK11;USP47;NAIF1;TFRC;APBB1;CDKN2AIP;CIB1;BCAR1
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.3518791190521458,0.8944744382714077,0.6111111111111112,0.8570612051892533,1.0,15/48,22.05%,GNL3L;SOX4;ARRB1;AKT1;SMAD7;MARCHF7;OGT;U2AF2;SPOPL;ADGRB1;PRMT3;BAG2;N4BP1;HSPA1A;TAF1
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.44122745259574836,0.8944561518435062,0.5609756097560976,0.8567448075976579,1.0,5/16,22.62%,PRMT1;MEIS2;ZBTB16;CIB1;CDC73
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),0.422698953772402,0.8944535391864796,0.5945945945945946,0.856412884773367,1.0,6/16,20.33%,WNT7A;IGF1;FBXW7;GSK3B;REST;PCM1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.5335712802577169,-0.8937558047199798,0.6212121212121212,1.0,1.0,2/7,13.34%,ITGA5;MT3
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.25765953844703016,0.8937218731212185,0.9090909090909091,0.8575641420256912,1.0,35/178,18.36%,C18ORF32;VAPA;TAB3;RORA;EEF1D;MAPKBP1;CASP10;ATP2C1;UBE2N;TNFRSF10B;TRAF3IP2;NR1D1;PPM1A;CANT1;ROR1;MAP3K7;TICAM1;PRKN;LURAP1;CFLAR;PRKD1;ANKRD17;ECM1;TRADD;SIRT1;TNFRSF19;ZFAND6;BIRC2;TFG;MIB2;TFRC;NDFIP1;BCL10;TRIM8;CPNE1
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),-0.5190500000546432,-0.8936835438940789,0.6716417910447762,1.0,1.0,2/10,7.00%,VIL1;SEMA5A
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.2944287046140658,0.8936415880267213,0.8,0.8574686948864739,1.0,7/74,5.74%,FOXP1;SNCA;FOXO1;ASCL1;SOX9;RPS6KA3;FOXO3
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.36734833116160454,-0.8935801072638138,0.6455696202531646,1.0,1.0,11/83,16.17%,PSMB6;FBXL22;PSMB9;PSMA8;PSMA7;PSME1;PSMC3;FBXL18;SKP2;PSMC4;PSMA3
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),-0.3872177080743419,-0.8934139146752088,0.6923076923076923,1.0,1.0,13/80,17.31%,PSMB6;ANAPC15;PSMB9;ANAPC11;PSMA8;PSMA7;PSME1;PSMC3;CDC26;UBE2S;PSMC4;PSMA3;CCNB1
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),0.31747841673946103,0.8931437007438305,0.6666666666666666,0.8582087565543712,1.0,8/46,12.27%,SNCA;DNM3;PICALM;GRK3;RAB31;PIK3R4;SMURF1;GRK4
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.3929511345604117,0.8931047411111558,0.6666666666666666,0.8579319261661609,1.0,4/20,10.06%,ANK2;CASQ1;PKD2;GSTM2
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),0.48186937325061463,0.8931007473416988,0.6153846153846154,0.8576001947130942,1.0,3/10,17.34%,SLC12A2;KCNMA1;ATP1A4
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,0.2942550435677133,0.8929523716878851,0.6923076923076923,0.8574970156919326,1.0,19/124,9.75%,POSTN;HMCN1;PAWR;PDE3A;FAT4;NR4A2;ACTA2;DCN;CXCL12;PARVA;PDGFRA;CDH11;PCDH18;ADAMTSL4;DYRK1A;NCOA2;PRRX1;FAP;MAP3K20
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.4547440944836606,0.8926888548324114,0.6071428571428571,0.857787353696939,1.0,4/14,15.54%,GNL3L;PIAS1;HDAC4;PIAS4
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),-0.5489674746812204,-0.892462247682315,0.6296296296296297,1.0,1.0,1/5,14.70%,BEX4
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),0.408647805838556,0.8922861145278287,0.6060606060606061,0.8582898249541075,1.0,3/14,11.20%,NEDD4L;SMAD7;CAMK2D
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.40316324779343216,0.8921635759429948,0.5,0.8581943545423655,1.0,2/13,17.23%,EME2;ATF2
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),0.30705408703992143,0.8920757076822484,0.7692307692307693,0.8580125108944987,1.0,33/95,22.78%,MAPK10;BTRC;TAB3;MAP2K4;NFKB1;PSMA1;TEC;PIK3CA;PIK3R1;PSMD11;MAP3K7;PSMD10;TAB1;PSMF1;PSMD14;SOS1;FER;CUL1;MAPK1;MAPK8;PPP3CB;PSME4;MAP3K1;BCL10;NFATC3;FBXW11;MAPK9;NFATC2;PSMD1;PSMD13;PPP3CA;NFATC1;PSMB5
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.38835276625193266,0.8919792458680019,0.5789473684210527,0.857893661816925,1.0,8/26,19.31%,BOK;TP53BP2;BCL2;GSK3B;YWHAG;MAPK8;TFDP2;YWHAZ
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),0.42122097038708356,0.8919025741626128,0.7,0.8577434976186182,1.0,5/21,14.20%,ARAP1;CGNL1;PIK3R1;CLASP1;TJP1
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.36223466137535104,0.8915613277412778,0.6785714285714286,0.8580173336137331,1.0,6/38,9.35%,SDC4;HS3ST5;GPC5;UGDH;EXT1;EXT2
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),-0.5211375977652717,-0.8912959814871202,0.6226415094339622,1.0,1.0,1/7,15.72%,ARL13A
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),0.3230417307885325,0.8911560289346522,0.6956521739130435,0.8584243381159666,1.0,4/43,8.56%,DNA2;PRMT6;POLD3;NEIL2
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.4950793695550503,-0.8909943758822133,0.5967741935483871,1.0,1.0,4/11,24.70%,CUEDC2;WNT5A;CD74;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.33571339838827063,-0.890961992131983,0.7916666666666666,1.0,1.0,41/345,15.84%,IFI6;APIP;PRAME;POU4F1;GATA1;PTRH2;RPL10;RPS27A;DHCR24;PRDX5;IL7;IFIT3;ANXA1;AQP1;BCL2L2;HTR2B;ITGA5;THBS1;BDNF;PDPN;RPS3A;RNF213;GSTP1;UBC;BEX3;SFRP1;CTSH;NAA38;MT3;UNC5B;MIEN1;APOE;CCL2;FZD9;CX3CL1;ERBB3;PTMA;WNT5A;FHL2;BAG1;PLK3
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),0.3342598872907486,0.8908757232194655,0.7027027027027027,0.8586819919888418,1.0,10/40,18.51%,DNAJC15;PEX14;PEX2;PEX16;PEX5;PEX7;AKT2;PEX6;SEC61A2;AIFM1
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),0.47842213251206944,0.8904819063311022,0.5714285714285714,0.8593549641515115,1.0,2/6,11.89%,STIM2;STIM1
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.3022543130941815,0.8904621207752001,0.7142857142857143,0.8590477744929907,1.0,30/82,24.15%,SPRED2;ZEB2;SMAD2;MEN1;SPRED1;PPM1A;SMAD7;ZNF451;EP300;SMURF1;TGFBR2;SIRT1;HIPK2;TGFBR1;SMAD4;BCL9;LATS1;STK11;WFIKKN1;LEMD3;ZNF703;SNX25;CREBBP;SKIL;HSPA1A;SPRED3;SMAD3;TRIM33;SLC2A10;PRDM16
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.4132266148287349,-0.8904033321994183,0.6756756756756757,1.0,1.0,4/25,15.71%,FBXL22;PDE6B;RBM4B;ID2
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),0.38378862822953463,0.8903697522904381,0.6111111111111112,0.8588113365418709,1.0,3/23,8.14%,PRMT6;PRMT1;FBLL1
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),0.45930041191917437,0.890045738035493,0.5333333333333333,0.8590997420551697,1.0,5/9,29.05%,CHD7;NIPBL;FGFR2;MYO6;TMIE
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),0.4607571505834238,0.8894880017327009,0.47058823529411764,0.8598732197157557,1.0,2/8,18.04%,NOTCH2;RBPJ
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),0.307367956494671,0.889459051597397,0.6666666666666666,0.8595819646534583,1.0,33/95,22.78%,MAPK10;BTRC;TAB3;MAP2K4;NFKB1;PSMA1;TEC;PIK3CA;PIK3R1;PSMD11;MAP3K7;PSMD10;TAB1;PSMF1;PSMD14;SOS1;FER;CUL1;MAPK1;MAPK8;PPP3CB;PSME4;MAP3K1;BCL10;NFATC3;FBXW11;MAPK9;NFATC2;PSMD1;PSMD13;PPP3CA;NFATC1;PSMB5
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.3613807028781126,-0.8887904470583952,0.6265060240963856,1.0,1.0,11/80,17.83%,PSMB6;PSMB9;PSMA8;PSMA7;PSME1;PSMC3;WEE1;PSMC4;CCL2;PSMA3;KLF4
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),0.321571000116151,0.8887734901072105,0.6111111111111112,0.8606205466130552,1.0,20/52,27.47%,TRAPPC8;RAB23;ATG7;PIK3C3;SMURF1;UBQLN1;RAB1A;ATG2B;UBQLN2;ATG5;NSFL1C;UBXN2B;STX12;RB1CC1;STX17;VMP1;PACS2;RAB1B;ATG3;RUFY4
prerank,GO_Biological_Process_2021__positive regulation of epidermis development (GO:0045684),0.509052244502326,0.8886928020336649,0.6666666666666666,0.8603917696598877,1.0,1/5,1.18%,ELAPOR2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.4377635801987717,0.8882984908671783,0.5384615384615384,0.8607961839366116,1.0,4/15,18.27%,AKT1;SIRT1;UBQLN1;NFE2L2
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.4167911956685137,0.8882709680617268,0.5161290322580645,0.8604815908281956,1.0,11/18,22.03%,RAPGEF2;OCLN;PDLIM5;RAP1A;TJP1;ROCK2;CBFB;RUNX1;SETD5;ROCK1;RAP1B
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.41295836309898426,-0.8880634349020399,0.5952380952380952,1.0,1.0,2/35,4.87%,APIP;B2M
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell differentiation (GO:2000727),0.544941636699006,0.8879410801419108,0.6363636363636364,0.8608622183167514,1.0,1/5,9.89%,EFNB2
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),0.491862937155675,0.8879102574510958,0.6153846153846154,0.8605244348024822,1.0,4/7,24.56%,VCP;KLC1;DYRK3;ZFAND1
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),0.5029906872990414,0.8879042807910009,0.6326530612244898,0.8601869223825263,1.0,2/8,7.50%,LTC4S;PON2
prerank,GO_Biological_Process_2021__sequestering of BMP from receptor via BMP binding (GO:0038098),0.5327871636953347,0.8878599285045933,0.7209302325581395,0.8599120745831154,1.0,2/6,13.00%,BMP2;NBL1
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),0.5271808855468154,0.887804901902991,0.5952380952380952,0.8597465926519534,1.0,2/7,3.46%,EPHA4;PICALM
prerank,GO_Biological_Process_2021__regulation of coagulation (GO:0050818),0.578874643514324,0.8877203898638844,0.75,0.8595344854936281,1.0,1/5,2.74%,HS3ST5
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.3904517249437057,0.8876837077713924,0.6111111111111112,0.8592524395756335,1.0,2/17,3.77%,HDAC9;RBM24
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.35588173947103136,-0.8876418104423806,0.7674418604651163,1.0,1.0,20/123,19.11%,IFITM3;IRF1;ANXA1;IER3;BCL2L2;TIMP1;NEFH;CASP8;CD14;WEE1;CLU;ERBB3;BRCA1;IL18;GADD45B;GPX4;DDIT3;CD44;BTG3;RETSAT
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),-0.5028423365378215,-0.8874579915138172,0.7014925373134329,1.0,1.0,1/12,3.54%,APLNR
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),0.45663638320232,0.8870758802393782,0.5517241379310345,0.8602164976125516,1.0,1/10,1.50%,TNFSF4
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),0.3453608553609668,0.8867626507224164,0.7586206896551724,0.8606894156874065,1.0,8/32,18.39%,SAMHD1;DNA2;RFWD3;EXD2;PRIMPOL;EME2;ATRX;CDK9
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),0.33437736877965785,0.886706317714546,0.64,0.8604305877207433,1.0,10/33,27.41%,CTSK;ATG7;PRKN;FUNDC2;ATG2B;ATG5;RB1CC1;MARK2;USP30;ATG3
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),0.5246151891162683,0.8866446511851446,0.6153846153846154,0.8602108537849984,1.0,3/5,21.60%,HMGB1;TGFBR2;CAMK4
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),0.43172666745566557,0.886552335076602,0.65625,0.8600690384060686,1.0,1/18,0.11%,TNFSF13B
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),0.5137061114238621,0.8865267225256098,0.631578947368421,0.8598263110907749,1.0,3/6,12.84%,DIPK2A;IGF1;SIRT1
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.3805584083599075,-0.8864740107691551,0.6904761904761905,1.0,1.0,13/69,21.14%,RPS27A;RPA3;UBC;POLR2L;POLR2I;COPS6;POLR2J;COPS5;POLD2;RBX1;POLR2K;POLR2G;UBA52
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),-0.47226138476493434,-0.8864652724524907,0.609375,1.0,1.0,1/13,4.79%,ANXA1
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.3683643854637451,0.8863072643088011,0.625,0.859964413253698,1.0,6/17,20.64%,DNAJC13;RAB21;MAPK1;MTMR2;MAP2K2;PTPN23
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),-0.5394719951406324,-0.8857811345835851,0.7346938775510204,1.0,1.0,2/7,18.78%,CASP8;HTRA2
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),-0.4407858605088546,-0.8854291234255052,0.6527777777777778,1.0,1.0,1/21,0.72%,GAPDHS
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),0.3422887494431883,0.8854232304198635,0.7,0.8613448002725539,1.0,5/39,15.70%,MBP;NDRG2;ZNF148;SIRT2;PADI2
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),0.3550810332051454,0.8850409790086897,0.575,0.8617771370497856,1.0,7/31,17.83%,ELAPOR2;ASCL1;DOCK7;SIRT2;PTPRZ1;YAP1;YTHDF2
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.32551739662222456,0.8850177432892207,0.6538461538461539,0.8614720453835096,1.0,18/41,25.29%,SPRED2;DUSP10;LMO3;SPRED1;SPRY3;CAMK2N1;DUSP6;DLG1;SMAD4;PTEN;C3ORF33;FBLN1;SPRED3;SIRPA;PTPRR;PTPRC;SEMA6A;PTPN2
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.37405272960895986,-0.8849759815524502,0.7108433734939759,1.0,1.0,21/65,27.36%,GATA1;PTPN7;PNP;GMFG;TMC8;TSPAN32;BPGM;CD44;DOCK2;LMO2;ENG;TFR2;CDH1;GAB3;USE1;GFI1B;IGBP1;TALDO1;ADCY7;TUBB1;FERMT3
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.5148909729252457,0.8846722301120726,0.6176470588235294,0.861896230823311,1.0,1/6,9.05%,SMAD7
prerank,GO_Biological_Process_2021__cranial nerve development (GO:0021545),-0.5766217517549641,-0.8846428661299316,0.6875,1.0,1.0,3/5,15.19%,POU4F1;TMEM126A;ERBB3
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),0.4737158539884182,0.8845198583200995,0.5625,0.8618859332128204,1.0,1/10,17.16%,TICRR
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.3686170990748137,-0.8840963291725006,0.7261904761904762,1.0,1.0,7/90,16.09%,PIF1;RPA3;BLM;WDHD1;PNKP;POLE3;BRCA1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),-0.5508477471518861,-0.8836177121340006,0.6440677966101694,1.0,1.0,3/8,19.96%,PDCD1LG2;CD274;TNFRSF21
prerank,GO_Biological_Process_2021__ammonium transport (GO:0015696),-0.5756933072306165,-0.8833831524682338,0.7142857142857143,1.0,1.0,3/5,16.30%,AQP1;RHD;RHCE
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),0.44359504288049967,0.8832585352948379,0.5769230769230769,0.8642004924683858,1.0,3/13,14.26%,KAT2B;KAT2A;ALMS1
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),-0.3651929609345398,-0.8829491231308998,0.7058823529411765,1.0,1.0,5/84,6.81%,EIF2S3B;RPS4X;THBS1;RPS9;RPL5
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.4636110979404061,-0.8826337772485485,0.6428571428571429,1.0,1.0,5/17,16.09%,CCBE1;CXCL17;NODAL;NOX1;BRCA1
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),0.441574256532448,0.8825603913172118,0.6111111111111112,0.8653512462421313,1.0,1/9,4.21%,LTC4S
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),-0.4962335268146575,-0.8824494076267261,0.639344262295082,1.0,1.0,1/11,4.33%,P2RY12
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,0.2838742982217736,0.8820320890440041,0.8,0.8659745374758253,1.0,28/142,14.39%,CHST8;SLC24A3;NPY1R;NRIP1;TPD52L1;TFAP2C;ASCL1;CXCL12;RAB31;UGDH;CA2;RPS6KA2;FKBP5;LARGE1;ELOVL5;SCUBE2;SLC2A8;MEST;CA12;SLC22A5;NBL1;PAPSS2;FARP1;DLG5;AFF1;BCL2;ITPK1;ATP2B4
prerank,GO_Biological_Process_2021__hydrogen sulfide metabolic process (GO:0070813),0.5474031787750125,0.8817912478645623,0.675,0.8662180606713766,1.0,3/5,40.01%,SQOR;CBS;ETHE1
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),0.32439067477892986,0.8814877938994823,0.6363636363636364,0.866546498821407,1.0,13/56,15.46%,EFNA5;ARHGAP35;RHOQ;RHOBTB3;TESK1;FAM107A;EPHA5;PDGFA;PAK3;BST1;GPM6B;TAOK2;ROCK2
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),-0.5545545196624669,-0.8813554143339684,0.6615384615384615,1.0,1.0,2/8,16.26%,BDNF;XBP1
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.41964549591616984,-0.881210967293462,0.6521739130434783,1.0,1.0,2/21,4.16%,CFTR;ABCA12
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.47076044885002716,-0.8810431988479067,0.6911764705882353,1.0,1.0,6/18,25.43%,ITGA5;MT3;MMRN2;TMEM204;CADM4;PRKD2
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),-0.5195468213682715,-0.8808357745743067,0.6956521739130435,1.0,1.0,2/9,9.20%,ANGPTL3;PGP
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),-0.5011793988633606,-0.8808111880993937,0.6610169491525424,1.0,1.0,4/11,14.28%,CCDC39;DNAAF1;CFAP73;CFAP100
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,0.3473272393509209,0.8807629285235924,0.7727272727272727,0.8677099566313883,1.0,5/42,5.80%,C1ORF162;NR2F6;CSF1R;SLC15A3;PLEK
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.34867369904199597,-0.8806921916148949,0.6818181818181818,1.0,1.0,7/92,10.56%,ISG15;WARS1;IL5;MTLN;RPA3;TPPP3;PSMC3
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.3625280146545574,-0.8805961451793489,0.6301369863013698,1.0,1.0,7/65,8.40%,SFRP2;GATA1;ENPP2;IL5;ITGA5;EFNA1;FGF7
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),0.5392310412901941,0.8803303941052903,0.6216216216216216,0.8682694706286993,1.0,2/5,22.91%,CNTNAP2;CNTN2
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),0.49385633744558183,0.8802722547355569,0.675,0.8679939228893601,1.0,3/8,13.63%,MBD2;SIRT1;SIRT2
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.4314352923208475,-0.8802006174961223,0.6857142857142857,1.0,1.0,7/20,22.45%,THBS1;SFRP1;LTBR;HTRA2;GPER1;TNFRSF12A;AGT
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),0.33715767836235233,0.8797967480153777,0.72,0.8684910805623042,1.0,9/40,15.83%,TNFSF4;ADCY1;GRAMD1C;GOLPH3;AHR;OSBPL7;GNAI1;KLF9;SMO
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),-0.5006787981116068,-0.8797434770910922,0.6923076923076923,1.0,1.0,3/10,10.03%,RPP38;POP5;RPP25L
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),0.48482292071515787,0.8797418862229192,0.625,0.8682156636750481,1.0,5/9,17.32%,PDE3A;PDE3B;CDC34;PDE2A;PDE4D
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.45154708042000324,-0.879693554764253,0.6764705882352942,1.0,1.0,3/17,16.74%,STAT1;TLR3;RIPK2
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),0.47294705764693284,0.8793240052376204,0.6,0.8687046198631158,1.0,2/9,22.81%,DLAT;ACAT1
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.34915761643025184,0.8793111203196807,0.6,0.8684370524912349,1.0,6/28,19.64%,EXOSC6;DCP1B;EXOSC1;CNOT8;EDC3;DDX6
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),0.34438906004436437,0.8790799021574405,0.71875,0.8685630403881505,1.0,6/38,16.30%,DNA2;POLD3;LTO1;STN1;PTGES3;POT1
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),-0.47653439855706714,-0.8787512732113022,0.6610169491525424,1.0,1.0,2/15,12.44%,GATA1;ZNF385A
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),0.2670221102300573,0.8787352741250315,1.0,0.8688585384667467,1.0,42/277,12.01%,SPSB4;BTRC;FEM1B;SPSB2;STT3B;KEAP1;DCUN1D1;VHL;QSOX1;RHBDD1;CDH2;PRKCSH;SOCS6;MGAT4A;KBTBD7;VCAN;BTBD1;PSMA1;KLHL42;COPS7B;KBTBD6;FEM1C;MEN1;FBXL3;COPS2;FBXO30;LMO7;DCAF17;ASB3;PSMD11;PSMD10;FBXO11;DCAF5;GPS1;FBXW7;PSMF1;PSMD14;FBXL14;COP1;ZBTB16;FBXO21;WSB2
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),0.44679737423873617,0.8786785687268791,0.6666666666666666,0.8685681087606191,1.0,5/11,16.51%,CPT1C;ACADM;CRAT;BBOX1;CPT1A
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),-0.5916474146511024,-0.8785204503832195,0.7222222222222222,1.0,1.0,2/5,26.52%,APOE;ERLIN2
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),-0.5916474146511024,-0.8785204503832195,0.7222222222222222,1.0,1.0,2/5,26.52%,APOE;ERLIN2
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),-0.5916474146511024,-0.8785204503832195,0.7222222222222222,1.0,1.0,2/5,26.52%,APOE;ERLIN2
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.4150849196878621,-0.8781297237724844,0.6176470588235294,1.0,1.0,3/27,5.51%,DUOX1;ANXA1;VIL1
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),0.5157996427596551,0.8777785334748599,0.6382978723404256,0.8698185973246532,1.0,2/7,12.46%,ABCC2;ABCC3
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.4646009128766431,0.8777486935744093,0.627906976744186,0.8695434182201491,1.0,4/8,24.68%,SOX9;ROCK2;ROCK1;GAS6
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),-0.515801232486322,-0.8773974510607034,0.746031746031746,1.0,1.0,3/8,31.19%,BLM;DONSON;ZRANB3
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.33858708658258674,-0.8773305669391259,0.7011494252873564,1.0,1.0,28/155,16.73%,THSD4;MMP21;MMP25;COL10A1;SPARC;COL5A1;COL6A2;ITGA5;COL8A1;ECM2;THBS1;ELN;COL24A1;MMP19;COL4A4;MMP24;TEX14;COL9A2;VWF;FBLN5;MATN3;ADAMTS16;TNC;LAMA1;MARCOL;LAMB1;COL4A2;MADCAM1
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),0.38949132909553463,0.8769026571999435,0.7142857142857143,0.8708387146302032,1.0,7/17,15.87%,ASCL1;SOX9;EIF2AK4;CNTN4;DTX1;GSK3B;BMP7
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.3880873270881688,0.8766610189529801,0.625,0.8710634788255045,1.0,5/20,13.63%,BAHD1;MBD2;HELLS;SIRT1;SIRT2
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),0.4784643053338575,0.8764325346915556,0.6136363636363636,0.8711034751604703,1.0,1/8,1.50%,TNFSF4
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),-0.5118503813200843,-0.8763318343891078,0.6666666666666666,1.0,1.0,3/8,14.59%,CMPK2;AK7;PNKP
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.34030573387384705,-0.8758528813610855,0.735632183908046,1.0,1.0,28/155,16.73%,THSD4;MMP21;MMP25;COL10A1;SPARC;COL5A1;COL6A2;ITGA5;COL8A1;ECM2;THBS1;ELN;HRNR;COL24A1;MMP19;COL4A4;MMP24;COL9A2;VWF;FBLN5;MATN3;ADAMTS16;TNC;LAMA1;MARCOL;LAMB1;COL4A2;MADCAM1
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.30483828981984595,0.8755933294191415,0.8,0.8725888234331735,1.0,17/101,10.53%,CAPN13;MYO5B;EBF4;SOWAHA;HID1;FAM110C;PLEKHA6;BAIAP3;ZSWIM5;SRCIN1;DLG3;PPP1R1B;ZBTB7C;NDRG2;ATP9A;HOOK1;MAPK4
prerank,GO_Biological_Process_2021__regulation of antifungal innate immune response (GO:1905034),-0.5304074018197722,-0.8752678536345686,0.711864406779661,1.0,1.0,1/5,14.32%,SPI1
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),0.28285166414287544,0.8749007960008475,0.8888888888888888,0.8735580910170249,1.0,42/165,22.67%,EPHA7;LIMD1;PLPP1;ITPKB;ISYNA1;INPP5A;DUSP10;AKT1;PIK3CA;PLCB1;PPM1A;PLPP2;PANK2;ACP6;PTPRB;PLPP3;GK;PLBD1;MINPP1;PPA2;ITPK1;SYNJ1;IP6K2;PLPPR4;GPD2;PLCB3;PPP3CB;IPPK;PTEN;AGK;LHPP;DUSP18;DUSP12;PANK3;ACYP1;PLAAT3;GK5;PLPPR2;NUDT3;OCRL;IMPA2;PPP3CA
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.3904141926804918,0.8748048837891976,0.6764705882352942,0.8733973188050613,1.0,8/19,18.57%,GRIN1;CACNA2D1;ADRA1A;ATP2B4;JPH1;TRPM2;CACNB3;GRIN2B
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),0.48496243867755684,0.8745864053786631,0.6444444444444445,0.8734747257229822,1.0,3/7,20.68%,PRMT1;SLC6A9;ABCB10
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),-0.3952464055595293,-0.8745308883612208,0.7391304347826086,1.0,1.0,3/36,6.67%,KCNB1;SELENOS;THBS1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.510321595706774,-0.8744211652617292,0.6964285714285714,1.0,1.0,3/10,17.68%,PLN;CAV3;NOS1
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),0.5183420923376937,0.8743975929520569,0.6578947368421053,0.8731613008129194,1.0,1/6,1.82%,RCN3
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),0.5183420923376937,0.8743975929520569,0.6578947368421053,0.8731613008129194,1.0,1/6,1.82%,RCN3
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.47371919582732924,-0.8740799417379397,0.6363636363636364,1.0,1.0,5/14,22.89%,SELENOS;CREB3;XBP1;CREB3L1;PARK7
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell proliferation (GO:0046642),-0.5760446328249044,-0.874031136089221,0.6607142857142857,1.0,1.0,1/5,15.88%,CD274
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),-0.4536091988114912,-0.8740108335367289,0.6764705882352942,1.0,1.0,3/15,17.23%,SELENOS;CX3CL1;PTPN22
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.34408283883909974,0.8736252755239036,0.6923076923076923,0.8743892112567164,1.0,10/31,18.62%,RGCC;BMP2;AKT1;MBP;PTK2;MAP2K5;EPCAM;ZNF703;WNK1;PPM1F
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),-0.5713891246608578,-0.8735663321758639,0.6981132075471698,1.0,1.0,1/5,14.55%,CLU
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),-0.5698415947722415,-0.8735210040525162,0.7142857142857143,1.0,1.0,1/6,4.70%,ST6GAL1
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),0.47374257314406687,0.8732358621475618,0.6944444444444444,0.8748187864539774,1.0,2/9,7.81%,SHANK1;NRXN1
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),0.329429036256065,0.872875812943165,0.64,0.8751407274651098,1.0,14/49,20.95%,XPO1;MARCHF7;PRKN;FBXW7;PSMF1;PSMD14;OSBPL7;COMMD1;OPHN1;DNAAF4;UBQLN4;RAD23B;BAG2;FMR1
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),0.42820365271082217,0.872654099620722,0.6470588235294118,0.8752325863603269,1.0,3/14,18.01%,MGAM;PGM2;PYGB
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.32017288899328367,0.87228634106106,0.6666666666666666,0.875623032167254,1.0,17/68,24.57%,INTS13;SNAPC1;INTS7;INTS6;INTS8;SNAPC3;TAF8;POU2F1;CCNT2;RPRD1B;SNAPC5;CDK9;GTF2F2;INTS14;RPRD2;INTS11;GTF2B
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),0.5001455804673388,0.8722143698589166,0.675,0.875446706821516,1.0,1/9,2.63%,ANK2
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),0.3199731199947632,0.8721842717810397,0.68,0.8751633936248837,1.0,8/32,15.46%,TNFSF4;ADCY1;NR3C1;GOLPH3;AHR;GNAI1;KLF9;ROCK2
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.429433356420047,-0.871294125776389,0.7164179104477612,1.0,1.0,2/17,4.59%,CD63;SFRP4
prerank,GO_Biological_Process_2021__ganglioside catabolic process (GO:0006689),0.5148061110988762,0.8712025293830716,0.6744186046511628,0.876807824198131,1.0,2/5,15.61%,HEXB;NEU3
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.48568930391069415,-0.8709337985603115,0.7083333333333334,1.0,1.0,5/12,29.60%,TBX5;PKP2;ATP1A1;ATP1B1;GJC1
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.4017222293907027,-0.8706908900134518,0.6615384615384615,1.0,1.0,2/28,1.27%,TNNT1;LMOD1
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),-0.4168760721917043,-0.8706256405763884,0.6666666666666666,1.0,1.0,6/26,14.67%,TIMP1;EFNA1;TRIM21;CST3;CSTB;CDK5
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.5261254353399326,-0.8706107509269675,0.6724137931034483,1.0,1.0,2/10,14.37%,EMC6;EMC4
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),-0.5514674676487317,-0.8700510696986214,0.6724137931034483,1.0,1.0,1/6,15.84%,PLK3
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.3669752555621052,-0.8700158322913071,0.7471264367816092,1.0,1.0,10/70,16.08%,ANKRD53;LMOD1;VIL1;SEMA5A;CAV3;FES;APOE;CLU;CX3CL1;DRG1
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.403261033757386,0.8699558445037285,0.6857142857142857,0.8789173604259076,1.0,3/16,8.57%,NPTN;SPRY4;SPRY3
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.36377426583550115,0.8696154931851152,0.6410256410256411,0.8791985901231991,1.0,7/23,20.55%,RORA;MEGF10;MRTFA;SYNE1;NEBL;KDM1A;NEB
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),0.4036058111533425,0.8692314569746885,0.5806451612903226,0.8796476760855585,1.0,1/20,1.50%,TNFSF4
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),0.31606081926602764,0.8691705862829293,0.6923076923076923,0.8794167273769962,1.0,18/77,15.47%,FOXO1;DCN;FOXO3;SESN1;ATF6;MAP3K7;EIF2AK4;TICAM1;HMGB1;PRKN;GNAI3;PRKD1;TFEB;SIRT1;TPCN1;GSK3B;SESN3;STK11
prerank,GO_Biological_Process_2021__one-carbon compound transport (GO:0019755),-0.5424582535602859,-0.8690907574215955,0.6545454545454545,1.0,1.0,2/6,16.11%,AQP1;AQP11
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),-0.35475288689628687,-0.8690794398962962,0.7126436781609196,1.0,1.0,20/84,26.27%,MRPL20;MRPL40;TRMT112;MTRF1L;MRPL51;MRPL27;MRPL54;GADD45GIP1;MRPS33;MRPL36;MRPL34;AURKAIP1;MRPS21;MRPL23;MRPS34;MRPS26;MRPL21;MRPS22;OXA1L;MRPS16
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),-0.4777096611270526,-0.8689978711951618,0.6666666666666666,1.0,1.0,3/9,25.26%,KCNG1;NOS1AP;AKAP6
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.26485905977926766,0.8688844032954416,0.8,0.8795218505983127,1.0,53/120,28.58%,ANK2;TSPAN17;TSPAN14;PACS1;EHD4;NECTIN3;EPHA2;DENND4C;TNIK;RAPGEF2;EFR3A;RAB8B;ASB3;MRAP;TTC7B;BSG;SMURF1;AFDN;RAP1A;TSPAN33;DLG1;ROCK2;RAP2A;CACNB3;MYO5A;WNK3;ROCK1;RAB10;TSPAN5;SLMAP;ZDHHC2;P2RY1;GORASP2;TTC7A;DPP6;FGF13;RAMP1;RAB12;RAPGEF6;GAS6;SPTBN4;PACS2;CACNB2;CLASP2;SPTBN1;PPIL2;RAB40C;SCN3B;IKBKB;RAB15;KCNIP3;KCNIP4;RAB40B
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),0.294008256570774,0.8685983826488674,0.8181818181818182,0.8796955692325057,1.0,12/66,10.74%,IRAK2;TAB3;CTSK;RPS6KA3;UBE2D1;MAP3K7;PIK3R4;TICAM1;HMGB1;PIK3C3;TAB1;MAPKAPK2
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),-0.4038684616224097,-0.868595021457801,0.6901408450704225,1.0,1.0,4/33,9.20%,ACMSD;MST1;CEACAM1;PGP
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),-0.5153508020442977,-0.8685539487856335,0.6666666666666666,1.0,1.0,2/8,15.55%,NOX1;WNT5A
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),0.4324211146277779,0.8681461788573658,0.6388888888888888,0.880212406483799,1.0,3/14,7.36%,ANK2;NEDD4L;KCNH2
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),0.3765953457476963,0.8670636070976462,0.64,0.8819564465952299,1.0,2/18,11.76%,DDO;ALDH7A1
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),0.40642537961133984,0.8670421336754259,0.5714285714285714,0.881625960715947,1.0,5/23,8.10%,EPHA4;PICALM;GRIN1;NCSTN;MBP
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),0.38601853899886845,0.8670055534065432,0.675,0.8813490662793231,1.0,7/20,22.79%,MACIR;PRKCE;PTK2;ARHGEF7;DDR2;FGF2;GNA12
prerank,GO_Biological_Process_2021__inner ear auditory receptor cell differentiation (GO:0042491),0.5118909966428855,0.8668071882412607,0.5757575757575758,0.881415105873694,1.0,2/6,25.84%,SLC4A7;MYO6
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),0.4101212141359065,0.8666078301407465,0.5833333333333334,0.8814354160299982,1.0,4/15,11.65%,CXCL12;SERPINE1;HMGB1;JAM2
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),-0.5511638867495805,-0.8665762654544519,0.7045454545454546,1.0,1.0,1/5,3.85%,STAT1
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),0.5284786221850658,0.8664922363236995,0.6578947368421053,0.8813339506995427,1.0,3/6,29.91%,RPGRIP1L;RORB;RP1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.45012237761546114,-0.866295620625778,0.675,1.0,1.0,2/20,13.16%,IRF1;TLR3
prerank,GO_Biological_Process_2021__histone-serine phosphorylation (GO:0035404),-0.5800591313581807,-0.8661749659531234,0.7419354838709677,1.0,1.0,1/5,3.86%,MST1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.44982742936891695,-0.8660966837125377,0.704225352112676,1.0,1.0,5/18,16.09%,CCBE1;CXCL17;NODAL;NOX1;BRCA1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.38238207570737864,0.8659606413847916,0.5652173913043478,0.882084548424317,1.0,9/26,17.84%,FLT1;PDGFRA;PIK3R1;IRS1;PIK3R4;PRKD1;PTK2;WDR91;WDR81
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.42232794636260773,-0.8658028181843221,0.6571428571428571,1.0,1.0,3/24,6.67%,DUOX1;ANXA1;THBS1
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),-0.4315923561988977,-0.865727140347402,0.6216216216216216,1.0,1.0,1/24,0.68%,SFRP2
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),-0.48199219048103065,-0.865679203966136,0.639344262295082,1.0,1.0,5/11,26.99%,CASP8;TLR3;SCIMP;TNIP2;RFTN1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.46871177071937675,0.8656081387477874,0.5609756097560976,0.8823859217581959,1.0,3/9,18.62%,RGCC;EPCAM;PPM1F
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.34311738373122,0.8655762457813984,0.7916666666666666,0.8820865765603366,1.0,8/30,27.19%,DVL1;SCRIB;VASP;MTHFR;BCL10;STIL;PHACTR4;TGFB2
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.466508154796178,0.8653857646580625,0.5882352941176471,0.8821445750323476,1.0,6/12,26.01%,PEX14;BICD2;CLASP1;PCM1;CLASP2;SAXO2
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.2957896814770747,0.8653093818085549,0.6785714285714286,0.8819518895286035,1.0,19/59,22.89%,CRADD;SORT1;BOK;TNFRSF10B;DCC;TRADD;BCL2;GSK3B;RNF41;CIB1;IL6R;FAS;CASP3;MLLT11;BAG3;SIVA1;BCL2L1;G0S2;SMAD3
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.3440802751509389,-0.8652211732285362,0.7411764705882353,1.0,1.0,22/163,17.31%,PSMB6;CETN2;CENPE;ANAPC15;RPS27A;PSMB9;ANAPC11;PSMA8;PSMA7;PSME1;PSMC3;UBC;CEP72;CDC26;UBE2S;CEP135;PSMC4;ID2;PSMA3;TUBB;TPX2;CCNB1
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),0.47866793373448413,0.865028589769568,0.6,0.8820858167522004,1.0,2/8,11.19%,GRIP1;DVL1
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),-0.5143582317604573,-0.8648639056934956,0.6727272727272727,1.0,1.0,1/7,4.79%,ANXA1
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.48465787811597694,-0.8647898093846466,0.6349206349206349,1.0,1.0,1/10,7.15%,DDX11
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),0.47937683584695323,0.8646974410482801,0.7297297297297297,0.8822879420647919,1.0,2/9,13.55%,NSMCE2;SMC6
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.3239822038983968,0.8639121751568871,0.6111111111111112,0.8834761183741777,1.0,8/57,8.04%,ACE2;CAPN13;ARHGEF16;HID1;EGFR;PLEKHA6;ALS2CL;PPP1R1B
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),-0.3988702236931041,-0.8637537542322964,0.6987951807228916,1.0,1.0,6/37,14.61%,GCNT1;GALNT15;ST6GAL1;B3GNT5;CHST4;B3GNT3
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.3019434550176319,0.8636808470981833,0.5833333333333334,0.8836017111614296,1.0,12/61,13.81%,SLC26A7;SLC19A1;SLC25A41;CA2;ABCC5;CA5B;SLC25A24;SLC4A7;SLC2A8;CA12;SLC4A10;SLC4A4
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),-0.4055057445330299,-0.8635674324023922,0.684931506849315,1.0,1.0,8/28,21.85%,HSD17B8;AWAT1;FAR2;GGTA1;SLC25A1;ALOX12;FASN;ALOX5
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.37108666258988326,0.863416695256622,0.7777777777777778,0.8837196257148229,1.0,8/21,18.87%,STOX1;PLK1;RPTOR;MAPK1;BMP7;CAB39;WNK3;AXIN1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.4607844704637527,-0.8633003808354226,0.6190476190476191,1.0,1.0,1/11,1.39%,RPS21
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.48984567689664676,-0.8630807264827594,0.7213114754098361,1.0,1.0,1/12,1.38%,ISG15
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),-0.40955845296457294,-0.8629316275231403,0.6527777777777778,1.0,1.0,5/32,17.21%,ANKRD53;CHMP2A;BORA;DRG1;TPX2
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),0.5250912581714837,0.8628466658512686,0.7555555555555555,0.8843981723832003,1.0,2/6,31.54%,PCID2;NUP107
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.3635284173575628,-0.8625346379933954,0.725,1.0,1.0,15/79,17.92%,IRF1;HLA-A;HLA-B;B2M;HLA-C;ERAP1;CASP8;KLRD1;RSAD2;CD160;HERC5;MADCAM1;MICA;PTPN22;SPINK5
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),0.4769272182720209,0.8622496597693009,0.6410256410256411,0.8852504015778451,1.0,2/7,13.63%,NF1;SIRT2
prerank,MSigDB_Hallmark_2020__Notch Signaling,0.34520211953207314,0.8621063381129129,0.6111111111111112,0.8851782501106442,1.0,8/29,14.26%,NOTCH2;ARRB1;FZD5;MAML2;DTX4;KAT2A;DTX1;CUL1
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.32016035137304105,0.862058591393836,0.68,0.8848639627174868,1.0,17/69,24.57%,INTS13;SNAPC1;INTS7;INTS6;INTS8;SNAPC3;TAF8;POU2F1;CCNT2;RPRD1B;SNAPC5;CDK9;GTF2F2;INTS14;RPRD2;INTS11;GTF2B
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),-0.5241561878034363,-0.8619719838899492,0.6964285714285714,1.0,1.0,1/6,9.81%,CASP8
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.4002264786511736,-0.8619554162771028,0.7272727272727273,1.0,1.0,10/32,29.68%,CENPN;ITGB3BP;OIP5;CENPH;RNF8;CENPU;NPM1;CENPX;SMARCA5;KNL1
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.3581996195196562,-0.8619504695350363,0.6923076923076923,1.0,1.0,10/65,18.06%,PSMB6;PSMB9;PSMA8;PSMA7;PSME1;PSMC3;TLR3;PSMC4;PSMA3;TNFRSF10A
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.4853004377510384,-0.8619109594702029,0.6610169491525424,1.0,1.0,5/13,25.50%,LSM2;PRPF8;DDX20;PRPF3;PRPF6
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.291374251878951,0.8618816947449369,0.6842105263157895,0.8847920177646027,1.0,13/84,14.22%,RAD54B;SEM1;SAMHD1;UBE2N;RAD51B;RAD52;RFWD3;PSMD14;NSMCE2;NIPBL;EXD2;SMC6;REV3L
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",0.5418789856827879,0.8617137729589905,0.7454545454545455,0.8847352540090937,1.0,1/5,5.33%,NCSTN
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.40688355123277153,-0.8615422147501259,0.6615384615384615,1.0,1.0,15/23,33.43%,IFI35;SPI1;WNT5A;RPS19;POLR3G;NLRC5;RIOK3;HLA-E;ADAM8;SLC15A4;POLR3D;TRIM62;FADD;NMI;PLSCR1
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.3806199276155081,0.8608805830389923,0.6785714285714286,0.8861299920062315,1.0,6/26,10.88%,TNFSF4;FOXP1;MAPK11;PLCB1;HMGB1;MAST2
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),0.5272128993187908,0.8605334566369052,0.6346153846153846,0.8864128055323107,1.0,3/5,28.57%,ATIC;HPRT1;AMPD2
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.36716375367996623,-0.8602869739212156,0.7682926829268293,1.0,1.0,5/64,5.51%,AKR1C1;OVOL2;OVOL3;ANXA1;VIL1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.5104930094564357,-0.8600838118766321,0.7068965517241379,1.0,1.0,5/9,29.18%,FOXM1;SP100;TFAP4;KAT5;RPS27L
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),0.543254467449797,0.8600134675282687,0.6904761904761905,0.8869446747514497,1.0,2/6,14.79%,VCPIP1;VCP
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),0.3789581887582303,0.8596026253417143,0.6896551724137931,0.8874761308682826,1.0,8/18,22.03%,RIMS3;RAB3GAP1;RAP1A;GSK3B;RIMS2;FMR1;NLGN1;RAP1B
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),-0.5043963756138647,-0.8591137302295414,0.7692307692307693,1.0,1.0,1/7,4.59%,IGFBP5
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.4580162488960205,0.8590291397695007,0.6571428571428571,0.8881505851562885,1.0,5/10,21.99%,EPHA4;ARHGAP35;CNTN4;CDK5R1;EPHB3
prerank,GO_Biological_Process_2021__intracellular pH elevation (GO:0051454),-0.5293254247742227,-0.8588491362864416,0.6417910447761194,1.0,1.0,2/6,12.88%,CFTR;NOX1
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),0.45888969341504104,0.85840136944095,0.6052631578947368,0.8890508662272186,1.0,2/10,12.84%,CSF1R;SIRT1
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),-0.496774813228153,-0.8580562647226597,0.6724137931034483,1.0,1.0,2/9,12.81%,DDX11;BLM
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.4534535779416038,-0.8577428888971005,0.7096774193548387,1.0,1.0,7/15,32.42%,TIMP1;APOE;TIMP2;ADAM8;PTPN3;PACSIN3;TIMP3
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,0.2797841715010708,0.8574976739864935,0.9230769230769231,0.8905161049235508,1.0,30/129,16.51%,OSTC;HADH;MGLL;ENO3;LTC4S;HSPH1;ADIPOR2;PRDX6;UGDH;MAOA;CA2;BMPR1B;AUH;NSDHL;SDHC;ELOVL5;SMS;BCKDHB;SLC22A5;HCCS;HSD17B4;ACADVL;NCAPH2;RAP1GDS1;PTPRG;ACADM;SUCLG2;CRAT;GPD2;CPT1A
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),-0.49847970509529704,-0.8573233792361367,0.647887323943662,1.0,1.0,5/10,29.93%,PSMC3;POU2F3;TFAP4;JUN;TARDBP
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),0.39010293183843986,0.8567476732919483,0.7333333333333333,0.8915429362661836,1.0,5/20,17.54%,NCKAP5;ZNF207;CKAP5;HDGFL3;KATNB1
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.37227523701669885,0.8565454110099225,0.6296296296296297,0.8916344785729788,1.0,5/19,19.34%,AGMO;GAL3ST1;ARV1;AGK;TEX2
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.3338048530751661,-0.8565173468343057,0.8,1.0,1.0,33/147,18.10%,LMOD1;ADIRF;F8;APLNR;SPARC;CD9;AQP1;COX7A1;ANGPTL2;STAB2;S100A10;PDPN;HEXIM1;C1R;MEOX1;PROCR;VWF;A2M;MGP;FMO2;ABCG2;USHBP1;KCNJ8;FHL2;ELK3;RAMP3;PODXL;SCARF1;CALCRL;MADCAM1;SOD3;ADGRL4;C1S
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.3389182702476136,-0.8564729317747127,0.813953488372093,1.0,1.0,36/147,22.33%,GPR183;IRF1;IER3;IFIT2;CXCL2;KLF2;EFNA1;IFNGR2;IER2;HES1;CCN1;TNFAIP2;CEBPD;CCL2;DUSP1;ID2;TNC;SOCS3;IL18;RIPK2;IL15RA;GADD45B;TRIP10;KLF4;CD44;TUBB2A;BTG1;BTG3;SPHK1;SLC16A6;NFKB2;EIF1;TNIP1;GADD45A;ZFP36;FOS
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),-0.3664461037802458,-0.8564541163928536,0.7464788732394366,1.0,1.0,12/47,23.83%,ACKR4;P2RY12;HTR2B;PPP1R9A;RCAN3;APOE;CXCR4;NOS1;SPHK1;AGT;RCAN2;EDNRB
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),-0.4098484931723606,-0.8561429586296102,0.734375,1.0,1.0,2/18,7.90%,GGCX;TTLL6
prerank,GO_Biological_Process_2021__epoxygenase P450 pathway (GO:0019373),0.4810435677501772,0.855925761013638,0.575,0.8925696811486209,1.0,2/6,27.25%,CYP2J2;CYP4F12
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),-0.3588331291035273,-0.8556206510507652,0.7654320987654321,1.0,1.0,14/74,18.09%,ENPP2;SPARC;VIL1;THBS1;RAB11A;FGF7;PIK3CB;CTSH;HYAL1;RRAS;FGF1;WNT5A;GPI;PFN1
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.4166790703893233,-0.8548515212763947,0.6818181818181818,1.0,1.0,4/21,14.94%,CASP8;SLC25A4;CDC37;FZD9
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),0.5077533149435626,0.8548179161981997,0.717391304347826,0.894212016612122,1.0,2/5,15.76%,CHD7;PTPN11
prerank,GO_Biological_Process_2021__deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),0.5422771818656416,0.8543218817932541,0.6744186046511628,0.8948820353345995,1.0,3/5,24.32%,DCP1B;EDC3;DCP1A
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),0.4827011002559639,0.8541742151115348,0.6086956521739131,0.894799078645048,1.0,1/7,5.37%,RPS6KA3
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.4845685661479697,0.8540805537396821,0.6551724137931034,0.8946108829355993,1.0,6/10,27.16%,SOX9;NFIB;NFATC3;REST;RELA;PPARD
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),-0.37691792886746667,-0.8540631331908048,0.7435897435897436,1.0,1.0,4/40,9.45%,STAT1;IGFBP5;ANXA1;STAT2
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),-0.34907605324494295,-0.8540531210451573,0.7532467532467533,1.0,1.0,9/83,10.62%,PSMB6;IL1R1;RPS27A;PSMB9;PSMA8;PSMA7;PSME1;PSMC3;UBC
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),-0.5161042275620689,-0.8537294692373086,0.6666666666666666,1.0,1.0,1/7,3.70%,KDELR3
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,-0.35778407598454914,-0.8536231243766534,0.7125,1.0,1.0,24/69,21.42%,LMOD1;IGFBP5;AQP1;ANGPTL2;SEMA5A;ELN;C1R;MGP;MATN2;COL4A2;PAMR1;SOD3;CRYAB;ADGRL4;C1S;CPXM2;THBS2;TNS2;TAGLN;CALD1;SRPX2;COL14A1;EDNRA;CREB3L1
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.39248340790397396,-0.8534549455675516,0.7,1.0,1.0,18/44,23.06%,OVOL2;CD9;ANXA1;PGR;TMC4;TRIM29;CEBPD;B3GNT3;ERBB3;WNT5A;IL20RA;PPL;BTG1;CD74;EPS8L2;CDH1;SYTL2;AR
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),-0.5144573062423035,-0.8531184558403472,0.6491228070175439,1.0,1.0,2/6,17.11%,ASIP;GIPC1
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),-0.5144573062423035,-0.8531184558403472,0.6491228070175439,1.0,1.0,2/6,17.11%,ASIP;GIPC1
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.39940369571430123,-0.8527648993500783,0.7333333333333333,1.0,1.0,7/30,21.10%,POLR2L;POLR2I;GTF2F1;POLR2J;NCBP2;POLR2K;POLR2G
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.39940369571430123,-0.8527648993500783,0.7333333333333333,1.0,1.0,7/30,21.10%,POLR2L;POLR2I;GTF2F1;POLR2J;NCBP2;POLR2K;POLR2G
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),0.5314973253550663,0.852750143638327,0.723404255319149,0.8963468797095104,1.0,2/5,13.85%,CPSF6;DHX9
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),0.5314973253550663,0.852750143638327,0.723404255319149,0.8963468797095104,1.0,2/5,13.85%,CPSF6;DHX9
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),-0.3721525794210976,-0.8526794805254908,0.7027027027027027,1.0,1.0,9/48,16.82%,TLCD1;ORMDL2;ANGPTL3;PNPLA3;FABP3;APOE;ORMDL1;XBP1;RBP1
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),0.3980483985959572,0.852573829319016,0.6111111111111112,0.8963010499147598,1.0,2/12,5.11%,SOX8;BMP2
prerank,GO_Biological_Process_2021__vesicle localization (GO:0051648),-0.538597805927093,-0.8524255497891121,0.7,1.0,1.0,1/5,7.72%,RAB11A
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),-0.37730117935965785,-0.8510353513497427,0.7108433734939759,1.0,1.0,12/53,17.78%,DHCR24;ANGPTL3;MVK;SQLE;MT3;APOE;HSD17B7;SCARF1;FDPS;DHCR7;ACAT2;ABCA5
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),0.3824304236214865,0.8508731169313801,0.7407407407407407,0.8988837682679133,1.0,5/28,10.72%,AJAP1;RCC2;SERPINE1;FAM107A;MAP4K4
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),0.44066498473830146,0.8505034768834397,0.6216216216216216,0.8992573940292571,1.0,7/11,34.10%,BICD2;PCM1;NINL;HOOK3;CEP19;BICD1;CCDC120
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.3785808158959275,0.8504155733112059,0.7272727272727273,0.899060409193834,1.0,7/19,20.49%,NEDD4L;CAMK2D;COMMD1;ATP2B4;DLG1;UTRN;SLMAP
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.4560250308433026,0.850283344004255,0.6666666666666666,0.8989385897952913,1.0,4/8,24.37%,ELF1;CBFB;RUNX1;PTPRC
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),0.24745012654561707,0.8501834197370016,1.0,0.8987943690029886,1.0,98/285,24.71%,BTRC;SASH1;ANAPC1;FBXL17;UBE2G1;UBE2T;RNF217;KBTBD7;RNF146;NEDD4L;MARCHF6;RNF6;PSMA1;KLHL42;CDC27;RNF144A;KBTBD6;UBE2E3;FBXL3;RUSC1;FBXO30;LMO7;UBE2D1;UBE2N;TRAF3IP2;UBR5;RNF26;TMEM129;PSMD11;ITCH;RNF14;PSMD10;FBXO11;UBE3C;PRKN;RMND5A;FBXW7;PSMF1;PSMD14;FBXL14;FBXO21;SMURF1;MKRN3;TRIP12;UBE2E1;CDC34;UBE2E2;FBXO28;BCL2;CUL1;BLMH;ARIH1;TRIM36;BFAR;HACE1;BIRC2;MIB2;RNF41;FBXW2;RNF166;PSME4;CBFB;CUL3;UBE2L5;MDM2;FBXW11;FBXO31;LNPEP;UBE2D3;MKRN1;FBXO38;RBBP6;HECTD1;PSMD1;UBE3B;FBXO15;PELI1;ANAPC13;SHPRH;UBE2H;TAF1;CTNNB1;PSMD13;TNKS2;PSMB5;LRSAM1;HUWE1;UBE2G2;FBXL7;TRAF3;AMFR;AREL1;FBXL15;PSMC2;FBXO10;RNF20;TNKS;UBE2K
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.3304284062268046,0.8500791400472162,0.76,0.8985977904819571,1.0,5/38,14.25%,SGMS1;BOK;DAPK2;BCL2;UBQLN1
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),0.3861896471193088,0.8497194799755831,0.6176470588235294,0.8987759970748608,1.0,4/18,17.80%,FZD5;PRKN;FBXW7;CSNK2A2
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),0.36671741822281856,0.8495227929988302,0.5277777777777778,0.8989016378730447,1.0,3/12,15.70%,ARID1B;SERTAD2;PADI2
prerank,MSigDB_Hallmark_2020__DNA Repair,0.26321888524509635,0.8492525827580707,0.8571428571428571,0.8990122081089871,1.0,11/134,9.84%,NUDT21;VPS37B;AK3;AK1;CSTF3;DUT;POLD3;HCLS1;CANT1;SMAD5;RAD52
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),0.5427824684849823,0.8484395922707215,0.6904761904761905,0.9003800086056253,1.0,3/5,27.86%,SIRT1;CTBP1;CTBP2
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),0.305010144469168,0.8484346082090026,0.782608695652174,0.9000410564993024,1.0,20/97,14.97%,RCN3;TMX1;PPP1R15B;TMEM33;RHBDD1;PDIA2;MARCHF6;ERP44;ATF6;TNFRSF10B;PIK3R1;PRKN;MAP3K5;UBXN6;NCK1;BCL2;TMEM117;UBQLN1;VCP;GSK3B
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.341003070141667,-0.8483894718902728,0.735632183908046,1.0,1.0,14/119,10.69%,PSMB6;HLA-A;BTN3A1;PSMB9;PSMA8;INPP5D;THEMIS;PSMA7;FYB2;HHLA2;PIK3CB;PSME1;PSMC3;PRKCQ
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),0.3846405271649699,0.8483445666431412,0.6153846153846154,0.8998369738626393,1.0,3/9,17.05%,NR1D1;IGF1;CD200R1
prerank,GO_Biological_Process_2021__macrophage chemotaxis (GO:0048246),-0.557517706096933,-0.8481541926511644,0.7547169811320755,1.0,1.0,4/6,23.83%,CXCL17;CCL2;SFTPD;EDNRB
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),0.45057988643440716,0.8480987706416361,0.6458333333333334,0.8999245882855286,1.0,3/9,17.05%,NR1D1;IGF1;CD200R1
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),0.4172079835236869,0.8478647877651383,0.6578947368421053,0.900146640636188,1.0,3/11,12.72%,PDE3B;PPP2R5A;ASXL3
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),-0.4880118951604933,-0.8474552426240729,0.6935483870967742,1.0,1.0,4/8,24.68%,ANXA1;SPHK1;C2CD5;ANXA2
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),-0.4286633935578623,-0.8473223788486386,0.6666666666666666,1.0,1.0,4/22,11.51%,CMPK2;PNP;NMNAT3;AK7
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),-0.3524619857526331,-0.8472084904016913,0.7307692307692307,1.0,1.0,12/74,16.64%,PSMB6;GATA1;PSMB9;PSMA8;HES1;PSMA7;PSME1;PSMC3;PSMC4;PSMA3;EIF2AK2;SLC4A11
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),-0.4164012936006108,-0.8471298091169119,0.6666666666666666,1.0,1.0,9/20,21.85%,CYP2D6;GSTP1;ACSBG2;FADS1;GPX4;CYP3A4;ALOX12;ASAH2;ALOX5
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.3351818115688825,-0.8470904627000883,0.7741935483870968,1.0,1.0,20/127,19.53%,CENPE;RPS27;ERCC6L;ZWILCH;SPC24;RAB11A;KIF2C;NUF2;SPDL1;MIS12;ABRAXAS1;KIF4A;CENPN;ITGB3BP;CENPH;TPX2;CCNB1;DSN1;TBCE;DCTN2
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),-0.48538494810195154,-0.8468732161313276,0.71875,1.0,1.0,1/12,3.86%,MST1
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),-0.4047866954527411,-0.8467256745678403,0.7142857142857143,1.0,1.0,2/32,3.85%,GATA1;STAT1
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),0.49288635963669325,0.8467220706067864,0.6585365853658537,0.9020043744893252,1.0,2/6,9.70%,MYORG;IGF1
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),-0.5242558838953775,-0.8466862569914682,0.6229508196721312,1.0,1.0,1/6,6.67%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),-0.5242558838953775,-0.8466862569914682,0.6229508196721312,1.0,1.0,1/6,6.67%,THBS1
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),0.28216841135622156,0.846650846390965,0.8888888888888888,0.9018073181571281,1.0,14/109,12.21%,ADCY1;MACIR;PRKACB;RORA;GIT1;CD247;CALCB;PRKAR1B;NR1D1;IGF1;GPR176;ADRB1;VIPR1;ADRB2
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),0.4070574288303679,0.8466014880546202,0.5897435897435898,0.9015581657492139,1.0,6/15,25.79%,NEDD1;C2CD3;PCM1;STIL;CSNK1D;HOOK3
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),0.510985501932554,0.8465398349543319,0.6842105263157895,0.9012942824649649,1.0,4/5,47.49%,BDP1;CRCP;GTF3C1;BRF1
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.3558667475446924,-0.8465183786526831,0.7906976744186046,1.0,1.0,18/97,22.39%,CETN2;RPS27A;RPA3;UBC;SLX4;POLR2L;POLR2I;PNKP;COPS6;POLR2J;COPS5;POLD2;RBX1;POLR2K;POLR2G;UBA52;BRCA2;RNF111
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),-0.4470641721086026,-0.8458587275996788,0.7096774193548387,1.0,1.0,3/15,7.15%,P2RY12;HTR2B;BDNF
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),-0.545546272226303,-0.8458179377311452,0.7419354838709677,1.0,1.0,2/5,25.07%,PTPN22;FLOT1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.4907143016727911,-0.8452241241794707,0.7049180327868853,1.0,1.0,5/10,29.18%,FOXM1;SP100;TFAP4;KAT5;RPS27L
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),0.49398153265990363,0.8450882004804411,0.6666666666666666,0.9036857149335107,1.0,2/6,5.99%,HS3ST5;SERPINE1
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.26749988271526814,0.8450612059888373,0.95,0.9033690309696136,1.0,38/113,25.13%,SOX8;EGFR;PARVA;SOX9;LIMCH1;EPHA2;RBFOX2;HSPA12A;ZNF423;PLPP3;ENAH;NCKAP1;TJP1;SH3PXD2B;SCRIB;YAP1;DDAH1;PARD3B;LIFR;NTN4;RUNX1;SNX7;BCAR1;CHST3;CASKIN2;NFATC2;MESP1;DOCK1;PLS3;ADCY6;TMEM47;TEAD1;ERRFI1;HTRA1;KITLG;SH3BP4;FZD7;GNG12
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),0.40646033009993754,0.844665151950522,0.65625,0.9034143056366736,1.0,4/13,18.14%,RAB27A;MKKS;BBS2;MYO5A
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),0.40646033009993754,0.844665151950522,0.65625,0.9034143056366736,1.0,4/13,18.14%,RAB27A;MKKS;BBS2;MYO5A
prerank,MSigDB_Hallmark_2020__UV Response Up,0.25007451268296244,0.8446216026014697,0.9444444444444444,0.9031502167900092,1.0,37/137,24.18%,RAB27A;STARD3;GLS;RRAD;NPTXR;BMP2;CTSV;HNRNPU;KCNH2;MAOA;CA2;ATP6V1C1;TGFBRAP1;BSG;CDC34;EPCAM;TACR3;STIP1;LHX2;TFRC;SIGMAR1;CCND3;SLC6A12;H2AX;NTRK3;CASP3;CDO1;FURIN;NR4A1;PLCL1;CDC5L;NPTX2;CNP;POLG2;STK25;FKBP4;MARK2
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.3592376957250912,-0.8445942312689408,0.725,1.0,1.0,10/63,13.82%,LHFPL5;OTOS;MYO3A;TIMM10;MYO3B;TIMM8B;SLC26A5;CLRN1;CEMIP;KCNQ1
prerank,GO_Biological_Process_2021__regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),-0.5380127294790107,-0.8445468713762897,0.7049180327868853,1.0,1.0,3/6,13.16%,CD14;LY96;TLR3
prerank,GO_Biological_Process_2021__negative regulation of heart rate (GO:0010459),-0.5299796285665734,-0.8444119656382912,0.6825396825396826,1.0,1.0,1/5,5.68%,PLN
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),-0.518772444465841,-0.8440305038540504,0.6666666666666666,1.0,1.0,1/6,10.15%,CHMP2A
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.42318777778028255,-0.8438558271012161,0.6901408450704225,1.0,1.0,1/21,3.39%,PRDX5
prerank,PanglaoDB_Augmented_2021__Paneth Cells,-0.4070945109076954,-0.8432637272941407,0.7794117647058824,1.0,1.0,7/18,21.44%,CEACAM1;WNT9B;WNT3;GPX2;RIPK2;GUCY2C;IL4R
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.4137560708288906,-0.8432229696815067,0.7121212121212122,1.0,1.0,10/26,29.68%,CENPN;CENPV;ITGB3BP;OIP5;CENPH;CENPU;NPM1;CENPX;SMARCA5;KNL1
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.27187062524809874,0.8429790463713263,0.9285714285714286,0.9059308879912383,1.0,21/108,14.92%,VPS37B;GDAP1;PARD3;ZDHHC18;KIF13B;AP1S3;ZDHHC11;MFF;RAB3IP;CACNG3;VPS37A;TRAK1;ZDHHC21;TRAK2;TOMM22;GOLGA7;PEX16;PIKFYVE;SRPRB;ZFAND6;TAOK2
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.37793808946019813,0.8429010180465367,0.7,0.9057999772204415,1.0,7/18,24.63%,MEN1;PLK1;LATS1;PTEN;IPO5;IPO7;CDKN1B
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),-0.5219007169203117,-0.8428535790610557,0.7692307692307693,1.0,1.0,5/8,29.30%,OAS3;TRIM25;IRF3;PHB2;IFIH1
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),-0.4684578427362931,-0.8425477152820776,0.6923076923076923,1.0,1.0,4/10,26.04%,CUTC;ATOX1;STEAP2;SLC31A2
prerank,GO_Biological_Process_2021__gas transport (GO:0015669),-0.5596359659513273,-0.8423681803356031,0.7258064516129032,1.0,1.0,1/5,5.32%,AQP1
prerank,GO_Biological_Process_2021__skeletal muscle contraction (GO:0003009),0.41617342173133715,0.8422100533928062,0.7777777777777778,0.9068220893585048,1.0,1/10,0.14%,TCAP
prerank,GO_Biological_Process_2021__alpha-amino acid biosynthetic process (GO:1901607),-0.5181084347827095,-0.8421637813402613,0.6833333333333333,1.0,1.0,3/7,29.21%,SDS;PAH;SDSL
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.4635820885002297,-0.8420113862336621,0.7101449275362319,1.0,1.0,2/15,14.37%,EMC6;EMC4
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.3872108293073537,-0.8418633447235412,0.7076923076923077,1.0,1.0,4/36,10.91%,EEF1AKMT2;BHMT;TRMT112;EEF2KMT
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.33683765062068044,-0.8417759276697108,0.825,1.0,1.0,15/108,16.17%,PSMB6;SFRP2;PDE6B;SFRP4;PSMB9;PSMA8;PSMA7;WNT9B;PSME1;PSMC3;SFRP1;PSMC4;FZD9;WNT5A;PSMA3
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.47400155196063676,-0.8410372018652348,0.6779661016949152,1.0,1.0,2/9,12.15%,ERLEC1;SVIP
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.43732144441831416,-0.8407621496006519,0.704225352112676,1.0,1.0,4/20,17.07%,DUOX1;PDPN;RPS19;PHPT1
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.35011770376878737,-0.8399399809639388,0.7323943661971831,1.0,1.0,9/44,19.16%,MICOS10;TIMM10;TIMM8B;ATP5ME;ATP5F1E;ATP5PD;ATP5MC3;ROMO1;MICOS13
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),0.37704003459135765,0.8394882309180137,0.7222222222222222,0.9119849190932949,1.0,2/18,6.56%,NMNAT2;KYNU
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),-0.5066663653957013,-0.838946948098907,0.6885245901639344,1.0,1.0,1/8,7.06%,LRRC19
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),-0.40544205616151024,-0.8387183244600741,0.7014925373134329,1.0,1.0,2/30,5.32%,ANXA1;AQP1
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),-0.5548869105529608,-0.8386397109769439,0.7021276595744681,1.0,1.0,1/5,5.68%,PLN
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),0.3843681011217515,0.8386346715881365,0.6410256410256411,0.9132342937872815,1.0,5/16,15.74%,SLC39A11;SLC30A4;SLC30A9;SLC30A1;TRPM2
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),-0.48997416434150554,-0.8385847227443951,0.703125,1.0,1.0,2/9,7.00%,VIL1;SEMA5A
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),0.43190369882280655,0.8385076052117574,0.7037037037037037,0.9130339251941063,1.0,3/15,3.18%,CACNA1G;CACNA1I;RAB27A
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),0.4508447463830473,0.8383438276448005,0.7058823529411765,0.9130193808346957,1.0,3/7,18.22%,DNAJB6;KLHL24;MTM1
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),0.385319259511076,0.8381953962572192,0.696969696969697,0.9129009114309573,1.0,3/17,9.70%,BIN1;NTRK2;IGF1
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.39809768238431675,-0.8377537238902794,0.7183098591549296,1.0,1.0,5/21,10.71%,COL5A1;ITGA5;CEACAM1;PDPN;CCN1
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),-0.48870543629685204,-0.8376212485830709,0.6666666666666666,1.0,1.0,2/9,23.24%,CHST9;XYLT2
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),0.40222902383227344,0.8374902114634327,0.71875,0.9137101796122781,1.0,3/15,18.01%,MGAM;PGM2;PYGB
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),-0.50783368022785,-0.8374483428306995,0.71875,1.0,1.0,2/7,17.83%,KLF2;KLF4
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),0.2834705251165121,0.8372326719995642,0.7727272727272727,0.9139179442596709,1.0,17/64,17.80%,NR4A2;SH3RF1;CSNK2A1;AKT1;PSMD10;IGF1;PRKN;HGF;CFLAR;ACVR1;CAAP1;TGFBR1;OPA1;BCL2;PHIP;ITGA6;CSNK2A2
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),0.45137114119695576,0.8371951059280213,0.7631578947368421,0.913628710823332,1.0,3/10,19.82%,PRKN;HIF1A;REST
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.4887638634287497,-0.8371435140416867,0.7727272727272727,1.0,1.0,1/11,2.68%,SLC51B
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",0.27882608577887097,0.8370290554851874,0.85,0.9136139674308171,1.0,23/79,25.97%,TBC1D5;BAIAP3;VTI1A;RHOBTB3;ARFRP1;RAB9A;PIKFYVE;TRAPPC10;SNX5;TBC1D10A;TBC1D23;GGA1;ERC1;PHETA1;VAMP3;SNX1;TBC1D17;VPS54;RIC1;VPS50;VPS51;VPS26B;STX5
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),0.297839761200428,0.8368439022618096,0.8461538461538461,0.9136066451400774,1.0,6/41,7.49%,SEMA5B;AMOTL1;SOX8;ERBB4;AKT1;AMOT
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),0.26277292431610527,0.8366188780190775,0.9473684210526315,0.9136215495531085,1.0,24/112,16.21%,NRIP1;ADCY1;PDE3A;PDE12;LCOR;EGFR;SLC26A3;RORA;CCDC62;RAPGEF2;NCOA3;NR3C1;PKD2;GOLPH3;SSH1;RAP1A;AHR;GABRB1;GNAI1;PDE2A;ROCK2;HRH1;TRPM2;IMPACT
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.4354409732151181,0.8365375440403782,0.75,0.9134069117645898,1.0,5/12,21.99%,EPHA4;ARHGAP35;CNTN4;CDK5R1;EPHB3
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),0.3489552555165228,0.8362851368164724,0.7307692307692307,0.9135106976910651,1.0,6/24,18.01%,NR1D1;PGM2;UGP2;GSK3B;PGM1;PYGB
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),0.376419039598763,0.8361549169366488,0.6764705882352942,0.9134072442220003,1.0,3/18,8.24%,NPTN;MPP2;TSHZ3
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),-0.45880990247042536,-0.836014597379955,0.7213114754098361,1.0,1.0,3/14,16.26%,IL7;RHOH;XBP1
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.3301832792772372,-0.8353891269157052,0.7840909090909091,1.0,1.0,10/95,12.43%,ACOT2;LIPI;ACOT1;HSD17B8;ACOT6;ANGPTL3;PNPLA3;ACSM6;ACSBG2;ACSM5
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),0.4077894485473357,0.8351996029369361,0.7435897435897436,0.9148347942338486,1.0,3/13,8.27%,PLIN5;AKT1;IRS1
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.4089101935386962,-0.8348157948983774,0.7428571428571429,1.0,1.0,4/29,15.55%,ARG2;B2M;RSAD2;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),0.29321572309282967,0.8347686133707768,0.8823529411764706,0.9152484231638188,1.0,26/86,19.31%,MTCL1;ARHGEF16;EGFR;MFF;EPHA2;AKT1;PIK3R1;PTPN9;PRKN;PRKCE;TP53BP2;CLIP3;ZDHHC5;BCL2;ATP2B4;DLG1;YWHAG;MAPK8;TFDP2;AKT2;FYN;WNK3;CIB1;MIEF2;ARF6;YWHAZ
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),0.4426717974858252,0.8347622131017477,0.8292682926829268,0.9149079423812679,1.0,4/12,19.92%,SDE2;RFWD3;FBXO31;WAC
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.41604983061509576,0.8347438193360601,0.6785714285714286,0.9146194317170572,1.0,1/13,0.76%,LEPR
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.42437304233140116,-0.8345661593740159,0.7341772151898734,1.0,1.0,4/22,13.16%,RAB7B;CD14;LY96;TLR3
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),0.49090617827513866,0.8342955409213091,0.6578947368421053,0.9151655928128571,1.0,1/7,4.14%,CXCL12
prerank,PanglaoDB_Augmented_2021__Stromal Cells,-0.3432552384283483,-0.8342359309365327,0.8170731707317073,1.0,1.0,24/89,21.24%,LMOD1;SPARC;COL5A1;SNED1;AQP1;COL6A2;ANGPTL2;ELN;C1R;TLR3;FBLN5;TNC;COL4A2;MADCAM1;PAMR1;SOD3;ADGRL4;C1S;THBS2;MMRN2;TAGLN;SRPX2;COL14A1;EDNRA
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),-0.43417770387150684,-0.8340695130107878,0.7096774193548387,1.0,1.0,3/16,14.27%,RDX;ATP5IF1;APOE
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),-0.4348129640898286,-0.8335540380609219,0.7096774193548387,1.0,1.0,1/17,2.03%,GBP1
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),0.4495790250482635,0.8333738870118839,0.7272727272727273,0.9162944961012639,1.0,5/10,32.30%,MEST;MESP1;GDF11;JAK2;TBX6
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.39916181591125355,0.833314161587027,0.7272727272727273,0.9160574402257363,1.0,5/12,34.89%,ALG6;ALG13;ALG2;MPDU1;ALG12
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),-0.48917012549101546,-0.8332702011705647,0.7076923076923077,1.0,1.0,2/9,5.95%,ANXA1;CEACAM1
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),0.3348217384478076,0.833214382799246,0.5833333333333334,0.9158426926068732,1.0,7/31,18.80%,AP3S1;AP3B1;RAB21;KIF1B;OPA1;HIF1A;FBXW11
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),-0.5180807064763514,-0.8331545458929104,0.7719298245614035,1.0,1.0,2/6,26.08%,PRELID1;ARL6IP5
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),0.46773424876636543,0.8330249866351476,0.6428571428571429,0.9157682012247994,1.0,4/7,30.74%,DCLRE1C;DCLRE1A;TERF2IP;TERF2
prerank,GO_Biological_Process_2021__water homeostasis (GO:0030104),-0.5061837449014758,-0.8327569560206263,0.7166666666666667,1.0,1.0,3/5,21.40%,AQP1;AQP11;CLN3
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.4896014531663505,-0.832505024726335,0.6949152542372882,1.0,1.0,2/6,16.11%,SVIP;AQP11
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),-0.505186819008009,-0.8324891904778878,0.6825396825396826,1.0,1.0,2/8,11.51%,CMPK2;AK7
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),-0.46175359324324206,-0.8322288556904559,0.7777777777777778,1.0,1.0,4/15,15.12%,P2RY12;THBS1;CXCL17;CX3CL1
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,0.36224322981649537,0.8322015107597975,0.7619047619047619,0.9168656821634507,1.0,4/22,13.94%,ABCC8;FOXO1;PAK3;SRPRB
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),0.2565846543003808,0.8320861477329253,1.0,0.9167540208578624,1.0,31/129,18.14%,LIMD1;CCDC88C;MLLT3;AMER2;SOX9;BMP2;PSMA1;INVS;TLE2;FRZB;PSMD11;TMEM170B;PSMD10;GLI3;PRKN;PSMF1;DVL1;PSMD14;DACT3;TMEM131L;SCYL2;SOX13;BICC1;GSK3B;LATS1;STK11;PTPRO;PSME4;CUL3;LRP4;RBMS3
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),-0.44152131027755426,-0.8319922625641362,0.7384615384615385,1.0,1.0,1/12,4.16%,ABCA12
prerank,GO_Biological_Process_2021__somite development (GO:0061053),-0.5329500714323312,-0.8319004557354126,0.7413793103448276,1.0,1.0,2/8,10.31%,SFRP2;MEOX1
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),0.42549216247603233,0.8318875451200102,0.7272727272727273,0.9168044731797756,1.0,3/12,11.86%,PLPP1;PLPP2;PLPP3
prerank,GO_Biological_Process_2021__regulation of epithelial cell apoptotic process (GO:1904035),0.49338414812227915,0.8318694641073678,0.8478260869565217,0.916523589758826,1.0,2/8,15.23%,BOK;YAP1
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.4689278750315283,-0.8317741498127713,0.7096774193548387,1.0,1.0,2/10,14.90%,PSMC3;PSMC4
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),0.3922713399440344,0.8317343597521796,0.6451612903225806,0.9164489816317702,1.0,5/15,16.96%,PUM2;ANKRD17;SEC14L1;BIRC2;PUM1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),-0.5335609411442037,-0.8315787596822586,0.7735849056603774,1.0,1.0,1/5,12.90%,FGF1
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),0.46850479794508115,0.831509251916643,0.6341463414634146,0.9165215618897704,1.0,1/8,1.93%,FOXP1
prerank,GO_Biological_Process_2021__intestinal epithelial cell differentiation (GO:0060575),0.5170508567002637,0.8314534018657908,0.6842105263157895,0.9162705194289726,1.0,4/5,31.25%,YAP1;NPY;IL6ST;SRC
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),0.5092468885643011,0.8313540846402321,0.7,0.9157690037646583,1.0,2/5,22.83%,PCID2;DYNC1LI1
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),0.5092468885643011,0.8313540846402321,0.7,0.9157690037646583,1.0,2/5,22.83%,PCID2;DYNC1LI1
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),-0.4529113212253951,-0.8312269628357252,0.6891891891891891,1.0,1.0,4/12,17.92%,RPP38;POP5;RPP25L;TRMT10C
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),0.38049472107484494,0.8311333505228582,0.5806451612903226,0.9157903128730279,1.0,6/15,24.16%,BMPR1B;ACVR1;NBL1;BMPR1A;AIDA;FBXL15
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.3974460809699811,-0.830642912124002,0.8088235294117647,1.0,1.0,6/31,14.33%,ANAPC15;RPS27A;ANAPC11;UBC;CDC26;UBE2S
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),0.3268797990088458,0.8306229323992633,0.6666666666666666,0.9164504212689657,1.0,12/35,25.05%,ITPKB;TPK1;GPHN;GPAM;GK;IP6K2;IPPK;GK5;FGF2;AGPAT5;LPCAT1;IPMK
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),0.39557056216496855,0.8305826219551395,0.6923076923076923,0.9162145593749743,1.0,3/14,15.70%,RBFOX2;TRIP4;PADI2
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.32718041236959305,-0.8303890515912231,0.8470588235294118,1.0,1.0,12/151,9.26%,THSD4;PRSS23;OVOL2;MYOF;PDZK1;KAZN;RASGRP1;SVIL;SH3BP5;PGR;HES1;ALDH3B1
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.4136139605051676,0.8303073543553233,0.6875,0.9163163850282725,1.0,7/16,20.53%,KAT2B;MAML2;PBX1;EP300;MAML1;RBPJ;CREBBP
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.46544942943511847,0.830074314078875,0.6744186046511628,0.9164474714457288,1.0,2/6,18.62%,ADARB1;PPM1F
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),-0.4090143403954892,-0.8299788086082158,0.7702702702702703,1.0,1.0,2/24,1.98%,KMO;ACMSD
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),-0.4688266577889481,-0.8299534254018531,0.6911764705882353,1.0,1.0,2/11,12.48%,PNP;NT5C
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),-0.4654574061072595,-0.8299294951249782,0.6818181818181818,1.0,1.0,2/9,10.84%,APOBEC3G;APOBEC2
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.31146690899488755,0.8298612392487131,0.8333333333333334,0.9164904794378066,1.0,8/54,9.03%,HNRNPH1;SPRED2;FLRT2;CBL;FGF17;SPRED1;SHOC2;RBFOX2
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.28922807232402403,0.8296555733324693,0.8823529411764706,0.9165554416088643,1.0,17/70,17.21%,PPARGC1A;SNCA;PDE12;SOX4;ADNP2;INPP5A;RAD18;AKT1;NPAS2;PRKN;PRKD1;NCK1;GSK3B;BMP7;IMPACT;CD200R1;FYN
prerank,GO_Biological_Process_2021__positive regulation of type I interferon-mediated signaling pathway (GO:0060340),-0.5466542061513338,-0.829606584545148,0.7291666666666666,1.0,1.0,2/5,23.32%,WNT5A;NLRC5
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),0.29678661828794156,0.8295854762633253,0.8636363636363636,0.9162980061791957,1.0,16/56,19.69%,EFNA5;AJAP1;LIMCH1;PLEKHA2;MAP4K4;NF1;BST1;GPM6B;PTK2;CLASP1;CDH13;GSK3B;ROCK2;CIB1;UTRN;ROCK1
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),0.38087789922972787,0.8294974205379958,0.84375,0.9160554113670051,1.0,3/14,17.54%,NCKAP5;CKAP5;KATNB1
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),0.5202362658582117,0.8293736316948893,0.7674418604651163,0.9159520904218326,1.0,3/6,16.54%,ADIPOR2;PRCP;NDNF
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.36583641081005774,0.829288487627653,0.71875,0.9158122580805472,1.0,13/23,23.18%,MARVELD3;DCN;DUSP10;SLIT2;PTPRG;ADIPOR1;ADGRB1;PTEN;PTPN23;MCC;VASH1;PTPRR;DNAJA4
prerank,PanglaoDB_Augmented_2021__Eosinophils,-0.35925557106399303,-0.8292862536329404,0.7125,1.0,1.0,11/34,16.56%,IL5;TAGAP;CLEC12A;DPEP2;GMFG;ARHGAP9;TRAF3IP3;PGLYRP1;SPI1;ARHGAP30;MYO1F
prerank,GO_Biological_Process_2021__cell migration involved in heart development (GO:0060973),-0.4763115732152352,-0.829190136364163,0.6956521739130435,1.0,1.0,2/5,25.23%,TBX5;FLRT3
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.3691614732277823,-0.8287280398036994,0.6901408450704225,1.0,1.0,14/46,26.68%,RPS27A;RPA3;UBC;SLX4;FANCI;RAD51AP1;RNF8;UBA52;MUS81;HROB;UBB;DCLRE1B;XRCC3;CENPX
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),-0.45337793459886566,-0.8286476899354471,0.7692307692307693,1.0,1.0,1/14,4.59%,SFRP4
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),0.40891190795933924,0.8281469045651227,0.6578947368421053,0.917435465383478,1.0,4/13,21.84%,TTLL12;MTHFR;JARID2;NSD1
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),-0.4797102420175927,-0.8276704732627818,0.6557377049180327,1.0,1.0,2/10,20.89%,HES1;CRLF2
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),0.47919598916371275,0.8272001119305076,0.631578947368421,0.918699147622869,1.0,4/7,40.47%,SERPINE2;GAS1;LRRK2;PRNP
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),-0.5282626167072034,-0.8268856895787589,0.7358490566037735,1.0,1.0,2/6,9.23%,TTN;RDX
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),-0.43653263474775933,-0.8267173579820818,0.6721311475409836,1.0,1.0,9/15,28.34%,S100A10;CAV3;EMP2;NAXE;CLN3;ANXA2;FLOT1;RFTN1;NPC1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.4139854064949363,-0.8264445544820259,0.6111111111111112,1.0,1.0,1/13,10.79%,SLX4
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),0.2911979916426357,0.8264144740240691,0.7272727272727273,0.919881474339149,1.0,13/103,8.04%,TXNIP;RCN3;SLC6A13;ABCC2;SLC15A3;SLC43A1;LRP1B;SLC15A2;CMTM6;SLC12A2;CHMP1A;SLC7A11;CEP290
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),0.2734845255988806,0.8263800356633925,0.8125,0.9196015456973273,1.0,22/95,19.22%,CDC25A;SNCA;CSF1R;TESK1;CCNG2;AKT1;CCNA2;CDK12;CDK5R2;RALB;DUSP19;ADRB2;SIRT1;INCENP;RPTOR;CCNT2;TRIB2;CAB39;CIB1;CDK5R1;CCND3;MAP2K2
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),0.4690239451205933,0.8262097478126693,0.6666666666666666,0.9196285990978509,1.0,1/7,1.98%,SAMHD1
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.3536668736638589,-0.8259898234265606,0.7808219178082192,1.0,1.0,8/60,15.52%,SELP;ACKR4;P2RY12;HTR2B;PPP1R9A;RCAN3;CXCR4;FIS1
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),0.4443573981576686,0.8259495727721884,0.7105263157894737,0.9197432483318209,1.0,2/10,13.00%,BMP2;NBL1
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),0.3054451680295952,0.825777848816592,0.9090909090909091,0.9197921240459263,1.0,8/56,11.15%,CHRNA4;SNCA;SYT3;NEDD4L;CA2;KCNA2;PRKN;NKAIN2
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),0.44500404696699225,0.8256058012096752,0.7,0.9197388209490592,1.0,3/12,14.99%,CGNL1;TJP1;SCRIB
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.3667119500050011,-0.8250943865696885,0.7380952380952381,1.0,1.0,9/42,19.90%,RPL23;DDX11;CDK5;CACNB1;XBP1;RIPK2;PTPN22;SNX6;GPER1
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),0.527458960554775,0.8250841753797271,0.7142857142857143,0.9202398357107424,1.0,2/6,3.46%,EPHA4;PICALM
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),0.41761448739773105,0.8249708133397958,0.75,0.9200770487857701,1.0,5/13,24.68%,ANP32B;GSK3B;BAG3;TCF7L2;GAS6
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.40078436747139295,0.8249347410163018,0.6857142857142857,0.9197613429717909,1.0,7/17,18.55%,RAB27A;KIF5A;TESK1;KIF5C;SYNJ1;TMEM230;DNM2
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),-0.44970080242985766,-0.8248354887689078,0.631578947368421,1.0,1.0,1/11,0.80%,DOCK8
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),-0.43888588880948354,-0.8248344381329998,0.7076923076923077,1.0,1.0,2/13,5.32%,ANXA1;AQP1
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),0.2767435445214476,0.8246272135784662,0.8888888888888888,0.92001409844851,1.0,19/69,18.59%,HNRNPH1;RBM12B;MBNL2;QKI;DYRK1A;PIK3R1;KHDRBS3;HNRNPLL;MBNL1;HNRNPH3;U2AF2;JMJD6;CLK1;PTBP2;RBM38;CELF1;SRPK2;PTBP1;KHDRBS2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.39971053861414463,-0.8244843818381486,0.6962025316455697,1.0,1.0,3/23,10.62%,RPS27A;RPA3;UBC
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.4295087850499344,-0.82446011207568,0.6710526315789473,1.0,1.0,5/20,23.08%,WARS1;SFRP1;SP100;EMP2;RNH1
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),0.30919172060559325,0.8243713108530017,0.8125,0.9201428671298796,1.0,9/64,10.77%,CHST8;CHST11;FUT9;CSGALNACT1;CANT1;BMPR1B;LARGE1;IGF1;GOLPH3
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,-0.3391865694225549,-0.8243286014177114,0.8295454545454546,1.0,1.0,26/92,21.24%,LMOD1;IGFBP5;AQP1;COX7A1;ANGPTL2;ELN;C1R;WNT2B;MGP;MATN2;RASD1;SAT2;GSTM3;COL4A2;PAMR1;SOD3;CRYAB;ADGRL4;C1S;CPXM2;THBS2;TNS2;TAGLN;CALD1;COL14A1;EDNRA
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),0.4044041474071185,0.8242943747697403,0.6578947368421053,0.9199148449963072,1.0,1/10,4.21%,LTC4S
prerank,GO_Biological_Process_2021__regulation of chloride transport (GO:2001225),-0.558778161967233,-0.8241688363056882,0.8421052631578947,1.0,1.0,2/5,23.37%,GABRE;ATP8B1
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),0.48713602956742896,0.8233479150838321,0.7021276595744681,0.9211714511695586,1.0,1/6,5.21%,BAIAP3
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),-0.4524398701537756,-0.8233384672214958,0.6607142857142857,1.0,1.0,2/9,18.02%,CCL2;DDIT3
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),0.25281624022382115,0.823270551004971,1.0,0.921015955150072,1.0,36/147,18.14%,LIMD1;CCDC88C;MLLT3;AMER2;SOX9;BMP2;PSMA1;INVS;TLE2;FRZB;NLK;PSMD11;TMEM170B;PSMD10;GLI3;PRKN;PSMF1;DVL1;PSMD14;DACT3;TMEM131L;WWOX;SCYL2;SOX13;VGLL4;BICC1;GSK3B;LATS1;STK11;PTPRO;PSME4;ALPK2;CUL3;CXXC4;LRP4;RBMS3
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),-0.5168841690476041,-0.8229968842773218,0.7142857142857143,1.0,1.0,1/5,2.15%,GPR183
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.39679797222796903,-0.8228806421196977,0.704225352112676,1.0,1.0,6/19,23.41%,PRKCQ;CCL2;SKAP1;CD44;HLA-DPB1;HSPD1
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),0.439584422255363,0.8226278062266502,0.75,0.9218203884185411,1.0,2/12,11.23%,HNRNPU;RBM15B
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),-0.4508806809803301,-0.8225989968438686,0.6885245901639344,1.0,1.0,3/11,17.21%,CD14;LY96;SCIMP
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),-0.5289687069649682,-0.8221278398788295,0.7758620689655172,1.0,1.0,3/6,27.42%,KCNK13;KCNK1;CHCHD10
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),0.4833124161065417,0.8219321221120385,0.7,0.9225588029113135,1.0,2/6,9.05%,TNFSF4;SMAD7
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),0.5179038653018823,0.8219013899431554,0.7027027027027027,0.9222576452516436,1.0,2/6,12.84%,BAHD1;SIRT1
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",0.44241105686196525,0.8217733430060126,0.7096774193548387,0.9221237653109066,1.0,3/11,9.56%,USP46;BAIAP3;ADRA1A
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.407440707548679,-0.8215883951093388,0.7272727272727273,1.0,1.0,4/22,16.80%,STAT1;STAT2;CCL2;CTR9
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.28510104175719336,0.8213128310798058,0.8421052631578947,0.9226071235789204,1.0,22/56,24.59%,ANO5;GABRG1;GABRA5;SLC12A2;GABRA4;GLRB;SLC37A1;GABRB1;SLC37A2;SLC12A8;SLC25A14;GABRG3;ANO4;CLCN3;SLC12A9;SLC6A1;GABRB3;SLC37A3;GLRA3;GABRR2;LRRC8A;SLC12A6
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),-0.33353928419307627,-0.8212912978908747,0.7613636363636364,1.0,1.0,14/99,18.93%,SFRP2;MT1H;BST2;MT1G;SFRP1;CRLF3;HYAL1;MT2A;MT3;MT1A;MT1E;TCHP;BTG1;MT1F
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),-0.4386933809450165,-0.8211312962611373,0.7571428571428571,1.0,1.0,1/12,3.54%,APLNR
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),0.447298533273319,0.8210434998252384,0.696969696969697,0.9227635227171119,1.0,1/9,3.44%,NR4A2
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.2770183380188921,0.821006667512468,0.9375,0.922462738158499,1.0,19/56,24.15%,SPRED2;SMAD2;SPRED1;PPM1A;SMAD7;ZNF451;SMURF1;TGFBR2;SIRT1;TGFBR1;WFIKKN1;LEMD3;SNX25;SKIL;HSPA1A;SPRED3;SMAD3;SLC2A10;PRDM16
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.40821102311287366,0.820733545363277,0.6666666666666666,0.9226480837809253,1.0,6/13,30.26%,UBR3;USP22;CELF1;RICTOR;TGFB2;CAMSAP3
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),0.4613015045726275,0.8202768409445318,0.7619047619047619,0.9232610188443755,1.0,3/10,15.17%,GCLC;BDH2;GGCT
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.3393910863223581,0.8201427304753622,0.8235294117647058,0.9231560520020887,1.0,13/32,16.12%,CDIP1;AEN;BOK;ZNF385B;EP300;TP53BP2;SIRT1;HIPK2;JMY;DYRK2;STK11;PDK2;MSH2
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),-0.5060373266299962,-0.819794270325027,0.7076923076923077,1.0,1.0,1/6,19.29%,NDUFA12
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.2670728451929038,0.8197916511725946,0.8666666666666667,0.9234351069929317,1.0,23/104,18.05%,CCDC88C;NUP42;EGFR;NUP37;NUP188;TESK1;EP300;NUP153;PTK2;SIRT1;OGT;SIRT2;FER;NDC1;NRP1;PHIP;PTGES3;BMP7;NUP205;HIF1A;ITGA6;BCL10;NUP214
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),0.29770331356820423,0.819756760008596,0.8,0.9231491154723307,1.0,7/49,12.30%,ABCA1;ATP11C;PRELID2;ATP9A;MTTP;ATP10A;ATP8A1
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.3193629080258299,-0.8197451617708571,0.7674418604651163,1.0,1.0,12/113,11.26%,PSMB6;SFRP2;SFRP4;PSMB9;PSMA8;SEMA5A;GPC3;NRARP;PSMA7;PSME1;PSMC3;SFRP1
prerank,GO_Biological_Process_2021__positive regulation of protein maturation (GO:1903319),0.4834819464423842,0.8195819406491816,0.6666666666666666,0.9231528899062853,1.0,2/7,4.12%,SOX4;RHBDD1
prerank,GO_Biological_Process_2021__depurination (GO:0045007),0.4520539359322084,0.8195715011156544,0.6976744186046512,0.9228165633690191,1.0,3/8,30.74%,POT1;TERF2IP;TERF2
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),0.3965616907406778,0.8195330862722283,0.6,0.9225528214656067,1.0,2/11,12.84%,FOXP1;SIRT1
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),-0.33632301283784605,-0.8188718658162539,0.8214285714285714,1.0,1.0,19/78,26.27%,MRPL20;MRPL40;MTRF1L;MRPL51;MRPL27;MRPL54;GADD45GIP1;MRPS33;MRPL36;MRPL34;AURKAIP1;MRPS21;MRPL23;MRPS34;MRPS26;MRPL21;MRPS22;OXA1L;MRPS16
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.362609487279962,0.8188401899486759,0.7142857142857143,0.9230017141748381,1.0,6/19,15.47%,ZEB2;MEN1;EP300;HIPK2;SMAD4;STK11
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.362609487279962,0.8188401899486759,0.7142857142857143,0.9230017141748381,1.0,6/19,15.47%,ZEB2;MEN1;EP300;HIPK2;SMAD4;STK11
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.3546552445718299,0.8186985034703272,0.7307692307692307,0.9228465781201771,1.0,6/22,10.42%,IRAK2;TAB3;UBE2N;ITCH;MAP3K7;TAB1
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),0.4086733055998237,0.8185883868572236,0.6666666666666666,0.9223272713923732,1.0,4/12,18.14%,RAB27A;MKKS;BBS2;MYO5A
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),0.4086733055998237,0.8185883868572236,0.6666666666666666,0.9223272713923732,1.0,4/12,18.14%,RAB27A;MKKS;BBS2;MYO5A
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,0.3453231677072148,0.8184518253765103,0.8275862068965517,0.922186993102928,1.0,8/35,14.52%,MYO5B;ARHGEF16;MAP2K4;FZD5;LGR4;SMAD5;HNF4G;EPCAM
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.41262519949636545,-0.8181519141686268,0.78125,1.0,1.0,5/19,17.23%,STAT1;APOBEC3G;PQBP1;DTX3L;PTPN22
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.3592580292580271,0.8178216390155969,0.8064516129032258,0.9227610693587682,1.0,3/25,8.20%,SDC4;GPC5;CTBS
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),0.3056591256891108,0.8177924022762385,1.0,0.9224981306561114,1.0,8/38,10.74%,IRAK2;TAB3;CTSK;RPS6KA3;MAP3K7;HMGB1;TAB1;MAPKAPK2
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.46772491915300046,-0.81758605224253,0.7285714285714285,1.0,1.0,3/11,15.64%,UQCRQ;UQCRFS1;UQCR10
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.2348805753144359,0.8175424491337505,1.0,0.9225670147765674,1.0,72/351,21.66%,LIMD1;VPS37B;SPAG16;FHDC1;MACIR;PARVA;CILK1;EXOC2;SEPTIN6;RAB3IP;EHD4;CYS1;UBAP2L;CHMP1A;RFX3;VPS37A;RAB8B;RAB23;SSX2IP;EXOC5;TTBK2;CEP290;G3BP1;EXOC8;ATG7;PIK3C3;EXOC6;ANLN;DZIP1;TTC8;DYNLL2;PRRC2C;SEPTIN7;KIAA0586;CHMP2B;EXOC4;BBS9;MAPRE1;UBQLN1;SH3PXD2B;CEP20;RP2;LZTFL1;TMOD2;CDC14A;RAB1A;ATG2B;UBQLN2;POGZ;ATAT1;VTA1;MKKS;BBS2;YTHDF2;ATG5;LSM14A;EDC3;NSFL1C;STX7;UBXN2B;STX12;DDX6;STAM2;TCTN1;PCM1;PTPN23;TSG101;GORASP2;ACTR3;CHMP6;YTHDF3;RB1CC1
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.43339641905902737,0.8173859005342146,0.7368421052631579,0.9224268556011967,1.0,1/9,3.00%,STMP1
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.32199723296698224,0.817336483338037,0.7222222222222222,0.922257984451488,1.0,9/45,13.33%,ANXA4;MAPKBP1;ARRB1;IL17D;SERPINE1;HMGB1;CD58;SSC5D;MAP2K5
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),-0.502783640992756,-0.8172750197333273,0.6964285714285714,1.0,1.0,1/6,8.94%,HES1
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),-0.502783640992756,-0.8172750197333273,0.6964285714285714,1.0,1.0,1/6,8.94%,HES1
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),-0.3754220352384509,-0.8172519177691797,0.8095238095238095,1.0,1.0,3/27,7.71%,CCDC39;DNAAF1;CFAP73
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.33507179853481395,0.8171503877280535,0.7777777777777778,0.9222620693628298,1.0,14/31,27.19%,SOX9;NFIB;FOXO3;NR3C1;HIF1A;NFATC3;ATOH8;REST;FGF2;SMAD3;TEAD1;RELA;PPARD;TGFB2
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),-0.4646236536382796,-0.8169050110559596,0.75,1.0,1.0,2/11,14.15%,DDX11;DTX3L
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),-0.5378440564849484,-0.8165058855277257,0.7333333333333333,1.0,1.0,2/7,13.16%,PRDX4;TLR3
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),-0.48985134288207577,-0.8161499316147697,0.7536231884057971,1.0,1.0,1/8,15.22%,SUV39H1
prerank,PanglaoDB_Augmented_2021__Myocytes,0.28790535355841507,0.8160623191365995,0.8125,0.9237850609797065,1.0,14/82,13.21%,TCAP;ANKRD2;ENO3;PRKG1;CASQ1;ARHGAP26;PRRX1;CHODL;TRIM54;CLOCK;ADAM12;PTK2;SGCD;MYH14
prerank,GO_Biological_Process_2021__negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),-0.5385151407315474,-0.815830489146283,0.7413793103448276,1.0,1.0,3/5,13.16%,CD14;LY96;TLR3
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),0.3951510529205438,0.8157201270922272,0.627906976744186,0.9239612807452994,1.0,3/8,9.74%,ABCC8;TRPM4;PKD2
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.3246593168013938,0.8156997997223743,0.8461538461538461,0.9236482258641836,1.0,2/19,3.89%,MAIP1;MCU
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),0.3704376076475506,0.8156503991750009,0.7741935483870968,0.9234288808223072,1.0,5/21,15.74%,ADO;GCLC;AHCY;SMS;MTHFR
prerank,GO_Biological_Process_2021__polyphosphate catabolic process (GO:0006798),-0.5165618583609989,-0.815389176247357,0.7419354838709677,1.0,1.0,2/5,30.71%,BNIP2;PRUNE2
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,-0.36625174122827386,-0.8150855912627452,0.75,1.0,1.0,10/41,15.80%,CD24;CFTR;OVOL2;AQP1;EFNA1;TMC4;GPX2;B3GNT3;ERBB3;PPL
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.5332699673370188,-0.8150590136016053,0.7272727272727273,1.0,1.0,1/5,14.92%,CCL2
prerank,GO_Biological_Process_2021__positive regulation of deoxyribonuclease activity (GO:0032077),-0.5299776386528229,-0.8145763806133202,0.75,1.0,1.0,1/5,7.15%,DDX11
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),0.3602000157298476,0.8145429164323412,0.6896551724137931,0.9249923168486877,1.0,5/21,19.41%,ANK2;NEDD4L;DLG1;CAB39;NETO1
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.36915597604801126,-0.8144020298044536,0.7631578947368421,1.0,1.0,12/33,24.26%,SPINK6;TIMP1;CST3;CSTB;SERPINF1;SPINK5;SERPIND1;TIMP2;AGT;PARK7;SPOCK2;GAPDH
prerank,PanglaoDB_Augmented_2021__Microglia,0.2967162162264549,0.8137633926910465,0.8,0.9260013274644892,1.0,7/59,5.80%,C1ORF162;SALL1;CSF1R;LTC4S;CMTM6;APBB1IP;PLEK
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),0.47915863677348125,0.8134970531545186,0.8,0.9261261243430412,1.0,2/7,15.83%,NF1;SMO
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),0.2877158740708413,0.8132334514189895,0.8695652173913043,0.9261646688563695,1.0,6/72,3.92%,EPHA4;PASK;SOX4;PICALM;CPEB3;ZCCHC4
prerank,GO_Biological_Process_2021__regulation of leukocyte tethering or rolling (GO:1903236),-0.5129947002562087,-0.8130807756559634,0.7301587301587301,1.0,1.0,2/5,7.72%,SELP;CCL28
prerank,PanglaoDB_Augmented_2021__Osteoclasts,0.25141015035955827,0.8128920844416763,0.9523809523809523,0.9263897964269351,1.0,15/87,16.81%,PID1;ABCA1;CSF1R;SLC15A3;CTSK;NRP2;KCNMA1;CA2;EFNB2;ARHGEF10L;TNFAIP6;SMAD4;GRM8;SEMA4D;HIF1A
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),0.435670469079081,0.812784824061874,0.7714285714285715,0.9263564680237193,1.0,5/9,18.01%,SPX;PRCP;DDAH1;PLCB3;DRD2
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),-0.35746693213543973,-0.8127437480216786,0.7792207792207793,1.0,1.0,3/48,5.74%,CD24;RASGRP1;HTR2B
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),0.42737618208288697,0.8123649823814793,0.75,0.9264404429061298,1.0,4/10,21.18%,FTO;ASCC3;ASCC1;ALKBH5
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),0.42737618208288697,0.8123649823814793,0.75,0.9264404429061298,1.0,4/10,21.18%,FTO;ASCC3;ASCC1;ALKBH5
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.3270888263941587,0.8121888093466743,0.84,0.9263784655540167,1.0,4/28,7.71%,BRINP3;SOX9;ADNP2;ABL2
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),0.4247149341021019,0.8121593075396705,0.7297297297297297,0.9260801171531619,1.0,1/7,2.40%,SNCA
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),0.408563426786117,0.8119326682634659,0.7105263157894737,0.9261758712686176,1.0,2/10,9.98%,ATG7;PIK3C3
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.41923939689802575,-0.8117823394738208,0.6567164179104478,1.0,1.0,6/12,24.70%,CD14;CCL2;IL18;PTPN22;CD6;TGFB1
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.3444386166242027,0.81176697846324,0.7714285714285715,0.9261713307272086,1.0,3/30,5.75%,ANK2;HOMER1;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.34740718332620596,0.8116124532520799,0.8,0.9261596372954097,1.0,6/25,9.56%,FLT1;EGFR;PDGFRA;NTRK2;ABL2;ADRA1A
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),0.44610483421908076,0.8115735447594897,0.6842105263157895,0.9258403476763963,1.0,1/8,3.61%,GLS
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),-0.4858255945200155,-0.8113744475148187,0.7358490566037735,1.0,1.0,2/6,14.27%,ABCA12;APOE
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),0.5232903053518482,0.811295396513418,0.717948717948718,0.9259360491081503,1.0,1/5,15.97%,HLA-DRA
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),-0.36552864020839304,-0.811194760035145,0.8026315789473685,1.0,1.0,1/40,0.19%,PIF1
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),-0.4749001043612611,-0.8111577496596122,0.6949152542372882,1.0,1.0,1/6,14.92%,CCL2
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),0.45450088911108877,0.8111209022902378,0.6842105263157895,0.9258529716760537,1.0,4/13,10.77%,FHDC1;VTI1A;TRIP11;GOLPH3
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.3350441760455132,-0.8106816686168667,0.7631578947368421,1.0,1.0,6/53,12.13%,SFRP2;P2RY12;ECM2;IL12A;HYAL1;NODAL
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),-0.3867567907195642,-0.8105474717458577,0.7466666666666667,1.0,1.0,3/36,10.15%,TLCD1;S100A10;CHMP2A
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),-0.4815653814960231,-0.8103202612062211,0.7205882352941176,1.0,1.0,1/8,3.86%,MST1
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),-0.37738067493853006,-0.8102267709068661,0.6933333333333334,1.0,1.0,3/26,14.17%,KCNJ13;KCNQ1;KCNJ8
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.30723802154015356,0.8101958090765708,0.8571428571428571,0.9268846864899536,1.0,13/41,24.02%,SNCA;PIP4P2;PRKN;PRKD1;MTMR2;NRG1;NDFIP1;PTEN;PPM1F;NDFIP2;SIRPA;LRSAM1;PXK
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),0.40439106782790235,0.8101847981362701,0.6764705882352942,0.9265513135280807,1.0,1/12,3.13%,ERBB4
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),-0.3829082933844222,-0.8094950036360522,0.7428571428571429,1.0,1.0,4/27,16.08%,ANKRD53;CAV3;FES;DRG1
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),0.46457784073742725,0.8094019074370278,0.78125,0.9276891210678733,1.0,5/11,35.33%,SIRT1;AKT3;TERF2;CDK6;SLC30A10
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),-0.4758073351488198,-0.809330816585819,0.7288135593220338,1.0,1.0,3/9,18.21%,FICD;XBP1;COPS5
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),-0.4849211559980797,-0.8092272833991307,0.7666666666666667,1.0,1.0,2/7,26.08%,PRELID1;ARL6IP5
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.3406509279508471,0.8090271709755883,0.8695652173913043,0.9280123791134913,1.0,7/38,11.64%,DGKB;PLD6;ABHD5;DGKH;DGKZ;ACP6;GPAM
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),0.2664035211319712,0.80891884017026,0.75,0.9277859876893608,1.0,18/103,15.87%,CPNE2;ADCY1;SNCA;SYT3;EGFR;ITPKB;SLC12A2;AKT1;PKD2;PRKN;SLC25A24;BRAF;CAMK2D;SYT9;MAPK1;CPNE3;TRPM2;MAPK8
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),-0.4023951748582931,-0.808846219833226,0.7183098591549296,1.0,1.0,1/19,1.63%,RPS23
prerank,MSigDB_Hallmark_2020__E2F Targets,0.24319799455018212,0.8084145812730315,1.0,0.9283443490358873,1.0,30/169,18.89%,NUDT21;CDC25A;XPO1;DUT;EED;HMMR;POLD3;UBE2T;CNOT9;PDS5B;CKS1B;SYNCRIP;HELLS;NAP1L1;NUP153;PLK1;MXD3;LBR;SMC6;DCK;ESPL1;MSH2;NUP205;TFRC;PPP1R8;TUBG1;ASF1A;PPM1D;HNRNPD;H2AX
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.3717864292005223,-0.8079478620386132,0.7538461538461538,1.0,1.0,1/35,1.38%,ISG15
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),-0.3623882044624099,-0.8077029527999288,0.7808219178082192,1.0,1.0,1/35,1.71%,KMO
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.2822823032739241,0.8075391331888687,0.8636363636363636,0.9294014002160671,1.0,8/52,11.33%,TBKBP1;IRAK2;TAB3;AKT1;MAP3K7;TICAM1;TAB1;TRADD
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),0.3998042105178652,0.8073892702946449,0.6470588235294118,0.9292887866150776,1.0,2/13,6.67%,NUDT21;CPSF6
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),-0.51833825360383,-0.8073494098406235,0.7213114754098361,1.0,1.0,2/5,16.26%,CIITA;XBP1
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.344060216062301,-0.8073103695114481,0.7901234567901234,1.0,1.0,10/66,13.82%,LHFPL5;OTOS;MYO3A;TIMM10;MYO3B;TIMM8B;SLC26A5;CLRN1;CEMIP;KCNQ1
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),-0.4123896636253871,-0.8068784416837189,0.8656716417910447,1.0,1.0,4/17,16.72%,HSD17B8;HSD17B7;HSD17B14;DHCR7
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),0.43615052653763753,0.8067637197238962,0.6904761904761905,0.9298032348840664,1.0,5/8,31.00%,RUBCNL;VPS39;PIP4K2B;ARL8B;PIP4K2A
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.3108713355159771,0.8066415790126891,0.75,0.9296050907267638,1.0,5/41,7.71%,BRINP3;ASCL1;SOX9;ADNP2;ABL2
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),-0.495990716319183,-0.8064515591034436,0.6984126984126984,1.0,1.0,1/8,9.42%,GSTP1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),0.49921577324326893,0.8064079869477914,0.6875,0.9296491562924839,1.0,2/5,16.81%,PRKN;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.3244846962811402,-0.8063096723275117,0.8192771084337349,1.0,1.0,9/87,10.85%,GATA1;ENPP2;IL5;PARP14;ITGA5;EFNA1;FGF7;HES1;IL12A
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),0.4129479342846026,0.8062353663164822,0.6829268292682927,0.9296077863009566,1.0,3/9,21.07%,GSTM2;TRPM2;P2RY1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.33572400645186895,-0.8060275345525965,0.7654320987654321,1.0,1.0,9/65,10.62%,PSMB6;RPS27A;PSMB9;PSMA8;ELOB;PSMA7;PSME1;PSMC3;UBC
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),0.22952861684497441,0.8059725326922904,1.0,0.9297798767075832,1.0,62/268,20.48%,ADAMTS3;TLL2;CCDC88C;SNCA;MYO5B;NCKAP5;ZNF207;CRIPT;COL9A1;NCSTN;TSPAN14;COL25A1;CGNL1;LOXL2;RHOBTB3;LOXL1;CARMIL1;COL23A1;CORO6;PLOD2;PRKN;HOOK1;NF1;CAMSAP2;CKAP5;GGA2;CLIP3;TGFBR1;COL15A1;KATNAL1;TSPAN33;COL7A1;DLG1;PLOD1;HDGFL3;DNAJB6;HIP1;USP9X;TMOD2;COL21A1;SLAIN2;KLHL24;RUFY3;ITGA6;CRTAP;KATNB1;MYO5A;MTM1;MDM2;SHROOM3;CIB1;BCAR1;ARHGAP17;TPM2;MPRIP;KATNAL2;GGA1;DDR2;SAMD14;MARCKS;PCM1;TSPAN5
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),0.43134441641085103,0.8059389363105193,0.7647058823529411,0.9295180253726486,1.0,2/8,15.61%,HEXB;NEU3
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.33448996872389,0.8055344075102467,0.7586206896551724,0.9299317333461403,1.0,6/24,10.42%,IRAK2;TAB3;UBE2N;ITCH;MAP3K7;TAB1
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.3332824218418488,-0.8052522279881663,0.8048780487804879,1.0,1.0,9/72,17.13%,PIF1;ERCC6L;DEPDC1B;ATAD5;BLM;WDHD1;HK2;CENPH;FANCI
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),0.3460700074268955,0.804625820458703,0.8,0.9311268579329416,1.0,7/23,17.89%,ZNF207;NSL1;PLK1;LATS1;ESPL1;CHAMP1;TUBG1
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),-0.4345372168350214,-0.8041157296139031,0.7536231884057971,1.0,1.0,3/16,12.00%,MST1;THBS1;CXCL17
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.33274299829292847,0.8040046572822693,0.896551724137931,0.9316888585338402,1.0,6/23,10.42%,IRAK2;TAB3;UBE2N;ITCH;MAP3K7;TAB1
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),0.3295892289562715,0.8039476544525233,0.9117647058823529,0.9314266925252436,1.0,5/35,6.10%,EFNA5;AJAP1;RCC2;KANK1;SPRY4
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),0.36199674155239225,0.8036866539893904,0.7368421052631579,0.9315906431242993,1.0,3/16,6.62%,SNCA;ANK2;CASQ1
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.3113239756303903,-0.8035017473405914,0.8255813953488372,1.0,1.0,16/124,19.48%,TOMM7;SLC51B;KIF20B;KCNB1;PDZK1;CASP8;UBL5;ARIH2;AKAP5;CEMIP;FIS1;PLK3;NMT1;HTRA2;PPP3CC;EMD
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.31997680122526684,-0.8035009687614253,0.8522727272727273,1.0,1.0,14/134,10.69%,PSMB6;HLA-A;BTN3A1;PSMB9;PSMA8;INPP5D;THEMIS;PSMA7;FYB2;HHLA2;PIK3CB;PSME1;PSMC3;PRKCQ
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),0.39188699608781874,0.8033684888643895,0.7241379310344828,0.9318183395106739,1.0,4/14,27.16%,CAMK2A;HCRT;FMR1;SNCAIP
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.38051626990715665,-0.8033149277714587,0.7887323943661971,1.0,1.0,5/37,11.26%,FTH1;S100A6;AQP1;GSTP1;SFRP1
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),-0.45455564283074557,-0.8032938372530058,0.7796610169491526,1.0,1.0,3/9,19.79%,KCNQ1;ERBB3;POFUT2
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),-0.49934267442747193,-0.8031299076573507,0.7586206896551724,1.0,1.0,3/9,21.97%,A2M;SUSD4;CR1
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.4202496637724279,-0.8030841928837156,0.6811594202898551,1.0,1.0,5/14,19.44%,SIGIRR;LY96;CX3CL1;SCIMP;TRIM5
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,-0.32916468254412007,-0.802220481626931,0.8947368421052632,1.0,1.0,15/70,24.93%,TLCD1;RPL8;CCDC86;PRDX4;MBNL3;DHCR7;GIPC1;SLC25A1;POLD2;FASN;TNFRSF12A;LAS1L;HMGB3;HDGF;TRAF4
prerank,GO_Biological_Process_2021__proton-transporting V-type ATPase complex assembly (GO:0070070),-0.5321845098077689,-0.802088774044529,0.7627118644067796,1.0,1.0,1/5,6.97%,ALDOB
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),-0.49656847714450647,-0.8019088530877442,0.796875,1.0,1.0,1/8,14.89%,SLCO3A1
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),-0.49271266777883216,-0.8018764838152552,0.6949152542372882,1.0,1.0,1/8,7.72%,RAB11A
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),-0.4825153166546597,-0.8017532868619065,0.7592592592592593,1.0,1.0,1/6,5.74%,HTR2B
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),-0.3417735658575719,-0.801733587190442,0.8082191780821918,1.0,1.0,5/58,11.26%,SFRP2;OVOL2;EFNA1;PDPN;SFRP1
prerank,MSigDB_Hallmark_2020__Glycolysis,-0.3098514227334296,-0.8015970666428874,0.8791208791208791,1.0,1.0,25/168,18.77%,LDHC;GAPDHS;GMPPB;CACNA1H;KDELR3;COL5A1;SLC16A3;IER3;ALDOB;GPC3;GPR87;GLRX;GNE;CHST4;HK2;B3GNT3;PSMC4;CXCR4;PRPS1;LDHA;PGLS;GYS1;CD44;AKR1A1;SAP30
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.42593545343392125,0.8011367914904444,0.7027027027027027,0.9353089134499571,1.0,3/12,16.17%,OPHN1;SCRIB;RAP2A
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),0.2814923360243501,0.8009796634948358,0.9047619047619048,0.9351450834694174,1.0,18/65,23.18%,CARMIL1;WASL;DNAJB2;FAP;EP300;PRKD1;PEX5;SACS;GSK3B;DNAJB6;MTMR2;IMPACT;DNM2;TMEFF2;AIDA;HSPA1A;LRSAM1;DNAJA4
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),0.3849578686584359,0.8009383338788035,0.7333333333333333,0.934534349021817,1.0,1/17,0.14%,TCAP
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),0.3849578686584359,0.8009383338788035,0.7333333333333333,0.934534349021817,1.0,1/17,0.14%,TCAP
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.38208060660838494,0.8007476150377177,0.7567567567567568,0.9345197282303808,1.0,9/19,21.30%,IGF1;CAMTA1;ATP2B4;GSK3B;DYRK2;SPPL3;PTBP1;CIB1;HOMER2
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),0.2975756385323649,0.8006661376819926,0.7307692307692307,0.9342926983760939,1.0,2/36,4.61%,SNRPF;SART1
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.3233638432943815,-0.8005264739935033,0.872093023255814,1.0,1.0,10/84,16.05%,CETN2;SOX15;RPS27A;NUF2;UBC;COPS6;CENPV;SUV39H1;CENPH;POLE3
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.41406740803421294,-0.8005203356736307,0.7424242424242424,1.0,1.0,6/20,20.53%,HLA-A;B2M;CD160;WNT5A;SCIMP;HLA-F
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.3147883223603029,0.8003948653118416,0.75,0.9344197377876704,1.0,19/44,30.16%,PRKN;CFLAR;TRADD;CLIP3;SPPL2A;BIRC2;CPNE1;TAX1BP1;OTULIN;HSPA1A;GAS6;UBE2K;PTPN2;CYLD;IKBKB;SPATA2;HIPK1;RBCK1;GPS2
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.3411079088986385,0.8002620506734582,0.8695652173913043,0.9342778155976555,1.0,7/37,11.64%,DGKB;PLD6;ABHD5;DGKH;DGKZ;ACP6;GPAM
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),-0.5025974940970231,-0.8001396293497506,0.7384615384615385,1.0,1.0,2/6,7.95%,PLN;PDPN
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.3107850970827047,0.7994139486693974,0.875,0.9352818113037867,1.0,7/30,12.21%,ANK2;CASQ1;PKD2;GSTM2;SHANK3;NLGN3;ADRB2
prerank,GO_Biological_Process_2021__regulation of microvillus organization (GO:0032530),-0.4971881790409054,-0.7994032192405349,0.746031746031746,1.0,1.0,4/7,23.37%,PODXL;FSCN1;CDHR2;ATP8B1
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.3746372715878848,0.7993096078480225,0.75,0.9351184677748798,1.0,2/14,3.21%,ST6GALNAC5;FUT9
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,-0.31000673780885446,-0.7991011588559709,0.8762886597938144,1.0,1.0,33/179,19.43%,ETFB;COX7C;NDUFA6;COX4I1;TIMM10;PDHX;NDUFA2;NDUFC1;TIMM8B;UQCRQ;UQCRFS1;SLC25A4;ATP5ME;COX5B;SURF1;ATP5F1E;ATP5PD;ATP6V1F;ATP5MC3;UQCR10;NDUFB3;ATP6V1D;LDHA;GPI;COX7A2;NDUFA1;GPX4;HTRA2;SLC25A5;MAOB;NDUFB7;RETSAT;MRPL34
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),-0.3260198024138975,-0.799083704124212,0.8604651162790697,1.0,1.0,17/112,16.72%,PSMB6;ZFP69;HELZ2;PSMB9;PSMA8;PSMA7;PSME1;PSMC3;MVK;SQLE;APOE;PSMC4;ID2;EDF1;PSMA3;FDPS;DHCR7
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.31529688046214416,0.7990219718515698,0.78125,0.935266225661837,1.0,9/30,26.12%,EXOSC6;DCP1B;EXOSC1;CNOT8;EDC3;DDX6;DIS3L2;DCP1A;DIS3
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.3353253625434029,0.7989370489747467,0.76,0.935039419529096,1.0,8/26,22.08%,SERPINE1;TNFRSF10B;CFLAR;TRADD;GSK3B;FAS;FAIM2;BCL2L1
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),0.3574457019586916,0.7989238069503115,0.7878787878787878,0.9347139010216552,1.0,4/20,20.22%,RANGAP1;RAB23;SUFU;CABP1
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",0.47228549889673027,0.7989185015330506,0.7222222222222222,0.9343815588223998,1.0,3/5,24.33%,ADRA1A;NLGN1;NLGN2
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),-0.5046600743057732,-0.7987420716186834,0.71875,1.0,1.0,1/6,10.81%,GTF3C6
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),0.39422196838721263,0.798524289913558,0.7894736842105263,0.9345858298678267,1.0,3/13,18.04%,BMP2;TGFBR1;RBPJ
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),-0.41693484458055896,-0.7979972495914289,0.7540983606557377,1.0,1.0,4/11,29.38%,GNPDA1;ACOT8;ACOT4;PON3
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.43232546317812504,-0.7978803529174148,0.7671232876712328,1.0,1.0,3/14,13.16%,CD14;LY96;TLR3
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),0.4980014977340147,0.7975671755653215,0.7777777777777778,0.9361021762153477,1.0,4/5,24.33%,NRXN1;NRXN2;NLGN1;NLGN2
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),0.4460210684113102,0.7975155396679401,0.6808510638297872,0.9358754782001657,1.0,3/7,13.72%,CDH2;AFDN;FER
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),-0.4918789357523064,-0.7973507805965765,0.7608695652173914,1.0,1.0,5/7,27.91%,IL12A;MICA;PTPN22;PRDM1;DCAF15
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),-0.5161303177587258,-0.7972487205884375,0.7818181818181819,1.0,1.0,2/5,20.85%,HEY2;ENG
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),0.42413646011147155,0.7971046486292568,0.6857142857142857,0.9363186802581911,1.0,3/11,18.41%,GMPS;ATIC;LHPP
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),-0.36718198041227074,-0.796911560024699,0.8142857142857143,1.0,1.0,16/42,27.43%,TOMM7;TIMM10;TIMM8B;HK2;FIS1;ROMO1;SLC25A6;AIP;HSPD1;GRPEL1;TSPO;BCAP31;TOMM34;TIMM44;PINK1;TIMM17B
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),0.33460885925393674,0.7965393463881895,0.7741935483870968,0.9368813650376788,1.0,8/27,16.02%,STARD13;PRKX;LOXL2;PIK3CA;FAP;CDH13;NRP1;PXN
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.30012385293995986,0.7964656607222502,0.9090909090909091,0.936654631118592,1.0,10/28,26.89%,MEN1;SETD3;WDR5B;CXXC1;WDR82;ASH2L;SMYD3;PRDM5;KDM6A;SETD6
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),-0.46801178897178486,-0.7962587145743147,0.6935483870967742,1.0,1.0,1/7,5.45%,IGSF1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell differentiation (GO:0051150),0.4714277120091396,0.7960095514705929,0.7222222222222222,0.9369632678161439,1.0,1/6,3.04%,RBPMS2
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.37446425112066484,0.7958148835932026,0.7777777777777778,0.9369548972487962,1.0,2/15,3.21%,ST6GALNAC5;FUT9
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),0.4761842912295154,0.7957172880447048,0.6285714285714286,0.9367706054488483,1.0,5/8,31.25%,CBL;CTNNB1;CBLL1;GRB2;SRC
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.37914131327757933,-0.795680612644749,0.8405797101449275,1.0,1.0,8/25,25.20%,POLR2L;POLR2I;GTF2F1;POLR2J;POLR2K;POLR2G;NELFCD;NELFE
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),0.33485263887348177,0.7955946745262554,0.7575757575757576,0.9366075506374736,1.0,1/22,0.34%,LPIN3
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),0.4097740756764001,0.795489345988127,0.7368421052631579,0.9363813257541901,1.0,1/8,1.50%,TNFSF4
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,-0.37695183142463284,-0.7954641032491846,0.8181818181818182,1.0,1.0,13/35,24.03%,TAGAP;IGSF6;CIITA;SPI1;ARHGAP30;MYO1F;PTAFR;CD74;HLA-F;ALOX5;WDFY4;HLA-DPB1;NFAM1
prerank,GO_Biological_Process_2021__kidney epithelium development (GO:0072073),0.499406085830162,0.795145753638468,0.7073170731707317,0.9365067374086451,1.0,1/5,2.80%,SALL1
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),-0.36048241791735003,-0.7949152331596956,0.8026315789473685,1.0,1.0,2/41,1.30%,SFRP2;ADIRF
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),-0.33576027676128567,-0.7938596354524193,0.8902439024390244,1.0,1.0,9/73,12.43%,SLC3A1;AKR1C1;SLC51B;SLC38A4;CEACAM1;PDPN;SLC51A;SLC25A45;ABCG2
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),0.29589746707084635,0.79319821053492,0.84,0.939274179877378,1.0,3/41,2.40%,SGMS1;PCSK5;CERS3
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.32118168934109337,0.7930773870024074,0.7727272727272727,0.9391245049841255,1.0,11/28,24.93%,SEMA5B;RNF6;SEMA3C;KIAA0319;SEMA6C;SEMA4D;SEMA3D;PTPRS;SEMA6A;SEMA4F;TRIM46
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.3504204552414635,0.7930569819902615,0.8064516129032258,0.938813435801065,1.0,8/19,21.39%,CBARP;PKD2;GSTM2;UBQLN1;DRD2;GPR35;FMR1;THADA
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.4233553597706021,0.7929931727685723,0.6904761904761905,0.93857980360911,1.0,3/9,14.44%,BIN1;TRPM4;DLG1
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.38429189890944304,-0.7927357743073458,0.6923076923076923,1.0,1.0,4/24,14.27%,EFNA1;PSME1;ATP5IF1;APOE
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),0.3115388025723139,0.7927280760867746,0.8148148148148148,0.938697178807268,1.0,14/37,23.49%,SNCA;NRXN1;PIP5K1C;DVL1;STX1A;SLC32A1;PCLO;LIN7C;NRXN2;RIMS2;UNC13A;DNAJC5;PTPRN2;LIN7A
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),-0.36011980297330143,-0.7924525548809528,0.8028169014084507,1.0,1.0,4/25,14.92%,THBS1;SEMA5A;CD160;CCL2
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.3603437580831204,0.7922567051395473,0.8125,0.9390389251260319,1.0,4/15,23.30%,PRDX6;CELF3;TRA2A;NUP98
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),0.315024193942119,0.7921433293571395,0.9166666666666666,0.9389246635218452,1.0,18/55,26.14%,ZDHHC18;ATG7;ZDHHC21;PIK3C3;ZDHHC5;ZDHHC16;PIGP;ATG5;PGAP4;ZDHHC14;ZDHHC2;ZDHHC13;PIGQ;ZDHHC17;PIGU;PORCN;DPM1;GLUL
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),0.507253346560333,0.7920079787978653,0.7954545454545454,0.9387474016165614,1.0,2/5,12.84%,AUTS2;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),-0.4501715612770011,-0.7919613384134357,0.7384615384615385,1.0,1.0,1/8,5.68%,PLN
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),-0.4481801735987367,-0.7918504040513739,0.7333333333333333,1.0,1.0,1/11,3.44%,IL7
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),-0.4481801735987367,-0.7918504040513739,0.7333333333333333,1.0,1.0,1/11,3.44%,IL7
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),0.4104679456340724,0.7916861321929197,0.7096774193548387,0.9388155006025729,1.0,2/12,6.67%,NUDT21;CPSF6
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),-0.44925369689849304,-0.7916294131358269,0.8245614035087719,1.0,1.0,5/8,34.08%,FUCA2;FUCA1;GBA3;GBA2;NAGA
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.3212370712266385,0.791412298135126,0.8846153846153846,0.9388555339779713,1.0,20/50,23.98%,EPHA4;KANK1;HDAC2;PTPN9;RTN4RL1;EFNB2;DCC;KIAA0319;PTPRO;RUFY3;LRP4;PTEN;CIB1;ARHGDIA;MCF2;NLGN1;ADCY6;CBFA2T2;PTPRS;FKBP4
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.31767921751777756,-0.7912883557668265,0.8452380952380952,1.0,1.0,21/92,26.27%,MRPL20;EEF1B2;MRPL40;MRPL51;MRPL27;MRPL54;GADD45GIP1;MRPS33;GTPBP2;MRPL36;MRPL34;AURKAIP1;MRPS21;MRPL23;MRPS34;MRPS26;EEF1A1;MRPL21;MRPS22;OXA1L;MRPS16
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),-0.42720169214405146,-0.7909373003115584,0.7702702702702703,1.0,1.0,4/16,20.59%,PDZK1;SLC25A26;SLC22A4;SLC22A1
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),0.488302734774135,0.7908119661865495,0.75,0.939371648327,1.0,2/6,12.84%,EIF2AK4;SIRT1
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),-0.4896701894673049,-0.7906962830276573,0.7681159420289855,1.0,1.0,1/8,7.15%,DDX11
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),0.4627306743667285,0.7900698992413743,0.7,0.9401463575966117,1.0,3/6,29.30%,NRP1;NR4A1;CORO1B
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.2985276622493761,0.7899945355330675,0.9375,0.9399549818543028,1.0,9/61,14.91%,OSTC;STT3B;MGAT4A;ST3GAL1;GAL3ST1;ALG6;FUT8;UGGT1;ALG10
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),0.2589576116593866,0.789806478581211,0.8421052631578947,0.9398546665605642,1.0,15/79,17.05%,PPARGC1A;LIG4;SNCA;AGAP2;INPP5A;NTRK2;AKT1;CPEB4;PRKN;BCL2;PTPRZ1;GSK3B;MSH2;NDNF;CD200R1
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),0.3221898011227422,0.7890546060680858,0.8571428571428571,0.9407332395907094,1.0,10/42,18.62%,GPC5;CSNK1E;RALB;DVL1;VCPIP1;ABCA2;VCP;SETD2;KDM1A;PPM1F
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),-0.4776879475019211,-0.78894182343429,0.796875,1.0,1.0,3/8,27.56%,HK2;GFPT2;FBP1
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.39325646055260455,-0.7888059630957402,0.8428571428571429,1.0,1.0,3/25,10.13%,SFRP4;RPL13;PPIB
prerank,PanglaoDB_Augmented_2021__Adipocytes,-0.30491920475711237,-0.7887888103025166,0.8488372093023255,1.0,1.0,27/129,19.23%,LMOD1;PXMP2;IL1R1;HSD11B1;EPSTI1;AQP1;COL6A2;COX7A1;TIMP1;ANGPTL2;ECM2;RSPO3;FGF7;C1R;FMO2;APOL6;MT2A;FBLN5;SERPINF1;SOD3;CRYAB;TRIP10;ADGRL4;C1S;MAOB;THBS2;TNS2
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),0.39333477225091734,0.7887049022904651,0.75,0.9407864753490353,1.0,3/13,18.41%,GMPS;ATIC;LHPP
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.3150146363442555,0.7881850391135778,0.9523809523809523,0.9412379044713602,1.0,16/52,18.62%,PICALM;MMD;TESK1;CEP290;CSNK1E;FBXW7;DVL1;RAB9A;AFDN;KIAA0586;DLG1;DNAJB6;MAPK8;RABGAP1L;KDM1A;PPM1F
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),0.4416398279578895,0.7876794811319167,0.8157894736842105,0.9418147214739502,1.0,2/7,3.76%,LIG4;EXOSC6
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.2756647424973835,0.7876156806048156,0.875,0.9415463624510597,1.0,20/59,26.17%,PDE3B;PLXNA2;PLXNA1;SERPINE1;PTK2;CDH13;SEMA4D;PTPRO;PLXNA4;ARHGDIA;FBLN1;TBCD;PTPRC;CBLL1;SEMA6A;FZD7;LPXN;ADAM10;PLXNA3;JAG1
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),-0.416327874825798,-0.7873082933018072,0.7580645161290323,1.0,1.0,1/11,6.67%,THBS1
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),-0.48998286449941625,-0.7872185347758806,0.7735849056603774,1.0,1.0,2/7,11.37%,CEACAM1;KLRD1
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.27650365919215236,0.7869786771041438,0.8666666666666667,0.9421645286329926,1.0,18/71,18.56%,WNT7A;PARD3;ARHGAP35;CTNNA2;SLITRK2;RTN4RL1;DOCK7;DCC;PAK3;CAMSAP2;SLITRK1;CNTN4;PLPPR4;TAOK2;ADGRB1;APBB1;DRD2;CDK5R1
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),-0.3213058768514393,-0.7868721077232026,0.8488372093023255,1.0,1.0,18/78,26.27%,MRPL20;MRPL40;MRPL51;MRPL27;MRPL54;GADD45GIP1;MRPS33;MRPL36;MRPL34;AURKAIP1;MRPS21;MRPL23;MRPS34;MRPS26;MRPL21;MRPS22;OXA1L;MRPS16
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),0.2884960052979048,0.7867394256612102,1.0,0.9422869202488319,1.0,3/52,7.93%,LPIN3;CSNK2A1;SLC44A5
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),0.28184081438121966,0.7867035841995845,0.9473684210526315,0.9420117066326923,1.0,8/75,6.56%,ADAMTS3;PCSK5;MMP16;NCSTN;MYRF;MME;SDE2;KLKB1
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.30872121406857284,-0.7866732485100094,0.8804347826086957,1.0,1.0,33/143,20.03%,SFRP2;WARS1;APLNR;SPARC;STAT1;AQP1;CEACAM1;THBS1;ISM1;SEMA5A;ANGPTL3;SFRP1;CTSH;HYAL1;NODAL;RRAS;FGF1;CD160;HK2;SP100;WNT5A;AGGF1;BRCA1;XBP1;SERPINF1;COL4A2;KLF4;SPINK5;BTG1;THBS2;SPHK1;EMP2;NAXE
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),0.403484478435708,0.7864571237363073,0.7419354838709677,0.9420922363385761,1.0,4/11,14.73%,KIAA0319;TGFBR1;SMAD4;BMPR1A
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),-0.41889651210488965,-0.7862683505605973,0.7419354838709677,1.0,1.0,1/15,6.12%,GLYAT
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.3738220584131765,0.7862571018854887,0.8571428571428571,0.9420542354738356,1.0,2/16,3.54%,RCC2;LRCH1
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),-0.444931472392777,-0.7857367095522868,0.7547169811320755,1.0,1.0,1/6,6.67%,THBS1
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.3209483623627397,-0.7856212062335544,0.891566265060241,1.0,1.0,13/91,12.80%,F8;SELP;SPARC;CD9;CD63;TIMP1;THBS1;F13A1;TTN;F5;VWF;A2M;PCYOX1L
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),-0.45648619691329806,-0.7854808657257369,0.7384615384615385,1.0,1.0,5/8,34.25%,GINS3;MCMDC2;MCM3;MCM4;LIG1
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.32902613971296957,-0.7854202822666806,0.8255813953488372,1.0,1.0,5/74,12.73%,CENPE;KDELR3;KIF2C;ARF5;KIF4A
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),-0.3359502642739576,-0.7853570556361665,0.7848101265822784,1.0,1.0,2/53,1.27%,ANKRD53;LMOD1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.3667981452046285,0.7852105472283163,0.7692307692307693,0.9432632642352096,1.0,6/14,18.24%,MARCHF7;PRKN;SIRT1;BCL2;KDM1A;MDM2
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),0.45723864072416526,0.7850003291408716,0.7073170731707317,0.9433084391530986,1.0,4/6,19.91%,VCPIP1;VCP;SETD2;WAPL
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),-0.30438804958692717,-0.7848827108247027,0.8863636363636364,1.0,1.0,14/133,11.26%,PSMB6;SFRP2;SFRP4;PSMB9;PSMA8;SEMA5A;GPC3;RSPO3;NRARP;PSMA7;DEPDC1B;PSME1;PSMC3;SFRP1
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),-0.375974365874753,-0.7843836984294007,0.6901408450704225,1.0,1.0,3/21,9.20%,MST1;SELENOS;PGP
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),-0.4247994312471562,-0.7841768238895797,0.8115942028985508,1.0,1.0,5/17,27.65%,MADCAM1;ZP3;ICAM1;PLVAP;ADAM8
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),-0.4473714519895809,-0.7841312862713566,0.7384615384615385,1.0,1.0,1/10,6.67%,THBS1
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.3344599824026963,0.7833798919971771,0.8461538461538461,0.9455534173936644,1.0,11/37,22.09%,NPY1R;ADCY1;GNAI3;GABBR1;GNAI1;PDE2A;GRM8;DRD2;ADCY9;CHRM3;ADCY6
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),-0.44144840951464437,-0.7829010705143321,0.7536231884057971,1.0,1.0,4/12,19.68%,HLA-A;CTSH;MICA;EMP2
prerank,PanglaoDB_Augmented_2021__Myoblasts,0.26680723103704745,0.7828342317262948,0.9,0.945959609018486,1.0,13/90,11.55%,POSTN;PDZRN3;EGFR;RBM24;ENO3;PARVA;CACNA2D1;PRKG1;PRRX1;ADAM12;PKDCC;BRAF;ZBTB16
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),0.3961211895275486,0.7826408805125157,0.8108108108108109,0.9458785533151082,1.0,1/9,2.09%,ARFIP1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),0.33379508028108684,0.7825330084862668,0.8484848484848485,0.9456932450535479,1.0,7/21,19.69%,PIK3R1;PTPRJ;MAP4K4;NRP1;PPM1F;ARF6;ROCK1
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.3148285217278354,-0.782510743363271,0.8620689655172413,1.0,1.0,20/93,26.27%,MRPL20;MRPL40;MTRF1L;MTIF3;MRPL51;MRPL27;MRPL54;GADD45GIP1;MRPS33;MRPL36;MRPL34;AURKAIP1;MRPS21;MRPL23;MRPS34;MRPS26;MRPL21;MRPS22;OXA1L;MRPS16
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.42554449617062845,-0.7823631497819726,0.7704918032786885,1.0,1.0,4/19,16.80%,STAT1;STAT2;CCL2;CTR9
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),0.391145659384212,0.7816081099040871,0.7368421052631579,0.9467593482276514,1.0,4/10,22.37%,NT5C1A;NT5M;UPP1;NT5C3A
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),0.42954998267065636,0.7815730579202754,0.7837837837837838,0.946497417912701,1.0,1/10,5.47%,TRAPPC8
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),-0.4045572171427253,-0.7814948544501314,0.696969696969697,1.0,1.0,4/16,13.34%,AQP1;DDX11;BLM;MT3
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),-0.4189685663418017,-0.7814639281268686,0.8285714285714286,1.0,1.0,1/14,4.95%,RASGRP1
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),0.3411146731828732,0.7810408878180379,0.8260869565217391,0.9470067454094204,1.0,2/21,4.93%,IBA57;LYRM4
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),-0.49262241955712543,-0.7807861713973139,0.813953488372093,1.0,1.0,3/5,29.00%,OAS3;TRIM25;PHB2
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.37146418193457065,-0.7806435499896245,0.7916666666666666,1.0,1.0,4/24,10.85%,HLA-A;HLA-B;B2M;IL12A
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.4411037537035914,-0.7804760523984581,0.7428571428571429,1.0,1.0,3/12,13.16%,CD14;LY96;TLR3
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.48902964601973276,-0.780255383305269,0.7666666666666667,1.0,1.0,4/7,25.07%,SKAP1;CD44;GCNT2;FLOT1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.39748966656670215,0.7800881326299122,0.696969696969697,0.948265672065577,1.0,4/9,26.33%,GALNT1;GALNT2;MGAT5B;POGLUT1
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.40560899883881407,0.7800642351079177,0.7674418604651163,0.9479896012645722,1.0,5/11,19.82%,HNRNPU;YTHDF2;ESRRB;N4BP2L2;REST
prerank,GO_Biological_Process_2021__protein side chain deglutamylation (GO:0035610),0.48077002408703207,0.7800497176263688,0.7924528301886793,0.9476790317912764,1.0,1/5,15.84%,AGTPBP1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.40939088848981237,0.780019572472424,0.7631578947368421,0.9473894939240326,1.0,1/8,2.63%,ANK2
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),0.3033365671371576,0.7798958350415607,0.825,0.9472457806807025,1.0,9/28,28.89%,TAF4;MTERF1;RSF1;NAT14;NCOA6;GTF2B;SETX;TAF12;POLA1
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),-0.4806105156310745,-0.7796613858098842,0.8356164383561644,1.0,1.0,1/8,4.70%,ST6GAL1
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),0.248501820849635,0.7795670559485653,1.0,0.9474140974618801,1.0,20/88,20.52%,CEP152;RAB3IP;CEP97;TTBK2;CEP290;NEDD1;CSNK1E;PLK1;C2CD3;CKAP5;CLASP1;MAPRE1;ALMS1;YWHAG;RPGRIP1L;TUBG1;TCTN1;NPHP4;PCM1;PPP2R1A
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),-0.46816958971692624,-0.7794510742699791,0.7454545454545455,1.0,1.0,2/6,11.26%,MEOX1;SFRP1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),-0.329314869305662,-0.7794386157074317,0.8536585365853658,1.0,1.0,8/65,17.31%,SOX15;KIF20B;SVIL;DDX11;CENPV;USP19;GIPC1;CCNB1
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),0.3463293749734314,0.7789604373281821,0.8,0.9479218276770508,1.0,8/27,16.48%,NFKB1;PLIN5;RIN3;PRKN;SIRT2;ABCA2;MTMR2;AATF
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),0.3316851266845836,0.778672845816808,0.8461538461538461,0.9480759301193956,1.0,2/22,4.93%,IBA57;LYRM4
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),-0.44590587092301853,-0.7779175700591374,0.7704918032786885,1.0,1.0,3/11,19.98%,GLRX;NOS1;WNK4
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),-0.3887947362830775,-0.7778227059319829,0.8088235294117647,1.0,1.0,8/32,16.40%,STAT1;IGFBP5;THBS1;NOX1;CX3CL1;ID2;P2RY6;IL18
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),-0.3698651556848129,-0.7777856601379847,0.7142857142857143,1.0,1.0,4/17,16.80%,STAT1;SPI1;SOCS3;CTR9
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),0.49222492137734825,0.777782784367008,0.7428571428571429,0.9490885382045079,1.0,1/5,2.23%,SASH1
prerank,PanglaoDB_Augmented_2021__Chondrocytes,-0.3102817646415504,-0.7774710234160739,0.8433734939759037,1.0,1.0,30/109,21.24%,LMOD1;COL10A1;SPARC;STAT1;COL5A1;IGFBP5;COL6A2;ANGPTL2;SEMA5A;ELN;CHAD;C1R;RUNX2;SFRP1;MGP;MATN3;TNC;COL4A2;PAMR1;SOD3;GADD45B;CRYAB;ADGRL4;C1S;THBS2;TAGLN;CALD1;NID2;COL14A1;EDNRA
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),-0.4303057264162862,-0.777430757196394,0.8421052631578947,1.0,1.0,1/11,4.24%,KCNB1
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),-0.44905893578246703,-0.7773811205804718,0.765625,1.0,1.0,1/9,2.86%,CACNA1H
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),-0.29492518214925456,-0.7766105934065883,0.9368421052631579,1.0,1.0,8/175,5.19%,IFI6;IRF1;BCL2L14;DHCR24;MX1;IFI27L2;IER3;IFIT2
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),-0.35122774468518386,-0.7764660411327136,0.7875,1.0,1.0,4/45,10.69%,GATA1;RAB7B;THBS1;PRKCQ
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),0.45725127712201047,0.7764436408828116,0.8181818181818182,0.9508133761450436,1.0,3/7,9.31%,BIN1;CBARP;SESTD1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),-0.4777134405912441,-0.7764043231012747,0.7169811320754716,1.0,1.0,1/6,5.14%,MTLN
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),-0.4654270789994148,-0.7760854045617909,0.8421052631578947,1.0,1.0,1/7,6.04%,PNP
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),0.4624602659739796,0.7754655765287636,0.75,0.9518796444479435,1.0,2/6,4.85%,AMH;SOX9
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,0.36936031457903695,0.7754291693761174,0.71875,0.9515825193185184,1.0,2/19,2.26%,POSTN;SLC10A6
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.3777976158216588,-0.7754001294141346,0.7910447761194029,1.0,1.0,5/25,17.23%,STAT1;APOBEC3G;PQBP1;DTX3L;PTPN22
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.2656480480031967,0.7749019221650845,0.9166666666666666,0.9520323680694904,1.0,14/59,15.03%,SNCA;EGFR;CNOT9;HCLS1;AKT1;CAPRIN2;DOCK7;BRAF;PRKD1;STOX1;RPTOR;TENM1;ATP2B4;LATS1
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),0.2688714980913822,0.7748701951022954,0.9333333333333333,0.9517423119094609,1.0,29/84,22.71%,BTRC;SALL1;AMER2;BMP2;KANK1;CSNK2A1;GSKIP;FRZB;NLK;PRKN;ZRANB1;DACT3;WWOX;VGLL4;GNAQ;CBFB;ZNF703;CTNND2;CXXC4;RUNX1;CDK14;AXIN1;OTULIN;PPP2R1A;MACF1;FGFR2;CTNNB1;CDC73;NFATC1
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),0.26045545904015494,0.774639694516432,1.0,0.9517288440519245,1.0,81/373,18.76%,TIAM2;RCN3;STARD13;SGMS1;PIP5K1B;ARHGEF6;ARAP2;ARHGEF16;DNA2;ARHGEF12;EGFR;RHOT1;ARAP1;ARHGAP35;SLC15A2;RHOQ;MAPK11;ARHGEF26;ARHGAP24;PTPN13;TNIK;NTRK2;PRKAR1B;CSNK2A1;PEX5L;ARHGAP5;AKT1;DAPK2;ARHGAP26;SPRED1;DIPK2A;TAF4;HDAC2;FGD4;ITSN1;TTI1;PIP5K1C;PIP4K2C;MBD3;MOB3B;ARHGAP32;MAP4K4;PAK3;EP300;TP53BP2;GNA13;BST1;SOS1;HIPK2;PRKAB1;MCF2L;MAPKAPK5;JMY;OPHN1;DLG1;MAPK1;MDM4;GNAI1;ZFAND6;TP53RK;PDE2A;TAOK2;DYRK2;STK11;ARHGEF7;BIRC2;USP2;RBBP4;RNF41;TRIO;TAF2;CSNK2A2;ARHGAP31;PTEN;TBCK;MDM2;CPNE1;TAF4B;CDK5R1;TAF3;ARHGAP17
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),-0.40965327538893825,-0.7743080324118197,0.7714285714285715,1.0,1.0,1/14,1.27%,LMOD1
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),0.45170845727682035,0.7742015046184205,0.7222222222222222,0.9521643472115886,1.0,2/6,11.99%,SMOX;SMS
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),0.4120985962817243,0.7740668609915644,0.7428571428571429,0.9520540739991517,1.0,2/11,14.35%,ADRA1A;DGKG
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),0.33923761865001456,0.7740647116352016,0.8125,0.9517230088270795,1.0,2/14,6.34%,SAMHD1;NT5C1A
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),-0.4824338448426927,-0.7740545621817139,0.7321428571428571,1.0,1.0,1/6,20.52%,TMED9
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),-0.4824338448426927,-0.7740545621817139,0.7321428571428571,1.0,1.0,1/6,20.52%,TMED9
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),-0.4824338448426927,-0.7740545621817139,0.7321428571428571,1.0,1.0,1/6,20.52%,TMED9
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),-0.4823511610527473,-0.7735120601496952,0.803921568627451,1.0,1.0,5/6,30.27%,DDX60;RIOK3;DHX58;TKFC;C1QBP
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.31365596098870147,0.772975748268237,0.7857142857142857,0.9530964158855336,1.0,5/24,13.85%,NSMCE2;SIRT1;SMC6;MAPKAPK5;OPA1
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),0.4487061716743867,0.772723226660538,0.7297297297297297,0.9531928483414664,1.0,4/5,27.69%,NTRK3;DOK5;ZDHHC17;TMEM108
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.39263505828110434,-0.7726694500234881,0.7761194029850746,1.0,1.0,10/25,31.18%,SLU7;PRPF4;DDX23;PRPF8;MPHOSPH10;PRPF3;PRPF6;GEMIN2;SRSF10;SRSF4
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.3146486078650465,-0.7723791367104887,0.85,1.0,1.0,13/60,17.23%,SELENOS;CXCL2;GSTP1;CD14;LY96;PDCD1LG2;CCL2;WNT5A;CD274;XBP1;IL18;CTR9;PTPN22
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),0.40942343440635015,0.7723544148986288,0.8,0.9534340043097425,1.0,4/11,14.73%,SERPINE1;PRKG1;SLIT2;BMPR1A
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),0.36414302521018577,0.7722616362020231,0.7666666666666667,0.9532407675729152,1.0,11/19,28.60%,CACNB4;CBARP;CACNB3;DRD2;GPR35;FMR1;STAC;PDE4B;CACNB2;SRI;DMD
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),-0.4000831407958412,-0.7721193271176613,0.75,1.0,1.0,2/23,5.50%,MUSK;LRRC7
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),0.4935434996042011,0.7720401221389622,0.8947368421052632,0.9532819266329464,1.0,3/5,31.11%,EIF3E;FMR1;NCBP1
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.3831822340225244,0.7719194134097989,0.7647058823529411,0.9531577559229963,1.0,3/14,7.83%,TNFSF4;DUSP10;KAT2A
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.3387091383279151,0.7718163906687514,0.8181818181818182,0.9529579372011565,1.0,7/22,13.81%,SLC26A7;CA2;CA5B;SLC4A7;CA12;SLC4A10;SLC4A4
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.34417797302380615,-0.7717032046570105,0.8181818181818182,1.0,1.0,5/46,8.76%,ENPP2;PDXDC1;ERAP2;ERAP1;CYP2D6
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),-0.4867930644973783,-0.7714557891124662,0.8035714285714286,1.0,1.0,2/7,19.58%,TOM1L1;AURKAIP1
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.4800148273017831,-0.7713751089551151,0.8888888888888888,1.0,1.0,1/8,14.55%,CLU
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.2909331547419983,-0.7710164475378009,0.956989247311828,1.0,1.0,34/217,16.73%,THSD4;MMP21;MMP25;COL10A1;P4HA3;SPARC;COL5A1;COL6A2;ITGA5;TIMP1;COL8A1;ECM2;THBS1;CTSL;ELN;COL24A1;MMP19;COL4A4;MMP24;PPIB;COL9A2;VWF;A2M;SCUBE3;KIF9;FBLN5;MATN3;ADAMTS16;TNC;LAMA1;MARCOL;LAMB1;COL4A2;MADCAM1
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),0.30144855340314475,0.7709476582404163,0.896551724137931,0.9540177847657911,1.0,13/36,23.49%,SNCA;NRXN1;PIP5K1C;DVL1;STX1A;SLC32A1;PCLO;LIN7C;NRXN2;UNC13A;DNAJC5;PTPRN2;LIN7A
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),0.3513000685904567,0.770785095867966,0.8181818181818182,0.9539347667662553,1.0,1/14,1.50%,TNFSF4
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.42704460163240054,-0.7705887497688184,0.7580645161290323,1.0,1.0,2/12,12.15%,ERLEC1;SVIP
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),-0.44914182891643983,-0.7705058149487641,0.7333333333333333,1.0,1.0,1/9,2.04%,CFTR
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),-0.44914182891643983,-0.7705058149487641,0.7333333333333333,1.0,1.0,1/9,2.04%,CFTR
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),-0.4218682325310157,-0.7701772332816411,0.7887323943661971,1.0,1.0,2/14,15.27%,P2RY12;DPYSL3
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),0.4808582901759602,0.7698792949282064,0.7941176470588235,0.9551241968128428,1.0,2/6,15.55%,HAVCR2;LRFN5
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),-0.43289643877205164,-0.7697316310291067,0.7307692307692307,1.0,1.0,3/9,22.89%,SLC25A4;SLC25A5;PARK7
prerank,GO_Biological_Process_2021__regulation of response to reactive oxygen species (GO:1901031),-0.4757911049767114,-0.7696030235004712,0.7536231884057971,1.0,1.0,1/5,13.54%,FBLN5
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.30017778458795674,0.7693141027530961,0.8285714285714286,0.955749007138628,1.0,10/39,22.29%,HDAC9;AKT1;HMGB1;PRKD1;SIRT1;HIF1A;CIB1;AKT3;PRKCA;FGF2
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),0.3544225298167772,0.7692615127579318,0.8125,0.9554867693584435,1.0,3/18,9.05%,ANK2;ASB3;SMAD7
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),-0.4581573997344007,-0.7692007122968965,0.8305084745762712,1.0,1.0,4/7,22.84%,TRMT10C;TRMT10B;TRNT1;TRMT10A
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.25043466098359085,0.7691423467103174,1.0,0.9552865513075914,1.0,26/135,20.53%,AIFM2;TRIM24;CRADD;ACER3;SOX9;CASP10;AKT1;DAPK2;TNFRSF10B;MAGED1;FBXO11;PRKN;LRP8;TP53BP2;ANP32B;SIRT1;VCP;HIP1;BIRC2;CHM;ALPK2;BCAR1;FAS;TNFRSF25;PHLPP1;CREBBP
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.3321782034682586,-0.7690084906714493,0.84,1.0,1.0,7/63,11.38%,ISG15;RPS27A;PSMA8;CTSL;CASP8;UBC;CTSH
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),-0.3082000041792728,-0.76886455535026,0.8795180722891566,1.0,1.0,9/111,10.62%,PSMB6;RPS27A;CSDC2;PSMB9;PSMA8;PSMA7;PSME1;PSMC3;UBC
prerank,GO_Biological_Process_2021__positive regulation of Golgi to plasma membrane protein transport (GO:0042998),0.4917017389579682,0.768325107771598,0.7674418604651163,0.9561647604792284,1.0,2/5,19.86%,ATP2C1;ACSL3
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),-0.4151994835672485,-0.7681604813749493,0.796875,1.0,1.0,4/12,19.46%,CD9;CEACAM1;APOE;ALOX12
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.4558736650315365,-0.7675536828509112,0.8448275862068966,1.0,1.0,4/10,33.60%,MMRN2;CADM4;NIBAN2;EMILIN1
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.433174203006644,0.7675355147792783,0.8,0.9569942899869351,1.0,4/7,25.13%,HMGB1;CBFB;RUNX1;TARM1
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),-0.36668506658448957,-0.7664381778268508,0.7972972972972973,1.0,1.0,2/33,4.16%,KIF20B;ABCA12
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),-0.4216153375014786,-0.7663011246769005,0.7538461538461538,1.0,1.0,3/14,13.34%,HTR2B;CTSH;MT3
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),0.39203750937551946,0.7661166604688097,0.7804878048780488,0.9584821023859703,1.0,4/9,22.37%,NT5C1A;NT5M;UPP1;NT5C3A
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.3713249642881612,0.7655567650067254,0.78125,0.9590152147360783,1.0,5/11,24.23%,DOC2B;RIMS3;RIMS2;UNC13A;SYT5
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.3579856023488812,-0.765262252412147,0.8055555555555556,1.0,1.0,7/34,19.68%,S100A10;CCL28;SFRP1;RRAS;CX3CL1;SKAP1;EMP2
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.3327556764087897,0.7650576912851537,0.8260869565217391,0.9593353414646191,1.0,9/29,21.06%,GRIN1;CAMK2B;DLG3;CAMK2A;DLG1;GRIN2B;GRIA2;SLC6A9;NLGN1
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,-0.31547719782180306,-0.7649094563297227,0.9404761904761905,1.0,1.0,21/98,23.06%,GBP2;IGFBP5;C1R;CAV2;FMO2;FGF1;MATN2;LURAP1L;COL4A2;SOD3;CRYAB;ADGRL4;C1S;S100A16;TNS2;SRPX2;EDNRA;CDH1;PLA2R1;AMOTL2;AR
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.34418457692167426,-0.7647097351479584,0.8243243243243243,1.0,1.0,6/32,21.85%,CYP4Z1;CYP2D6;AWAT1;GPX4;ALOX12;ALOX5
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),0.4162514865403142,0.7645389076529271,0.7,0.9597443698300016,1.0,1/7,4.14%,CXCL12
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.3397103766082018,0.7644572684376132,0.7419354838709677,0.9595157309080871,1.0,4/28,6.23%,SASH1;PRMT1;BMP2;DUSP10
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),0.27827514634493783,0.7643582402902179,0.96875,0.9592804019909543,1.0,9/37,19.69%,EGFR;AGAP2;NFKB1;SIRT2;MDM4;SF3B3;ADGRB1;FMN2;ROCK1
prerank,GO_Biological_Process_2021__xenobiotic transport across blood-brain barrier (GO:1990962),0.4607115641898536,0.7641617814847561,0.7727272727272727,0.9592643975382636,1.0,1/6,3.20%,ABCC2
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),-0.3303440973352997,-0.7640151608226865,0.881578947368421,1.0,1.0,1/46,0.78%,RPL23
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.3756554131397509,0.7638216074670433,0.8529411764705882,0.9594469469774054,1.0,5/13,25.54%,LARGE1;CHST3;MGAT3;CHST1;OGA
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),-0.4708278677113156,-0.7636380831011015,0.8225806451612904,1.0,1.0,5/10,25.19%,CTSL;HTRA2;KLK6;SPRTN;AFG3L2
prerank,MSigDB_Hallmark_2020__Complement,-0.2976669708280855,-0.7634155200273645,0.9139784946236559,1.0,1.0,14/145,11.38%,CP;F8;IRF1;RASGRP1;TIMP1;PSMB9;APOBEC3G;CTSL;ERAP2;PRSS3;PHEX;C1R;F5;CTSH
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),0.3413863569411477,0.7633013500522481,0.8,0.9598620600794767,1.0,7/19,24.37%,HTR2C;PKD2;TRPM2;DRD2;FGF2;IBTK;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),-0.49116314872669087,-0.7630954960801916,0.7931034482758621,1.0,1.0,4/7,28.72%,AKAP5;EHD2;EHD1;ACTN2
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,-0.36090047533959624,-0.7628439741139028,0.8333333333333334,1.0,1.0,8/23,18.39%,TAGAP;CLEC12A;IGSF6;DPEP2;SPI1;ARHGAP30;MYO1F;PTAFR
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),-0.47029092422146357,-0.7627980431284743,0.828125,1.0,1.0,2/7,16.71%,PDPN;FSCN1
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),0.38238203588887676,0.7625536584831961,0.6666666666666666,0.9605300157895262,1.0,1/10,1.91%,MICAL1
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.30287139348286235,-0.7624773760398478,0.9130434782608695,1.0,1.0,31/118,21.24%,LMOD1;SPARC;COL5A1;SFRP4;IGFBP5;COL6A2;ITGA5;ANGPTL2;PHEX;C1R;RUNX2;CX3CL1;CALB1;WNT5A;TNC;SOCS3;COL4A2;PAMR1;SOD3;ADGRL4;TNFRSF10A;C1S;CD44;THBS2;TNS2;GPER1;TAGLN;CALD1;SRPX2;COL14A1;EDNRA
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),0.3994503293078455,0.7624594587677818,0.7857142857142857,0.9603289393455087,1.0,3/8,24.61%,ZC3H14;CDK9;RNF20
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),0.3629482147026973,0.7623562994603261,0.7692307692307693,0.9600938209646156,1.0,5/19,11.42%,ZCCHC4;METTL15;FBLL1;TFB1M;NSUN3
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.36644414029114836,-0.7620974275313407,0.8125,1.0,1.0,1/25,0.68%,SFRP2
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),0.4395578259127183,0.7618978248821908,0.7894736842105263,0.9604602831997969,1.0,2/8,17.32%,CAMK2D;PDE4D
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),-0.47734940782843144,-0.7616956069923395,0.8208955223880597,1.0,1.0,2/5,17.23%,RSAD2;PTPN22
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),0.35015746214790827,0.7616534417246336,0.8571428571428571,0.9605258859014381,1.0,1/18,0.49%,LVRN
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",0.376279790952908,0.7614833584939413,0.8222222222222222,0.9604138764511702,1.0,4/17,14.79%,RHBDD1;TMEM129;DERL2;VCP
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),0.388250260153055,0.7614731371588336,0.7894736842105263,0.960083479543804,1.0,3/11,26.33%,NECTIN2;BCL10;RELA
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.33721133476143167,0.7606555777916266,0.8275862068965517,0.9609135084420255,1.0,7/24,15.76%,PID1;NFKB1;CBL;FER;SMAD4;YAP1;PTPN11
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),-0.5063808958975411,-0.7606064556097587,0.8235294117647058,1.0,1.0,3/5,35.55%,LDLR;LRP2;RNF128
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),-0.47521176657012376,-0.7604493076903868,0.8166666666666667,1.0,1.0,2/5,22.42%,SVIP;DBI
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),0.4095656116121974,0.7601415216602412,0.75,0.9611767060236142,1.0,3/10,18.71%,SMOX;SMS;HDAC10
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),0.36497307982183375,0.7601245507130047,0.8108108108108109,0.9608736687438311,1.0,5/13,22.37%,NT5C1A;NT5M;UPP1;ERH;NT5C3A
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.2351763286970359,0.7599589979748854,1.0,0.9607140112832203,1.0,52/123,28.58%,ANK2;TSPAN17;TSPAN14;PACS1;EHD4;EPHA2;DENND4C;TNIK;RAPGEF2;EFR3A;RAB8B;MRAP;TTC7B;BSG;SMURF1;RAP1A;TSPAN33;DLG1;ROCK2;RAP2A;CACNB3;LIN7C;MYO5A;WNK3;ROCK1;RAB10;TSPAN5;SLMAP;ZDHHC2;P2RY1;TTC7A;DPP6;FGF13;LIN7A;RAMP1;RAB12;RAPGEF6;GAS6;ARL3;SPTBN4;PACS2;CACNB2;CLASP2;SPTBN1;PPIL2;RAB40C;SCN3B;IKBKB;RAB15;KCNIP3;KCNIP4;RAB40B
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),-0.44914277030079397,-0.7597799367922097,0.7627118644067796,1.0,1.0,2/6,12.98%,P4HA3;P4HTM
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.48673817441214606,-0.7589245965958964,0.8148148148148148,1.0,1.0,2/5,25.74%,UFC1;DDRGK1
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.48673817441214606,-0.7589245965958964,0.8148148148148148,1.0,1.0,2/5,25.74%,UFC1;DDRGK1
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.48673817441214606,-0.7589245965958964,0.8148148148148148,1.0,1.0,2/5,25.74%,UFC1;DDRGK1
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),0.43438811453365345,0.7582316109314957,0.75,0.9626671471767487,1.0,3/6,14.73%,SOX4;ACVR1;BMPR1A
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.32235185197101135,0.7578122735188466,0.8709677419354839,0.9629089232860605,1.0,5/22,17.52%,AUTS2;SIRT1;OGT;SMAD4;JARID2
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),-0.3934988701870372,-0.7577854308258614,0.7647058823529411,1.0,1.0,2/16,9.93%,BUD23;TRMT112
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),0.49382757228202684,0.7575782925959598,0.75,0.9628713066081966,1.0,2/5,29.86%,PPP2CB;PPP5C
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),0.4310053350583284,0.7575263419551083,0.7551020408163265,0.9626226700496998,1.0,3/6,22.71%,NFATC3;NFATC2;NFATC1
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.30704931557638665,-0.7572873100075881,0.9166666666666666,1.0,1.0,17/81,17.40%,USP18;IRF1;IL1R1;P2RY12;PDE6B;ANXA1;LRRC19;ERAP1;NLRP1;CASP8;AKNA;HERC5;CXCR4;CX3CL1;WNT5A;PTPN22;NMT1
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.34324471355716296,0.757101534513815,0.75,0.962871013408949,1.0,3/25,8.82%,ERBB4;VHL;NLK
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),-0.38088450224841847,-0.757009080825791,0.7361111111111112,1.0,1.0,2/17,9.44%,HSD17B8;FAR2
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),0.4300559676291579,0.756993299957128,0.7560975609756098,0.9626905827318518,1.0,1/6,1.50%,MTCL1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.4475651344548309,-0.7569526780497459,0.8679245283018868,1.0,1.0,1/12,1.38%,ISG15
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.341626201352239,-0.7565838367757793,0.8695652173913043,1.0,1.0,6/36,17.53%,GATA1;P2RY12;PIK3CB;MYL12A;TLN1;CLIC1
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.34512327276888277,-0.7563978869586256,0.8783783783783784,1.0,1.0,4/41,10.62%,ISG15;RPS27A;RPA3;UBC
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.38891731325849754,-0.7563105677956011,0.8676470588235294,1.0,1.0,4/15,20.44%,KLF2;CLU;KLF4;NOS1AP
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),0.3654750636706852,0.7560499874024673,0.8148148148148148,0.9636732148990815,1.0,6/19,22.17%,TOX;NAP1L1;FZD3;KDM1A;DRD2;CTNNB1
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),0.3410305295668499,0.7559795052950703,0.8125,0.9634042504332861,1.0,5/13,14.73%,BMP2;ACVR1;TGFBR2;MDM4;BMPR1A
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.3175732187102908,-0.7559681425285796,0.8941176470588236,1.0,1.0,9/74,10.51%,COL10A1;P4HA3;COL5A1;COL6A2;COL8A1;COL24A1;COL4A4;PPIB;COL9A2
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.37029557212939446,0.7558343784540692,0.7647058823529411,0.9632102304819706,1.0,5/13,21.91%,AKT1;IRS1;PRKCE;AKT2;IRS2
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.4474417297291273,-0.7557859778525491,0.8166666666666667,1.0,1.0,4/8,17.78%,APOM;APOE;CLU;ABCA5
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),-0.37257798520119717,-0.7557086744824979,0.8181818181818182,1.0,1.0,2/19,11.74%,GMPPB;UAP1
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),0.37464897351776366,0.7555711035217617,0.7894736842105263,0.9632133625515503,1.0,1/12,0.79%,LIMD1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.3149826474997609,-0.7555324315005882,0.8554216867469879,1.0,1.0,10/76,10.62%,PSMB6;RPS27A;KLF2;PSMB9;PSMA8;ELOB;PSMA7;PSME1;PSMC3;UBC
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.24331817960095084,0.7553081677843358,1.0,0.9631825359464876,1.0,16/78,15.04%,GALNT14;ST3GAL1;TRAK1;POMK;TMTC2;GALNT7;LARGE1;PLOD2;MUC20;CRPPA;C1GALT1;OGT;B4GALT5;TMTC4;PLOD1;FKRP
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),0.28852840529800206,0.7545364391014872,0.9047619047619048,0.9639324573667513,1.0,8/34,18.55%,HNRNPU;DNAJB2;DYNLL2;DHX9;MSH2;POT1;DNAJB11;TOR1AIP2
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),-0.45164377007706497,-0.7543934121647894,0.7619047619047619,1.0,1.0,1/8,3.53%,DGAT2L6
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.33389177105334117,0.7534822439707857,0.875,0.9650008234355177,1.0,16/29,28.86%,NEDD4L;PRKCE;CAMK2D;WNK3;WNK1;UTRN;NETO1;FGF14;SLMAP;FGF13;HECW1;FXYD7;SCN3B;NEDD4;DMD;YWHAH
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),0.3558353940726137,0.7533582737154721,0.825,0.9648133690847002,1.0,2/17,5.33%,RCN3;NCSTN
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.314663512957713,-0.753192556030743,0.8695652173913043,1.0,1.0,8/56,15.84%,SFRP2;CETN2;HTR2B;RAB11A;BLM;FGF1;NLRP5;PLK3
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),-0.4352108600030307,-0.7530727783916703,0.8620689655172413,1.0,1.0,3/9,25.62%,GPER1;CD74;MYO18A
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.3353376231559895,0.7530492865827005,0.9210526315789473,0.9650193911888878,1.0,8/23,32.75%,SLC25A18;SFXN1;SLC7A9;SLC25A13;SLC38A2;SLC25A12;SLC1A2;SLC7A2
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),-0.3008120338839291,-0.7530299922992064,0.967032967032967,1.0,1.0,26/134,21.24%,LMOD1;COL5A1;IGFBP5;PI16;AQP1;ITGA5;COX7A1;ANGPTL2;COL4A4;C1R;AFAP1L1;PROCR;CRACR2B;CALCRL;COL4A2;SOD3;HEY2;ADGRL4;C1S;S100A16;TNS2;MMRN2;CALD1;SRPX2;COL14A1;EDNRA
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),0.36529513628979926,0.7528364633336058,0.7058823529411765,0.9649473118637253,1.0,6/11,16.92%,PDE3A;HTR2C;GUCY1B1;PDE2A;KCNC2;IRAG1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),0.3762224292282428,0.7526754492548586,0.7714285714285715,0.9648142889345889,1.0,3/9,22.25%,WHRN;MKKS;COL11A1
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),-0.41174731728569736,-0.7523138769555282,0.7714285714285715,1.0,1.0,5/15,26.69%,HSD17B8;SLC25A1;FASN;CBR4;GCDH
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),0.4770564282048901,0.75214850967326,0.85,0.9651759142276624,1.0,4/6,32.27%,PADI2;SPTY2D1;TLK1;TLK2
prerank,GO_Biological_Process_2021__positive regulation of inositol phosphate biosynthetic process (GO:0060732),0.4842972745406848,0.7517706920273806,0.75,0.9653950677616601,1.0,1/5,2.40%,SNCA
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.3539745755742473,-0.7514919705298346,0.855072463768116,1.0,1.0,4/30,10.57%,STAT1;GSTP1;CASP8;RHOH
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),0.36321545858703264,0.751447250832887,0.7647058823529411,0.9654854383888881,1.0,3/10,14.63%,ZBTB1;TICAM1;AP1G1
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),-0.42489924559530273,-0.7514459452378826,0.7678571428571429,1.0,1.0,1/10,8.94%,HES1
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,-0.29897927941991104,-0.7512411648803967,0.9534883720930233,1.0,1.0,19/95,18.30%,SELP;CLEC12A;P2RY13;F13A1;FPR3;GPR171;PROCR;CD14;VWF;ABCG2;FES;SPI1;IL3RA;CXCR4;SCARF1;ARID3A;GNL3;C1QB;CD44
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.3202059220526788,-0.7512374863964092,0.8918918918918919,1.0,1.0,16/41,27.95%,CYP4Z1;CYP2D6;AWAT1;GSTP1;FADS1;GPX4;PTGR1;ALOX12;ALOX5;FADS3;ACOT8;CYP4F3;FADS2;PLA2G4A;ACAA1;CYP1B1
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),-0.4087350376529677,-0.7509175513452727,0.8793103448275862,1.0,1.0,2/13,7.95%,VIL1;PDPN
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),0.42748306012654325,0.7507856001413897,0.75,0.9660765528709372,1.0,2/6,13.21%,ZBTB1;TGFBR1
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),-0.43723464740276985,-0.7507559696040023,0.8,1.0,1.0,1/9,7.72%,RAB11A
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),-0.2920126504955108,-0.7506208115951879,0.896551724137931,1.0,1.0,17/114,21.40%,KCNJ13;SLC18A2;SLC5A10;AQP1;KCNQ4;CNGB3;KCNG1;SLC8A3;KCNJ8;SLC4A11;SCN7A;SLC8B1;CNGA3;SLC22A4;TRPM1;SLC22A1;CLN3
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.4166476019392982,-0.7505575198541076,0.7777777777777778,1.0,1.0,1/10,3.86%,MST1
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.39366945975997775,-0.7504705005740607,0.8382352941176471,1.0,1.0,7/22,24.70%,APLNR;ADM;AGGF1;HEY2;ENG;TGFBR3L;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),-0.42553203241757426,-0.750311096894151,0.7121212121212122,1.0,1.0,3/12,10.85%,HLA-A;PNP;IL12A
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.3205683786253645,0.7501428742141593,0.8125,0.9665657764368243,1.0,3/14,19.58%,NR3C1;BMP7;ABHD2
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),0.3616314141336412,0.7500619605287862,0.8709677419354839,0.9663310239107891,1.0,4/16,11.24%,HNRNPU;FAM107A;NR3C1;SLIT2
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.3136644175519995,-0.7499860047174126,0.8444444444444444,1.0,1.0,10/78,17.43%,PATL2;ORMDL2;IGFBP5;TYMS;RPL13A;APOE;ORMDL1;CLU;EIF2AK2;IGF2BP3
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),0.3845090138349304,0.7499837120601156,0.75,0.9661234770322302,1.0,5/10,32.00%,RPTOR;ICE1;MTOR;ICE2;CHD8
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),-0.4038908699248175,-0.7497344953961871,0.8461538461538461,1.0,1.0,2/16,11.26%,S100A10;SFRP1
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),-0.36147539945878043,-0.7495724224350766,0.8939393939393939,1.0,1.0,2/25,4.45%,CD63;PDZK1
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),0.3987233212979696,0.7495599122190221,0.7586206896551724,0.9662945364147106,1.0,6/14,18.44%,OR9Q1;OR3A2;UBR3;MKKS;DRD2;SLC24A4
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.30351839806806385,-0.7493018602732543,0.8470588235294118,1.0,1.0,17/106,16.17%,PSMB6;RPS27A;AQP1;PSMB9;PSMA8;ELOB;PSMA7;PSME1;PSMC3;UBC;SLC8A3;SFRP1;MT3;PSMC4;SUV39H1;PLK3;PSMA3
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),0.4748487343888129,0.7491529077885204,0.8536585365853658,0.9665600595432122,1.0,3/6,22.21%,VCP;WDR48;TANK
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),0.4649707579947747,0.7488348141257829,0.8205128205128205,0.9666295451273732,1.0,3/6,20.44%,TRPM4;SIRT1;PLAAT3
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),-0.32163822973045164,-0.7487697878696452,0.8658536585365854,1.0,1.0,3/48,9.99%,TOMM7;TIMM10;TIMM8B
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),-0.4128102091713773,-0.7487201484666951,0.8076923076923077,1.0,1.0,1/15,4.51%,SELENOS
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.3552218403541599,-0.7486658053230554,0.8354430379746836,1.0,1.0,7/37,17.23%,PAQR3;GSTP1;PIK3CB;CAV3;APOE;DUSP1;PTPN22
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),-0.3120992145489902,-0.7486375433543563,0.8863636363636364,1.0,1.0,17/84,16.26%,SFRP2;APLNR;AQP1;ITGA5;THBS1;SEMA5A;ANGPTL3;CTSH;HYAL1;NODAL;RRAS;FGF1;HK2;WNT5A;AGGF1;BRCA1;XBP1
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),0.44471955914483213,0.7485117604873582,0.78125,0.9666314703594884,1.0,2/6,6.45%,TNFSF4;SH3RF1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.3756907053518249,-0.7483005705020132,0.8235294117647058,1.0,1.0,4/23,21.42%,KLF2;MT3;DDIT3;CREB3L1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),0.3157458999213621,0.7478589876666903,0.875,0.9670788194414867,1.0,4/23,9.56%,ANK2;ASB3;SMAD7;ADRA1A
prerank,GO_Biological_Process_2021__N-acylethanolamine metabolic process (GO:0070291),0.4133262331468063,0.7478265266575749,0.8,0.9664484008728954,1.0,1/5,31.70%,GDE1
prerank,GO_Biological_Process_2021__ethanolamine-containing compound metabolic process (GO:0042439),0.4133262331468063,0.7478265266575749,0.8,0.9664484008728954,1.0,1/5,31.70%,GDE1
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),-0.47788940252120626,-0.7475442759413059,0.8360655737704918,1.0,1.0,2/5,22.36%,DPM3;DPY19L2
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),-0.47788940252120626,-0.7475442759413059,0.8360655737704918,1.0,1.0,2/5,22.36%,DPM3;DPY19L2
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),-0.40321722407449817,-0.7475102235044987,0.828125,1.0,1.0,2/13,7.75%,MTLN;ANGPTL3
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),-0.4099367879536361,-0.7473326301389428,0.7857142857142857,1.0,1.0,1/14,3.05%,SELP
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),-0.43998689899541943,-0.7472869572298011,0.8208955223880597,1.0,1.0,1/8,6.04%,PNP
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),0.3326287661110622,0.7472057566329526,0.8484848484848485,0.966875122551781,1.0,3/15,14.53%,TNFSF4;HMGB1;HAVCR2
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),-0.3551065864086265,-0.7471825736937171,0.8666666666666667,1.0,1.0,2/25,4.79%,POU4F1;ANXA1
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),-0.31554049513973004,-0.7471233147847519,0.8571428571428571,1.0,1.0,3/54,6.86%,P2RY10;LPAR4;GPR18
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.326373995558787,-0.7470499198219314,0.9078947368421053,1.0,1.0,10/63,16.69%,SFRP2;B2M;FGF7;SFRP1;HYAL1;NODAL;FGF1;AQP11;LAMB1;FUT2
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),0.3900799053962254,0.7466081375008409,0.8611111111111112,0.9673419854654245,1.0,5/12,14.35%,TNFSF4;EIF2AK4;SIRT1;AHR;SAMSN1
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.36577026107667177,0.7463536250710401,0.8717948717948718,0.9673369226601165,1.0,6/13,27.95%,SLC12A2;TRPM4;SLC9A9;SLC6A1;HCN2;SLC9C2
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.3852931535162982,-0.7455796490535255,0.8533333333333334,1.0,1.0,3/17,16.73%,ITGA5;CTNNA3;MADCAM1
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),-0.4492485036492385,-0.7455051672009345,0.8064516129032258,1.0,1.0,1/6,2.15%,GPR183
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),-0.381815590150823,-0.7454562951192379,0.8125,1.0,1.0,2/18,10.62%,RPS27A;UBC
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),-0.4074402190201548,-0.7452028900532665,0.7777777777777778,1.0,1.0,4/15,21.67%,HES1;CXCR4;TNFRSF21;IL34
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),0.3161821443582237,0.7449748482053811,0.875,0.9687057708063765,1.0,6/31,13.93%,MAIP1;MTX2;CHCHD3;SAMM50;OPA1;BCL2
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),0.38975588326077304,0.744759828475276,0.8055555555555556,0.9686463792150888,1.0,3/9,24.61%,ZC3H14;CDK9;RNF20
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.3429769824156231,-0.7445750524962764,0.8428571428571429,1.0,1.0,11/31,31.39%,CENPN;ITGB3BP;OIP5;CENPH;CENPU;NPM1;CENPX;SMARCA5;KNL1;CABIN1;MIS18A
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),-0.33594164758621614,-0.7442366426367565,0.8666666666666667,1.0,1.0,7/30,21.40%,CFTR;NOX1;SLC9A2;SLC4A2;SLC9A7;SLC9B1;CLN3
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),0.2599542814651667,0.7441782576675191,1.0,0.9690917920902641,1.0,15/72,15.87%,FOXO1;SPRED2;SPRY4;DUSP10;LMO3;SPRED1;SPRY3;PSMD10;PTPRJ;CAMK2N1;NF1;DUSP6;DLG1;SMAD4;BMP7
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),0.34315630767632155,0.7439581196886197,0.8235294117647058,0.968958301687524,1.0,3/18,6.62%,SNCA;GRIN1;CASQ1
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.2882244923369872,-0.7438891454079428,0.967391304347826,1.0,1.0,41/165,22.02%,LMOD1;IL1R1;SPON2;SPARC;COL5A1;PI16;COL6A2;KLF2;COX7A1;ANGPTL2;COL8A1;ELN;FBLN7;COL4A4;C1R;MEOX1;MGP;FMO2;P4HTM;FBLN5;HHIP;GSTM5;LAMB1;COL4A2;PAMR1;SOD3;LRRK1;KLF4;ADGRL4;C1S;CD44;ADAMTS10;THBS2;CXCL14;TAGLN;SRPX2;NID2;COL14A1;EDNRA;IL34;ITGBL1
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.36682368243577257,-0.743755571284242,0.7777777777777778,1.0,1.0,3/19,15.97%,RPS21;ERI2;WDR12
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.39920697143465633,0.7436761567638144,0.8205128205128205,0.9689661395969685,1.0,2/9,6.62%,ANK2;CASQ1
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.2685483571689008,0.7432324618385436,0.9473684210526315,0.9692630695354217,1.0,11/60,14.93%,EGFR;RGCC;AKT1;FAM107A;PLCB1;PKD2;ANKRD17;UBE2E2;RPTOR;DLG1;CDK2AP2
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),0.2743167552850748,0.7431411317388276,1.0,0.9690019617778901,1.0,13/58,15.32%,NCK2;PLEK;HCLS1;BIN1;CARMIL1;PRKCE;KATNBL1;NCK1;NCKAP1;FER;TENM1;NRP1;VASP
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),-0.3934996177746376,-0.7423467886167666,0.8524590163934426,1.0,1.0,5/12,26.69%,ERBB3;HHIP;GLRA1;OPRM1;BRAP
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),0.3332066737637853,0.742217190308447,0.9310344827586207,0.9700041219051969,1.0,2/17,7.94%,MYO5B;WASL
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),-0.4481224537028363,-0.7421019739116305,0.8064516129032258,1.0,1.0,2/9,10.85%,BST2;IL12A
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),-0.33808725530707834,-0.7420399765248874,0.8055555555555556,1.0,1.0,6/31,24.64%,NEFH;CRYAB;REEP5;HAP1;ANTKMT;DNAJC30
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),0.4224648422577605,0.7418318393819214,0.7560975609756098,0.9701324798647442,1.0,1/7,9.24%,ME2
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),-0.46637510776576435,-0.7416961287106939,0.8070175438596491,1.0,1.0,3/5,16.61%,P2RY12;VWF;GPI
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),-0.383966795982304,-0.7416658861767237,0.8857142857142857,1.0,1.0,4/31,5.89%,OVOL2;OVOL3;ANXA1;FLG
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),0.4366183721303382,0.7415459622556979,0.7948717948717948,0.9701734683451959,1.0,1/5,1.50%,TNFSF4
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.29238622253879704,0.7411241457285042,0.9285714285714286,0.9702949676417707,1.0,2/30,2.40%,LEPR;SNCA
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),-0.32037728102722374,-0.7410916885813419,0.863013698630137,1.0,1.0,7/46,16.74%,RPL11;B2M;TRIM21;BDNF;DTX3L;APOE;RIPK2
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),0.3643882924027076,0.7409566422956948,0.8055555555555556,0.969820069783411,1.0,1/12,11.76%,ALDH7A1
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),0.3643882924027076,0.7409566422956948,0.8055555555555556,0.969820069783411,1.0,1/12,11.76%,ALDH7A1
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),-0.4107211558342959,-0.740795136135141,0.7636363636363637,1.0,1.0,1/7,6.67%,THBS1
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),-0.38271777800967677,-0.7406413639288094,0.8,1.0,1.0,1/14,2.77%,KIF20B
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.37686851301771795,0.7401537604902682,0.7804878048780488,0.9704913465320572,1.0,4/12,14.87%,SALL1;TMEM65;MDM4;PDE2A
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.44250566869068214,-0.7401047068283547,0.8589743589743589,1.0,1.0,3/11,13.62%,COX7C;COX4I1;COX5B
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.2807171485713249,-0.7400163729139636,0.967032967032967,1.0,1.0,6/143,3.62%,POU4F1;SFRP2;PTRH2;OVOL2;APLNR;PARP14
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),0.41638756870053056,0.739978501625488,0.8157894736842105,0.9704182009064422,1.0,5/8,17.10%,CRIPT;HNRNPU;MID1;MAPRE1;CHAMP1
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),-0.30382581959337923,-0.7394094788896406,0.8888888888888888,1.0,1.0,8/53,15.55%,SFRP2;SFRP4;WNT9B;WNT2B;SFRP1;WNT3;FZD9;WNT5A
prerank,MSigDB_Hallmark_2020__Apical Surface,0.2901550357626146,0.7392542711099523,0.84375,0.9710151085952617,1.0,3/35,9.87%,EFNA5;ADIPOR2;RTN4RL1
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),0.39402557770354496,0.7391809236209198,0.8484848484848485,0.9707944830782227,1.0,1/12,6.79%,GPHN
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.34277587221616324,0.7388819093167383,0.8611111111111112,0.9708083490214339,1.0,2/14,5.11%,SORT1;BMP2
prerank,PanglaoDB_Augmented_2021__Trichocytes,-0.3428876979979596,-0.7388152269638185,0.8933333333333333,1.0,1.0,7/30,18.54%,ABCA12;GPR87;TRIM29;B3GNT3;DMKN;TUFT1;S100A16
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),0.36933408483548247,0.7384419587509922,0.8918918918918919,0.9710163056056135,1.0,5/13,25.56%,DFFB;HMGB1;CASP3;EXOG;DICER1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.3830566965809339,-0.7384326645662052,0.8493150684931506,1.0,1.0,4/15,10.85%,CD63;CCBE1;PIK3CB;IL12A
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),0.3558406402028613,0.7384017739514337,0.8,0.9707156177583168,1.0,2/13,6.56%,RHBDD1;KLKB1
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.336821193329649,0.7382220107776282,0.92,0.9705622838944009,1.0,4/20,13.21%,PDGFRA;RAB33B;WWOX;TGFBR1
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),0.29557979940514834,0.7380217946751043,0.8076923076923077,0.9704491727173356,1.0,7/29,15.83%,TTBK2;GLI3;HIPK2;KIAA0586;MAP3K10;DYRK2;SMO
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),-0.4055329946537969,-0.7379965746668993,0.7702702702702703,1.0,1.0,1/12,5.28%,CYP4Z1
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),-0.37100780467981587,-0.7376348297266269,0.7285714285714285,1.0,1.0,1/16,2.77%,KIF20B
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),-0.3370947949534805,-0.7376023052252597,0.8928571428571429,1.0,1.0,9/29,29.16%,ALDOB;SORD;AKR1A1;FUCA2;PMM1;DCXR;FBP1;FUCA1;KHK
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),-0.34537085264668643,-0.7372664839144012,0.881578947368421,1.0,1.0,6/31,25.79%,TAF1D;POLR2L;POLR1C;POLR2K;TBP;CDK7
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.29455413236201916,-0.737259380053621,0.9125,1.0,1.0,8/69,15.12%,WARS1;MTLN;VIL1;CHMP2A;SLX4;HYAL1;CLU;CX3CL1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),0.430162436638329,0.7372439411828446,0.8292682926829268,0.9710312655920689,1.0,1/7,5.50%,TPK1
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.4465311609638406,-0.7371806850191469,0.8524590163934426,1.0,1.0,2/7,10.85%,PIK3CB;IL12A
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.47021738681948,-0.7371215875758572,0.8518518518518519,1.0,1.0,4/5,33.49%,CTR9;RTF1;PAF1;LEO1
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),-0.47021738681948,-0.7371215875758572,0.8518518518518519,1.0,1.0,4/5,33.49%,CTR9;RTF1;PAF1;LEO1
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.3616652452466426,-0.7371059573297201,0.875,1.0,1.0,2/24,6.50%,TRIM21;SIGIRR
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),0.3246050072562112,0.7368620082741287,0.918918918918919,0.9712254250394661,1.0,7/17,30.03%,REEP4;LEMD3;TOR1B;SUN2;DMPK;TOR1AIP1;LEMD2
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),0.44883435271882033,0.7368355092322254,0.813953488372093,0.9709452197660684,1.0,3/5,14.87%,PDE10A;RUNDC3A;PDE2A
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),0.3078035719938264,0.7366516420190394,0.9565217391304348,0.9708855486243794,1.0,7/42,13.92%,SGMS1;CERS3;ACER3;PLPP1;PLPP2;PLPP3;ABCA2
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),-0.34143274511364957,-0.7365121438065162,0.8289473684210527,1.0,1.0,7/33,25.79%,TAF1D;POLR2L;POLR1C;POLR2K;TTF1;TBP;CDK7
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.4151364983716903,-0.7362254088339729,0.8666666666666667,1.0,1.0,1/11,3.95%,CD9
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.2723587547706414,0.7360677344725907,1.0,0.9712264021646767,1.0,7/46,16.03%,ESYT3;PGAP1;ESYT2;ABCA2;HEXB;NEU3;STS
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.29872255959856897,-0.7359171453096724,0.9156626506024096,1.0,1.0,19/99,16.74%,MMP25;PRDX5;ANXA1;CXCL2;THBS1;ADM;TACR1;FPR3;CIITA;CD14;HYAL1;NOX1;SLC11A1;CCL2;CXCR4;CX3CL1;IL18;GPR68;RIPK2
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),-0.4035138936371895,-0.7358085673824515,0.8771929824561403,1.0,1.0,5/10,26.69%,ERBB3;HHIP;GLRA1;OPRM1;BRAP
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),0.27629868872547864,0.7355996150800332,1.0,0.9714802800692083,1.0,10/48,15.33%,HADH;ECHDC1;AUH;BDH2;PEX2;HSD17B4;ACADVL;ACADM;ABCD3;CRAT
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.37862239788667684,0.7355915363190255,0.8,0.9711536808253671,1.0,5/13,17.04%,PDS5B;NIPBL;PDS5A;NAA50;POGZ
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.35931694220837346,-0.7355835969305525,0.7746478873239436,1.0,1.0,4/19,14.27%,F8;A2M;CPB2;APOE
prerank,GO_Biological_Process_2021__positive regulation of activin receptor signaling pathway (GO:0032927),0.44829730397428114,0.7353287561648386,0.7878787878787878,0.9712340451408892,1.0,2/5,13.70%,SMAD2;ACVR2A
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle contraction (GO:0045987),-0.45823087200515766,-0.7350528345052438,0.8103448275862069,1.0,1.0,3/7,19.90%,SRF;SPHK1;GPER1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),-0.37635086302595083,-0.7348617750512689,0.8484848484848485,1.0,1.0,4/16,20.44%,KLF2;CLU;KLF4;NOS1AP
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),0.3474333047722037,0.7346366529085363,0.8461538461538461,0.9717209544725183,1.0,2/15,7.94%,MYO5B;WASL
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),0.3966526437357559,0.7346252839625673,0.7435897435897436,0.971407935109374,1.0,1/7,4.70%,SCD5
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.3548622860439629,0.7345486240019267,0.9117647058823529,0.9711817233290548,1.0,7/18,26.93%,PPP1R36;GPATCH2;ARPP19;PPP1R8;PPP1R26;ENSA;PPP1R16B
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),0.32639321743450767,0.7344031967202763,0.9696969696969697,0.9710289124907074,1.0,8/20,24.37%,HTR2C;PKD2;TRPM2;DRD2;LETM1;FGF2;IBTK;PTPRC
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.33993128078772766,-0.7339775025925018,0.8888888888888888,1.0,1.0,8/37,16.43%,MX1;CD9;CEACAM1;ADM;ARR3;CAV3;RAMP3;CALCRL
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),0.3817853867348523,0.7337893714846797,0.8157894736842105,0.9715019123826852,1.0,1/12,0.93%,MSH4
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),-0.31580918789336787,-0.7335650069518957,0.8953488372093024,1.0,1.0,5/61,9.58%,ISG15;ITGA5;CEACAM1;ANGPTL3;FYB2
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),0.2825799593344851,0.7333874535816833,0.85,0.9716485342017231,1.0,3/35,9.50%,ST6GALNAC5;B4GALT6;LARGE1
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),-0.3337069063308137,-0.7333476575236422,0.8974358974358975,1.0,1.0,2/40,5.32%,ANXA1;AQP1
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),0.34797933065502096,0.7331428136748925,0.75,0.9716819735109189,1.0,4/15,29.73%,KIF5A;FBXW11;TMEM108;PAFAH1B1
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.240315275223623,0.7331243215090117,1.0,0.9713829090266,1.0,16/112,14.91%,FUT9;STT3B;MGAT4A;ST3GAL1;TRAK1;POMK;GAL3ST1;GALNT7;LARGE1;PLOD2;ALG6;FUT8;OGT;B4GALT5;PLOD1;ALG10
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),0.33803429161342047,0.7328110704627905,0.875,0.9714297109734372,1.0,4/17,15.84%,TENM3;NF1;NIPBL;AGTPBP1
prerank,PanglaoDB_Augmented_2021__Basophils,0.25824216009357376,0.7327976977952383,1.0,0.9711043568289733,1.0,14/69,13.68%,ST6GALNAC5;CSF1R;LTC4S;SLC26A3;OTUB2;PLEK;TEC;CABLES1;INF2;HGF;PDZD4;SUPT3H;JAZF1;GABBR1
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),0.4548068260835208,0.7326828317303304,0.8421052631578947,0.9708921526472426,1.0,1/5,3.27%,VAPA
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),0.3878267472620739,0.732403042973255,0.7692307692307693,0.9708859499753503,1.0,2/10,11.23%,HNRNPU;RBM15B
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),0.3355710184598259,0.7323184020963059,0.8,0.9706274973898333,1.0,5/13,19.58%,PLPP1;NR3C1;BMP7;NR3C2;ABHD2
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.42273551631902023,-0.7322974303763697,0.7777777777777778,1.0,1.0,3/11,14.27%,PPIB;CAV2;APOE
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,-0.3048122949191467,-0.7317570475682611,0.9411764705882353,1.0,1.0,20/80,21.24%,LMOD1;SPARC;COL5A1;IGFBP5;AQP1;ANGPTL2;ELN;C1R;COL4A2;PAMR1;SOD3;CRYAB;ADGRL4;C1S;THBS2;TNS2;TAGLN;CALD1;COL14A1;EDNRA
prerank,GO_Biological_Process_2021__artery development (GO:0060840),-0.399570124011434,-0.7316457865581962,0.828125,1.0,1.0,3/18,8.94%,APLNR;ANGPTL3;HES1
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.34382923458438763,0.7315908153240323,0.8918918918918919,0.9712385374134813,1.0,6/16,24.30%,GNAI3;NF1;STIM1;DRD2;ORAI1;GABBR2
prerank,GO_Biological_Process_2021__amino-acid betaine biosynthetic process (GO:0006578),-0.4803635107880197,-0.7313927093245621,0.8888888888888888,1.0,1.0,1/5,8.95%,TMLHE
prerank,GO_Biological_Process_2021__carnitine biosynthetic process (GO:0045329),-0.4803635107880197,-0.7313927093245621,0.8888888888888888,1.0,1.0,1/5,8.95%,TMLHE
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.31306638210655885,-0.7310998513803071,0.9240506329113924,1.0,1.0,7/57,11.94%,IFIT1;B2M;IFIT2;DDX11;LRPAP1;EFHB;TMC8
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.29560498559675896,0.7310708276620788,0.875,0.9714644037189969,1.0,12/36,23.68%,NEDD4L;SSH1;MAP2K5;SPOPL;FAF1;ROCK2;MAPK8;MDM2;FURIN;ZDHHC2;CHMP6;TRAF3
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),-0.312155915108455,-0.7308827610829471,0.9195402298850575,1.0,1.0,16/72,16.26%,SFRP2;APLNR;AQP1;THBS1;SEMA5A;ANGPTL3;CTSH;HYAL1;NODAL;RRAS;FGF1;HK2;WNT5A;AGGF1;BRCA1;XBP1
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),0.34914089861132125,0.7308823496531772,0.8076923076923077,0.9713519107371653,1.0,5/12,19.58%,MBD2;HELLS;SIRT1;CHD1;SETD5
prerank,GO_Biological_Process_2021__adenosine metabolic process (GO:0046085),0.45368091364815866,0.7307551947088232,0.8974358974358975,0.971159943897405,1.0,3/5,23.09%,NT5C1A;ADA;NT5C2
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),0.3974986606149129,0.7307276128295888,0.8181818181818182,0.970848822734801,1.0,2/9,12.46%,ABCC2;ABCC3
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),-0.4221050105121046,-0.7304199055549724,0.85,1.0,1.0,4/8,28.20%,ANK1;PDZD11;CRB2;WDR1
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),-0.4221050105121046,-0.7304199055549724,0.85,1.0,1.0,4/8,28.20%,ANK1;PDZD11;CRB2;WDR1
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),0.36526225272953344,0.7303983494070501,0.8787878787878788,0.9710347658184504,1.0,5/14,11.65%,ADGRB3;SORT1;IGF1;ADAM12;JAM2
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.28188130942543704,0.7302601219613266,0.9,0.970829858269185,1.0,7/27,13.63%,AKT1;PIK3CA;PIK3R1;IRS1;IGF1;NF1;SIRT2
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.329295927227514,0.7302472913236596,0.7916666666666666,0.9704993067341938,1.0,3/15,13.28%,ZBTB20;AKT1;MLXIPL
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.32493977588468537,-0.7302164999234252,0.8571428571428571,1.0,1.0,3/28,10.60%,CD63;SFRP4;LRPAP1
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),-0.43731474949577787,-0.7300540594722311,0.8620689655172413,1.0,1.0,1/7,5.95%,CEACAM1
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),0.37679743399699805,0.7300501530752154,0.9,0.9704403154300527,1.0,2/12,9.15%,TNFRSF10B;MAP3K7
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),0.2978865205677292,0.729980862694603,0.8611111111111112,0.9702292036238167,1.0,5/22,17.32%,RAPGEF2;RAP1A;COL15A1;PDE2A;PDE4D
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),-0.3612391540060116,-0.7297626983629022,0.7538461538461538,1.0,1.0,3/20,9.93%,NOP10;BUD23;TRMT112
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.30929384762014145,-0.7295838973428742,0.9367088607594937,1.0,1.0,11/70,17.27%,IFIT1;IFIT2;PLN;DDX11;CYP2D6;LRPAP1;EFHB;TMC8;SP100;GTF2F1;ZFPM1
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.246286656897787,0.7294961106046502,1.0,0.9704811755327779,1.0,10/95,10.11%,SLC24A3;KCNQ3;ABCC8;KCNA4;SLC12A2;KCNH2;KCNQ2;PKD2;KCNH7;KCNA2
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),-0.38813800616676913,-0.7294885263738888,0.8548387096774194,1.0,1.0,5/13,32.30%,HYAL1;GPR68;MCOLN1;PKD1L3;RAB11FIP5
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),0.4290437844596276,0.7288894660028389,0.8378378378378378,0.9708255326290888,1.0,3/7,9.14%,SERPINE1;KLKB1;FAP
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.4206786775731599,-0.728671662615054,0.796875,1.0,1.0,1/10,4.67%,BHMT
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.3766355922878727,0.7280324553447621,0.8285714285714286,0.9714670576649184,1.0,2/11,7.99%,SPRED2;SPRED1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),0.3496665925714376,0.7280116449998146,0.8947368421052632,0.9711766036547144,1.0,6/15,22.37%,NT5C1A;DPYSL4;NT5M;DPYSL5;UPP1;NT5C3A
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.3788825358493327,-0.7277257632124952,0.8059701492537313,1.0,1.0,3/17,16.64%,AQP1;RCSD1;SLC4A11
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),-0.43642913203939165,-0.7272619468386115,0.8214285714285714,1.0,1.0,2/10,18.49%,HSD17B7;CYP3A4
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),-0.40595932151851594,-0.7270448436764075,0.890625,1.0,1.0,3/12,16.71%,PDPN;CST3;FSCN1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),0.35329706372884984,0.726619617360661,0.896551724137931,0.9726167113929424,1.0,4/19,14.44%,ANK2;TRPM4;CAMK2D;DLG1
prerank,PanglaoDB_Augmented_2021__Macrophages,-0.29653622113266337,-0.7259135294501576,0.9540229885057471,1.0,1.0,17/80,18.59%,TAGAP;RAB7B;PARP14;CLEC12A;IGSF6;CXCL2;F13A1;GPR171;CD14;SLC11A1;SPI1;CCL2;P2RY6;MYO1F;SCIMP;PTAFR;CLEC5A
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),0.3709650209357276,0.7256947727606259,0.8461538461538461,0.9733229967305896,1.0,1/10,4.67%,SLC15A2
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.40311582027120374,0.7256757039536835,0.8,0.9730124086301437,1.0,2/8,5.51%,FOXO1;GUCY1B1
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),-0.3231963760100037,-0.7253518777614384,0.8701298701298701,1.0,1.0,6/51,10.56%,PSMB6;PSMB9;PSMA8;PSMA7;PSME1;PSMC3
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),0.4064597229132953,0.724970722072965,0.75,0.9735597350636683,1.0,3/8,18.48%,DLG1;WNK3;WNK1
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.34964977124359964,-0.7247631636492321,0.8309859154929577,1.0,1.0,5/32,22.52%,RPA3;PNKP;POLD2;APEX1;PARG
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),-0.431004337556256,-0.7246216590983929,0.7540983606557377,1.0,1.0,2/6,12.35%,CTSL;CAV2
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),-0.48169445491369656,-0.7243561354289832,0.8571428571428571,1.0,1.0,1/5,5.51%,VIL1
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),-0.3428351686602319,-0.7241556461290382,0.8356164383561644,1.0,1.0,1/26,2.42%,MUSK
prerank,GO_Biological_Process_2021__tricuspid valve development (GO:0003175),0.44142248770082426,0.723928484720919,0.7567567567567568,0.9744232733670052,1.0,2/5,14.73%,TGFBR2;BMPR1A
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),-0.3192014436419517,-0.7236483654072416,0.8552631578947368,1.0,1.0,6/45,11.73%,ENPP2;VIL1;CEACAM1;RAB11A;CTSH;HYAL1
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),-0.4724799102956207,-0.7236439522029146,0.8245614035087719,1.0,1.0,1/6,9.93%,TRMT112
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.30725266409188073,-0.7236074798149068,0.95,1.0,1.0,9/57,17.23%,HLA-B;RAB7B;SELENOS;TLR3;CX3CL1;WNT5A;XBP1;SCIMP;PTPN22
prerank,GO_Biological_Process_2021__tubulin complex assembly (GO:0007021),-0.46426428861609625,-0.7233263063146959,0.8076923076923077,1.0,1.0,2/6,20.19%,TBCE;VBP1
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.27112556875031246,0.7230953754481105,1.0,0.975088428623622,1.0,7/63,5.80%,YJEFN3;FLT1;PRKX;CSF1R;TOX;NOTCH2;PLEK
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),0.37706033635969455,0.7230917863625245,0.868421052631579,0.9747776632080942,1.0,4/10,22.17%,FZD3;KDM1A;DRD2;CTNNB1
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.3015291954706567,0.7230150512229522,0.9629629629629629,0.9744868747439893,1.0,5/33,12.84%,LIG4;EEF1D;INTS7;CLOCK;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.2872530466578683,-0.7228044138513602,0.9642857142857143,1.0,1.0,19/120,18.02%,ISG15;GBP1;SELENOS;ANXA1;CEACAM1;SIGIRR;THBS1;IL12A;CUEDC2;PDCD1LG2;HERC5;INHA;SLC11A1;CX3CL1;CD274;PTPN22;ZFPM1;KLF4;DDIT3
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),-0.4190060783954065,-0.7222046782839385,0.8,1.0,1.0,1/11,4.33%,P2RY12
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.3797745886481812,-0.7220843001949572,0.8857142857142857,1.0,1.0,1/15,3.05%,SELP
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),0.480325653962979,0.7218596534178304,0.8571428571428571,0.9754477270619578,1.0,2/5,24.16%,GRM5;TCAF1
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),-0.468576312384957,-0.72167143982885,0.8392857142857143,1.0,1.0,2/6,22.89%,NOS1;PARK7
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.3420614689537066,-0.7214984420748102,0.863013698630137,1.0,1.0,7/26,20.34%,ANXA1;VAMP8;IL12A;RSAD2;APOE;ERP29;PNKD
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),-0.42320868519934707,-0.7213043239797414,0.8307692307692308,1.0,1.0,1/7,13.29%,FES
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.28596204902077577,0.7211850784516105,0.9428571428571428,0.9759470265171756,1.0,8/34,17.32%,SNCA;ANK2;CASQ1;GSTM2;CAMK2D;JPH1;UBASH3B;PDE4D
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),0.28649731302336096,0.7208915810886869,1.0,0.9759589135028379,1.0,9/42,15.68%,CCDC88C;KAT2B;SPRED2;SPRED1;ATG7;PTK2;FER;ABCA2;PHIP
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),0.32110287160740597,0.7207549423162863,0.9166666666666666,0.9757997161010036,1.0,8/26,14.98%,NPNT;SALL1;BMP2;EPHA2;PKD2;SLIT2;TGFBR2;NRP1
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.33651801323914127,0.720660354718199,0.7941176470588235,0.9756011606102547,1.0,3/17,6.20%,EPS8;KANK1;ARHGAP24
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),-0.4822630755385086,-0.7204324652715262,0.7924528301886793,1.0,1.0,2/5,27.65%,PARK7;ADAM8
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),-0.2901588188780583,-0.720243212659333,0.9529411764705882,1.0,1.0,9/123,12.69%,CD24;APIP;RASGRP1;CEACAM1;GSTP1;CCN1;CAV2;RRAS;CAV3
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",0.4363100950390576,0.7198275658818456,0.8181818181818182,0.9763364474859787,1.0,2/6,6.20%,WNT7A;ARHGAP24
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.29904938444388296,-0.7197305245750455,0.935064935064935,1.0,1.0,9/77,16.17%,PSMB6;PSMB9;PSMA8;PSMA7;PSME1;PSMC3;PSMC4;WNT5A;PSMA3
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.28150001222253357,-0.7197029153474227,0.9782608695652174,1.0,1.0,34/156,21.16%,SPARC;COL5A1;SFRP4;COL6A2;ITGA5;TIMP1;ECM2;THBS1;BDNF;ELN;EMP3;GLIPR1;PPIB;CCN1;SFRP1;MGP;MATN2;FBLN5;MATN3;DPYSL3;WNT5A;ID2;TNC;LAMA1;COL4A2;SNTB1;GADD45B;CD44;THBS2;TAGLN;CALD1;PFN2;GPX7;NID2
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.342186710115606,0.7196872714582634,0.8292682926829268,0.9761772839104532,1.0,5/13,19.43%,LIG4;NIPBL;MSH2;BRCC3;XRCC4
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),0.33142751801295417,0.7194480763385335,0.8125,0.9761365052771563,1.0,5/20,18.17%,VPS37B;CHMP2B;TRIM28;TRIM35;TRIM8
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),0.37360858938598346,0.7194166135671478,0.875,0.9758395731542119,1.0,2/7,14.50%,SERPINB9;MAPK1
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.33154269283017435,-0.7190414334457805,0.9090909090909091,1.0,1.0,9/36,24.26%,GAPDHS;ALDOB;SORD;GPI;SLC25A1;PGAM1;ENO1;PCK2;GAPDH
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.2862407189731393,-0.7190349126795176,0.9883720930232558,1.0,1.0,11/89,16.17%,PSMB6;STAT1;PSMB9;PSMA8;PSMA7;PSME1;PSMC3;LTBR;TXNDC17;PSMC4;PSMA3
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),-0.4433504413311291,-0.7189658885628579,0.9090909090909091,1.0,1.0,2/6,19.91%,WNT5A;CD74
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),-0.440988204582872,-0.7187869883886967,0.7962962962962963,1.0,1.0,2/7,14.17%,KCNQ1;KCNJ8
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.30084685059332106,-0.7185248508871225,0.8987341772151899,1.0,1.0,9/57,15.19%,POU4F1;BDNF;MT3;UNC5B;APOE;CCL2;FZD9;CX3CL1;ERBB3
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.3744800294116447,-0.718405510885272,0.8307692307692308,1.0,1.0,2/13,11.50%,HES1;CRLF3
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.33768486213356536,-0.7181247741149586,0.9027777777777778,1.0,1.0,2/33,6.97%,GAPDHS;ALDOB
prerank,GO_Biological_Process_2021__negative regulation of T cell differentiation (GO:0045581),-0.4592104551437861,-0.7180165124355011,0.7936507936507936,1.0,1.0,1/6,2.61%,IRF1
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.3952505321270626,0.7179055761076939,0.8421052631578947,0.9773749024214198,1.0,4/10,16.54%,GUCY1B1;DDAH1;KCNC2;NDNF
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.3068380150081516,-0.7176633967798962,0.9615384615384616,1.0,1.0,12/54,15.55%,USP18;IRF1;IL1R1;ANXA1;LRRC19;ERAP1;NLRP1;CASP8;AKNA;HERC5;APOE;WNT5A
prerank,GO_Biological_Process_2021__cellular response to indole-3-methanol (GO:0071681),-0.49054885239290247,-0.71737686374236,0.8727272727272727,1.0,1.0,3/5,28.99%,BRCA1;CDH1;JUP
prerank,GO_Biological_Process_2021__response to indole-3-methanol (GO:0071680),-0.49054885239290247,-0.71737686374236,0.8727272727272727,1.0,1.0,3/5,28.99%,BRCA1;CDH1;JUP
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,0.2380160526423987,0.7172703976886654,1.0,0.9778654698189977,1.0,30/142,17.13%,PHLDA1;ENO3;RORA;ALCAM;ANXA4;SPRED2;PLPP1;BMP2;GUCY1B1;SPRY4;PDCD2L;CDC42SE2;CA2;NCOA3;MAPKAPK2;ECM1;AHCY;IKZF2;RGS16;HIPK2;TTC39B;AHR;BCL2;UCK2;NRP1;POU2F1;SWAP70;RABGAP1L;CYFIP1;ITGA6
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),0.3332871346462855,0.7170157519386703,0.8717948717948718,0.9777782418231352,1.0,5/15,14.40%,HMMR;LYVE1;ABCC5;CEMIP2;HEXB
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),-0.2810431392571351,-0.7165050725022774,0.9438202247191011,1.0,1.0,2/114,0.30%,CD24;PRAME
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),-0.4568251685768991,-0.7163688322813778,0.8181818181818182,1.0,1.0,1/7,6.09%,GRIN2D
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),0.31644089477436677,0.7162893480304355,0.8620689655172413,0.9783601804439306,1.0,5/26,16.90%,CHMP1A;SIRT1;CHMP2B;ALMS1;CEP120
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),-0.3942061099799581,-0.7162296067274677,0.8615384615384616,1.0,1.0,1/12,6.48%,TRIM21
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),0.38158244998182056,0.7161895254894918,0.85,0.9781285757503866,1.0,6/9,32.91%,MBNL1;TGFB2;FBXW4;MEGF8;SKI;MYH3
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.34190198924125154,-0.7160412872336333,0.8955223880597015,1.0,1.0,4/23,11.73%,ANXA1;MTBP;RDX;HYAL1
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.32524025021293473,-0.7159540881978639,0.9444444444444444,1.0,1.0,7/25,22.12%,ARG2;PM20D1;NOS1;SPHK1;ASAH2;ASAH1;GCHFR
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),0.3237239336282566,0.715948984605865,0.8666666666666667,0.9780806800147028,1.0,6/20,13.85%,LIG4;PDGFRA;PDGFA;IGF1;PDGFC;DHX9
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),-0.4696590830305233,-0.7158640641470844,0.7796610169491526,1.0,1.0,1/5,4.51%,SELENOS
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),-0.4696590830305233,-0.7158640641470844,0.7796610169491526,1.0,1.0,1/5,4.51%,SELENOS
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.2705045138068317,0.7158120825620005,1.0,0.9778689853860841,1.0,17/56,20.67%,EGFR;ADNP2;RPS6KA3;CSNK2A1;AKT1;PLCB1;PSMD10;DERL2;TGFBR1;RPTOR;BCL2;USP47;CDKN2AIP;CIB1;PPM1F;ZNF639;ZPR1
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),0.32364068724129913,0.7157695883497579,0.9428571428571428,0.9775919230170791,1.0,7/18,27.07%,DFFB;HMGB1;BLCAP;CASP3;EXOG;DICER1;ACVR1C
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.38277589396549244,-0.7153964693843116,0.7936507936507936,1.0,1.0,1/14,7.15%,DDX11
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),-0.4304532851173151,-0.7151121930043048,0.8032786885245902,1.0,1.0,1/8,12.13%,NODAL
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.39532795567432477,-0.7151101284755355,0.8656716417910447,1.0,1.0,3/12,25.81%,FAM161A;KAT5;CAMK1
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),0.35359470852843217,0.715081974708768,0.8823529411764706,0.9780747118775568,1.0,4/16,15.97%,TNFSF4;PTPRJ;ANKRD17;HLA-DRA
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",-0.447112926257386,-0.7150722238540347,0.8461538461538461,1.0,1.0,1/7,15.11%,SEC62
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),-0.36926832548159205,-0.7149648455346217,0.8142857142857143,1.0,1.0,4/18,16.93%,RBKS;HK2;GPI;PGLS
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.3901804714197784,0.7148114749101863,0.7666666666666667,0.9781185515717143,1.0,4/8,15.68%,BMP2;MYORG;IGF1;PHIP
prerank,GO_Biological_Process_2021__response to interleukin-4 (GO:0070670),-0.44318712792629267,-0.714780686257199,0.85,1.0,1.0,2/5,24.46%,XBP1;TCF7
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),-0.2871543394701617,-0.713983365917289,0.96,1.0,1.0,16/87,17.68%,SELP;SELENOS;CXCL2;GSTP1;IL12A;CD14;LY96;PDCD1LG2;SLC11A1;CCL2;WNT5A;CD274;XBP1;CTR9;PTPN22;NOS1
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.2801369891082405,0.7135802256395272,0.9666666666666667,0.9792291028973127,1.0,8/32,18.57%,HTR2C;GRIN1;CACNA2D1;PKD2;ATP2B4;TRPM2;DRD2;GRIN2B
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",-0.443623464841712,-0.7135502438150121,0.8113207547169812,1.0,1.0,1/6,7.72%,RAB11A
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),0.37794983520161934,0.7133218940720856,0.8048780487804879,0.9792201868900614,1.0,1/10,5.72%,SLC25A18
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),-0.37597463696459066,-0.7132113633008776,0.9056603773584906,1.0,1.0,2/14,12.43%,BEST1;ABCG2
prerank,GO_Biological_Process_2021__membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915),-0.45700217739691573,-0.7128347094947987,0.7857142857142857,1.0,1.0,2/5,14.17%,KCNQ1;KCNJ8
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),0.3296743923049273,0.7127443051737082,0.8181818181818182,0.9795055778536381,1.0,4/16,21.21%,EP300;CHD1;ZNF639;LEF1
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),-0.42995582394687726,-0.7127051761128592,0.803030303030303,1.0,1.0,1/6,8.54%,GMFG
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),-0.42995582394687726,-0.7127051761128592,0.803030303030303,1.0,1.0,1/6,8.54%,GMFG
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.3282558871726077,-0.7126901070184419,0.9104477611940298,1.0,1.0,3/33,4.87%,CD63;SFRP4;B2M
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),0.2909261750269405,0.7123987127681688,0.96875,0.9795227261685616,1.0,10/37,18.26%,BRINP3;RGCC;HECA;ANGEL2;PRCC;SCRIB;FZD3;BMP7;TRIM35;BRINP1
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.26415539852226,0.7121486895743717,0.9411764705882353,0.9795137204553442,1.0,11/58,18.50%,KIFC2;ZNF207;EPS8;NSL1;PLK1;CLASP1;TOGARAM1;ESPL1;ABRAXAS2;TUBG1;LSM14A
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.3626894816518371,0.712074904993091,0.9,0.9792695173555747,1.0,4/12,21.60%,TICAM1;SIRT1;BCL10;CAMK4
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),-0.38919194637181176,-0.7118335742976356,0.8596491228070176,1.0,1.0,1/9,4.05%,ASIP
prerank,MSigDB_Hallmark_2020__Androgen Response,0.2713089259796729,0.7116217417116323,1.0,0.9794565397741714,1.0,23/92,19.86%,VAPA;PLPP1;RPS6KA3;ZBTB10;AKT1;BMPR1B;GSR;FKBP5;ANKH;GNAI3;ELOVL5;PIAS1;SMS;ELK4;MERTK;PDLIM5;RAB4A;MAF;LIFR;CCND3;TSC22D1;ABHD2;ACSL3
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),-0.4164546630692413,-0.7115291536732357,0.8125,1.0,1.0,2/11,16.09%,CEACAM1;BRCA1
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),0.41058753591293856,0.7113403551991822,0.7608695652173914,0.9795259138510153,1.0,3/6,29.91%,AGTPBP1;ARL3;RP1
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,-0.3512145123185032,-0.7111502034547332,0.9324324324324325,1.0,1.0,9/31,18.99%,OVOL2;CEACAM1;TMC4;TRIM29;CXCL17;GPX2;B3GNT3;FUT2;POF1B
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),0.2760179196610433,0.7108470848034542,0.9230769230769231,0.9796735635448833,1.0,12/53,18.36%,SASH1;EGFR;NFAT5;PPM1A;EP300;TRADD;DLG1;ADIPOR1;BMP7;TRIM44;NR3C2;CPNE1
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),0.4307241438316748,0.7108121862388836,0.7380952380952381,0.9793774373226742,1.0,4/5,36.81%,MAPK8;MAPK3;MAPK14;CAP2
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),-0.3555295539312274,-0.710531949393551,0.8028169014084507,1.0,1.0,3/12,21.69%,CCNB2;CCNB1;DCTN1
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),-0.3959871600789963,-0.7103548971071435,0.835820895522388,1.0,1.0,1/11,3.54%,APLNR
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),-0.3846830081766995,-0.7102576850283855,0.875,1.0,1.0,2/14,7.98%,MYO3A;MYO3B
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),0.40901121223731174,0.7102560913374527,0.7560975609756098,0.9796620096421245,1.0,3/7,12.69%,CXCL12;HCLS1;MERTK
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.38347778067946225,0.7101132469358835,0.7333333333333333,0.9795160524154258,1.0,4/12,15.87%,PKD2;NF1;NIPBL;BMP7
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.3854146089532874,-0.7100876239666657,0.835820895522388,1.0,1.0,2/9,10.85%,PIK3CB;IL12A
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.28783011204873765,0.7100733103559229,0.8846153846153846,0.9788856039677915,1.0,9/27,32.13%,SCRIB;VASP;MTHFR;BCL10;STIL;PHACTR4;TGFB2;COBL;SKI
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.28783011204873765,0.7100733103559229,0.8846153846153846,0.9788856039677915,1.0,9/27,32.13%,SCRIB;VASP;MTHFR;BCL10;STIL;PHACTR4;TGFB2;COBL;SKI
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.3570903252725256,0.7100164018434355,0.825,0.9786358338529842,1.0,2/18,3.46%,EPHA4;PICALM
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.37884907789280103,-0.7099815327101204,0.8653846153846154,1.0,1.0,2/15,11.50%,HES1;CRLF3
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),-0.4357552053869247,-0.7099044084963156,0.7903225806451613,1.0,1.0,1/6,13.29%,FES
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),0.41954916637699463,0.7096811488837625,0.8409090909090909,0.9787118084648512,1.0,1/6,14.70%,KAT7
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),-0.38836086099224637,-0.7096609444273994,0.8235294117647058,1.0,1.0,1/15,6.67%,THBS1
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),-0.384489742971132,-0.7092377175518806,0.9310344827586207,1.0,1.0,2/12,14.27%,THBS1;APOE
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.2817677242899473,-0.7092339492154183,0.9882352941176471,1.0,1.0,18/135,14.67%,F8;SELP;SPARC;CD9;ABCA12;CD63;TIMP1;THBS1;F13A1;TTN;SNAPIN;F5;SYT2;VWF;A2M;PCYOX1L;CLU;CDK5
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),0.32257334848802,0.7092249538073032,0.9166666666666666,0.9789309383176852,1.0,4/17,14.50%,CSF1R;SLIT2;PTK2;MAPK1
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.28786194434980317,0.7091297193375719,1.0,0.9786879109941321,1.0,10/28,31.06%,UGGT1;DNAJB13;PTGES3;HSPA1A;DNAJB5;DNAJB14;CHCHD4;SDF2;GAK;SELENOF
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),-0.35026798498900913,-0.7090917197228738,0.9253731343283582,1.0,1.0,4/26,15.12%,KIF20B;IGSF10;NEXMIF;CX3CL1
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),-0.4552673996013939,-0.7088186921723865,0.875,1.0,1.0,1/7,11.26%,SFRP1
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),0.2550548693138997,0.7087313505965445,0.95,0.9788483570996639,1.0,14/62,22.76%,EAF2;MLLT3;IWS1;CDK12;NELFA;CDK13;CCNT2;PCID2;SETD2;CDK9;GTF2F2;ELP2;CDC73;TCEA1
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),-0.4133468780787065,-0.7084327929657446,0.8620689655172413,1.0,1.0,3/9,16.06%,P4HA3;P4HTM;OGFOD1
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),0.27325214076206034,0.7082858387727855,1.0,0.9790932327715268,1.0,6/43,9.61%,PICALM;SERPINB9;NCSTN;SERPINE1;AKT1;A2ML1
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.3158315487171376,-0.708042867021906,0.9154929577464789,1.0,1.0,7/38,15.12%,ACKR4;SEMA5A;CCL28;PRKCQ;DEFB109B;CXCR4;CX3CL1
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),0.4160035425248991,0.707450086247268,0.8780487804878049,0.9796694785358495,1.0,2/8,11.89%,ADGRB3;ANKS1A
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),0.285118659252767,0.7073946673588422,0.9459459459459459,0.9794135322953617,1.0,8/25,18.55%,EGFR;AKT1;WASL;ZDHHC21;ATP2B4;DDAH1;HIF1A;DNM2
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),-0.4345426608053429,-0.7072930117789228,0.8305084745762712,1.0,1.0,1/6,13.96%,SAT2
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.34938743972242137,-0.7071954320434395,0.9324324324324325,1.0,1.0,2/28,3.89%,MX1;MYOF
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),0.27716095841038046,0.7068750703664979,0.8888888888888888,0.9795930104914694,1.0,3/30,5.33%,RHBDD1;NFKB1;NCSTN
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),0.27957672429717617,0.706360380931367,0.9393939393939394,0.9799152400895813,1.0,9/36,18.36%,IGF1;HMGB1;PRKN;SIRT2;RSF1;SMO;MAPK8;KDM1A;CPNE1
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),0.3989188187895828,0.7058727286959405,0.8787878787878788,0.9801723346953991,1.0,1/8,9.87%,RTN4RL1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",0.4152576259185244,0.7057854390452732,0.8260869565217391,0.9799295419586987,1.0,1/7,4.59%,DCP1B
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.37461050269175616,-0.7055811131173767,0.8088235294117647,1.0,1.0,2/15,9.20%,MST1;PGP
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,-0.29040222879748107,-0.7053202067743547,0.9882352941176471,1.0,1.0,27/100,21.24%,LMOD1;SPARC;COL5A1;IGFBP5;COL6A2;TIMP1;ANGPTL2;PNPLA3;C1R;CCN1;KCNJ8;CCL2;COL4A2;PAMR1;RBP1;SOD3;CRYAB;ADGRL4;C1S;THBS2;TNS2;TAGLN;CALD1;SRPX2;NID2;COL14A1;EDNRA
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.2830769342491735,0.7053074167424782,0.9,0.9802059231717026,1.0,4/29,15.31%,ABCA1;HOOK1;TFEB;TMEM106B
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),0.35215085362041887,0.7046391698046695,0.9142857142857143,0.9802265002033747,1.0,4/15,18.17%,RCC2;FAM107A;DUSP22;PTEN
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),0.35215085362041887,0.7046391698046695,0.9142857142857143,0.9802265002033747,1.0,4/15,18.17%,RCC2;FAM107A;DUSP22;PTEN
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),0.4474571904189513,0.704568461967157,0.8837209302325582,0.9800034566194263,1.0,2/5,21.94%,REST;LANCL1
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),-0.2932227792772679,-0.7045449482052825,0.926829268292683,1.0,1.0,5/67,10.19%,USP6;GGCX;ST3GAL6;PHEX;UBL5
prerank,GO_Biological_Process_2021__negative regulation of plasminogen activation (GO:0010757),-0.44554551833468936,-0.7039953636328558,0.8421052631578947,1.0,1.0,1/5,6.67%,THBS1
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),-0.33504560311490605,-0.7038400798359974,0.8888888888888888,1.0,1.0,5/30,13.82%,TNNT1;TTN;STAC3;RCSD1;KCNQ1
prerank,GO_Biological_Process_2021__cellular response to interleukin-4 (GO:0071353),-0.4299725074101397,-0.70346199034156,0.8307692307692308,1.0,1.0,2/6,24.46%,XBP1;TCF7
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),0.3870242285387042,0.7034049928534988,0.8333333333333334,0.9808625549750497,1.0,1/8,2.12%,BCO2
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),-0.44363600689359345,-0.703269114138437,0.8518518518518519,1.0,1.0,1/6,16.09%,BRCA1
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),0.24788607313506306,0.7024489756640829,1.0,0.981507345143565,1.0,18/86,18.60%,GNL3L;SNCA;NEDD4L;CAMK2B;NRXN1;SHANK3;ATP10A;CLIP3;TGFBR1;VCP;GSK3B;FAF1;NRG1;BMP7;TFRC;RUNX1;LRP4;ADD1
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),0.31938810552990665,0.7020079920001715,1.0,0.9816920031230436,1.0,3/19,13.32%,CHMP1A;SIRT1;CHMP2B
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.35055272748272537,-0.7019414319165208,0.890625,1.0,1.0,4/20,16.11%,ABCA12;PDPN;ABCG2;AQP11
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),0.28292903821035026,0.7018416154329762,0.9166666666666666,0.9814881862781875,1.0,4/31,7.34%,SERPINB9;SERPINE1;BIN1;AKT1
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.4181422576223329,-0.7015196532516599,0.8775510204081632,1.0,1.0,1/8,9.80%,ATG14
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),-0.41471299474475287,-0.701508364455973,0.7936507936507936,1.0,1.0,1/7,2.77%,KIF20B
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",0.3343056538423686,0.7014342788413539,0.8571428571428571,0.9815821424483793,1.0,7/14,30.87%,POT1;ATRX;TNKS2;TNKS;TERF2IP;TERF2;XRCC5
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),0.2716535378900933,0.7013499449549311,1.0,0.9813526248574402,1.0,16/45,25.56%,GPM6A;TNIK;MAP4K4;NCKAP1;NBL1;TAOK2;BMP7;WASF1;TRIO;ALS2;DNM2;CNTNAP2;NYAP2;SNX1;TAOK1;DICER1
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.34089466050941053,0.7012219478936867,0.8,0.9811491242177056,1.0,1/14,3.71%,BTN3A3
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),-0.31574475953762027,-0.7011872745891153,0.9054054054054054,1.0,1.0,1/38,0.51%,ANKRD53
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.39012433889889264,-0.7009478342755342,0.8387096774193549,1.0,1.0,1/12,3.62%,PARP14
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.35886798847008206,-0.7004620545673759,0.9014084507042254,1.0,1.0,3/17,16.09%,SLC18A2;MT3;BRCA1
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.3760488583266678,-0.7003618919422337,0.8382352941176471,1.0,1.0,2/17,20.46%,DTX3L;RNF8
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.3535059866402894,-0.7002555396423451,0.9375,1.0,1.0,3/17,15.79%,SVIL;CAV2;MYL6B
prerank,GO_Biological_Process_2021__telencephalon cell migration (GO:0022029),0.3909195002890017,0.7000126011966589,0.8333333333333334,0.98220622412132,1.0,2/5,23.12%,PEX13;FGF13
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),0.38578751171279696,0.699931942048252,0.875,0.9816181916942373,1.0,1/8,3.20%,ABCC2
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),0.38578751171279696,0.699931942048252,0.875,0.9816181916942373,1.0,1/8,3.20%,ABCC2
prerank,GO_Biological_Process_2021__tRNA thio-modification (GO:0034227),0.4172958295965178,0.6996687667985353,0.8717948717948718,0.9814665330704113,1.0,1/5,12.17%,CTU1
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),0.297900344743848,0.6996345677855483,0.8717948717948718,0.9811794130081815,1.0,1/18,1.44%,LIG4
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.32271435249505864,-0.6994562164816724,0.9027777777777778,1.0,1.0,9/36,21.10%,POLR2L;POLR2I;PTMA;DRG1;POLR2J;RRAGC;PAX8;POLR2K;POLR2G
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.3376384385674548,-0.6994362026496626,0.9027777777777778,1.0,1.0,6/24,24.29%,IGFBP5;IL12A;OGN;GPER1;VIP;APLN
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.365354632487511,-0.6990688310700475,0.859375,1.0,1.0,4/21,19.96%,ISG15;PDCD1LG2;CD274;TNFRSF21
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),0.35174126148669993,0.6989573272233038,0.8888888888888888,0.9816152416610634,1.0,5/12,19.45%,SORT1;NTRK2;SOS1;BCAR1;CASP3
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.27275426570937605,0.6986360215402144,0.9393939393939394,0.9815992071565555,1.0,2/34,3.21%,ST6GALNAC5;FUT9
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.34674352541169384,-0.6985499467362126,0.9344262295081968,1.0,1.0,7/25,19.44%,IRF1;ERAP1;CASP8;HERC5;CX3CL1;PTPN22;TRIM5
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.3908593116636575,-0.6985251727203626,0.8947368421052632,1.0,1.0,1/10,4.59%,IGFBP5
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.29094613334638186,-0.6983382994961789,0.987012987012987,1.0,1.0,9/77,16.17%,PSMB6;PSMB9;PSMA8;PSMA7;PSME1;PSMC3;PSMC4;WNT5A;PSMA3
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.3276864049584348,0.6981526854091846,0.9142857142857143,0.9818991802136914,1.0,3/12,12.52%,BMP2;SOX6;HDAC4
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),0.38959280028521653,0.6978870123421118,0.875,0.9818185944120125,1.0,2/6,14.50%,SERPINB9;MAPK1
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),0.26511909429839947,0.6977436580101667,1.0,0.9816285031210971,1.0,6/53,14.87%,TNFSF4;SNCA;SERPINE1;TRADD;DHX9;PDE2A
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),0.35242624014416546,0.697670508059136,0.9230769230769231,0.9813547852188631,1.0,1/15,3.43%,STT3B
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,0.2596418301952553,0.6976455473168638,1.0,0.9810554871572105,1.0,2/53,4.56%,ANXA11;RPS6KB2
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.36064345743815157,0.6976195847988956,0.9090909090909091,0.9807628255460199,1.0,4/10,18.27%,ABCA1;SMAD7;MAP2K5;NFE2L2
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.3033741030700043,0.6975817688717447,0.9090909090909091,0.980457485468983,1.0,5/22,15.03%,PDE3A;LHFPL2;PLCB1;SIRT2;TACR3
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.3830781975615769,-0.697208993223585,0.8840579710144928,1.0,1.0,6/20,21.46%,PNP;NT5C;PRPS1;PPAT;PRPSAP1;DNPH1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.288991119984587,-0.6969623293909772,0.9540229885057471,1.0,1.0,4/78,7.76%,CENPE;HLA-A;CTSL;KIF2C
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.4150204143562973,-0.6967622816199038,0.8870967741935484,1.0,1.0,2/8,9.28%,ADM;ARR3
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),-0.28080031874540073,-0.6966687529552559,0.948051948051948,1.0,1.0,13/86,18.42%,KCNJ13;CCDC51;KCNB1;AQP1;LRRC55;KCNQ4;KCNG1;KCNQ1;KCNJ8;SLC9A2;KCNK13;SLC24A1;SLC9A7
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),0.33740942100334886,0.6965005602379195,0.875,0.9811560481803793,1.0,1/15,4.16%,POLD3
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),0.3103835388349296,0.6959138718823695,0.8823529411764706,0.9813846236349755,1.0,9/20,25.73%,PHC1;UBE2N;UBE2E1;USP22;WAC;CDC73;HUWE1;RNF20;UBR2
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.3262643256323371,-0.6954286492009323,0.9130434782608695,1.0,1.0,7/23,21.09%,APLNR;CEMIP;CX3CL1;P2RY6;GPER1;HAP1;TRDN
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.39452391444798474,-0.6950953073123571,0.7966101694915254,1.0,1.0,2/10,4.24%,CACNA1H;KCNB1
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.3897250030286531,-0.6948221968794148,0.8709677419354839,1.0,1.0,1/11,3.70%,KDELR3
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),0.32358126373179186,0.6948125633268691,0.9285714285714286,0.9818091831808327,1.0,3/10,15.74%,CACNA2D1;ATP2B4;TRPM2
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),0.32358126373179186,0.6948125633268691,0.9285714285714286,0.9818091831808327,1.0,3/10,15.74%,CACNA2D1;ATP2B4;TRPM2
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),-0.3276329403484898,-0.6946505273446266,0.9571428571428572,1.0,1.0,2/25,7.26%,VIL1;KNSTRN
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),0.2855113804100228,0.6945097275553441,0.9230769230769231,0.9817995736455272,1.0,1/36,0.78%,SPIRE2
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),-0.44518205281260226,-0.6944182134152745,0.8507462686567164,1.0,1.0,1/5,7.15%,BDNF
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.31136075672253544,-0.6941849899681698,0.9166666666666666,1.0,1.0,7/33,18.06%,THBS1;CASP8;SFRP1;TMC8;SP100;BRCA1;TNFRSF10A
prerank,GO_Biological_Process_2021__enzyme-directed rRNA pseudouridine synthesis (GO:0000455),0.44365022358716777,0.6936626702466769,0.8809523809523809,0.9823102619117196,1.0,1/6,11.27%,DKC1
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),0.34318562898704397,0.6935490001980121,0.8857142857142857,0.9821206988033339,1.0,5/16,18.17%,EPHA2;AKT1;IGF1;SIRT2;PTEN
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),-0.3342211361095789,-0.6935486778234093,0.855072463768116,1.0,1.0,1/21,7.15%,DDX11
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),0.37154023087668697,0.6930354742314997,0.8108108108108109,0.9823356647921345,1.0,1/9,2.26%,PCSK5
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),0.26142654748973665,0.6930175983613437,0.9565217391304348,0.9820371295684701,1.0,8/44,20.03%,EPS8;ARHGAP5;GNA13;CDH13;ROCK2;ARHGDIA;ROCK1;CNKSR1
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.31271186697945713,-0.6926829246887395,0.96,1.0,1.0,10/47,24.26%,GAPDHS;ALDOB;SORD;GPI;SLC25A1;AKR1A1;PGAM1;ENO1;PCK2;GAPDH
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.30868852397624047,0.692338715680293,0.8787878787878788,0.9823482043996802,1.0,7/20,18.27%,BMP2;SMAD5;EP300;SMAD4;HIF1A;RBPJ;NFE2L2
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),0.25299514589121863,0.6922132904429062,0.9615384615384616,0.9821524661018727,1.0,12/40,28.49%,KLHL15;ARID2;SETD2;UBQLN4;KDM1A;WDR48;ERCC6;PPP4R2;PARPBP;TERF2IP;PPP4C;SMCHD1
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),-0.447085366976978,-0.6915737437075289,0.8245614035087719,1.0,1.0,1/5,25.54%,BCAP31
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),0.37376695845907865,0.6915719723503959,0.8571428571428571,0.9824889403563908,1.0,5/15,19.45%,EPHA4;PICALM;ABCA2;ROCK2;CASP3
prerank,GO_Biological_Process_2021__pericardium morphogenesis (GO:0003344),0.3704143353161634,0.6915398682568124,0.8,0.9821843396683422,1.0,1/5,15.87%,BMP7
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),0.32254931718782986,0.6914074673189216,0.8823529411764706,0.9820465066219602,1.0,6/17,25.79%,NEDD1;C2CD3;PCM1;STIL;CSNK1D;HOOK3
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),0.271469263893423,0.691285258983029,1.0,0.9818511255873179,1.0,2/30,3.18%,ABCA1;STARD3
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),0.2878191898621704,0.6906498629185048,0.9666666666666667,0.9822896911134378,1.0,3/18,14.99%,SDC4;DLG5;SCRIB
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.3326378763134209,-0.6903188977353573,0.9166666666666666,1.0,1.0,8/36,26.18%,IL12A;CA1;RPLP0;AIP;ANXA2;IL12RB1;TALDO1;GSTO1
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),-0.38103836255543283,-0.6895822350447471,0.8360655737704918,1.0,1.0,4/9,26.86%,RAN;SREBF1;SEC14L2;SREBF2
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),-0.392238432014463,-0.6895718851299129,0.9117647058823529,1.0,1.0,2/8,27.54%,CLN3;PROM2
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),-0.2706538124814244,-0.6894476342528651,0.9885057471264368,1.0,1.0,22/143,19.77%,PSMB6;ANAPC15;KIF20B;FBXO43;PSMB9;ANAPC11;PSMA8;PSMA7;PSME1;PSMC3;CAV2;BORA;CDC26;UBE2S;PSMC4;PSMA3;CCNB1;BTG1;BTG3;SPHK1;ASAH2;OBSL1
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),0.4084473161333231,0.6893486767403768,0.8,0.9832911761540137,1.0,1/6,13.26%,MINPP1
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),-0.4090631627339737,-0.6892712656356921,0.9180327868852459,1.0,1.0,1/8,13.29%,FES
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),-0.3247016249567839,-0.6892105767193693,0.918918918918919,1.0,1.0,6/27,20.94%,EEF2KMT;PRDM7;SUV39H1;CSKMT;CTR9;ANTKMT
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),0.24842411368654368,0.6891783712542958,1.0,0.983101976415141,1.0,10/41,20.31%,FOXO1;EGFR;MID1;MAP4K4;MAPK1;TAOK2;RAP2A;MAP2K2;FAS;PHLPP1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),-0.40682597293843287,-0.6889273464906986,0.8571428571428571,1.0,1.0,3/9,21.19%,PLAAT4;ETV4;MACROH2A2
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.31970502598857725,0.6886671746163857,0.8787878787878788,0.9832518829479506,1.0,6/16,22.89%,RGCC;BMP2;CLASP1;RUNX1;DDR2;SMAD3
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),0.28992251201097596,0.688649529152711,1.0,0.9829477325269934,1.0,2/34,2.85%,KIFC2;ZNF207
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),0.2820679213332611,0.6884440203245769,0.9411764705882353,0.9828674908010971,1.0,5/20,23.30%,PRDX6;CELF3;TRA2A;CDC73;NUP98
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.27277435856622617,0.6883002373591037,0.9428571428571428,0.9827170164614826,1.0,6/27,15.77%,SEMA5B;ROBO1;SEMA3C;SLIT2;SEMA6C;SEMA4D
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),-0.4137305079660747,-0.6880434690435406,0.8852459016393442,1.0,1.0,1/7,13.29%,FES
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),-0.4323103445872537,-0.687873407446083,0.8032786885245902,1.0,1.0,1/6,10.57%,RHOH
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),-0.3520157920670486,-0.6877854509125712,0.8857142857142857,1.0,1.0,4/16,19.92%,PNP;TYMS;GMPR2;POLD2
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),-0.33414685143389805,-0.6876671413591392,0.890625,1.0,1.0,1/23,4.51%,SELENOS
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.29832166356669304,-0.6875899493489149,0.9736842105263158,1.0,1.0,13/48,23.18%,OVOL2;BTN3A1;RUNX2;TRIM29;ABCG2;B3GNT3;PPL;S100A16;RARRES1;BTN2A2;EPS8L2;CDH1;MMP14
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),-0.43156796985917995,-0.6875578539938351,0.8448275862068966,1.0,1.0,2/6,27.83%,HADHA;PLA2G4A
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),-0.40871304536048114,-0.6875233194607298,0.8153846153846154,1.0,1.0,1/8,7.15%,BDNF
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,-0.2945575070678269,-0.6874495628494106,0.9240506329113924,1.0,1.0,3/74,4.59%,LMOD1;COL5A1;IGFBP5
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),0.3019569113276966,0.68724808074579,0.8620689655172413,0.9834928253571424,1.0,4/16,14.50%,CSF1R;BST1;PTK2;MAPK1
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.3811464373022749,-0.687173835489418,0.8571428571428571,1.0,1.0,1/12,4.37%,PDE6B
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),0.43435659241202046,0.686609068575144,0.7857142857142857,0.9838594603246498,1.0,4/6,39.05%,GAMT;CKB;SLC6A8;GATM
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),0.33699824805172757,0.6859556045321897,0.8235294117647058,0.9840854223033433,1.0,4/14,25.36%,PGM2;PYGB;RB1CC1;PHKA1
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.2727980667189094,-0.6853888163078973,0.9746835443037974,1.0,1.0,9/73,16.74%,RPL11;B2M;TRIM21;DDX11;HES1;DTX3L;APOE;EDF1;RIPK2
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),-0.4370602682064827,-0.6850303562669691,0.8269230769230769,1.0,1.0,2/5,20.53%,CEP135;HAP1
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),0.35534814980501284,0.6848754405741068,0.8529411764705882,0.9848663994470317,1.0,5/7,28.46%,SERPINB9;MAPK1;BCL2L1;MAPK3;SFPQ
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",0.24943943829881488,0.6848395768238725,1.0,0.9845879342208045,1.0,14/64,22.76%,EAF2;MLLT3;IWS1;CDK12;NELFA;CDK13;CCNT2;PCID2;SETD2;CDK9;GTF2F2;ELP2;CDC73;TCEA1
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.29014514874027425,-0.6847830056076768,0.971830985915493,1.0,1.0,11/53,20.03%,SPARC;STAT1;THBS1;ISM1;CD160;SERPINF1;COL4A2;KLF4;SPINK5;THBS2;NAXE
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),0.4308112679723215,0.6847366976191906,0.8888888888888888,0.984386175698979,1.0,1/5,21.00%,HIBCH
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.2780632362916999,-0.6846696430193117,0.975609756097561,1.0,1.0,14/96,17.27%,IFIT1;RPL11;B2M;IFIT2;TRIM21;DDX11;LRPAP1;SNAPIN;EFHB;TMC8;DTX3L;GTF2F1;RIPK2;ZFPM1
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),0.34198223786296894,0.6842474837528536,0.918918918918919,0.9844331710799953,1.0,3/9,14.73%,SOX4;ACVR1;BMPR1A
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),-0.3047543938790091,-0.6839441585944246,0.9466666666666667,1.0,1.0,2/42,2.04%,ANO2;CFTR
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),0.4538375578919546,0.6836761960334568,0.85,0.9847286757680781,1.0,3/6,18.57%,HOMER1;FYN;GRIN2B
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),-0.42194951654843327,-0.6836389702720077,0.8793103448275862,1.0,1.0,2/6,26.18%,SUV39H1;SETDB1
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),-0.423857283505219,-0.6835452788767096,0.8032786885245902,1.0,1.0,2/6,12.69%,MYOF;CAV3
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),0.3498171543032426,0.6834853170113948,0.8529411764705882,0.9842810146678186,1.0,1/11,8.26%,PLCB1
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),0.3498171543032426,0.6834853170113948,0.8529411764705882,0.9842810146678186,1.0,1/11,8.26%,PLCB1
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),0.2571718619923331,0.6829094019307286,1.0,0.9847481761069501,1.0,17/50,27.47%,RAB23;ATG7;PIK3C3;UBQLN1;RAB1A;ATG2B;UBQLN2;ATG5;NSFL1C;UBXN2B;STX12;RB1CC1;VMP1;PACS2;RAB1B;ATG3;RUFY4
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,-0.26314891372994953,-0.6827905900440626,1.0,1.0,1.0,24/179,18.21%,WARS1;DHCR24;CD9;IGFBP5;PNP;M6PR;EIF2S2;GLRX;SQLE;RDH11;SORD;HK2;PSMC4;CXCR4;PSMA3;XBP1;ATP6V1D;LDHA;FADS1;GPI;DHCR7;NMT1;DDIT3;COPS5
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),0.2649363395334834,0.682414082154344,0.96,0.9849159011848114,1.0,9/40,19.27%,NUDT21;FOXO3;PUM2;EIF4E;MAPKAPK5;CYFIP1;PUM1;LARP4;ZC3H7A
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),0.4175609682942388,0.6822061800813185,0.8717948717948718,0.9848544702142561,1.0,1/6,8.11%,GMPS
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),-0.3507065804077375,-0.6819791438028423,0.8648648648648649,1.0,1.0,2/13,21.05%,GTF3A;NIFK
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),-0.4299049471877284,-0.6812158886294282,0.890625,1.0,1.0,1/7,4.79%,ANXA1
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.2751687112423332,-0.6810074193049513,0.9880952380952381,1.0,1.0,7/82,11.37%,PSMB6;PSMB9;PSMA8;PSMA7;PSME1;PSMC3;KLRD1
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),-0.2751687112423332,-0.6810074193049513,0.9880952380952381,1.0,1.0,7/82,11.37%,PSMB6;PSMB9;PSMA8;PSMA7;PSME1;PSMC3;KLRD1
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.2751687112423332,-0.6810074193049513,0.9880952380952381,1.0,1.0,7/82,11.37%,PSMB6;PSMB9;PSMA8;PSMA7;PSME1;PSMC3;KLRD1
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.2854870454341262,0.6807939210701265,0.9310344827586207,0.985969737788788,1.0,12/29,28.86%,NKAIN2;ATP2B4;DLG1;DRD2;WNK3;WNK1;NKAIN3;SLMAP;SPTBN4;SCN3B;NEDD4;YWHAH
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),0.38150878684270817,0.6807810059418402,0.8055555555555556,0.985660031193221,1.0,4/8,19.40%,POMK;ITPK1;IPPK;FGGY
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),-0.4295262983841929,-0.6806042752843611,0.9130434782608695,1.0,1.0,3/7,20.59%,SLC25A45;SLC22A4;SLC22A1
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),-0.4159111048912164,-0.6802790565146992,0.896551724137931,1.0,1.0,5/8,29.24%,PARK7;PRELID1;NUPR1;PINK1;ISCU
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.4031212268743962,0.6799555568640256,0.875,0.9857274658912994,1.0,2/7,5.51%,FOXO1;GUCY1B1
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.4031212268743962,0.6799555568640256,0.875,0.9857274658912994,1.0,2/7,5.51%,FOXO1;GUCY1B1
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated protein folding (GO:1903644),0.4407841095440893,0.6798673118656403,0.8974358974358975,0.9854689580104868,1.0,1/5,8.86%,DNAJB2
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),-0.343998568144241,-0.6795748988561787,0.9315068493150684,1.0,1.0,6/20,25.52%,IHO1;MEI4;FSHR;GDF9;HROB;M1AP
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),-0.39852606630640447,-0.6795178125773931,0.8709677419354839,1.0,1.0,4/7,27.39%,ATP5IF1;SREBF1;HAX1;PINK1
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.4400070510152869,-0.67950623877929,0.8888888888888888,1.0,1.0,4/5,27.39%,ATP5IF1;SREBF1;HAX1;PINK1
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),0.2938227323860731,0.6783814742443279,0.9310344827586207,0.9867981013654211,1.0,6/24,15.46%,SHANK1;PLEK;PRKN;SHANK3;ALMS1;ROCK2
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),-0.36674915169661415,-0.678374368075915,0.9,1.0,1.0,5/15,16.17%,SVBP;CTSH;CST3;CSTB;PSMA3
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),-0.3410664974682421,-0.6780963937377524,0.9180327868852459,1.0,1.0,4/21,13.29%,ABCA12;CTSL;PLAAT4;ETV4
prerank,GO_Biological_Process_2021__lysosomal lumen acidification (GO:0007042),-0.43118874249959527,-0.6780363735769864,0.8518518518518519,1.0,1.0,3/6,34.08%,CLN3;TMEM9;ATP6AP2
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.3356654964879803,-0.6780048879864701,0.8732394366197183,1.0,1.0,6/21,20.62%,VIL1;PFN4;TMSB10;PFN1;KANK3;PFN2
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.40012741255465073,-0.6776309544126002,0.859375,1.0,1.0,5/11,34.50%,NAXE;PARP9;PARP10;NNMT;NAMPT
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),-0.2772218245821522,-0.6775954383293581,0.9743589743589743,1.0,1.0,11/58,16.80%,SELENOS;CXCL2;GSTP1;CD14;LY96;PDCD1LG2;CCL2;WNT5A;CD274;XBP1;CTR9
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),-0.37853234058636187,-0.6774823781313678,0.8333333333333334,1.0,1.0,2/9,12.81%,SLX4;BLM
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),-0.37853234058636187,-0.6774823781313678,0.8333333333333334,1.0,1.0,2/9,12.81%,SLX4;BLM
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),-0.37853234058636187,-0.6774823781313678,0.8333333333333334,1.0,1.0,2/9,12.81%,SLX4;BLM
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),0.23756547744899492,0.6774470992201542,1.0,0.9873138512258811,1.0,8/66,9.03%,HNRNPH1;SPRED2;FLRT2;CBL;FGF17;SPRED1;SHOC2;RBFOX2
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.2788031553218529,-0.6773538926156378,0.95,1.0,1.0,14/55,23.44%,BCL2L14;THBS1;GSTP1;CASP8;TMC8;LTBR;SP100;TNFRSF10A;GPER1;TNFRSF12A;AGT;PARK7;AR;NOL3
prerank,PanglaoDB_Augmented_2021__Clara Cells,-0.3231488210749751,-0.6772990681461531,0.927536231884058,1.0,1.0,10/36,15.80%,DUOX1;TEKT1;TMC4;TRIM29;SYT2;FOXM1;CXCL17;FMO2;B3GNT3;PPL
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.34309020528840206,0.6770824123627461,0.8378378378378378,0.9872835269521553,1.0,5/11,34.80%,ABCA2;AGO2;BACE2;SOAT1;NECAB2
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.29868088170353446,-0.6769699111724363,0.9722222222222222,1.0,1.0,8/45,19.68%,OVOL2;ABCA12;TRIM29;MSX2;TUFT1;TOM1L1;SH2D4A;EMP2
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),0.37042600091165057,0.6764533741086609,0.8484848484848485,0.9875830956085145,1.0,1/8,8.11%,GMPS
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),0.3436284394678645,0.6761126170530455,0.868421052631579,0.9872624081310689,1.0,2/12,13.92%,ACER3;ABCA2
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),0.3436284394678645,0.6761126170530455,0.868421052631579,0.9872624081310689,1.0,2/12,13.92%,ACER3;ABCA2
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),0.3369585621171833,0.6760684021463242,0.9655172413793104,0.9869596271808362,1.0,2/14,8.89%,RGCC;HDAC2
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.2838444103872343,0.6758099624601175,0.896551724137931,0.9868407714850184,1.0,4/27,13.76%,OSTC;STT3B;FUT8;UGGT1
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),0.3883698728875278,0.6757641137062339,0.8947368421052632,0.9865826588046401,1.0,1/7,17.13%,ITGA6
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.2807582279059928,0.6754938260784217,0.9666666666666667,0.9864766659054075,1.0,5/38,7.56%,RCC2;LRCH1;PPP1R36;PLIN5;CAMK2A
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),-0.3892161281776305,-0.6752880383468347,0.8787878787878788,1.0,1.0,1/7,2.15%,GPR183
prerank,GO_Biological_Process_2021__cellular response to UV-B (GO:0071493),0.3879867897604173,0.6752558245420021,0.8157894736842105,0.9863454249751555,1.0,2/5,15.47%,MME;STK11
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),-0.3745070089277287,-0.6751131628973244,0.8709677419354839,1.0,1.0,1/13,4.33%,P2RY12
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),0.24940808312952745,0.6744403105892163,1.0,0.9867330998249869,1.0,9/58,15.55%,MACIR;RORA;MAPKBP1;NR1D1;RNF26;ITCH;SIRT2;TNFAIP6;LRFN5
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),-0.31010642680024214,-0.674401002274165,0.9868421052631579,1.0,1.0,11/42,29.42%,HSD11B1;SQLE;DHCR7;TM7SF2;MSMO1;INSIG1;HMGCR;ACOT8;ACOX2;DHRS11;LSS
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),-0.4256414567748993,-0.6743865050126502,0.8947368421052632,1.0,1.0,2/7,12.81%,DDX11;BLM
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),-0.3725143566077389,-0.6741541788132762,0.8615384615384616,1.0,1.0,2/11,16.33%,PNP;GMPR2
prerank,GO_Biological_Process_2021__positive regulation of vesicle fusion (GO:0031340),0.36659151905069737,0.6737639644397995,0.85,0.9870256453274578,1.0,2/6,8.99%,SNCA;DOC2B
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.2945202482371676,0.6737614232696322,0.9705882352941176,0.9867046613777579,1.0,1/18,5.69%,MFF
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),-0.3584072995047605,-0.6736725595529768,0.9285714285714286,1.0,1.0,1/15,0.44%,POU4F1
prerank,PanglaoDB_Augmented_2021__Schwann Cells,0.22582729889201883,0.6733971356800882,1.0,0.9867125796224868,1.0,38/124,24.05%,ANK2;PDZRN3;PSD2;RBFOX1;PRIMA1;MEGF10;NTRK2;CAMK2A;FAM107A;PPP1R1B;ASTN1;HSPA12A;MAPK4;CLIP3;OLIG1;HAPLN2;BCHE;PLPPR4;TMEM178A;NPY;OPCML;LRP4;FAM13C;POU3F1;GRIA2;ARNT2;PHYHIPL;SLC6A1;BAG3;CHST1;SDC3;FAIM2;CNTFR;CNP;CNTN2;SLCO1C1;TCEAL7;PMP22
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,-0.25955427347700455,-0.6726646147117333,1.0,1.0,1.0,5/186,2.73%,PDE4A;ANO2;PPP1R14C;CFAP52;CIBAR2
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.32586017204789997,0.6725614804107893,0.8275862068965517,0.987175458878305,1.0,6/15,20.92%,PLCB1;RGS10;LY6H;GNAQ;CDK5R1;CHRM3
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),-0.3899195429569315,-0.6721676080754934,0.8571428571428571,1.0,1.0,3/8,22.89%,AGA;MAN2A2;PARK7
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.32446554568781294,-0.6719713280515205,0.9166666666666666,1.0,1.0,7/27,16.43%,ANXA1;HTR2B;CHRM2;TSHR;CHRM5;CCL2;CALCRL
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.3689741919915572,-0.6716993385762171,0.8823529411764706,1.0,1.0,2/16,16.21%,IGFBP5;P2RY6
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.34199732512259823,0.6716118243281931,0.9428571428571428,0.9877012065825354,1.0,3/12,9.73%,HNRNPU;FAM107A;NR3C1
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),0.34921185802697935,0.6714298612967358,0.9069767441860465,0.987531977097623,1.0,3/15,14.71%,ZMYND10;ODAD3;DNAAF4
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.3330330606341928,0.6712354092666186,0.9047619047619048,0.9873691703215554,1.0,4/14,22.24%,HSD17B4;CRAT;ACOX1;SCP2
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),0.38375809687428,0.6709833334372255,0.8846153846153846,0.9873137523303572,1.0,2/6,21.60%,TICAM1;CAMK4
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.2901543801563339,0.670789050433662,0.9285714285714286,0.9871763569025729,1.0,4/26,13.76%,OSTC;STT3B;FUT8;UGGT1
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.32156912378376057,0.6706545882398663,0.9090909090909091,0.9869507571319545,1.0,6/22,18.68%,SEMA5B;SEMA3C;NRP1;SEMA6C;SEMA4D;SEMA3D
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),-0.4019953962672179,-0.670426656090484,0.864406779661017,1.0,1.0,1/7,5.74%,HTR2B
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",-0.36350259300955,-0.6703038399541018,0.8939393939393939,1.0,1.0,3/15,16.86%,SNRNP200;DDX23;NCBP2
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.42101811881087986,-0.6699441455292932,0.8983050847457628,1.0,1.0,1/7,3.46%,MX1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.42101811881087986,-0.6699441455292932,0.8983050847457628,1.0,1.0,1/7,3.46%,MX1
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),0.4280726813387013,0.669727081064127,0.8936170212765957,0.9874251177873331,1.0,1/5,9.88%,SLC38A6
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.24408764241697037,-0.6695315285387067,1.0,1.0,1.0,21/545,6.67%,IFI6;APIP;PRAME;SFRP2;GATA1;RPL10;BCL2L14;RPS27A;DHCR24;PRDX5;IL7;STAT1;IFIT3;SFRP4;ANXA1;IFIT2;AQP1;BCL2L2;HTR2B;RPS6;THBS1
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.3374886659972027,0.6691618861875441,0.9024390243902439,0.9870260879029407,1.0,4/11,17.32%,CDC27;NSMCE2;ESPL1;CUL3
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.3374886659972027,0.6691618861875441,0.9024390243902439,0.9870260879029407,1.0,4/11,17.32%,CDC27;NSMCE2;ESPL1;CUL3
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),0.3374886659972027,0.6691618861875441,0.9024390243902439,0.9870260879029407,1.0,4/11,17.32%,CDC27;NSMCE2;ESPL1;CUL3
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.3377825363914403,-0.6689672100715254,0.8813559322033898,1.0,1.0,6/19,22.89%,SELENOS;CREB3;XBP1;DDIT3;CREB3L1;PARK7
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.22718112425058548,0.6689408854427834,1.0,0.9869268313814478,1.0,14/55,22.57%,ATP2C1;CEP290;IGF1;GOLPH3;TENM1;SYTL4;RUFY3;APBB1;ARF6;ACSL3;ADAM9;PCM1;MYOM1;FRMD4A
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.3068213884724362,-0.6689215823460589,0.9436619718309859,1.0,1.0,5/31,16.40%,PARP14;HES1;IL12A;SOCS3;IL18
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell differentiation (GO:0046637),-0.4236196662857916,-0.6688383902041295,0.875,1.0,1.0,1/5,6.04%,PNP
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.29714677764865394,0.6688264503135326,0.90625,0.9866954561624229,1.0,6/20,14.98%,SMAD7;PKD2;NF1;TGFBR1;BMPR1A;NRP1
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),-0.3434599308459102,-0.6684842018651768,0.9714285714285714,1.0,1.0,2/18,10.69%,ERAP1;PRKCQ
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),-0.3929795224356832,-0.6682226571022883,0.864406779661017,1.0,1.0,1/8,15.55%,WNT5A
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),0.3550286948535902,0.6678535110091824,0.8604651162790697,0.987194147909752,1.0,3/9,11.89%,HOMER1;CASQ1;STIM1
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),0.23857421845941174,0.667728387566578,1.0,0.9870005780415987,1.0,17/70,23.80%,STT3B;MARCHF6;TMEM129;DNAJB2;ECPAS;DERL2;UBQLN1;VCP;UBQLN2;EDEM1;RNF185;DERL1;JKAMP;UBE2G2;BAG6;RNF103-CHMP3;AMFR
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.35606559566952733,-0.6673453376105206,0.8448275862068966,1.0,1.0,3/10,20.46%,DTX3L;CTR9;RNF8
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),0.31974333350851447,0.6671903616136877,0.9696969696969697,0.9872158741558,1.0,2/12,19.90%,SCRIB;RAB10
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),-0.3520620929151474,-0.6667630239544039,0.8840579710144928,1.0,1.0,2/10,17.31%,CCNB2;CCNB1
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),-0.42092795199290955,-0.6661013700128802,0.8297872340425532,1.0,1.0,2/5,25.98%,ATP23;OXA1L
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),0.39523322647591275,0.6660824511478272,0.8157894736842105,0.9879402202647751,1.0,4/6,33.14%,TRIO;PTPRU;FRS2;PTPRD
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.316719991123469,-0.6660307353485377,0.953125,1.0,1.0,3/28,14.59%,USP51;DTX3L;PNKP
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.3321749770796991,0.665570046740154,0.9117647058823529,0.9880482411795317,1.0,7/17,22.08%,BOK;DCC;BCL2;GSK3B;FAS;CASP3;BCL2L1
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),-0.36063966716116874,-0.6654697223900812,0.9076923076923077,1.0,1.0,5/14,27.14%,CUTC;MT2A;ATOX1;SLC31A2;CCDC22
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),0.3623811911007046,0.6654466106830406,0.8918918918918919,0.9874790492688849,1.0,4/9,21.30%,ATP2B4;GSK3B;DYRK2;HOMER2
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.3623811911007046,0.6654466106830406,0.8918918918918919,0.9874790492688849,1.0,4/9,21.30%,ATP2B4;GSK3B;DYRK2;HOMER2
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),-0.3632328269776578,-0.6653760896358553,0.8873239436619719,1.0,1.0,2/11,12.13%,IGSF1;NODAL
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),0.3489592334284416,0.6653055048000367,0.8863636363636364,0.9872606497529303,1.0,5/10,25.35%,PRKN;RAB21;MTMR2;PTPN23;EIPR1
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),0.3841879862932558,0.6649161000095546,0.8809523809523809,0.9873561982720473,1.0,2/6,23.54%,NIPBL;MACROH2A1
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),-0.2982349680190002,-0.664889032804915,0.974025974025974,1.0,1.0,1/27,2.77%,KIF20B
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),-0.38621168488366453,-0.6647560901407946,0.8852459016393442,1.0,1.0,3/9,24.70%,CUEDC2;HLA-F;TGFB1
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),-0.3500471680468853,-0.6647022134737027,0.9682539682539683,1.0,1.0,3/15,15.12%,CXCL2;CCL2;CX3CL1
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),0.3775963896620826,0.6646859527062124,0.875,0.9872697357744048,1.0,2/8,10.12%,PPP2R5A;PIP4K2C
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),0.3533120525967628,0.6640924516705299,0.775,0.9874279406353489,1.0,3/7,25.51%,TBC1D8B;TMEM63C;XPNPEP3
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),0.36356644372731495,0.6640724220176271,0.875,0.9871220583483156,1.0,2/11,14.57%,ZNF451;SMAD4
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),0.3513326501734413,0.6639992897672408,0.9166666666666666,0.9868915898510444,1.0,4/11,22.62%,CDK12;CDK13;BRD4;CDC73
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),0.396798764078111,0.6639850504230435,0.9302325581395349,0.986579811537935,1.0,2/7,6.62%,BMP2;BIN1
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),-0.2886779832447183,-0.6638981842474723,0.9571428571428572,1.0,1.0,8/38,23.86%,RPL13A;TMC8;SVIP;CLU;CRYAB;CPTP;PARK7;RIOK3
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),0.30989749067384775,0.6636113148558929,1.0,0.9866753947049579,1.0,3/12,23.54%,JARID2;KDM1A;MACROH2A1
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),0.29622749330715437,0.6635546577135235,0.9230769230769231,0.9864014587935898,1.0,1/15,3.10%,ABCA1
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),-0.27158027162361953,-0.66309524749193,0.9866666666666667,1.0,1.0,12/87,17.20%,CFTR;P2RY12;IGFBP5;AQP1;TSHR;SFRP1;KCNQ1;LAMTOR2;BRCA1;P2RY6;XBP1;RRAGC
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.3060108006727713,0.6627979061728202,0.8918918918918919,0.9867411768843194,1.0,2/11,13.99%,EPS8;CLASP1
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),0.3276517960103616,0.6621444678416908,0.9375,0.9869742909619136,1.0,1/16,1.50%,TNFSF4
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),-0.36106862027160375,-0.6621118299170279,0.9344262295081968,1.0,1.0,1/10,7.90%,TTLL6
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),-0.4121989676100514,-0.6621007558528025,0.9166666666666666,1.0,1.0,1/7,3.85%,STAT1
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.26879230204595456,0.6617495934763361,0.9523809523809523,0.986919481453702,1.0,12/43,19.82%,GRIN1;CYFIP2;HMGB1;MAP3K5;SIRT1;ASPH;TBC1D10A;FYN;BCL10;GRIN2B;PPM1F;REST
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),0.3077584243681389,0.6609999303441915,0.9629629629629629,0.9873587680781808,1.0,7/25,19.78%,CA2;SLC4A7;SLC4A10;SLC4A4;TM9SF4;ATP1A4;SLC9A9
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),-0.26345740389083205,-0.660942455176622,0.9880952380952381,1.0,1.0,17/92,19.53%,POU4F1;CACNA1H;PTPN7;IGFBP5;SIGIRR;SFRP1;CCL2;CXCR4;DPYSL3;RAMP3;IL18;NOS1;KLF4;HTRA2;EMD;SPHK1;ASAH2
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.2627091395684275,-0.6608185991126361,1.0,1.0,1.0,15/163,17.43%,RPS4X;RPL10;PATL2;IGFBP5;THBS1;RPL5;TYMS;RPL13A;ZNF385A;SHFL;RBM4B;OGFOD1;EIF2AK2;NCBP2;IGF2BP3
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.32495405973776775,-0.6604850597999194,0.8970588235294118,1.0,1.0,2/23,12.08%,GCNT1;B3GNT5
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.31435931025257613,0.6604473644734589,0.9375,0.987566451007699,1.0,5/15,25.54%,LARGE1;CHST3;MGAT3;CHST1;OGA
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),-0.28454591431546533,-0.6601616585702346,0.9487179487179487,1.0,1.0,3/52,7.96%,TLCD1;ANGPTL3;PNPLA3
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),-0.3576081148912834,-0.6595775981956362,0.9436619718309859,1.0,1.0,5/15,21.30%,PNP;NMNAT3;PRPS1;PPAT;PRPSAP1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),0.2622539640305761,0.6595665536970833,0.9583333333333334,0.9878677491407617,1.0,6/32,17.81%,IL17D;SERPINE1;HMGB1;CD58;RAB1A;BCL10
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),0.2989874240542538,0.6595360384624325,0.972972972972973,0.9875690546368017,1.0,6/21,17.32%,CACNB4;ANK2;CAMK2D;JPH1;CACNB3;PDE4D
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),-0.31102633467462193,-0.6592988402219473,0.95,1.0,1.0,1/28,1.68%,RPL10
prerank,GO_Biological_Process_2021__catecholamine catabolic process (GO:0042424),0.42737095764981226,0.6592812093996853,0.8936170212765957,0.9874829126077111,1.0,1/5,7.83%,MAOA
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),0.36014459975451374,0.6592737443372043,0.8936170212765957,0.9871782896327392,1.0,2/9,15.55%,NR1D1;LRFN5
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),0.2663406125052618,0.6582320346851408,1.0,0.9877477267040219,1.0,8/34,18.62%,NPNT;RSU1;NF1;BST1;PTK2;PTPRO;NDNF;PPM1F
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),0.29033640957008783,0.6581251036134418,0.9666666666666667,0.987505613123972,1.0,5/21,18.22%,ENO3;TBC1D12;PIKFYVE;UBQLN2;MTM1
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.26372755250991337,-0.6580926038040865,0.9882352941176471,1.0,1.0,27/122,23.06%,GATA1;LMOD1;IGFBP5;SLC16A3;AQP1;C1R;MATN2;CST3;INHA;CLU;LURAP1L;RXRB;SOD3;CRYAB;C1S;BCAM;S100A16;MAOB;TNS2;FSHR;OBSL1;CTSA;SEMA3B;F10;AGT;AMOTL2;AR
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),-0.37637438045790644,-0.6580834734625864,0.864406779661017,1.0,1.0,1/10,3.54%,APLNR
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.22817930200270237,0.6580030642648426,1.0,0.9872948443140606,1.0,23/100,18.15%,RNF6;FRZB;GNG4;SMARCA2;DNAJB2;CAPRIN2;PTPRJ;DCC;SLIT2;DACT3;ST7L;KIAA0319;NDRG3;APBB2;SIRT1;VGLL4;SMAD4;SERTAD2;IP6K2;STK11;NAIF1;APBB1;CDKN2AIP
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),0.34355657361936265,0.6577613153479024,0.8974358974358975,0.987183984832558,1.0,4/10,25.97%,VCPIP1;YWHAZ;STK25;STX5
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),0.32091603064523594,0.6571093203471823,0.9069767441860465,0.987359955102736,1.0,5/12,24.77%,ELOVL5;HSD17B4;ACOX1;SCP2;ELOVL1
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.3089552052093472,-0.6565672325380613,0.9333333333333333,1.0,1.0,8/38,26.18%,IL12A;CA1;RPLP0;AIP;ANXA2;IL12RB1;TALDO1;GSTO1
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),0.2776946261036704,0.6565336113819277,0.9583333333333334,0.9874797255975963,1.0,7/27,24.95%,PGAP1;PIGX;PIGP;PGAP4;PIGQ;PIGU;DPM1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.34400512900569447,0.6565013356591427,0.9523809523809523,0.9872007064306744,1.0,1/11,7.98%,ATF6
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),0.37640678907446845,0.6559936106318015,0.8974358974358975,0.9872208049073811,1.0,2/6,17.21%,SHANK3;FYN
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),-0.3623285334440005,-0.6559661050107478,0.9130434782608695,1.0,1.0,3/12,17.76%,BRCA1;CTR9;SNW1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.31523809702664096,-0.6557478243396824,0.9583333333333334,1.0,1.0,2/29,5.51%,ENPP2;VIL1
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),-0.33038682285925297,-0.6555963402593067,0.9393939393939394,1.0,1.0,8/21,25.27%,IL7;RHOH;XBP1;SPINK5;CR1;PRELID1;TCF7;PRDM1
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),-0.3866259952035765,-0.6554460065938759,0.8392857142857143,1.0,1.0,1/7,14.92%,CCL2
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.3005769282648308,-0.6554199951257473,0.9736842105263158,1.0,1.0,3/27,17.11%,RPL11;SVIP;GIPC1
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),-0.3616240075737689,-0.6552327466450381,0.8518518518518519,1.0,1.0,1/12,2.67%,ARG2
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.3777021756755843,0.6551134669905195,0.84375,0.9876580257821972,1.0,3/7,13.34%,RAPGEF2;MAGI2;RAP1A
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),-0.3046254124720909,-0.6550053632290845,0.9866666666666667,1.0,1.0,5/37,13.16%,IRF1;AQP1;CASP8;LTBR;TLR3
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),0.39743087229136254,0.6543044377429399,0.8823529411764706,0.9879580408005018,1.0,1/5,1.86%,TENM3
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),0.39712863373821344,0.6540246559990999,0.8958333333333334,0.9878783269961977,1.0,4/6,27.13%,SMAD2;SMAD4;SMAD3;SMAD1
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),-0.4003746076743951,-0.65388886535759,0.9245283018867925,1.0,1.0,7/7,59.98%,CAMLG;PPP2R3C;DOCK11;TNFAIP3;LYN;MEF2C;DOCK10
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.3230579309968789,0.653615092081246,0.9523809523809523,0.9879044029104603,1.0,4/10,29.17%,NAA50;NAA16;METAP1D;NAA35
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.280592933607356,0.653613054563866,0.9722222222222222,0.9876009115659238,1.0,10/24,23.18%,DCN;RGCC;HMGB1;SLIT2;ATP2B4;ADGRB1;FGF2;VASH1;MECP2;DNAJA4
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),-0.38360705930523664,-0.653402823532189,0.9433962264150944,1.0,1.0,3/11,21.82%,P2RY12;PFN1;EPS8L2
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.2927887063789647,0.6532340852533579,1.0,0.9875586840711726,1.0,8/23,32.75%,SLC25A18;SLC47A1;SLC6A9;SLC25A13;SLC22A2;SLC25A12;SLC1A2;SLC7A2
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.265926836285371,-0.6532213477118479,1.0,1.0,1.0,15/132,17.31%,PSMB6;CETN2;PSMB9;PSMA8;RAB11A;PSMA7;PSME1;PSMC3;CEP72;CEP135;PSMC4;PSMA3;TUBB;TPX2;CCNB1
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.3288600330304312,0.6531201696611084,0.9166666666666666,0.9873052088901733,1.0,3/12,12.57%,TBC1D24;KIF1B;ERC2
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.2438634376501548,0.653015155252014,1.0,0.9870767435773691,1.0,17/74,19.42%,AP2B1;AP1S3;CTSV;KIF5A;DCTN5;DYNLL2;PIKFYVE;SEC24B;AP1G1;KIF15;HLA-DRA;KLC1;OSBPL1A;SEC23A;DNM2;CTSS;KLC2
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),0.29529998199956686,0.6529731474295726,0.9714285714285714,0.9867739043007698,1.0,2/21,4.50%,SOX4;ZBTB20
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),0.3013057257732985,0.6529131303825177,0.9696969696969697,0.9864712584081273,1.0,3/15,17.38%,POLD3;SIRT1;WRNIP1
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.3002646353492008,-0.6522404664044965,0.935064935064935,1.0,1.0,6/32,20.28%,AKR1C1;APOM;APOE;CLU;ABCA5;LIMA1
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),-0.4047113639338711,-0.6520680879708262,0.9436619718309859,1.0,1.0,2/8,11.11%,ST6GAL1;GNE
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.3283574225084315,-0.6514236347666401,0.90625,1.0,1.0,6/14,31.35%,ATAD5;GLI1;NPM1;DDRGK1;PHB2;PAF1
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),0.2134156266615546,0.6512207514728148,1.0,0.9875031016346512,1.0,11/75,15.11%,CEP152;HMMR;CEP290;NEDD1;CSNK1E;PLK1;CKAP5;CLASP1;MAPRE1;ALMS1;YWHAG
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),-0.3637758200260092,-0.6510519507720768,0.9166666666666666,1.0,1.0,1/12,4.59%,IGFBP5
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),-0.3495694179854528,-0.6506900316723413,0.9090909090909091,1.0,1.0,2/13,15.55%,NOX1;WNT5A
prerank,GO_Biological_Process_2021__alditol metabolic process (GO:0019400),-0.4255647895689056,-0.6506053484741197,0.8305084745762712,1.0,1.0,1/5,7.75%,ANGPTL3
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),-0.2623906645087439,-0.6502674270928133,0.9887640449438202,1.0,1.0,9/119,14.27%,GAPDHS;TRIM22;MTLN;TRIM21;RDX;PIK3CB;SVIP;DTX3L;APOE
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.2797885932699164,-0.6501854441253762,0.972972972972973,1.0,1.0,8/48,17.31%,CCNE2;CCNB3;CCNB2;BLM;CDKN3;HERC5;CDC37;CCNB1
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),0.3540578724360388,0.6496834466131519,0.8888888888888888,0.9883357568639924,1.0,1/10,3.71%,BTN3A3
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),-0.3192888655187268,-0.6495874241173206,0.8767123287671232,1.0,1.0,3/17,14.92%,PLN;CAV3;CCL2
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),-0.3649956692791537,-0.6493056414578713,0.9090909090909091,1.0,1.0,2/12,13.82%,ADM;KCNQ1
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),-0.3854857654879339,-0.6488763343758562,0.9090909090909091,1.0,1.0,1/9,6.12%,GLYAT
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),0.29718232961897556,0.6485969830009103,0.918918918918919,0.9888887878181455,1.0,6/15,17.87%,LARGE1;CFLAR;DISP1;MYH14;FXR1;ZBTB18
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.32196238300946467,-0.6483980183663218,0.9565217391304348,1.0,1.0,4/23,13.11%,RPS27A;UBC;CD14;LY96
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),-0.41587788633047756,-0.6483499988663874,0.8235294117647058,1.0,1.0,2/5,14.27%,DTX3L;APOE
prerank,GO_Biological_Process_2021__DNA deamination (GO:0045006),0.37461161779021956,0.6482034023511956,0.8292682926829268,0.9888958580969547,1.0,2/7,8.96%,EXOSC6;APOBEC3F
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.24075068453859405,0.6480697447024735,1.0,0.9886364049571251,1.0,17/76,19.42%,AP2B1;AP1S3;CTSV;KIF5A;DCTN5;DYNLL2;PIKFYVE;SEC24B;AP1G1;KIF15;HLA-DRA;KLC1;OSBPL1A;SEC23A;DNM2;CTSS;KLC2
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),0.3034247290283635,0.6479485614143842,0.96,0.9884019017355137,1.0,5/18,18.68%,SEMA5B;SEMA3C;SEMA6C;SEMA4D;SEMA3D
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),-0.4014830967866132,-0.6479235436241589,0.8852459016393442,1.0,1.0,1/7,12.70%,SQLE
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),-0.362221561474692,-0.647220117076055,0.8490566037735849,1.0,1.0,1/11,2.67%,ARG2
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",0.35135728802950833,0.6467308684377471,0.868421052631579,0.9886330611337272,1.0,6/9,37.17%,AGO3;AGO2;AGO1;NOTCH4;TNRC6C;TNRC6A
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),0.35135728802950833,0.6467308684377471,0.868421052631579,0.9886330611337272,1.0,6/9,37.17%,AGO3;AGO2;AGO1;NOTCH4;TNRC6C;TNRC6A
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),-0.28172628680225525,-0.6466714837527183,0.96,1.0,1.0,4/51,11.31%,TOMM7;TIMM10;TIMM8B;SLC25A4
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.2672245284229662,-0.6466006735571512,0.9882352941176471,1.0,1.0,10/88,17.78%,AKR1C1;SLC51B;ABCA12;CEACAM1;SLC51A;FABP3;APOE;SLCO3A1;SLC10A1;ABCA5
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.27245936821392525,-0.6463419642285584,0.9876543209876543,1.0,1.0,10/76,17.43%,PATL2;IGFBP5;TYMS;RPL13A;CST3;CSTB;APOE;CDK5;EIF2AK2;IGF2BP3
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.3945052119393082,0.6462729396596592,0.9354838709677419,0.9887330548889376,1.0,2/7,24.71%,SERAC1;LPCAT1
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),-0.3147777539965604,-0.6462584989808884,0.9324324324324325,1.0,1.0,3/27,14.94%,ISG15;CCN1;FZD9
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),-0.3493293339562502,-0.6462224219442441,0.9117647058823529,1.0,1.0,3/15,17.83%,KLF2;PAX8;KLF4
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),0.33281932972566963,0.6461498667111107,0.9459459459459459,0.9884802546941045,1.0,3/14,17.40%,PAG1;SAMSN1;FGL1
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",-0.38890473610178,-0.6460915907483252,0.8269230769230769,1.0,1.0,1/7,7.72%,RAB11A
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),0.3214628840364554,0.6457773362435064,1.0,0.9884441352342137,1.0,1/15,2.32%,SDC4
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),-0.3205972308124121,-0.6453417135661292,0.9090909090909091,1.0,1.0,3/24,16.80%,DTX3L;RAG1;CTR9
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.3013201464656269,-0.6451972015496844,0.935064935064935,1.0,1.0,4/32,14.40%,EMC6;TRAM1L1;EMC4;CCDC47
prerank,"GO_Biological_Process_2021__regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",0.388666090339979,0.6449797692438036,0.82,0.9887605446682305,1.0,1/5,3.47%,MLLT3
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),-0.3128899268365784,-0.6449575344145919,0.9583333333333334,1.0,1.0,8/38,17.62%,APLNR;CCBE1;ADM;ANGPTL3;HES1;AGGF1;LAMA1;HEY2
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),-0.3856533134833887,-0.6444354841917342,0.8717948717948718,1.0,1.0,1/10,6.66%,APOBEC3G
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.37987464976971497,-0.644405659506592,0.9672131147540983,1.0,1.0,1/11,15.11%,SEC62
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),-0.35391651450959233,-0.6442301623482428,0.8571428571428571,1.0,1.0,4/11,27.14%,MT2A;ATOX1;SLC31A2;CCDC22
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),0.36336608234841705,0.6440426398076737,0.9230769230769231,0.9891447587153247,1.0,1/7,3.44%,NR4A2
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),0.2388580631351035,0.643456781242748,1.0,0.9892876935778296,1.0,6/37,15.97%,TNFSF4;EIF2AK4;AKIRIN2;SIRT1;DHX9;HLA-DRA
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),0.3874358174708294,0.6433533796652401,0.8913043478260869,0.9890474756298445,1.0,1/5,6.53%,MYORG
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),0.3311530907747066,0.6432452549382927,0.8333333333333334,0.9888135867543397,1.0,3/10,23.54%,NIPBL;POT1;MACROH2A1
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.2801042064237833,0.6432206484580474,1.0,0.9885119269835524,1.0,4/20,21.51%,CDKL5;NRP1;RUFY3;MACF1
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),-0.3136261627058979,-0.6430486648204236,0.9682539682539683,1.0,1.0,3/29,7.95%,SPARC;VIL1;PDPN
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),0.35006278384363093,0.6419219271628492,0.8648648648648649,0.989290652313466,1.0,3/8,25.51%,TBC1D8B;TMEM63C;XPNPEP3
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),0.24378591963552518,0.6415559862813723,1.0,0.9892913908236463,1.0,10/46,21.42%,ABCA1;STARD3;NSDHL;LBR;ARV1;INSIG2;OSBPL1A;FDX1;OSBPL5;FDXR
prerank,MSigDB_Hallmark_2020__Myc Targets V1,-0.2524175628558673,-0.6412988688518192,1.0,1.0,1.0,34/185,24.28%,RPL34;SNRPD2;RPS6;RPL18;EEF1B2;TYMS;EIF2S2;PSMA7;PRDX4;DDX18;RPL14;LSM2;RPL6;HDDC2;PSMC4;POLE3;LDHA;NCBP2;GNL3;RPS2;COPS5;RPLP0;POLD2;VBP1;EIF3J;APEX1;IMPDH2;CBX3;RAN;HSPD1;MRPL23;NPM1;NOP16;HDGF
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),0.3844049512170088,0.6412523079304427,0.9210526315789473,0.9892674543928018,1.0,2/5,33.40%,HMGCLL1;IVD
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),-0.26415530081760524,-0.6410055692492256,0.9875,1.0,1.0,8/67,16.61%,SPARC;THBS1;SEMA5A;PIK3CB;RRAS;FGF1;WNT5A;GPI
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),0.34943354708848723,0.6407401365249668,0.868421052631579,0.9893606997171229,1.0,2/8,13.49%,CD22;AHR
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.3390649473569127,0.6406303992878807,0.9117647058823529,0.9891826388275463,1.0,3/12,11.20%,PIK3CA;GSTM2;CAMK2D
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),0.37052374357890827,0.6404316157224821,0.8421052631578947,0.98899236530825,1.0,3/8,19.74%,PTGES3;PRXL2B;TBXAS1
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.2690153990821581,0.6404047671186458,0.9629629629629629,0.9886974787707051,1.0,2/22,11.41%,PIK3CA;CAMSAP2
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),0.3110080542878725,0.6398804335715862,0.9512195121951219,0.9887784687975224,1.0,6/16,20.95%,PDE12;ATP2B4;ROCK2;ATRX;RTF2;FMR1
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),-0.410321361573301,-0.6395004028316499,0.9661016949152542,1.0,1.0,1/6,5.74%,HTR2B
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),0.36085621468359075,0.6394271312113147,0.8181818181818182,0.9887608971623978,1.0,5/9,18.44%,OR9Q1;UBR3;MKKS;DRD2;SLC24A4
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),0.3070302647551107,0.639332915811051,0.896551724137931,0.9884971386872528,1.0,3/14,12.81%,PLIN5;RAB18;RAB3GAP1
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),0.35469210007991736,0.6389933943370143,0.9696969696969697,0.9884858202032842,1.0,4/10,32.74%,NRP1;ARF6;TOLLIP;TMEM30A
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.2984218358570221,-0.6389458881657242,0.9452054794520548,1.0,1.0,7/31,26.37%,RPS7;FIS1;DDIT3;NUPR1;BCAP31;UBB;GSDME
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),0.32709124077803664,0.6389139296109239,0.8648648648648649,0.988277675126545,1.0,2/10,9.64%,DUSP10;DUSP19
prerank,GO_Biological_Process_2021__peptidyl-glutamine methylation (GO:0018364),-0.41961980963970885,-0.6382706050344088,0.8771929824561403,1.0,1.0,1/5,9.93%,TRMT112
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),0.36248975713853787,0.6381534536779392,0.8409090909090909,0.988592336012268,1.0,4/8,25.65%,KCNH2;KCNE4;KCNIP2;KCNE2
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),-0.321068744371801,-0.6377355437120577,0.9428571428571428,1.0,1.0,2/20,7.57%,EFNA1;ELN
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.29207484474435685,-0.6376157495217442,0.972972972972973,1.0,1.0,3/28,11.11%,ST6GAL1;GLYAT;GNE
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),-0.3576152962920558,-0.6373055242510429,0.9253731343283582,1.0,1.0,5/14,19.49%,PRKCQ;IL12A;IL18;DDIT3;SPHK1
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.33776976501098993,0.637180372619591,0.9696969696969697,0.9890912128974853,1.0,3/13,11.20%,PIK3CA;GSTM2;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),-0.3484543935744888,-0.6369788891847084,0.8636363636363636,1.0,1.0,5/13,30.27%,TRMT10C;COA3;RPUSD3;RMND1;C1QBP
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.3311731051592323,0.6367642992798379,0.9,0.9890305591813886,1.0,10/10,66.90%,JAK2;GHR;STAT5B;STAT3;LYN;JAK3;PTPN1;STAT5A;STAT6;PRLR
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.2830797359151076,-0.636412212835541,0.9444444444444444,1.0,1.0,5/37,16.40%,PARP14;HES1;IL12A;SOCS3;IL18
prerank,GO_Biological_Process_2021__cellular response to nutrient (GO:0031670),-0.3854052315749973,-0.6363620327645438,0.8852459016393442,1.0,1.0,2/5,26.98%,XBP1;USF1
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),-0.358355414562388,-0.6360226214529767,0.8939393939393939,1.0,1.0,4/12,34.13%,BLM;DONSON;ZRANB3;LIG3
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),-0.3435869708051222,-0.6359933706704542,0.864406779661017,1.0,1.0,2/13,9.81%,RASGRP1;CASP8
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),-0.37669589367694356,-0.6348202357917309,0.9038461538461539,1.0,1.0,3/8,19.91%,VAMP8;ERBB3;CD74
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),-0.3405399062382007,-0.6347946915115148,0.873015873015873,1.0,1.0,3/11,23.83%,AKAP5;PHPT1;EDNRB
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.33912017135021855,0.634689644128029,0.9024390243902439,0.9902723193588707,1.0,1/10,5.19%,NFKB1
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),0.27711125643184104,0.6346156760462466,1.0,0.9900148080004035,1.0,6/18,26.71%,FKBP5;CWC27;PPIL6;PPIG;FKBP4;PPIL2
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),0.3779280576031422,0.6342148087033527,0.9047619047619048,0.9899600595101729,1.0,2/5,18.26%,NEDD4L;CAB39
prerank,GO_Biological_Process_2021__response to UV-B (GO:0010224),-0.37311067038733053,-0.6341055956599849,0.9508196721311475,1.0,1.0,2/8,11.73%,IL12A;HYAL1
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.35583677360797766,-0.6339131609950708,0.8985507246376812,1.0,1.0,1/10,9.42%,GSTP1
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.2534730870028351,-0.6333527779817472,0.9868421052631579,1.0,1.0,10/90,17.67%,WARS1;SELP;MTLN;TMC8;SVIP;KIF9;APOE;CLU;EIF2AK2;CRYAB
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),0.3567978482786892,0.6330298970467735,0.9130434782608695,0.9903717928070893,1.0,2/6,11.89%,NF1;STIM1
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),0.2460723087642296,0.6326638835002873,1.0,0.9903353728006046,1.0,9/26,22.46%,SASH1;PUM2;AKIRIN2;ANKRD17;DHX9;PUM1;POLR3B;PRKCA;POLR3F
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.30505466367584966,0.6324437219529104,0.90625,0.9898211223973569,1.0,6/19,19.31%,TP53BP2;BCL2;YWHAG;MAPK8;TFDP2;YWHAZ
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.30505466367584966,0.6324437219529104,0.90625,0.9898211223973569,1.0,6/19,19.31%,TP53BP2;BCL2;YWHAG;MAPK8;TFDP2;YWHAZ
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),0.24446857484321668,0.6323882080562072,1.0,0.9895519809306197,1.0,5/33,15.08%,FOXO3;MRPS2;GATB;GFM2;LARS2
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.3392905960804964,-0.6321356767728648,0.9242424242424242,1.0,1.0,1/14,11.87%,PLAAT4
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.2932586261448651,-0.6316257319374401,0.9714285714285714,1.0,1.0,4/31,14.67%,STX19;SNAPIN;SYT2;CDK5
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),-0.42976394959906344,-0.6310876268905463,0.9491525423728814,1.0,1.0,2/6,12.55%,HTR2B;FABP3
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),-0.37069046531482985,-0.6306908370844314,0.8656716417910447,1.0,1.0,1/8,17.73%,MAP2K6
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.2517737698198049,0.6304559208346735,1.0,0.9905269509010795,1.0,9/29,24.82%,TUB;INVS;ZNF423;BBS9;TCTN1;NPHP4;CSNK1D;TTC21B;ARL3
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.2574831716336322,-0.6299751555372135,1.0,1.0,1.0,21/113,23.48%,TRIM22;RPS27A;RAB7B;TRIM21;UBC;PRKCQ;CLU;SLCO3A1;CX3CL1;WNT5A;EIF2AK2;IL18;RIPK2;TRIM5;SPHK1;UBA52;NFKB2;AGT;AIM2;AR;NPM1
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),-0.25009476794003876,-0.629333091375763,1.0,1.0,1.0,10/134,10.62%,PSMB6;RPS27A;CSDC2;PSMB9;PSMA8;DND1;PSMA7;PSME1;PSMC3;UBC
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),-0.3878671451460121,-0.6293252094483115,0.9464285714285714,1.0,1.0,1/6,6.48%,TRIM21
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.27559965340168097,0.6293143714582675,0.9444444444444444,0.9910969996674066,1.0,8/21,25.65%,KCNH2;ATP7B;SLC4A4;ATP2B4;ATP1A4;KCNE4;KCNIP2;KCNE2
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),-0.30217222481780276,-0.6289124067814592,0.9078947368421053,1.0,1.0,3/30,14.94%,ISG15;CCN1;FZD9
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),-0.2983839784971772,-0.6287184076451614,0.9710144927536232,1.0,1.0,6/27,16.40%,IL7;OAS3;TLR3;WNT5A;EIF2AK2;IL18
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),0.31952077369294,0.6282346510292122,0.9428571428571428,0.9915380867747563,1.0,5/13,24.62%,FAP;RUNX1;DDR2;SLC2A10;RIC1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),0.2871552545369145,0.6280233716507201,0.9487179487179487,0.9913360857137137,1.0,3/17,15.16%,TNFSF4;TICAM1;CYRIB
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),-0.33258859693570353,-0.6279945702124852,0.8939393939393939,1.0,1.0,1/16,6.67%,THBS1
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.26335046557637937,-0.6279764324052819,0.9775280898876404,1.0,1.0,9/86,17.02%,APIP;B2M;RNF213;CHMP2A;CLYBL;BLM;POLQ;AQP11;CBY1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.33519675899083967,-0.6277464302300663,0.8985507246376812,1.0,1.0,2/13,19.98%,GLRX;WNK4
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),-0.342337175376478,-0.6275911100565275,0.9423076923076923,1.0,1.0,2/12,16.80%,PRDM7;CTR9
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),-0.366927824724149,-0.6271734629884937,0.9193548387096774,1.0,1.0,3/8,29.41%,NOS1;PKP2;SCN1B
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),-0.3311308950596666,-0.62682381280486,0.90625,1.0,1.0,4/12,26.86%,RAN;SREBF1;SEC14L2;SREBF2
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),0.3994769555601456,0.6262057037607147,0.9215686274509803,0.9914770246803062,1.0,2/5,22.94%,EDEM1;EDEM3
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),0.3994769555601456,0.6262057037607147,0.9215686274509803,0.9914770246803062,1.0,2/5,22.94%,EDEM1;EDEM3
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),0.3994769555601456,0.6262057037607147,0.9215686274509803,0.9914770246803062,1.0,2/5,22.94%,EDEM1;EDEM3
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),-0.27186105172029573,-0.6261422437600457,0.9876543209876543,1.0,1.0,11/64,16.61%,SPARC;CEACAM1;THBS1;PIK3CB;SVBP;RRAS;FGF1;APOE;SP100;WNT5A;GPI
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.3106111142075192,-0.6258619593712677,0.9365079365079365,1.0,1.0,4/19,17.30%,IL12A;RSAD2;APOE;ERP29
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),0.34884882303831244,0.6254002680357355,0.8571428571428571,0.9916176978914621,1.0,2/7,25.74%,PEX5;USP30
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),0.24400918374711855,0.6252838257249567,1.0,0.9913854274097424,1.0,6/31,15.87%,MEGF10;SMAD7;PLPP3;AFDN;TJP1;BMP7
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),-0.39258556052413796,-0.6252350239958422,0.9056603773584906,1.0,1.0,1/7,9.42%,GSTP1
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),-0.34860770912560013,-0.6251480457817388,0.9264705882352942,1.0,1.0,2/13,12.49%,APOBEC3G;BTBD18
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),0.28288977940598276,0.6249871022661329,0.9655172413793104,0.9913305062633032,1.0,7/19,22.00%,PSMG3;BBS10;PTGES3;HSPA4;MKKS;PSMG2;HSPA1A
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),0.35167730622941473,0.6248866474748088,0.8780487804878049,0.9911106890335898,1.0,2/9,15.17%,GCLC;GGCT
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),-0.3325866339578849,-0.6247050710529249,0.9420289855072463,1.0,1.0,4/13,18.89%,SELP;PRKCQ;APOE;CELA2A
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),0.33693831269045166,0.6244376779896542,0.8285714285714286,0.9911047416480954,1.0,3/8,25.72%,OXSR1;WNK1;ADAM10
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),-0.27675494699414493,-0.6241303157194444,0.9411764705882353,1.0,1.0,5/35,16.80%,OBI1;TRIM21;DTX3L;RAG1;CTR9
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),0.2857084082263279,0.6238857582712181,0.9523809523809523,0.9910987979972228,1.0,6/26,26.61%,CELF2;CELF3;CELF1;LUC7L;SETX;SFSWAP
prerank,GO_Biological_Process_2021__nucleoside triphosphate catabolic process (GO:0009143),0.3559424984814741,0.6238287647220188,0.8636363636363636,0.9907999242277776,1.0,5/5,64.41%,ENPP3;SMPDL3A;DCTPP1;ENPP1;ITPA
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",-0.2950819280111323,-0.6233535139730395,0.8970588235294118,1.0,1.0,3/23,15.39%,RPS27A;UBC;MAN1C1
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),-0.37512878424027357,-0.6228458018999828,0.9178082191780822,1.0,1.0,1/11,6.66%,APOBEC3G
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),0.31495048931037056,0.6226809557213514,0.9,0.9912211411052353,1.0,6/12,28.59%,CLASP1;ESPL1;LLGL1;CLASP2;LLGL2;MAP4
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),0.4021474244407779,0.6226177305569549,0.9166666666666666,0.9909834060582352,1.0,1/5,4.59%,FTO
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),0.34725452006671154,0.6223028252752125,0.9230769230769231,0.9905571442038776,1.0,3/7,25.72%,OXSR1;WNK1;ADAM10
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),0.34725452006671154,0.6223028252752125,0.9230769230769231,0.9905571442038776,1.0,3/7,25.72%,OXSR1;WNK1;ADAM10
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.31142718807216563,-0.6222739906453301,0.967741935483871,1.0,1.0,3/20,17.19%,TIMM10;TIMM8B;ROMO1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),-0.3833231768219639,-0.6222136460857878,0.9016393442622951,1.0,1.0,1/8,8.40%,FGF7
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),0.34753980040849813,0.6221207593461412,0.95,0.9904112391368612,1.0,1/8,10.30%,TRIT1
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.3471013107568029,-0.6220838842781541,0.9038461538461539,1.0,1.0,2/8,11.26%,RSPO3;SFRP1
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.2602215759480053,0.6219002832991555,0.9655172413793104,0.990216694952036,1.0,6/27,17.16%,PLK1;FOXN3;TAOK2;UIMC1;BRCC3;TICRR
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),-0.30529871252496366,-0.6218561948696695,0.9565217391304348,1.0,1.0,6/19,26.86%,FMO5;APOE;RAN;SREBF1;SEC14L2;SREBF2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),0.33715195522605435,0.6215904483620291,0.8378378378378378,0.9901197031745796,1.0,4/9,21.10%,SNCA;SIRT1;KLF15;CTBP1
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),0.4086962822542535,0.6215064068666671,0.9038461538461539,0.9898766720611862,1.0,3/5,33.94%,JAK2;PIBF1;GHR
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),-0.31786787225429436,-0.621268511161839,0.921875,1.0,1.0,4/13,21.85%,GSTP1;FADS1;ALOX12;ALOX5
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),-0.39450675648417477,-0.6210940830159835,0.8867924528301887,1.0,1.0,1/7,9.23%,RDX
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),-0.37388076769492407,-0.6210782758254043,0.9310344827586207,1.0,1.0,2/7,22.83%,OGN;OMD
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),-0.2849761871619029,-0.6198616245044004,0.9428571428571428,1.0,1.0,3/30,16.92%,KCNJ13;KCNJ8;ATP12A
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.29495551943880605,0.6193390325295712,0.92,0.99088134058412,1.0,7/23,23.67%,TNFRSF10B;MAP3K5;BCL2;TMEM117;AIFM1;BAG6;ERN1
prerank,GO_Biological_Process_2021__oxaloacetate transport (GO:0015729),0.3816976510279228,0.6192599651958444,0.9318181818181818,0.9906443069391526,1.0,2/5,32.11%,SLC25A14;SLC13A5
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),-0.35825874225493426,-0.6186297529996364,0.9166666666666666,1.0,1.0,1/8,6.67%,THBS1
prerank,GO_Biological_Process_2021__pyridine-containing compound metabolic process (GO:0072524),0.3818668072925675,0.6183962441668118,0.8181818181818182,0.9909243737728973,1.0,1/5,25.47%,AOX1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.3791675624354558,-0.6183399643453533,0.9354838709677419,1.0,1.0,3/9,17.23%,HLA-A;IL18;PTPN22
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),0.3434016999644564,0.618238842210099,0.8936170212765957,0.9906692352440288,1.0,3/6,28.14%,CUL1;FBXL7;CAND2
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),0.228707084525383,0.6182160909861191,1.0,0.9903777882973497,1.0,6/37,18.46%,CTSK;ATG7;PRKN;FUNDC2;ATG2B;ATG5
prerank,GO_Biological_Process_2021__fibrinolysis (GO:0042730),0.37787292098047154,0.6179966737102804,0.8695652173913043,0.990183740926374,1.0,1/6,5.99%,SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),0.3791424177489886,0.6171414026772934,0.9,0.9904878984304616,1.0,1/6,9.56%,ADRA1A
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.32028182426451207,-0.6170902526129977,0.9838709677419355,1.0,1.0,4/19,21.69%,CHMP2A;EMD;GPER1;DCTN1
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),-0.3500511757606699,-0.61706833125046,0.9384615384615385,1.0,1.0,2/12,8.99%,SEMA5A;NRARP
prerank,MSigDB_Hallmark_2020__Myc Targets V2,-0.27421373650131475,-0.6167534578113162,0.9857142857142858,1.0,1.0,15/50,26.40%,DDX18;SORD;HK2;GNL3;NIP7;MPHOSPH10;CBX3;IMP4;HSPD1;NPM1;PLK4;LAS1L;NOP16;TMEM97;MCM5
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),-0.36907170673505596,-0.6166122017563421,0.9322033898305084,1.0,1.0,1/8,5.14%,MTLN
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),-0.40902208729170897,-0.616125462257653,0.9545454545454546,1.0,1.0,2/6,11.81%,GSTP1;FOXM1
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),-0.29608637480083266,-0.6160456121056372,0.9315068493150684,1.0,1.0,4/31,15.55%,ISG15;CCN1;FZD9;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),0.3135569755909847,0.6143954307724737,0.96875,0.9919395294549962,1.0,5/17,13.92%,BMP2;FBXW7;ASXL3;ACADVL;ABCA2
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),-0.29692121733464016,-0.613993723256038,0.971830985915493,1.0,1.0,4/25,20.03%,ABCA12;APOE;ABCA5;NAXE
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),0.22652901281541524,0.6138758687817041,1.0,0.9920426257400624,1.0,16/46,29.16%,NEDD4L;BIN1;KCNMA1;KCNH2;GABBR1;DLG1;CAB39;KCNN3;DPP6;KCNIP2;GABBR2;KCNE2;NEDD4;KCNIP3;KCNIP4;KCNJ10
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.3081878245008771,0.6137247114021082,0.9285714285714286,0.9918240270004699,1.0,3/12,24.03%,ARID2;WDR48;ERCC6
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),-0.3306651303187892,-0.6133342597141908,0.9054054054054054,1.0,1.0,3/14,19.49%,CHRM2;SRF;SPHK1
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),-0.3632117763199585,-0.6126355634533982,0.9193548387096774,1.0,1.0,1/8,8.94%,HES1
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),0.37215407545445683,0.6123159401046512,0.9024390243902439,0.9923396244525896,1.0,1/5,6.57%,MEGF10
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),-0.3004634181381138,-0.6122915411195002,0.9466666666666667,1.0,1.0,2/20,10.62%,PNP;HINT1
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.287840587747834,0.6114156947189713,1.0,0.9925516643848953,1.0,5/23,15.46%,SOX9;BMP2;ROBO1;SLIT2;ROCK2
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),-0.35602183368488266,-0.6111319624846742,0.9253731343283582,1.0,1.0,1/9,3.85%,STAT1
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.290012986545785,0.6105547192264236,0.9736842105263158,0.9927393207758995,1.0,5/19,17.32%,PKD2;GSTM2;CAMK2D;JPH1;PDE4D
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),-0.38006632541372654,-0.610400810379808,0.9253731343283582,1.0,1.0,1/6,7.15%,BDNF
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),-0.269022774893298,-0.6103907315501574,1.0,1.0,1.0,7/54,17.27%,GATA1;THBS1;PRKCQ;FES;SPI1;CTR9;ZFPM1
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),-0.27003225047928736,-0.6097844663438424,0.9866666666666667,1.0,1.0,7/43,21.85%,CLU;ERBB3;HHIP;AQP11;KLF4;SPINK5;ALOX5
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),-0.3106526423028174,-0.6095283718235894,0.9746835443037974,1.0,1.0,2/16,20.68%,POLR2L;POLR2K
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),-0.29650903540476303,-0.6094296585795964,0.984375,1.0,1.0,4/16,22.00%,APOE;APH1A;CLN3;KLK6
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.2941926447957386,-0.6091703610755778,0.9692307692307692,1.0,1.0,2/21,12.69%,RDX;CAV3
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),-0.36675318655649736,-0.6087656000799615,0.95,1.0,1.0,3/9,19.90%,KLF2;NOS1;GPER1
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),-0.27049552189492027,-0.6087616138652727,0.9848484848484849,1.0,1.0,11/45,24.03%,GPR183;RASGRP1;CASP8;AKAP17A;RAG1;SLC25A5;BANK1;BLNK;DNAJB9;HSPD1;NFAM1
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),-0.3924629310237925,-0.6084879294084877,0.9454545454545454,1.0,1.0,2/6,20.53%,CEP135;HAP1
prerank,GO_Biological_Process_2021__regulation of superoxide metabolic process (GO:0090322),0.3301439440448445,0.6066343882579841,0.8333333333333334,0.9947815067412699,1.0,2/6,15.87%,BST1;BMP7
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.26859929387252657,0.6064742328799907,0.9545454545454546,0.9945866312954719,1.0,6/14,27.19%,MID1;TAOK2;STK25;TAOK1;RNF13;TGFB2
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),-0.35107632414918044,-0.6063041397634835,0.9166666666666666,1.0,1.0,2/10,14.16%,ART4;ART3
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.32652782338302566,-0.606273982093515,0.9705882352941176,1.0,1.0,2/16,14.32%,IFI35;SPI1
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.343172418073371,-0.6060039591075327,0.9411764705882353,1.0,1.0,3/14,22.31%,PQBP1;SLU7;SCNM1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),-0.3350782094940134,-0.6056282115238673,0.9577464788732394,1.0,1.0,4/12,24.70%,ID2;TBX5;PKP2;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),-0.2434436967333182,-0.6051639443253517,1.0,1.0,1.0,18/78,24.70%,P2RY12;THBS1;IFI35;DDX60;LY96;TLR3;CX3CL1;WNT5A;SCARF1;IL18;SCIMP;ZP3;POLR3G;TNIP1;AGT;RIOK3;DHX58;TGFB1
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,-0.25487789887857554,-0.6051069351833076,1.0,1.0,1.0,6/96,11.61%,THSD4;PDPN;COL4A4;GRAMD2A;AKAP5;TRIM29
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),0.3658578946429566,0.6044751116532647,0.9761904761904762,0.9956033093092899,1.0,2/6,21.97%,ERC2;ERC1
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),0.3048009945218596,0.6042824411607122,0.9705882352941176,0.9953901334883771,1.0,5/12,28.98%,PTGES3;PRXL2B;TBXAS1;HPGDS;PTGIS
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),0.3313945419902217,0.604260045373326,0.9473684210526315,0.9951165565183104,1.0,3/7,16.96%,PUM2;ANKRD17;PUM1
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.3172146076857144,-0.6041946597495403,0.9516129032258065,1.0,1.0,2/13,14.17%,KCNQ1;KCNJ8
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),0.25501549634239207,0.6039627022106707,0.9714285714285714,0.9949944374569738,1.0,3/20,17.89%,NSUN3;MRPS27;FASTKD3
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),-0.36591959769263654,-0.6038337588267902,0.9322033898305084,1.0,1.0,2/6,27.38%,LAPTM4B;LDLR
prerank,GO_Biological_Process_2021__establishment of monopolar cell polarity (GO:0061162),-0.37922449291563526,-0.6033900041785004,0.9056603773584906,1.0,1.0,1/5,16.71%,FSCN1
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.31018594511164366,-0.603249172046181,1.0,1.0,1.0,3/18,15.52%,SELENOK;CCDC47;FIS1
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),-0.36608162384144843,-0.603231776225686,0.9032258064516129,1.0,1.0,1/7,17.40%,SLC24A1
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),0.26954130165299905,0.6018594465770265,1.0,0.9957193414311867,1.0,2/23,5.75%,RBM24;HNRNPU
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.33191828506506027,-0.6016267323518857,0.9833333333333333,1.0,1.0,1/13,4.79%,ANXA1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.23649468143101893,0.6014040204720813,1.0,0.9957120179077615,1.0,5/29,18.17%,FAM107A;PKD2;DLG1;CDK2AP2;PTEN
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),0.29930741319420645,0.601391509374988,0.975609756097561,0.9954144976809695,1.0,3/12,25.97%,TRAPPC10;SNX1;STX5
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),0.3749337859333625,0.6013664143345915,0.9743589743589743,0.9951111184414891,1.0,3/7,12.84%,AKT1;HMGB1;SIRT1
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),0.33622317313048844,0.6011388861979855,0.8863636363636364,0.9946317701660563,1.0,3/9,17.55%,CHMP1A;CHMP2B;VTA1
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),0.33622317313048844,0.6011388861979855,0.8863636363636364,0.9946317701660563,1.0,3/9,17.55%,CHMP1A;CHMP2B;VTA1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.25571897738290583,0.6009716849711367,0.9666666666666667,0.994419491898414,1.0,7/22,24.68%,SERPINE1;YAP1;NDNF;NFE2L2;PAK4;TCF7L2;GAS6
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),-0.34796802446509373,-0.6008486900869542,0.9393939393939394,1.0,1.0,2/9,18.02%,XBP1;DDIT3
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.32922349019629715,-0.600708799246289,0.9375,1.0,1.0,4/10,19.91%,ZNF385A;CD44;TAF9B;CD74
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.32922349019629715,-0.600708799246289,0.9375,1.0,1.0,4/10,19.91%,ZNF385A;CD44;TAF9B;CD74
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),0.23400146525524543,0.6000287238295116,0.9615384615384616,0.9946721539739908,1.0,8/38,19.32%,TNFSF4;IL17D;MBP;HMGB1;DHX9;PTPN11;BCL10;IL6R
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),-0.35741615409358135,-0.5995436047239754,0.9841269841269841,1.0,1.0,2/8,16.26%,APOE;XBP1
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),0.237807175584825,0.5994369808988611,1.0,0.9946772405749188,1.0,6/35,17.16%,PLK1;FOXN3;TAOK2;UIMC1;BRCC3;TICRR
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),-0.2784206696653654,-0.59912456739172,0.9605263157894737,1.0,1.0,5/28,20.68%,GTF3C6;POLR2L;GTF3A;POLR3G;POLR2K
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),0.33854720323968623,0.5983761885829169,0.8888888888888888,0.9945306020178766,1.0,6/6,66.16%,CDC42;WASHC1;CDC42EP4;CDC42EP3;APC;CDC42EP1
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),0.33854720323968623,0.5983761885829169,0.8888888888888888,0.9945306020178766,1.0,6/6,66.16%,CDC42;WASHC1;CDC42EP4;CDC42EP3;APC;CDC42EP1
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.27742332422274796,-0.5979357811522233,0.9315068493150684,1.0,1.0,5/38,15.50%,RPS27A;B2M;UBC;CST3;CALB1
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),0.3354771571417519,0.5978308714747282,0.9722222222222222,0.9944935248675633,1.0,5/9,34.10%,PCM1;NINL;HOOK3;CEP19;CCDC120
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),0.339201877354929,0.5976978549878911,0.8571428571428571,0.9942696300302867,1.0,2/6,14.44%,DUSP10;DLG1
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),0.28958944992735236,0.5975401936256964,1.0,0.9940518992072483,1.0,1/17,4.16%,POLD3
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),-0.39643476530642086,-0.5973436643587027,0.9365079365079365,1.0,1.0,2/6,21.67%,CXCR4;IL34
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.26381270882578217,-0.5970846137651369,1.0,1.0,1.0,3/35,14.08%,DDX11;BLM;TONSL
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),0.31469032204612957,0.5966623012452165,0.8709677419354839,0.9942017297232006,1.0,4/12,17.32%,TRPM4;ADRA1A;ADRB1;PDE4D
prerank,GO_Biological_Process_2021__chitin metabolic process (GO:0006030),0.3548614724461389,0.596165903401691,0.8837209302325582,0.9938329307745075,1.0,1/5,8.20%,CTBS
prerank,GO_Biological_Process_2021__chitin catabolic process (GO:0006032),0.3548614724461389,0.596165903401691,0.8837209302325582,0.9938329307745075,1.0,1/5,8.20%,CTBS
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),0.3310198345261084,0.595623064398301,0.9696969696969697,0.993784102824318,1.0,3/11,12.84%,SNCA;ZNF451;SIRT1
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),-0.31322432456354043,-0.5955832208900789,0.948051948051948,1.0,1.0,3/17,21.05%,GTF3C6;GTF3A;NIFK
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),-0.28822717685708776,-0.5953128177579405,0.9855072463768116,1.0,1.0,2/36,10.80%,DYNLRB1;DYNLRB2
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.3330459779555999,0.5950765797409628,0.90625,0.9938195281030004,1.0,2/8,13.63%,RCC2;SIRT2
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.2776521799262115,-0.5942668429716476,0.9827586206896551,1.0,1.0,8/25,27.09%,ATP5ME;ATP5F1E;ATP5PD;ATP5MC3;MICOS13;AFG3L2;ATP5PF;SPG7
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),-0.3054597892844022,-0.59421415654295,0.90625,1.0,1.0,4/18,24.62%,SVIL;MYL6B;MYOZ2;MYL6
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),0.35303985555856865,0.5938746948716191,0.8837209302325582,0.994197733385694,1.0,2/5,17.97%,PRIMPOL;SRPK2
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),-0.380223118892562,-0.592672105914047,0.9,1.0,1.0,3/7,24.58%,SLC11A1;CD74;ICAM1
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.29132266531152506,0.5915526353804372,0.9387755102040817,0.9949965594131315,1.0,2/14,14.97%,BOK;GSK3B
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),0.26181943332622165,0.5910524571455559,0.96875,0.9949173803846731,1.0,4/16,22.08%,CAMK2A;BCL2;NAIF1;BCL2L1
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.26226737601537997,-0.5909587580535752,1.0,1.0,1.0,8/66,14.96%,PAQR3;HEXIM1;GSTP1;PIK3CB;SLC8A3;CAV3;APOE;DUSP1
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),0.3033225779367122,0.5906921821811425,0.96,0.9947841738530027,1.0,10/15,36.45%,SMS;MTHFR;SLC25A13;MSRA;NAT8L;FOLH1;SLC25A12;ASPA;GOT2;NAALAD2
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),0.3098186769181265,0.5899986140061415,0.9772727272727273,0.9947471558172919,1.0,1/9,9.34%,ATP9A
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),-0.3444007593864258,-0.5899584231017155,0.9523809523809523,1.0,1.0,2/13,16.09%,CEACAM1;BRCA1
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),0.33453062730135746,0.5897777084322327,0.9777777777777777,0.9945660458771755,1.0,2/7,12.60%,SNCA;PIKFYVE
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),0.32712362053255045,0.5894826302006598,0.9032258064516129,0.994427068264872,1.0,7/7,67.30%,HMGCLL1;IVD;BCAT2;MCCC1;HMGCL;MCCC2;BCAT1
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),-0.3409390987419809,-0.5893600334434411,0.9705882352941176,1.0,1.0,2/7,16.26%,CIITA;XBP1
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),-0.38585746102449886,-0.5891504342718547,0.953125,1.0,1.0,5/5,61.43%,ARMC1;DNM1L;MAPT;CLUH;LRRK2
prerank,GO_Biological_Process_2021__endothelium development (GO:0003158),-0.3542278481552219,-0.5891231754714845,0.9838709677419355,1.0,1.0,1/6,16.00%,EDF1
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",-0.3613889963597475,-0.5889685827000111,0.9245283018867925,1.0,1.0,2/5,24.71%,ZFAND2B;SRP54
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),0.295570156027776,0.5876548275774097,0.9655172413793104,0.9949122882820601,1.0,5/21,17.91%,ATP6V1A;NNT;ATP1A4;SLC25A14;DMAC2L
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),-0.2749526613313215,-0.5876064869866292,0.974025974025974,1.0,1.0,5/28,19.70%,KLF2;LAMTOR2;XBP1;RRAGC;GLRA1
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),-0.3246287758950767,-0.5874220213080797,0.9482758620689655,1.0,1.0,4/9,21.97%,SLC25A4;ABCC6;SLC25A5;CR1
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),0.3826288330289906,0.587396732118509,0.8918918918918919,0.9947732895999696,1.0,2/6,25.31%,SEC14L1;GPATCH3
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),0.31829254952028607,0.5871162601084446,0.9743589743589743,0.9945804003068097,1.0,1/11,13.92%,MMGT1
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),0.31388401775505187,0.5870833024419219,0.8974358974358975,0.9942917015872631,1.0,4/9,29.73%,FBXW11;SUN2;MTOR;PAFAH1B1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte proliferation (GO:0010838),0.3460014083237249,0.5864723133467944,0.9696969696969697,0.9942549152403672,1.0,2/6,13.90%,NOTCH2;TGM1
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),0.3083005110284439,0.586225606501671,0.975609756097561,0.9940563721900321,1.0,2/12,13.20%,PLCB1;B4GALT5
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),0.30440453720848515,0.5858831707365171,0.9743589743589743,0.9939238412817477,1.0,1/11,4.38%,GRIN1
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),-0.3658433231240679,-0.5856900309360935,0.9814814814814815,1.0,1.0,1/5,11.73%,HYAL1
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.24412691515957827,0.5852503017295819,0.9714285714285714,0.9940249293905374,1.0,9/27,24.68%,SOX4;ZBTB20;MLXIPL;RAB11FIP2;PTPRN2;ZNF236;ERN1;PRKAA1;GAS6
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),0.30564116771586425,0.5852231475035462,0.95,0.9937428324101493,1.0,4/8,32.00%,NIPBL;FGFR2;COBL;CHD8
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),-0.35226881370934227,-0.5833729487972525,0.9538461538461539,1.0,1.0,1/9,6.05%,EFNA1
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),0.3048444117504317,0.5831560150331083,0.9666666666666667,0.9943944835801002,1.0,3/9,19.35%,GSK3B;NSFL1C;UBXN2B
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),0.34148316881802043,0.5829052171674527,0.9545454545454546,0.9941842378154166,1.0,6/6,65.86%,TERF2;ERCC1;ERCC4;SMG6;NBN;ATM
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),-0.3761071630446318,-0.5827892023561562,0.9344262295081968,1.0,1.0,2/7,17.21%,WNT5A;SCIMP
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),0.3315903135843709,0.5826191095833152,0.9574468085106383,0.9940339290960275,1.0,2/7,9.98%,PIK3CA;PIK3C3
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),0.31726641453762244,0.5825501798263754,1.0,0.9937760920557701,1.0,3/11,16.37%,RIN3;MTMR2;UBQLN2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.26133750472514916,0.5821627977282133,0.9642857142857143,0.993631978309474,1.0,8/30,24.63%,TAFA5;PRKG1;IGF1;BMPR1A;PTEN;FGF2;ERN1;CDKN1B
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),-0.38475315963152845,-0.5819867937384904,0.9444444444444444,1.0,1.0,1/5,23.48%,NPM1
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),-0.34791192103264995,-0.5813997999787478,0.9420289855072463,1.0,1.0,6/6,65.22%,SYK;DNASE1;PRKCD;IL15;KMT2E;PREX1
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),-0.3762438225281828,-0.5810002318541609,0.9310344827586207,1.0,1.0,1/5,25.21%,S100A13
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),-0.3762438225281828,-0.5810002318541609,0.9310344827586207,1.0,1.0,1/5,25.21%,S100A13
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),-0.3263430819626538,-0.5809300882699593,0.9365079365079365,1.0,1.0,2/13,12.69%,PLN;CAV3
prerank,GO_Biological_Process_2021__sphingosine-1-phosphate receptor signaling pathway (GO:0003376),-0.3749014693705067,-0.5806055179567011,0.8703703703703703,1.0,1.0,1/5,10.27%,PIK3CB
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),-0.34881954155601236,-0.5786439436015756,0.9090909090909091,1.0,1.0,2/6,21.78%,PODXL;MYO1E
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),0.34410885543481984,0.5783813081106848,0.9444444444444444,0.995053470312058,1.0,3/6,23.64%,HIF1A;ARNT;SLCO1C1
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),-0.2702335912496326,-0.5778863907047362,0.9733333333333334,1.0,1.0,6/32,21.40%,AGPAT4;DOLK;FDPS;FADS1;DHDDS;CLN3
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),-0.3483577952343946,-0.5778507218103952,0.9242424242424242,1.0,1.0,2/7,21.78%,PODXL;MYO1E
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),-0.29654232550082504,-0.5777679548420634,0.9850746268656716,1.0,1.0,3/19,12.69%,PLN;CTNNA3;CAV3
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),0.34243734636602646,0.5777130947691672,0.9090909090909091,0.9950285210925466,1.0,3/5,24.61%,KDM1A;CDK9;RNF20
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.35994128366066,0.5775800639964342,0.9459459459459459,0.9947886100992737,1.0,5/5,64.01%,PPARG;MFN2;E2F3;PDCD4;SOD2
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.263678082188605,-0.5773317041013986,0.984375,1.0,1.0,8/36,21.06%,LRRC19;IFI35;CD14;TLR3;EIF2AK2;SPHK1;C1QTNF4;ILK
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),-0.3624168749308698,-0.5771420037687587,0.9622641509433962,1.0,1.0,1/6,12.26%,SLC25A33
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.26066237715492147,-0.5769427591623193,0.9871794871794872,1.0,1.0,7/41,21.40%,SLC16A3;SLC16A4;SLC17A5;SLC16A11;SLC38A1;SLC16A6;CLN3
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),0.3831534300675121,0.5766387674071667,0.9743589743589743,0.9948831525727617,1.0,1/5,4.72%,HSPH1
prerank,GO_Biological_Process_2021__serine family amino acid catabolic process (GO:0009071),-0.35418970686634405,-0.5762979889981183,0.953125,1.0,1.0,3/8,31.10%,SDS;THNSL2;DAO
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),-0.33636406589935625,-0.5762860672538472,0.9672131147540983,1.0,1.0,1/10,4.87%,B2M
prerank,GO_Biological_Process_2021__heat acclimation (GO:0010286),0.35720053015273967,0.5751776650067354,0.8947368421052632,0.9949169451460271,1.0,1/5,22.00%,HSPA1A
prerank,GO_Biological_Process_2021__cellular heat acclimation (GO:0070370),0.35720053015273967,0.5751776650067354,0.8947368421052632,0.9949169451460271,1.0,1/5,22.00%,HSPA1A
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),0.33669381879699367,0.5745387065561264,0.94,0.994874183294137,1.0,2/7,13.92%,STARD4;ABCA2
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),0.35219930995147,0.574339034288451,0.9487179487179487,0.9946466123380644,1.0,3/6,30.30%,GLUL;NVL;POLR1A
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),0.34459466735006233,0.5740849409137989,0.8709677419354839,0.9944668657278197,1.0,2/5,30.16%,TRIM44;GPS2
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),0.338986700728995,0.5726634149664919,1.0,0.9946805084694591,1.0,1/5,15.30%,LZTFL1
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),0.304923626846594,0.5725963635888823,0.9473684210526315,0.994405550415811,1.0,4/9,24.18%,KAT7;TICRR;WRNIP1;GMNN
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),0.32515091728501033,0.5719072975610193,0.9285714285714286,0.9943689658038176,1.0,1/7,13.96%,WHRN
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),0.3390101879596647,0.5716023421661132,0.9487179487179487,0.9942371507634302,1.0,2/7,17.41%,CFLAR;ADGRB1
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.2844770941855982,-0.5710343535615667,0.9696969696969697,1.0,1.0,5/19,25.07%,CASP8;CDC37;ASAH1;NUPR1;FLOT1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.29792670336015814,-0.5707089887008238,0.9523809523809523,1.0,1.0,6/12,28.52%,THBS1;CREB3L1;APLN;SPRY1;GPC1;SULF2
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),-0.34927386577212854,-0.5704492743029205,0.9666666666666667,1.0,1.0,1/7,21.40%,CLN3
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),0.3140663465271243,0.570447517960957,0.9761904761904762,0.9943256211678423,1.0,1/8,7.71%,ABL2
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),0.239565406807694,0.5697347115887974,1.0,0.9943723898186692,1.0,8/29,28.50%,TFEB;TMEM106B;SYTL4;KLC2;BORCS5;MAP6;ARL8B;DEF8
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),-0.33859798856853296,-0.5695606409812511,0.9508196721311475,1.0,1.0,1/8,12.19%,CLYBL
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),-0.33859798856853296,-0.5695606409812511,0.9508196721311475,1.0,1.0,1/8,12.19%,CLYBL
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.31827159009311107,-0.5693615584191529,0.9571428571428572,1.0,1.0,1/8,16.00%,EDF1
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),0.289789589955488,0.5670002799753247,0.972972972972973,0.995103131291161,1.0,2/11,14.53%,FER;HAVCR2
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),-0.3425794695282446,-0.5667830585397837,0.8867924528301887,1.0,1.0,5/5,65.76%,MTRES1;RACK1;LTN1;ZNF598;NEMF
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),-0.33762078817302366,-0.5663969142426926,0.8909090909090909,1.0,1.0,1/5,13.86%,SLC11A1
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),-0.33762078817302366,-0.5663969142426926,0.8909090909090909,1.0,1.0,1/5,13.86%,SLC11A1
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),-0.26957822623914485,-0.5656120347460755,0.9855072463768116,1.0,1.0,4/24,20.44%,KLF2;CLU;KLF4;NOS1AP
prerank,PanglaoDB_Augmented_2021__Pinealocytes,-0.2391359838607568,-0.5651423898593284,1.0,1.0,1.0,3/64,6.39%,KCNB1;PDE6B;PDE6C
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),-0.3721336046103509,-0.56492242368324,0.9,1.0,1.0,1/5,16.09%,BRCA1
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),-0.337017907939349,-0.5643621032018564,0.9661016949152542,1.0,1.0,7/10,36.32%,ICAM1;PLVAP;ADAM8;CD99;JAM3;THY1;XG
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),-0.3380756038444965,-0.5634236830202194,1.0,1.0,1.0,1/7,11.36%,MTIF3
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),-0.31836622603055725,-0.5627926156644362,0.9516129032258065,1.0,1.0,1/11,5.69%,KLF2
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),-0.3141382548994276,-0.5622174879384985,0.953125,1.0,1.0,2/12,12.00%,THBS1;CXCL17
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),-0.34760018563472606,-0.5620385093609737,0.967741935483871,1.0,1.0,1/7,12.69%,CAV3
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),-0.33565083889993236,-0.5619840540325947,0.9516129032258065,1.0,1.0,1/9,8.40%,FGF7
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),0.3249265197978455,0.5617981579471948,0.9024390243902439,0.9968858713059361,1.0,1/7,14.44%,KMT2C
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),-0.34156348716074625,-0.5608101396269397,0.9365079365079365,1.0,1.0,1/8,12.88%,NOX1
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),0.28461606344758433,0.5607336191728252,0.9705882352941176,0.9969496469566796,1.0,2/10,24.31%,RBBP4;MTA2
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.25977699470892024,0.5606854818312216,1.0,0.9966627828997909,1.0,4/16,28.49%,KLHL15;UBQLN4;PARPBP;SMCHD1
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),0.33693937741625657,0.5606221168694101,0.9318181818181818,0.9963879752732899,1.0,2/5,19.72%,UBASH3B;DDR2
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),0.34139184717426185,0.5605653880468124,0.9655172413793104,0.9961133355194991,1.0,1/6,8.15%,NR1D1
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),-0.3912458593285265,-0.560484446279884,0.9795918367346939,1.0,1.0,1/5,22.25%,ZFP36
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),0.2683420524916209,0.5603182203977372,1.0,0.9958626112516921,1.0,1/16,3.17%,COX10
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),-0.3005756927311241,-0.5601333991608,0.927536231884058,1.0,1.0,1/13,11.81%,FOXM1
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),-0.30369036607784944,-0.5598498360602275,0.9571428571428572,1.0,1.0,3/14,17.22%,COX7A1;SLC25A33;COX7A2
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),-0.3683266936808245,-0.5595004920821532,0.9454545454545454,1.0,1.0,1/5,15.19%,PRPS1
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),-0.3157570268062885,-0.5593492946100154,0.9838709677419355,1.0,1.0,1/10,6.67%,THBS1
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),-0.3023858833722536,-0.5592084861462078,0.9696969696969697,1.0,1.0,1/14,10.13%,PPIB
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),-0.355084967393029,-0.5590101213717245,0.96,1.0,1.0,1/5,6.67%,THBS1
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),0.33520506378223913,0.5580195873358477,0.926829268292683,0.9965082446071039,1.0,2/7,17.57%,DPYSL4;DPYSL5
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),-0.3636276706054762,-0.5575382141625488,0.9310344827586207,1.0,1.0,3/6,34.74%,KMT2B;SETD1A;SETD1B
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),0.3433292867417709,0.5566665032012063,0.9743589743589743,0.9963925620889201,1.0,1/5,15.46%,ROCK2
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),0.3433292867417709,0.5566665032012063,0.9743589743589743,0.9963925620889201,1.0,1/5,15.46%,ROCK2
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),0.29304233340085034,0.5565031322310258,1.0,0.9961894961147029,1.0,13/13,70.72%,TFRC;KMT5B;TP53BP1;HMCES;RIF1;SHLD2;PARP3;KMT5C;PAXIP1;SUPT6H;SHLD1;MAD2L2;SLC15A4
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),0.35259215904266783,0.5561887357996782,0.9772727272727273,0.9960161934189339,1.0,4/6,35.43%,MAPKAP1;RICTOR;SYAP1;PRR5
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.2971751203627181,-0.5561454003272684,1.0,1.0,1.0,4/14,18.30%,STAB2;HYAL1;CEMIP;CD44
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),-0.2596091148774357,-0.5557397326903777,0.9861111111111112,1.0,1.0,5/29,19.57%,NLRP1;CASP8;WNT5A;RIPK2;USP50
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),-0.36250353124895157,-0.5549790157816645,0.9848484848484849,1.0,1.0,1/5,13.34%,MT3
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),-0.3482943545446668,-0.5545373865326444,0.967741935483871,1.0,1.0,2/6,20.89%,TNFRSF21;CRLF2
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),0.29891980757549963,0.5540965316823578,1.0,0.9965007917776074,1.0,2/12,13.32%,CHMP1A;CHMP2B
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),-0.3145299681306698,-0.5536185396031106,0.9393939393939394,1.0,1.0,3/8,24.29%,NOS1;SCPEP1;APLN
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),-0.288917055995161,-0.553344893984453,0.9714285714285714,1.0,1.0,1/15,6.64%,CCBE1
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),0.28403421195469225,0.5530036650281485,1.0,0.9966829565913056,1.0,2/15,13.32%,CHMP1A;CHMP2B
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.35941504334269314,-0.552972951441044,0.9855072463768116,1.0,1.0,2/7,18.16%,PODXL;SKAP1
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),-0.3033536524442764,-0.5511415309618838,0.9538461538461539,1.0,1.0,3/14,19.36%,AKAP5;RAMP3;FSHR
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.2888603029140524,-0.5504935323079141,1.0,1.0,1.0,2/14,14.69%,CHRM2;CHRM5
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),-0.2828024165511415,-0.5503062076963251,1.0,1.0,1.0,5/22,21.30%,PNP;PRPS1;GMPR2;PPAT;PRPSAP1
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),-0.3148719235046341,-0.5495892378329645,0.9393939393939394,1.0,1.0,2/9,16.92%,PIAS3;GNL3
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),0.274933840879956,0.549133802659647,1.0,0.9977889164756295,1.0,2/11,10.06%,PGD;PGM2
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),0.3117495040870756,0.5487344604366362,1.0,0.9976390205178362,1.0,1/6,7.59%,PRPS2
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),0.3196149307384719,0.5481747323045648,0.9534883720930233,0.997542485640824,1.0,3/7,22.71%,NFATC3;NFATC2;NFATC1
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.2847892079610458,0.5481566743191808,1.0,0.9972389121515847,1.0,3/13,22.15%,IWS1;PCID2;THOC2
prerank,GO_Biological_Process_2021__positive regulation of steroid metabolic process (GO:0045940),-0.34279358282937505,-0.5475089753840661,0.9423076923076923,1.0,1.0,2/5,22.45%,APOE;AGT
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),-0.35462083105016395,-0.5471852718467964,0.9692307692307692,1.0,1.0,1/5,16.64%,SLC4A11
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.22761207963848978,-0.5470574817191173,1.0,1.0,1.0,3/63,11.53%,GOLGA8B;RAB11A;ABRAXAS1
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),-0.31567712728719416,-0.5468691382682215,0.9516129032258065,1.0,1.0,1/10,11.81%,FOXM1
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),-0.3562557786174224,-0.5463140008269474,0.9807692307692307,1.0,1.0,2/5,19.20%,OSGEP;LAGE3
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),0.338659269189685,0.5460315551275964,0.9545454545454546,0.9976690165439253,1.0,2/6,17.57%,DPYSL4;DPYSL5
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),0.3308242474729478,0.5449168302414219,1.0,0.9977558781453344,1.0,2/6,19.40%,RPE;FGGY
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.2977718313491724,-0.5446592117409776,0.9538461538461539,1.0,1.0,4/13,25.20%,HEXIM1;RNF8;NELFCD;NELFE
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),0.2678964981611748,0.5444007750901516,1.0,0.9976653368123032,1.0,4/17,17.41%,SOX8;NF1;ADGRB2;ADGRB1
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),0.31099562894594307,0.5440549873555867,0.9210526315789473,0.9974507431731766,1.0,2/6,29.73%,CHPT1;PAFAH1B1
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.312508387254093,-0.5438947966302616,0.9701492537313433,1.0,1.0,2/10,13.16%,DDX60;TLR3
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.30412112782344075,-0.5437920834416327,1.0,1.0,1.0,4/12,25.20%,HEXIM1;RNF8;NELFCD;NELFE
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),0.30653978538165616,0.5436889653284998,0.9487179487179487,0.9972658203358246,1.0,5/5,69.35%,GALC;GLA;NAGA;GBA2;GBA3
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),0.23159728207171287,0.5431489318016456,1.0,0.9971577915267884,1.0,6/23,27.22%,DNAJB13;PTGES3;HSPA1A;DNAJB5;DNAJB14;SDF2
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),0.32570277148677873,0.5430566345674906,0.9444444444444444,0.9968845026199663,1.0,1/6,9.83%,GLI3
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),-0.32577704973692984,-0.5427950965855741,0.9666666666666667,1.0,1.0,1/8,21.69%,DCTN1
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),-0.2746533884832291,-0.5422855002177337,0.984375,1.0,1.0,7/22,22.68%,CEACAM1;PDCD1LG2;CD274;PTPN22;TNFRSF21;CR1;SFTPD
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),0.32671333074527475,0.542240284616293,0.9375,0.9968356821345664,1.0,1/7,10.06%,GSTM2
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),-0.31420612198684195,-0.54155304978487,0.9473684210526315,1.0,1.0,3/9,22.89%,AKAP5;NOS1;PARK7
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),0.3025210084033614,0.5404298226036032,0.9534883720930233,0.996932800843348,1.0,7/7,69.76%,JAK1;STAT5B;SHC1;JAK3;STAT5A;PTK2B;SYK
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),0.3025210084033614,0.5404298226036032,0.9534883720930233,0.996932800843348,1.0,7/7,69.76%,JAK1;STAT5B;SHC1;JAK3;STAT5A;PTK2B;SYK
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),-0.27948132106508955,-0.54024690856816,0.9857142857142858,1.0,1.0,7/17,29.06%,ATP5IF1;ABCG2;UROD;TSPO;ALAD;PGRMC1;NFE2L1
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),0.3507076587458483,0.5393285462121153,0.8837209302325582,0.9969960593280445,1.0,1/5,7.34%,AKT1
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),-0.3338393251492556,-0.5387094664886256,1.0,1.0,1.0,2/6,21.04%,AP4M1;PDZD11
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.2686999987841516,-0.5382154823427919,0.971830985915493,1.0,1.0,2/25,18.07%,PRDM7;RAD51AP1
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.30318182527993065,-0.5381144515030227,0.9836065573770492,1.0,1.0,1/10,14.27%,APOE
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.2716617282379388,-0.5372930563706798,0.9571428571428572,1.0,1.0,3/16,17.76%,BRCA1;CTR9;SNW1
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),-0.25288158081440976,-0.5371398752536685,1.0,1.0,1.0,10/38,27.13%,SQLE;DHCR7;ALOX12;TM7SF2;MSMO1;PARK7;INSIG1;HMGCR;ACOT8;ACOX2
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),-0.28054119418262674,-0.5366043082021154,1.0,1.0,1.0,4/18,19.98%,PLN;CAV3;NOS1;WNK4
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),0.2781761313520569,0.5358628777332359,1.0,0.9978198038509969,1.0,1/10,7.36%,KCNH2
prerank,GO_Biological_Process_2021__iron import into cell (GO:0033212),-0.33578367011541244,-0.5345955645732243,0.9574468085106383,1.0,1.0,3/5,35.30%,TFR2;SLC39A14;SLC11A2
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.2574197746867214,0.5345000294827683,1.0,0.9979770551299889,1.0,3/14,18.41%,GMPS;ATIC;LHPP
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.26681315892835605,-0.5341507922146124,0.96875,1.0,1.0,7/24,23.82%,PRKCQ;CCL2;PTPN22;SPINK5;HLA-DPB1;HSPD1;PRELID1
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.23881342049421161,-0.5334326253638703,0.9705882352941176,1.0,1.0,2/29,10.72%,ATG14;VAMP8
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.23457509848411262,0.5333480577787468,1.0,0.9980281557364171,1.0,6/25,17.45%,SMAD2;SMAD7;SMAD4;BCL9;LATS1;ZNF703
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.3150015262350607,0.5331491291259187,0.9787234042553191,0.9978200574609314,1.0,2/6,21.60%,TICAM1;CAMK4
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),0.3399338025432523,0.5326069155411561,0.9473684210526315,0.9977121879647254,1.0,2/5,19.69%,ROCK2;ROCK1
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),0.2296434857702091,0.5325818766788196,1.0,0.9974101255402734,1.0,2/24,7.36%,ANK2;KCNH2
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),0.2518250562687413,0.5320450517341185,0.9696969696969697,0.9972789060845708,1.0,3/15,21.74%,PIGX;PIGP;PIGQ
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),-0.3161447342025926,-0.5316928819652891,0.9333333333333333,1.0,1.0,3/8,34.08%,CLN3;TMEM9;ATP6AP2
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),-0.32768875083509647,-0.530977603020395,0.9444444444444444,1.0,1.0,2/5,23.44%,ENO1;NOL3
prerank,GO_Biological_Process_2021__lipid transport across blood-brain barrier (GO:1990379),0.31256327191739225,0.5303217072813406,0.975609756097561,0.9973948541866146,1.0,5/5,68.75%,SLC27A1;MFSD2A;SLC27A4;FABP5;CD36
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),0.23591243945169624,0.529514575183337,1.0,0.997310768906485,1.0,3/20,22.24%,GPHN;FDXR;SCP2
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),-0.29606310745922443,-0.5295128423646206,1.0,1.0,1.0,3/19,18.44%,AQP1;LAMB1;TUFT1
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),0.23514300040371477,0.5291587418555459,0.96,0.997079747147296,1.0,6/24,24.95%,PGAP1;PIGP;PGAP4;PIGQ;PIGU;DPM1
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),-0.2299785472342164,-0.5278694579895963,1.0,1.0,1.0,6/25,29.00%,PSME1;ID2;GLI1;DDRGK1;PSME3;PHB2
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),0.2652546053744722,0.5278207814027217,0.9583333333333334,0.9972191611658212,1.0,3/12,18.27%,EIF2AK4;IMPACT;NFE2L2
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),-0.31213933312312037,-0.5276973286977357,0.9696969696969697,1.0,1.0,2/9,15.02%,CLU;CXCR4
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),-0.22428222917919696,-0.5273512335463326,1.0,1.0,1.0,7/55,18.42%,KCNJ13;SLC8A3;KCNJ8;SLC9A2;ATP12A;SLC24A1;SLC9A7
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),0.30977573026881994,0.5265928518613182,0.9666666666666667,0.997205716490143,1.0,8/8,69.03%,GSN;HIPK1;BMPR2;DAB2IP;RYR2;CAPN10;COL4A3;SIX3
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.2432911154530205,-0.5265791528086526,1.0,1.0,1.0,6/42,25.50%,SNRPD2;SNRNP200;DDX23;NOL3;SRSF5;PRPF6
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),0.3220025318316814,0.5262744509803442,0.9347826086956522,0.9970219291695864,1.0,3/5,24.61%,CDK9;WDR70;RNF20
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),-0.31117459690374083,-0.5262710659817349,1.0,1.0,1.0,2/8,23.38%,CHI3L2;GNPDA1
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),-0.3402119526699269,-0.526064576070591,0.9701492537313433,1.0,1.0,2/5,17.62%,ZFPM1;HEY2
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),0.2822791127350511,0.5255746860593655,0.9565217391304348,0.9968852319876041,1.0,2/6,22.17%,SMAD4;DCHS1
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.3026375740393864,-0.5252475356991674,0.9607843137254902,1.0,1.0,8/8,69.75%,JUP;VCL;THBS4;KIFC3;KIT;PLEKHA7;ITGB5;CAMSAP3
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),-0.32122964585879554,-0.5238504658185346,0.9830508474576272,1.0,1.0,3/7,29.00%,ANTKMT;DNAJC30;PHB2
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),-0.3038816317125898,-0.5237897126763814,1.0,1.0,1.0,3/9,24.70%,TBX5;GPER1;TGFB1
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),0.25509597784609084,0.523596372687357,1.0,0.9971830430273976,1.0,8/18,28.01%,MAP3K4;MAPKAPK5;MAPK1;HNRNPD;TNKS2;TNKS;MAPK3;USP7
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),-0.29170744032512186,-0.5225509811092591,1.0,1.0,1.0,2/12,16.74%,CASP8;RIPK2
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),-0.3193252071043413,-0.522433781436004,1.0,1.0,1.0,1/7,9.53%,STAC3
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),-0.3311681867457029,-0.5218695695502668,1.0,1.0,1.0,3/8,34.61%,DSCC1;RFC5;CHTF18
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),-0.3311681867457029,-0.5218695695502668,1.0,1.0,1.0,3/8,34.61%,DSCC1;RFC5;CHTF18
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),0.24465462557139067,0.521754232576506,0.972972972972973,0.9973574285338977,1.0,1/13,6.40%,ATP2C1
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),-0.3158412238708736,-0.5197864838559733,0.9830508474576272,1.0,1.0,2/7,24.70%,CST3;TGFB1
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),-0.3256049407714893,-0.5187062349235279,1.0,1.0,1.0,7/7,67.46%,FBN2;KDM2B;RARG;LRP6;TBX2;FBN1;EFEMP1
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),0.24113013957667911,0.518448603413431,0.9714285714285714,0.9980421442638996,1.0,2/20,10.92%,UQCRHL;SDHC
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.2522030981022196,-0.5184267959743921,0.9830508474576272,1.0,1.0,5/11,30.85%,GPER1;KLK6;C3;SLC39A14;ACP3
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),-0.2938897267060366,-0.5182691715793287,0.953125,1.0,1.0,1/6,23.38%,GNPDA1
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),0.29144286415648324,0.5179915711575448,0.972972972972973,0.997852516528428,1.0,2/10,17.57%,DPYSL4;DPYSL5
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),-0.2835672680380137,-0.5171280811629501,1.0,1.0,1.0,1/14,7.00%,SEMA5A
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.2808940327461937,0.5163322722381275,0.8717948717948718,0.9980558600540299,1.0,1/7,19.38%,LIN28B
prerank,GO_Biological_Process_2021__gap junction assembly (GO:0016264),0.3073077057900799,0.5153100434397325,0.9523809523809523,0.9979953014152341,1.0,2/5,29.34%,GJB6;GJA1
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),0.28089912229103287,0.5141223572811687,0.9722222222222222,0.9980109592962747,1.0,1/12,6.11%,CBL
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.28101975449091876,-0.5137768998313202,0.9733333333333334,1.0,1.0,2/13,14.59%,PRKCQ;PNKP
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),0.27299288440851155,0.513483579142401,1.0,0.9976498631928334,1.0,2/8,17.09%,ARHGEF10L;INSIG2
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),0.27299288440851155,0.513483579142401,1.0,0.9976498631928334,1.0,2/8,17.09%,ARHGEF10L;INSIG2
prerank,GO_Biological_Process_2021__dorsal aorta development (GO:0035907),-0.33275762078637855,-0.5132628213799587,0.9666666666666667,1.0,1.0,2/5,20.85%,HEY2;ENG
prerank,GO_Biological_Process_2021__dorsal aorta morphogenesis (GO:0035912),-0.33275762078637855,-0.5132628213799587,0.9666666666666667,1.0,1.0,2/5,20.85%,HEY2;ENG
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),-0.3153125790939003,-0.5131651996816919,0.9857142857142858,1.0,1.0,6/6,68.48%,SCARA3;XPA;GPX1;SDF4;ERCC2;CAT
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.2846478054363628,0.5126332476598757,1.0,0.9976012091610719,1.0,3/10,26.33%,CLASP1;CLASP2;POGLUT1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),-0.31876841236409414,-0.5123038873491694,0.9818181818181818,1.0,1.0,2/6,24.89%,CAV3;RANGRF
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),0.26653760139362087,0.5122849694484505,1.0,0.9974004078436335,1.0,4/11,25.65%,KCNH2;KCNE4;KCNIP2;KCNE2
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.28617163677113394,0.5121645750879246,0.9705882352941176,0.9971470667260697,1.0,4/8,35.22%,GALNT1;GALNT2;GALNTL6;GALNT11
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),-0.33427819396638997,-0.511814359928508,0.9454545454545454,1.0,1.0,5/5,66.59%,ITGB1BP1;KCNE1;INPP5K;GDI1;DMTN
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),0.30265755504935443,0.5104058299349861,0.9523809523809523,0.9972506928837315,1.0,6/6,69.74%,AGO2;SYDE1;ACVR1B;SMURF2;VEGFA;C1QBP
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),0.29582520653418554,0.5103865457206788,0.9473684210526315,0.9969683108566438,1.0,1/7,17.47%,SLC6A6
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.2776247817137312,0.5098530454225859,0.9722222222222222,0.996861475820604,1.0,3/10,15.87%,NF1;STIM1;MAPK8
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),0.26911307941139273,0.5097285897046281,0.967741935483871,0.9965969129801514,1.0,4/14,18.48%,MBP;MAP2K5;BMP7;WNK1
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),-0.27770426364697376,-0.5096062503839065,1.0,1.0,1.0,3/10,27.09%,ATP23;AFG3L2;SPG7
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.2739364584048123,-0.50957609055378,1.0,1.0,1.0,4/13,25.74%,FICD;COPS5;DNAJB9;DDRGK1
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),-0.2232441956814153,-0.5088405780098736,1.0,1.0,1.0,5/31,22.37%,ATP10B;SNAPIN;GNPTAB;CLN3;TPP1
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),-0.28536708860759497,-0.508234559662348,0.9873417721518988,1.0,1.0,11/11,71.48%,IDH2;GOT1;GPT2;AADAT;PHYH;IDH1;L2HGDH;DLST;GOT2;OGDH;D2HGDH
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.24718430605017738,-0.50813179418118,1.0,1.0,1.0,4/26,14.55%,PSMC3;ATP5IF1;CAV3;CLU
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),-0.3339309910015339,-0.5078470531019743,0.9692307692307692,1.0,1.0,2/5,25.67%,CD74;SLA2
prerank,GO_Biological_Process_2021__negative regulation of nervous system process (GO:0031645),-0.3266739287152911,-0.507749033843357,0.9508196721311475,1.0,1.0,2/5,19.96%,GLRA1;TNFRSF21
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.30655778909119424,0.5075338190168505,0.9767441860465116,0.9967473190426493,1.0,2/7,17.32%,CAMK2D;PDE4D
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),0.26073053621193,0.5066909887192383,1.0,0.9966640092195901,1.0,4/9,30.74%,DCLRE1C;DCLRE1A;TERF2IP;TERF2
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),-0.2503519332804448,-0.5052400082191232,1.0,1.0,1.0,4/23,16.40%,FGF1;MT3;WNT5A;IL18
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),-0.2403695492184465,-0.5011528253132514,1.0,1.0,1.0,7/30,25.13%,TPPP3;PLEKHG2;PFN1;ARHGAP28;PFN2;COTL1;HAX1
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),0.2470886075949366,0.5002078904792471,1.0,0.9979003372539493,1.0,11/11,75.30%,BIN3;WHAMM;PACSIN1;FNBP1L;SNX33;SNX9;PACSIN2;MICALL1;BIN2;PACSIN3;EHD2
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),-0.30937091956034823,-0.4992526267075605,0.9655172413793104,1.0,1.0,1/5,14.32%,SPI1
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),0.2953476403051057,0.49922467061006476,0.9736842105263158,0.9977875456476637,1.0,2/5,21.52%,SLC39A12;SLC39A8
prerank,GO_Biological_Process_2021__retinal cone cell development (GO:0046549),0.32187310658321755,0.4989461102367405,0.9705882352941176,0.9972704840480592,1.0,2/5,29.91%,RORB;RP1
prerank,GO_Biological_Process_2021__retinal cone cell differentiation (GO:0042670),0.32187310658321755,0.4989461102367405,0.9705882352941176,0.9972704840480592,1.0,2/5,29.91%,RORB;RP1
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.22883175867495592,-0.4976717221202545,1.0,1.0,1.0,5/32,20.92%,WEE1;CCL2;PLK3;KLF4;PRMT2
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),0.2776668053850809,0.49741406385150444,0.95,0.9973562667349004,1.0,5/8,27.79%,UBQLN1;UBQLN2;NFE2L2;USP14;SGTA
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),-0.2990876509190682,-0.49689453389493443,0.9473684210526315,1.0,1.0,2/7,28.25%,PCK2;MMAA
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.24458906189557691,-0.49659530077105246,1.0,1.0,1.0,7/23,24.70%,SRF;SPI1;GNL3;KLF4;FOS;APLN;TGFB1
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),-0.25924477313406413,-0.49558202321017675,1.0,1.0,1.0,1/13,12.81%,BLM
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),-0.23099988112276895,-0.49514587110129427,1.0,1.0,1.0,8/32,25.71%,NLRP1;CASP8;WNT5A;RIPK2;USP50;AIM2;S100A13;NLRP2
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),-0.329081245254366,-0.49413215075432443,0.9696969696969697,1.0,1.0,6/6,67.11%,CELSR1;VANGL2;FUZ;NPHP1;BRSK2;BRSK1
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),0.27645033917181355,0.4939359016180422,1.0,0.9977684852699816,1.0,7/7,72.36%,PRKCA;DEF8;ATP6AP1;PLEKHM1;SPP1;SYK;ADAM8
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),-0.2620759128220983,-0.49272501338378605,1.0,1.0,1.0,5/14,24.70%,HES1;CXCR4;ID2;IL34;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),0.24896202531645562,0.4904188889146339,0.972972972972973,0.9982095985845268,1.0,11/11,75.12%,TM9SF4;TMEM35A;ABCA7;STX4;SNX33;MAP1A;HSP90AB1;GPD1L;STX3;RIC3;RANGRF
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),0.25635814883431707,0.48892809293911466,0.926829268292683,0.998213449823238,1.0,2/8,24.29%,TGFBR2;KITLG
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),0.24705048356878834,0.488378312190795,1.0,0.997972653356162,1.0,12/12,75.31%,TFRC;KMT5B;TP53BP1;HMCES;RIF1;CD40;SHLD2;KMT5C;PAXIP1;SHLD1;MAD2L2;TGFB1
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.25528802671309275,-0.4880913384556143,1.0,1.0,1.0,1/16,9.23%,RDX
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.25167645853284354,0.4876432243161466,0.9736842105263158,0.9978018788729744,1.0,2/9,19.33%,CAAP1;FAS
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),0.2537402035166183,0.4867168963494812,1.0,0.9977010634796774,1.0,4/13,25.65%,KCNH2;KCNE4;KCNIP2;KCNE2
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),0.2614334249348476,0.4859158142112684,0.9761904761904762,0.9975595708163655,1.0,2/8,21.32%,CRAT;PCCA
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.21694434597660403,0.4857201701727895,1.0,0.9972901686172467,1.0,14/14,78.32%,GSK3B;PICK1;ABCD2;ABCD1;PRNP;MAP1A;INSR;PSEN1;LGMN;CHRNA7;ARF1;APP;PLS1;DCTN1
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),-0.32240320539563716,-0.4850235016004365,0.9830508474576272,1.0,1.0,1/5,13.82%,KCNQ1
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),-0.316410204494837,-0.4842759300719841,0.9836065573770492,1.0,1.0,5/5,68.37%,EXOSC8;EXOSC7;EXOSC10;EXOSC2;EXOSC9
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),-0.316410204494837,-0.4842759300719841,0.9836065573770492,1.0,1.0,5/5,68.37%,EXOSC8;EXOSC7;EXOSC10;EXOSC2;EXOSC9
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),-0.316410204494837,-0.4842759300719841,0.9836065573770492,1.0,1.0,5/5,68.37%,EXOSC8;EXOSC7;EXOSC10;EXOSC2;EXOSC9
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),-0.316410204494837,-0.4842759300719841,0.9836065573770492,1.0,1.0,5/5,68.37%,EXOSC8;EXOSC7;EXOSC10;EXOSC2;EXOSC9
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),-0.22511282228786644,-0.48427019466546817,1.0,1.0,1.0,1/32,3.13%,RPL11
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),-0.3074851802904183,-0.48395796816554687,0.9666666666666667,1.0,1.0,3/6,25.72%,EHD2;FLOT1;EHD1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),0.25813945737449717,0.4829132018286221,1.0,0.9974862218611998,1.0,1/8,14.63%,AP1G1
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),0.29423972464061565,0.4827025550521239,0.9555555555555556,0.9971995594050644,1.0,5/5,70.58%,SFSWAP;PRPF39;PSIP1;SRSF12;SNRPC
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),-0.29566407799088357,-0.4823254890803881,1.0,1.0,1.0,2/8,27.17%,NOS1;PAH
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),0.2574508016014281,0.48175278898224255,0.9459459459459459,0.9970874493713757,1.0,5/11,32.88%,SLC29A1;GLUL;SLC22A2;SLC22A3;ATP1A2
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.24214656242736599,-0.47982801586557633,0.96875,1.0,1.0,2/14,14.67%,FES;CDK5
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),0.2860035434067324,0.47912845277803867,1.0,0.9972891983845418,1.0,6/6,71.41%,RHOU;CDC42;RHOJ;WAS;NTN1;SHTN1
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),-0.28286556213456115,-0.47804032536059954,0.9824561403508771,1.0,1.0,1/7,14.70%,BEX4
prerank,GO_Biological_Process_2021__protein localization to site of double-strand break (GO:1990166),-0.33463113971459096,-0.47736411625332664,0.9642857142857143,1.0,1.0,1/5,20.97%,IFFO1
prerank,GO_Biological_Process_2021__vitamin K metabolic process (GO:0042373),-0.2724879777271577,-0.4767075867577778,1.0,1.0,1.0,6/6,72.76%,CYP4F3;CBR1;VKORC1L1;CYP4F11;UBIAD1;CYP4F12
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),-0.28537560595983047,-0.47462916973917857,0.9803921568627451,1.0,1.0,2/8,19.49%,CX3CL1;SPHK1
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),0.282100297593462,0.4741856020417702,1.0,0.9979032819914672,1.0,3/5,33.59%,ATP2B4;DMD;SNTA1
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),0.25,0.47297451208028746,1.0,0.9978317146690752,1.0,9/9,75.01%,SLC2A10;AGO2;BACE2;ABCA7;JAK3;ITM2A;ITM2B;ITM2C;ACOT8
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),-0.2770486346851802,-0.4727722787916728,0.9821428571428571,1.0,1.0,4/11,25.81%,FAM161A;PARK7;KAT5;CAMK1
prerank,GO_Biological_Process_2021__sensory perception of taste (GO:0050909),0.27864177254424705,0.47233606208623524,0.975609756097561,0.9976382691636209,1.0,1/6,16.41%,ASIC3
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),-0.25861660350135895,-0.4716988472757069,0.984375,1.0,1.0,1/15,9.65%,POP5
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),-0.23236964942546723,-0.4703994588103047,1.0,1.0,1.0,1/23,6.67%,THBS1
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),-0.21630783680304205,-0.4701910858482145,0.9855072463768116,1.0,1.0,2/27,14.60%,M6PR;AP4M1
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),-0.31271107613250804,-0.47014072631256165,0.953125,1.0,1.0,1/5,21.68%,PDCD7
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),-0.2943201376936317,-0.4699617650385109,1.0,1.0,1.0,7/7,70.58%,DHODH;CTPS1;AK5;UMPS;CTPS2;CMPK1;CAD
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.2618385758300521,-0.46871907313489536,0.9855072463768116,1.0,1.0,4/9,25.81%,EHD2;FLOT1;EHD1;CAMK1
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),-0.2761504493574394,-0.4684840782608596,1.0,1.0,1.0,1/9,11.27%,AKAP5
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),-0.2761504493574394,-0.4684840782608596,1.0,1.0,1.0,1/9,11.27%,AKAP5
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",-0.31368627278435973,-0.4681037554085114,0.9777777777777777,1.0,1.0,1/6,15.88%,CD274
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.21206512133960556,-0.4676716039138239,1.0,1.0,1.0,4/31,20.84%,MTIF3;KIF9;PLK3;UFC1
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),-0.23551255889538159,-0.46750080828387264,1.0,1.0,1.0,7/19,29.06%,ATP5IF1;ABCG2;UROD;TSPO;ALAD;PGRMC1;NFE2L1
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),0.20841561598055597,0.46537530045417264,1.0,0.9985825280785839,1.0,12/12,79.17%,ATG2B;RB1CC1;UFM1;UBA5;ULK1;ATG2A;ULK2;TEX264;UFL1;RETREG1;DDRGK1;UFC1
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),0.2589676220324993,0.46532172092383417,1.0,0.9982845326956896,1.0,1/8,18.27%,NFE2L2
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),0.2762352740510381,0.46525989063935724,1.0,0.9979983162386041,1.0,2/6,20.26%,GSTM2;CRYZ
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),-0.2988104277398127,-0.464253573874544,0.984375,1.0,1.0,6/6,70.13%,AEBP1;EMILIN1;CHADL;EFEMP2;RB1;COLGALT1
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),0.2725457956543704,0.46384675228719024,0.9591836734693877,0.9979790167840367,1.0,1/7,21.93%,NUFIP1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),0.2754383588042236,0.4618528610027581,1.0,0.9979655259410322,1.0,2/7,18.48%,WNK3;WNK1
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),-0.3052876943971429,-0.46080751408116166,0.9850746268656716,1.0,1.0,1/5,16.64%,SLC4A11
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),-0.28377625917489246,-0.4589676502441909,0.9836065573770492,1.0,1.0,6/6,71.64%,ITM2C;ITM2B;ITM2A;ABCA7;BACE2;AGO2
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),0.2955298930628051,0.45866921254370774,1.0,0.9981838581539385,1.0,1/5,17.81%,BCL10
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),0.261783020300714,0.45837798644572547,0.9722222222222222,0.9979675366168883,1.0,8/8,73.83%,GSTO2;SLC2A1;SLC23A2;SLC2A3;CYB5A;CYB5R3;RGN;GSTO1
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),0.24809228585463117,0.45802573201176927,1.0,0.99771080049931,1.0,3/8,27.78%,ATPSCKMT;XRCC4;GCLM
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.2640281100761408,0.45547183768922994,0.96875,0.9977147761936712,1.0,5/9,30.35%,ANTXR2;ADAM10;SLC22A2;RAB40B;SLC22A3
prerank,GO_Biological_Process_2021__T-helper 1 type immune response (GO:0042088),-0.27820487938695526,-0.455391186515836,1.0,1.0,1.0,2/6,21.48%,IL18;IL18BP
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),0.2376777614768057,0.4545456108593381,1.0,0.9975508837739245,1.0,2/9,17.34%,SLC4A4;ATP1A4
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),-0.29429034217452926,-0.4526331192296659,0.9811320754716981,1.0,1.0,5/5,70.58%,DHODH;CTPS1;UMPS;CTPS2;CAD
prerank,GO_Biological_Process_2021__regulation of neutrophil extravasation (GO:2000389),-0.28477424579874466,-0.452352229593838,1.0,1.0,1.0,5/5,71.53%,ADAM8;CD99;XG;MDK;RIPOR2
prerank,GO_Biological_Process_2021__positive regulation of neutrophil extravasation (GO:2000391),-0.28477424579874466,-0.452352229593838,1.0,1.0,1.0,5/5,71.53%,ADAM8;CD99;XG;MDK;RIPOR2
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),-0.22370974617196074,-0.4522261170068382,1.0,1.0,1.0,6/23,29.59%,PPIB;OGFOD1;NTMT1;FKBP7;P3H2;PPIL1
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.24715051553739015,-0.4509150808354748,0.9852941176470589,1.0,1.0,2/16,20.38%,DOLK;DHDDS
prerank,GO_Biological_Process_2021__heart process (GO:0003015),-0.2574549090150419,-0.4502865308764663,0.9850746268656716,1.0,1.0,2/10,21.09%,RAMP3;TRDN
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),-0.22003936175721037,-0.4485689632319949,1.0,1.0,1.0,1/16,14.07%,BRD8
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),-0.2715399412777159,-0.4469827615448075,1.0,1.0,1.0,7/7,72.86%,MYL5;PVALEF;TPM1;ATP1A2;PPP1R12B;ANXA6;SRI
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),-0.29117725483264995,-0.4465307758708206,1.0,1.0,1.0,1/6,15.19%,PRPS1
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),0.2449132082416301,0.4463364064448451,1.0,0.9983071823613648,1.0,3/11,23.19%,FBXW7;TMEM178A;GPR137B
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),-0.28114401417362694,-0.4436989306086472,1.0,1.0,1.0,6/6,71.90%,FKBP7;FKBP10;METAP2;TTLL4;METAP1;METAP1D
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),-0.2732178760623306,-0.44167675932095446,1.0,1.0,1.0,2/7,25.87%,COL4A2;ITGA2
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),-0.2694872111333664,-0.44154264397539195,0.9841269841269841,1.0,1.0,1/7,17.92%,SPINK5
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),-0.2491519416738393,-0.44140113909396844,1.0,1.0,1.0,10/10,75.10%,HADHA;PLA2G4A;PLA2G5;PNPLA8;PLA2G6;PGS1;LCLAT1;HADHB;SLC27A1;TAMM41
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell proliferation (GO:1902033),-0.2835377071333243,-0.4406036227214893,0.9824561403508771,1.0,1.0,2/5,24.14%,EIF2AK2;THPO
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),0.23822454612529828,0.439873495761149,1.0,0.9988547698417,1.0,1/9,18.27%,NFE2L2
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),-0.22633744244312337,-0.4369275312673312,1.0,1.0,1.0,5/16,29.80%,ROMO1;GRPEL1;TIMM44;TIMM17B;TIMM21
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.24244897798756102,-0.43203283827326994,1.0,1.0,1.0,3/12,26.34%,PARP2;PARP12;PARP10
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),0.2721650540232098,0.4312812346686193,1.0,0.9996044473799093,1.0,1/5,16.54%,NECTIN2
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),0.2569881091713079,0.43062693683105996,1.0,0.9993881536934487,1.0,1/5,16.54%,NECTIN2
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.22353264170488663,-0.4297148341520412,1.0,1.0,1.0,1/16,11.26%,SFRP1
prerank,GO_Biological_Process_2021__regulation of transmission of nerve impulse (GO:0051969),0.25865759882370526,0.4290193887820863,0.9767441860465116,0.9992471269162968,1.0,2/5,20.95%,HCRT;FMR1
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),0.2357229647630621,0.42867500967322164,1.0,0.9986938322448987,1.0,9/9,76.44%,NSMAF;SPHK2;PLA2G6;SMPD2;TNFRSF1A;SMPD3;PRKCD;RACK1;SIRT3
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),0.2357229647630621,0.42867500967322164,1.0,0.9986938322448987,1.0,9/9,76.44%,NSMAF;SPHK2;PLA2G6;SMPD2;TNFRSF1A;SMPD3;PRKCD;RACK1;SIRT3
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),0.24949686033728874,0.4286304525463582,1.0,0.9984087693213168,1.0,1/6,17.46%,APBA1
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.24661819019322173,0.42684666418641126,1.0,0.9983605689217893,1.0,1/9,11.47%,SEC14L1
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),-0.27765122753733235,-0.4264770780324777,0.984375,1.0,1.0,6/6,72.25%,IL12RB1;STAT4;P4HB;TYK2;STAT3;JAK2
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),0.26324184976373,0.42176234659587913,0.9772727272727273,0.9985663340042397,1.0,3/6,35.09%,FGFR2;TGFB2;EZR
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),-0.2652611719632545,-0.4210719901461217,1.0,1.0,1.0,2/6,25.98%,ATP23;OXA1L
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),-0.24495928726208233,-0.41853617209708954,1.0,1.0,1.0,3/10,21.30%,PRPS1;PPAT;PRPSAP1
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),-0.2346554954621297,-0.41410316491849153,1.0,1.0,1.0,1/7,23.38%,GNPDA1
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),-0.22852714152795656,-0.41361359226694544,1.0,1.0,1.0,2/13,20.85%,HEY2;ENG
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),-0.25749198342091584,-0.4134403075260702,0.967741935483871,1.0,1.0,1/8,14.27%,APOE
prerank,GO_Biological_Process_2021__medium-chain fatty acid biosynthetic process (GO:0051792),0.2457922972586945,0.41184092804865163,0.967741935483871,0.999043147226345,1.0,3/6,29.72%,ABHD2;ACOT7;ABHD3
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),-0.27061264013264147,-0.4013280520881061,1.0,1.0,1.0,1/5,21.19%,MACROH2A2
prerank,GO_Biological_Process_2021__neurotransmitter reuptake (GO:0098810),0.2435263054429762,0.3991888716611542,1.0,0.9997907673705381,1.0,3/6,30.35%,SLC29A1;SLC22A2;SLC22A3
prerank,GO_Biological_Process_2021__isoleucine metabolic process (GO:0006549),-0.2535935933638811,-0.3991530009751209,1.0,1.0,1.0,2/5,29.21%,SDS;SDSL
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),-0.2523234890998872,-0.39623565265816607,1.0,0.9999381925362608,1.0,4/5,35.15%,DNAJB9;DDRGK1;HSPA5;UFL1
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),0.20857591251961743,0.3908523706349205,1.0,0.9998633036178874,1.0,8/8,79.15%,NEU3;MAN2C1;MANBA;MAN2B1;NEU4;MAN2B2;GBA3;NEU1
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),0.23806005375280817,0.39024083087645484,1.0,0.9996014588512157,1.0,4/5,34.87%,FAM120B;RXRA;ACTN4;PPARG
prerank,GO_Biological_Process_2021__regulation of cellular response to osmotic stress (GO:0106049),0.23373323760258197,0.3806209541633626,1.0,0.9997028219086974,1.0,2/5,28.03%,LETM1;EFHD1
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),0.24149625430249042,0.37266304472521616,1.0,0.9995967277336099,1.0,5/5,75.86%,SLC6A9;SLC6A17;SLC25A38;SLC7A8;SLC36A1
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.2132442284325638,-0.36730844302422694,1.0,1.0,1.0,9/9,78.69%,PDZD11;BTD;MCCC2;MCCC1;PCCB;HLCS;PC;SLC5A6;PCCA
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),-0.22135350368920384,-0.36216003164877864,1.0,0.9997678403626112,1.0,2/7,28.62%,AGBL5;AGBL3
